<graphml xmlns="http://graphml.graphdrawing.org/xmlns" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://graphml.graphdrawing.org/xmlns http://graphml.graphdrawing.org/xmlns/1.0/graphml.xsd">
  <graph edgedefault="undirected">
    <node id="DISCRETE CHOICE EXPERIMENTS" />
    <node id="SWING WEIGHTING WITH DIRECT RATING" />
    <node id="ITALY" />
    <node id="BELGIUM" />
    <node id="COHEN'S WEIGHTED KAPPA" />
    <node id="DIRICHLET REGRESSION" />
    <node id="NORTH CAROLINA" />
    <node id="CANCER INFORMATION AND POPULATION HEALTH RESOURCE" />
    <node id="AREA HEALTH EDUCATION CENTER" />
    <node id="TREATMENT DELAY" />
    <node id="BLACK PATIENTS" />
    <node id="NON-BLACK PATIENTS" />
    <node id="AMERICAN SOCIETY OF CLINICAL ONCOLOGY" />
    <node id="ACADEMIC ONCOLOGY" />
    <node id="INDUSTRY" />
    <node id="UNITED STATES" />
    <node id="SURVEY" />
    <node id="COLLABORATIVE RELATIONSHIPS" />
    <node id="MENTORSHIP" />
    <node id="PHARMACEUTICAL COMPANIES" />
    <node id="BIOTECHNOLOGY COMPANIES" />
    <node id="OMIC COMPANIES" />
    <node id="MEDICAL DEVICE COMPANIES" />
    <node id="US NATIONAL LUNG SCREENING TRIAL" />
    <node id="DUTCH-BELGIAN NELSON" />
    <node id="ITALUNG" />
    <node id="COSMOS" />
    <node id="BIOLOGICAL EFFECTS OF IONIZING RADIATION, REPORT VII" />
    <node id="UNITED STATES PREVENTIVE SERVICES TASK FORCE" />
    <node id="AMERICAN CANCER SOCIETY" />
    <node id="ATHENS" />
    <node id="GREECE" />
    <node id="PWUD" />
    <node id="FOCUS GROUP DISCUSSIONS" />
    <node id="TELEHEALTH" />
    <node id="INTERNET" />
    <node id="POLICYMAKERS" />
    <node id="NATIONAL CANCER INSTITUTE" />
    <node id="BASAL CELL CARCINOMAS" />
    <node id="CUTANEOUS SQUAMOUS CELL CARCINOMAS" />
    <node id="PARKINSON'S DISEASE" />
    <node id="ARTIFICIAL INTELLIGENCE" />
    <node id="CONVOLUTIONAL NEURAL NETWORKS" />
    <node id="RANDOM FOREST" />
    <node id="LOGISTIC REGRESSION" />
    <node id="SUPPORT VECTOR MACHINE" />
    <node id="EXTREME BOOT CLASSIFIER" />
    <node id="VOTING CLASSIFIER" />
    <node id="COVID-19" />
    <node id="NATURAL LANGUAGE PROCESSING" />
    <node id="PUBLIC HEALTH RESEARCH" />
    <node id="INTEGRASE STRAND TRANSFER INHIBITOR (INSTI)" />
    <node id="US FOOD AND DRUG ADMINISTRATION" />
    <node id="NORTH AMERICAN AIDS COHORT COLLABORATION ON RESEARCH AND DESIGN" />
    <node id="HIV CARE" />
    <node id="RACIAL AND ETHNIC DIFFERENCES" />
    <node id="TREATMENT GUIDELINES" />
    <node id="CLINICAL SITES" />
    <node id="ART" />
    <node id="INTENSIVE CARE UNIT" />
    <node id="ELECTRONIC HEALTH RECORDS" />
    <node id="MACHINE LEARNING MODELS" />
    <node id="KNOWLEDGE GRAPH" />
    <node id="MIMIC-III" />
    <node id="BIOMEDICAL ONTOLOGIES" />
    <node id="PREDICTIVE MODEL" />
    <node id="TL;DR DATASET" />
    <node id="REDDIT" />
    <node id="CNN/DM" />
    <node id="ROUGE" />
    <node id="HUMAN PREFERENCES" />
    <node id="US PREVENTIVE SERVICES TASK FORCE" />
    <node id="DENTAL CARIES" />
    <node id="PERIODONTAL DISEASE" />
    <node id="MEDLINE" />
    <node id="COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS" />
    <node id="COCHRANE DATABASE OF SYSTEMATIC REVIEWS" />
    <node id="SCOPUS" />
    <node id="EVIDENCE SYNTHESIS PROJECT" />
    <node id="OPENALEX" />
    <node id="IMMUNE CHECKPOINT INHIBITORS" />
    <node id="ADVANCED MELANOMA" />
    <node id="CIRCULATING TUMOR DNA" />
    <node id="COHORT A" />
    <node id="COHORT B" />
    <node id="COHORT C" />
    <node id="ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY" />
    <node id="AYAS" />
    <node id="NON-AYAS" />
    <node id="PUBMED" />
    <node id="LEUKEMIA" />
    <node id="BREAST CANCER" />
    <node id="LYMPHOMA" />
    <node id="COLORECTAL CANCER" />
    <node id="CENTRAL NERVOUS SYSTEM CANCER" />
    <node id="MELANOMA" />
    <node id="SARCOMA" />
    <node id="ST. JUDE LIFETIME COHORT STUDY" />
    <node id="ADULT SURVIVORS OF CHILDHOOD CANCER" />
    <node id="NUTRITION GUIDELINES" />
    <node id="NATURALNESS PREFERENCE SCALE" />
    <node id="AMAZON MECHANICAL TURK" />
    <node id="STUDY 1" />
    <node id="STUDY 2" />
    <node id="STUDY 3" />
    <node id="EVSI" />
    <node id="ITS" />
    <node id="DISCRETE SAMPLING METHOD" />
    <node id="INTERPOLATED ITS METHOD" />
    <node id="CORONARY ARTERY CALCIUM SCORE" />
    <node id="MACHINE LEARNING" />
    <node id="PRECISION MEDICINE" />
    <node id="HYPERTENSIVE PATIENTS" />
    <node id="OBSTRUCTIVE CORONARY ARTERY DISEASE" />
    <node id="EXTREME GRADIENT BOOSTING" />
    <node id="CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY" />
    <node id="DUAL-SOURCE COMPUTED TOMOGRAPHY" />
    <node id="XGBOOST" />
    <node id="R" />
    <node id="TIME-INDEPENDENT CSTMS" />
    <node id="COHORT STATE-TRANSITION MODEL" />
    <node id="DECISION MODELS" />
    <node id="PROBABILISTIC SENSITIVITY ANALYSIS" />
    <node id="COST-EFFECTIVENESS ANALYSIS" />
    <node id="CANCER" />
    <node id="RHODE ISLAND" />
    <node id="BREAST AND CERVICAL CANCER SCREENING" />
    <node id="WOMEN OF COLOR" />
    <node id="US" />
    <node id="LATENT TUBERCULOSIS INFECTION" />
    <node id="HEPATOBILIARY CANCER RESEARCH" />
    <node id="IMMUNOTHERAPEUTICS" />
    <node id="CHECKPOINT INHIBITORS" />
    <node id="GERM CELL TUMOR EPIDEMIOLOGY STUDY" />
    <node id="GERM CELL TUMORS (GCTS)" />
    <node id="GENETIC OVERLAP BETWEEN ANOMALIES AND CANCER IN KIDS STUDY" />
    <node id="BIRTH DEFECTS" />
    <node id="SYNDROMIC DEFECTS" />
    <node id="NONSYNDROMIC DEFECTS" />
    <node id="DEEP REINFORCEMENT LEARNING" />
    <node id="SEPSIS" />
    <node id="DEEP INVERSE REINFORCEMENT LEARNING" />
    <node id="MIMIC-III DATASET" />
    <node id="SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS DATABASE" />
    <node id="CANCER DIAGNOSIS" />
    <node id="SUICIDE" />
    <node id="AMERICAN JOINT COMMITTEE ON CANCER" />
    <node id="OUTCOME PREDICTION MODELS" />
    <node id="ALBERTA" />
    <node id="ALBERTA CANCER REGISTRY" />
    <node id="CANADIAN CENSUS" />
    <node id="SOCIOECONOMIC STATUS" />
    <node id="ACORN" />
    <node id="CEFEPIME" />
    <node id="PIPERACILLIN-TAZOBACTAM" />
    <node id="CONSOLIDATED STANDARDS OF REPORTING TRIALS" />
    <node id="PREFERRED REPORTING ITEMS FOR SYSTEMATIC REVIEWS AND META-ANALYSES" />
    <node id="QUALITY OF REPORTING OF META-ANALYSIS" />
    <node id="TRANSPARENT REPORTING OF EVALUATIONS WITH NONRANDOMIZED DESIGNS" />
    <node id="META-ANALYSIS OF OBSERVATIONAL STUDIES IN EPIDEMIOLOGY" />
    <node id="STRENGTHENING THE REPORTING OF OBSERVATIONAL STUDIES IN EPIDEMIOLOGY" />
    <node id="CUMULATIVE INDEX TO NURSING AND ALLIED HEALTH LITERATURE" />
    <node id="WEB OF SCIENCE" />
    <node id="EMBASE" />
    <node id="THIOREDOXIN-INTERACTING PROTEIN" />
    <node id="CALCIUM CHANNEL BLOCKERS" />
    <node id="VERAPAMIL" />
    <node id="TYPE 1 DIABETES" />
    <node id="CLINICAL TRIAL" />
    <node id="ETP-ALL" />
    <node id="TP53" />
    <node id="STEM CELL TRANSPLANTATION" />
    <node id="LMICS" />
    <node id="DEVELOPMENTAL MOTOR DISORDERS REGISTRY SYSTEM" />
    <node id="UNIVERSITY PHYSICAL NETWORK" />
    <node id="ASP.NET FRAMEWORK" />
    <node id="VISUAL STUDIO 2018" />
    <node id="C# PROGRAMMING LANGUAGE" />
    <node id="NET 4.5 TECHNOLOGY PLATFORM" />
    <node id="PEKING UNION MEDICAL COLLEGE HOSPITAL" />
    <node id="RIDGE CLASSIFIER" />
    <node id="ALLGENEIC BLOOD TRANSFUSION" />
    <node id="SHAPLEY ADDITIVE EXPLANATIONS" />
    <node id="AMERICAN SOCIETY OF ANESTHESIOLOGISTS" />
    <node id="HIP SURGERY" />
    <node id="SWEDISH PHYSICIANS" />
    <node id="EVIDENCE-BASED MEDICINE" />
    <node id="SWEDISH NURSES" />
    <node id="SWEDISH OCCUPATIONAL THERAPISTS" />
    <node id="SWEDISH DENTISTS" />
    <node id="SWEDISH DENTAL HYGIENISTS" />
    <node id="KOMFO ANOKYE TEACHING HOSPITAL" />
    <node id="GHANA" />
    <node id="ELECTRONIC HEALTH RECORDS (EHRS)" />
    <node id="KERMAN" />
    <node id="USABILITY EVALUATION" />
    <node id="SHAHID BEHESHTI HOSPITAL" />
    <node id="AFZALIPOUR HOSPITAL" />
    <node id="JOHNS HOPKINS HOSPITALS" />
    <node id="HUMAN PAPILLOMAVIRUS (HPV)" />
    <node id="MOUNT SINAI ICAHN SCHOOL OF MEDICINE" />
    <node id="HPV16" />
    <node id="OROPHARYNGEAL CANCER" />
    <node id="PORTUGUESE ACADEMIC COMMUNITY" />
    <node id="DIGITAL MENTAL HEALTH APPS STUDY" />
    <node id="UNIVERSITY OF PORTO" />
    <node id="PORTO" />
    <node id="DIGITAL MENTAL HEALTH APPS" />
    <node id="RESEARCHERS" />
    <node id="NANCY CARTWRIGHT" />
    <node id="SIMULACRUM ACCOUNT" />
    <node id="ENTITY REALISM" />
    <node id="NATIONAL CENTER FOR HEALTH STATISTICS" />
    <node id="MIDWEST" />
    <node id="APPALACHIA" />
    <node id="SOUTH" />
    <node id="EAST COAST" />
    <node id="SOUTHERN BORDER" />
    <node id="CONGRESSIONAL DISTRICT" />
    <node id="LUNG CANCER" />
    <node id="FEMALE BREAST CANCER" />
    <node id="PROSTATE CANCER" />
    <node id="PROSTATE CANCER SCREENING" />
    <node id="AFRICAN AMERICAN MEN" />
    <node id="NON-HISPANIC WHITE MEN" />
    <node id="BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM" />
    <node id="SYSTEMIC RACISM" />
    <node id="EDUCATION LEVEL" />
    <node id="INCOME" />
    <node id="PROSTATE-SPECIFIC ANTIGEN (PSA) SCREENING" />
    <node id="HEPATITIS C VIRUS" />
    <node id="MEDICAID" />
    <node id="BLACK INDIVIDUALS" />
    <node id="WHITE INDIVIDUALS" />
    <node id="AMERICAN INDIAN/ALASKA NATIVE" />
    <node id="HISPANIC" />
    <node id="MIMIC III" />
    <node id="ASSOCIATION OF ADVANCEMENT OF MEDICAL INSTRUMENTATION" />
    <node id="BRITISH HYPERTENSION SOCIETY" />
    <node id="HPV" />
    <node id="HPV VACCINATION" />
    <node id="CERVICAL CANCER SCREENING" />
    <node id="COLPOSCOPY" />
    <node id="FLORIDA" />
    <node id="MARTINIQUE" />
    <node id="CARIBBEAN BLACKS" />
    <node id="GUADELOUPE" />
    <node id="ENDOMETRIAL CANCER" />
    <node id="NON-HISPANIC BLACKS (NHB)" />
    <node id="NON-HISPANIC WHITES (NHW)" />
    <node id="EPIRRETINAL MEMBRANE" />
    <node id="STYLEGAN2" />
    <node id="HEALTHCARE CENTER" />
    <node id="EFFICIENTNETB0" />
    <node id="EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY" />
    <node id="GERMAN INSTITUTE FOR QUALITY AND EFFICIENCY IN HEALTH CARE" />
    <node id="NORWAY" />
    <node id="CRLM" />
    <node id="LIVER TRANSPLANTATION" />
    <node id="ERASMUS MEDICAL CENTER" />
    <node id="INVASIVE LOBULAR CARCINOMA" />
    <node id="CHEMOTHERAPY" />
    <node id="ADJUVANT ENDOCRINE THERAPY" />
    <node id="INTEGRATIVE THEORETICAL FRAMEWORK" />
    <node id="STUDY" />
    <node id="CHINA" />
    <node id="CAR-BASED IMMUNOTHERAPY" />
    <node id="T CELLS" />
    <node id="NATURAL KILLER CELLS" />
    <node id="MACROPHAGES" />
    <node id="TUMOR ANTIGENS" />
    <node id="IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT" />
    <node id="CLINICAL TRIALS" />
    <node id="DESIGN SCIENCE RESEARCH METHODOLOGY" />
    <node id="FUZZY CLASSIFIER ALGORITHM" />
    <node id="DECISION MODEL AND NOTATION" />
    <node id="EMERGENCY DEPARTMENTS" />
    <node id="HEALTHCARE" />
    <node id="ONCOLOGY DEPARTMENTS" />
    <node id="PSYCHIATRY DEPARTMENTS" />
    <node id="THYMIC EPITHELIAL TUMORS" />
    <node id="IMMUNOTHERAPIES" />
    <node id="IMMUNE CHECKPOINT BLOCKADE" />
    <node id="THYMUS" />
    <node id="SURGERY" />
    <node id="TREATMENT" />
    <node id="CLINICAL STUDIES" />
    <node id="THYMOMA" />
    <node id="THYMIC CARCINOMA" />
    <node id="IMMUNE-RELATED ADVERSE EVENTS" />
    <node id="PARANEOPLASTIC AUTOIMMUNE DISORDERS" />
    <node id="SARCOPENIA" />
    <node id="MULTIPLE MYELOMA" />
    <node id="MACHINE LEARNING-BASED CONVOLUTIONAL NEURAL NETWORK ALGORITHM" />
    <node id="FLUORESCENCE IN SITU HYBRIDIZATION (FISH) CYTOGENETICS" />
    <node id="DEEP LEARNING-BASED SEGMENTATION" />
    <node id="CLINICAL COMPUTED TOMOGRAPHY (CT) IMAGES" />
    <node id="L3 VERTEBRAE" />
    <node id="SKELETAL MUSCLE INDEX" />
    <node id="LORUNDROSTAT" />
    <node id="NCT05001945" />
    <node id="CLINICALTRIALS.GOV" />
    <node id="SCIENTIFIC PRACTICE" />
    <node id="EPISTEMIC ARTIFACTS" />
    <node id="WORKING SCIENTISTS" />
    <node id="SEMANTIC CONCEPTION OF MODELS" />
    <node id="LANGUAGE&#8208;TECHNOLOGICAL ARTIFACT" />
    <node id="PARSER" />
    <node id="HIV" />
    <node id="ACUTE MYOCARDIAL INFARCTION" />
    <node id="CANADA" />
    <node id="ENGLAND" />
    <node id="THE NETHERLANDS" />
    <node id="STEMI" />
    <node id="TAIWAN" />
    <node id="ISRAEL" />
    <node id="NSTEMI" />
    <node id="AUSTRALIAN HEALTHCARE SECTOR" />
    <node id="CYBERSECURITY ATTACKS" />
    <node id="FOCUS GROUP" />
    <node id="IMMUNOSUPPRESSIVE AGENTS" />
    <node id="SYSTEMIC STEROIDS" />
    <node id="ANTI-PROGRAMMED DEATH 1 MONOTHERAPY" />
    <node id="ANTI-CTLA-4 THERAPY" />
    <node id="PRIVATE EQUITY" />
    <node id="US HOSPITALS" />
    <node id="HOSPITAL-ACQUIRED CONDITIONS" />
    <node id="MEDICARE" />
    <node id="CENTERS FOR MEDICARE &amp; MEDICAID SERVICES" />
    <node id="HOSPITALIZATIONS" />
    <node id="CAREGIVERS" />
    <node id="CLINICAL TEAM MEMBERS" />
    <node id="PATIENTS" />
    <node id="CAPACITY INSTRUMENT" />
    <node id="PANCREATECTOMY" />
    <node id="SWEDEN" />
    <node id="SWEDISH NATIONAL MEDICAL BIRTH REGISTER" />
    <node id="SWEDISH CARDIOPULMONARY BIOIMAGE STUDY" />
    <node id="PROGESTERONE RECEPTOR" />
    <node id="ESTROGEN RECEPTOR" />
    <node id="KI67" />
    <node id="ENDOCRINE THERAPY" />
    <node id="LUMINAL BREAST CANCER" />
    <node id="CORE NEEDLE BIOPSIES" />
    <node id="TUMOR GRADE" />
    <node id="NODE STAGE" />
    <node id="EVIDENCE BRIEFS FOR POLICY" />
    <node id="STEP" />
    <node id="EQUATOR NETWORK" />
    <node id="STEP WORKING GROUP" />
    <node id="CORONARY HEART DISEASE RISK-PREDICTION MODEL" />
    <node id="PEOPLE LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS" />
    <node id="ELECTRONIC MEDICAL RECORDS" />
    <node id="LIGHT GRADIENT-BOOSTING MACHINE" />
    <node id="SHAPLEY ADDITIVE EXPLANATION" />
    <node id="SHARED DECISION MAKING (SDM)" />
    <node id="ONCOLOGIST" />
    <node id="OPTION12" />
    <node id="4SDM" />
    <node id="RANDOMIZED CLINICAL TRIAL" />
    <node id="DIABETES MELLITUS" />
    <node id="PEMBROLIZUMAB" />
    <node id="METASTATIC NON-SMALL CELL LUNG CANCER" />
    <node id="NSCLC PATIENTS" />
    <node id="MACCABI HEALTHCARE SERVICES" />
    <node id="TERTIARY CENTER" />
    <node id="VIRTUAL REALITY TO OBSERVE ONCOLOGY DATA MODELS (VROOM)" />
    <node id="VIRTUAL REALITY (VR)" />
    <node id="CLINICIANS" />
    <node id="GENETIC SCIENTISTS" />
    <node id="BIOINFORMATICS" />
    <node id="DATA ANALYSTS" />
    <node id="PLWH" />
    <node id="NIVOLOMAB" />
    <node id="KAPOSI SARCOMA" />
    <node id="CLINICALTRIALS.GOV IDENTIFIER: NCT02408861" />
    <node id="SMILOW CANCER HOSPITAL" />
    <node id="ONCOLOGY HOSPITALISTS" />
    <node id="ONCOLOGISTS" />
    <node id="INPATIENT HOSPICE" />
    <node id="HOSPICE TRANSITIONS" />
    <node id="ADVANCED CANCER" />
    <node id="GOALS OF CARE DISCUSSIONS" />
    <node id="NATIONAL CANCER CONTROL PLANS" />
    <node id="ZIMBABWE" />
    <node id="ZAMBIA" />
    <node id="UGANDA" />
    <node id="PUBLIC HEALTH ADVOCATES" />
    <node id="OBJECTIVES" />
    <node id="METHODS" />
    <node id="INFORMATION SOURCES" />
    <node id="SEARCH" />
    <node id="SELECTION OF SOURCES OF EVIDENCE" />
    <node id="DATA CHARTING PROCESS" />
    <node id="SYNTHESIS OF RESULTS" />
    <node id="DISCUSSION" />
    <node id="LIMITATIONS" />
    <node id="CONCLUSIONS" />
    <node id="AUCKLAND" />
    <node id="NEW ZEALAND" />
    <node id="PUBLIC HOSPITALS IN AUCKLAND" />
    <node id="WORLD HEALTH ORGANIZATION" />
    <node id="SEVERE ACUTE RESPIRATORY INFECTION" />
    <node id="CLINICAL DECISION SUPPORT SYSTEMS (CDSS)" />
    <node id="AI2" />
    <node id="COMMUNITY MENTAL HEALTH CLINIC" />
    <node id="NON-ADHERENCE EVENTS" />
    <node id="FOLLOW-UP" />
    <node id="ELECTRONIC ASTHMA MANAGEMENT SYSTEM" />
    <node id="THEORETICAL DOMAINS FRAMEWORK" />
    <node id="GUIDELINE IMPLEMENTATION WITH DECISION SUPPORT" />
    <node id="TORONTO" />
    <node id="MIRVETUXIMAB" />
    <node id="PLATINUM-RESISTANT OVARIAN CANCER" />
    <node id="POLY(ADP-RIBOSE) POLYMERASE INHIBITOR" />
    <node id="PLATINUM-SENSITIVE OVARIAN CARCINOMA" />
    <node id="CARCINOSARCOMA" />
    <node id="CLEAR CELL CARCINOMA" />
    <node id="MICROSIMULATION MODELS" />
    <node id="HEALTH POLICY" />
    <node id="FAMILIAL HYPERCHOLESTEROLEMIA" />
    <node id="MYOCARDIAL INFARCTION" />
    <node id="STROKE" />
    <node id="MULTIFACTORIAL DYSLIPIDEMIA" />
    <node id="COVID-19 PANDEMIC" />
    <node id="HEALTHCARE ESTABLISHMENT" />
    <node id="COVID INTERFACE TERMINOLOGY (CIT)" />
    <node id="SNOMED CT" />
    <node id="CORONAVIRUS INFECTIOUS DISEASE ONTOLOGY (CIDO)" />
    <node id="MERATIVE MARKETSCAN" />
    <node id="METASTATIC PROSTATE CANCER" />
    <node id="BELANTAMAB MAFODOTIN" />
    <node id="DREAMM-2" />
    <node id="DOCETAXEL" />
    <node id="ABIRATERONE ACETATE" />
    <node id="MICROSIMULATION FRAMEWORK" />
    <node id="DISCRETE-TIME STATE TRANSITION MODEL" />
    <node id="ANTIRETROVIRAL THERAPY (ART)" />
    <node id="SARS-COV-2 PANDEMIC" />
    <node id="MONKEYPOX VIRUS OUTBREAK" />
    <node id="CABOTEGRAVIR" />
    <node id="RILPIVIRINE" />
    <node id="PREDIABETES" />
    <node id="DIABETES" />
    <node id="CARDIOVASCULAR EVENTS" />
    <node id="MORTALITY" />
    <node id="METFORMIN" />
    <node id="LIFESTYLE MODIFICATION" />
    <node id="INTERNATIONAL REGISTRY FOR MEN WITH ADVANCED PROSTATE CANCER (IRONMAN)" />
    <node id="CANCER JOURNAL" />
    <node id="BLACK MEN" />
    <node id="WHITE MEN" />
    <node id="COMPUTATIONAL SCIENCE" />
    <node id="COMPUTER SIMULATIONS" />
    <node id="PHILOSOPHICAL ACCOUNT" />
    <node id="SCIENTIFIC INSTRUMENTS" />
    <node id="EMPIRICISM" />
    <node id="EPISTEMOLOGY" />
    <node id="SELECTIVE REALISM" />
    <node id="SCIENTIFIC METHODS" />
    <node id="COMPUTATIONAL TEMPLATES" />
    <node id="TECHNOLOGY" />
    <node id="DRUG-DRUG SIMILARITY" />
    <node id="JACCARD SIMILARITY MEASURE" />
    <node id="COMPUTATIONAL METHOD" />
    <node id="DRUG THERAPY SIMILARITY" />
    <node id="PATIENT SIMILARITY" />
    <node id="TREATMENT MODALITIES" />
    <node id="CLARKE ET AL." />
    <node id="DEFENSIVE INFORMATION PROCESSING" />
    <node id="BREAST CANCER SCREENING PROGRAMS" />
    <node id="LOGISTIC REGRESSION MODELS" />
    <node id="PUBLIC HEALTH POLICY MAKERS" />
    <node id="MEXICO" />
    <node id="PUBLIC HEALTH LEADERS" />
    <node id="HEALTHCARE PROVIDERS" />
    <node id="IMMIGRANTS" />
    <node id="COLOSENSE" />
    <node id="CRC-PREVENT" />
    <node id="DALIAN" />
    <node id="LIAONING PROVINCE" />
    <node id="ORNITHINE" />
    <node id="PALMITOYLCARNITINE" />
    <node id="PLASMA METABOLITES" />
    <node id="METABOLOMICS" />
    <node id="YOUTH HEALTH REPORT SYSTEM" />
    <node id="YOUTH HEALTH CLINIC" />
    <node id="HEALTHCARE PROFESSIONALS" />
    <node id="YOUTH PARTICIPANTS" />
    <node id="AUTISM SPECTRUM DISORDER" />
    <node id="AUTISM DIAGNOSTIC OBSERVATION SCHEDULE-SECOND EDITION" />
    <node id="AUTISM DIAGNOSTIC INTERVIEW" />
    <node id="EARLY START DENVER MODEL" />
    <node id="RISPERIDONE" />
    <node id="ARIPIPRAZOLE" />
    <node id="CHATGPT" />
    <node id="HEALTH CARE SYSTEM" />
    <node id="MEDICAL ONCOLOGY" />
    <node id="J. NIEHANS" />
    <node id="MODEL-BUILDING ERA" />
    <node id="SIMULATION ERA" />
    <node id="NUCLEAR PHYSICS" />
    <node id="PAINKILLERS STUDY" />
    <node id="PARTICIPANTS" />
    <node id="GRAPHICAL REPRESENTATION" />
    <node id="NUMERICAL REPRESENTATION" />
    <node id="EXPERIMENT" />
    <node id="UNDERGRADUATE STUDENTS" />
    <node id="GRAPH LITERACY" />
    <node id="NUMERACY" />
    <node id="NO CHOICE CONDITION" />
    <node id="CHOICE CONDITION" />
    <node id="TP53-ALTERED MYELODYSPLASTIC SYNDROME" />
    <node id="TP53-ALTERED ACUTE MYELOID LEUKEMIA" />
    <node id="LIVING SYSTEMATIC REVIEW" />
    <node id="TRAINEES" />
    <node id="EXPERIENTIAL EVIDENCE-BASED MEDICINE EDUCATION" />
    <node id="INTERNATIONAL COLLABORATION" />
    <node id="FUDAN TINNITUS RELIEVING SYSTEM" />
    <node id="SHANGHAI" />
    <node id="JIANGSU" />
    <node id="ZHEJIANG" />
    <node id="GUANGDONG" />
    <node id="SHANDONG" />
    <node id="MAY 2018" />
    <node id="BREAST CANCER SURVEILLANCE CONSORTIUM" />
    <node id="SECOND BREAST CANCER" />
    <node id="AMERICAN JOINT COMMISSION ON CANCER" />
    <node id="ER-NEGATIVE BREAST CANCER" />
    <node id="ER-POSITIVE BREAST CANCER" />
    <node id="TECLISTAMAB" />
    <node id="MAJESTEC-1 STUDY" />
    <node id="CLINICAL TRIAL REGISTRATION NCT03145181/NCT04557098" />
    <node id="PNEUMOCYSTIS JIROVECII PNEUMONIA" />
    <node id="RESPIRATORY INFECTIONS" />
    <node id="VIRAL INFECTIONS" />
    <node id="GASTROINTESTINAL INFECTIONS" />
    <node id="MASS SPECTROMETRY" />
    <node id="MACHINE LEARNING TECHNIQUES" />
    <node id="PROSTATE-RELATED DISEASES" />
    <node id="GITHUB" />
    <node id="PROSTATE DATASETS" />
    <node id="SOUTHERN TAIWAN HOSPITAL" />
    <node id="ENSEMBLE LEARNING" />
    <node id="EMERGENCY DEPARTMENT OVERCROWDING" />
    <node id="MULTI-LAYER PERCEPTRON" />
    <node id="BREAST CANCER SURVIVORS" />
    <node id="NONCANCER CONTROLS" />
    <node id="HORVATH" />
    <node id="EXTRINSIC EPIGENETIC AGE (EEA)" />
    <node id="GRIMAGE" />
    <node id="DUNEDIN PACE OF AGING" />
    <node id="EPIGENETIC AGING" />
    <node id="FUNCTIONAL OUTCOMES" />
    <node id="DUTCH CHILDHOOD CANCER SURVIVOR STUDY" />
    <node id="CHILDHOOD CANCER SURVIVORS" />
    <node id="NETHERLANDS" />
    <node id="ROSENBERG SELF-ESTEEM SCALE" />
    <node id="HOSPITAL ANXIETY AND DEPRESSION SCALE" />
    <node id="DISTRESS THERMOMETER" />
    <node id="SELF-RATING SCALE FOR POST-TRAUMATIC STRESS DISORDER" />
    <node id="SHORT FORM-36" />
    <node id="DESMOID TUMORS" />
    <node id="CTNNB1 GENE" />
    <node id="APC GENE" />
    <node id="TIGECYCLINE" />
    <node id="HYPOFIBRINOGENEMIA" />
    <node id="XGBOOST MODEL" />
    <node id="RANDOM SURVIVAL FOREST" />
    <node id="ROC CURVE" />
    <node id="CALIBRATION CURVE" />
    <node id="DECISION CURVE ANALYSIS" />
    <node id="CLINICAL IMPACT CURVE ANALYSIS" />
    <node id="SURVIVAL ANALYSIS" />
    <node id="CORRECTIONAL FACILITIES" />
    <node id="COMMUNITY" />
    <node id="MAGNIFICATION-REFLECTION DYNAMIC" />
    <node id="CORRECTIONAL STAFF" />
    <node id="ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS" />
    <node id="NONPROLIFERATIVE DIABETIC RETINOPATHY" />
    <node id="AFLIBERCEPT" />
    <node id="EARLY TREATMENT DIABETIC RETINOPATHY STUDY" />
    <node id="DIABETIC MACULAR EDEMA" />
    <node id="SHAM" />
    <node id="CLINICAL SITES IN THE US AND CANADA" />
    <node id="ANTIPLATELET TRIALISTS' COLLABORATION" />
    <node id="GIERE" />
    <node id="UNIVERSITY OF CHICAGO PRESS" />
    <node id="CHICAGO" />
    <node id="VON THUNEN" />
    <node id="VON THUNEN'S ECONOMIC MODEL" />
    <node id="ISOLATED STATE" />
    <node id="PAKISTAN" />
    <node id="AYUB MEDICAL HOSPITAL" />
    <node id="WATERBORNE DISEASE POLLUTION STUDY" />
    <node id="GLOBAL BURDEN OF DISEASE STUDY" />
    <node id="TOBACCO USE" />
    <node id="ELISABETH LLOYD" />
    <node id="EVOLUTIONARY BIOLOGY" />
    <node id="FINANCIAL TOXICITY" />
    <node id="CANCER TREATMENT" />
    <node id="SMART WATCHERS" />
    <node id="ELASTIC WATCHERS" />
    <node id="APACHE NIFI" />
    <node id="ELECTRONIC PATIENT RECORD (EPR) FRONT-END" />
    <node id="INTERNET OF THINGS" />
    <node id="LIGHTWEIGHT CRYPTOGRAPHY" />
    <node id="RECTANGLE" />
    <node id="PATIENT DATA" />
    <node id="RASPBERRY PI 3" />
    <node id="BLACK WOMEN" />
    <node id="BREAST CANCER SURVIVORSHIP" />
    <node id="HEALTH CARE PROVIDERS" />
    <node id="FOCUS GROUPS" />
    <node id="GLUCAGON-LIKE PEPTIDE RECEPTOR 1 AGONISTS" />
    <node id="TIRZEPATIDE" />
    <node id="PHENTERMINE-TOPIRAMATE" />
    <node id="NALTREXONE-BUPROPION" />
    <node id="ORLISTAT" />
    <node id="OBESITY" />
    <node id="CARDIOVASCULAR DISEASE" />
    <node id="TYPE 2 DIABETES" />
    <node id="HYPERTENSION" />
    <node id="ACUTE LYMPHOBLASTIC LEUKEMIA" />
    <node id="IKZF3" />
    <node id="MLLT1" />
    <node id="TAF1" />
    <node id="POLR2A" />
    <node id="RAD21" />
    <node id="BOGEN" />
    <node id="WOODWARD" />
    <node id="LEIBOVICH PROGNOSTIC MODEL" />
    <node id="RENAL CELL CARCINOMA" />
    <node id="QUANTUM SPHERICAL FUZZY M-SWARA TECHNIQUE" />
    <node id="ANTIDEPRESSANT DRUGS" />
    <node id="TEHRAN" />
    <node id="TEHRAN LIPID AND GLUCOSE STUDY" />
    <node id="GRADIENT BOOSTING MODEL" />
    <node id="SUPER LEARNER" />
    <node id="COX PROPORTIONAL HAZARD MODEL" />
    <node id="CLINICAL MEDICINE" />
    <node id="DIABETES PREDICTION" />
    <node id="MEDICAL DOMAIN KNOWLEDGE" />
    <node id="ML PIPELINE" />
    <node id="CENTRAL NERVOUS SYSTEM" />
    <node id="HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2" />
    <node id="IMMUNOTHERAPY" />
    <node id="GENOMIC MEDICINE FOR ILL NEONATES AND INFANTS (GEMINI) STUDY" />
    <node id="GENOMIC SEQUENCING" />
    <node id="TARGETED NEONATAL GENE-SEQUENCING TEST" />
    <node id="FRANCE" />
    <node id="NCT04653597" />
    <node id="SURGICAL ONCOLOGY" />
    <node id="BREAST CARE" />
    <node id="SENTINEL LYMPH NODE BIOPSY" />
    <node id="BREAST CONSERVATION" />
    <node id="GENETICS" />
    <node id="FERTILITY" />
    <node id="SURGEONS" />
    <node id="METRICS SYSTEM" />
    <node id="SURVEILLANCE TRACKING SYSTEM" />
    <node id="OHIO" />
    <node id="MEDICAID EXPANSION" />
    <node id="GEORGIA" />
    <node id="ENGLISH NATIONAL HEALTH SERVICE" />
    <node id="RECTAL CANCER SURGERY" />
    <node id="CANCER SURGERY CENTER" />
    <node id="WEARABLE DEVICES" />
    <node id="ELDERLY CARE INSTITUTIONS" />
    <node id="TECHNOLOGY ACCEPTANCE MODEL" />
    <node id="VALUE ATTITUDE BEHAVIOUR MODEL" />
    <node id="STRUCTURAL EQUATION MODELLING" />
    <node id="FUZZY SET QUALITATIVE COMPARATIVE ANALYSIS" />
    <node id="PERCEIVED USEFULNESS" />
    <node id="PERCEIVED RELIABILITY" />
    <node id="SELF-PERCEIVED AGEING" />
    <node id="HEALTH PROMOTION" />
    <node id="PERCEIVED EASE OF USE" />
    <node id="M&amp;S STANDARDS DEVELOPMENT" />
    <node id="INTELLECTUAL PROPERTY" />
    <node id="TECHNOLOGICAL INNOVATION" />
    <node id="ECONOMIC COMPETITIVENESS" />
    <node id="MENTAL HEALTH QUALITY OF LIFE QUESTIONNAIRE (MHQOL)" />
    <node id="DUTCH VALUE SET" />
    <node id="DUTCH ADULT POPULATION" />
    <node id="IMMUNE-CHECKPOINT INHIBITORS (ICIS)" />
    <node id="NON-SMALL-CELL LUNG CANCER" />
    <node id="TGF-&#914;" />
    <node id="EXTRACELLULAR VESICLES (EVS)" />
    <node id="PLASMA SAMPLES" />
    <node id="LOW-GRADE SEROUS OVARIAN CARCINOMA" />
    <node id="PLATINUM-BASED CHEMOTHERAPY" />
    <node id="BEVACIZUMAB" />
    <node id="COMPREHENSIVE CANCER CENTER" />
    <node id="RESPONSE EVALUATION CRITERIA IN SOLID TUMORS (RECIST) V1.1" />
    <node id="CONGENITAL ANOMALIES" />
    <node id="YOLO8" />
    <node id="PARADISE" />
    <node id="MONARCHE TRIAL" />
    <node id="ABEMACICLIB" />
    <node id="NATIONAL CANCER DATABASE" />
    <node id="SEOUL NATIONAL UNIVERSITY HOSPITAL" />
    <node id="SEOUL" />
    <node id="CLINICAL TRIAL NO. NCT02487901" />
    <node id="JAPANESE ORTHOPEDIC ASSOCIATION" />
    <node id="LONG SHORT-TERM MEMORY (LSTM)" />
    <node id="OLDER ADULTS" />
    <node id="HEALTH MONITORING SYSTEMS" />
    <node id="INFORMATION AND COMMUNICATION TECHNOLOGIES (ICTS)" />
    <node id="ACTIVITIES OF DAILY LIVING (ADLS)" />
    <node id="CONCEPTUAL MODEL" />
    <node id="PENILE SQUAMOUS CELL CARCINOMA" />
    <node id="HUMAN PAPILLOMAVIRUS" />
    <node id="PROGRAMMED CELL DEATH PROTEIN 1 INHIBITOR-BASED COMBINATION THERAPY" />
    <node id="GLDC" />
    <node id="CYP4F12" />
    <node id="RAGE" />
    <node id="PI3K/AKT" />
    <node id="SCREENING ULTRASOUND" />
    <node id="SCREENING MAMMOGRAM" />
    <node id="INTERVAL INVASIVE CANCER" />
    <node id="PHYSICAL ACTIVITY" />
    <node id="HEALTHCARE NEED" />
    <node id="HYBRID MICRO-SIMULATION LIFETABLE MODEL" />
    <node id="DISEASE INCIDENCE" />
    <node id="LONGEVITY" />
    <node id="DEMENTIA" />
    <node id="COMPARATIVE RISK ASSESSMENT (CRA) METHODS" />
    <node id="MYELOFIBROSIS" />
    <node id="JANUS KINASE INHIBITOR MONOTHERAPY" />
    <node id="RUXOLITINIB" />
    <node id="B-CELL LYMPHOMA PROTEIN BCL-EXTRA LARGE" />
    <node id="NAVITOCLAX" />
    <node id="DNA" />
    <node id="MESSENGER RNA" />
    <node id="DNA SEQUENCING" />
    <node id="RNA SEQUENCING" />
    <node id="FUNCTIONOMICS" />
    <node id="INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH (ICF)" />
    <node id="FAIR PRINCIPLES" />
    <node id="CHRONIC MYELOID LEUKEMIA" />
    <node id="EUROPEAN LEUKEMIANET" />
    <node id="CLINICALTRIALS.GOV IDENTIFIER NCT04384848" />
    <node id="BONE MARROW" />
    <node id="CYTOCHROME P450 ENZYMES" />
    <node id="CYP3A4" />
    <node id="HEMATOPOIETIC STEM CELLS" />
    <node id="CLARITHROMYCIN" />
    <node id="MEROPENEM" />
    <node id="CROATIA" />
    <node id="KAZAKHSTAN" />
    <node id="RUSSIA" />
    <node id="MULTILEVEL NETWORK META-REGRESSION (ML-NMR)" />
    <node id="NETWORK META-ANALYSIS (NMA)" />
    <node id="PSOBEST REGISTRY" />
    <node id="PROSPECT COHORT STUDY" />
    <node id="CHIRICOZZI 2019 COHORT STUDY" />
    <node id="PLAQUE PSORIASIS" />
    <node id="AGGREGATE DATA (AGD)" />
    <node id="INDIVIDUAL PATIENT DATA (IPD)" />
    <node id="INDIRECT COMPARISONS" />
    <node id="ORAL ANTICOAGULANTS" />
    <node id="ATRIAL FIBRILLATION" />
    <node id="SHARED DECISION MAKING" />
    <node id="PATIENT DECISION AID" />
    <node id="OUTPATIENT CARDIOLOGY CLINIC" />
    <node id="DENTAL CARIES UTILITY INDEX" />
    <node id="AUSTRALIA" />
    <node id="DISCRETE CHOICE EXPERIMENT" />
    <node id="VISUAL ANALOGUE SCALE" />
    <node id="PROVENT STUDY" />
    <node id="TIXAGEVIMAB-CILGAVIMAB" />
    <node id="ANTI-CD20 MONOCLONAL ANTIBODIES" />
    <node id="B-NON-HODGKIN LYMPHOMA" />
    <node id="SARS-COV-2" />
    <node id="HEMATOLOGICAL DISEASES" />
    <node id="BONE MARROW TRANSPLANT" />
    <node id="MYELOPROLIFERATIVE DISORDERS" />
    <node id="AUTOIMMUNE DISEASES" />
    <node id="LYMPHOPROLIFERATIVE DISORDERS" />
    <node id="JAPANESE MEDICAL INSTITUTIONS" />
    <node id="CLINICAL RESEARCH COORDINATORS" />
    <node id="JAPAN" />
    <node id="SHARED DECISION-MAKING" />
    <node id="SHARED DECISION-MAKING QUESTIONNAIRE FOR DOCTORS" />
    <node id="THEORY OF PLANNED BEHAVIOUR" />
    <node id="MATERNAL MORTALITY" />
    <node id="AMERICAN INDIAN AND ALASKA NATIVE" />
    <node id="BLACK" />
    <node id="ASIAN, NATIVE HAWAIIAN, OR OTHER PACIFIC ISLANDER" />
    <node id="WHITE" />
    <node id="IRAN" />
    <node id="PLT" />
    <node id="PLT-APHERESIS" />
    <node id="RBC" />
    <node id="LR-RBC" />
    <node id="FFP" />
    <node id="LSTM MODEL" />
    <node id="DATABASEIII" />
    <node id="DATABASEDII" />
    <node id="CERVICAL CANCER" />
    <node id="ALCOHOL USE DISORDER" />
    <node id="COCHRANE LIBRARY" />
    <node id="COCHRANE CENTRAL TRIALS REGISTRY" />
    <node id="PSYCINFO" />
    <node id="CINAHL" />
    <node id="ACAMPROSATE" />
    <node id="NALTREXONE" />
    <node id="DIGITAL HEALTH TECHNOLOGIES" />
    <node id="WEB-DELPHI" />
    <node id="UNITED KINGDOM" />
    <node id="GERMANY" />
    <node id="FIRST-TIME ANTERIOR SHOULDER DISLOCATION (FTASD)" />
    <node id="PATIENT PREFERENCES" />
    <node id="PATIENT-PROVIDER COMMUNICATION" />
    <node id="CLINICAL PRACTICE GUIDELINES" />
    <node id="ICONIC MODELS" />
    <node id="ASTRONOMY" />
    <node id="PHYSICS" />
    <node id="BIOLOGY" />
    <node id="CHEMISTRY" />
    <node id="PSYCHOLOGY" />
    <node id="ACADEMIC MEDICAL CENTER" />
    <node id="SOUTH KOREA" />
    <node id="ARX" />
    <node id="EMERGENCY DEPARTMENT LENGTH OF STAY" />
    <node id="PRISMA 2020" />
    <node id="LSR" />
    <node id="LITERATURE SURVEILLANCE" />
    <node id="SCOPING REVIEW" />
    <node id="ONLINE MEDICAL CONSULTATION" />
    <node id="IN-PERSON CONSULTATION" />
    <node id="EDUCATIONAL ACUTE-CARE HOSPITAL IN JAPAN" />
    <node id="PHYSICIAN" />
    <node id="PATIENTS' FAMILIES" />
    <node id="ACUTE MYELOID LEUKEMIA" />
    <node id="ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION" />
    <node id="MYELODYSPLASTIC SYNDROME" />
    <node id="MYELOPROLIFERATIVE NEOPLASM" />
    <node id="REDUCED-INTENSITY CONDITIONING" />
    <node id="MYELOABLATIVE CONDITIONING" />
    <node id="ACUTE GRAFT-VERSUS-HOST DISEASE" />
    <node id="CYTOGENETIC RISK" />
    <node id="SARS-COV-2 VACCINES" />
    <node id="PRIMARY VACCINATION" />
    <node id="BOOSTER VACCINATION" />
    <node id="VACCINATION MANDATES" />
    <node id="MONETARY INCENTIVES" />
    <node id="HER2-LOW" />
    <node id="TRASTUZUMAB DERUXTECAN" />
    <node id="BENDAMUSTINE HYDROCHLORIDE" />
    <node id="INDOLENT NON-HODGKIN LYMPHOMA" />
    <node id="CHINESE CORPORATION" />
    <node id="RITUXIMAB" />
    <node id="R/R INDOLENT NON-HODGKIN LYMPHOMA" />
    <node id="DISEASE EXPENDITURE PROJECT" />
    <node id="KIDNEY CANCER" />
    <node id="INSTITUTE FOR HEALTH METRICS AND EVALUATION" />
    <node id="TARGETED THERAPIES" />
    <node id="PROSTATE CANCER STUDIES" />
    <node id="BREAST CANCER STUDIES" />
    <node id="SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAM" />
    <node id="21ST CENTURY CURES ACT" />
    <node id="MEDICARE ADVANTAGE" />
    <node id="ESRD" />
    <node id="ONCOTYPEDX" />
    <node id="RSCLIN" />
    <node id="STAGE I-III HR+/HER2- BREAST CANCER" />
    <node id="NATIONAL CANCER DATA BASE" />
    <node id="ARKSEY AND O'MALLEY" />
    <node id="CHILD AND YOUTH MULTIMORBIDITY" />
    <node id="LEVAC ET AL." />
    <node id="MULTIMORBIDITY" />
    <node id="ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT)" />
    <node id="PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ ALL)" />
    <node id="TYROSINE KINASE INHIBITORS (TKIS)" />
    <node id="COMPLETE MOLECULAR REMISSION (CMR)" />
    <node id="PONATINIB" />
    <node id="IMATINIB" />
    <node id="CARBOHYDRATE ANTIGEN 19-9 (CA 19-9)" />
    <node id="INTRAHEPATIC CHOLANGIOCARCINOMA (ICCA)" />
    <node id="PROGRESSION-FREE SURVIVAL (PFS)" />
    <node id="OVERALL SURVIVAL (OS)" />
    <node id="RESPONSE EVALUATION CRITERIA IN SOLID TUMORS VERSION 1.1" />
    <node id="CLINICAL DECISION SUPPORT SYSTEM" />
    <node id="PHYSICIANS" />
    <node id="ACUTE POSTOPERATIVE ENDOPHTHALMITIS" />
    <node id="DECISION TREE CLASSIFIER" />
    <node id="K-NEAREST NEIGHBORS" />
    <node id="OPHTHALMOLOGISTS" />
    <node id="ISRUC-SLEEP SUBGROUP1" />
    <node id="MULTI-MODAL POLYSOMNOGRAPHY" />
    <node id="SLEEP-EDF" />
    <node id="PHYSIO BANK CAP SLEEP DATABASE" />
    <node id="ADA BOOST WITH RANDOM FOREST" />
    <node id="RELIEFF" />
    <node id="MORSE FALL SCALE" />
    <node id="FALL EVENTS" />
    <node id="MACHINE LEARNING MODEL" />
    <node id="CEREBROVASCULAR SPECIALTY HOSPITAL" />
    <node id="COMPUTER SIMULATION" />
    <node id="EXPERIMENTAL MEASUREMENT" />
    <node id="PEGASUS" />
    <node id="UNIFIED MEDICAL LANGUAGE SYSTEM" />
    <node id="MARCH 2021 US EDITION OF SNOMED CT" />
    <node id="STA PROGRAM" />
    <node id="SMART-VEST" />
    <node id="HOMECARE NURSES" />
    <node id="EQUIPE" />
    <node id="HRQOL" />
    <node id="EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER" />
    <node id="MEMORIAL SLOAN KETTERING CANCER CENTER" />
    <node id="ALPELISIB" />
    <node id="HYPERGLYCEMIA" />
    <node id="FULVESTRANT" />
    <node id="AMERICAN COLLEGE OF SURGEONS NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM" />
    <node id="NCT03269994" />
    <node id="PROSPERO" />
    <node id="SCIBERT" />
    <node id="METAMAP" />
    <node id="SYSTEMATIC REVIEWS" />
    <node id="TRIAL REGISTRATIONS" />
    <node id="TRIAL ARTICLES" />
    <node id="PICO" />
    <node id="BONE MARROW TRANSPLANT SURVIVOR STUDY" />
    <node id="BMT SURVIVORS" />
    <node id="TRANSPLANT CENTERS" />
    <node id="CHRONIC GRAFT-VS-HOST DISEASE" />
    <node id="ELECTRONIC PATIENT-REPORTED OUTCOMES" />
    <node id="ELECTRONIC HEALTH REPORT FORM" />
    <node id="SWEDISH YOUTH HEALTH CLINICS" />
    <node id="YOUNG PEOPLE" />
    <node id="EXPERT PANEL" />
    <node id="MEDICAL CROWDSOURCING COMPETITIONS" />
    <node id="DOCTORS" />
    <node id="ONLINE PLATFORM" />
    <node id="INFERTILITY" />
    <node id="MOBILE PHONE-BASED APPLICATION" />
    <node id="NUTRITION SPECIALISTS" />
    <node id="INFERTILITY SPECIALISTS" />
    <node id="PANEL OF EXPERTS" />
    <node id="DERMOSCOPY ELEMENTS OF VISUALS ONTOLOGY (DEVO)" />
    <node id="DERMOSCOPIC ANALYSIS" />
    <node id="SIMULTANEOUS MAXIMUM ACCEPTABLE RISK THRESHOLDS" />
    <node id="MAXIMUM ACCEPTABLE RISK" />
    <node id="DIFFUSE LARGE B-CELL LYMPHOMA" />
    <node id="LONCASTUXIMAB TESIRINE-LPYL" />
    <node id="ASPIRIN" />
    <node id="ATHEROSCLEROTIC CARDIOVASCULAR DISEASE" />
    <node id="LOW-INCOME COUNTRIES" />
    <node id="LOWER-MIDDLE-INCOME COUNTRIES" />
    <node id="UPPER-MIDDLE-INCOME COUNTRIES" />
    <node id="HIGH-INCOME COUNTRIES" />
    <node id="WORLDWIDE" />
    <node id="CVD" />
    <node id="OPENAI" />
    <node id="MICROSOFT BING AI" />
    <node id="PEYRONIE DISEASE" />
    <node id="BARON AND KENNY APPROACH" />
    <node id="STRUCTURAL EQUATION MODELING" />
    <node id="CANTO" />
    <node id="CHEMOTHERAPY DOSE-REDUCTIONS" />
    <node id="POSTCHEMOTHERAPY-TOXICITIES" />
    <node id="PRISMA GUIDELINE" />
    <node id="HL7 FHIR" />
    <node id="CDA" />
    <node id="HIPAA" />
    <node id="SNOMED-CT" />
    <node id="SOA" />
    <node id="RIM" />
    <node id="XML" />
    <node id="API" />
    <node id="JAVA" />
    <node id="SQL" />
    <node id="TURING MACHINE" />
    <node id="COMPUTER" />
    <node id="PRACTITIONERS" />
    <node id="ELECTRONIC DIGITAL COMPUTERS" />
    <node id="ARDSFLAG" />
    <node id="BERLIN DEFINITION" />
    <node id="FORENSIC PSYCHIATRY DATABASE" />
    <node id="MEDICAL TREATMENT AND SUPERVISION ACT (MTSA)" />
    <node id="THE FEBS JOURNAL" />
    <node id="SCIENTIFIC COMMUNITY" />
    <node id="LITERATURE REVIEWS" />
    <node id="REVIEW ARTICLES" />
    <node id="RESEARCH" />
    <node id="CVD EVENTS" />
    <node id="CORONAVIRUS DISEASE 2019" />
    <node id="NORTH AMERICAN ASSOCIATION OF CENTRAL CANCER REGISTRIES" />
    <node id="APRIL 2020" />
    <node id="ASIANS/PACIFIC ISLANDERS" />
    <node id="PROGRAM VERIFICATION" />
    <node id="ALGORITHMS" />
    <node id="PROGRAMS" />
    <node id="CESAREAN SECTION-INDUCED POSTPARTUM HEMORRHAGE" />
    <node id="SHIJIAZHUANG OBSTETRICS AND GYNECOLOGY HOSPITAL" />
    <node id="COMBINATION IMMUNOTHERAPY TREATMENTS" />
    <node id="PRECISION-DRIVEN APPROACH" />
    <node id="ITALIAN SPECIALIZED CENTERS" />
    <node id="HEMOGLOBINOPATHIES STUDY" />
    <node id="HEPATOCELLULAR CARCINOMA (HCC)" />
    <node id="TRANSFUSION-DEPENDENT &#914;-THALASSEMIA" />
    <node id="BPPV" />
    <node id="AI-BASED METHODS" />
    <node id="MULTIMODAL DEEP LEARNING DIAGNOSTIC MODEL" />
    <node id="HOSPITAL" />
    <node id="PANCREATIC DUCTAL ADENOCARCINOMA" />
    <node id="BIOMEDICAL RESEARCH" />
    <node id="QIAGEN INGENUITY PATHWAY ANALYSIS" />
    <node id="GENEMANIA" />
    <node id="RNASEQ DATA" />
    <node id="PUBLIC REPOSITORIES" />
    <node id="RANDOM FOREST MODEL" />
    <node id="CROSS-VALIDATION" />
    <node id="CALORIC RESTRICTION" />
    <node id="COMBINED EXERCISE + CALORIC RESTRICTION" />
    <node id="PHYSICAL ACTIVITY + CALORIC RESTRICTION" />
    <node id="RESISTANCE EXERCISE" />
    <node id="MULTIMODAL EXERCISE AND DIET PROGRAMS" />
    <node id="WOMEN" />
    <node id="SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS" />
    <node id="RANDOMIZED CONTROLLED TRIALS" />
    <node id="MAY 2022" />
    <node id="PRIME" />
    <node id="NCD SCENARIO MODELS" />
    <node id="SHARED DECISION MAKING PROCESS" />
    <node id="MONTREAL COGNITIVE ASSESSMENT TEST" />
    <node id="SURE SCALE" />
    <node id="ELECTIVE SURGERY" />
    <node id="ORAL HEALTH CONDITIONS" />
    <node id="ICU" />
    <node id="MULTIPLE IMPUTATION" />
    <node id="DEEP NEURAL NETWORKS" />
    <node id="SHORT-TERM MORTALITY" />
    <node id="PENALIZED REGRESSION" />
    <node id="STATISTICAL LEARNING APPROACHES" />
    <node id="RONALD GIERE" />
    <node id="ENLIGHTENMENT" />
    <node id="UNIVERSE" />
    <node id="INTENSIVE CARE UNIT (ICU)" />
    <node id="MIMIC-III DATABASE" />
    <node id="EXTREME GRADIENT BOOSTING (XGBOOST)" />
    <node id="EXTRA TREE" />
    <node id="LOGISTIC REGRESSION (LR)" />
    <node id="SMOTE-TOMEK LINK" />
    <node id="BRUNO LATOUR" />
    <node id="ROGER GUILLEMIN" />
    <node id="SALK INSTITUTE" />
    <node id="EPSTEIN-BARR VIRUS" />
    <node id="TET2" />
    <node id="LILRB1" />
    <node id="PCLO" />
    <node id="PHILOSOPHERS" />
    <node id="SCIENTISTS" />
    <node id="UNITY OF SCIENCE" />
    <node id="ORDER OF THINGS" />
    <node id="METAPHYSICS" />
    <node id="INNBC DAPP" />
    <node id="BNB SMART CHAIN" />
    <node id="AES ENCRYPTION" />
    <node id="COLORECTAL CANCER SCREENING" />
    <node id="DEFENSIVE INFORMATION PROCESSING (DIP)" />
    <node id="FECAL IMMUNOCHEMICAL TEST (FIT)" />
    <node id="MCQUEEN DIP MEASURE" />
    <node id="CARDIOVASCULAR DISEASES" />
    <node id="ISFAHAN COHORT STUDY" />
    <node id="BAYESIAN ADDITIVE REGRESSION TREES" />
    <node id="MISSFOREST" />
    <node id="RECURSIVE FEATURE ELIMINATION" />
    <node id="QUADRATIC DISCRIMINANT ANALYSIS" />
    <node id="DECISION TREES" />
    <node id="TP53-RELATED CANCER SYNDROME" />
    <node id="SWEDISH TP53 STUDY" />
    <node id="WHOLE-BODY MRI" />
    <node id="AMERICAN HEART ASSOCIATION" />
    <node id="GET WITH THE GUIDELINES-STROKE REGISTRY" />
    <node id="DOOR-IN-DOOR-OUT TIME" />
    <node id="NATIONAL INSTITUTES OF HEALTH" />
    <node id="GENOMICS-BASED CLINICAL DIAGNOSIS" />
    <node id="GENETICISTS" />
    <node id="DATA DISPERSION" />
    <node id="CLINVAR" />
    <node id="ONCOLOGY" />
    <node id="CARDIOLOGY" />
    <node id="ENSEMBL" />
    <node id="GWAS CATALOG" />
    <node id="LOVD" />
    <node id="CIVIC" />
    <node id="CARDIODB" />
    <node id="IMMUNE-CHECKPOINT BLOCKADE THERAPY" />
    <node id="TRIPLE-NEGATIVE BREAST CANCER" />
    <node id="TYPE-I PROTEIN ARGININE METHYLTRANSFERASES" />
    <node id="SINGLE-CELL TRANSCRIPTOMIC ANALYSIS" />
    <node id="TUMOR MICROENVIRONMENT" />
    <node id="MS023" />
    <node id="CD8 T-CELL" />
    <node id="ANTI-PROGRAMMED CELL DEATH PROTEIN 1 ANTIBODY" />
    <node id="SYNGENEIC MURINE MODEL" />
    <node id="SINGLE-CELL T-CELL RECEPTOR SEQUENCING" />
    <node id="T-DXD" />
    <node id="ADCS" />
    <node id="EXPERTS IN CHINA" />
    <node id="US FETAL THERAPY CENTERS" />
    <node id="NCT03101891" />
    <node id="PREDICTIVE ALGORITHMS" />
    <node id="ONLINE CALCULATORS" />
    <node id="BLACK BOX MACHINE LEARNING METHODS" />
    <node id="JOURNALS" />
    <node id="FUNDERS" />
    <node id="CLINICAL GUIDELINES" />
    <node id="EXTERNAL VALIDATION" />
    <node id="ALGORITHM IMPLEMENTATION" />
    <node id="COMFORT-I" />
    <node id="COMFORT-II" />
    <node id="PLACEBO/BAT" />
    <node id="LEFT VENTRICULAR ASSIST DEVICES" />
    <node id="VITAMIN K ANTAGONISTS" />
    <node id="INTERNATIONAL STUDY" />
    <node id="CLINICALTRIALS.GOV IDENTIFIER: NCT04069156" />
    <node id="MYCOSIS FUNGOIDES" />
    <node id="T-CELL RECEPTOR GENE REARRANGEMENT" />
    <node id="FLOW CYTOMETRY" />
    <node id="LACTATE DEHYDROGENASE" />
    <node id="SPANISH POPULATION" />
    <node id="GOMPERTZ DISTRIBUTION" />
    <node id="WEIBULL DISTRIBUTION" />
    <node id="LOG-NORMAL DISTRIBUTION" />
    <node id="DENTAL SERVICES UTILIZATION STUDY" />
    <node id="CRISP-DM" />
    <node id="RAPIDMINER" />
    <node id="VIRTUAL REALITY DEMENTIA DIAGNOSIS TOOLS" />
    <node id="PRIMARY HEALTHCARE ORGANIZATIONS" />
    <node id="NCCN/FACT BLADDER SYMPTOM INDEX-18" />
    <node id="JAVELIN BLADDER 100" />
    <node id="EUROQOL-5D UTILITY INDEX" />
    <node id="EASTERN COOPERATIVE ONCOLOGY GROUP" />
    <node id="AVELUMAB" />
    <node id="RA PRO DASHBOARD" />
    <node id="RA PATIENTS" />
    <node id="ECOLOGICAL MODEL OF HEALTH" />
    <node id="DISTILLERSR" />
    <node id="MAY 2020 RELEASE" />
    <node id="PSILOCYBIN" />
    <node id="MAJOR DEPRESSIVE DISORDER" />
    <node id="NIACIN" />
    <node id="MONTGOMERY-ASBERG DEPRESSION RATING SCALE" />
    <node id="SHEEHAN DISABILITY SCALE" />
    <node id="NCT03866174" />
    <node id="UK" />
    <node id="INFECTIOUS DISEASE MODELLING" />
    <node id="SCIENTIFIC ADVISORY GROUP FOR EMERGENCIES (SAGE)" />
    <node id="SPI-M-O (SCIENTIFIC PANDEMIC INFLUENZA GROUP ON MODELLING-OPERATIONAL)" />
    <node id="UK GOVERNMENT" />
    <node id="JANUARY 2020" />
    <node id="JULY 2020" />
    <node id="CALIFORNIA" />
    <node id="INSURANCE GENDER NONDISCRIMINATION ACT" />
    <node id="WASHINGTON" />
    <node id="ARIZONA" />
    <node id="NATIONAL INSTITUTE OF HEALTH" />
    <node id="ALL OF US" />
    <node id="ADVERSE DRUG EVENTS" />
    <node id="SELECTIVE SEROTONIN REUPTAKE INHIBITOR" />
    <node id="OLDER WOMEN WITH BREAST CANCER" />
    <node id="TOXICITY-RELATED HOSPITALIZATION" />
    <node id="GERIATRIC ASSESSMENT" />
    <node id="FALL HISTORY" />
    <node id="US DIABETES, OBESITY, CARDIOVASCULAR DISEASE MICROSIMULATION (DOC-M) MODEL" />
    <node id="NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES)" />
    <node id="MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS" />
    <node id="PRODUCE PRESCRIPTION PROGRAM" />
    <node id="ETNK1 MUTATION" />
    <node id="MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM" />
    <node id="ASXL1 MUTATION" />
    <node id="TET2 MUTATION" />
    <node id="EZH2 MUTATION" />
    <node id="RUNX1 MUTATION" />
    <node id="SRSF2 MUTATION" />
    <node id="ATHENA COVID-19 FEASIBILITY STUDY" />
    <node id="QUEENSLAND" />
    <node id="QUEENSLAND HEALTH" />
    <node id="FACULTY MEMBERS" />
    <node id="ACADEMIC MEDICINE" />
    <node id="MINORITIZED GROUPS" />
    <node id="TANZANIA" />
    <node id="SICKLE PAN AFRICA RESEARCH CONSORTIUM (SPARCO)" />
    <node id="MULAGO NATIONAL REFERRAL HOSPITAL" />
    <node id="JINJA REGIONAL REFERRAL HOSPITAL" />
    <node id="MBALE REGIONAL REFERRAL HOSPITAL" />
    <node id="LIRA REGIONAL REFERRAL HOSPITAL" />
    <node id="EASTERN COOPERATIVE ONCOLOGY GROUP-AMERICAN COLLEGE OF RADIOLOGY IMAGING NETWORK" />
    <node id="E1900" />
    <node id="E3999" />
    <node id="ACUTE MYELOID LEUKEMIA (AML)" />
    <node id="CAROL BENNETT" />
    <node id="COLLEAGUES" />
    <node id="FERNET ENCRYPTION ALGORITHM" />
    <node id="LGBM ALGORITHM" />
    <node id="LIME ANALYSIS" />
    <node id="FDA" />
    <node id="510(K) PATHWAY" />
    <node id="CLASS I RECALL" />
    <node id="DEVICES@FDA" />
    <node id="REGULATORY INTELLIGENCE PLATFORM" />
    <node id="HYPERLEDGER-FABRIC" />
    <node id="LONG SHORT TERM MEMORY NEURAL NETWORKS" />
    <node id="FUZZY LOGIC" />
    <node id="EMERGENCY CLINICIANS" />
    <node id="DIGITAL HEALTHCARE SERVICES" />
    <node id="PATIENT" />
    <node id="BLOCKCHAIN NETWORK" />
    <node id="CNN-RES" />
    <node id="NEUROSCIENCE CENTER OF TABRIZ UNIVERSITY OF MEDICAL SCIENCES" />
    <node id="SPES 2015" />
    <node id="MRI" />
    <node id="TABRIZ" />
    <node id="COCHRANE RAPID REVIEWS METHODS GROUP" />
    <node id="RAPID REVIEWS" />
    <node id="VAN FRAASSEN" />
    <node id="SCIENTIFIC REALISM" />
    <node id="PASC" />
    <node id="RECOVER" />
    <node id="WASHINGTON, DC" />
    <node id="PUERTO RICO" />
    <node id="INVOLUNTARY DISPLACEMENT" />
    <node id="CENTERS FOR DISEASE CONTROL AND PREVENTION" />
    <node id="NATIONAL HIV BEHAVIORAL SURVEILLANCE" />
    <node id="SUBSTANCE USE DISORDER" />
    <node id="OVERDOSE MORTALITY" />
    <node id="SERIOUS INJECTION-RELATED INFECTIONS" />
    <node id="MEDICATIONS FOR OPIOID USE DISORDER" />
    <node id="GRAVES DISEASE" />
    <node id="HYPERTHYROIDISM" />
    <node id="TOXIC NODULES" />
    <node id="THYROTOXICOSIS" />
    <node id="THYROIDITIS" />
    <node id="CRUZR" />
    <node id="ANDROID" />
    <node id="WEBSOCKET" />
    <node id="GOOGLE CLOUD" />
    <node id="HEALTHCARE USE CASES" />
    <node id="ANDROID TABLET" />
    <node id="PEPPER" />
    <node id="CLOUD SERVICES" />
    <node id="PYTHON" />
    <node id="NHS" />
    <node id="SOUTH WEST OF ENGLAND" />
    <node id="LONDON" />
    <node id="YORKSHIRE" />
    <node id="WELSH AMBULANCE SERVICES" />
    <node id="FACEBOOK'S PROPHET" />
    <node id="ARIMA" />
    <node id="LAB2CLEAN" />
    <node id="R FUNCTIONS" />
    <node id="ELECTRONIC MEDICAL RECORD DATABASES" />
    <node id="CLINICAL LABORATORY DATA" />
    <node id="MACHINE LEARNING MODELS IN HEALTHCARE" />
    <node id="CLINICAL RESEARCH" />
    <node id="REPORTING GUIDELINES" />
    <node id="STUDY DESIGNS" />
    <node id="COVID HOTLINE" />
    <node id="NURSING TRIAGE" />
    <node id="EMERGENCY DEPARTMENT" />
    <node id="CHARLSON COMORBIDITY INDEX" />
    <node id="CMEIE DATASET" />
    <node id="CHINESE-ROBERTA-CRF MODEL" />
    <node id="ACTIVE LEARNING" />
    <node id="DISTANT SUPERVISION" />
    <node id="RELATION EXTRACTION" />
    <node id="MEDICAL RESEARCH" />
    <node id="UNSTRUCTURED TEXTS" />
    <node id="PERSIAN LANGUAGE" />
    <node id="PERTO" />
    <node id="F1-SCORE" />
    <node id="ONCOLOGIC PROBLEM" />
    <node id="VASCULAR PROBLEM" />
    <node id="CLINICALTRIALS.GOV IDENTIFIER: NCT02623335" />
    <node id="CANCER DISPARITIES" />
    <node id="ANTHROPOGENIC CLIMATE CHANGE" />
    <node id="AUTOMATION" />
    <node id="MACHINE LEARNING METHODS" />
    <node id="RAPID ANTIGEN TEST" />
    <node id="OMICRON WAVE" />
    <node id="AUSTRALIA NEW ZEALAND CLINICAL TRIAL REGISTRY" />
    <node id="NEURAL NETWORK-BASED MODEL" />
    <node id="OTORHINOLARYNGOLOGY" />
    <node id="PEDIATRICS" />
    <node id="HYBRID MODEL" />
    <node id="MACHINE LEARNING ALGORITHMS" />
    <node id="ARTIFICIAL NEURAL NETWORKS" />
    <node id="BAGGING ALGORITHMS" />
    <node id="BOOSTING ALGORITHMS" />
    <node id="RANDOM FOREST ALGORITHMS" />
    <node id="NYHA FUNCTIONAL CLASSIFICATION" />
    <node id="CNN-LSTM-SE MODEL" />
    <node id="LOBAR RESECTION" />
    <node id="SUBLOBAR RESECTION" />
    <node id="LOBECTOMY" />
    <node id="GENERAL PRACTITIONERS" />
    <node id="NATIONAL HEALTH SERVICE" />
    <node id="AI DIAGNOSIS ASSISTANT WEB APPLICATION" />
    <node id="COMPLAINT SYMPTOMS INTEGRATION METHOD" />
    <node id="INTEGRATION DATASET" />
    <node id="SYMPTOM DOT SEPARATING METHOD" />
    <node id="BERT+CNN HYBRID ARCHITECTURE" />
    <node id="NEUROLOGICAL DISEASES" />
    <node id="ROME CRITERIA" />
    <node id="FGID" />
    <node id="PURE CLUSTERS" />
    <node id="GI SYMPTOMS" />
    <node id="PSYCHOLOGICAL FACTORS" />
    <node id="UNSUPERVISED MACHINE LEARNING ALGORITHM" />
    <node id="CROSS-SECTIONAL STUDY" />
    <node id="NEW CLUSTERS" />
    <node id="NON-PURE CLUSTERS" />
    <node id="INFLUENZA VIRUS INFECTIONS" />
    <node id="2021-2022 INFLUENZA SEASON" />
    <node id="A(H3N2) VIRUS" />
    <node id="GUROBI SOLVER ENGINE" />
    <node id="CONSTRAINED OPTIMIZATION" />
    <node id="HEALTH APPLICATIONS" />
    <node id="STEREOTACTIC BODY RADIOTHERAPY (SBRT)" />
    <node id="MAGNETIC RESONANCE-GUIDED DAILY ADAPTIVE SBRT (MRG-A-SBRT)" />
    <node id="COMPUTED TOMOGRAPHY-GUIDED NON-ADAPTIVE PROSTATE SBRT (CT-SBRT)" />
    <node id="PRISMA GUIDELINES" />
    <node id="META-ANALYSIS" />
    <node id="MEDLINE (PUBMED)" />
    <node id="GOOGLE SCHOLAR" />
    <node id="NRG/RADIATION THERAPY ONCOLOGY GROUP" />
    <node id="RTOG 9406" />
    <node id="RTOG 0126" />
    <node id="L4-L5" />
    <node id="L5" />
    <node id="FGIDS" />
    <node id="RE-CLUSTERING" />
    <node id="DIGITAL MAMMOGRAPHY" />
    <node id="NATIVE AMERICAN WOMEN" />
    <node id="RURAL RESIDENTS" />
    <node id="POLIO ANTIVIRAL DRUGS" />
    <node id="POLIO ERADICATION" />
    <node id="ORAL POLIOVIRUS VACCINE" />
    <node id="SABIN OPV" />
    <node id="IMMUNODEFICIENCY-RELATED VACCINE-DERIVED POLIOVIRUS" />
    <node id="AIRWAY STENOSIS" />
    <node id="LUNG TRANSPLANTATION" />
    <node id="LOGISTIC REGRESSION MODEL" />
    <node id="RANDOM FOREST ALGORITHM" />
    <node id="NCT02582957" />
    <node id="TRAUMA PATIENTS" />
    <node id="ACUTE RESPIRATORY DISTRESS SYNDROME" />
    <node id="U.S. COVID-19 SCENARIO MODELING HUB" />
    <node id="EPIDEMIC" />
    <node id="NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY" />
    <node id="DEEP CONVOLUTIONAL AUTOENCODERS" />
    <node id="K-MEANS ALGORITHM" />
    <node id="EARLY-MORNING MOVERS" />
    <node id="HIGHEST ACTIVITY" />
    <node id="LOWEST ACTIVITY" />
    <node id="LEAST SEDENTARY MOVERS" />
    <node id="CATARACT SURGERY" />
    <node id="MAIN SURGEON" />
    <node id="CNN" />
    <node id="LSTM" />
    <node id="CATARACT-101" />
    <node id="TIMELSTM" />
    <node id="RSDNET" />
    <node id="CATANET" />
    <node id="SOUTH DAKOTA" />
    <node id="US PREVENTIVE SERVICES TASK FORCE (USPSTF)" />
    <node id="PLCOM2012" />
    <node id="MONUMENT HEALTH CANCER CARE INSTITUTE" />
    <node id="SCOPING REVIEWS" />
    <node id="EVIDENCE SYNTHESIS" />
    <node id="RED GIANT STAR" />
    <node id="PHILOSOPHY OF SCIENCE" />
    <node id="NETWORK META-ANALYSIS" />
    <node id="TRI-STATE MARKOV MODEL" />
    <node id="EVIDENCE BASE" />
    <node id="TIME-TO-EVENT OUTCOMES" />
    <node id="OVERALL SURVIVAL" />
    <node id="PROGRESSION-FREE SURVIVAL" />
    <node id="PARAMETRIC SURVIVAL FUNCTIONS" />
    <node id="FRACTIONAL POLYNOMIALS" />
    <node id="CANCER SCREENING" />
    <node id="UK POPULATION" />
    <node id="PHENOTYPIC RISK PREDICTION MODELS" />
    <node id="POLYGENIC RISK PREDICTION MODELS" />
    <node id="HEART FAILURE-A CONTROLLED TRIAL INVESTIGATING OUTCOMES OF EXERCISE TRAINING (HF-ACTION)" />
    <node id="NOMOGRAM MODEL" />
    <node id="AMERICAN POPULATION" />
    <node id="MACHINE LEARNING TOOLS" />
    <node id="TITLE AND ABSTRACT SCREENING" />
    <node id="AUTOMATED SIMULATION" />
    <node id="SEMI-AUTOMATED SIMULATION" />
    <node id="TRAUMA-INFORMED CARE" />
    <node id="SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ASSOCIATION" />
    <node id="SIMULATION" />
    <node id="SWEDISH QUALITY REGISTER FOR EAR SURGERY" />
    <node id="SWEDISH OTOSURGICAL SOCIETY" />
    <node id="HEALTH PROFESSIONS' STUDENTS" />
    <node id="KNOWLEDGE, ATTITUDES, AND PRACTICES (KAP)" />
    <node id="JORDAN" />
    <node id="ONLINE QUESTIONNAIRE" />
    <node id="QUANTILE REGRESSION MODELS" />
    <node id="SAN FRANCISCO BAY-DELTA MODEL" />
    <node id="LOTKA-VOLTERRA MODEL" />
    <node id="SCHELLING'S SEGREGATION MODEL" />
    <node id="POPULATION ASSESSMENT OF TOBACCO AND HEALTH STUDY" />
    <node id="CANCER SURVIVORS" />
    <node id="SKIN CANCER" />
    <node id="CHOLANGIOCARCINOMA" />
    <node id="BILIARY TRACT" />
    <node id="BCDR-F03" />
    <node id="WDBC" />
    <node id="GSE10810" />
    <node id="GSE15852" />
    <node id="GENERALIZED FISHER SCORE" />
    <node id="MORTON NEUROMA" />
    <node id="PLANTAR FASCIITIS" />
    <node id="ACHILLES TENDINOPATHY" />
    <node id="PUBLIC HEALTH" />
    <node id="SYSTEMS SCIENCE" />
    <node id="GLOBAL PANDEMICS" />
    <node id="SYSTEM DYNAMICS" />
    <node id="NETWORK ANALYSIS" />
    <node id="AGENT-BASED MODELING" />
    <node id="INFECTIOUS DISEASE" />
    <node id="TOBACCO CONTROL" />
    <node id="CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH" />
    <node id="HIGH-RISK MULTIPLE MYELOMA" />
    <node id="AUTOLOGOUS STEM CELL TRANSPLANT" />
    <node id="LENALIDOMIDE" />
    <node id="BORTEZOMIB" />
    <node id="E3311" />
    <node id="NRG HN002" />
    <node id="CHECKMATE 651" />
    <node id="JUPITER-02" />
    <node id="NIVOLUMAB" />
    <node id="IPILIMUMAB" />
    <node id="CETUXIMAB" />
    <node id="SINGAPORE" />
    <node id="TORIPALIMAB" />
    <node id="GEMCITABINE" />
    <node id="CISPLATIN" />
    <node id="MATERNAL, NEWBORN, AND CHILD HEALTHCARE CONTINUUM" />
    <node id="DEMOCRATIC REPUBLIC OF CONGO" />
    <node id="KENYA" />
    <node id="EAST AFRICAN COMMUNITY" />
    <node id="DECISION TREE" />
    <node id="ARTIFICIAL NEURAL NETWORK" />
    <node id="EGFR" />
    <node id="CKD-EPI" />
    <node id="MDRD" />
    <node id="HYPERTENSIVE DISORDERS OF PREGNANCY" />
    <node id="CAR-T" />
    <node id="FUNCTIONAL ASSESSMENT OF CANCER THERAPY-GENERAL" />
    <node id="POST-TRAUMATIC STRESS CHECKLIST" />
    <node id="PROGNOSTIC AWARENESS IMPACT SCALE" />
    <node id="NEW SOUTH WALES" />
    <node id="BREAST CANCER SCREENING AND CARE STUDY" />
    <node id="BREASTSCREEN" />
    <node id="MENTAL HEALTH SERVICE" />
    <node id="WOMEN WITH MENTAL HEALTH CONDITIONS" />
    <node id="POPULATION CANCER REGISTER" />
    <node id="BRCA1" />
    <node id="BRCA2" />
    <node id="KAPLAN-MEIER METHOD" />
    <node id="DONANEMAB" />
    <node id="ALZHEIMER DISEASE" />
    <node id="MULTICENTER TRIAL" />
    <node id="NCT04437511" />
    <node id="CLINICAL DECISION SUPPORT SYSTEM (CDSS)" />
    <node id="PHYSIOTHERAPISTS" />
    <node id="NORWEGIAN PHYSIOTHERAPY PRIMARY HEALTHCARE SECTOR" />
    <node id="MUSCULOSKELETAL PAIN DISORDERS" />
    <node id="RANDOMISED CONTROLLED TRIAL" />
    <node id="OCTOBER AND NOVEMBER 2020" />
    <node id="NATIONAL HEALTH INTERVIEW SURVEY" />
    <node id="LGB AYACS" />
    <node id="LGB INDIVIDUALS WITHOUT A HISTORY OF CANCER" />
    <node id="HETEROSEXUAL AYACS" />
    <node id="INTERNATIONAL COLLABORATION FOR THE AUTOMATION OF SYSTEMATIC REVIEWS" />
    <node id="TEXT MINING" />
    <node id="VIENNA" />
    <node id="COCHRANE" />
    <node id="PROBAST" />
    <node id="SYSTEMATIC REVIEW AND META-ANALYSIS" />
    <node id="TRAINING SET" />
    <node id="VALIDATION SET" />
    <node id="AUGUST 9TH, 2022" />
    <node id="PRE-TRAINED LANGUAGE MODELS" />
    <node id="SWEDISH CLINICAL BERT MODELS" />
    <node id="CLINICAL DOMAIN" />
    <node id="PSEUDONYMIZATION" />
    <node id="POLICY MAKERS" />
    <node id="FACEBOOK" />
    <node id="GERM CELL TUMOR SURVIVOR SISTERS FACEBOOK GROUP" />
    <node id="TWITTER" />
    <node id="ANTI-THROMBOTIC THERAPY" />
    <node id="DEEP LEARNING ALGORITHM" />
    <node id="THROMBOSIS" />
    <node id="BLEEDING" />
    <node id="PREDICTION MODEL" />
    <node id="BIO MED CENTRAL LTD." />
    <node id="SPRINGER NATURE" />
    <node id="RESEARCH STUDY" />
    <node id="OUR BREAST HEALTH: THE ACCESS PROJECT" />
    <node id="BLACK SEXUAL MINORITY WOMEN" />
    <node id="COMMUNITY-BASED ORGANIZATIONS" />
    <node id="PRECISION ONCOLOGY" />
    <node id="NON-SMALL CELL LUNG CANCER" />
    <node id="EPIDERMAL GROWTH FACTOR RECEPTOR" />
    <node id="ANAPLASTIC LYMPHOMA KINASE" />
    <node id="TYROSINE KINASE INHIBITORS" />
    <node id="KOREAN RENAL CELL CARCINOMA DATABASE" />
    <node id="CHRONIC KIDNEY DISEASE" />
    <node id="NEPHRECTOMY" />
    <node id="GRADIENT BOOST ALGORITHM" />
    <node id="PLEUROPULMONARY BLASTOMA" />
    <node id="INTERNATIONAL PPB/DICER1 REGISTRY" />
    <node id="HEPATOCELLULAR CARCINOMA" />
    <node id="CHRONIC HEPATITIS B VIRUS INFECTION" />
    <node id="PRE-S2 GENE DELETION MUTATION" />
    <node id="MONOCYTE CHEMOATTRACTANT PROTEIN-1" />
    <node id="RANDOMIZED CONTROLLED TRIAL" />
    <node id="REAL-WORLD EVIDENCE" />
    <node id="METASTATIC COLORECTAL CANCER" />
    <node id="ANTIANGIOGENIC TREATMENTS" />
    <node id="JOHNS HOPKINS HOSPITAL" />
    <node id="QUALITY METRIC REPORTING" />
    <node id="BALTIMORE" />
    <node id="LUNG CANCER CLINICAL GUIDELINES" />
    <node id="NEVER-SMOKERS" />
    <node id="LUNG CANCER DIAGNOSTICIANS" />
    <node id="MODEL OF PATHWAYS TO TREATMENT" />
    <node id="HEMOPTYSIS" />
    <node id="ELECTROCARDIOGRAM (ECG)" />
    <node id="NESTED LONG SHORT-TERM MEMORY (NESTED LSTM)" />
    <node id="SUDDEN CARDIAC DEATH" />
    <node id="ACTIV-6 PLATFORM" />
    <node id="FLUVOXAMINE" />
    <node id="CLINICAL PRACTICE RESEARCH DATALINK (CPRD) AURUM" />
    <node id="ENGLISH PRIMARY CARE DATABASE" />
    <node id="DEPRESSION" />
    <node id="MENTAL HEALTH (MH) CONDITIONS" />
    <node id="CARDIOVASCULAR, RENAL, AND METABOLIC (CRM) CONDITIONS" />
    <node id="PTSD" />
    <node id="SCHIZOPHRENIA" />
    <node id="BIPOLAR DISORDER" />
    <node id="EATING DISORDERS" />
    <node id="LIVER RESECTION" />
    <node id="RANDOM SURVIVAL FOREST MODEL" />
    <node id="INTERNATIONAL UNION AGAINST CANCER" />
    <node id="NOTCH MUTATIONS" />
    <node id="T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA" />
    <node id="EUROPEAN LEUKEMIA NET 2017" />
    <node id="FIFTH HOSPITAL OF SHANXI MEDICAL UNIVERSITY" />
    <node id="SHANXI" />
    <node id="BPS/IC" />
    <node id="HYDRODISTENTION SURGERY" />
    <node id="CD117" />
    <node id="P2X3R" />
    <node id="NGF" />
    <node id="TRKA" />
    <node id="AGE" />
    <node id="LUNG CANCER SCREENING" />
    <node id="PRIMARY CARE PROVIDERS" />
    <node id="QUALITY IMPROVEMENT PROJECT" />
    <node id="LUNG-RADS" />
    <node id="TRANSIT DESERTS" />
    <node id="CANNABIS USE" />
    <node id="CANNABIS USE DISORDER" />
    <node id="PAIN" />
    <node id="SLEEP PROBLEMS" />
    <node id="ANXIETY" />
    <node id="NAUSEA/VOMITING" />
    <node id="HEADACHES" />
    <node id="MUSCLE SPASMS" />
    <node id="INDIVIDUALS WITHOUT A HISTORY OF CANCER" />
    <node id="CANNABIS USE FOR MEDICAL PURPOSES" />
    <node id="TEHRAN UNIVERSITY OF MEDICAL SCIENCE" />
    <node id="CANCER INSTITUTE" />
    <node id="METASTASIS" />
    <node id="PROLIFIC.CO" />
    <node id="PRIMARY CARE PHYSICIANS" />
    <node id="LORRAINE DASTON" />
    <node id="PETER GALISON" />
    <node id="REPRESENTATIONS" />
    <node id="THE IMAGE OF OBJECTIVITY" />
    <node id="THE REGENTS OF THE UNIVERSITY OF CALIFORNIA" />
    <node id="ELECTRONIC MEDICAL DATA" />
    <node id="NON-COMMUNICABLE DISEASES" />
    <node id="MNCLCDA" />
    <node id="CIRCRNAS" />
    <node id="MEDICAL INFORMATION MART FOR INTENSIVE CARE IV" />
    <node id="LIME" />
    <node id="SOFA SCORE" />
    <node id="SIMPLIFIED ACUTE PHYSIOLOGY SCORE II" />
    <node id="ARDS" />
    <node id="VV-ECMO" />
    <node id="PSA SCREENING" />
    <node id="FIRST PROSTATE BIOPSY" />
    <node id="VETERANS" />
    <node id="MULTIVARIABLE LOGISTIC REGRESSION MODELS" />
    <node id="PROSTATE-SPECIFIC ANTIGEN" />
    <node id="PERCEIVER" />
    <node id="PHYSIONET-2012 CHALLENGE" />
    <node id="CONTINUOUS PATIENT STATE MODELS" />
    <node id="NEURAL ORDINARY DIFFERENTIAL EQUATIONS" />
    <node id="ELECTRONIC HEALTH RECORD" />
    <node id="CLINICAL PREDICTION MODELS (CPMS)" />
    <node id="HEART FAILURE STUDY" />
    <node id="LUNG SCREENING RECOMMENDATION EXPANSION 2021" />
    <node id="LUNG CANCER MODELS" />
    <node id="SCREENING BENEFITS" />
    <node id="SCREENING HARMS" />
    <node id="TAIWAN BIOBANK" />
    <node id="CORONARY ARTERY DISEASE (CAD)" />
    <node id="TRADITIONAL EXPERIMENTATION" />
    <node id="OXFORD CENTRE FOR EVIDENCE-BASED MEDICINE" />
    <node id="MEDRXIV" />
    <node id="BIORXIV" />
    <node id="ARXIV" />
    <node id="METEOR" />
    <node id="G-EVAL" />
    <node id="MULTIMEDQA" />
    <node id="NANCY NERSESSIAN" />
    <node id="CREATING SCIENTIFIC CONCEPTS" />
    <node id="WALSH ET AL." />
    <node id="THREE DIFFERENT CENTERS" />
    <node id="OPENAI GPT-4" />
    <node id="GPT-4-TURBO" />
    <node id="GPT-4-VISION" />
    <node id="SPORTS MEDICINE AND EXERCISE SCIENCE CLINICAL TRIAL REPORTS" />
    <node id="META LLAMA2" />
    <node id="LLAMA 2 70B" />
    <node id="TRAIN DATASET" />
    <node id="TEST DATASET" />
    <node id="FINE-TUNING" />
    <node id="HYPERPARAMETER TUNING" />
    <node id="HEART FAILURE" />
    <node id="HEALTHCARE SYSTEMS" />
    <node id="INTRODUCTION PART I" />
    <node id="PART II" />
    <node id="PART III" />
    <node id="NOMOLOGICAL MACHINES" />
    <node id="ARISTOTELIAN NATURES" />
    <node id="SOCIO-ECONOMIC MACHINES" />
    <node id="PROBABILITY MACHINES" />
    <node id="BRIDGE PRINCIPLES" />
    <node id="PRALSETINIB" />
    <node id="ARROW TRIAL" />
    <node id="CHINESE PATIENTS" />
    <node id="RET" />
    <node id="NSCLC" />
    <node id="NCT03037385" />
    <node id="ASYSD" />
    <node id="ENDNOTE" />
    <node id="SYSTEMATIC REVIEW ASSISTANT DEDUPLICATION MODULE" />
    <node id="BIOMEDICAL REVIEWS" />
    <node id="UK NATIONAL HEALTH SERVICE" />
    <node id="SEPTIC SHOCK TRIAL" />
    <node id="EU CLINICAL TRIALS REGISTER" />
    <node id="ISRCTN" />
    <node id="LANDIOLOL" />
    <node id="NOREPINEPHRINE" />
    <node id="SEQUENTIAL ORGAN FAILURE ASSESSMENT (SOFA) SCORE" />
    <node id="BRAZIL" />
    <node id="SMARTPHONE APPLICATION" />
    <node id="CENTRO UNIVERSIT&#193;RIO CHRISTUS" />
    <node id="SYSTEM USABILITY SCALE" />
    <node id="NOVEL TARGETED THERAPIES" />
    <node id="CYTOGENETIC/MOLECULAR TESTING" />
    <node id="TIME FROM DIAGNOSIS TO TREATMENT" />
    <node id="COMPLETE REMISSION" />
    <node id="PROLONGED TDT" />
    <node id="OLDER AGE" />
    <node id="LOWER PROLIFERATION BURDEN" />
    <node id="LASSO" />
    <node id="PROPOSED METHOD" />
    <node id="RSF-VS" />
    <node id="SCAD" />
    <node id="COXBOOST" />
    <node id="COXPH" />
    <node id="RSF" />
    <node id="DEEPHIT NN" />
    <node id="EPILEPSY" />
    <node id="ELECTROENCEPHALOGRAM (EEG)" />
    <node id="CONVOLUTIONAL NEURAL NETWORK (CNN)" />
    <node id="DISCRETE WAVELET TRANSFORM (DWT)" />
    <node id="BONN EEG DATASETS" />
    <node id="NEW DELHI DATASETS" />
    <node id="PRESCRIPTION DRUG OVERDOSE" />
    <node id="CLINICAL DECISION SUPPORT INTERVENTION" />
    <node id="LARGE MULTI-CENTER HEALTHCARE SYSTEM" />
    <node id="CHOOSING WISELY" />
    <node id="ANZCTR376477" />
    <node id="BERNIE STUDY" />
    <node id="EUROPEAN PAEDIATRIC SOFT TISSUE SARCOMA STUDY GROUP" />
    <node id="MTS 2008 STUDY" />
    <node id="PEDIATRIC HEMATOLOGY-ONCOLOGY ASSOCIATION OF CENTRAL AMERICA (AHOPCA)" />
    <node id="AHOPCA-ALL REC 2014 PROTOCOL" />
    <node id="CENTRAL AMERICA" />
    <node id="ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)" />
    <node id="VALUE-OF-INFORMATION METHODOLOGY" />
    <node id="EXPECTED VALUE OF PERFECT INFORMATION (EVPI)" />
    <node id="BOOTSTRAP-BASED METHODS" />
    <node id="ASYMPTOTIC METHODS" />
    <node id="NON-US SUBSETS" />
    <node id="FRAUD, WASTE, AND ABUSE (FWA)" />
    <node id="HEALTHCARE CLAIMS" />
    <node id="UNSUPERVISED MACHINE LEARNING" />
    <node id="DEEP AUTOENCODERS" />
    <node id="DENSITY-BASED CLUSTERING MODEL" />
    <node id="IPSILATERAL BREAST TUMOR RECURRENCE (IBTR)" />
    <node id="REPEAT SENTINEL LYMPH NODE BIOPSY (RSLNB)" />
    <node id="AXILLARY LYMPH NODE DISSECTION (ALND)" />
    <node id="BRAIN TUMORS" />
    <node id="3D CONVOLUTIONAL NEURAL NETWORKS" />
    <node id="VISION TRANSFORMER" />
    <node id="SWIN UNET3D" />
    <node id="BRATS2021" />
    <node id="BRATS2018" />
    <node id="AMERICAN SOCIETY FOR COLPOSCOPY AND CERVICAL PATHOLOGY" />
    <node id="2019 ASCCP GUIDELINES" />
    <node id="OBSTETRICS AND GYNECOLOGY PHYSICIANS" />
    <node id="FAMILY MEDICINE PHYSICIANS" />
    <node id="INTERNAL MEDICINE PHYSICIANS" />
    <node id="EVIDENCE PROJECT" />
    <node id="CRD42023464746" />
    <node id="HIGH-DOSE METHOTREXATE" />
    <node id="PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA" />
    <node id="XGBOOST ALGORITHM" />
    <node id="SMOTE" />
    <node id="VIRTUAL REALITY REHABILITATION" />
    <node id="IEEE" />
    <node id="PSYCNET" />
    <node id="DA COSTA" />
    <node id="FRENCH" />
    <node id="DEEPVAQ" />
    <node id="HEMODIALYSIS PATIENTS" />
    <node id="PHOTOPLETHYSMOGRAPHY (PPG) SENSORS" />
    <node id="ULTRASOUND DILUTION TECHNIQUE (UDT)" />
    <node id="DEEP LEARNING" />
    <node id="VASCULAR ACCESS (VA)" />
    <node id="DIALYSIS" />
    <node id="TECHNETIUM-99" />
    <node id="INDOCYANINE GREEN" />
    <node id="BLUE DYE" />
    <node id="PEDIATRIC PATIENTS" />
    <node id="YOUNG ADULT POPULATION" />
    <node id="AMERICAN RADIUM SOCIETY" />
    <node id="APPROPRIATE USE CRITERIA" />
    <node id="LIVER METASTASES" />
    <node id="RICHARD LEVINS" />
    <node id="MICHAEL WEISBERG" />
    <node id="WIMSATT" />
    <node id="POPULATION BIOLOGY" />
    <node id="MODEL-BASED SCIENCE" />
    <node id="STANFORD" />
    <node id="CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS" />
    <node id="CHEERS 2022" />
    <node id="HEALTH ECONOMIC EVALUATIONS" />
    <node id="HEALTH TECHNOLOGY ASSESSMENT BODIES" />
    <node id="PEER REVIEWED JOURNALS" />
    <node id="TAIWAN PEDIATRIC ONCOLOGY GROUP" />
    <node id="TPOG-ALL-2013" />
    <node id="TPOG-ALL-2002" />
    <node id="ETV6-RUNX1" />
    <node id="BCR-ABL1" />
    <node id="DUX4-REARRANGED" />
    <node id="ZNF384-REARRANGED" />
    <node id="MEF2D-REARRANGED" />
    <node id="PAX5ALT" />
    <node id="KMT2A-REARRANGED" />
    <node id="T-CELL ALL" />
    <node id="US CITIES" />
    <node id="DIETARY SODIUM STUDY" />
    <node id="CLINICALTRIALS.GOV IDENTIFIER: NCT04258332" />
    <node id="HIGH-SODIUM DIET" />
    <node id="LOW-SODIUM DIET" />
    <node id="PERITONEUM" />
    <node id="INTRA-ABDOMINAL CHEMOTHERAPY" />
    <node id="SCIENCE" />
    <node id="MEASUREMENT" />
    <node id="MATHEMATICAL PHYSICS" />
    <node id="GPT-3" />
    <node id="INSTRUCTGPT" />
    <node id="REMAP-CAP" />
    <node id="IL-6 RECEPTOR ANTAGONISTS" />
    <node id="ANTIPLATELET AGENTS" />
    <node id="THERAPEUTIC ANTICOAGULATION" />
    <node id="CONVALESCENT PLASMA" />
    <node id="LOPINAVIR-RITONAVIR" />
    <node id="HYDROXYCHLOROQUINE" />
    <node id="CORTICOSTEROIDS" />
    <node id="NEUROPSI" />
    <node id="WILCOXON PAIRED SIGNED-RANK TEST" />
    <node id="BIOMED CENTRAL LTD." />
    <node id="&quot;THE STRUCTURE OF SCIENTIFIC REVOLUTIONS&quot;" />
    <node id="&quot;THOMAS KUHN&quot;" />
    <node id="&quot;IAN HACKING&quot;" />
    <node id="&quot;1962&quot;" />
    <node id="CHINESE ACADEMY OF MEDICAL SCIENCES" />
    <node id="CORNEAL REFRACTIVE SURGERY" />
    <node id="CANNABIS" />
    <node id="CANCER PAIN" />
    <node id="MINORITIZED RACIAL IDENTITIES" />
    <node id="OPIOID RISK MITIGATION STRATEGIES" />
    <node id="20% TAX ON SUGAR SWEETENED DRINKS" />
    <node id="PROTICNN-BILSTM" />
    <node id="BAYESIAN OPTIMISATION" />
    <node id="PDB-14,189" />
    <node id="CARIS LIFE SCIENCES" />
    <node id="NEXT-GENERATION SEQUENCING" />
    <node id="IMMUNE-CHECKPOINT INHIBITORS" />
    <node id="PROGRAMMED DEATH LIGAND 1" />
    <node id="MICROSATELLITE INSTABILITY" />
    <node id="TUMOR MUTATIONAL BURDEN" />
    <node id="WHOLE-EXOME SEQUENCING" />
    <node id="TRACHEOSTOMY AND PROLONGED MECHANICAL VENTILATION DECISION MAKING" />
    <node id="SURROGATE DECISION MAKERS" />
    <node id="CILIOPATHIES" />
    <node id="DIAGNOSIS SUPPORT SYSTEMS" />
    <node id="ORPHANET" />
    <node id="HUMAN PHENOTYPE ONTOLOGY" />
    <node id="WORLD CANCER RESEARCH FUND" />
    <node id="AMERICAN INSTITUTE FOR CANCER RESEARCH" />
    <node id="CANCER PREVENTION RECOMMENDATIONS" />
    <node id="PANCREATIC CANCER" />
    <node id="CHRONIC LYMPHOCYTIC LEUKEMIA" />
    <node id="MICROFOUNDATIONAL SIMULATION" />
    <node id="TWEAKING" />
    <node id="TELEMEDICINE-ASSISTED STRUCTURED SMBG" />
    <node id="TRADITIONAL BGM" />
    <node id="CHINESE CLINICAL TRIAL REGISTRY" />
    <node id="ISLET AUTOIMMUNITY" />
    <node id="PRIMARY ORAL INSULIN TRIAL" />
    <node id="EUROPE" />
    <node id="GRAPHICAL REPRESENTATION FORMATS" />
    <node id="COGNITIVE PROCESSES" />
    <node id="TIME PRESSURE" />
    <node id="INCONSISTENT REPRESENTATION" />
    <node id="CONSISTENT REPRESENTATION" />
    <node id="PAUL EDWARDS" />
    <node id="A VAST MACHINE" />
    <node id="GLOBAL WARMING" />
    <node id="METEOROLOGY" />
    <node id="NURSES' HEALTH STUDY" />
    <node id="LOW-CARBOHYDRATE DIETS" />
    <node id="NURSES' HEALTH STUDY II" />
    <node id="BREAST CANCER DIAGNOSIS" />
    <node id="PART I" />
    <node id="COMPLEXITY" />
    <node id="PLURALISM" />
    <node id="CONSTITUTIVE COMPLEXITY" />
    <node id="DYNAMIC COMPLEXITY" />
    <node id="EVOLVED DIVERSITY" />
    <node id="LAWS" />
    <node id="DISUNITY" />
    <node id="REVISED INTERNATIONAL STAGING SYSTEM" />
    <node id="US-BASED COMMUNITY ONCOLOGY PRACTICES" />
    <node id="WILLIAM BECHTEL" />
    <node id="ROBERT RICHARDSON" />
    <node id="DISCOVERING COMPLEXITY" />
    <node id="MIT PRESS" />
    <node id="AMYOTROPHIC LATERAL SCLEROSIS" />
    <node id="COMMISSION BIAS" />
    <node id="EMOTIONAL SENSITIVITY TO PROBABILITIES (ESP)" />
    <node id="POSSIBILITY PROBABILITY QUESTIONNAIRE (PPQ)" />
    <node id="COMPUTATIONAL MODELS" />
    <node id="INFECTIOUS DISEASES" />
    <node id="REPRODUCIBILITY GUIDELINES" />
    <node id="SCIENTIFIC COMMUNITIES" />
    <node id="EUROPEAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION" />
    <node id="ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION" />
    <node id="CR2" />
    <node id="MATCHED SIBLING DONOR" />
    <node id="MATCHED UNRELATED DONOR" />
    <node id="MISMATCHED UNRELATED DONOR" />
    <node id="HAPLOIDENTICAL DONOR" />
    <node id="CORD BLOOD" />
    <node id="GVHD" />
    <node id="LEUKEMIA-FREE SURVIVAL" />
    <node id="NONRELAPSE MORTALITY" />
    <node id="NORTH CAROLINA CENTRAL CANCER REGISTRY" />
    <node id="SOCIETY FOR ASSISTED REPRODUCTIVE TECHNOLOGY" />
    <node id="FERTILITY PRESERVATION" />
    <node id="WORLD CANCER RESEARCH FUND/AMERICAN INSTITUTE FOR CANCER RESEARCH" />
    <node id="MEDICAL EXPENDITURE PANEL SURVEY" />
    <node id="CANCER PATIENTS" />
    <node id="EMPLOYERS" />
    <node id="VACCINE ADVERSE EVENTS REPORTING SYSTEM" />
    <node id="MEDICAL DICTIONARY FOR REGULATORY ACTIVITIES" />
    <node id="GUILLAIN-BARR&#201; SYNDROME" />
    <node id="INFLUENZA VACCINATION" />
    <node id="SYSTEM ORGAN CLASS" />
    <node id="LOWEST LEVEL TERMS" />
    <node id="PRENATAL GENETIC SCREENS" />
    <node id="DIAGNOSTIC TESTS" />
    <node id="SHARED DECISION-MAKING (SDM) INSTRUMENT" />
    <node id="NEST" />
    <node id="OPTION SCALE" />
    <node id="TSCE MODEL" />
    <node id="CARET" />
    <node id="GERMLINE GENETIC TESTING" />
    <node id="SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS REGISTRIES" />
    <node id="LOGISTIC REGRESSION MODELING" />
    <node id="VISION TRANSFORMER (VIT)" />
    <node id="ORTHODONTISTS" />
    <node id="EFFICIENTNETV2_S" />
    <node id="WESTERN EDUCATED INDUSTRIALISED RICH DEMOCRATIC" />
    <node id="PRISMA PROCESS" />
    <node id="MICHAEL LYNCH" />
    <node id="BOSTON UNIVERSITY" />
    <node id="STEVE WOOLGAR" />
    <node id="BRUNEL UNIVERSITY" />
    <node id="UXBRIDGE" />
    <node id="FLUORIDE SUPPLEMENTS" />
    <node id="FLUORIDE GELS" />
    <node id="FLUORIDE VARNISH" />
    <node id="RESIN-BASED SEALANTS" />
    <node id="ONTOLOGY RESEARCH" />
    <node id="PROJECT MANAGEMENT" />
    <node id="KNOWLEDGE MANAGEMENT" />
    <node id="BUILDING INFORMATION MODELING" />
    <node id="COMPLIANCE CONTROL" />
    <node id="SCIENTOMETRIC ANALYSIS" />
    <node id="CRITICAL REVIEW" />
    <node id="DOMAIN ONTOLOGY" />
    <node id="INDUSTRY FOUNDATION CLASSES" />
    <node id="AUTOMATED COMPLIANCE CHECKING" />
    <node id="CLINICAL PATHWAYS" />
    <node id="TEMPORAL TOPIC MODEL" />
    <node id="INTELLIGENT HEALTHCARE SERVICES" />
    <node id="EXPERIMENTAL RESEARCH" />
    <node id="AOTEAROA NEW ZEALAND" />
    <node id="PATIENT PERCEPTIONS STUDY" />
    <node id="HEALTH SERVICES" />
    <node id="WORD EMBEDDINGS" />
    <node id="UMLS" />
    <node id="SEMREP" />
    <node id="WORD EVOLUTION" />
    <node id="GRIMM ET AL" />
    <node id="MODELING INFECTIOUS DISEASES IN HEALTHCARE NETWORK" />
    <node id="AGENT-BASED MODELS" />
    <node id="MULTIDRUG-RESISTANT ORGANISMS" />
    <node id="HEALTHCARE-ASSOCIATED INFECTIONS" />
    <node id="USA" />
    <node id="DIABETES INCIDENCE" />
    <node id="DIABETES MORTALITY" />
    <node id="CANCER DIAGNOSIS IN PREGNANCY" />
    <node id="MULTIMODALITY IMAGING" />
    <node id="IONIZING RADIATION IMAGING" />
    <node id="NOVEL ANTICANCER THERAPIES" />
    <node id="MULTIDISCIPLINARY MANAGEMENT" />
    <node id="VENOUS THROMBOEMBOLISM" />
    <node id="CANCER-ASSOCIATED THROMBOSIS" />
    <node id="LOW MOLECULAR WEIGHT HEPARINS" />
    <node id="DIRECT ORAL ANTICOAGULANTS" />
    <node id="FLANDERS" />
    <node id="ABATACEPT" />
    <node id="CENICRIVIROC" />
    <node id="INFLIXIMAB" />
    <node id="NCT04593940" />
    <node id="LATIN AMERICA" />
    <node id="SUCCESSFUL AGING" />
    <node id="ADAPTIVE NEURO-FUZZY INFERENCE SYSTEM" />
    <node id="MULTILAYER PERCEPTRON" />
    <node id="DECISION SUPPORT SYSTEM" />
    <node id="MICHAEL POLANYI" />
    <node id="THOMAS KUHN" />
    <node id="KARL POPPER" />
    <node id="THE TACIT DIMENSION" />
    <node id="ALZHEIMER'S DISEASE" />
    <node id="NATIONAL ALZHEIMER'S COORDINATING CENTER" />
    <node id="ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE" />
    <node id="WORD2VEC" />
    <node id="BIOWORDVEC" />
    <node id="COMMON DATA ELEMENTS REPOSITORY" />
    <node id="FAST TRACK" />
    <node id="HIP AND KNEE ARTHROPLASTY" />
    <node id="IRCCS OSPEDALE GALEAZZI-SANT&#8217;AMBROGIO" />
    <node id="EXPLAINABLE AI" />
    <node id="CAUTIOUS PREDICTION" />
    <node id="PATIENT-REPORTED OUTCOME MEASURES" />
    <node id="VIRAL PNEUMONIA" />
    <node id="BACTERIAL PNEUMONIA" />
    <node id="MIDDLE EAST RESPIRATORY SYNDROME" />
    <node id="SEVERE ACUTE RESPIRATORY SYNDROME" />
    <node id="TUBERCULOSIS" />
    <node id="RADAM" />
    <node id="NADAM" />
    <node id="SNOWFLAKE" />
    <node id="LIGHT GRADIENT BOOSTING MACHINE" />
    <node id="HOSPITAL LENGTH OF STAY" />
    <node id="ADOLESCENTS AND YOUNG ADULTS (AYAS)" />
    <node id="AYA ONCOLOGY" />
    <node id="MULTICOMPONENT PROGRAMS" />
    <node id="TRANSACTIONAL MODEL OF STRESS AND COPING" />
    <node id="EHEALTH MODALITIES" />
    <node id="IGF2BP3" />
    <node id="BRAIN METASTASIS" />
    <node id="PD-1 CHECKPOINT PATHWAY" />
    <node id="HER2-HER3 SIGNALING" />
    <node id="EPITHELIAL-MESENCHYMAL TRANSITION" />
    <node id="UK BIOBANK" />
    <node id="DEMENTIA STUDY" />
    <node id="SCOTLAND" />
    <node id="WALES" />
    <node id="WOMEN WITH EPILEPSY OF CHILD-BEARING AGE ONTOLOGY" />
    <node id="ONLINE QUESTION AND ANSWER SYSTEM" />
    <node id="EXPERIMENTAL PHYSICISTS" />
    <node id="MODERN TECHNOLOGY" />
    <node id="MICROPHYSICS" />
    <node id="TRADING ZONES" />
    <node id="AUTHOR" />
    <node id="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK" />
    <node id="US WOMEN" />
    <node id="DIGITAL BREAST TOMOSYNTHESIS" />
    <node id="MAMMOGRAPHY SCREENING" />
    <node id="BREAST CANCER MORTALITY" />
    <node id="MMIR" />
    <node id="MULTIMODAL HISTOLOGY IMAGE REGISTRATION" />
    <node id="HISTOLOGY" />
    <node id="MICROSCOPY MODALITIES" />
    <node id="US MULTI-SOCIETY TASK FORCE" />
    <node id="SURVEILLANCE COLONOSCOPY" />
    <node id="MASS GENERAL BRIGHAM COLONOSCOPY COHORT" />
    <node id="COLORECTAL POLYPECTOMY" />
    <node id="HIGH-RISK POLYPS" />
    <node id="SYSTEMATIC REVIEW" />
    <node id="REVIEWERS" />
    <node id="WORKFLOW" />
    <node id="HUMANS" />
    <node id="MACHINES" />
    <node id="SCIENTIFIC REPRESENTATION" />
    <node id="SIMILARITY" />
    <node id="ISOMORPHISM" />
    <node id="PATIENTS WITH METASTATIC CANCER" />
    <node id="FAMILY CAREGIVERS" />
    <node id="JOINT DECISION MAKING" />
    <node id="PATIENT-LED DECISION MAKING" />
    <node id="QUALITY OF LIFE" />
    <node id="QUALITY OF CARE" />
    <node id="E-CIGARETTE USE" />
    <node id="DETROIT RESEARCH ON CANCER SURVIVORS" />
    <node id="AFRICAN AMERICAN CANCER SURVIVOR POPULATION" />
    <node id="LEUKEMIA TRIAL" />
    <node id="NICE TSD 21.1" />
    <node id="EXPERT OPINION" />
    <node id="BAYESIAN METHOD" />
    <node id="FREQUENTIST APPROACH" />
    <node id="ECOACH" />
    <node id="SPARQL" />
    <node id="PMDATA" />
    <node id="MOX2-5" />
    <node id="GRADIENT BOOST (GB) CLASSIFIER" />
    <node id="HERMIT REASONER" />
    <node id="AI" />
    <node id="RESIDUAL ERROR MINIMIZATION (REM)" />
    <node id="NA&#207;VE-BASED INTERVAL PREDICTION" />
    <node id="ENSEMBLE MULTI-CLASS CLASSIFICATION" />
    <node id="TIME-SERIES PREDICTION" />
    <node id="ADASYN" />
    <node id="GLOBAL BURDEN OF DISEASE" />
    <node id="DISABILITY-ADJUSTED LIFE YEAR" />
    <node id="GRANULOSA CELL TUMOR-SURVIVOR SISTERS" />
    <node id="GCT-SS FACEBOOK GROUP" />
    <node id="GCT" />
    <node id="JUVENILE GCT" />
    <node id="ADULT GCT" />
    <node id="TELEMEDICINE" />
    <node id="JOANNA BRIGGS INSTITUTE" />
    <node id="CRITICAL APPRAISAL TOOL FOR ANALYTICAL CROSS-SECTIONAL STUDIES" />
    <node id="PATIENT SATISFACTION" />
    <node id="BERTRAND RUSSELL" />
    <node id="CARNAP" />
    <node id="PUTNAM" />
    <node id="PICTURE THEORY OF SCIENCE" />
    <node id="BILDTHEORIE" />
    <node id="BONE MARROW TRANSPLANTATION" />
    <node id="CHRONIC HEALTH CONDITIONS" />
    <node id="ACUTE MYELOID LEUKEMIA/MYELODYSPLASTIC SYNDROME" />
    <node id="CHILDHOOD" />
    <node id="TOTAL BODY IRRADIATION" />
    <node id="GRAFT-VERSUS-HOST DISEASE" />
    <node id="SURVIVORS" />
    <node id="SIBLINGS" />
    <node id="FOLLICULAR LYMPHOMA" />
    <node id="OBINUTUZUMAB" />
    <node id="DECO-MOM" />
    <node id="CHUNCHEON" />
    <node id="GONGJU" />
    <node id="KCT0007725" />
    <node id="POLICY MODELLING" />
    <node id="GLOBAL LEADERS" />
    <node id="COMMUNITIES" />
    <node id="PHYSICAL SCIENCES" />
    <node id="BIOLOGICAL SCIENCES" />
    <node id="SOCIAL SCIENCES" />
    <node id="CELLULAR AUTOMATA" />
    <node id="POST-ERCP PANCREATITIS" />
    <node id="CHINESE TERTIARY HOSPITAL" />
    <node id="LASSO REGRESSION" />
    <node id="R SHINY PACKAGE" />
    <node id="WEB SERVER" />
    <node id="ERCP" />
    <node id="NON-ELDERLY PATIENTS" />
    <node id="COMMON BILE DUCT STONES" />
    <node id="NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION" />
    <node id="GENE EXPRESSION OMNIBUS" />
    <node id="CIBERSORT" />
    <node id="R SOFTWARE" />
    <node id="GSE10846" />
    <node id="GSE53786" />
    <node id="LOGICAL POSITIVISM" />
    <node id="OBSERVATION-SENTENCES" />
    <node id="CORRESPONDENCE RULES" />
    <node id="OBSERVATIONAL VOCABULARY" />
    <node id="THEORETICAL VOCABULARY" />
    <node id="THYROID CANCER" />
    <node id="GATED RECURRENT UNITS (GRUS)" />
    <node id="BI-DIRECTIONAL LSTM (BI-LSTM)" />
    <node id="INDEPENDENT SET TEST (IST)" />
    <node id="ENSEMBLE LEARNING MODEL" />
    <node id="ASIA.ENSEMBL.ORG" />
    <node id="INTOGEN.ORG" />
    <node id="SELF-CONSISTENCY TEST (SCT)" />
    <node id="10-FOLD CROSS-VALIDATION TEST (10-FCVT)" />
    <node id="HAHN MOMENTS" />
    <node id="CENTRAL MOMENTS" />
    <node id="RAW MOMENTS" />
    <node id="HEPATITIS D VIRUS" />
    <node id="HEPATITIS B VIRUS" />
    <node id="INTERFERON ALFA" />
    <node id="BULEVIRTIDE" />
    <node id="LONAFARNIB" />
    <node id="SCREENING MAMMOGRAPHY" />
    <node id="QUALITY-ADJUSTED LIFE-YEARS (QALYS)" />
    <node id="WOMEN OLDER THAN 40 YEARS" />
    <node id="U.S. GUIDELINES" />
    <node id="SENSITIVITY ANALYSIS" />
    <node id="NATIONAL POISON DATA SYSTEM" />
    <node id="RSTI" />
    <node id="ACUTE ACETAMINOPHEN EXPOSURE" />
    <node id="DECISION TREE ALGORITHM" />
    <node id="NATURAL LANGUAGE PROCESSING PIPELINE" />
    <node id="DJANGO" />
    <node id="THE AUTHOR(S)" />
    <node id="ORIGINAL ARTICLE" />
    <node id="EQ. 1" />
    <node id="PERSONAL HEALTH RECORDS" />
    <node id="ELECTRONIC HEALTH" />
    <node id="INTEGRATED PHR" />
    <node id="SELF-CARE" />
    <node id="DELPHI TECHNIQUE" />
    <node id="HEALTHCARE ORGANIZATIONS" />
    <node id="SECURITY REQUIREMENTS" />
    <node id="QUESTIONNAIRE" />
    <node id="EXPERTS" />
    <node id="LITERATURE REVIEW" />
    <node id="PROFESSIONAL MEDICAL ORGANIZATIONS" />
    <node id="POSTPARTUM CARE" />
    <node id="PREGNANCY RISK ASSESSMENT MONITORING SYSTEM" />
    <node id="NEW YORK CITY" />
    <node id="LOW-INCOME IMMIGRANTS" />
    <node id="OREGON" />
    <node id="NONIMMIGRANTS" />
    <node id="19 STATES" />
    <node id="BERTSUM" />
    <node id="BART" />
    <node id="GPT-3.5" />
    <node id="BERTSCORE" />
    <node id="BAYESIAN APPROACH" />
    <node id="DIRICHLET PROCESS MIXTURE MODEL" />
    <node id="TYPE 2 DIABETES SECOND-LINE THERAPIES" />
    <node id="PUBMED/MEDLINE" />
    <node id="ERIC" />
    <node id="COVID PANDEMIC" />
    <node id="SMARTWATCHES" />
    <node id="HEALTHCARE SECTOR" />
    <node id="AI-HOSPITAL ASSISTANTS" />
    <node id="CHATEXTRACT" />
    <node id="CHATGPT-4" />
    <node id="MATERIALS DATA" />
    <node id="CRITICAL COOLING RATES OF METALLIC GLASSES" />
    <node id="YIELD STRENGTHS OF HIGH ENTROPY ALLOYS" />
    <node id="CONTINUOUS RENAL REPLACEMENT THERAPY" />
    <node id="TRANSFER LEARNING" />
    <node id="CONDITIONAL GENERATIVE ADVERSARIAL NEURAL NETWORK" />
    <node id="SCREENING FOR DEPRESSION" />
    <node id="SCREENING FOR SUICIDE RISK" />
    <node id="HMIC" />
    <node id="ECONLIT" />
    <node id="LANCAR AND LOUVIERE FRAMEWORK" />
    <node id="HEREDITARY CANCER SYNDROMES" />
    <node id="MULTI-CANCER EARLY DETECTION TEST" />
    <node id="NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE" />
    <node id="CANCER SIGNAL ORIGIN" />
    <node id="POSITIVE PREDICTIVE VALUE" />
    <node id="RESIDUAL CURRENT CANCER RISK" />
    <node id="AREN0532" />
    <node id="WILMS TUMOR" />
    <node id="AREN03B2" />
    <node id="VINCRISTINE/DACTINOMYCIN/DOXORUBICIN (DD4A)" />
    <node id="SUICIDE RISK FACTORS" />
    <node id="SID" />
    <node id="NEURAL NETWORK" />
    <node id="COX" />
    <node id="SUICIDE RISK PREDICTION" />
    <node id="SUICIDE ATTEMPTS" />
    <node id="DEMENTIA PATIENTS" />
    <node id="JAPANESE TRANSCRIBED INTERVIEWS" />
    <node id="LATENT NEEDS" />
    <node id="Z-SCORE ADAPTATION" />
    <node id="NAIVE BAYES" />
    <node id="SOCIETAL DECISION MAKING" />
    <node id="FIRST AFFILIATED HOSPITAL OF KUNMING MEDICAL UNIVERSITY" />
    <node id="KUNMING" />
    <node id="SHAP VALUE" />
    <node id="PERMUTATION IMPORTANCE" />
    <node id="PARTIAL DEPENDENCE PLOTS" />
    <node id="CHRONIC HEART FAILURE" />
    <node id="RANDOM FOREST CLASSIFIER" />
    <node id="EXTREME GRADIENT BOOST" />
    <node id="K-NEAREST NEIGHBOR" />
    <node id="BRAF-TARGETED THERAPY" />
    <node id="DABRAFENIB" />
    <node id="TRAMETINIB" />
    <node id="IMMUNE CHECKPOINT INHIBITION" />
    <node id="NEOADJUVANT IMMUNOTHERAPY" />
    <node id="PROGRAMMED DEATH-1" />
    <node id="PROGRAMMED CELL DEATH LIGAND-1" />
    <node id="CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED ANTIGEN-4" />
    <node id="PRISMA" />
    <node id="MOOSE" />
    <node id="PICOD" />
    <node id="NEOADJUVANT CHEMOIMMUNOTHERAPY" />
    <node id="BLACK POPULATION" />
    <node id="WHITE POPULATION" />
    <node id="HEART DISEASE" />
    <node id="MEDMGF" />
    <node id="FOCAL LOSS" />
    <node id="GRAPHICAL CONVOLUTIONAL NETWORK" />
    <node id="SYNTHETIC MINORITY OVERSAMPLING TECHNIQUE" />
    <node id="PEDIATRIC SEPSIS DATASET" />
    <node id="WALTON" />
    <node id="MIMESIS AS MAKE-BELIEVE" />
    <node id="HARVARD UNIVERSITY PRESS" />
    <node id="CAMBRIDGE/MA" />
    <node id="QUALITY ASSESSMENT OF DIAGNOSTIC ACCURACY STUDIES-2" />
    <node id="ADMINISTRATIVE DATABASES" />
    <node id="PREGNANT WOMEN" />
    <node id="SPSS" />
    <node id="MHEALTH" />
    <node id="OBSTETRICS AND GYNECOLOGY CLINIC" />
    <node id="SOCIAL MEDIA" />
    <node id="FAMILY MEDICINE DEPARTMENTS" />
    <node id="EDUCATION SOURCE" />
    <node id="OSF REGISTRIES" />
    <node id="LEVAC ET AL" />
    <node id="POSTGRADUATE FAMILY MEDICINE TRAINING" />
    <node id="DIGITAL LEARNING TOOLS" />
    <node id="NSCLC RISK ASSESSMENT MODEL" />
    <node id="PARTICLE FILTERING" />
    <node id="PARAMETER ESTIMATION" />
    <node id="POSTOPERATIVE SURVIVAL RISK ASSESSMENT MODEL" />
    <node id="EMPIRICAL ANALYSIS EXPERIMENT" />
    <node id="MEDICAL MAXIMIZING ORIENTATION" />
    <node id="LOW-VALUE CARE" />
    <node id="THYROID ULTRASONOGRAPHY" />
    <node id="RISK PERCEPTION" />
    <node id="KNOWLEDGE" />
    <node id="SOUTH KOREAN WOMEN" />
    <node id="REBOA" />
    <node id="UK TRAUMA CENTERS" />
    <node id="ISRCTN16184981" />
    <node id="EXSANQUINATING HEMORRHAGE" />
    <node id="STANDARD CARE" />
    <node id="TERTIARY REFERRAL HOSPITAL" />
    <node id="KOREA" />
    <node id="KOREAN NATIONAL HEALTH INSURANCE DATABASE" />
    <node id="TNM 7TH EDITION" />
    <node id="BATTERMAN" />
    <node id="ASYMPTOTIC REASONING" />
    <node id="UNIVERSAL BEHAVIOUR" />
    <node id="ROBOTREVIEWER" />
    <node id="MONASH RESEARCH OFFICE" />
    <node id="COVIENCE" />
    <node id="SYSTEMATIC REVIEWERS" />
    <node id="TRIAL" />
    <node id="UNIVERSITY COLLEGE LONDON" />
    <node id="MONASH UNIVERSITY" />
    <node id="RISK-OF-BIAS ASSESSMENTS" />
    <node id="ELECTRONIC HEALTH RECORD SYSTEMS" />
    <node id="HEALTH PROFESSIONALS" />
    <node id="MAY TO JUNE 2023" />
    <node id="SNOMED&#8212;CT" />
    <node id="SMART CARE SYSTEM" />
    <node id="GERMAN POPULATION" />
    <node id="ICON ARRAYS" />
    <node id="ONLINE EXPERIMENT" />
    <node id="CARDIOVASCULAR RISK" />
    <node id="ATEZOLIZUMAB" />
    <node id="ADVANCED HEPATOCELLULAR CARCINOMA" />
    <node id="VEGF INHIBITION" />
    <node id="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK (CISNET)" />
    <node id="SCREENING WOMEN &#8805; 75 YEARS OLD" />
    <node id="U.S. WOMEN BORN IN 1940" />
    <node id="MICROSIMULATION MODELING" />
    <node id="SHARED DECISION-MAKING (SDM)" />
    <node id="FAMILY HISTORY" />
    <node id="BREAST DENSITY" />
    <node id="PRIOR BIOPSY" />
    <node id="MOZAMBIQUE" />
    <node id="INFOM&#211;VEL" />
    <node id="MOBILE HEALTH" />
    <node id="ANTIRETROVIRAL TREATMENT" />
    <node id="COMMUNITY HEALTH WORKERS" />
    <node id="COMMCAREHQ.ORG" />
    <node id="UNITED NATIONS" />
    <node id="POISSON REGRESSION ANALYSIS" />
    <node id="DIFFERENTIALLY PRIVATE GENERATIVE MODELLING" />
    <node id="ASSESSMENT CENTERS" />
    <node id="COLLABORATIVE LEARNING" />
    <node id="PRIVACY-PRESERVING COLLABORATIVE LEARNING" />
    <node id="COOPERATIVE OSTEOSARCOMA STUDY GROUP" />
    <node id="OSTEOSARCOMA" />
    <node id="CANTATA-D" />
    <node id="CANTATA-D2" />
    <node id="UK PRIMARY CARE" />
    <node id="SGLT2-INHIBITOR" />
    <node id="DPP4-INHIBITOR" />
    <node id="CLINICAL PRACTICE RESEARCH DATALINK" />
    <node id="PACIFIC TRIAL" />
    <node id="DURVALUMAB" />
    <node id="STEREOTACTIC BODY RADIATION THERAPY (SBRT)" />
    <node id="NON-SMALL CELL LUNG CANCER (NSCLC)" />
    <node id="PI3K-AKT-MTOR" />
    <node id="PI3K ACTIVITY SIGNATURE" />
    <node id="CLARIOM D ASSAY" />
    <node id="KAPLAN-MEIER CURVES" />
    <node id="COX REGRESSIONS" />
    <node id="EXERCISE STRESS ECG" />
    <node id="HFQRS ANALYSIS" />
    <node id="CHD GROUP" />
    <node id="NON-CHD GROUP" />
    <node id="XGBOOST CLASSIFIER" />
    <node id="LIGHTGBM CLASSIFIER" />
    <node id="RANDOMFOREST CLASSIFIER" />
    <node id="COMMUNITY OUTREACH INITIATIVES" />
    <node id="NORTHEAST COMMUNITIES" />
    <node id="STATINS" />
    <node id="RCT" />
    <node id="ENGLISH-LANGUAGE RANDOMIZED CLINICAL TRIALS" />
    <node id="OBSERVATIONAL STUDIES" />
    <node id="FRAMINGHAM HEART STUDY" />
    <node id="LAROTRECTINIB" />
    <node id="GENETIC VARIATIONS" />
    <node id="DNA METHYLATION" />
    <node id="TWO-STAGE CASE-CONTROL DESIGN" />
    <node id="FIXED-EFFECT META-ANALYSIS" />
    <node id="MULTI-OMICS FUNCTIONAL ANNOTATION" />
    <node id="INTERNATIONAL SOCIETY OF UROLOGICAL PATHOLOGISTS" />
    <node id="ISUP PATHOLOGISTS" />
    <node id="PATHOLOGY RESIDENTS" />
    <node id="PROSTATE CANCER GRADING" />
    <node id="HISTOLOGIC CASES" />
    <node id="MAGNETIC RESONANCE IMAGING" />
    <node id="EFFICIENTNETB2" />
    <node id="BD-BRAINTUMOR" />
    <node id="BRAIN-TUMOR-DETECTION" />
    <node id="BRAIN-MRI-IMAGES-FOR-BRAIN-TUMOR-DETECTION" />
    <node id="MODELS" />
    <node id="EXPERIMENTS" />
    <node id="COCHRANE RISK OF BIAS TOOL" />
    <node id="ML MODEL" />
    <node id="TRIAL REPORT" />
    <node id="RISK OF BIAS ASSESSMENT" />
    <node id="EXPERIENCED REVIEWERS" />
    <node id="FEATURE SELECTION" />
    <node id="CLINICAL PRACTICE" />
    <node id="ONCOLOGY TRIALS" />
    <node id="SEER" />
    <node id="RANDOM-EFFECTS META-ANALYSIS" />
    <node id="EUROPEAN PAEDIATRIC SOFT TISSUE SARCOMA STUDY GROUP (EPSSG)" />
    <node id="INDIVIDUAL PATIENTS" />
    <node id="INDIVIDUAL RADIOLOGISTS" />
    <node id="INDIVIDUAL NODULES" />
    <node id="COVID-19 VACCINE" />
    <node id="PATIENTS WITH CANCER" />
    <node id="SEVERE ACUTE RESPIRATORY SYNDROME-CORONAVIRUS 2" />
    <node id="DENMARK" />
    <node id="TRANS STUDY" />
    <node id="TRANSGENDER INDIVIDUALS" />
    <node id="NONTRANSGENDER INDIVIDUALS" />
    <node id="RCT ABSTRACTS" />
    <node id="GENERATIVE PRE-TRAINED TRANSFORMER 4" />
    <node id="RCTS IN PLASTIC SURGERY" />
    <node id="PLASTIC SURGERY JOURNALS" />
    <node id="EWING SARCOMA" />
    <node id="LOCAL RECURRENCE-FREE SURVIVAL" />
    <node id="METASTASIS-FREE SURVIVAL" />
    <node id="EVENT-FREE SURVIVAL" />
    <node id="INTERNATIONAL INSTITUTIONS" />
    <node id="NATIONAL LONGITUDINAL COHORT OF HEMATOLOGICAL DISEASES IN CHINA" />
    <node id="EARLY RELAPSE" />
    <node id="INTERNATIONAL STAGING SYSTEM" />
    <node id="FOOD AND DRUG ADMINISTRATION" />
    <node id="ASCIMINIB" />
    <node id="BREXUCABTAGENE AUTOLEUCEL" />
    <node id="ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN" />
    <node id="LATENT DIRICHLET ALLOCATION" />
    <node id="HELIMINTH DATASET" />
    <node id="WILSON DISEASE DATASET" />
    <node id="AUTOMATED SCREENING METHODOLOGY" />
    <node id="SIMULATION STUDY" />
    <node id="CYCLIN E1 (CCNE1)" />
    <node id="HIGH-GRADE SEROUS CARCINOMA (HGSC)" />
    <node id="OVARIAN TUMOR TISSUE ANALYSIS CONSORTIUM" />
    <node id="SKIN CANCER SCREENING PROGRAMS" />
    <node id="PEDIATRIC DYSLIPIDEMIA" />
    <node id="US COHORT STUDIES" />
    <node id="BEHAVIORAL COUNSELING TRIALS" />
    <node id="LIPID SCREENING" />
    <node id="WEBCEPH" />
    <node id="CEPHALOMETRIC ANALYSIS" />
    <node id="CEPHX" />
    <node id="AI-DRIVEN TOOLS" />
    <node id="ORTHODONTIC DIAGNOSIS" />
    <node id="MANUAL METHOD" />
    <node id="INTRA-GROUP COMPARISON" />
    <node id="INTER-GROUP COMPARISON" />
    <node id="MMR" />
    <node id="MSI" />
    <node id="LYNCH SYNDROME" />
    <node id="IMMUNOHISTOCHEMISTRY" />
    <node id="DIGITAL SPATIAL TRANSCRIPTOMICS" />
    <node id="MLH1" />
    <node id="PMS2" />
    <node id="MSH6" />
    <node id="EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER" />
    <node id="EORTC QLQ-NHL-HG29" />
    <node id="EORTC QLQ-NHL-LG20" />
    <node id="HEALTH-RELATED QUALITY OF LIFE" />
    <node id="NON-HODGKIN LYMPHOMA" />
    <node id="UNIVERSITY OF GONDAR COMPREHENSIVE AND SPECIALIZED HOSPITAL" />
    <node id="VIROLOGICAL FAILURE" />
    <node id="UNIVERSITY OF GONDAR" />
    <node id="MACHINE LEARNING PREDICTIVE ALGORITHMS" />
    <node id="CD4 COUNT" />
    <node id="CLINICAL VOCABULARY" />
    <node id="INFORMATION SYSTEM FOR CLINICAL CONCEPT SEARCHING" />
    <node id="CLINICAL CONCEPT TAGGING" />
    <node id="PATIENT ALLERGIES" />
    <node id="BECKWITH-WIEDEMANN SYNDROME" />
    <node id="HEPATOBLASTOMA" />
    <node id="TEXAS" />
    <node id="TEXAS BIRTH DEFECTS REGISTRY" />
    <node id="TEXAS CANCER REGISTRY" />
    <node id="HEPATOSPLENOMEGALY" />
    <node id="MACROGLOSSIA" />
    <node id="NVIVO 11" />
    <node id="POSITIVE WEIGHT CONTROLLERS" />
    <node id="PATIENTS INACTIVE DUE TO FATIGUE" />
    <node id="YOUNG PATIENTS WHO AVOIDED COMMUNICATION" />
    <node id="OVERWEIGHT PATIENTS WITH TREATMENT PRIORITY" />
    <node id="PATIENTS WHO ENGAGED IN IRREGULAR EXERCISE" />
    <node id="USER RETENTION" />
    <node id="ENGAGEMENT" />
    <node id="USER PERSONA" />
    <node id="QUESTIONNAIRE SURVEY" />
    <node id="CHINESE DIABETES MELLITUS ONTOLOGY" />
    <node id="T5 MODEL" />
    <node id="CHINESE CLINICAL PRACTICE GUIDELINES" />
    <node id="EXPERT CONSENSUS" />
    <node id="HOSPITAL INFORMATION SYSTEM DATABASE" />
    <node id="SEMANTIC WEB RULE LANGUAGE" />
    <node id="CHINESE NATURAL LANGUAGE MEDICAL QUESTION ANSWERING" />
    <node id="EQ-5D-5L" />
    <node id="CTTO" />
    <node id="POLISH VALUATION STUDY" />
    <node id="NLP RESEARCHERS" />
    <node id="RECOGNIZING TEXTUAL ENTAILMENT (RTE)" />
    <node id="NATURAL LANGUAGE UNDERSTANDING" />
    <node id="MACHINE TRANSLATION" />
    <node id="SEMANTIC SEARCH" />
    <node id="INFORMATION EXTRACTION" />
    <node id="GOVERNMENT AGENCIES" />
    <node id="HEALTHCARE BODIES" />
    <node id="AUSTRALIANS" />
    <node id="SECONDARY USE OF ELECTRONIC HEALTH DATA" />
    <node id="REFLECTIVE PRACTICE" />
    <node id="SIBLINGS OF CHILDHOOD CANCER SURVIVORS" />
    <node id="FINANCIAL HARDSHIP" />
    <node id="GENERAL POPULATION" />
    <node id="MEDICAL BILLS" />
    <node id="NUTRITIOUS FOODS" />
    <node id="MEDICAL CARE" />
    <node id="PRESCRIPTION MEDICATIONS" />
    <node id="DENTAL CARE" />
    <node id="PSILOCYBIN-ASSISTED GROUP THERAPY" />
    <node id="COMMUNITY CANCER CENTER" />
    <node id="PCOS" />
    <node id="KAGGLE" />
    <node id="VGG16" />
    <node id="NA&#207;VE BAYES" />
    <node id="GANSU MEDICAL MEDIATION COMMITTEE" />
    <node id="BERT MODELS" />
    <node id="HAGAZIEKENHUIS" />
    <node id="MEDROBERTA.NL-HAGA" />
    <node id="CLINICALBERT" />
    <node id="PATIENT LIFESTYLE CLASSIFICATION" />
    <node id="DUTCH BERT MODELS" />
    <node id="ENGLISH BERT MODELS" />
    <node id="YOUNG BREAST CANCER" />
    <node id="SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS" />
    <node id="TIANJIN MEDICAL UNIVERSITY CANCER INSTITUTE AND HOSPITAL" />
    <node id="LEAST ABSOLUTE SHRINKAGE AND SELECTION OPERATOR" />
    <node id="COX REGRESSION MODEL" />
    <node id="NEURAL TUBE DEFECTS" />
    <node id="FOLIC ACID SUPPLEMENTATION" />
    <node id="MODELE PARFAIT" />
    <node id="PHOTOGRAPHIE" />
    <node id="BRUTON TYROSINE KINASE INHIBITORS" />
    <node id="BCL2 INHIBITION" />
    <node id="ANTI-CD20 ANTIBODIES" />
    <node id="FRONTLINE TREATMENT LANDSCAPE" />
    <node id="RANDOMIZED TRIALS" />
    <node id="PHASE 2 AND 3 STUDIES" />
    <node id="STANDARD OF CARE" />
    <node id="ONGOING STUDIES" />
    <node id="FUTURE PLANNED TRIALS" />
    <node id="IBRUTINIB" />
    <node id="ACALABRUTINIB" />
    <node id="ZANUBRUTINIB" />
    <node id="VENETOCLAX" />
    <node id="INTERNATIONAL SOCIETY OF PAEDIATRIC ONCOLOGY" />
    <node id="UK CHILDREN'S CANCER AND LEUKAEMIA GROUP" />
    <node id="GESELLSCHAFT F&#220;R P&#196;DIATRISCHE ONKOLOGIE UND H&#196;MATOLOGIE" />
    <node id="STAGE I INTERMEDIATE-RISK WILMS TUMOR" />
    <node id="STAGE I EPITHELIAL TYPE WILMS TUMOR" />
    <node id="STAGE I STROMAL TYPE WILMS TUMOR" />
    <node id="OTHER INTERMEDIATE-RISK WILMS TUMOR" />
    <node id="KOREAN NATIONAL HEALTH INSURANCE" />
    <node id="CRC SURVIVORS" />
    <node id="POLYPHARMACY" />
    <node id="MARYLAND" />
    <node id="MARYLAND MULTI-DRUG RESISTANT ORGANISM PREVENTION COLLABORATIVE" />
    <node id="ACUTE CARE HOSPITALS" />
    <node id="LONG-TERM CARE FACILITIES" />
    <node id="ACINETOBACTER BAUMANNII" />
    <node id="CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII (CRAB)" />
    <node id="CANDIDA AURIS" />
    <node id="MECHANICAL VENTILATION" />
    <node id="SURVEILLANCE CULTURES" />
    <node id="MARYLAND DEPARTMENT OF HEALTH" />
    <node id="2D CONVOLUTIONAL NEURAL NETWORK" />
    <node id="MRI BRAIN IMAGES" />
    <node id="AUTO-ENCODER NETWORK" />
    <node id="NATIONAL CANCER CENTER, KOREA" />
    <node id="CARDIOVASCULAR (CV) EVENTS" />
    <node id="ATRIAL FIBRILLATION AND FLUTTER (AF)" />
    <node id="PNEUMONECTOMY" />
    <node id="CEREBROVASCULAR DISEASE (CEVD)" />
    <node id="SYSTEMIC THERAPY" />
    <node id="LARGE LANGUAGE MODELS" />
    <node id="GENERATIVE PRE-TRAINED TRANSFORMER-2" />
    <node id="CALGARY" />
    <node id="NEOADJUVANT CHEMOTHERAPY" />
    <node id="STEPWISE APPROACH TO NCD RISK FACTOR SURVEILLANCE" />
    <node id="57 COUNTRIES" />
    <node id="HIGH BLOOD PRESSURE" />
    <node id="NONCOMMUNICABLE DISEASES" />
    <node id="ACCURACY" />
    <node id="PRECISION" />
    <node id="RECALL" />
    <node id="F1 SCORE" />
    <node id="EMERGENCY MEDICINE" />
    <node id="CLINICAL DECISION-MAKING" />
    <node id="EFFICIENCY, WORKFLOW, AND INFORMATION MANAGEMENT" />
    <node id="RISKS, ETHICS, AND TRANSPARENCY" />
    <node id="EDUCATION AND COMMUNICATION" />
    <node id="PRISMA-SCR" />
    <node id="OVID MEDLINE" />
    <node id="HEAD AND NECK SQUAMOUS CELL CARCINOMA" />
    <node id="RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA" />
    <node id="HPV-POSITIVE DISEASE" />
    <node id="HPV-NEGATIVE DISEASE" />
    <node id="OLIGOMETASTATIC DISEASE" />
    <node id="POLYMETASTATIC DISEASE" />
    <node id="WORLD" />
    <node id="SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS-MEDICARE" />
    <node id="INDETERMINATE PULMONARY NODULES (IPNS)" />
    <node id="CHEST COMPUTED TOMOGRAPHY (CT)" />
    <node id="POSITRON EMISSION TOMOGRAPHY (PET)/PET-CT" />
    <node id="BRONCHOSCOPY" />
    <node id="NEEDLE BIOPSY" />
    <node id="INTERNATIONAL CLASSIFICATION OF DISEASES (ICD)" />
    <node id="POISSON REGRESSION MODELS" />
    <node id="STAGE REDISTRIBUTION" />
    <node id="COM-B MODEL" />
    <node id="PRIME THEORY" />
    <node id="GEORGETOWN UNIVERSITY-ALBERT EINSTEIN COLLEGE OF MEDICINE" />
    <node id="MODEL GE" />
    <node id="CISNET" />
    <node id="CAR T-CELL THERAPY" />
    <node id="LARGE B CELL LYMPHOMAS" />
    <node id="18 F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY" />
    <node id="DEUVILLE SCORE" />
    <node id="STANDARDIZED UPTAKE VALUE" />
    <node id="SINGLE-CENTER PROSPECTIVE STUDY" />
    <node id="PARTIAL RESPONSE" />
    <node id="STABLE DISEASE" />
    <node id="ANXIETY DISORDERS SCREENING" />
    <node id="ACUTE KIDNEY INJURY" />
    <node id="ACUTE PANCREATITIS" />
    <node id="AUTOMATED MACHINE LEARNING" />
    <node id="LASSO ALGORITHM" />
    <node id="RECEIVER OPERATING CHARACTERISTIC CURVES" />
    <node id="LOCALLY INTERPRETABLE MODEL-AGNOSTIC EXPLANATIONS" />
    <node id="DANISH HEALTH AUTHORITY" />
    <node id="BREAST CANCER SCREENING" />
    <node id="DANISH WOMEN" />
    <node id="MAMMOGRAPHY SCREENING INVITATION" />
    <node id="INDIA" />
    <node id="POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH" />
    <node id="NIL RATAN SIRCAR MEDICAL COLLEGE AND HOSPITAL" />
    <node id="CHANDIGARH" />
    <node id="KOLKATA" />
    <node id="SCS BTT" />
    <node id="SUSOKA" />
    <node id="SHINE &amp; LAL" />
    <node id="MCV &#8804; 80 FL" />
    <node id="ALBINISM" />
    <node id="MOBILE HEALTH APPLICATION" />
    <node id="MICROSOFT VISIO 2021" />
    <node id="MOBILE APPLICATION USABILITY QUESTIONNAIRE (MAUQ)" />
    <node id="2022" />
    <node id="MHEALTH APPLICATION" />
    <node id="PATIENTS WITH ALBINISM" />
    <node id="DUTCH CHILDHOOD CANCER SURVIVOR LATER STUDY" />
    <node id="CHILDHOOD CANCER SURVIVORS (CCSS)" />
    <node id="MALE SIBLINGS" />
    <node id="SINGHEALTH-DUKE-GLAXOSMITHKLINE COPD AND ASTHMA REAL-WORLD EVIDENCE (SDG-CARE) COLLABORATION" />
    <node id="SINGHEALTH COPD AND ASTHMA DATA MART (SCDM)" />
    <node id="BURKINA FASO" />
    <node id="DIGITAL HEALTH INTERVENTIONS" />
    <node id="NATIONAL HEALTH INFORMATION SYSTEM" />
    <node id="HEALTHCARE INFORMATION MANAGERS" />
    <node id="SOFTWARE DEVELOPERS" />
    <node id="PRIVATE SECTOR" />
    <node id="TECHNICAL AND FINANCIAL PARTNERS" />
    <node id="CONGRESS" />
    <node id="MATHEMATICAL THEORY OF GROUPS" />
    <node id="SET THEORY" />
    <node id="DECEASED ORGAN DONATION" />
    <node id="CENTRE HOSPITALIER DE L'UNIVERSIT&#201; DE MONTR&#201;AL" />
    <node id="SUBSTITUTE DECISION-MAKERS" />
    <node id="NCT03850847" />
    <node id="SKELETAL MUSCLE DECONDITIONING" />
    <node id="EXERCISE CAPACITY" />
    <node id="PEDIATRIC CNS TUMORS" />
    <node id="RADIATION THERAPY" />
    <node id="SOCIAL COGNITION" />
    <node id="ADULT SURVIVORS" />
    <node id="INFRATENTORIAL TUMORS" />
    <node id="SUPRATENTORIAL TUMORS" />
    <node id="CRANIOSPINAL IRRADIATION" />
    <node id="SOCIAL ADJUSTMENT" />
    <node id="EXECUTIVE FUNCTIONING" />
    <node id="NONVERBAL REASONING" />
    <node id="FULL-TIME EMPLOYMENT" />
    <node id="COLLEGE EDUCATION" />
    <node id="BLACK COMMUNITIES IN CANADA" />
    <node id="CANCER RESEARCH" />
    <node id="FEDERAL AND PROVINCIAL GOVERNMENTS" />
    <node id="UNIVERSITIES" />
    <node id="SECONDHAND SMOKE" />
    <node id="OPEN BIOMEDICAL ONTOLOGIES" />
    <node id="WOMEN'S HEALTH INITIATIVE" />
    <node id="LIVER CANCER INCIDENCE" />
    <node id="CHRONIC LIVER DISEASE MORTALITY" />
    <node id="POSTMENOPAUSAL WOMEN" />
    <node id="SUGAR-SWEETENED BEVERAGES" />
    <node id="ARTIFICIALLY SWEETENED BEVERAGES" />
    <node id="M-HEALTH" />
    <node id="INTERVENTION GROUP" />
    <node id="HEALTH LITERACY INTERVENTION" />
    <node id="CONTROL GROUP" />
    <node id="PRIMARY HYPERTENSION" />
    <node id="SECONDARY HYPERTENSION" />
    <node id="PUBMED CENTRAL" />
    <node id="QUALITY ASSESSMENT OF DIAGNOSTIC ACCURACY STUDIES TOOL" />
    <node id="MEDICAL INFORMATION MART FOR INTENSIVE CARE (MIMIC)-IV" />
    <node id="KIDNEY DISEASE IMPROVING GLOBAL OUTCOME (KDIGO)" />
    <node id="EXTREME GRADIENT BOOSTING (XGB)" />
    <node id="ACUTE KIDNEY INJURY (AKI)" />
    <node id="BASELINE SERUM CREATININE (SCR)" />
    <node id="FALSE POSITIVE (FP) EVENTS" />
    <node id="EXPLAINABLE AI (XAI)" />
    <node id="MODIFICATION OF DIET IN RENAL DISEASE (MDRD) EQUATION" />
    <node id="LUNG VOLUME REDUCTION SURGERY" />
    <node id="EMPHYSEMA" />
    <node id="NATIONAL EMPHYSEMA TREATMENT TRIAL" />
    <node id="THE CANCER GENOME ATLAS" />
    <node id="SMAD4" />
    <node id="INTERNATIONAL CANCER GENOME CONSORTIUM" />
    <node id="PANCREATIC ADENOCARCINOMA" />
    <node id="DELTA SERUM PHOSPHATE" />
    <node id="IN-HOSPITAL MORTALITY" />
    <node id="28-DAY MORTALITY" />
    <node id="WESLEY C. SALMON" />
    <node id="SCIENTIFIC EXPLANATION" />
    <node id="EPISTEMIC CONCEPTION" />
    <node id="MODAL CONCEPTION" />
    <node id="ONTIC CONCEPTION" />
    <node id="AI METHODS" />
    <node id="CDSR" />
    <node id="EPISTEMONIKOS" />
    <node id="CALIFORNIA CANCER REGISTRY" />
    <node id="KAPLAN-MEIER SURVIVAL ANALYSIS" />
    <node id="COX REGRESSION ANALYSIS" />
    <node id="AFRICAN AMERICAN/BLACK MEN" />
    <node id="WHITE WOMEN" />
    <node id="RACE/ETHNICITY" />
    <node id="SURVIVAL" />
    <node id="LIMESURVEY CLOUD" />
    <node id="EVALUATION SAMPLE" />
    <node id="GERMAN FUNDING INITIATIVE" />
    <node id="HEALTH REGISTRIES" />
    <node id="NATIONAL FREE PRECONCEPTION HEALTH EXAMINATION PROJECT" />
    <node id="RADIATION EXPOSURE" />
    <node id="LGA BIRTHS" />
    <node id="SIR MODEL" />
    <node id="PUBLIC HEALTH AUTHORITIES" />
    <node id="VALUE OF INFORMATION" />
    <node id="VACCINATION CAMPAIGN" />
    <node id="HER2-POSITIVE BREAST CANCER" />
    <node id="SWEDISH NATIONAL BREAST CANCER REGISTER" />
    <node id="SPD MODELS" />
    <node id="EH MODELS" />
    <node id="AKAIKE INFORMATION CRITERION" />
    <node id="GENERAL POPULATION MORTALITY" />
    <node id="STAGE I CANCER" />
    <node id="STAGE II CANCER" />
    <node id="STAGE III CANCER" />
    <node id="STAGE IV CANCER" />
    <node id="HONG KONG PUBLIC INSTITUTION" />
    <node id="RHEUMATOID ARTHRITIS" />
    <node id="METHOTREXATE" />
    <node id="BIOSIMILAR INFLIXIMAB (CT-P13)" />
    <node id="BIOSIMILAR ADALIMUMAB (ABP-501)" />
    <node id="LEFLUNOMIDE" />
    <node id="MARKOV DISEASE TRANSITION MODEL" />
    <node id="EAST CHINA" />
    <node id="CORONARY ARTERY BYPASS GRAFTING (CABG)" />
    <node id="LIGHTGBM" />
    <node id="SHAPLEY ADDITIVE EXPLANATIONS (SHAP)" />
    <node id="POHEM:NEUROLOGICAL" />
    <node id="ALZHEIMER'S AND RELATED DEMENTIAS" />
    <node id="SUBSEQUENT SOLID CANCERS" />
    <node id="HLA-DPB1" />
    <node id="HLA-A" />
    <node id="HLA-B" />
    <node id="HLA-C" />
    <node id="HLA-DRB1/3/4/5" />
    <node id="HLA-DQB1" />
    <node id="PIRCHE" />
    <node id="HLAMATCHMAKER" />
    <node id="CYCLOPHOSPHAMIDE" />
    <node id="US PRIMARY CARE PHYSICIANS" />
    <node id="SPECIALISTS" />
    <node id="E/M PAYMENT POLICY CHANGE" />
    <node id="FAMILY PRACTICE PHYSICIAN" />
    <node id="RADIOLOGIST" />
    <node id="DERMATOLOGY" />
    <node id="PSYCHIATRY" />
    <node id="GENERAL SURGERY" />
    <node id="SINONASAL CANCER" />
    <node id="HPV16/18" />
    <node id="HPV-NEGATIVE" />
    <node id="HPV16/18-POSITIVE" />
    <node id="OTHER HIGH-RISK HPV" />
    <node id="LOW-RISK HPV" />
    <node id="TENSORFLOW" />
    <node id="TENSORFLOW RANKING" />
    <node id="LEARNING-TO-RANK" />
    <node id="INFORMATION RETRIEVAL" />
    <node id="INTERNISTS" />
    <node id="CHILDHOOD CANCER SURVIVOR STUDY" />
    <node id="NEUROBLASTOMA SURVIVORS" />
    <node id="SIBLING CONTROLS" />
    <node id="NEUROCOGNITIVE QUESTIONNAIRE" />
    <node id="PLATINUM EXPOSURE" />
    <node id="HEARING LOSS" />
    <node id="CARDIOVASCULAR CONDITIONS" />
    <node id="NEUROLOGIC CONDITIONS" />
    <node id="RESPIRATORY CONDITIONS" />
    <node id="GEFAPIXANT" />
    <node id="VITALOJAK" />
    <node id="LEICESTER COUGH QUESTIONNAIRE" />
    <node id="GRADE" />
    <node id="RANDOMIZED CLINICAL TRIALS" />
    <node id="CHRONIC COUGH" />
    <node id="TASTE-RELATED ADVERSE EVENTS" />
    <node id="TREATMENT-RELATED ADVERSE EVENTS" />
    <node id="PATHWAYS STUDY" />
    <node id="ALCOHOL CONSUMPTION" />
    <node id="WOMEN DIAGNOSED WITH STAGE I-IV BC" />
    <node id="BMI" />
    <node id="PROSTATE SUBTYPING CLASSIFIER" />
    <node id="LUMINAL DIFFERENTIATED" />
    <node id="LUMINAL PROLIFERATING" />
    <node id="BASAL IMMUNE" />
    <node id="BASAL NEUROENDOCRINE" />
    <node id="ANDROGEN RECEPTOR ACTIVITY" />
    <node id="MYC ACTIVITY" />
    <node id="HOMOLOGOUS RECOMBINATION DEFICIENCY" />
    <node id="INTERFERON &#915; ACTIVITY" />
    <node id="IMMUNE INFILTRATION" />
    <node id="RADIOTHERAPY" />
    <node id="NEUROENDOCRINE EXPRESSION PATTERNS" />
    <node id="PREMATURE CORONARY ARTERY DISEASE" />
    <node id="LASSO LOGISTIC REGRESSION" />
    <node id="EGE-UNET" />
    <node id="HEMOGLOBIN LEVEL PREDICTION" />
    <node id="DHA(C3AE)" />
    <node id="MOBILE MEDICAL SETTINGS" />
    <node id="PERIOPERATIVE ENVIRONMENTS" />
    <node id="SLAMS" />
    <node id="ML CLASSIFIERS" />
    <node id="PICTURE DESCRIPTION TASK" />
    <node id="STORY RECALL TASK" />
    <node id="PHONE-BASED RECORDINGS" />
    <node id="WEB-BASED RECORDINGS" />
    <node id="ACOUSTIC FEATURES" />
    <node id="LINGUISTIC FEATURES" />
    <node id="WILSON" />
    <node id="BELOT" />
    <node id="QUINE" />
    <node id="AZZOUNI" />
    <node id="RAYO" />
    <node id="PEACOCKE" />
    <node id="JENKINS" />
    <node id="EULER'S FORMULA" />
    <node id="BLACK-SCHOLES MODEL" />
    <node id="SPEED OF SOUND" />
    <node id="CENTRES FOR MEDICARE AND MEDICAID SERVICES (CMS)" />
    <node id="DE-SYNPUF" />
    <node id="ASSOCIATION RULE MINING" />
    <node id="UNSUPERVISED LEARNING TECHNIQUES" />
    <node id="FRAUD DETECTION METHODOLOGY" />
    <node id="CBLOF" />
    <node id="IF" />
    <node id="ECOD" />
    <node id="OCSVM" />
    <node id="INSURANCE INDUSTRY" />
    <node id="HEALTHCARE PROGRAMS" />
    <node id="ANOMALY DETECTION ALGORITHMS" />
    <node id="DIFFERENCE AND REPETITION" />
    <node id="DELEUZE" />
    <node id="HEGEL" />
    <node id="KIERKEGAARD" />
    <node id="FREUD" />
    <node id="ALTHUSSER" />
    <node id="NIETZSCHE" />
    <node id="WESTERN METAPHYSICS" />
    <node id="MARX" />
    <node id="EVENT" />
    <node id="FREDERICK SUPPE" />
    <node id="THE STRUCTURE OF SCIENTIFIC THEORIES" />
    <node id="UNIVERSITY OF ILLINOIS PRESS" />
    <node id="J. P. DAY" />
    <node id="THE PHILOSOPHICAL QUARTERLY" />
    <node id="HEALTH INEQUITIES" />
    <node id="NATIVE HAWAIIAN AND OTHER PACIFIC ISLANDER" />
    <node id="MEDICAL EXPENDITURE PANEL SURVEY (MEPS)" />
    <node id="BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM (BRFSS)" />
    <node id="NATIONAL VITAL STATISTICS SYSTEM" />
    <node id="IPUMS AMERICAN COMMUNITY SURVEY" />
    <node id="FEDERAL POLICY MAKERS" />
    <node id="STATE POLICY MAKERS" />
    <node id="LOCAL POLICY MAKERS" />
    <node id="PATIENT DECISION AIDS" />
    <node id="PDAIN" />
    <node id="MYOPIA" />
    <node id="IPDAS" />
    <node id="CORNEAL SPECIALIST OPHTHALMOLOGISTS" />
    <node id="HEALTH EDUCATION EXPERT" />
    <node id="LASER CORRECTION" />
    <node id="METAVERSE" />
    <node id="DIGITAL PROFESSIONALISM" />
    <node id="POLAND" />
    <node id="ROMANIA" />
    <node id="MAXQDA" />
    <node id="VER BI GMBH" />
    <node id="GLOBAL BURDEN OF DISEASES, INJURIES, AND RISK FACTORS STUDY (GBD)" />
    <node id="PUBLIC" />
    <node id="2050" />
    <node id="PERSONALISED MEDICINE" />
    <node id="HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT" />
    <node id="GENERAL DATA PROTECTION REGULATION" />
    <node id="U.S." />
    <node id="GEMELLI GENERATOR - REAL WORLD DATA SANDBOX" />
    <node id="DOCKER" />
    <node id="IDENTITY AND ACCESS MANAGEMENT AGENT" />
    <node id="BLOCKCHAIN-BASED NOTARISATION MODULE" />
    <node id="SGM CANCER PATIENTS" />
    <node id="SGM WELCOMING ENVIRONMENT" />
    <node id="CANCER CARE STUDY" />
    <node id="BIPOC" />
    <node id="B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA" />
    <node id="BLINATUMOMAB" />
    <node id="DEXAMETHASONE" />
    <node id="RELAPSED/REFRACTORY B-ALL" />
    <node id="BASELINE BONE MARROW BLAST PERCENTAGE" />
    <node id="MINIMAL/MEASURABLE RESIDUAL DISEASE RESPONSE" />
    <node id="CLIMATE MODEL" />
    <node id="ENSEMBLE APPROACH" />
    <node id="RISK STRATIFICATION ALGORITHM" />
    <node id="OOPHORECTOMY" />
    <node id="CHILDREN'S HOSPITALS" />
    <node id="PATIENT DECISION AID (PTDA)" />
    <node id="HIP AND KNEE OSTEOARTHRITIS" />
    <node id="JOINT REPLACEMENT SURGERY" />
    <node id="LYMPHOMA STUDY" />
    <node id="ANN ARBOR STAGE" />
    <node id="LASSO REGRESSION ANALYSIS" />
    <node id="COX STEPWISE REGRESSION ANALYSIS" />
    <node id="NOMOGRAM" />
    <node id="WEB-BASED DYNAMIC NOMOGRAM" />
    <node id="LOUISIANA" />
    <node id="AFFORDABLE CARE ACT (ACA)" />
    <node id="BREAST MRI" />
    <node id="SCREENING BREAST MRI" />
    <node id="STROKE PREVENTION TRIAL" />
    <node id="CDK4/6 INHIBITORS" />
    <node id="SURVEY EPIDEMIOLOGY AND END RESULTS-MEDICARE DATABASE" />
    <node id="KAPLAN-MEIER METHODS" />
    <node id="COX REGRESSION MODELS" />
    <node id="HORMONE RECEPTOR-POSITIVE METASTATIC BREAST CANCER" />
    <node id="HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-2 NEGATIVE" />
    <node id="ENDROCRINE THERAPY" />
    <node id="GENITAL HERPES" />
    <node id="HERPES SIMPLEX VIRUS TYPE 1 (HSV-1)" />
    <node id="HERPES SIMPLEX VIRUS TYPE 2 (HSV-2)" />
    <node id="NEONATAL HERPES INFECTION" />
    <node id="CONCORDANCE" />
    <node id="DISCORDANT CARE" />
    <node id="DECISION AIDS" />
    <node id="FINNISH PENSIONERS&#8217; FEDERATION" />
    <node id="CASTLE" />
    <node id="MULLER" />
    <node id="HALDANE" />
    <node id="LEWONTIN" />
    <node id="ROBUSTNESS" />
    <node id="HEURISTICS" />
    <node id="REDUCTIONISM" />
    <node id="EMERGENCE" />
    <node id="CANCER CLINICAL TRIAL" />
    <node id="NURSES" />
    <node id="HOSPITAL HEALTH SYSTEMS" />
    <node id="ACADEMIC CENTERS" />
    <node id="PROFESSIONAL SOCIETIES" />
    <node id="ADVOCACY ORGANIZATIONS" />
    <node id="INDUSTRY NETWORKS" />
    <node id="PERITONEAL MESOTHELIOMA" />
    <node id="GERMLINE MUTATIONS" />
    <node id="BRCA1-ASSOCIATED PROTEIN 1 (BAP1)" />
    <node id="CYTOREDUCTIVE SURGERIES" />
    <node id="SURGICAL PROCEDURES" />
    <node id="PROSPECTIVE STUDY" />
    <node id="ROC ANALYSIS" />
    <node id="RUX-MF RETROSPECTIVE STUDY" />
    <node id="PRIMARY MYELOFIBROSIS" />
    <node id="SECONDARY MYELOFIBROSIS" />
    <node id="DYNAMIC INTERNATIONAL PROGNOSTIC SCORE SYSTEM" />
    <node id="MYELOFIBROSIS SECONDARY TO POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA PROGNOSTIC MODEL" />
    <node id="CYTOPENIC MYELOFIBROSIS" />
    <node id="THROMBOCYTOPENIA" />
    <node id="ANEMIA" />
    <node id="LEUKEMIC TRANSFORMATION" />
    <node id="POLYGENIC RISK SCORE" />
    <node id="ROTTERDAM STUDY" />
    <node id="ROTTERDAM" />
    <node id="CHD RISK PREDICTION" />
    <node id="TRADITIONAL RISK FACTORS" />
    <node id="ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (ADNI)" />
    <node id="BIOMEDICAL DATA" />
    <node id="COMPUTATIONAL ONTOLOGIES" />
    <node id="BIOTECHNOLOGY" />
    <node id="COMPUTER SCIENCE" />
    <node id="AUTISM DIAGNOSIS STUDY" />
    <node id="SPECIALTY AUTISM CLINICS" />
    <node id="EYE-TRACKING MEASUREMENT" />
    <node id="EXPERT CLINICAL DIAGNOSIS" />
    <node id="CHILDREN" />
    <node id="NCT03469986" />
    <node id="REMOTE GERIATRIC ASSESSMENT AND IMPLEMENTATION PROGRAM" />
    <node id="BRAZILIAN CANCER CENTER" />
    <node id="FUNCTIONAL ASSESSMENT OF CANCER THERAPY - GENERAL" />
    <node id="GERIATRIC DEPRESSION SCALE" />
    <node id="INSTRUMENTAL ACTIVITIES OF DAILY LIVING" />
    <node id="TAICHUNG VETERANS GENERAL HOSPITAL" />
    <node id="FRIED'S FRAILTY PHENOTYPE" />
    <node id="VANDERBILT UNIVERSITY MEDICAL CENTER" />
    <node id="DUKE UNIVERSITY HEALTH SYSTEM" />
    <node id="PREDICTION CALCULATORS" />
    <node id="QUALITY OUTCOMES DATABASE" />
    <node id="WEB-BASED PREDICTION CALCULATORS" />
    <node id="ORTHOPEDIC AND NEUROSURGERY HEALTH CARE PROVIDERS" />
    <node id="SPINE SURGERY" />
    <node id="HEALTH CARE ADMINISTRATORS" />
    <node id="PATIENTS UNDERGOING ELECTIVE SPINE SURGERY" />
    <node id="UNIT NORMAL LOSS INTEGRAL" />
    <node id="PREDTOOLS" />
    <node id="MONTE CARLO SIMULATIONS" />
    <node id="3-ARM CLINICAL TRIAL" />
    <node id="DECISION ANALYSIS" />
    <node id="RISK MODELING" />
    <node id="ESOPHAGEAL SQUAMOUS CELL CARCINOMA" />
    <node id="CONCURRENT CHEMORADIOTHERAPY" />
    <node id="ELDERLY ESCC PATIENTS" />
    <node id="NOMOGRAMS" />
    <node id="KAPLAN&#8211;MEIER CURVES" />
    <node id="HISTOLOGIC GRADE" />
    <node id="T STAGE" />
    <node id="TAMOXIFEN" />
    <node id="AROMATASE INHIBITORS" />
    <node id="BREAST CANCER DEATH" />
    <node id="INVASIVE BREAST CANCER" />
    <node id="HORMONE RECEPTOR&#8211;POSITIVE BREAST CANCER" />
    <node id="IDH2" />
    <node id="NPM1" />
    <node id="OLDER/UNFIT PATIENTS" />
    <node id="TRAINING COHORT" />
    <node id="VALIDATION GROUP" />
    <node id="INSTITUTION" />
    <node id="THERAPYSELECTOR" />
    <node id="HEPATITIS C" />
    <node id="DNA DAMAGE RESPONSE" />
    <node id="FANCONI ANEMIA" />
    <node id="PALB2" />
    <node id="PARP3" />
    <node id="MKI67" />
    <node id="NATIONAL HEALTH SERVICE (NHS)" />
    <node id="CORONARY ARTERY BYPASS GRAFT (CABG)" />
    <node id="TOTAL HIP REPLACEMENT (THR)" />
    <node id="HOSPITAL EPISODE STATISTICS" />
    <node id="OFFICE FOR NATIONAL STATISTICS" />
    <node id="AMAZON'S MTURK" />
    <node id="US PARTICIPANTS" />
    <node id="UNFAMILIAR FUNGAL DISEASE" />
    <node id="FINNISH PHYSICIANS" />
    <node id="DIGITALIZATION OF HEALTHCARE" />
    <node id="TELECONSULTATIONS" />
    <node id="INFORMATION SYSTEMS" />
    <node id="TELEHEALTH SERVICES" />
    <node id="BIDIRECTIONAL LONG SHORT-TERM MEMORY (BI-LSTM) NEURAL NETWORK" />
    <node id="CHARACTER EMBEDDING" />
    <node id="CLINICAL CORPUS" />
    <node id="MEDICAL DATASET" />
    <node id="EXTRACELLULAR VESICLES" />
    <node id="GLIOBLASTOMA" />
    <node id="IMMUNE SYSTEM" />
    <node id="CELL CYCLE" />
    <node id="PROGRAMMED CELL DEATH" />
    <node id="PLASMA-DERIVED EVS" />
    <node id="SALIVA-DERIVED EVS" />
    <node id="ALDOLASE A" />
    <node id="14-3-3 PROTEIN &#917;" />
    <node id="ENOYL COA HYDRATASE 1" />
    <node id="TRANSMEMBRANE PROTEASE SERINE 11B" />
    <node id="MEDICAL DICTIONARY FOR REGULATORY ACTIVITIES (MEDDRA)" />
    <node id="UNIFIED MEDICAL LANGUAGE SYSTEM (UMLS)" />
    <node id="OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP COMMON DATA MODEL (OMOP CDM)" />
    <node id="MAPPING STATUS" />
    <node id="MAPPING STATISTICS" />
    <node id="QUALITY ANALYSIS" />
    <node id="MAPPING COVERAGE" />
    <node id="ARTIFICIAL INTELLIGENCE TOOLS" />
    <node id="ACADEMIC WRITING" />
    <node id="RESEARCH SYNTHESIS" />
    <node id="WEEKEND WARRIOR" />
    <node id="ACTIVE REGULAR" />
    <node id="INACTIVE" />
    <node id="DOCTOR-PATIENT RELATIONSHIPS" />
    <node id="EMPATHY AND COMPASSION" />
    <node id="TRUST RELATIONSHIPS" />
    <node id="US KIDNEY ALLOCATION SYSTEM" />
    <node id="SCIENTIFIC REGISTRY OF TRANSPLANT RECIPIENTS" />
    <node id="MICROSIMULATION MODEL" />
    <node id="OLDER CANDIDATES" />
    <node id="DECEASED DONOR KIDNEYS" />
    <node id="ARTIFICIAL VISCOSITY" />
    <node id="COMPUTATIONAL FLUID DYNAMICS" />
    <node id="MODEL BUILDING TECHNIQUES" />
    <node id="SIMULATION MODELS" />
    <node id="CREDIBILITY OF SIMULATION MODELS" />
    <node id="NEURO-TTRANSFORM" />
    <node id="EPLONTERSEN" />
    <node id="NEURO-TTR" />
    <node id="INOTERSEN" />
    <node id="ATTRV AMYLOIDOSIS" />
    <node id="COUTINHO STAGE 1 OR 2" />
    <node id="15 COUNTRIES" />
    <node id="CARDIAC ARRHYTHMIA" />
    <node id="INTRACEREBRAL HEMORRHAGE" />
    <node id="LOW BACK PAIN" />
    <node id="LUMBAR DISC HERNIATION" />
    <node id="LUMBAR SPINAL STENOSIS" />
    <node id="DEEP LEARNING MODEL" />
    <node id="DECOMPRESSION SURGERY" />
    <node id="ORAL ANTICOAGULANT" />
    <node id="ELDERLY PATIENTS" />
    <node id="HEMATOLOGICAL CANCER" />
    <node id="MRI-TARGETED PROSTATE BIOPSY" />
    <node id="SYSTEMATIC BIOPSY" />
    <node id="PROSTATECTOMY" />
    <node id="COX REGRESSION" />
    <node id="HIGH-GRADE GROUP PROSTATE CANCER" />
    <node id="ADVERSE PATHOLOGY" />
    <node id="BIOCHEMICAL RECURRENCE" />
    <node id="VERSION 9 AJCC STAGING SYSTEM" />
    <node id="ANAL CANCER" />
    <node id="8TH EDITION AJCC STAGE GROUPS" />
    <node id="COX PROPORTIONAL HAZARDS MODELS" />
    <node id="CARDIOVASCULAR TOXICITIES" />
    <node id="PATIENTS WITH CLL" />
    <node id="CYTOKINE RELEASE SYNDROME" />
    <node id="PHASE 1/2" />
    <node id="TOCILIZUMAB" />
    <node id="AMERICAN SOCIETY FOR TRANSPLANTATION AND CELLULAR THERAPY" />
    <node id="INTELLECTUAL OR DEVELOPMENTAL DISABILITIES (IDD)" />
    <node id="METASTATIC CANCER" />
    <node id="ONTARIO" />
    <node id="MANITOBA" />
    <node id="TREATMENT DECISION-MAKING" />
    <node id="CAREGIVER" />
    <node id="OUTPATIENT CLINICS" />
    <node id="FAMILY" />
    <node id="THE COCHRANE LIBRARY" />
    <node id="RAYYAN" />
    <node id="MICROSOFT WORD" />
    <node id="PRISMA 2020 EXTENSION" />
    <node id="FECAL OCCULT BLOOD TESTING" />
    <node id="FECAL IMMUNOCHEMICAL TESTING" />
    <node id="MULTITARGET STOOL DNA TESTING" />
    <node id="FLEXIBLE SIGMOIDOSCOPY" />
    <node id="COMPUTED TOMOGRAPHIC COLONOGRAPHY" />
    <node id="COLONOSCOPY" />
    <node id="CRC SCREENING STRATEGIES" />
    <node id="LIFE-YEARS GAINED" />
    <node id="SCREENING BURDEN" />
    <node id="HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)" />
    <node id="SODIUM-GLUCOSE COTRANSPORTER TYPE 2 INHIBITORS" />
    <node id="FUROSEMIDE" />
    <node id="TORSEMIDE" />
    <node id="H2FPEF SCORE" />
    <node id="DAPAGLIFLOZIN" />
    <node id="EMPAGLIFLOZIN" />
    <node id="EBM" />
    <node id="AFRICAN COUNTRIES" />
    <node id="CAPACITY-BUILDING EBM TRAINING" />
    <node id="TECHNICAL SUPPORT" />
    <node id="INTERNET ACCESS" />
    <node id="GOVERNMENT" />
    <node id="DIFFERENCE-IN-DIFFERENCES ANALYSIS" />
    <node id="FIXED EFFECT PANEL-DATA REGRESSION MODEL" />
    <node id="CHILDREN'S HOSPITAL IN HELSINKI" />
    <node id="HELSINKI" />
    <node id="FINNISH NATIONAL REGISTRIES" />
    <node id="HEMATOPOIETIC STEM CELL THERAPY" />
    <node id="TESTICULAR RADIATION" />
    <node id="MEDICAL INFORMATION MART FOR INTENSIVE CARE-IV" />
    <node id="KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES" />
    <node id="ELECTRONIC INTENSIVE CARE UNIT DATABASE" />
    <node id="COLOMBIAN OPEN HEALTH DATABASE" />
    <node id="LIPOPROTEIN METABOLISM DISORDERS" />
    <node id="ESSENTIAL HYPERTENSION" />
    <node id="FLUID, ELECTROLYTE, AND ACID-BASE BALANCE DISORDERS" />
    <node id="HEART-KIDNEY CROSSTALK" />
    <node id="LUNG-KIDNEY CROSSTALK" />
    <node id="LIVER" />
    <node id="KIDNEYS" />
    <node id="HEART" />
    <node id="BRAIN" />
    <node id="LUNGS" />
    <node id="GUT" />
    <node id="DEEP LEARNING MODELS" />
    <node id="EEG" />
    <node id="BEAM" />
    <node id="CHB-MIT DATASET" />
    <node id="WHITE-BOX ATTACKS" />
    <node id="GPBEAM" />
    <node id="GPBEAM-DE" />
    <node id="ENDOSONOGRAPHERS" />
    <node id="DEEP-LEARNING RADIOMICS (DLR) MODEL" />
    <node id="ENDOSCOPIC ULTRASONOGRAPHY (EUS)" />
    <node id="PANCREATIC DUCTAL ADENOCARCINOMA (PDAC)" />
    <node id="JUNIOR ENDOSONOGRAPHER GROUP" />
    <node id="SENIOR ENDOSONOGRAPHER GROUP" />
    <node id="COSMIC313" />
    <node id="BELZUTIFAN" />
    <node id="ENFORTUMAB VEDOTIN" />
    <node id="SACITUZUMAB GOVITECAN" />
    <node id="PEACE-1" />
    <node id="ARASENS" />
    <node id="STAMPEDE" />
    <node id="VISION" />
    <node id="THERAP" />
    <node id="ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TYROSINE KINASE INHIBITORS" />
    <node id="METASTATIC CASTRATE SENSITIVE PROSTATE CANCER" />
    <node id="ANDROGEN-SIGNALING INHIBITORS" />
    <node id="ANDROGEN DEPRIVATION THERAPY" />
    <node id="METASTATIC CASTRATE RESISTANT PROSTATE CANCER" />
    <node id="RADIOLIGAND THERAPY 177 LU-PSMA-617" />
    <node id="ULTRASOUND-GUIDED RADIOFREQUENCY ABLATION" />
    <node id="PAPILLARY THYROID CARCINOMA" />
    <node id="BIPOLAR RFA PROCEDURE" />
    <node id="VOLUME REDUCTION RATE" />
    <node id="COMPLETE DISAPPEARANCE RATE" />
    <node id="DELAYED SURGERY" />
    <node id="T1N0M0 PTC" />
    <node id="LYMPH NODE METASTASIS" />
    <node id="RECURRENT TUMOR" />
    <node id="PERSISTENT TUMOR" />
    <node id="DISTANT METASTASIS" />
    <node id="T1A GROUP" />
    <node id="T1B GROUP" />
    <node id="CANCER THERAPY EVALUATION PROGRAM STUDY 9557" />
    <node id="AT13387" />
    <node id="BRAF V600E-MUTANT SOLID TUMORS" />
    <node id="HSP90" />
    <node id="BRAF" />
    <node id="MEK" />
    <node id="NDW" />
    <node id="KENYA HEALTH INFORMATION SYSTEM" />
    <node id="KHIS" />
    <node id="EMRS" />
    <node id="BIO-MED CENTRAL LTD" />
    <node id="HPV VACCINATION STUDY" />
    <node id="PSYCHOSOCIAL CONSTRUCTS" />
    <node id="PROVIDER RECOMMENDATION" />
    <node id="POSITIVE HPV VACCINE ATTITUDES" />
    <node id="PROSTATE CANCER CONSULTATIONS" />
    <node id="AGGRESSIVE TREATMENT" />
    <node id="NONAGGRESSIVE TREATMENT" />
    <node id="MULTIDISCIPLINARY PROVIDERS" />
    <node id="CODERS" />
    <node id="SUPPES" />
    <node id="OXFORD" />
    <node id="SAATSI" />
    <node id="2004 PSA MEETING" />
    <node id="CORONAVIRUS DISEASE 2019 (COVID-19) PANDEMIC" />
    <node id="EPIDEMIOLOGICAL MODELING" />
    <node id="VISUAL TRANSFORMER" />
    <node id="CONVOLUTIONAL NEURAL NETWORKS (CNNS)" />
    <node id="VIDEO SWIN TRANSFORMERS" />
    <node id="CT SCAN IMAGES" />
    <node id="CLINICAL DATA" />
    <node id="HOSPITALIZATION RATES" />
    <node id="MORTALITY RISKS" />
    <node id="DEEP-LEARNING-BASED SCHEMES" />
    <node id="3D DATA FUSION" />
    <node id="CONVENTIONAL CLASSIFIERS" />
    <node id="CLINICAL OUTCOMES" />
    <node id="SURGICAL SITE INFECTION" />
    <node id="INTERNATIONAL ORGANIZATIONS" />
    <node id="ANTIBIOTIC PROPHYLAXIS" />
    <node id="CHLORHEXIDINE GLUCONATE" />
    <node id="ALCOHOL-BASED SKIN PREPARATION" />
    <node id="NEGATIVE PRESSURE WOUND THERAPY" />
    <node id="PERIOPERATIVE GLYCEMIC CONTROL" />
    <node id="DECOLONIZATION" />
    <node id="CENTRAL CHINA" />
    <node id="BI SYSTEM" />
    <node id="FINANCIAL BALANCE" />
    <node id="2016&#8211;2019 ML-IDENTIFIED MEASURES" />
    <node id="HUMANLY DECIDED MEASURES" />
    <node id="ANNUAL MEETING MINUTES" />
    <node id="HOSPITAL OPERATIONS MANAGEMENT" />
    <node id="WUHAN" />
    <node id="SHAPELY ADDITIVE EXPLANATIONS (SHAP)" />
    <node id="HISPANIC POPULATIONS" />
    <node id="NON-HISPANIC WHITE INDIVIDUALS" />
    <node id="ALLAN FRANKLIN" />
    <node id="SHERLOCK HOLMES STRATEGY" />
    <node id="CLINICAL DECISION-SUPPORT SYSTEMS" />
    <node id="COUNTERFACTUAL POLICY LEARNING" />
    <node id="BOOTSTRAP METHOD" />
    <node id="ADVERSARIAL LEARNING ALGORITHM" />
    <node id="BDNCO" />
    <node id="EMBRYONAL TUMORS" />
    <node id="NEUROBLASTOMA" />
    <node id="NEPHROBLASTOMA" />
    <node id="MULTISTATE REGISTRY-LINKAGE COHORT STUDY" />
    <node id="INFORMATION TECHNOLOGY" />
    <node id="EMERGENCY LABORATORY TESTING" />
    <node id="DECEMBER 2021" />
    <node id="OCTOBER 2021" />
    <node id="JANUARY 2021" />
    <node id="SEPTEMBER 2021" />
    <node id="JANUARY 2022" />
    <node id="SEPTEMBER 2022" />
    <node id="DEEP LEARNING RADIOMICS NOMOGRAM" />
    <node id="HOSPITAL 1" />
    <node id="HOSPITAL 2" />
    <node id="DEEP LEARNING RADIOMICS" />
    <node id="HISTORIANS" />
    <node id="PHILOSOPHERS OF SCIENCE" />
    <node id="THEORETICAL PHYSICS" />
    <node id="MOLECULAR BIOLOGY" />
    <node id="HORMONAL THERAPY" />
    <node id="DUCTAL CARCINOMA IN SITU (DCIS)" />
    <node id="CONTRALATERAL INVASIVE BREAST CANCER (IBC)" />
    <node id="BREAST-CONSERVING SURGERY (BCS)" />
    <node id="RADIATION THERAPY (RT)" />
    <node id="NEW JERSEY" />
    <node id="NEW YORK" />
    <node id="SIBLING CONTROL GROUP" />
    <node id="30-YEAR MCC" />
    <node id="DCCSS LATER" />
    <node id="RISK STRATIFICATIONS" />
    <node id="ACUTE RESPIRATORY FAILURE" />
    <node id="RED BLOOD CELL DISTRIBUTION WIDTH TO ALBUMIN RATIO" />
    <node id="AGENTS" />
    <node id="MODEL" />
    <node id="PURPOSE" />
    <node id="COGNITIVE LINGUISTICS" />
    <node id="DILATED CARDIOMYOPATHY" />
    <node id="AFRICAN ANCESTRY" />
    <node id="EUROPEAN ANCESTRY" />
    <node id="NATIVE AMERICAN ANCESTRY" />
    <node id="TTN" />
    <node id="NON-HISPANIC BLACK" />
    <node id="NON-HISPANIC WHITE" />
    <node id="NORTH CYPRUS" />
    <node id="NEU HOSPITAL" />
    <node id="INTERNAL MEDICINE DEPARTMENT" />
    <node id="ELASTIC-NET ORDINAL REGRESSION" />
    <node id="ORDINAL LOGISTIC REGRESSION" />
    <node id="US COVID-19 TRENDS AND IMPACT SURVEY" />
    <node id="AMERICAN COMMUNITY SURVEY" />
    <node id="COVID-19 VACCINATION" />
    <node id="POPULATION HEALTH MEASUREMENT" />
    <node id="EMERGENCY USE AUTHORIZATION" />
    <node id="COUNTY-LEVEL VACCINATION COVERAGE" />
    <node id="WASSERSTEIN TABULAR GENERATIVE ADVERSARIAL NETWORK" />
    <node id="DEEP FNN" />
    <node id="HEALTHCARE SYSTEM" />
    <node id="DRUG DEVELOPMENT SECTORS" />
    <node id="GENE EXPRESSION DATASETS" />
    <node id="MICROARRAY GENE EXPRESSION DATASETS" />
    <node id="MEMORIAL SLOAN KETTERING-INTEGRATED MUTATION PROFILING OF ACTIONABLE CANCER TARGETS" />
    <node id="MEMORIAL SLOAN KETTERING" />
    <node id="EAST ASIAN ANCESTRY" />
    <node id="SOUTH ASIAN ANCESTRY" />
    <node id="ADMIXED ANCESTRY" />
    <node id="DANA-FARBER BRIGHAM CANCER CENTER" />
    <node id="HOSPITAL CLINIC OF BARCELONA" />
    <node id="HOSPITAL CLINICO OF VALENCIA" />
    <node id="UPFRONT SURGERY" />
    <node id="PROSTATE, LUNG, COLORECTAL AND OVARIAN CANCER SCREENING TRIAL" />
    <node id="NATIONAL LUNG SCREENING TRIAL" />
    <node id="LIFE YEARS FROM SCREENING-CT" />
    <node id="COX MODELS" />
    <node id="UROLOGISTS" />
    <node id="UROLOGY PRACTICES" />
    <node id="RADIATION VAULTS" />
    <node id="INTENSITY-MODULATED RADIATION THERAPY (IMRT)" />
    <node id="PITOBRUTINIB" />
    <node id="IDELALISIB" />
    <node id="DUVELISIB" />
    <node id="LISOCABTAGENE MARALEUCEL" />
    <node id="ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT" />
    <node id="BRUTON TYROSINE KINASE INHIBITOR" />
    <node id="B-CELL LEUKEMIA/LYMPHOMA 2 INHIBITOR" />
    <node id="PHOSPHOINOSITIDE 3'-KINASE INHIBITOR" />
    <node id="PROLONGED DISORDERS OF CONSCIOUSNESS" />
    <node id="COMA RECOVERY SCALE-REVISED" />
    <node id="MUSIC THERAPY ASSESSMENT TOOL FOR AWARENESS IN DISORDERS OF CONSCIOUSNESS" />
    <node id="IRELAND" />
    <node id="ZHONGSHAN HOSPITAL" />
    <node id="CKD PREDICTION INTERPRETATION FRAMEWORK" />
    <node id="CHRONIC KIDNEY DISEASE (CKD)" />
    <node id="ENSEMBLE MODEL" />
    <node id="MACHINE LEARNING CLASSIFIERS" />
    <node id="LINEAR MODEL LOGISTIC REGRESSION (LR)" />
    <node id="SJ&#214;GREN&#8217;S DISEASE" />
    <node id="INDIANA NETWORK FOR PATIENT CARE" />
    <node id="INDIANA UNIVERSITY SCHOOL OF DENTISTRY" />
    <node id="ELECTRONIC DENTAL RECORD" />
    <node id="LIVER DISEASE" />
    <node id="GRADIENT BOOSTING" />
    <node id="GASTRIC CANCER" />
    <node id="AYATOLLAH TALLEGHANI HOSPITAL" />
    <node id="TUMOR STAGE" />
    <node id="HISTORY OF OTHER CANCERS" />
    <node id="LYMPHATIC INVASION" />
    <node id="TUMOR SITE" />
    <node id="TYPE OF TREATMENT" />
    <node id="BODY WEIGHT" />
    <node id="HISTOLOGICAL TYPE" />
    <node id="ADDICTION" />
    <node id="ABADAN" />
    <node id="XG BOOST" />
    <node id="TUMOR-BASED NEXT-GENERATION SEQUENCING" />
    <node id="OVARIAN CANCER" />
    <node id="HIGH-GRADE EPITHELIAL OVARIAN CARCINOMA" />
    <node id="AKT2" />
    <node id="USPSTF" />
    <node id="NATIONAL LUNG CANCER ROUNDTABLE" />
    <node id="MEDICAL TREATMENT REIMBURSEMENT DECISIONS" />
    <node id="BEHAVIORAL EXPERIMENT" />
    <node id="BEDSIDE LEVEL" />
    <node id="POLICY LEVEL" />
    <node id="WITHDRAWING TREATMENT" />
    <node id="WITHHOLDING TREATMENT" />
    <node id="PROLONGED INTERMITTENT RENAL REPLACEMENT THERAPY" />
    <node id="CHILDREN'S ONCOLOGY GROUP" />
    <node id="PEDIATRIC HEALTH INFORMATION SYSTEM" />
    <node id="US CENSUS BUREAU" />
    <node id="SOCIAL DISORGANIZATION INDEX" />
    <node id="SEPTIC SHOCK" />
    <node id="SEPTIC SHOCK-ASSOCIATED DEATH" />
    <node id="UCI REPOSITORY" />
    <node id="XLSTAT SOFTWARE" />
    <node id="CVD RISK FACTORS" />
    <node id="SEX DIFFERENCES" />
    <node id="PRINCIPAL COMPONENT ANALYSIS" />
    <node id="LATENT CLASS ANALYSIS" />
    <node id="INTENSIVE DIABETES MANAGEMENT" />
    <node id="NCT04233034" />
    <node id="THIRD AFFILIATED HOSPITAL OF ANHUI MEDICAL UNIVERSITY" />
    <node id="MGA-XGBOOST" />
    <node id="COLORECTAL CANCER SURGERY" />
    <node id="LINEAR REGRESSION" />
    <node id="BP NEURAL NETWORK" />
    <node id="POSTOPERATIVE INFECTIOUS COMPLICATIONS" />
    <node id="SOCIETY FOR ASSISTED REPRODUCTIVE TECHNOLOGY CLINIC OUTCOME REPORTING SYSTEM" />
    <node id="FEMALE SURVIVORS" />
    <node id="CRANIAL RADIATION THERAPY" />
    <node id="PELVIC RADIATION THERAPY" />
    <node id="ALKYLATOR EXPOSURE" />
    <node id="BOSTON MEDICAL CENTER" />
    <node id="ITALIAN COHORT STUDY" />
    <node id="TUMOR MITOTIC RATE (TMR)" />
    <node id="SENTINEL LYMPH-NODE BIOPSY" />
    <node id="ACTIV-6" />
    <node id="IVERMECTIN" />
    <node id="PLACEBO" />
    <node id="EVIDENCE-BASED PRACTICE" />
    <node id="ELECTRONIC DATABASES" />
    <node id="SOFTWARE REPOSITORIES" />
    <node id="COMPUTATIONAL TOOLS" />
    <node id="PAJO MODEL" />
    <node id="BERT MODEL" />
    <node id="NECK PAIN" />
    <node id="METAMODELS" />
    <node id="SUPPORT VECTOR REGRESSION" />
    <node id="QUALITY-ADJUSTED LIFE-YEARS" />
    <node id="INCREMENTAL COST-EFFECTIVENESS RATIO" />
    <node id="COST-EFFECTIVENESS ANALYSIS CURVE" />
    <node id="EXPECTED VALUE OF PERFECT INFORMATION" />
    <node id="ROOT MEAN SQUARED ERROR" />
    <node id="PEARSON&#8217;S R2" />
    <node id="CAUSAL GRAPH LEARNING" />
    <node id="META-LEARNING" />
    <node id="CLINICAL DECISION SUPPORT SYSTEMS" />
    <node id="STRUCTURAL HAMMING DISTANCE" />
    <node id="FALSE DISCOVERY RATE" />
    <node id="BIOMEDICINE" />
    <node id="CANADIAN TASK FORCE ON PREVENTIVE HEALTH CARE" />
    <node id="ELECTRONIC CIGARETTES" />
    <node id="HNC COMMUNICATION PLATFORM" />
    <node id="HNC TREATMENT JOURNEY MAP" />
    <node id="CANCER SURVIVOR STORIES" />
    <node id="OPERATION CONSENT REDESIGN" />
    <node id="NON-VERBAL COMMUNICATION TOOLKIT" />
    <node id="DOCTOR-PATIENT RELATIONSHIP" />
    <node id="ELECTRONIC HEALTH RECORD SYSTEM" />
    <node id="SERVICE BLUEPRINT" />
    <node id="CANCER SCREENING PROGRAM IN URBAN CHINA" />
    <node id="BREAST CANCER RISK-PREDICTION MODEL" />
    <node id="WEB-BASED CALCULATOR" />
    <node id="URBAN CHINA" />
    <node id="RESPONDENT-DRIVEN SAMPLING" />
    <node id="WEBRDS" />
    <node id="YEMEN" />
    <node id="ODK" />
    <node id="YEMENI DIASPORA" />
    <node id="WHATSAPP" />
    <node id="SMS" />
    <node id="SURVEY UPTAKE" />
    <node id="LANGUAGE SUPPORT" />
    <node id="SURVEY LINKS" />
    <node id="LOW-GRADE SEROUS OVARIAN CANCER" />
    <node id="KRAS" />
    <node id="MEK INHIBITORS" />
    <node id="BRAF KINASE INHIBITORS" />
    <node id="CDK 4/6 INHIBITORS" />
    <node id="HEALTH RESEARCH" />
    <node id="CANADIAN TRIAGE AND ACUITY SCALE" />
    <node id="MACHINE LEARNING ALGORITHM" />
    <node id="GRADIENT BOOSTING REGRESSOR" />
    <node id="VIRTUAL URGENT CARE" />
    <node id="HIGH ACUITY" />
    <node id="LOW ACUITY" />
    <node id="GEISINGER MYCODE COMMUNITY HEALTH INITIATIVE" />
    <node id="VENOUS THROMBOEMBOLISM (VTE)" />
    <node id="BRITISH" />
    <node id="IRISH" />
    <node id="SEX CHROMOSOME ANEUPLOIDY" />
    <node id="GOVERNMENTS" />
    <node id="COUNTRIES" />
    <node id="GOVERNMENTAL INTERVENTION" />
    <node id="SOCIAL SCIENCE DISCIPLINES" />
    <node id="COMMUNICATION STRATEGY" />
    <node id="INFECTIOUS DISEASE MODELS" />
    <node id="SOCIAL DETERMINANTS OF HEALTH" />
    <node id="EPIDEMIOLOGISTS" />
    <node id="LEGAL EPIDEMIOLOGY" />
    <node id="CAUSAL INFERENCE" />
    <node id="INDIVIDUALIZED TREATMENT EFFECTS" />
    <node id="HEALTH TECHNOLOGY ASSESSMENT" />
    <node id="OBSERVATIONAL DATA" />
    <node id="TIME-VARYING CONFOUNDING" />
    <node id="GLP-1 RECEPTOR AGONISTS" />
    <node id="GOOGLE PATENTS" />
    <node id="FDA APPROVAL" />
    <node id="PITUITARY ADENOMAS" />
    <node id="MACROADENOMAS" />
    <node id="MICROADENOMAS" />
    <node id="PROLACTINOMAS" />
    <node id="SOMATOTROPINOMAS" />
    <node id="CORTICOTROPINOMAS" />
    <node id="TRANSSPHENOIDAL PITUITARY SURGERY" />
    <node id="BROMOCRIPTINE" />
    <node id="CABERGOLINE" />
    <node id="ICI GASTRITIS" />
    <node id="ICI ENTERITIS" />
    <node id="ICI COLITIS" />
    <node id="GASTRIC BIOPSIES" />
    <node id="GLUCOCORTICOIDS" />
    <node id="MATTHEW H. NITECKI" />
    <node id="ANTONI HOFFMAN" />
    <node id="DAVID M. RAUP" />
    <node id="NLP-DRIVEN CDSS" />
    <node id="NORWEGIAN HOSPITAL" />
    <node id="THE UNIFIED THEORY OF ACCEPTANCE AND USE OF TECHNOLOGY (UTAUT)" />
    <node id="OSTEOARTHRITIS" />
    <node id="MENISCAL TEARS" />
    <node id="KNEE JOINT REPLACEMENT" />
    <node id="PATELLOFEMORAL PAIN" />
    <node id="MCMURRAY TEST" />
    <node id="HIP AND KNEE STRENGTHENING EXERCISES" />
    <node id="FOOT ORTHOSES" />
    <node id="PATELLAR TAPING" />
    <node id="CONSERVATIVE MANAGEMENT" />
    <node id="EXERCISE THERAPY" />
    <node id="KNEE OA" />
    <node id="WEIGHT LOSS" />
    <node id="EDUCATION AND SELF-MANAGEMENT PROGRAMS" />
    <node id="SURGICAL REFERRAL" />
    <node id="AL-ZAHRA HOSPITAL" />
    <node id="ISFAHAN" />
    <node id="SCENARIO 19" />
    <node id="SCENARIO 34" />
    <node id="HEALTHCARE INDUSTRY" />
    <node id="DATA ANALYTIC (DA)" />
    <node id="DATA SCIENTISTS" />
    <node id="MEDICAL PROVIDERS" />
    <node id="FUZZY ANALYTIC HIERARCHY PROCESS (FUZZY AHP)" />
    <node id="FUZZY TECHNIQUES FOR ORDER PREFERENCE BY SIMILARITY TO IDEAL SOLUTION (FUZZY TOPSIS)" />
    <node id="CAYA" />
    <node id="US STATES" />
    <node id="CANCER CARE CONTINUUM" />
    <node id="FEMALE RISK ESTIMATION TOOLS" />
    <node id="MATURE OOCYTE/EMBRYO CRYOPRESERVATION" />
    <node id="OVARIAN TISSUE CRYOPRESERVATION" />
    <node id="OVARIAN SUPPRESSION WITH GNRH AGONISTS" />
    <node id="IN VITRO OOCYTE MATURATION" />
    <node id="GYNECOLOGIC CANCERS" />
    <node id="SPERM CRYOPRESERVATION" />
    <node id="HEALTH INSURERS" />
    <node id="CIRRHOSIS" />
    <node id="WITHING'S BIOIMPEDANCE SCALE" />
    <node id="CLIF-CONSORTIUM ACUTE DECOMPENSATION (CLIF-C AD) SCORES" />
    <node id="CLINICAL FRAILTY SCORE (CFS)" />
    <node id="REMOTE MONITORING" />
    <node id="DECOMPENSATED CIRRHOSIS" />
    <node id="NUTRITIONAL STATUS" />
    <node id="KRAS-POSITIVE NSCLC" />
    <node id="ADVANCE DECISION TO REFUSE TREATMENT (ADRT)" />
    <node id="WESTERN EUROPE" />
    <node id="ADVANCE DIRECTIVE" />
    <node id="ORGANIZATIONS THAT DESIGN TEMPLATES FOR ADVANCE CARE PLANNING" />
    <node id="AMERICAN CANCER SOCIETY CANCER ACTION NETWORK" />
    <node id="2019 SUMMIT" />
    <node id="ETHIOPIAN NATIONAL KIDNEY TRANSPLANTATION CENTER" />
    <node id="ETHIOPIA" />
    <node id="KIDNEY TRANSPLANT" />
    <node id="GRAFT FAILURE" />
    <node id="PROBABILITY THRESHOLD MOVING" />
    <node id="TREE-BASED ENSEMBLE LEARNING" />
    <node id="BAGGED TREE" />
    <node id="STACKING ENSEMBLE LEARNING" />
    <node id="STOCHASTIC GRADIENT BOOSTING" />
    <node id="PROBABILITY CALIBRATIONS" />
    <node id="PANCREATICOBILIARY CANCER" />
    <node id="LIQUID BIOPSY" />
    <node id="ERBB2" />
    <node id="ATM" />
    <node id="NF1" />
    <node id="PIK3CA" />
    <node id="IDH1" />
    <node id="BILE" />
    <node id="PLASMA" />
    <node id="WEST CHINA HOSPITAL" />
    <node id="SICHUAN UNIVERSITY" />
    <node id="INTERNET OF MEDICAL THINGS (IOMT)" />
    <node id="COMPUTED TOMOGRAPHY (CT) EQUIPMENT" />
    <node id="ANOMALIES" />
    <node id="MEDICAL EQUIPMENT" />
    <node id="MAINTENANCE" />
    <node id="ADVANCED MACHINE LEARNING MODELS" />
    <node id="INTERPRETABLE MACHINE LEARNING TOOLS" />
    <node id="MEDICAL DECISION MAKING" />
    <node id="INTERPRETABILITY" />
    <node id="HOSPITAL READMISSION PREDICTION" />
    <node id="TWO-STEP EXTRACTED REGRESSION TREE APPROACH" />
    <node id="NEURAL NETWORKS" />
    <node id="LARGE TEACHING HOSPITAL IN ASIA" />
    <node id="PREDICTION ACCURACY" />
    <node id="RISK FACTORS" />
    <node id="DEBORAH MAYO" />
    <node id="ERROR-STATISTICAL APPROACH" />
    <node id="CHILDHOOD CANCER" />
    <node id="CRANIAL IRRADIATION" />
    <node id="ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT" />
    <node id="ENDOCRINE DISORDERS" />
    <node id="SUBSEQUENT NEOPLASMS" />
    <node id="KENTUCKY CANCER REGISTRY" />
    <node id="CHINESE CHILDREN'S CANCER GROUP" />
    <node id="ALL-2015 PROTOCOL" />
    <node id="TCF3::PBX1" />
    <node id="LUAD" />
    <node id="PD-(L)1 INHIBITORS" />
    <node id="TP53 VARIANT ALLELE FREQUENCY" />
    <node id="LOCAL COHORT" />
    <node id="DISCOVERY COHORT" />
    <node id="VALIDATION COHORT" />
    <node id="PORTUGAL" />
    <node id="STOCHASTIC GRADIENT DESCENT" />
    <node id="PORTUGUESE HOSPITAL" />
    <node id="EXPERIMENT 1" />
    <node id="EXPERIMENT 3" />
    <node id="EXPERIMENT 2" />
    <node id="CORONARY ARTERY DISEASE" />
    <node id="IRAN-PREMATURE CORONARY ARTERY DISEASE STUDY" />
    <node id="RAZI HOSPITAL" />
    <node id="BIRJAND" />
    <node id="RAPID SCOPING REVIEW" />
    <node id="MEDICAL LIBRARIAN" />
    <node id="DECEMBER 4, 2020" />
    <node id="APRIL 14, 2023" />
    <node id="BIOMEDICAL STUDIES" />
    <node id="LITERATURE SEARCH" />
    <node id="GREY LITERATURE SEARCH" />
    <node id="EXTENSIVE-STAGE SMALL CELL LUNG CANCER" />
    <node id="BRAIN METASTASES" />
    <node id="ANTIPROGRAMMED DEATH LIGAND 1 THERAPY" />
    <node id="LOCAL TEXT REUSE DETECTION" />
    <node id="PLAGIARISM DETECTION" />
    <node id="JOURNALISTS' USE OF PRESS RELEASES" />
    <node id="SCIENTISTS' CITATION OF EARLIER PAPERS" />
    <node id="CITATION LOCALIZATION DATASET" />
    <node id="PHILADELPHIA-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA" />
    <node id="CRLF2" />
    <node id="JAK2" />
    <node id="PHI-RACE CLASSIFIER" />
    <node id="DEVELOPING COUNTRIES" />
    <node id="PHILADELPHIA" />
    <node id="ANAPLASTIC LYMPHOMA KINASE (ALK)-MUTATED NON-SMALL CELL LUNG CANCER (NSCLC)" />
    <node id="LORLATINIB" />
    <node id="ALECTINIB" />
    <node id="ENSARTINIB" />
    <node id="BRIGATINIB" />
    <node id="CRIZOTINIB" />
    <node id="CERITINIB" />
    <node id="PEMETREXED-BASED CHEMOTHERAPY" />
    <node id="INTERNATIONAL CONFERENCES" />
    <node id="CAPTURE" />
    <node id="US PRIMARY CARE" />
    <node id="COPD" />
    <node id="PRIMARY CARE PRACTICE-BASED RESEARCH NETWORKS" />
    <node id="CHRONIC OBSTRUCTIVE PULMONARY DISEASE" />
    <node id="CHRONIC KIDNEY DISEASE EPIDEMIOLOGY COLLABORATION" />
    <node id="KIDNEY FAILURE" />
    <node id="ACUTE RESPIRATORY INFECTIONS" />
    <node id="ELECTRONIC HEALTH RECORD-INTEGRATED CPR" />
    <node id="CLINICAL PREDICTION RULES" />
    <node id="REGISTERED NURSE" />
    <node id="PRIMARY CARE SETTINGS" />
    <node id="NUDGES" />
    <node id="PRESCRIBING DECISIONS" />
    <node id="PUBLICATION BIAS" />
    <node id="COST-EFFECTIVENESS" />
    <node id="HEALTH AND SOCIAL SCIENCE DATABASES" />
    <node id="OPIOID PRESCRIBING" />
    <node id="ANTIBIOTIC PRESCRIBING" />
    <node id="AMERICAN COLLEGE OF RADIOLOGY" />
    <node id="BI-RADS" />
    <node id="TECSALUD HOSPITALS MONTERREY" />
    <node id="BREAST RADIOLOGY DEPARTMENT" />
    <node id="GOOGLE TRANSLATE" />
    <node id="MONTERREY" />
    <node id="BIOGPT" />
    <node id="BERT" />
    <node id="TUMOR IMMUNE MICROENVIRONMENT" />
    <node id="UBIQUITIN-PROTEASOME SYSTEM" />
    <node id="UBIQUITINATION" />
    <node id="P53" />
    <node id="PHOSPHATASE AND TENSIN HOMOLOG (PTEN)" />
    <node id="MYC PROTEIN" />
    <node id="LARGE LANGUAGE MODEL" />
    <node id="OPENAI GPT-3.5" />
    <node id="REPORTING GUIDELINE COMPLIANCE" />
    <node id="SPORTS MEDICINE CLINICAL TRIAL REPORTS" />
    <node id="HYPERPARAMETER AND MODEL FINE-TUNING" />
    <node id="MODEL PERFORMANCE ASSESSMENT" />
    <node id="DIABETIC PERIPHERAL NEUROPATHY" />
    <node id="DIABETIC FOOT ULCERS" />
    <node id="MACHINE LEARNING PREDICTIVE MODELS" />
    <node id="URINARY ALBUMIN-TO-CREATININE RATIO" />
    <node id="GLYCOSYLATED HEMOGLOBIN" />
    <node id="SERUM CREATININE" />
    <node id="CAROTID STENOSIS" />
    <node id="DECREASED SERUM ALBUMIN" />
    <node id="LOWER LYMPHOCYTE COUNT" />
    <node id="LOWER EXTREMITY ARTERIAL DISEASE" />
    <node id="ELEVATED NEUTROPHIL-TO-LYMPHOCYTE RATIO" />
    <node id="HIGHER D-DIMER LEVELS" />
    <node id="PARTICLE SWARM OPTIMIZATION" />
    <node id="SIMULATION MODELLING" />
    <node id="ENVIRONMENTAL CHALLENGES" />
    <node id="SCIENTIFIC MODELLING COMMUNITIES" />
    <node id="PARTICIPATORY MODELLING APPROACHES" />
    <node id="CHINA HEALTH AND RETIREMENT LONGITUDINAL STUDY" />
    <node id="SLEEP DURATION" />
    <node id="MEN" />
    <node id="DANISH HOSPITALS" />
    <node id="ICD-10" />
    <node id="NEURAL NET" />
    <node id="SHAP" />
    <node id="C-REACTIVE PROTEIN" />
    <node id="ESTIMATED GLOMERULAR FILTRATION" />
    <node id="THROMBOTIC DISEASES" />
    <node id="ATHEROSCLEROTIC DISEASES" />
    <node id="SEASONAL VARIATION" />
    <node id="HYPERPARAMETER OPTIMIZATION" />
    <node id="AUROC" />
    <node id="AUPRC" />
    <node id="R-CHOP" />
    <node id="DLBCL" />
    <node id="CREB1" />
    <node id="N4BP1" />
    <node id="UBAP2" />
    <node id="DEAF1" />
    <node id="INTERNATIONAL PROGNOSTIC INDEX" />
    <node id="HIGH-DENSITY ANTIGEN MICROARRAY" />
    <node id="SPLC-RAT" />
    <node id="MAYO CLINIC" />
    <node id="NATIONAL COMPREHENSIVE CANCER NETWORK" />
    <node id="SECOND PRIMARY LUNG CANCER (SPLC)" />
    <node id="SPLC-RAT DEVELOPMENT COHORT" />
    <node id="CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER (CKD-MBD)" />
    <node id="MACHINE LEARNING PREDICTION METHODS" />
    <node id="SEQUENTIAL FORWARD FEATURE SELECTION" />
    <node id="CALCIUM ABNORMALITY" />
    <node id="PHOSPHORUS ABNORMALITY" />
    <node id="PTH ABNORMALITY" />
    <node id="RABBIT ANTITHYMOCYTE GLOBULIN (ATG)" />
    <node id="GRAFT-VERSUS-HOST DISEASE (GVHD)" />
    <node id="HEMATOPOIETIC CELL TRANSPLANTATION" />
    <node id="POSTTRANSPLANT CYCLOPHOSPHAMIDE (PTCY)" />
    <node id="PHILADELPHIA CHROMOSOME-POSITIVE ALL" />
    <node id="LEUKEMIA-FREE SURVIVAL (LFS)" />
    <node id="MATCHED UNRELATED DONORS" />
    <node id="WANG" />
    <node id="ANTIBIOTIC OVERPRESCRIPTION" />
    <node id="DOCTOR-PATIENT INTERACTIONS" />
    <node id="HEALTH COMMUNICATION" />
    <node id="NON-PRESCRIBED ANTIBIOTICS USE" />
    <node id="KRASG12C" />
    <node id="EXON 20 INSERTIONS" />
    <node id="RET MUTATIONS" />
    <node id="ANTIBODY DRUG CONJUGATES" />
    <node id="MIMIC-IV DATABASE" />
    <node id="GOOGLE BIGQUERY" />
    <node id="SHAP (SHAPLEY ADDITIVE EXPLANATIONS)" />
    <node id="SYNTHETIC MINORITY OVER-SAMPLING TECHNIQUE (SMOTE)" />
    <node id="MULTILAYER PERCEPTRONS (MLP)" />
    <node id="SUPPORT VECTOR MACHINES (SVM)" />
    <node id="SEQUENTIAL HALVING AND CLASSIFICATION (SHAC)" />
    <node id="MASTECTOMY" />
    <node id="CANCER CENTERS" />
    <node id="HEALTH SYSTEMS" />
    <node id="SINGLE SPECIALTY PRACTICES" />
    <node id="MULTISPECIALTY PRACTICES" />
    <node id="PHASE 2/3 AND PHASE 3 TRIALS" />
    <node id="ADOLESCENT AND YOUNG ADULT PATIENTS" />
    <node id="NON-HISPANIC BLACKS" />
    <node id="NON-HISPANIC WHITES" />
    <node id="GERM CELL TUMOR TRIALS" />
    <node id="ZIP CODES WITH MEDIAN HOUSEHOLD INCOME &#8804;150% OF FEDERAL POVERTY LINE" />
    <node id="PEDIATRIC CLINICAL TRIALS" />
    <node id="IMMUNE CHECKPOINT INHIBITOR" />
    <node id="MERKEL CELL CARCINOMA" />
    <node id="FDG-PET/CT" />
    <node id="RECURRENCE-FREE SURVIVAL" />
    <node id="NOVEMBER 2017 TO FEBRUARY 2022" />
    <node id="THEORETICAL DOMAINS FRAMEWORK (TDF)" />
    <node id="ACUTE LOW BACK PAIN MANAGEMENT" />
    <node id="PRIMARY CARE" />
    <node id="IMPLEMENTATION RESEARCH" />
    <node id="INTERVENTION DEVELOPMENT" />
    <node id="SMALL GROUP WORKSHOPS" />
    <node id="OCULAR FUNDUS DISEASES" />
    <node id="GLOBAL AGING" />
    <node id="DIAGNOSTIC INTELLIGENT DECISION SUPPORT PLATFORM" />
    <node id="SOFTLEXICON-GLOVE-WORD2VEC MODEL" />
    <node id="JUNIOR DOCTORS" />
    <node id="EXPERIENCED DOCTORS" />
    <node id="MULTIDISCIPLINARY SPANISH DIGESTIVE CANCER GROUP" />
    <node id="CYP2D6" />
    <node id="GEMCAD COHORT" />
    <node id="ANAL SQUAMOUS CELL CARCINOMA" />
    <node id="DISEASE-FREE SURVIVAL" />
    <node id="5-FLUOROURACIL" />
    <node id="MITOMYCIN C" />
    <node id="PARAFFIN TUMOR SAMPLES" />
    <node id="NORTHERN CALIFORNIA" />
    <node id="MIGRAINE" />
    <node id="TRADITIONAL RWE" />
    <node id="ADVANCED RWE" />
    <node id="LIVING SYSTEMATIC REVIEWS" />
    <node id="JOURNAL PUBLISHERS" />
    <node id="HEALTHCARE POLICY" />
    <node id="COCHRANE REVIEW" />
    <node id="OPEN SCIENCE FRAMEWORK" />
    <node id="PAXLOVID" />
    <node id="NIRMATRELVIR" />
    <node id="RITONAVIR" />
    <node id="RH IMMUNOGLOBULIN" />
    <node id="FIRST-TRIMESTER ABORTION" />
    <node id="RH SENSITIZATION" />
    <node id="GESTATION" />
    <node id="ABORTION CARE" />
    <node id="MEDICATION ABORTION" />
    <node id="PROCEDURAL ABORTION" />
    <node id="HIGH-THROUGHPUT FLOW CYTOMETRY" />
    <node id="MULTICENTER OBSERVATIONAL PROSPECTIVE COHORT STUDY" />
    <node id="HIGH-DOSE CHEMOTHERAPY" />
    <node id="GERM CELL TUMORS" />
    <node id="AMERICAN SPEECH-LANGUAGE-HEARING ASSOCIATION" />
    <node id="WEB OF KNOWLEDGE" />
    <node id="DATA QUALITY IN HEALTH INFORMATION SYSTEMS" />
    <node id="SCIENCE DIRECT" />
    <node id="EMERALD" />
    <node id="CONSISTENCY" />
    <node id="SECURITY" />
    <node id="TIMELINESS" />
    <node id="COMPLETENESS" />
    <node id="RELIABILITY" />
    <node id="ACCESSIBILITY" />
    <node id="OBJECTIVITY" />
    <node id="RELEVANCY" />
    <node id="UNDERSTANDABILITY" />
    <node id="NAVIGATION" />
    <node id="REPUTATION" />
    <node id="EFFICIENCY" />
    <node id="VALUE-ADDED" />
    <node id="ACE-R" />
    <node id="CHC MODEL" />
    <node id="FUZZY EXPERT SYSTEM" />
    <node id="EDDIE" />
    <node id="TECHNOLOGY AGENCY OF THE CZECH REPUBLIC" />
    <node id="MAURICIO SUAREZ" />
    <node id="INTRODUCTION" />
    <node id="ARTHUR FINE" />
    <node id="THE NATURE OF FICTIONS IN SCIENCE" />
    <node id="JOSEPH ROUSE" />
    <node id="ANOUK BARBEROUSSE" />
    <node id="PASCAL LUDWIG" />
    <node id="CATHERINE ELGIN" />
    <node id="THE EXPLANATORY POWER OF FICTIONS" />
    <node id="ALISA BOKULICH" />
    <node id="MARGARET MORRISON" />
    <node id="CARSTEN HELD" />
    <node id="FICTIONS IN THE PHYSICAL SCIENCES" />
    <node id="ERIC WINSBERG" />
    <node id="RACHEL ANKENY" />
    <node id="FICTIONS IN THE SPECIAL SCIENCES" />
    <node id="TARJA KNUUTTILA" />
    <node id="PAUL TELLER" />
    <node id="FICTIONS AND REALISM" />
    <node id="RONALD N. GIERE" />
    <node id="AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION" />
    <node id="MINIMAL RESIDUAL DISEASE" />
    <node id="VERY GOOD PARTIAL RESPONSE" />
    <node id="COMPLETE RESPONSE" />
    <node id="SINGLE-CENTER STUDY" />
    <node id="HIGH-RISK CYTOGENETIC ABNORMALITIES" />
    <node id="NEXT-GENERATION FLOW CYTOMETRY" />
    <node id="BURN CENTER" />
    <node id="INFORMAL CAREGIVERS" />
    <node id="CHILDREN WITH BURN INJURIES" />
    <node id="E-HEALTH LITERACY" />
    <node id="MOBILE PHONE USAGE" />
    <node id="HEALTH CARE NEEDS" />
    <node id="ELECTRONIC HEALTH LITERACY" />
    <node id="MOBILE HEALTH (MHEALTH) INTERVENTIONS" />
    <node id="ACUTE MYOCARDITIS" />
    <node id="INFLUENZA" />
    <node id="CORONAVIRUS" />
    <node id="SYSTEMIC LUPUS ERYTHEMATOSUS" />
    <node id="SMALLPOX VACCINE" />
    <node id="MRNA COVID-19 VACCINES" />
    <node id="MYOCARDIUM" />
    <node id="TROPONINS" />
    <node id="ELECTROCARDIOGRAPHIC ST SEGMENTS" />
    <node id="ECHOCARDIOGRAPHIC WALL MOTION ABNORMALITIES" />
    <node id="CARDIAC MAGNETIC RESONANCE IMAGING" />
    <node id="ENDOMYOCARDIAL BIOPSY" />
    <node id="EXTRACORPOREAL LIFE SUPPORT" />
    <node id="GUIDELINES INTERNATIONAL NETWORK" />
    <node id="G-I-N PERFORMANCE MEASURES WORKING GROUP" />
    <node id="SAMSUNG MEDICAL CENTER" />
    <node id="DEEP LEARNING-BASED NLP" />
    <node id="BIOBERT" />
    <node id="BIDIRECTIONAL LSTM WITH CONDITIONAL RANDOM FIELDS" />
    <node id="GENERALIZED JOINT HYPER-MOBILITY" />
    <node id="EHLERS-DANLOS SYNDROME" />
    <node id="HYBRIDPOSENET" />
    <node id="MOBILENET-V2" />
    <node id="HYPERLSTM" />
    <node id="ASCVD" />
    <node id="ML-BASED ANN MODEL" />
    <node id="ELECTROCARDIOGRAPH" />
    <node id="ECHOCARDIOGRAPHY" />
    <node id="PCE" />
    <node id="CHINA-PAR" />
    <node id="ACTIVITY COACH" />
    <node id="NCT05235763" />
    <node id="PHYSICAL INACTIVITY" />
    <node id="SEDENTARY LIFESTYLE" />
    <node id="REGISTRY" />
    <node id="CLAIMS DATA" />
    <node id="GENOMIC TESTING" />
    <node id="EARLY-STAGE BREAST CANCER" />
    <node id="CHEMOENDOCRINE THERAPY" />
    <node id="MEDICATION DELIVERY SYSTEM" />
    <node id="MINISTRY OF HEALTH" />
    <node id="ELECTRONIC HEALTH SOLUTIONS" />
    <node id="MY HAKEEM APP" />
    <node id="LIKERT SCALE" />
    <node id="GEMINI" />
    <node id="FLESCH READING EASE SCORE (FRES)" />
    <node id="MODIFIED DISCERN SCALE" />
    <node id="GLOBAL QUALITY SCALE (GQS)" />
    <node id="COPILOT" />
    <node id="OUTPATIENT SERVICE" />
    <node id="CPLEX" />
    <node id="SENIOR DOCTORS" />
    <node id="ASSOCIATE SENIOR DOCTORS" />
    <node id="CARDIOVASCULAR RISK FACTORS STUDY" />
    <node id="HYPERLIPIDEMIA" />
    <node id="MEXICAN AMERICAN ADULTS" />
    <node id="BLACK ADULTS" />
    <node id="OTHER HISPANIC ADULTS" />
    <node id="INGUINAL HERNIA" />
    <node id="INTESTINAL NECROSIS" />
    <node id="BOWEL RESECTION SURGERY" />
    <node id="LASSO REGRESSION MODEL" />
    <node id="NOMOGRAM GRAPH" />
    <node id="EUROQOL VALUATION TECHNOLOGY" />
    <node id="EQ-VT DESIGN" />
    <node id="RMSE" />
    <node id="MAE" />
    <node id="ELECTRONIC NOSE TECHNOLOGY" />
    <node id="BENIGN PROSTATIC HYPERPLASIA" />
    <node id="VISUAL ELECTROPHYSIOLOGY" />
    <node id="FLASH VISUAL EVOKED POTENTIAL" />
    <node id="ARTIFICIAL INTELLIGENCE ALGORITHM" />
    <node id="MCAC-NET" />
    <node id="RETINITIS PIGMENTOSA" />
    <node id="FVEP DATASET" />
    <node id="PLATINUM-ETOPOSIDE" />
    <node id="EASTERN COOPERATIVE GROUP" />
    <node id="ES-SCLC" />
    <node id="MAYO CLINIC HEALTH SYSTEM" />
    <node id="PHASE 3 CLINICAL TRIALS" />
    <node id="PATIENT-DETECTED BREAST CANCER" />
    <node id="MAMMOGRAPHY-DETECTED BREAST CANCER" />
    <node id="INSTITUTIONAL COHORT" />
    <node id="PHYSICIAN-DETECTED BREAST CANCER" />
    <node id="1990-2019" />
    <node id="CHINESE GOVERNMENT" />
    <node id="ZERO-COVID POLICY" />
    <node id="BORDER REOPENING" />
    <node id="ERDOS RENYL NETWORK" />
    <node id="SEIRS MODEL" />
    <node id="JULY-SEPTEMBER WAVE" />
    <node id="OCT-DEC WAVE" />
    <node id="HEALTHSEARCHQA" />
    <node id="FLAN-PALM" />
    <node id="MEDQA" />
    <node id="MEDMCQA" />
    <node id="PUBMEDQA" />
    <node id="MMLU" />
    <node id="CLINICAL APPLICATIONS" />
    <node id="HUMAN EVALUATION" />
    <node id="PATHWAYS LANGUAGE MODEL" />
    <node id="MED-PALM" />
    <node id="INSTRUCTION PROMPT TUNING" />
    <node id="EORTC 26951 TRIAL" />
    <node id="RTOG 9402 TRIAL" />
    <node id="JUMPING DIAGNOSTIC ODDS RATIO SEQUENTIAL PATTERNS (JDORSP)" />
    <node id="HEALTH-CARE DOMAIN" />
    <node id="MEDICAL EXPERTS" />
    <node id="PATTERN MINING TECHNIQUES" />
    <node id="CLINICAL EVALUATION" />
    <node id="TEMPORAL DIMENSION" />
    <node id="MULTIVARIATE SEQUENTIAL PATTERNS" />
    <node id="SYMPTOM CHECKER APPLICATIONS" />
    <node id="HYPOCHONDRIA" />
    <node id="SELF-EFFICACY" />
    <node id="GERMAN CLINICAL TRIALS REGISTER" />
    <node id="UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER" />
    <node id="30-DAY MORTALITY" />
    <node id="PREDICTIVE MODELING" />
    <node id="MEDICINE" />
    <node id="HEALTHCARE SETTINGS" />
    <node id="ULTRA-ORTHODOX COMMUNITY" />
    <node id="WEB-BASED DECISION AID" />
    <node id="JEWISH ULTRA-ORTHODOX COMMUNITY" />
    <node id="MUSLIM-ARABS" />
    <node id="HEBREW-SPEAKING PARENTS" />
    <node id="YOUNG ADULTS" />
    <node id="CENTRAL BRAIN TUMOR REGISTRY OF THE UNITED STATES" />
    <node id="CENTER FOR DISEASE CONTROL AND PREVENTION" />
    <node id="NATIONAL PROGRAM OF CANCER REGISTRIES" />
    <node id="UNITED STATES CANCER STATISTICS" />
    <node id="PREVEST" />
    <node id="CANCER BURDEN" />
    <node id="RUSSIAN FEDERATION" />
    <node id="REGIONAL HEALTH AUTHORITIES" />
    <node id="EPIDEMIC PROCESS" />
    <node id="HY-PER TRIAL" />
    <node id="FRENCH HOSPITALS" />
    <node id="NCT02201732" />
    <node id="VACUUM ASPIRATION" />
    <node id="HYSTEROSCOPY" />
    <node id="METHODOLOGICAL QUALITY" />
    <node id="RISK OF BIAS" />
    <node id="3-D MODELS" />
    <node id="WOODEN SHIPS" />
    <node id="PLASTIC MOLECULES" />
    <node id="WAX BODIES" />
    <node id="PERSPEX ECONOMY" />
    <node id="CORK MONUMENTS" />
    <node id="PLASTER MATHEMATICS" />
    <node id="CASTS OF DISEASES" />
    <node id="HABITAT DIORAMAS" />
    <node id="EXTINCT MONSTERS" />
    <node id="META-ANALYSES" />
    <node id="RESEARCH SCREENER" />
    <node id="ACUTE PROMYELOCYTIC LEUKEMIA" />
    <node id="RESNET-18" />
    <node id="INTERNATIONAL SOCIETY OF LABORATORY HEMATOLOGY" />
    <node id="TUFTS HEALTH SCIENCES INSTITUTIONAL REVIEW BOARD" />
    <node id="STUDY 1644" />
    <node id="TUFTS MEDICINE HEALTHCARE SYSTEM" />
    <node id="TUFTS MEDICINE SENIOR VICE PRESIDENT OF ACADEMIC INTEGRATION" />
    <node id="HOSPITAL EMPLOYEES" />
    <node id="INDEX SYSTEM" />
    <node id="DELPHI METHOD" />
    <node id="ANALYTIC HIERARCHY PROCESS" />
    <node id="DISEASE RISK PREDICTION" />
    <node id="BRCA1/2 MUTATIONS" />
    <node id="HER2/NEU-POSITIVE BC" />
    <node id="CLINICOPATHOLOGIC FEATURES" />
    <node id="SURVIVAL RATES" />
    <node id="GERMLINE BRCA MUTATIONS" />
    <node id="UNIVARIATE AND MULTIVARIABLE COX PROPORTIONAL HAZARDS REGRESSION MODELS" />
    <node id="CLASSICAL PARTICLE MECHANICS" />
    <node id="COLLISION MECHANICS" />
    <node id="RELATIVISTIC COLLISION MECHANICS" />
    <node id="LAGRANGIAN MECHANICS" />
    <node id="DALTONIAN STOICHIOMETRY" />
    <node id="SIMPLE EQUILIBRIUM THERMODYNAMICS" />
    <node id="PURE EXCHANGE ECONOMICS" />
    <node id="LUDWIG WITTGENSTEIN" />
    <node id="PHILOSOPHICAL INVESTIGATIONS" />
    <node id="GERMAN-ENGLISH VERSION" />
    <node id="ANSCOMBE" />
    <node id="PHILOSOPHY OF PSYCHOLOGY - A FRAGMENT" />
    <node id="FOURTH EDITION" />
    <node id="ENGLISH TRANSLATION" />
    <node id="EDITORIAL ENDNOTES" />
    <node id="TRANS AND GENDER-NONCONFORMING PATIENTS" />
    <node id="PROVIDER INCLUSIVITY SIGNALING" />
    <node id="HEALTH DISPARITIES" />
    <node id="POLITICALLY LIBERAL PARTICIPANTS" />
    <node id="POLITICALLY CONSERVATIVE PARTICIPANTS" />
    <node id="INCLUSIVITY IN HEALTH CARE" />
    <node id="PATIENT-PROVIDER INTERACTIONS" />
    <node id="BACKLASH" />
    <node id="RENAL REPLACEMENT TREATMENT" />
    <node id="NEPHROLOGY MEDICAL TEAM" />
    <node id="BRIEF ILLNESS PERCEPTION QUESTIONNAIRE" />
    <node id="SOUTHERN TAIWAN" />
    <node id="AVALON" />
    <node id="VIALE-A" />
    <node id="EBV(-)M-PTLD" />
    <node id="PEDIATRIC MATURE B-NHL-SPECIFIC REGIMEN" />
    <node id="LOW-DOSE CYCLOPHOSPHAMIDE, PREDNISONE, AND RITUXIMAB" />
    <node id="EUROPEAN HEALTH DATA SPACE" />
    <node id="ELECTRONIC MEDICAL RECORD SYSTEM" />
    <node id="SURGICAL DEPARTMENTS" />
    <node id="DATA QUALITY" />
    <node id="IMPLEMENTATION PROCESS" />
    <node id="TISOTUMAB VEDOTIN" />
    <node id="HUMAN PAPILLOMAVIRUS VACCINE" />
    <node id="NORTH SHEWA ZONE" />
    <node id="DISTRICT HEALTH OFFICE" />
    <node id="DATA-INFORMED PLATFORM FOR HEALTH" />
    <node id="PERFORMANCE MONITORING TEAM" />
    <node id="CATBOOST ALGORITHM" />
    <node id="SELLA AREA" />
    <node id="SELLA HEIGHT POSTERIOR" />
    <node id="EXPERIMENT 4" />
    <node id="SELLA HEIGHT MEDIAN" />
    <node id="CHRONIC MYELOMONOCYTIC LEUKEMIA" />
    <node id="CLADRIBINE" />
    <node id="LOW-DOSE CYTARABINE" />
    <node id="HYPOMETHYLATING AGENTS" />
    <node id="INTERNATIONAL WORKING GROUP" />
    <node id="RETROSPECTIVE CHART REVIEW" />
    <node id="GULU CITY" />
    <node id="FAMILY PLANNING SELF-CARE INTERVENTIONS" />
    <node id="MOBILE PHONES" />
    <node id="NORTHERN UGANDA" />
    <node id="SPSS SOFTWARE" />
    <node id="HEALTHCARE PRACTITIONERS" />
    <node id="HEALTH DEVELOPMENT PARTNERS" />
    <node id="URGENT CARE" />
    <node id="CARE PARTNERS" />
    <node id="FEBRUARY 2022" />
    <node id="TRANSFORMER MODEL" />
    <node id="MEDBERT" />
    <node id="MASSGENIE" />
    <node id="BIOMEDICAL DOMAIN" />
    <node id="NATIONAL DEATH INDEX" />
    <node id="COHORT STUDY" />
    <node id="US HEALTH CARE WORKERS" />
    <node id="REGISTERED NURSES" />
    <node id="HEALTH TECHNICIANS" />
    <node id="HEALTH CARE SUPPORT WORKERS" />
    <node id="SOCIAL/BEHAVIORAL HEALTH WORKERS" />
    <node id="NON-HEALTH CARE WORKERS" />
    <node id="SUICIDE RISK" />
    <node id="SOFT DRINKS INDUSTRY LEVY" />
    <node id="IMPACT NCD GERMANY" />
    <node id="CARDIOMETABOLIC DISEASES" />
    <node id="CORONARY HEART DISEASE" />
    <node id="PRIMETIME" />
    <node id="JAK INHIBITOR RUXOLITINIB" />
    <node id="CANCER CENTER" />
    <node id="AACTT FRAMEWORK" />
    <node id="TACT FRAMEWORK" />
    <node id="FRENCH ET AL." />
    <node id="IMPLEMENTATION INTERVENTIONS" />
    <node id="HEALTH SYSTEM" />
    <node id="PRECISION MEDICINE FOR CHILDREN WITH CANCER (PRISM)" />
    <node id="PARENTS" />
    <node id="ADOLESCENT PATIENTS" />
    <node id="PISCF" />
    <node id="DECISION AID" />
    <node id="INTERNATIONAL PATIENT DECISION AID STANDARDS" />
    <node id="DECISIONAL CONFLICT SCALE" />
    <node id="RBC TRANSFUSION" />
    <node id="HEMOGLOBIN THRESHOLDS" />
    <node id="SEQUENTIAL ORGAN FAILURE ASSESSMENT" />
    <node id="PERSONALIZED DIABETES RISK INFORMATION" />
    <node id="RISK COMMUNICATION INTERVENTION" />
    <node id="MOTIVATED REASONING" />
    <node id="RISK SKEPTICISM" />
    <node id="BAYESIAN UPDATING" />
    <node id="PERSONAL RELEVANCE" />
    <node id="SLEEP APNEA SYNDROME" />
    <node id="POLYSOMNOGRAPHY" />
    <node id="MASSACHUSETTS GENERAL HOSPITAL" />
    <node id="AUTOENCODER" />
    <node id="ONE DIMENSIONAL CONVOLUTIONAL NEURAL NETWORK&#8212;LONG SHORT-TERM MEMORY (1D CNN-LSTM)" />
    <node id="LONG-TERM SURVIVORS" />
    <node id="FAECALIBACTERIUM PRAUSNITZII" />
    <node id="AKKERMANSIA MUCINIPHILA" />
    <node id="RUMINACOCCACEAE FAMILY" />
    <node id="ILLUMINA NEXTSEQ500" />
    <node id="PCA" />
    <node id="MICROBIOMESEQ" />
    <node id="PHYLOSEQ" />
    <node id="CONTROL PATIENTS" />
    <node id="TP53-MUTATED ACUTE MYELOID LEUKEMIA" />
    <node id="NON-HISPANIC WHITE PATIENTS" />
    <node id="NON-HISPANIC BLACK PATIENTS" />
    <node id="MULTICENTER RETROSPECTIVE STUDY" />
    <node id="INTENSIVE CHEMOTHERAPY" />
    <node id="ALLOGENEIC STEM CELL TRANSPLANTATION" />
    <node id="LOW-INTENSITY CHEMOTHERAPY" />
    <node id="BEST SUPPORTIVE CARE" />
    <node id="EXPERIMENTAL ECONOMICS" />
    <node id="PHILOSOPHER OF SCIENCE" />
    <node id="HEMATOMA EXPANSION" />
    <node id="SPONTANEOUS INTRACEREBRAL HEMORRHAGE" />
    <node id="CT IMAGE EXTRACTION" />
    <node id="INTRAOPERATIVE BLOOD TRANSFUSION" />
    <node id="INTRACRANIAL ANEURYSM SURGERY" />
    <node id="JANUARY 2019 TO DECEMBER 2021" />
    <node id="RANGER" />
    <node id="EXTREMELY GRADIENT BOOSTING MODEL" />
    <node id="EE GAP" />
    <node id="ROUTINE CLINICAL PRACTICE" />
    <node id="TRAUMA CENTERS" />
    <node id="EMS PRACTITIONERS" />
    <node id="RURAL AREAS" />
    <node id="TRIAGE" />
    <node id="PUBLIC HEALTH PROFESSIONALS" />
    <node id="PREGNANCY" />
    <node id="PREGNANCY RISK ASSESSMENT MONITORING SYSTEM (PRAMS)" />
    <node id="CARDIOVASCULAR HEALTH (CVH)" />
    <node id="ADVERSE PREGNANCY OUTCOMES (APOS)" />
    <node id="CARDIOVASCULAR DISEASE (CVD)" />
    <node id="EUROPEAN SOCIETY OF CARDIOLOGY" />
    <node id="CONVOLUTIONAL NEURAL NETWORK" />
    <node id="BIOMEDICAL RELATION EXTRACTION" />
    <node id="SHORTEST DEPENDENCY PATHS" />
    <node id="RE CLASSIFIERS" />
    <node id="NATIONAL CENTER FOR HEALTH INSURANCE RESEARCH" />
    <node id="KHUZESTAN" />
    <node id="HEALTH INSURANCE CLAIMS DATA" />
    <node id="GESTATIONAL DIABETES MELLITUS SCREENING" />
    <node id="UNIVERSAL SCREENING" />
    <node id="CURRENT GUIDELINES" />
    <node id="HIGH-RISK SCREENING" />
    <node id="NO SCREENING" />
    <node id="TYPE 2 DIABETES MELLITUS" />
    <node id="PERINATAL DEATH" />
    <node id="DECISION FATIGUE" />
    <node id="ANTIBIOTICS" />
    <node id="OSTEOPOROSIS MEDICATIONS" />
    <node id="BENZODIAZEPINES" />
    <node id="OPIOIDS" />
    <node id="BETTERING THE EVALUATION AND CARE OF HEALTH PROGRAM" />
    <node id="OCTOBER 2022" />
    <node id="5-YEAR SURVIVAL RATES" />
    <node id="INCIDENCE" />
    <node id="LAYPEOPLE" />
    <node id="INDIGENOUS PEOPLES" />
    <node id="ALBERTA PROSTATE CANCER RESEARCH INITIATIVE" />
    <node id="COST-EFFECTIVENESS PLANES" />
    <node id="NET MONETARY BENEFIT LINES" />
    <node id="COST-EFFECTIVENESS ACCEPTABILITY CURVES" />
    <node id="EXPECTED LOSS CURVES" />
    <node id="GLOBAL DIETARY DATABASE" />
    <node id="LATIN AMERICA AND THE CARIBBEAN" />
    <node id="1990" />
    <node id="SUB-SAHARAN AFRICA" />
    <node id="SSB" />
    <node id="2020" />
    <node id="LATENT SEMANTIC INDEXING" />
    <node id="GPT-4" />
    <node id="AZURE" />
    <node id="ICD-9" />
    <node id="SOCIAL AND BEHAVIORAL DETERMINANTS OF HEALTH" />
    <node id="MACHINE LEARNING APPROACHES" />
    <node id="SIAP" />
    <node id="SIAP-ALL" />
    <node id="ISR" />
    <node id="PYTHON 3.6" />
    <node id="TRADITIONAL CHINESE MEDICINE" />
    <node id="FORMULARY" />
    <node id="SIAP + ALL" />
    <node id="NONINVASIVE PRENATAL TESTING" />
    <node id="TRISOMY 21" />
    <node id="TREEAGE" />
    <node id="PREDICTION MODELLING" />
    <node id="PERITONITIS" />
    <node id="DECISION CURVE ANALYSIS (DCA)" />
    <node id="OPEN ABDOMEN TREATMENT" />
    <node id="MORTALITY PREDICTION MODELS" />
    <node id="CALIBRATION BELTS" />
    <node id="RECEIVER OPERATING CHARACTERISTIC CURVE (AUROC)" />
    <node id="PRECISION RECALL CURVE (AUPRC)" />
    <node id="BRIER SCORE" />
    <node id="LOGHMAN HAKIM HOSPITAL" />
    <node id="HEMODIALYSIS STUDY" />
    <node id="HISTGRADIENT BOOSTING (HGB)" />
    <node id="K-NEAREST NEIGHBORS (KNN)" />
    <node id="ADAPTIVE BOOSTING (ADABOOST)" />
    <node id="MACHINE LEARNING PREDICTION MODEL" />
    <node id="POISONED PATIENTS" />
    <node id="SDMMCC INTERVENTION" />
    <node id="GERIATRICIANS" />
    <node id="OUTPATIENT GERIATRIC CLINICS" />
    <node id="OPTIONMCC" />
    <node id="OLDER ADULTS WITH MULTIPLE CHRONIC CONDITIONS" />
    <node id="HUNGARY" />
    <node id="RA HIP SURGERY" />
    <node id="AI-BASED MEDICAL IMAGE EVALUATION" />
    <node id="EHEALS QUESTIONNAIRE" />
    <node id="12-LEAD ELECTROCARDIOGRAM (ECG)" />
    <node id="DEEP-LEARNING ALGORITHM" />
    <node id="BIDIRECTIONAL LONG SHORT-TERM MEMORY" />
    <node id="CHILD ABUSE AND NEGLECT" />
    <node id="U.S. ACADEMIC HEALTH CENTER" />
    <node id="CHILD ABUSE EXPERTS" />
    <node id="SOCIAL WORKERS" />
    <node id="PEDIATRIC PRIMARY CARE CLINICS" />
    <node id="SCIENTIFIC DISCOURSE" />
    <node id="AUTOMATIC CLASSIFIER" />
    <node id="CORPUS" />
    <node id="ANTIMICROBIAL RESISTANCE" />
    <node id="ARTIFICIAL INTELLIGENCE-BASED DECISION SUPPORT SYSTEMS" />
    <node id="ANTIMICROBIAL USE" />
    <node id="HOSPITAL MANAGERS" />
    <node id="HUMAN-ORGANIZATION-TECHNOLOGY-FIT MODEL" />
    <node id="ANTIBIOTIC PRESCRIPTION" />
    <node id="GERMAN HOSPITALS" />
    <node id="DECISION SUPPORT SYSTEM IMPLEMENTATION" />
    <node id="UNIVERSITY OF PENNSYLVANIA" />
    <node id="IN-PERSON CLINIC VISITS" />
    <node id="ADVANCE CARE PLANNING" />
    <node id="UNPLANNED HOSPITALIZATIONS" />
    <node id="SARCOMAS" />
    <node id="SURVSARC" />
    <node id="AYA SARCOMA SURVIVORS" />
    <node id="ISF" />
    <node id="CARDIOLOGISTS" />
    <node id="LOGISTIC TENSOR REGRESSION" />
    <node id="HYPOTENSION" />
    <node id="PULMONARY HEART DISEASE" />
    <node id="MITRAL REGURGITATION" />
    <node id="ATHEROSCLEROTIC HEART DISEASE" />
    <node id="SICKKIDS" />
    <node id="STANFORDPEDS" />
    <node id="STANFORDADULTS" />
    <node id="DIAGNOSTIC CODES" />
    <node id="CLINICAL PREDICTION MODELS" />
    <node id="HYPERKALEMIA" />
    <node id="NEUTROPENIA" />
    <node id="MULTICENTER NETWORK STUDIES" />
    <node id="VITAMIN D3" />
    <node id="ANTI-PD-1 IMMUNOTHERAPY" />
    <node id="MEDICAL THERAPY" />
    <node id="SPRINGER HANDBOOK" />
    <node id="MODEL-BASED REASONING" />
    <node id="CHINESE NATIONAL MEDICAL CENTER" />
    <node id="MULTIPLE MYELOMA RESEARCH FOUNDATION" />
    <node id="1Q GAIN/AMPLIFICATION" />
    <node id="AUTOGENOUS STEM CELL TRANSPLANTATION" />
    <node id="HOUSTON" />
    <node id="TEACHING HOSPITAL" />
    <node id="HGB TESTS" />
    <node id="HEALTHCARE COSTS" />
    <node id="PATIENT OUTCOMES" />
    <node id="COVID-19 GLOBAL PANDEMIC" />
    <node id="IRANIAN POPULATION" />
    <node id="SMOKER COVID-19 PATIENTS" />
    <node id="SIX MEDICAL CENTERS" />
    <node id="BILCAP TRIAL" />
    <node id="ADJUVANT RADIATION THERAPY" />
    <node id="PROPENSITY SCORE MATCHING" />
    <node id="MULTIVARIATE ANALYSIS" />
    <node id="ADJUVANT CAPECITABINE" />
    <node id="ESBENSHADE VANDERBILT MODELS" />
    <node id="STEM CELL TRANSPLANT" />
    <node id="ESVANALLOSCT" />
    <node id="SINGLE INSTITUTION" />
    <node id="BLOODSTREAM INFECTIONS" />
    <node id="NON-MELANOMA SKIN CANCER" />
    <node id="SCIENCEDIRECT" />
    <node id="SPRINGERLINK" />
    <node id="DIMENSIONS" />
    <node id="OTTAWA HOSPITAL" />
    <node id="PACLITAXEL" />
    <node id="H2RA" />
    <node id="DNM1" />
    <node id="MEIS1" />
    <node id="SUSD3" />
    <node id="CANCER GENOME ATLAS" />
    <node id="MACHINE-LEARNING TOOLS" />
    <node id="SVM-RFE" />
    <node id="KUHN" />
    <node id="HACKING" />
    <node id="FEYERABEND" />
    <node id="LAKATOS" />
    <node id="HIGH ENERGY PHYSICS" />
    <node id="MICROSCOPE IN CELL BIOLOGY" />
    <node id="VIMENTIN" />
    <node id="IMMUNE-CHECKPOINT INHIBITOR (ICI)" />
    <node id="PROGRAMMED DEATH-LIGAND 1 (PD-L1)" />
    <node id="TISSUE MICROARRAYS" />
    <node id="MULTICENTER STUDY" />
    <node id="OBJECTIVE RESPONSE RATE (ORR)" />
    <node id="INTERNATIONAL REGISTRY FOR MEN WITH ADVANCED PROSTATE CANCER" />
    <node id="ADVANCED PROSTATE CANCER" />
    <node id="CANCER AUSTRALIA NATIONAL CANCER CONTROL INDICATORS" />
    <node id="STUDY ENROLLMENT" />
    <node id="BLACK PARTICIPANTS" />
    <node id="WHITE PARTICIPANTS" />
    <node id="AGE AT ENROLLMENT" />
    <node id="DISEASE STATE AT ENROLLMENT" />
    <node id="SHARED DECISION-MAKING SUPPORT TRAINING" />
    <node id="BRONCHOPULMONARY DYSPLASIA" />
    <node id="GENERALIZED LINEAR MODELS" />
    <node id="NFE2L2" />
    <node id="GLS" />
    <node id="MONOCYTES" />
    <node id="GSE108754" />
    <node id="GSE190215" />
    <node id="GSE188944" />
    <node id="DECITABINE" />
    <node id="AZACITIDINE" />
    <node id="PD-1 INHIBITION" />
    <node id="EXPLAINABLE NLP" />
    <node id="HUMAN-ANNOTATED TEXTUAL EXPLANATIONS" />
    <node id="65 DATASETS" />
    <node id="DATA AUGMENTATION" />
    <node id="SUPERVISION" />
    <node id="GROUND-TRUTH EVALUATION" />
    <node id="LEFT VENTRICULAR ASSIST DEVICE (LVAD)" />
    <node id="DECISION-MAKING" />
    <node id="COPING" />
    <node id="LUNG ULTRASOUND" />
    <node id="PLEURAL EFFUSION" />
    <node id="DEEP-LEARNING MODEL" />
    <node id="LUS EXPERTS" />
    <node id="ALGORITHM" />
    <node id="DICE SIMILARITY COEFFICIENT" />
    <node id="NATIONAL EMERGENCY DEPARTMENT INFORMATION SYSTEM" />
    <node id="PUBLIC PRE-HOSPITAL CARE SYSTEM" />
    <node id="CARDIOVASCULAR EMERGENCY DISEASES" />
    <node id="INAPPROPRIATE HOSPITAL TRANSFER" />
    <node id="GAUTENG PROVINCE" />
    <node id="PUBLIC HEALTH DECISION- AND POLICY-MAKERS" />
    <node id="VIRUS HOT-SPOTS" />
    <node id="SOUTH AFRICA" />
    <node id="FIRST WAVE OF COVID-19" />
    <node id="SECOND WAVE OF COVID-19" />
    <node id="MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS" />
    <node id="NOVEMBER 8, 2020" />
    <node id="MARCH 5, 2005" />
    <node id="DELIBERATE THEN GENERATE" />
    <node id="ONCOLOGY RANDOMIZED CONTROLLED TRIALS" />
    <node id="LOW-MIDDLE/UPPER-MIDDLE INCOME COUNTRIES" />
    <node id="O'NEAL COMPREHENSIVE CANCER CENTER" />
    <node id="AFRICAN AMERICAN" />
    <node id="WHITE PATIENTS" />
    <node id="ONVACT" />
    <node id="NETHERLANDS TRIAL REGISTRY" />
    <node id="NL7335" />
    <node id="ARTIFICIAL INTELLIGENCE IN HEALTHCARE" />
    <node id="MEDICAL AI" />
    <node id="HEALTHCARE STAKEHOLDERS" />
    <node id="ETHICAL GOVERNANCE" />
    <node id="ALGORITHMIC BIAS" />
    <node id="OPACITY" />
    <node id="SAFETY AND SECURITY" />
    <node id="RESPONSIBILITY ATTRIBUTION" />
    <node id="BC CLINICIANS" />
    <node id="ONCOLOGY TEAM" />
    <node id="WEIGHT MANAGEMENT" />
    <node id="HEALTHY WEIGHT COUNSELING" />
    <node id="MEDICAL DIAGNOSIS" />
    <node id="FEEDBACK LOOP" />
    <node id="DIAGNOSTIC ERROR" />
    <node id="DISEASE ETIOLOGY" />
    <node id="ORTHOSTATIC HYPOTENSION" />
    <node id="ALL-CAUSE MORTALITY" />
    <node id="CENTRAL" />
    <node id="HYPERTENSION TRIAL PARTICIPANTS" />
    <node id="STANDING HYPOTENSION" />
    <node id="MARGINAL ZONE LYMPHOMAS" />
    <node id="HISTOLOGIC TRANSFORMATION" />
    <node id="DIFFUSE LARGE B-CELL LYMPHOMAS" />
    <node id="TBL1XR1" />
    <node id="PIM1" />
    <node id="BIOMEDICAL LITERATURE SURVEY" />
    <node id="KAMPNET" />
    <node id="GRAPH ATTENTION NETWORK" />
    <node id="GRAPH CONVOLUTIONAL NETWORK" />
    <node id="FORWARD HEAD POSTURE DETECTION STUDY" />
    <node id="EXTRA TREE CLASSIFIER" />
    <node id="DIABETIC RETINOPATHY" />
    <node id="MARKOV MODELING" />
    <node id="SCREENING INTERVENTION" />
    <node id="SIMULATION MODELING" />
    <node id="PREVENTIVE HEALTH INTERVENTION" />
    <node id="MENOPAUSE" />
    <node id="VASOMOTOR SYMPTOMS" />
    <node id="GENITOURINARY SYNDROME OF MENOPAUSE (GSM)" />
    <node id="CONJUGATED EQUINE ESTROGENS (CEE)" />
    <node id="PAROXETINE" />
    <node id="VENLAFAXINE" />
    <node id="VAGINAL PRASTERONE" />
    <node id="ORAL OSPEMIFENE" />
    <node id="MEDROXYPROGESTERONE ACETATE (MPA)" />
    <node id="BAZEDOXIFENE" />
    <node id="SPATIAL MOLECULAR PROFILING" />
    <node id="HUMAN HERPES SIMPLEX VIRUS INFECTION" />
    <node id="CYTO MODEL" />
    <node id="DEEP LEARNING-BASED CELL SEGMENTATION MODELS" />
    <node id="CELLPOSE" />
    <node id="IMMUNOFLUORESCENCE IMAGES" />
    <node id="SKIN TISSUE" />
    <node id="REGER" />
    <node id="CHINESE FERTILITY CENTER" />
    <node id="ELECTRONIC MEDICAL RECORD" />
    <node id="PREMATURE OVARIAN DECLINE" />
    <node id="REGEXGENERATOR++" />
    <node id="CHINESE REPRODUCTIVE EMRS" />
    <node id="GENETIC PROGRAMMING" />
    <node id="TURNING THE PAGE ON BREAST CANCER" />
    <node id="COMMUNITY EVENTS" />
    <node id="TPBC WEBSITE" />
    <node id="DEL(1P13.3)" />
    <node id="1Q21 GAIN" />
    <node id="1Q21 AMP" />
    <node id="INTERNATIONAL STAGING SYSTEM (ISS) STAGE 3" />
    <node id="GENE EXPRESSION PROFILING (GEP)70 HIGH RISK" />
    <node id="AHCYL1 GENE" />
    <node id="CKS1B LOCUS" />
    <node id="NATURAL FREQUENCIES FORMAT" />
    <node id="BAYESIAN INFERENCE" />
    <node id="CHORIONIC VILLUS SAMPLING TEST" />
    <node id="SOUTH KOREAN ADULTS" />
    <node id="STRICT ROUNDING" />
    <node id="LOOSE ROUNDING" />
    <node id="ABSOLUTE DEVIATION" />
    <node id="50-SPLIT" />
    <node id="WEB-BASED EXPERIMENTAL SURVEY" />
    <node id="POPULATION GENETICS" />
    <node id="POPULATION ECOLOGY" />
    <node id="MATHEMATICAL BIOGEOGRAPHY" />
    <node id="EVOLUTION" />
    <node id="DEMOGRAPHIC TIME" />
    <node id="EVOLUTIONARY TIME" />
    <node id="MAGIC EVIDENCE ECOSYSTEM FOUNDATION" />
    <node id="MAGICAPP" />
    <node id="BMJ RAPID RECOMMENDATIONS" />
    <node id="ENCOUNTER DECISION AIDS" />
    <node id="THE RESEARCH ETHICS COMMITTEE UZ/KU LEUVEN" />
    <node id="CLINICAL ENCOUNTERS" />
    <node id="EQ-5D-5L HEALTH STATE VALUATION STUDIES" />
    <node id="ONLINE RESPONDENTS" />
    <node id="FACE-TO-FACE SCREENED RESPONDENTS" />
    <node id="ONLINE PANELS" />
    <node id="MOBILITY" />
    <node id="ANXIETY/DEPRESSION" />
    <node id="PROXIMAL POLICY OPTIMIZATION" />
    <node id="TRUST REGION POLICY OPTIMIZATION" />
    <node id="DISCRETE-EVENT SIMULATION" />
    <node id="EVENT SCHEDULING" />
    <node id="PROCESS INTERACTION" />
    <node id="ACTIVITY SCANNING" />
    <node id="SINGLE-SERVER QUEUEING SYSTEM" />
    <node id="MULTIPLE-SERVER FINITE CAPACITY QUEUEING SYSTEM" />
    <node id="CONTINUOUS SIMULATION" />
    <node id="AGENT-BASED SIMULATION" />
    <node id="GAME OF LIFE MODEL" />
    <node id="VARIATION MODEL" />
    <node id="EMERGENT BEHAVIOR" />
    <node id="MONTE-CARLO SIMULATION" />
    <node id="CITATION BLOCK DETERMINATION" />
    <node id="RESEARCH PAPER SUMMARISATION" />
    <node id="IDEA ATTRIBUTION" />
    <node id="SENTIMENT ANALYSIS" />
    <node id="DE-IDENTIFICATION PIPELINE" />
    <node id="CHU DE RENNES" />
    <node id="EHOP CLINICAL DATA WAREHOUSE" />
    <node id="RENNES UNIVERSITY HOSPITAL" />
    <node id="FRENCH DE-IDENTIFICATION DATASET" />
    <node id="PRODIGY" />
    <node id="BI-LSTM + CRF" />
    <node id="FLAIR + FASTTEXT" />
    <node id="DEEP LEARNING-BASED MODELS" />
    <node id="NAMED ENTITY RECOGNITION" />
    <node id="PERITONEAL DIALYSIS" />
    <node id="CATBOOST" />
    <node id="PYTHON 3.8.3" />
    <node id="LEAF CAF&#201;" />
    <node id="SYDNEY" />
    <node id="TELEPHONE INTERVIEW FOR COGNITIVE STATUS-MODIFIED (TICS-M)" />
    <node id="BREAST CANCER CARE" />
    <node id="PRISM" />
    <node id="HEALTHCARE DELIVERY SETTINGS" />
    <node id="CLINICAL TEAM" />
    <node id="ORGANISATIONAL SUPPORT" />
    <node id="REGULATORY PROVISIONS" />
    <node id="GRADIENT BOOSTING MACHINE" />
    <node id="CD19-TARGETING CAR T CELLS" />
    <node id="ANTISYNTHETASE SYNDROME" />
    <node id="FLUDARABINE" />
    <node id="MYCOPHENOLATE MOFETIL" />
    <node id="AZATHIOPRINE" />
    <node id="UNIVERSITY HOSPITAL T&#220;BINGEN" />
    <node id="T&#220;BINGEN" />
    <node id="GET WITH THE GUIDELINES-STROKE PROGRAM" />
    <node id="ENDOVASCULAR THROMBECTOMY" />
    <node id="ACUTE ISCHEMIC STROKE" />
    <node id="INTRAHEPATIC CHOLANGIOCARCINOMA" />
    <node id="FOXP3" />
    <node id="CD68" />
    <node id="CD8&#913;" />
    <node id="PD-L1" />
    <node id="CLINICOPATHOLOGICAL CHARACTERISTICS" />
    <node id="PROGNOSIS" />
    <node id="MULTIPLEX IMMUNOFLUORESCENCE" />
    <node id="TREGIII" />
    <node id="RELAPSE-FREE SURVIVAL" />
    <node id="PRIMARY ANGLE CLOSURE SUSPECT (PACS)" />
    <node id="AI-AIDED DIAGNOSTIC SYSTEM" />
    <node id="ANTERIOR SEGMENT OPTICAL COHERENCE TOMOGRAPHY" />
    <node id="RANDOM FOREST (RF)" />
    <node id="CLASSIFICATION AND REGRESSION TREE (CART)" />
    <node id="ALEXNET" />
    <node id="VGG-16" />
    <node id="EXPERIENCED OPHTHALMOLOGISTS" />
    <node id="JUNIOR PHYSICIANS" />
    <node id="CONVOLUTIONAL NEURAL NETWORKS (CNN)" />
    <node id="PRO" />
    <node id="SMARTPHONE-BASED SELF-MANAGEMENT PLATFORM" />
    <node id="MALE PATIENTS" />
    <node id="FEMALE PATIENTS" />
    <node id="MINDRAY MC-100I" />
    <node id="ARTIFICIAL INTELLIGENCE (AI)" />
    <node id="BLOOD SAMPLES" />
    <node id="JUNIOR TECHNOLOGISTS" />
    <node id="INTERMEDIATE TECHNOLOGISTS" />
    <node id="LEUKOCYTE DIFFERENTIATION" />
    <node id="PERIPHERAL LEUKOCYTES" />
    <node id="HEMATOLOGY ANALYZERS" />
    <node id="US-MEXICO BORDER" />
    <node id="TEXAS-MEXICO BORDER" />
    <node id="CHILDREN WITH ALL" />
    <node id="CHILDREN WITH AML" />
    <node id="CHILDHOOD LEUKEMIA STUDY" />
    <node id="INTEROPERABILITY" />
    <node id="CHIEF CLINICAL INFORMATION OFFICERS" />
    <node id="NHS ENGLAND" />
    <node id="BEH&#199;ET&#8217;S DISEASE" />
    <node id="EGYPTIAN COLLEGE OF RHEUMATOLOGY" />
    <node id="VISION-THREATENING BEH&#199;ET&#8217;S DISEASE" />
    <node id="MACHINE-LEARNING MODELS" />
    <node id="SHAPLEY ADDITIVE EXPLANATION VALUE" />
    <node id="MAXQDA10" />
    <node id="HEALTHCARE MANAGERS" />
    <node id="MICROSOFT EXCEL 2013" />
    <node id="SYSTEMATIC SEARCH" />
    <node id="PAN-EUROPEAN NETWORK FOR CARE OF SURVIVORS AFTER CHILDHOOD AND ADOLESCENT CANCER" />
    <node id="PANCARESURFUP" />
    <node id="HODGKIN LYMPHOMA" />
    <node id="BONE SARCOMA" />
    <node id="NONALCOHOLIC FATTY LIVER DISEASE" />
    <node id="MAGNESIUM" />
    <node id="UNIVERSITY OF PITTSBURGH MEDICAL CENTER" />
    <node id="RECOGNIZING TEXTUAL ENTAILMENT" />
    <node id="NLP SYSTEMS" />
    <node id="COPD SELF-MANAGEMENT APPLICATION" />
    <node id="CLINICALTRIALS.GOV NCT03857061" />
    <node id="SMARTPHONE" />
    <node id="SMARTWATCH" />
    <node id="ISCHEMIC HEART DISEASE" />
    <node id="DXLR MODEL" />
    <node id="SICHUAN" />
    <node id="HOSPITAL DISCHARGE RECORDS" />
    <node id="SHAPLEY ADDICTIVE EXPLANATIONS" />
    <node id="YALE" />
    <node id="METASTATIC UVEAL MELANOMA" />
    <node id="ANTI-PD-1 THERAPY" />
    <node id="PRIMARY UVEAL MELANOMA" />
    <node id="HEPATIC METASTASES" />
    <node id="EXTRAHEPATIC-ONLY METASTASES" />
    <node id="GO2 FOR LUNG CANCER" />
    <node id="PATIENT-REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM SEXUAL FUNCTION AND SATISFACTION MEASURES" />
    <node id="PATIENTS-CAREGIVER DYAD DECISION-MAKING STUDY" />
    <node id="DECISION-MAKING ROLE PREFERENCES" />
    <node id="DYADIC DISCORDANCE" />
    <node id="PRECISION MEDICINE FOR CHILDREN WITH CANCER TRIAL" />
    <node id="GERMLINE GENOME SEQUENCING" />
    <node id="CLINICIAN" />
    <node id="CANCER PREDISPOSITION GENES" />
    <node id="TRAUMATIC BRAIN INJURIES" />
    <node id="EMBASE.COM" />
    <node id="GCS SCORE" />
    <node id="CT CLASSIFICATION" />
    <node id="PUPIL SIZE/LIGHT REFLEX" />
    <node id="GLUCOSE" />
    <node id="SYSTOLIC BLOOD PRESSURE" />
    <node id="FDA MANDATE" />
    <node id="NATIONAL INPATIENT SAMPLE" />
    <node id="ACUTE LIVER FAILURE STUDY GROUP" />
    <node id="OPIOID TOXICITY" />
    <node id="ACETAMINOPHEN" />
    <node id="HOSPITALIZATION" />
    <node id="ACUTE LIVER FAILURE" />
    <node id="TRS DEMONSTRATOR" />
    <node id="PSORIASIS" />
    <node id="DERMATOLOGISTS" />
    <node id="NATIONAL DERMATOLOGY CONFERENCE" />
    <node id="SYSTEM USABILITY SCALE (SUS)" />
    <node id="BREAST SCREENING PROGRAM" />
    <node id="UK WOMEN" />
    <node id="ALZHEIMER&#8217;S DISEASE NEUROIMAGING INITIATIVE" />
    <node id="NATIONAL ALZHEIMER&#8217;S COORDINATING CENTER" />
    <node id="EXTREME GRADIENT BOOSTING-SHAPLEY ADDITIVE EXPLANATIONS" />
    <node id="WORLD TRADE CENTER BOMBING" />
    <node id="PUBLIC HEALTH SURVEILLANCE" />
    <node id="ELECTRONIC AND INFORMATION TECHNOLOGIES" />
    <node id="PUBLIC HEALTH WORKFORCE" />
    <node id="MODELLING STUDIES" />
    <node id="POPULATION MODELLING" />
    <node id="ECONOMIC EVALUATION STUDIES" />
    <node id="TONGUE FEATURE" />
    <node id="TUMOR MARKER" />
    <node id="NON-ADVANCED NSCLC" />
    <node id="ADVANCED NSCLC" />
    <node id="MULTIMODAL CRC SCREENING POLICIES" />
    <node id="MONTE CARLO SIMULATION FRAMEWORK" />
    <node id="MARKOV MODEL" />
    <node id="FECAL OCCULT BLOOD TEST" />
    <node id="FECAL IMMUNOCHEMICAL TEST" />
    <node id="NORTHEAST" />
    <node id="NON-HISPANIC WHITE WOMEN" />
    <node id="NON-HISPANIC ASIAN OR PACIFIC ISLANDER WOMEN" />
    <node id="WOMEN AGED 45 TO 64" />
    <node id="WOMEN AGED 65 OR OLDER" />
    <node id="ALBERTA MOVING BEYOND BREAST CANCER (AMBER) COHORT STUDY" />
    <node id="ACTIGRAPH" />
    <node id="ACTIVPAL" />
    <node id="QUALITY OF LIFE (QOL)" />
    <node id="FATIGUE" />
    <node id="R SOJOURN PACKAGE" />
    <node id="PAL SOFTWARE" />
    <node id="DENSENET121_448" />
    <node id="NMLS DETECTION STUDY" />
    <node id="MOBILENET_448" />
    <node id="CANCER PREVENTION STUDY II" />
    <node id="COMORBIDITY TRAJECTORIES" />
    <node id="SMOKING" />
    <node id="IEEE XPLORE DIGITAL LIBRARY" />
    <node id="AUTOMATED LITERATURE SCREENING" />
    <node id="HUMAN INVESTIGATORS" />
    <node id="RSGP" />
    <node id="ROBERTA" />
    <node id="CMEIE" />
    <node id="FOOD FREQUENCY QUESTIONNAIRES" />
    <node id="DIET-DISEASE RELATIONSHIPS" />
    <node id="MEASUREMENT ERROR" />
    <node id="UNDERREPORTING" />
    <node id="MODELS AS MEDIATORS" />
    <node id="STANDARD MODEL" />
    <node id="MEALS" />
    <node id="EXERCISES" />
    <node id="ARTIFICIAL BETA-CELL SYSTEMS" />
    <node id="BLOOD GLUCOSE" />
    <node id="MODEL TRAINING" />
    <node id="MODEL SELECTION" />
    <node id="BINARY CLASSIFIERS" />
    <node id="DATA-DRIVEN INDIVIDUALIZED APPROACH" />
    <node id="LENVATINIB" />
    <node id="PROGRAMMED CELL DEATH PROTEIN 1 (PD-1)" />
    <node id="ADVANCED HEPATOCELLULAR CARCINOMA (AD-HCC)" />
    <node id="HEPATIC ARTERIAL INFUSION CHEMOTHERAPY (HAIC)" />
    <node id="APRIL 2016 TO SEPTEMBER 2021" />
    <node id="LOG-RANK TEST" />
    <node id="FORWARD STEPWISE COX REGRESSION MODEL" />
    <node id="INTERNAL REVENUE SERVICE" />
    <node id="2018 COMMERCIAL CLAIMS DATA" />
    <node id="HOSPITALS" />
    <node id="MEDICARE BENEFICIARIES" />
    <node id="VETERANS HEALTH ADMINISTRATION" />
    <node id="SMARTPHONE-BASED APP" />
    <node id="ANDROID STUDIO 3" />
    <node id="JAVA 8" />
    <node id="SQLITE" />
    <node id="USABILITY EVALUATION QUESTIONNAIRE" />
    <node id="USER SATISFACTION QUESTIONNAIRE (QUIS)" />
    <node id="INTEGRATIVE PLURALISM" />
    <node id="KIDS' INPATIENT DATABASE" />
    <node id="CHILD AND ADOLESCENT MENTAL HEALTH DISORDERS CLASSIFICATION SYSTEM" />
    <node id="PEDIATRIC MENTAL HEALTH HOSPITALIZATIONS" />
    <node id="ATTEMPTED SUICIDE, SUICIDAL IDEATION, OR SELF-INJURY" />
    <node id="CANCER REGISTRY SYSTEM" />
    <node id="COGNITIVE WALKTHROUGH" />
    <node id="SPSS 22" />
    <node id="ABSTRACKR" />
    <node id="WORDSTAT" />
    <node id="QDA MINER" />
    <node id="CRD42018084123" />
    <node id="REINFORCEMENT LEARNING SYSTEMS" />
    <node id="ATARI GAMES" />
    <node id="SIMULATED ROBOT LOCOMOTION" />
    <node id="REAL-WORLD ENVIRONMENTS" />
    <node id="HUMAN OVERSIGHT" />
    <node id="LYMPHATIC CANCER" />
    <node id="BRATS 2020 CHALLENGE DATASET" />
    <node id="SRI 24 ANATOMICAL ATLAS" />
    <node id="3D CONVOLUTIONAL NEURAL NETWORK" />
    <node id="TRANSVERSE TEMPORAL GYRUS" />
    <node id="FUSIFORM" />
    <node id="PALLADIUM" />
    <node id="GLIOMAS" />
    <node id="GRADIENT-WEIGHTED CLASS ACTIVATION MAPPING (GRAD-CAM)" />
    <node id="SHORT-TERM SURVIVAL" />
    <node id="MEDIUM-TERM SURVIVAL" />
    <node id="LONG-TERM SURVIVAL" />
    <node id="NEUROPHYSIOLOGIST" />
    <node id="MOTOR EVOKED POTENTIAL (MEP)" />
    <node id="SUPERVISED MACHINE LEARNING (ML)" />
    <node id="SUPRATENTORIAL SURGERY" />
    <node id="LOGISTIC REGRESSION (LOGREG)" />
    <node id="EXTENSOR DIGITORUM (EXT)" />
    <node id="ABDUCTOR POLLICIS BREVIS (APB)" />
    <node id="TIBIALIS ANTERIOR (TA)" />
    <node id="HUMANISED MICE" />
    <node id="CANCER STEM CELL RESEARCH" />
    <node id="ANTIBODY-DRUG CONJUGATES" />
    <node id="LYMPHOPENIA" />
    <node id="NAUSEA" />
    <node id="BLURRED VISION" />
    <node id="PERIPHERAL NEUROPATHY" />
    <node id="HYPOESTHESIA" />
    <node id="FEBRILE NEUTROPENIA" />
    <node id="JOURNAL EDITORS" />
    <node id="PUBLISHERS" />
    <node id="SOCIETY AT LARGE" />
    <node id="UK EQUATOR CENTRE" />
    <node id="GOODREPORTS.ORG" />
    <node id="PARTNER JOURNAL" />
    <node id="GOODREPORTS TOOL DEVELOPMENT" />
    <node id="RANDOMISED TRIAL" />
    <node id="RANDOM SAMPLE" />
    <node id="COVID" />
    <node id="COMMUNITY MEMBERS" />
    <node id="HEALTH CARE PROFESSIONALS" />
    <node id="OCCAM'S RAZOR" />
    <node id="DIAGNOSTIC REASONING" />
    <node id="HYPOTHETICAL SCENARIOS" />
    <node id="FLU" />
    <node id="MONONUCLEOSIS" />
    <node id="CANCER MORTALITY STUDY" />
    <node id="NON-HISPANIC WHITE ADULTS" />
    <node id="NON-HISPANIC BLACK ADULTS" />
    <node id="ADULTS WITH A COLLEGE DEGREE" />
    <node id="DIAGNOSTIC ERRORS" />
    <node id="VIRTUAL GROUPS" />
    <node id="COLLECTIVE INTELLIGENCE" />
    <node id="EUROQOL 5-DIMENSION (EQ-5D)" />
    <node id="ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT (OECD)" />
    <node id="PERIPHERAL ARTERIAL DISEASE" />
    <node id="STABLE ANGINA" />
    <node id="TRANSIENT ISCHEMIC ATTACK" />
    <node id="UNSTABLE ANGINA" />
    <node id="LOGISTIC LASSO REGRESSION" />
    <node id="LONG SHORT-TERM MEMORY" />
    <node id="BOOTSTRAPPING" />
    <node id="RAPID INPATIENT DETERIORATION" />
    <node id="MISSING DATA STRATEGIES" />
    <node id="MEAN IMPUTATION" />
    <node id="NORMAL-VALUE IMPUTATION" />
    <node id="CONDITIONAL IMPUTATION" />
    <node id="CATEGORICAL ENCODING" />
    <node id="MISSINGNESS EMBEDDINGS" />
    <node id="LAST OBSERVATION CARRIED FORWARD" />
    <node id="COHORT 1" />
    <node id="HF-LAB9" />
    <node id="COHORT 2" />
    <node id="CEREBRAL AMYLOID ANGIOPATHY" />
    <node id="RED BLOOD CELL TRANSFUSION" />
    <node id="BLOOD DONORS" />
    <node id="TRANSFUSION RECIPIENTS" />
    <node id="DIGITAL TWIN TECHNOLOGY" />
    <node id="HEALTHCARE BIG DATA" />
    <node id="BROAD LEARNING SYSTEM" />
    <node id="DAE-BLS" />
    <node id="YOUNG WOMEN'S BREAST CANCER STUDY" />
    <node id="NEONATAL INTENSIVE CARE UNIT" />
    <node id="INSIGHTSLEEPNET" />
    <node id="MESA" />
    <node id="CFS" />
    <node id="CAP" />
    <node id="VALUE OF INFORMATION (VOI)" />
    <node id="1-WAY SENSITIVITY ANALYSIS (OWSA)" />
    <node id="DISTRIBUTIONAL COST-EFFECTIVENESS ANALYSIS (DCEA)" />
    <node id="PROBABILISTIC SENSITIVITY ANALYSIS (PSA)" />
    <node id="ONCOLOGY CASE STUDY" />
    <node id="R CODE" />
    <node id="THE AUTHOR(S) 2024" />
    <node id="ESOPHAGEAL CANCER" />
    <node id="WILEY" />
    <node id="ENDOSCOPIC IMAGES" />
    <node id="COMPUTED TOMOGRAPHY IMAGES" />
    <node id="WHITE LIGHT IMAGING" />
    <node id="COMPUTER VISION" />
    <node id="BCR::ABL1 TYROSINE KINASE INHIBITORS" />
    <node id="PH-POSITIVE CML" />
    <node id="PHILADELPHIA CHROMOSOME" />
    <node id="SEER DATABASE" />
    <node id="ECOG-ACRIN" />
    <node id="CANCER PATIENT TOBACCO USE QUESTIONNAIRE (C-TUQ)" />
    <node id="AREA DEPRIVATION INDEX" />
    <node id="NEIGHBORHOOD SOCIOECONOMIC DISADVANTAGE (NSD)" />
    <node id="JBI SCOPING REVIEW METHODOLOGY GROUP" />
    <node id="SCOPING REVIEW PROTOCOL" />
    <node id="HEALTH CARE" />
    <node id="E-PRESCRIBING" />
    <node id="URMIA UNIVERSITY OF MEDICAL SCIENCES" />
    <node id="TECHNICAL INFRASTRUCTURE" />
    <node id="UNIVERSITY OF ALABAMA AT BIRMINGHAM" />
    <node id="LILA" />
    <node id="GI CANCERS" />
    <node id="BIRMINGHAM" />
    <node id="US DEPARTMENT OF AGRICULTURE ECONOMIC RESEARCH SERVICE" />
    <node id="CARE FRAILTY INDEX" />
    <node id="WORK SAVED OVER SAMPLING (WSS)" />
    <node id="AVERAGE TIME TO DISCOVERY (ATD)" />
    <node id="TF-IDF" />
    <node id="CPAP" />
    <node id="OSA" />
    <node id="MACCE" />
    <node id="SAVE" />
    <node id="ISAACC" />
    <node id="RICCADSA" />
    <node id="CURRENT CONTROLLED TRIALS" />
    <node id="ISRCTN REGISTRY" />
    <node id="EUROPEAN UNION CLINICAL TRIALS DATABASE" />
    <node id="BORDERLINE PERSONALITY DISORDER" />
    <node id="DIALECTICAL BEHAVIOR THERAPY" />
    <node id="PSYCHODYNAMIC THERAPY" />
    <node id="ESCITALOPRAM" />
    <node id="SERTRALINE" />
    <node id="FLUOXETINE" />
    <node id="QUETIAPINE" />
    <node id="PROMETHAZINE" />
    <node id="DIAZEPAM" />
    <node id="LORAZEPAM" />
    <node id="ANXIETY DISORDERS" />
    <node id="SUBSTANCE USE DISORDERS" />
    <node id="SUICIDAL BEHAVIOR" />
    <node id="SELF-MUTILATION" />
    <node id="CRISIS MANAGEMENT" />
    <node id="GENETIC FACTORS" />
    <node id="ADVERSE CHILDHOOD EXPERIENCES" />
    <node id="NEOADJUVANT IMMUNE CHECKPOINT INHIBITORS (NICI)" />
    <node id="FREE FLAP RECONSTRUCTION" />
    <node id="TRANSORAL ROBOTIC SURGERY (TORS)" />
    <node id="COMPLICATIONS" />
    <node id="REGRESSION ANALYSIS" />
    <node id="ADVANCED NON-SMALL CELL LUNG CANCER" />
    <node id="FIRST LINE OF THERAPY (1LOT)" />
    <node id="DIABETIC FOOT ULCER" />
    <node id="BLACK PEOPLE" />
    <node id="HISPANIC PEOPLE" />
    <node id="NATIVE AMERICAN PEOPLE" />
    <node id="WHITE PEOPLE" />
    <node id="HUMAN CELL ATLAS" />
    <node id="GUT CELL ATLAS" />
    <node id="GUT LINEAR MODEL" />
    <node id="ILEUM" />
    <node id="TRANSVERSE COLON" />
    <node id="ILEO-CAECAL VALVE" />
    <node id="HEPATIC FLEXURE" />
    <node id="SMALL INTESTINE" />
    <node id="LARGE INTESTINE" />
    <node id="CT SCAN" />
    <node id="US NATIONAL HEALTH INTERVIEW SURVEY" />
    <node id="AYA CANCER SURVIVORS" />
    <node id="SOCIODEMOGRAPHIC FACTORS" />
    <node id="MODIFIABLE RISK FACTORS" />
    <node id="MYCHART" />
    <node id="EPIC" />
    <node id="LEBANON" />
    <node id="MOBILE APPLICATION RATING SCALE" />
    <node id="BIO MED CENTRAL LTD" />
    <node id="SWOT MODEL" />
    <node id="CONTRALATERAL PROPHYLACTIC MASTECTOMY" />
    <node id="NEGATIVE AFFECT" />
    <node id="LUMPECTOMY" />
    <node id="SINGLE MASTECTOMY" />
    <node id="DOUBLE MASTECTOMY" />
    <node id="NARRATIVE MANIPULATION" />
    <node id="CANCER RISK PERCEPTIONS" />
    <node id="HYPERLEUKOCYTOSIS" />
    <node id="INSTITUTIONAL PROTOCOLS" />
    <node id="LEUKAPHERESIS" />
    <node id="LD-CYTARABINE" />
    <node id="HYDROXYUREA" />
    <node id="PULMONARY COMPLICATIONS" />
    <node id="METABOLIC COMPLICATIONS" />
    <node id="INFECTION" />
    <node id="IN-PERSON VISITS" />
    <node id="MAXQDA 18" />
    <node id="CHI-SQUARE TESTS" />
    <node id="DESCRIPTIVE STATISTICS" />
    <node id="EQ-5D" />
    <node id="QUALITY-ADJUSTED LIFE-YEAR LOSS" />
    <node id="INJURY EVENT" />
    <node id="NATIONAL INSTITUTE OF HEALTH AND SOCIAL CARE RESEARCH" />
    <node id="HEALTH INFORMATICS COLLABORATIVE" />
    <node id="OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP" />
    <node id="HEARING HEALTH" />
    <node id="ASHKENAZI JEWISH" />
    <node id="BLACK/AFRICAN AMERICAN" />
    <node id="AFRICAN" />
    <node id="NON-HISPANIC WHITE/EUROPEAN" />
    <node id="ASIAN" />
    <node id="OMAHA CLASSIFICATION SYSTEM" />
    <node id="HIP REPLACEMENT" />
    <node id="HOME-BASED REHABILITATION" />
    <node id="POPULATION AGING" />
    <node id="PHYSICAL HEALTH-RELATED PROBLEMS" />
    <node id="REHABILITATION CARE" />
    <node id="PRECISION CARE" />
    <node id="CRITICAL RESPIRATORY EVENTS" />
    <node id="GENERAL ANESTHESIA" />
    <node id="PERIOPERATIVE CARE" />
    <node id="GRADE A TERTIARY HOSPITAL" />
    <node id="TRIPOD CHECKLIST" />
    <node id="POST-ANESTHESIA CARE UNIT (PACU)" />
    <node id="CANADIAN YOUTH" />
    <node id="MCMASTER CHILDREN'S HOSPITAL" />
    <node id="CHILD AND YOUTH MENTAL HEALTH PROGRAM" />
    <node id="GRAPH NEURAL NETWORK" />
    <node id="RECURRENT NEURAL NETWORK" />
    <node id="ED REVISIT PREDICTION" />
    <node id="INTERNATIONAL COLLABORATION FOR AUTOMATION OF SYSTEMATIC REVIEWS" />
    <node id="THIRD MEETING OF ICASR" />
    <node id="LUNG CANCER SCREENING POLICIES" />
    <node id="KEVIN TEN HAAF" />
    <node id="MINORITY-SERVING HOSPITAL" />
    <node id="SURGEON" />
    <node id="FACILITY" />
    <node id="LOUISE MAPLE-BROWN" />
    <node id="CORRECTION ARTICLE" />
    <node id="ETHIOPIAN MINISTRY OF HEALTH" />
    <node id="CARDIAC SURGERY STUDY" />
    <node id="SUB-SAHARAN REGION" />
    <node id="PURE" />
    <node id="DEPARTMENT OF UROLOGY" />
    <node id="RIDGE REGRESSION" />
    <node id="BAGGED TREES" />
    <node id="BOOSTED TREES" />
    <node id="RANDOMFOREST" />
    <node id="BALTIMORE REGIONAL HOUSING PARTNERSHIP" />
    <node id="HOUSING MOBILITY PROGRAM" />
    <node id="URECA" />
    <node id="MSMPLUS" />
    <node id="RSHINY" />
    <node id="STATA" />
    <node id="BREAST CANCER DATA BASE SWEDEN 2.0" />
    <node id="STUDY II" />
    <node id="JOINT FRAILTY MODEL" />
    <node id="COLON CANCER" />
    <node id="STUDY IV" />
    <node id="STUDY I" />
    <node id="FLEXIBLE PARAMETRIC SURVIVAL MODELS" />
    <node id="STUDY III" />
    <node id="CYSTIC FIBROSIS" />
    <node id="CFTR" />
    <node id="F508DEL" />
    <node id="IVACAFTOR" />
    <node id="ELEXACAFTOR-TEZACAFTOR-IVACAFTOR" />
    <node id="DORNASE ALFA" />
    <node id="AZITHROMYCIN" />
    <node id="TOBRAMYCIN" />
    <node id="LYME DISEASE" />
    <node id="BERTWEET" />
    <node id="OMAHA PROBLEM CLASSIFICATION SYSTEM" />
    <node id="SENSITIVITY OUTCOME INDEX SYSTEM" />
    <node id="HOME NURSING" />
    <node id="ELDERLY LIVER TRANSPLANT PATIENTS" />
    <node id="GRAPH NEURAL NETWORKS" />
    <node id="TEXT CLASSIFICATION" />
    <node id="GRAPH FUSION NETWORK" />
    <node id="GRAPH LEARNING" />
    <node id="GRAPH CONVOLUTION" />
    <node id="GRAPH FUSION" />
    <node id="XGB MODEL" />
    <node id="SHAP FRAMEWORK" />
    <node id="MALE BREAST CANCER" />
    <node id="DELONG TEST" />
    <node id="BEHAVIOUR CHANGE INTERVENTIONS" />
    <node id="FRAMEWORKS OF BEHAVIOUR CHANGE INTERVENTIONS" />
    <node id="LDCT SCREENING" />
    <node id="NOVEL TREATMENTS" />
    <node id="CANADIAN PRIMARY CARE SENTINEL SURVEILLANCE NETWORK" />
    <node id="INTERNATIONAL CLASSIFICATION OF DISEASES, NINTH REVISION, CLINICAL MODIFICATION" />
    <node id="ANATOMICAL THERAPEUTIC CHEMICAL CLASSIFICATION" />
    <node id="PROBLEMATIC MENOPAUSE" />
    <node id="DREAMER" />
    <node id="NCD PREVENTION AND MANAGEMENT INTERVENTIONS" />
    <node id="EASTERN SUB-SAHARAN AFRICA" />
    <node id="SOUTH-EAST ASIA" />
    <node id="TOBACCO CONTROL POLICIES" />
    <node id="ALCOHOL CONTROL POLICIES" />
    <node id="CARDIOVASCULAR DISEASE TREATMENT" />
    <node id="CERVICAL CANCER TREATMENT" />
    <node id="EPILEPSY TREATMENT" />
    <node id="MENTAL HEALTH DISORDERS" />
    <node id="ADABOOST ALGORITHM" />
    <node id="SUPPORT VECTOR CLASSIFICATION (SVC)" />
    <node id="GRADIENT BOOSTING DECISION TREE (GBDT)" />
    <node id="MULTILAYER PERCEPTRON (MLP)" />
    <node id="LINEAR DISCRIMINANT ANALYSIS (LDA)" />
    <node id="GAUSSIAN NAIVE BAYES (GAUSSIANNB)" />
    <node id="LIGHT GRADIENT BOOSTING MACHINE (LIGHTGBM)" />
    <node id="SHAPLEY ADDITIVE EXPLANATION (SHAP)" />
    <node id="CA125" />
    <node id="CEA" />
    <node id="FBG" />
    <node id="TUMOR DIAMETER" />
    <node id="ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK CALCULATOR" />
    <node id="RISK SCORE CALCULATORS" />
    <node id="OUTPATIENT COMMUNITY-BASED CLINICAL SETTINGS" />
    <node id="RESIDENTS" />
    <node id="ATTENDING PHYSICIANS" />
    <node id="RISK SCORE ESTIMATES" />
    <node id="YOUNG ADULT CANCER SURVIVORS" />
    <node id="SOCIAL ISOLATION" />
    <node id="SOCIAL CONNECTEDNESS" />
    <node id="PEER-REVIEWED ARTICLES" />
    <node id="CANCER-RELATED OUTCOMES" />
    <node id="DATABASE SEARCHES" />
    <node id="MEDICAL IMAGE PROTOCOL ASSIGNMENT" />
    <node id="RADIOLIST" />
    <node id="CLINICAL SETTINGS" />
    <node id="LLMS" />
    <node id="STANDARDIZED EVALUATION FRAMEWORK" />
    <node id="EVIDENCE GAPS" />
    <node id="PATIENT NOTES" />
    <node id="BIASES IN TRAINING DATA" />
    <node id="ETHICAL, LEGAL, SOCIOECONOMIC, AND PRIVACY CONCERNS" />
    <node id="PHYSICIAN PREFERENCE ITEMS" />
    <node id="ITALIAN HOSPITAL ORTHOPEDISTS" />
    <node id="CLINICAL EVIDENCE" />
    <node id="QUALITY OF PRODUCTS" />
    <node id="COST" />
    <node id="RELATIONSHIP WITH SALES REPRESENTATIVE" />
    <node id="BEST-WORST SCALING" />
    <node id="STATA 16" />
    <node id="BASQUE COUNTRY" />
    <node id="JOHNS HOPKINS ADJUSTED CLINICAL GROUPS (ACG) SYSTEM" />
    <node id="UNPLANNED HOSPITALIZATION" />
    <node id="GRADIENT BOOSTING DECISION TREES" />
    <node id="SIMULATING INDIVIDUAL-LEVEL TRIAL DATA" />
    <node id="REAL-WORLD DATA (RWD)" />
    <node id="SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS&#8211;MEDICARE DATA" />
    <node id="KAPLAN-MEIER ESTIMATES" />
    <node id="CXCL2" />
    <node id="CXCL5" />
    <node id="CCL23" />
    <node id="CAUCASIANS" />
    <node id="CHEMOKINE ASSAY" />
    <node id="FLYBASE" />
    <node id="MOUSE GENOME INFORMATICS" />
    <node id="WORMBASE" />
    <node id="THE ARABIDOPSIS INFORMATION RESOURCE" />
    <node id="YOUNG RESEARCHER PHYSICIANS" />
    <node id="CONSORT" />
    <node id="ARRIVE" />
    <node id="GRRAS" />
    <node id="SAMPL" />
    <node id="ORGANIZATIONAL SYSTEMS" />
    <node id="PROCESSES" />
    <node id="DECISION-MAKERS" />
    <node id="HTA EXPERTS" />
    <node id="BARRIERS" />
    <node id="FACILITATORS" />
    <node id="FRAMINGHAM OFFSPRING" />
    <node id="ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC)" />
    <node id="MULTI-ETHNIC STUDY FOR ATHEROSCLEROSIS (MESA)" />
    <node id="REASONS FOR GEOGRAPHICAL AND RACIAL DIFFERENCES IN STROKE (REGARDS)" />
    <node id="FRAMINGHAM STROKE MODEL" />
    <node id="REGARDS SELF-REPORT MODEL" />
    <node id="POOLED COHORT EQUATIONS" />
    <node id="LONGSHI SCALE" />
    <node id="WECHAT" />
    <node id="SECOND PEOPLE'S HOSPITAL OF SHENZHEN" />
    <node id="CLINICAL TRIAL REGISTER CENTER" />
    <node id="NCT05214638" />
    <node id="SHENZHEN" />
    <node id="ETHICS COMMITTEE" />
    <node id="SELINEXOR" />
    <node id="NCT02419495" />
    <node id="ANTI-PD-1/PD-L1 THERAPY" />
    <node id="NUCLEAR EXPORT PROTEINS" />
    <node id="TUMOR SUPPRESSOR PROTEINS" />
    <node id="CHINESE BREAST CANCER MAMMOGRAPHY REPORTS" />
    <node id="BILSTM-HIGHWAY-CRF MODEL" />
    <node id="NEO4J GRAPH DATA PLATFORM" />
    <node id="TANOM-HS" />
    <node id="BIOPORTAL" />
    <node id="JBI" />
    <node id="JBI MANUAL FOR EVIDENCE SYNTHESIS" />
    <node id="INTERNATIONAL SCIENTIFIC COMMITTEE" />
    <node id="RDAL-CHECKLIST" />
    <node id="MASHHAD UNIVERSITY OF MEDICAL SCIENCES" />
    <node id="FAMILY PHYSICIAN PROGRAM" />
    <node id="SINA SYSTEM" />
    <node id="ELECTRONIC PATIENT REFERRAL SYSTEM" />
    <node id="INTERNET INFRASTRUCTURE" />
    <node id="APPOINTMENT SCHEDULING" />
    <node id="INTERDEPARTMENTAL COORDINATION" />
    <node id="RECORDING DEFINITIVE DIAGNOSIS CODES" />
    <node id="FALSE REFERRALS" />
    <node id="HEALTH INDICATORS" />
    <node id="BREASTCHOICE" />
    <node id="MIDWESTERN MEDICAL SPECIALTY CENTERS" />
    <node id="AUGUST 2020 TO APRIL 2021" />
    <node id="WEARABLE ELECTROCARDIOGRAM (ECG) SENSORS" />
    <node id="CONVOLUTION NEURAL NETWORKS (CNN)" />
    <node id="PANDEMICS" />
    <node id="HEALTHCARE FACILITIES" />
    <node id="DATABASE" />
    <node id="CENTRALIZED SERVER" />
    <node id="FRENCH UNIVERSITY HOSPITAL" />
    <node id="IN-HOSPITAL MORTALITY STUDY" />
    <node id="IDEALIZATION" />
    <node id="SCIENTIFIC THEORIES" />
    <node id="REPRESENTATIONAL IDEALS" />
    <node id="CERT" />
    <node id="SPORTS AND EXERCISE MEDICINE JOURNALS" />
    <node id="TIDIER" />
    <node id="J ORTHOP SPORTS PHYS THER" />
    <node id="EARLY-MID CAREER RESEARCHERS" />
    <node id="SENIOR RESEARCHERS" />
    <node id="FIBROIDS" />
    <node id="CONVERSATION AIDS" />
    <node id="MORVILLE'S HONEYCOMB FRAMEWORK" />
    <node id="FRAME" />
    <node id="SPANISH TRANSLATIONS" />
    <node id="DECEMBER 2018" />
    <node id="IMPLEMENTATION PROJECT" />
    <node id="UTERINE FIBROIDS" />
    <node id="BRCA1/2" />
    <node id="INTERNATIONAL CANCER OF THE PANCREAS SCREENING (CAPS)" />
    <node id="AMERICAN COLLEGE OF GASTROENTEROLOGY (ACG)" />
    <node id="XG-BOOST" />
    <node id="AU-ROC" />
    <node id="MYELOPROLIFERATIVE NEOPLASMS" />
    <node id="POLYCYTHEMIA VERA" />
    <node id="ROPEGINTERFERON ALFA-2B" />
    <node id="HEPCIDIN MIMESIS" />
    <node id="ESSENTIAL THROMBOCYTHEMIA" />
    <node id="U.S. NATIONAL HEALTH INTERVIEW SURVEYS" />
    <node id="1890 BIRTH COHORT" />
    <node id="SMOKING HISTORY GENERATOR" />
    <node id="MICRO-SIMULATION MODELS" />
    <node id="TOBACCO CONTROL INTERVENTIONS" />
    <node id="CIGARETTE SMOKING INTERVENTION STRATEGIES" />
    <node id="MULTIPLE SCLEROSIS" />
    <node id="EXPANDED DISABILITY STATUS SCALE" />
    <node id="NEUROIMAGING DATA" />
    <node id="CLINICAL NOTES" />
    <node id="SCIENTIFIC COMPUTING" />
    <node id="MODELLING AND SIMULATION" />
    <node id="VERIFICATION AND VALIDATION" />
    <node id="ENGINEERING" />
    <node id="TECHNOLOGY AND INDUSTRY" />
    <node id="ENVIRONMENTAL REGULATIONS AND SAFETY" />
    <node id="PRODUCT AND PLANT SAFETY" />
    <node id="FINANCIAL INVESTING" />
    <node id="GOVERNMENTAL REGULATIONS" />
    <node id="RESEARCHERS, PRACTITIONERS, AND DECISION MAKERS" />
    <node id="PARTIAL DIFFERENTIAL AND INTEGRAL EQUATIONS" />
    <node id="NUMERICAL SOLUTION" />
    <node id="CHD MODELLING STUDIES" />
    <node id="CHD POLICY MODELS" />
    <node id="LIFE TABLE ANALYSES" />
    <node id="MICRO-SIMULATION" />
    <node id="CELL-BASED MODELS" />
    <node id="QUALITY OF LIFE QUESTIONNAIRE CORE 30" />
    <node id="HEALTH ECONOMICS RESEARCHERS" />
    <node id="EQ-5D-3L INDEX" />
    <node id="MAPPING STUDIES" />
    <node id="SAMPLE SIZE CALCULATION" />
    <node id="IMPLEMENTATION SCIENCE" />
    <node id="CBCT" />
    <node id="DENTAL DISEASES" />
    <node id="NEOPLASTIC/CYSTIC DISEASES" />
    <node id="EXPERT REVIEWERS" />
    <node id="PATHOLOGICAL DIAGNOSIS" />
    <node id="PD-1/PD-L1 IMMUNE CHECKPOINT" />
    <node id="GENERAL CIRCULATION MODELS" />
    <node id="CLIMATE RESEARCH" />
    <node id="MULTIDISCIPLINARY TEAMS (MDTS)" />
    <node id="CLINICAL DECISION SUPPORT SYSTEMS (CDSSS)" />
    <node id="MATHIJS P. HENDRIKS" />
    <node id="KEES C. EBBEN" />
    <node id="JANINE A. VAN TIL" />
    <node id="AGNES JAGER" />
    <node id="SABINE SIESLING" />
    <node id="SAN ANTONIO BREAST CANCER SYMPOSIUM" />
    <node id="SAN ANTONIO, TX" />
    <node id="AACR" />
    <node id="CANCER RES" />
    <node id="EQ-5D-3L" />
    <node id="UK EQ-5D-3L VALUATION STUDY" />
    <node id="UTILITY SCORES" />
    <node id="MARKOV CHAIN MONTE CARLO (MCMC)" />
    <node id="KULLBACK&#8211;LEIBLER (KL) DIVERGENCE" />
    <node id="BROYDEN&#8211;FLETCHER&#8211;GOLDFARB&#8211;SHANNO (BFGS) ALGORITHM" />
    <node id="HIERARCHICAL MODEL" />
    <node id="ECONOMIC EVALUATIONS" />
    <node id="POSTERIOR DISTRIBUTIONS" />
    <node id="MIXTURES OF NORMAL DISTRIBUTIONS" />
    <node id="ACE-ITS PROGRAM" />
    <node id="NATIONAL INSTITUTE OF MINORITY HEALTH AND HEALTH DISPARITIES" />
    <node id="PRACTICAL ROBUST IMPLEMENTATION AND SUSTAINABILITY MODEL" />
    <node id="BLACK AND HISPANIC WOMEN" />
    <node id="GENETIC COUNSELORS" />
    <node id="COMMUNITY PARTNERS" />
    <node id="GENETIC RISK ASSESSMENT" />
    <node id="GENETIC COUNSELING/TESTING" />
    <node id="VERILOGUE POINT-OF-PRACTICE DATABASE" />
    <node id="DOAC PRESCRIPTION" />
    <node id="WARFARIN PRESCRIPTION" />
    <node id="INFORMED DECISION MAKING" />
    <node id="FINANCIAL COSTS" />
    <node id="CLINICAL DEEP PHENOTYPING" />
    <node id="PHENOTYPE ANNOTATION" />
    <node id="GPT-3.5-TURBO" />
    <node id="GPT-4.0" />
    <node id="IN-CONTEXT LEARNING" />
    <node id="RARE DISORDERS FIELD" />
    <node id="PUBLICATION ABSTRACTS" />
    <node id="CLINICAL OBSERVATIONS" />
    <node id="COVID INTERFACE TERMINOLOGY" />
    <node id="RESOURCE DESCRIPTION FRAMEWORK" />
    <node id="DEMOCRATIC PARTY" />
    <node id="VACCINATION" />
    <node id="MAY 2020" />
    <node id="NOVEL HEALTHCARE TECHNOLOGIES" />
    <node id="ONLINE SURVEY" />
    <node id="GENERAL PRACTITIONER" />
    <node id="LASER-BASED TOOL" />
    <node id="VIRTUAL REALITY TOOL" />
    <node id="NON-INVASIVE CONTINUOUS GLUCOSE MONITOR" />
    <node id="MOBILE APP" />
    <node id="HYPERTENSION MANAGEMENT STUDY" />
    <node id="SPSS STATISTICS 24" />
    <node id="INSURANCE INFORMATION DISCLOSURE" />
    <node id="JANUARY 2023" />
    <node id="PHARMACEUTICAL DISCOUNT DISCLOSURE" />
    <node id="PROVIDERS" />
    <node id="NATIONAL HOSPITAL AMBULATORY MEDICAL CARE SURVEY" />
    <node id="MENTAL HEALTH-RELATED ED VISITS" />
    <node id="SUICIDE-RELATED VISITS" />
    <node id="THEORETICAL BIOLOGY" />
    <node id="CELL BIOLOGY" />
    <node id="X-RAY CRYSTALLOGRAPHY" />
    <node id="NANOSCIENCE" />
    <node id="INFECTIOUS DISEASE SCIENTISTS" />
    <node id="NOVEL CORONAVIRUS" />
    <node id="MAXIMUM CARE HOSPITAL" />
    <node id="MEDICAL DATA INTEGRATION CENTER (MEDIC)" />
    <node id="STHLM3" />
    <node id="PROSTATA MODEL" />
    <node id="C++" />
    <node id="CHARLES HUGGINS" />
    <node id="NOBEL PRIZE IN MEDICINE" />
    <node id="TESTOSTERONE" />
    <node id="ORCHIECTOMY" />
    <node id="SEPSIS-ASSOCIATED ACUTE KIDNEY INJURY" />
    <node id="CRYOSTAT-2" />
    <node id="CLINICALTRIALS.GOV IDENTIFIER: NCT04704869" />
    <node id="ISRCTN IDENTIFIER: ISRCTN14998314" />
    <node id="HOMEOSTASIS IMBALANCE PROCESS ONTOLOGY (HOIP)" />
    <node id="COVID-19 ONTOLOGY HARMONISATION WORKING GROUP" />
    <node id="CLINICAL TRIAL SCREENING FRAMEWORK" />
    <node id="PATIENT ELECTRONIC HEALTH RECORD" />
    <node id="REGIONAL TRIAL ELIGIBILITY SCREENING" />
    <node id="AUTOMATED REGIONAL SEARCH TOOL" />
    <node id="FIND TMF" />
    <node id="THEORIES, MODELS AND FRAMEWORKS (TMFS)" />
    <node id="ROCHESTER, MINNESOTA" />
    <node id="HFPEF" />
    <node id="NCT02145351" />
    <node id="PACEMAKER" />
    <node id="KANSAS CITY CARDIOMYOPATHY QUESTIONNAIRE" />
    <node id="REGULEM" />
    <node id="UNIFIED PROTOCOL" />
    <node id="DESCRIPTIVE FOREST" />
    <node id="C4.5 TREE" />
    <node id="HEART FAILURE&#8211;PREDICTION DATASET" />
    <node id="HEART DISEASE HEALTH&#8211;INDICATORS DATASET" />
    <node id="CARDIOVASCULAR CARE" />
    <node id="AI-ENABLED MEDICAL DEVICES" />
    <node id="AGE-RELATED MACULAR DEGENERATION" />
    <node id="REHAB-AMD" />
    <node id="VISION REHABILITATION EXPERT" />
    <node id="AMD PATIENTS" />
    <node id="IMPLEMENTATION SUPPORT TEAM" />
    <node id="EXPERT RECOMMENDATIONS FOR IMPLEMENTING CHANGE" />
    <node id="PROCTOR ET AL.'S REPORTING FRAMEWORK" />
    <node id="CONSOLIDATED FRAMEWORK FOR IMPLEMENTATION RESEARCH" />
    <node id="FRAMEWORK FOR REPORTING ADAPTATIONS AND MODIFICATIONS-ENHANCED" />
    <node id="CLINICALTRIALS.GOV ID: NCT03607617" />
    <node id="COMMUNITY CLINICS" />
    <node id="FACILITATION-FOCUSED STRATEGY" />
    <node id="CLINIC-LEVEL STRATEGY ADDITION" />
    <node id="STUDY-LEVEL STRATEGY ADDITION" />
    <node id="SOCIAL DETERMINANTS OF HEALTH-RELATED ACTIVITIES" />
    <node id="SURVIVORSHIP CARE PLANS" />
    <node id="ADULT CANCER SURVIVORS" />
    <node id="PARENT PROXIES" />
    <node id="CANCER-RELATED FOLLOW-UP CARE" />
    <node id="NIGERIA" />
    <node id="2018 NIGERIA DEMOGRAPHIC AND HEALTH SURVEY" />
    <node id="UNDER-FIVE MORTALITY" />
    <node id="K-NEAREST NEIGHBOURHOOD" />
    <node id="HEALTH AND RETIREMENT STUDY" />
    <node id="LOW-WAGE EARNING" />
    <node id="EMPLOYMENT INSTABILITY" />
    <node id="COX PROPORTIONAL HAZARDS" />
    <node id="ADDITIVE HAZARDS REGRESSION MODELS" />
    <node id="FEDERAL POVERTY LINE" />
    <node id="MINIMUM WAGE LAWS" />
    <node id="DRUG REPURPOSING" />
    <node id="PROTEIN SEQUENCES" />
    <node id="CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)" />
    <node id="EXTREME OBESITY" />
    <node id="AALL03N1" />
    <node id="ERYTHROCYTE THIOGUANINE NUCLEOTIDE (TGN) LEVELS" />
    <node id="STEREOTACTIC BODY RADIATION THERAPY" />
    <node id="SPINAL INSTABILITY NEOPLASTIC SCORE" />
    <node id="INSTITUTION ONE" />
    <node id="INSTITUTION TWO" />
    <node id="SPINAL METASTASES" />
    <node id="KAMPO MEDICINE" />
    <node id="JAPANESE PHARMACOPOEIA" />
    <node id="IBM WATSON" />
    <node id="NATURAL LANGUAGE CLASSIFIER" />
    <node id="PHARMACISTS" />
    <node id="PHARMACY STUDENTS" />
    <node id="VALIDATION QUESTIONS" />
    <node id="HEALTH DISPARITIES AND MINORITY HEALTH" />
    <node id="HDMH MONITOR" />
    <node id="MENTAL HEALTH" />
    <node id="ENDOCRINE/METABOLIC DISORDERS" />
    <node id="HEARING CONDITIONS" />
    <node id="VISION CONDITIONS" />
    <node id="SKIN-RELATED CONDITIONS" />
    <node id="TRK FUSION SARCOMAS" />
    <node id="NTRK GENE FUSIONS" />
    <node id="RECIST V1.1" />
    <node id="ADVERSE EVENTS" />
    <node id="TREATMENT-EMERGENT ADVERSE EVENTS" />
    <node id="FERMI" />
    <node id="V-A THEORY" />
    <node id="PARITY NONCONSERVATION" />
    <node id="WORLD WAR II" />
    <node id="BETA-DECAY THEORY" />
    <node id="CRGNB" />
    <node id="SVM" />
    <node id="BARIATRIC SURGERY" />
    <node id="CHRONIC MYELOID LEUKEMIA (CML)" />
    <node id="EARLY MOLECULAR RESPONSE" />
    <node id="COMPLETE CYTOGENETIC RESPONSE" />
    <node id="MAJOR MOLECULAR RESPONSE" />
    <node id="FAILURE-FREE SURVIVAL" />
    <node id="ACM DIGITAL LIBRARY" />
    <node id="QUADAS-2" />
    <node id="MEDICAL INSTITUTIONS" />
    <node id="FEDERATED LEARNING" />
    <node id="CONTINUAL LEARNING FRAMEWORK" />
    <node id="GENERATIVE ADVERSARIAL NETWORK" />
    <node id="ELECTROCARDIOGRAM DATASETS" />
    <node id="ARRHYTHMIA DETECTION MODEL" />
    <node id="SUPERVISED LEARNING METHODS" />
    <node id="FINETUNING APPROACHES" />
    <node id="NEW EMPIRICISM" />
    <node id="PROPERTIES" />
    <node id="ALLENEOGENEIC HEMATOPOIETIC CELL TRANSPLANT" />
    <node id="2013-2019" />
    <node id="FLT3" />
    <node id="COX PROPORTIONAL HAZARDS REGRESSION MODELS" />
    <node id="TEMPORAL ANALYSIS" />
    <node id="SCIENTIFIC DATA" />
    <node id="CLINICAL INTERVENTIONS" />
    <node id="SURVIVAL PREDICTIONS" />
    <node id="PREDICTION LATENCY" />
    <node id="AI-DRIVEN SELECTION SUPPORT SYSTEM" />
    <node id="CHONGQING MEDICAL UNIVERSITY" />
    <node id="POST-STROKE DEPRESSION" />
    <node id="LIVER FUNCTION TEST INDICES" />
    <node id="GBDT MODEL" />
    <node id="RADIOFREQUENCY ABLATION" />
    <node id="SINGLE MEDICAL CENTER" />
    <node id="HEMORRHAGE" />
    <node id="CARDIAC EFFUSION/TAMPONADE" />
    <node id="PNEUMONIA" />
    <node id="CURB-65" />
    <node id="BLOOD CULTURE PREDICTION INDEX (BCPI)" />
    <node id="30-DAY MORTALITY RATE" />
    <node id="EMERGENCY DEPARTMENT (ED)" />
    <node id="TERTIARY MEDICAL CENTER" />
    <node id="VALGANCICLOVIR" />
    <node id="LETERMOVIR" />
    <node id="CYTOMEGALOVIRUS" />
    <node id="MYELOSUPPRESSION" />
    <node id="LEUKOPENIA" />
    <node id="EUDRACT" />
    <node id="CMV DISEASE" />
    <node id="LINGO3G" />
    <node id="HUMAN RESEARCHER" />
    <node id="CLARK LEVEL II" />
    <node id="BRESLOW THICKNESS" />
    <node id="OVERDIAGNOSIS" />
    <node id="STAGE I LESIONS" />
    <node id="VERY-LOW RISK OF DEATH" />
    <node id="HIGH-RISK PATIENTS" />
    <node id="SHUGUANG HOSPITAL" />
    <node id="SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE" />
    <node id="MAMMARY DEPARTMENT" />
    <node id="NON-LACTATING MASTITIS" />
    <node id="INTRAOPERATIVE DISCHARGE" />
    <node id="TEST TRADEOFF CURVE" />
    <node id="RISK PREDICTION" />
    <node id="BENEFIT-COST RATIO" />
    <node id="RISK THRESHOLD" />
    <node id="RISK-COMMUNICATION APPROACHES STUDY" />
    <node id="DISCRETE CHOICE EXPERIMENTS (DCES)" />
    <node id="HEALTH LITERACY" />
    <node id="ROBERT AXELROD" />
    <node id="THE EVOLUTION OF COOPERATION" />
    <node id="THE COMPLEXITY OF COOPERATION" />
    <node id="TRADITIONAL MEDIA" />
    <node id="SCIENTIFIC ARTICLES" />
    <node id="INSTITUTION REVIEW BOARD" />
    <node id="PEARSON CHI-SQUARE" />
    <node id="FISHER&#8217;S EXACT TEST" />
    <node id="CHINESE PHARMACEUTICAL MARKET" />
    <node id="CHINESE REGULATORY AGENCIES" />
    <node id="ANTICANCER DRUGS" />
    <node id="DRUG APPROVAL" />
    <node id="RHEINBERGER" />
    <node id="EXPERIMENTAL SYSTEM" />
    <node id="EXPERIMENTAL LANDSCAPE" />
    <node id="SMALL CELL LUNG CANCER" />
    <node id="PD1 BLOCKADE" />
    <node id="IMMUNE CHECK POINT INHIBITORS" />
    <node id="WHOLE TRANSCRIPTOMICS" />
    <node id="CHEMOIMMUNOTHERAPY" />
    <node id="RADIATION" />
    <node id="CORONARY ANGIOGRAPHY" />
    <node id="AP" />
    <node id="HOSPITALS IN KERMAN" />
    <node id="SPSS 15" />
    <node id="DAS" />
    <node id="KEARNEY-FLESCHER SELF-CARE SURVEY" />
    <node id="PERSIAN CONDITION-SPECIFIC EHEALTH LITERACY SCALE FOR DIABETES (PERSIAN CEHLS-D)" />
    <node id="TYPE 2 DIABETES MELLITUS (T2DM)" />
    <node id="SWEDISH TRAUMA REGISTRY" />
    <node id="NEW INJURY SEVERITY SCORE" />
    <node id="TRAUMA" />
    <node id="MOTOR VEHICLE CRASHES" />
    <node id="FIELD TRIAGE" />
    <node id="HYBRID RESUNET MODEL" />
    <node id="ANT COLONY OPTIMIZATION (ACO)" />
    <node id="RESNET" />
    <node id="U-NET" />
    <node id="SKIN LESION SEGMENTATION" />
    <node id="SKIN LESION CLASSIFICATION" />
    <node id="PHYSIOTHERAPY" />
    <node id="CONTROL PREFERENCE SCALE" />
    <node id="SHARED DECISION-MAKING QUESTIONNAIRE (SDM-Q-9)" />
    <node id="ORAL MUCOSITIS" />
    <node id="SQUAMOUS CELL CARCINOMA" />
    <node id="LATENT GROUPS" />
    <node id="ILLUMINA" />
    <node id="IMMUNE CHECKPOINT INHIBITORS (ICIS)" />
    <node id="CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)" />
    <node id="CONGESTIVE HEART FAILURE (CHF)" />
    <node id="IMMUNE-RELATED ADVERSE EVENTS (IRAES)" />
    <node id="AUTHORS' INSTITUTION" />
    <node id="JANUARY 1, 2015" />
    <node id="JANUARY 1, 2021" />
    <node id="SOCIAL SCIENCE PREMIUM COLLECTION" />
    <node id="CANCER CARE" />
    <node id="CLINICAL GENETICS" />
    <node id="KMT2A-REARRANGED AML" />
    <node id="DISSEMINATED INTRAVASCULAR COAGULATION" />
    <node id="BREAST CANCER MODELING" />
    <node id="STATISTICAL MODELS" />
    <node id="BREAST CANCER TREATMENT" />
    <node id="ELECTRONIC COMMUNITY HEALTH INFORMATION SYSTEM" />
    <node id="HEALTH EXTENSION WORKERS" />
    <node id="REVISED TECHNOLOGY ACCEPTANCE MODEL" />
    <node id="SIX REGIONS OF ETHIOPIA" />
    <node id="COX PROPORTIONAL HAZARDS MODEL" />
    <node id="NAFLD" />
    <node id="FBS" />
    <node id="AFTERNOON SLEEP" />
    <node id="PREDIABETIC PATIENTS" />
    <node id="SOUTHWEST IRAN" />
    <node id="CUMULATIVE T2DM INCIDENCE" />
    <node id="AGITATION CLASSIFIER" />
    <node id="THRESHOLD" />
    <node id="COMMUNITY-ACADEMIC PARTNERSHIP" />
    <node id="COMMUNITY TASK FORCE" />
    <node id="BUFFALO, NEW YORK" />
    <node id="BREAST CANCER DISPARITIES" />
    <node id="HOSPITAL-INDUCED DELIRIUM" />
    <node id="MULTIDISCIPLINARY TASK FORCE" />
    <node id="PROGNOSTIC MODELS" />
    <node id="RETROSPECTIVE COHORT STUDY" />
    <node id="ADMINISTRATIVE AND ELECTRONIC HEALTH RECORDS" />
    <node id="GENERALIZED ANXIETY DISORDER (GAD)" />
    <node id="PSYCHINFO" />
    <node id="GAD-2" />
    <node id="GAD-7" />
    <node id="ENGLISH-LANGUAGE ORIGINAL STUDIES" />
    <node id="RCTS" />
    <node id="INVASIVE MICROPAPILLARY CARCINOMA" />
    <node id="OBSTRUCTIVE SLEEP APNEA" />
    <node id="EPWORTH SLEEPINESS SCALE" />
    <node id="BERLIN QUESTIONNAIRE" />
    <node id="ONLINE CALCULATOR" />
    <node id="INDONESIA" />
    <node id="TANYA OBAT" />
    <node id="BANDUNG CITY" />
    <node id="MIMIC IV" />
    <node id="HOSMER&#8211;LEMESHOW TEST" />
    <node id="DECISION-CURVE ANALYSIS" />
    <node id="APSIII" />
    <node id="SAPSII" />
    <node id="INFECTIVE ENDOCARDITIS" />
    <node id="LITHIUM" />
    <node id="VALPROATE" />
    <node id="LAMOTRIGINE" />
    <node id="ASENAPINE" />
    <node id="LURASIDONE" />
    <node id="CARIPRAZINE" />
    <node id="DUTCH CHILDHOOD CANCER SURVIVOR STUDY LATER" />
    <node id="ECONOMICS" />
    <node id="MODILM" />
    <node id="GRAPH ATTENTION NETWORKS" />
    <node id="MULTILAYER PERCEPTRON NETWORKS" />
    <node id="VIEW CORRELATION DISCOVERY NETWORK" />
    <node id="COMPLEX DISEASES" />
    <node id="MULTI-OMICS DATA" />
    <node id="MIRNA EXPRESSION" />
    <node id="MRNA" />
    <node id="VEXAS SYNDROME" />
    <node id="UBA1" />
    <node id="GEISINGER" />
    <node id="EXOME SEQUENCING" />
    <node id="QATAR BIOBANK" />
    <node id="RF" />
    <node id="T12" />
    <node id="TROCH" />
    <node id="TRUNK AREA" />
    <node id="DUAL ENERGY X-RAY ABSORPTIOMETRY" />
    <node id="IMPACT-AF" />
    <node id="NOVA SCOTIA" />
    <node id="COMPUTERIZED DECISION SUPPORT SYSTEM" />
    <node id="SEMANTIC WEB COMMUNITY" />
    <node id="RDF" />
    <node id="HL7 RIM" />
    <node id="CDISC CDASH" />
    <node id="DCT" />
    <node id="SIO" />
    <node id="FOAF" />
    <node id="ORDO" />
    <node id="GRDDL" />
    <node id="CHENGDU" />
    <node id="CEREBROVASCULAR DISEASE" />
    <node id="STACKING ENSEMBLE MODEL" />
    <node id="HOSPITAL ADMISSIONS" />
    <node id="AIR QUALITY DATA" />
    <node id="METEOROLOGICAL DATA" />
    <node id="HOSPITAL INFORMATION SYSTEMS" />
    <node id="EMERGENCY QUERY PROGRAM" />
    <node id="EMERGENCY PRESCRIPTION SYSTEM" />
    <node id="MICROSOFT POWER PLATFORM" />
    <node id="MICROSOFT TEAMS" />
    <node id="VIRTUAL REALITY" />
    <node id="EFFECTIVE PUBLIC HEALTH PRACTICE PROJECT (EPHPP) TOOL" />
    <node id="FEBRUARY 6, 2022" />
    <node id="KOREAN NATIONAL HEALTH INSURANCE SERVICE" />
    <node id="GASTRIC CANCER SURGERY" />
    <node id="IQ-OTHNCCD" />
    <node id="ECG MACHINES" />
    <node id="CONGESTIVE HEART FAILURE" />
    <node id="NORMAL SINUS RHYTHM" />
    <node id="RESNET 50" />
    <node id="MIT-BIH" />
    <node id="PHYSIONET" />
    <node id="BIDMC" />
    <node id="MANUFACTURER" />
    <node id="PAYER" />
    <node id="PRICE-THRESHOLD ANALYSES" />
    <node id="INDICATION-SPECIFIC PRICES" />
    <node id="REIMBURSEMENT DECISIONS" />
    <node id="MAXIMUM ENDURABLE TIME (MET)" />
    <node id="MONOTONICITY" />
    <node id="QALY MODELS" />
    <node id="PREFERENCE REVERSALS" />
    <node id="TRANSITIVITY VIOLATIONS" />
    <node id="LIGHT GRADIENT BOOSTING" />
    <node id="CATHEPSIN B" />
    <node id="ADA-BOOSTING OF DECISION TREE" />
    <node id="MULTILAYER PERCEPTION" />
    <node id="GRADIENT BOOSTING DECISION TREE" />
    <node id="INTRAOPERATIVE BLEEDING" />
    <node id="SURGICAL INPATIENTS" />
    <node id="AM-SAS" />
    <node id="ADENOMYOSIS" />
    <node id="NANCHONG CENTRAL HOSPITAL" />
    <node id="AFFILIATED HOSPITAL OF SOUTHWEST MEDICAL UNIVERSITY" />
    <node id="HAIFU HOSPITAL" />
    <node id="SWITZERLAND" />
    <node id="CPR SURVIVAL RATES STUDY" />
    <node id="SURVEY ON HEALTH, AGEING, AND RETIREMENT IN EUROPE (SHARE)" />
    <node id="CKD MANAGEMENT CENTER" />
    <node id="APP + OUTPATIENT FOLLOW-UP" />
    <node id="TRADITIONAL OUTPATIENT FOLLOW-UP" />
    <node id="PHOSPHORUS" />
    <node id="SODIUM" />
    <node id="TRIGLYCERIDE" />
    <node id="HEMOGLOBIN" />
    <node id="ELECTRONIC SURVEILLANCE SYSTEM" />
    <node id="KNOWLEDGE-BASED HEALTHCARE-ASSOCIATED INFECTIONS SURVEILLANCE SYSTEM (KBHAIS)" />
    <node id="GANSU PROVINCIAL HOSPITAL" />
    <node id="EARLY DETECTION" />
    <node id="MATHEMATICAL MODELING" />
    <node id="SCREENING PROTOCOLS" />
    <node id="BARRETT'S ESOPHAGUS" />
    <node id="ESOPHAGEAL ADENOCARCINOMA" />
    <node id="GASTROESOPHAGEAL REFLUX DISEASE" />
    <node id="U.S. CANCER REGISTRY" />
    <node id="TOTAL PRODUCT LIFECYCLE MANAGEMENT" />
    <node id="POST-MARKET SURVEILLANCE" />
    <node id="REAL-WORLD DATA" />
    <node id="INDIANA" />
    <node id="EMBOLIZATION COILS" />
    <node id="SOCIETY OF INTERVENTIONAL RADIOLOGY" />
    <node id="COOK MEDICAL" />
    <node id="COOK MEDICAL TORNADO" />
    <node id="NESTER" />
    <node id="MREYE" />
    <node id="MEDICAL DEVICE MANUFACTURER" />
    <node id="NON-PROFIT DATA INSTITUTE" />
    <node id="EVIDENCE REVIEWS" />
    <node id="STUDY SCREENING" />
    <node id="ALIGNMENT EVALUATIONS" />
    <node id="IMITATION LEARNING" />
    <node id="BINARY DISCRIMINATION" />
    <node id="RANKED PREFERENCE MODELING" />
    <node id="PREFERENCE MODEL PRE-TRAINING" />
    <node id="MID-NET&#174;" />
    <node id="SINGLE REGRESSION IMPUTATION" />
    <node id="INVERSE PROBABILITY WEIGHTED METHOD" />
    <node id="PROPENSITY SCORE WEIGHTING" />
    <node id="REGRESSION ADJUSTMENT" />
    <node id="SCENARIO 1" />
    <node id="SCENARIO 2" />
    <node id="ACUTE SINUSITIS" />
    <node id="AMOXICILLIN-CLAVULANATE" />
    <node id="AMOXICILLIN" />
    <node id="ADOLESCENTS" />
    <node id="MOBILE-BASED SELF-CARE APPLICATION" />
    <node id="PATIENTS WITH DEPRESSION AND ANXIETY" />
    <node id="AUTONOMY PREFERENCE INDEX" />
    <node id="API-URO" />
    <node id="UROLOGICAL CANCER TREATMENTS" />
    <node id="UNIVERSITY HOSPITAL" />
    <node id="UROLOGICAL OUTPATIENTS" />
    <node id="BLADDER CANCER PATIENTS" />
    <node id="POPULATION HEALTH INTERVENTION RESEARCH" />
    <node id="SIMULATION STUDIES" />
    <node id="DIABETIC KIDNEY DISEASE" />
    <node id="TYPE-2 DIABETES" />
    <node id="XIANGYANG CENTRAL HOSPITAL" />
    <node id="ARTIFICIAL INTELLIGENCE TECHNOLOGY" />
    <node id="NATURAL-HISTORY MODELING" />
    <node id="SOJOURN TIMES" />
    <node id="STAGE-SPECIFIC SENSITIVITIES" />
    <node id="SCREENING-INDUCED LUNG CANCER MORTALITY REDUCTIONS" />
    <node id="PERSONALIZED SCREENING RECOMMENDATIONS" />
    <node id="CANCER EPIDEMIOLOGY" />
    <node id="SEMI-SUPERVISED AUTOENCODERS" />
    <node id="UNSUPERVISED AUTOENCODERS" />
    <node id="OMICS DATA" />
    <node id="FINNISH PARTICIPANTS" />
    <node id="NULLIPAROUS PREGNANCY OUTCOMES STUDY: MONITORING MOTHERS-TO-BE" />
    <node id="US MEDICAL CENTERS" />
    <node id="PREGNANCY OUTCOMES" />
    <node id="PLACENTAL FUNCTION" />
    <node id="CANNABIS EXPOSURE" />
    <node id="FIRST TRIMESTER" />
    <node id="ONGOING EXPOSURE" />
    <node id="MONOCLONAL ANTIBODIES" />
    <node id="PUBLIC HEALTH CRISIS RESPONSES" />
    <node id="VALUE-OF-INFORMATION (VOI) APPROACH" />
    <node id="CUMULATIVE META-ANALYSIS" />
    <node id="REFERENCE STANDARD RETROSPECTIVE VOI ANALYSIS" />
    <node id="GENETIC EPIDEMIOLOGY OF COPD COHORT" />
    <node id="AIRWAY MUCUS PLUGS" />
    <node id="CHEST CT SCANS" />
    <node id="MEDICATION ADMINISTRATION CLINICAL DECISION SUPPORT SYSTEMS" />
    <node id="FAST HEALTHCARE INTEROPERABILITY RESOURCES" />
    <node id="PROQUEST" />
    <node id="BMC MED INFORM DECIS MAK" />
    <node id="CORRECTION" />
    <node id="PRINCIPAL COMPONENT ANALYSIS (PCA)" />
    <node id="MULTIPLE CO-INERTIA ANALYSIS (MCIA)" />
    <node id="DIMENSION REDUCTION" />
    <node id="T-DISTRIBUTED STOCHASTIC NEIGHBOR EMBEDDING (T-SNE)" />
    <node id="BAGPLOTS" />
    <node id="COMPUTED TOMOGRAPHY SCANS" />
    <node id="OUTLIER DETECTION" />
    <node id="HIPPOCAMPAL AVOIDANCE" />
    <node id="HIPPOCAMPUS" />
    <node id="MEDULLOBLASTOMA" />
    <node id="VMAT" />
    <node id="IMPT" />
    <node id="RESOLSTM-DEPTH" />
    <node id="EXPERIENCED RADIOLOGIST" />
    <node id="MEDICAL LIBRARY ASSOCIATION" />
    <node id="GROUP 6" />
    <node id="TECH MINING" />
    <node id="CDSS" />
    <node id="REDCAP" />
    <node id="STATA SE 15.1" />
    <node id="EXCEL" />
    <node id="NEPHROLOGISTS" />
    <node id="CKD PROGRESSION PREDICTION" />
    <node id="IN-SILICO SIMULATIONS" />
    <node id="LANCET COMMISSION ON GLOBAL SURGERY" />
    <node id="GLOBAL CANCER SURGERY" />
    <node id="CORONAVIRUS DISEASE 2019 PANDEMIC" />
    <node id="SWOT ANALYSIS" />
    <node id="COULOMB'S LAW" />
    <node id="ATOM" />
    <node id="NUCLEUS" />
    <node id="ELECTRON" />
    <node id="CLINICAL TEXT CORPUS" />
    <node id="ADLIFE" />
    <node id="SHARE APPROACH" />
    <node id="QUIS7 QUESTIONNAIRE" />
    <node id="SPAIN" />
    <node id="PATIENT EMPOWERMENT PROCESS" />
    <node id="PROMS" />
    <node id="CLINICAL PILOT STUDIES" />
    <node id="GASTRIC STROMAL TUMORS" />
    <node id="GANSU PROVINCE" />
    <node id="BIO-MED CENTRAL LTD." />
    <node id="SIMCRC" />
    <node id="MISCAN-COLON" />
    <node id="CRC-SPIN" />
    <node id="BAYESIAN ALGORITHM" />
    <node id="LATIN HYPERCUBE SAMPLING" />
    <node id="HAMILTONIAN MONTE CARLO" />
    <node id="ARTIFICIAL NEURAL NETWORKS (ANNS)" />
    <node id="BIGRU" />
    <node id="MANHATTAN DISTANCE" />
    <node id="ATTENTION MECHANISM" />
    <node id="ETHNIC MEDICINE" />
    <node id="CHECKMATE-017" />
    <node id="FLEXIBLE PARAMETRIC MODELS" />
    <node id="MIXTURE CURE MODELS" />
    <node id="CHECKMATE-057" />
    <node id="BAYESIAN MULTIPARAMETER EVIDENCE SYNTHESIS" />
    <node id="BRAF V600E MUTATIONS" />
    <node id="TRAK FUSIONS" />
    <node id="PRIMARY CNS LYMPHOMA" />
    <node id="OCTREOTIDE" />
    <node id="PROTON RADIOTHERAPY" />
    <node id="LEPTOMENINGEAL METASTASES" />
    <node id="DELPHI PANELS" />
    <node id="RAND/UCLA" />
    <node id="OPIOID MANAGEMENT STRATEGIES" />
    <node id="CANCER-RELATED PAIN" />
    <node id="BUCCAL/NALOXONE TRANSITION" />
    <node id="MEDICAL INDUSTRY" />
    <node id="SIAMESE NETWORK" />
    <node id="BEMPEDOIC ACID" />
    <node id="STATIN-INTOLERANT PATIENTS" />
    <node id="PRIMARY PREVENTION PATIENTS" />
    <node id="CARDIOVASCULAR OUTCOMES" />
    <node id="NCT02993406" />
    <node id="CORONARY REVASCULARIZATION" />
    <node id="CARDIOVASCULAR DEATH" />
    <node id="LOXO-TRK" />
    <node id="SCOUT" />
    <node id="NAVIGATE" />
    <node id="STARTRK" />
    <node id="VE-BASKET" />
    <node id="ROAR BASKET" />
    <node id="LIBRETTO-001" />
    <node id="ARROW" />
    <node id="FIGHT-203" />
    <node id="NATIONAL CANCER INSTITUTE-MOLECULAR ANALYSIS FOR THERAPY CHOICE" />
    <node id="BASKET TRIALS" />
    <node id="CANCER THERAPY" />
    <node id="NTRK FUSIONS" />
    <node id="BRAF MUTATIONS" />
    <node id="RET ALTERATIONS" />
    <node id="FGFR1 ALTERATIONS" />
    <node id="AFRICAN AMERICAN CANCER SURVIVORS" />
    <node id="DISCRIMINATION" />
    <node id="DEFICIT ACCUMULATION INDEX" />
    <node id="SPIROMICS I" />
    <node id="SPIROMICS II" />
    <node id="TEPS" />
    <node id="SYMPTOMATIC TEPS" />
    <node id="ASYMPTOMATIC TEPS" />
    <node id="BAYESIAN MODELS" />
    <node id="CALE MODEL" />
    <node id="HEALTH UTILITIES" />
    <node id="SPATIAL CORRELATION" />
    <node id="PREDICTIVE PRECISION" />
    <node id="ROOT MEAN SQUARED ERROR (RMSE)" />
    <node id="NATIONAL CLAIMS DATABASE" />
    <node id="GENERALIZED LINEAR MODEL" />
    <node id="SUPERLEARNER" />
    <node id="CHILDREN AND TEENAGERS" />
    <node id="MANIA" />
    <node id="HEALTH INFORMATION TECHNOLOGIES" />
    <node id="BARRIERS AND FACILITATORS REVIEW" />
    <node id="MANAGERS OF ORGANIZATIONS" />
    <node id="DESIGNERS OF HEALTH SYSTEMS" />
    <node id="WEB OF SCIENCES" />
    <node id="SOCIETY OF THORACIC SURGEONS" />
    <node id="AMERICAN COLLEGE OF CARDIOLOGY" />
    <node id="TRANS-CATHETER VALVE THERAPIES REGISTRY" />
    <node id="MITRACLIP" />
    <node id="ABBOTT" />
    <node id="DEGENERATIVE MITRAL REGURGITATION" />
    <node id="MR SUCCESS" />
    <node id="TRANS-CATHETER MITRAL VALVE REPAIR" />
    <node id="NON-PROFIT ORGANIZATIONS" />
    <node id="QUALITY ASSESSMENT TOOL" />
    <node id="UNITED KINGDOM FLEXIBLE SIGMOIDOSCOPY SCREENING TRIAL" />
    <node id="PHILOSOPHICAL ESSAYS" />
    <node id="PANDORA'S BLACK BOX" />
    <node id="LITERATURE" />
    <node id="CONTROVERSIES" />
    <node id="LABORATORIES" />
    <node id="CENTRES OF CALCULATION" />
    <node id="TRIBUNALS OF REASON" />
    <node id="RHETORIC" />
    <node id="STRONGHOLDS" />
    <node id="NETWORKS" />
    <node id="PEDIATRIC CANCER CENTERS" />
    <node id="CHILDREN WITH LEUKEMIA OR LYMPHOMA" />
    <node id="MEDICATION ERRORS" />
    <node id="PHYSICIAN REVIEWERS" />
    <node id="OUTPATIENT MEDICATION ERRORS" />
    <node id="IMPROVED COMMUNICATION" />
    <node id="HARM" />
    <node id="INTERLEUKIN-6 (IL-6)" />
    <node id="NEUROCOGNITION STUDY" />
    <node id="ACUTE PULMONARY THROMBOEMBOLISM" />
    <node id="PULMONARY EMBOLISM SEVERITY INDEX" />
    <node id="SIMPLIFIED PULMONARY EMBOLISM SEVERITY INDEX" />
    <node id="MULTI LAYER PERCEPTRON" />
    <node id="NONFED" />
    <node id="SURVINT" />
    <node id="PHASE III CLINICAL TRIALS" />
    <node id="TRANSLATOR" />
    <node id="OBJECTIVISM" />
    <node id="STRUCTURES" />
    <node id="HABITUS" />
    <node id="SYMBOLIC POWER" />
    <node id="PROOF OF PRINCIPLE STUDY" />
    <node id="FAIR DATA PRINCIPLES" />
    <node id="PERSONAL HEALTH TRAIN (PHT)" />
    <node id="EPRESCRIBING SYSTEMS" />
    <node id="STAKEHOLDERS" />
    <node id="DIGITALLY ADVANCED HOSPITAL SITES" />
    <node id="ELECTRONIC HEALTH RECORD ENTERPRISE SYSTEMS" />
    <node id="PATIENT SAFETY" />
    <node id="INTEGRATION &amp; CONTINUITY OF CARE" />
    <node id="OPTIMISING CARE PATHWAYS" />
    <node id="FULL PATIENT CARE SERVICES INTEROPERABILITY" />
    <node id="TCGA DATABASE" />
    <node id="MIRNA" />
    <node id="METHYLATION" />
    <node id="DNASEQ" />
    <node id="COPY NUMBER VARIATION" />
    <node id="HARRELL'S C-INDEX" />
    <node id="INTEGRATED BRIER SCORE" />
    <node id="IRAN ELECTRONIC HEALTH RECORD SYSTEM (SEPAS)" />
    <node id="DELONE AND MCLEAN MODEL" />
    <node id="HEALTH INFORMATION MANAGEMENT PERSONNEL" />
    <node id="SYSTEM QUALITY" />
    <node id="SEPAS BENEFITS" />
    <node id="COCHRANE COLLABORATION" />
    <node id="PRISMA STATEMENT" />
    <node id="BEHAVIOURAL CHANGE MODELS" />
    <node id="INFECTIOUS DISEASE TRANSMISSION" />
    <node id="PHAM ET AL." />
    <node id="BMC MEDICAL INFORMATICS AND DECISION MAKING" />
    <node id="CLALIT HEALTH SERVICES" />
    <node id="KAISER PERMANENTE SOUTHERN CALIFORNIA" />
    <node id="CHRONIC CONDITIONS" />
    <node id="OSTEOPOROSIS" />
    <node id="CARDIOMYOPATHY" />
    <node id="HEALTH SYSTEM IN THE US" />
    <node id="NUTRITION CARE" />
    <node id="BLOOD PRESSURE CONTROL" />
    <node id="LONGITUDINAL TARGETED MAXIMUM LIKELIHOOD ESTIMATION" />
    <node id="PREVENTIVE CARE VISITS" />
    <node id="PATIENT EDUCATION MATERIALS" />
    <node id="INFECTION CONTROL" />
    <node id="BIG DATA ANALYTICS" />
    <node id="INTERNATIONAL LOW GRADE GLIOMA REGISTRY" />
    <node id="LOWER GRADE GLIOMA" />
    <node id="MENINGIOMA CONSORTIUM" />
    <node id="CONNECTICUT" />
    <node id="MASSACHUSETTS" />
    <node id="MENINGIOMA" />
    <node id="SEISMOCARDIOGRAPHY" />
    <node id="ADAPTIVE BIDIRECTIONAL FILTERING" />
    <node id="WEARABLE SENSORS" />
    <node id="REDUNDANT MULTI-SCALE WAVELET DECOMPOSITION" />
    <node id="TIME-FREQUENCY MASKING" />
    <node id="NON-NEGATIVE MATRIX DECOMPOSITION" />
    <node id="ECG" />
    <node id="CCT" />
    <node id="STROKE SURVIVORS" />
    <node id="MOBILE APPLICATIONS" />
    <node id="TRUNK CONTROL ABILITY" />
    <node id="FUGL-MEYER ASSESSMENT" />
    <node id="LOW-DENSITY LIPOPROTEIN CHOLESTEROL" />
    <node id="GLYCOSYLATED HAEMOGLOBIN A1C" />
    <node id="CRC SCREENING" />
    <node id="MELANOMA PATHOLOGY STUDY" />
    <node id="PATHOLOGISTS" />
    <node id="BREAST PATHOLOGY STUDY" />
    <node id="METACOGNITIVE SENSITIVITY" />
    <node id="METACOGNITION" />
    <node id="SECONDARY DIAGNOSTIC ACTION" />
    <node id="INTEGRATIVE SYSTEMS BIOLOGY" />
    <node id="BIMODAL RESEARCHER" />
    <node id="UNIMODAL MODELING STRATEGY" />
    <node id="SYSTEMS BIOLOGY RESEARCH LABS" />
    <node id="MAYO CLINIC STUDY OF AGING" />
    <node id="MCI DIAGNOSIS" />
    <node id="DEMENTIA ONSET" />
    <node id="SEX-SPECIFIC IMPACT" />
    <node id="NEUROPSYCHIATRIC SYMPTOMS" />
    <node id="COGNITIVE DECLINE" />
    <node id="ROBOTANALYST" />
    <node id="EPPI-REVIEWER" />
    <node id="COMPUTATIONAL TEXT PHENOTYPING" />
    <node id="RARE DISEASES" />
    <node id="NLP" />
    <node id="SEMEHR" />
    <node id="NHS TAYSIDE" />
    <node id="ICD CODES" />
    <node id="VICTORIA" />
    <node id="GENERAL PRACTICES" />
    <node id="DIAGNOSIS UNDERREPORTING STUDY" />
    <node id="AGENCIES" />
    <node id="CHRONIC DISEASES" />
    <node id="CLINICAL DECISION SUPPORT" />
    <node id="RESOURCE ALLOCATION" />
    <node id="POPULATION HEALTHCARE PLANNING" />
    <node id="ALZHEIMER&#8217;S DISEASE DATA ELEMENT ONTOLOGY" />
    <node id="CROSS-COHORT QUERY SYSTEM" />
    <node id="FAIR" />
    <node id="HEALTH ECONOMIC MODELERS" />
    <node id="COMPLEX SYSTEMS MODELS" />
    <node id="WORKING GROUP" />
    <node id="MACHINE LEARNING IN MENTAL HEALTH RESEARCH" />
    <node id="OCTOBER 2022 TO MARCH 2024" />
    <node id="IMMIGRANTS, REFUGEES, MIGRANTS, AND RACIAL AND ETHNIC MINORITIES" />
    <node id="ASIAN IMMIGRANT POPULATIONS" />
    <node id="HISPANIC IMMIGRANT POPULATIONS" />
    <node id="CHINESE AMERICANS" />
    <node id="JAPANESE AMERICANS" />
    <node id="KOREAN AMERICANS" />
    <node id="US CENSUS" />
    <node id="SWEDISH CANCER REGISTRY" />
    <node id="PARAMETRIC MODELS" />
    <node id="SPLINE MODELS" />
    <node id="CANCER COHORTS" />
    <node id="RELATIVE SURVIVAL FRAMEWORK" />
    <node id="ALL-CAUSE SURVIVAL FRAMEWORK" />
    <node id="ETHICAL CONCERNS" />
    <node id="DAVID MOHER" />
    <node id="CANADIAN-LED INTERNATIONAL STUDY" />
    <node id="TERTIARY CARE CENTERS" />
    <node id="POSTOPERATIVE RADIATION THERAPY" />
    <node id="SALIVARY GLAND CANCER" />
    <node id="ACINIC CELL CARCINOMA" />
    <node id="MUCOEPIDERMOID CARCINOMA" />
    <node id="PAROTID GLAND" />
    <node id="SUBMANDIBULAR GLAND" />
    <node id="TOPSIS" />
    <node id="VIKOR" />
    <node id="PROMETHEE" />
    <node id="ENTROPY METHOD" />
    <node id="KIDNEY CANCER STUDY" />
    <node id="WWAS PLATFORM" />
    <node id="GROUNDWATER" />
    <node id="CHLORDANE" />
    <node id="DIELDRIN" />
    <node id="1,2-DICHLOROPROPANE" />
    <node id="2,4,5-TP" />
    <node id="GLYPHOSATE" />
    <node id="ENDOTHALL" />
    <node id="CARBARYL" />
    <node id="BROMIDE" />
    <node id="NEWTONIAN PHYSICS" />
    <node id="EINSTEIN" />
    <node id="MAMMOGRAPHY COMPLETION" />
    <node id="PROVIDER-INITIATED REFERRAL" />
    <node id="PARTICLE PHYSICS" />
    <node id="LABORATORY" />
    <node id="PHYSICISTS" />
    <node id="HEP EXPERIMENTS" />
    <node id="KNOWLEDGE SOCIETIES" />
    <node id="JIMMA HEALTH CENTER" />
    <node id="MATERNAL AND CHILD HEALTH SERVICE UNIT" />
    <node id="LOW-RESOURCE SETTING (LRS)" />
    <node id="US DEPARTMENT OF DEFENSE" />
    <node id="AUTOMATED CENTRAL TUMOR REGISTRY" />
    <node id="US MILITARY" />
    <node id="GENERAL US POPULATION" />
    <node id="CANCER OCCURRENCE STUDY" />
    <node id="TESTICULAR CANCER" />
    <node id="WOMEN'S HEALTH ACCELEROMETRY COLLABORATION" />
    <node id="WOMEN'S HEALTH STUDY" />
    <node id="WOMEN'S HEALTH INITIATIVE OBJECTIVE PHYSICAL ACTIVITY AND CARDIOVASCULAR HEALTH STUDY" />
    <node id="ACTIGRAPH GT3X+" />
    <node id="VECTOR MAGNITUDE COUNTS" />
    <node id="LIGHT PHYSICAL ACTIVITY" />
    <node id="MODERATE-TO-VIGOROUS PHYSICAL ACTIVITY" />
    <node id="TOTAL PHYSICAL ACTIVITY" />
    <node id="BIOBANKS" />
    <node id="COMPREHENSIVE BIOBANK INFORMATION MANAGEMENT SYSTEM" />
    <node id="BIG HEALTH" />
    <node id="BIG DATA" />
    <node id="PREGNANCY&#8211;BIRTH COHORT" />
    <node id="QUALITY BY DESIGN" />
    <node id="AI TOOL" />
    <node id="PEER REVIEW WORKFLOW" />
    <node id="CONFERENCES" />
    <node id="SCIENTIFIC LITERATURE" />
    <node id="AUTOMATED SCREENING TOOLS" />
    <node id="NORTH AMERICAN PARTICIPANTS" />
    <node id="STUDY 1A" />
    <node id="CHINESE PARTICIPANTS" />
    <node id="AMERICAN PARTICIPANTS" />
    <node id="NATURALNESS BIAS" />
    <node id="CANADIAN PARTICIPANTS" />
    <node id="STUDY 1B" />
    <node id="MEDICAL CONTEXT" />
    <node id="4TH WORLD CONGRESS ON SOCIAL SIMULATION" />
    <node id="PACIFIC-ASIAN ASSOCIATION FOR AGENT-BASED APPROACH IN SOCIAL SYSTEMS SCIENCES" />
    <node id="EUROPEAN SOCIAL SIMULATION ASSOCIATION" />
    <node id="COMPUTATIONAL SOCIAL SCIENCE SOCIETY OF THE AMERICAS" />
    <node id="SOCIAL SIMULATION" />
    <node id="AGENT-BASED SOCIAL SIMULATION" />
    <node id="ARTIFICIAL FINANCIAL MARKETS" />
    <node id="MACROECONOMIC FORECASTING" />
    <node id="SUPPLY CHAIN MANAGEMENT" />
    <node id="BANK NETWORKS" />
    <node id="SOCIAL NETWORKS" />
    <node id="URBAN PLANNING" />
    <node id="SOCIAL NORMS AND GROUP FORMATION" />
    <node id="CROSS-CULTURAL STUDIES" />
    <node id="POLITICAL PARTY COMPETITION" />
    <node id="VOTING BEHAVIOR" />
    <node id="COMPUTATIONAL DEMOGRAPHY" />
    <node id="COMPUTATIONAL ANTHROPOLOGY" />
    <node id="EVOLUTION OF LANGUAGES" />
    <node id="PUBLIC HEALTH AND EPIDEMICS" />
    <node id="AIDS" />
    <node id="SECURITY AND TERRORISM" />
    <node id="METHODOLOGICAL AND EPISTEMOLOGICAL ISSUES" />
    <node id="EMPIRICAL-BASED AGENT-BASED MODELING" />
    <node id="MODELING OF EXPERIMENTAL SOCIAL SCIENCE" />
    <node id="GAMING SIMULATION" />
    <node id="COGNITIVE AGENTS" />
    <node id="PARTICIPATORY SIMULATION" />
    <node id="THEORETICAL FOUNDATIONS OF SOCIAL SIMULATION" />
    <node id="CATEGORICAL SOCIAL SCIENCE" />
    <node id="JUMPSTART GUIDE" />
    <node id="DARTMOUTH ATLAS PROJECT" />
    <node id="NCT04281784" />
    <node id="PALLIATIVE CARE" />
    <node id="GOALS-OF-CARE DISCUSSIONS" />
    <node id="NEUROTOXICITY" />
    <node id="TEXAS CHILDREN'S CANCER CENTER" />
    <node id="LATINO CHILDREN" />
    <node id="SERUM CREATININE ELEVATION" />
    <node id="ITALIAN PATIENTS" />
    <node id="FRONTLINE TREATMENT" />
    <node id="DASATINIB" />
    <node id="NILOTINIB" />
    <node id="CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML)" />
    <node id="SECOND-GENERATION TKIS" />
    <node id="EUROPEAN LONG-TERM SURVIVAL RISK" />
    <node id="CLOTCATCHER" />
    <node id="EMORY UNIVERSITY HOSPITAL" />
    <node id="GRADY MEMORIAL HOSPITAL" />
    <node id="GOOGLE PEGASUS" />
    <node id="INTERNATIONAL CLASSIFICATION OF DISEASES" />
    <node id="PROGNOSTIC DISCLOSURE" />
    <node id="CHILDREN WITH ADVANCED CANCER" />
    <node id="TRANSFORMER ALGORITHM" />
    <node id="HOUSE" />
    <node id="MC-SEIRSV MODEL" />
    <node id="KEELING" />
    <node id="EPIDEMIC FORECASTS" />
    <node id="NPI" />
    <node id="VACCINE" />
    <node id="HOUSEHOLD TRANSMISSION" />
    <node id="COMMUNITY TRANSMISSION" />
    <node id="EPIDEMIC PEAK" />
    <node id="ULCERATIVE COLITIS" />
    <node id="NORTH AMERICA" />
    <node id="COLECTOMY" />
    <node id="PRIMARY SCLEROSING CHOLANGITIS" />
    <node id="MONTREAL CLASSIFICATION" />
    <node id="MAYO SCORE" />
    <node id="5-AMINOSALICYLIC ACID" />
    <node id="VEDOLIZUMAB" />
    <node id="USTEKINUMAB" />
    <node id="TOFACITINIB" />
    <node id="OZANIMOD" />
    <node id="CENTRAL DENMARK REGION" />
    <node id="BREAST CANCER SCREENING STUDY" />
    <node id="HYPOTHETICAL BREAST CANCER SCREENING" />
    <node id="SILENT HYPOXEMIA" />
    <node id="CLASSICAL ML" />
    <node id="STYLEGANV2-ADA" />
    <node id="GAZI BRAINS 2020" />
    <node id="BRATS 2021" />
    <node id="BR35H" />
    <node id="BRAIN TUMOR CLASSIFICATION" />
    <node id="GERMAN BREAST CANCER STUDY GROUP" />
    <node id="EXCESS HAZARD METHODS" />
    <node id="PARAMETRIC SURVIVAL MODELS" />
    <node id="RESTRICTED MEAN SURVIVAL TIME" />
    <node id="GENERAL POPULATION MORTALITY DATA" />
    <node id="COST-EFFECTIVENESS ANALYSES" />
    <node id="ADVANCED CARE PLANNING (ACP)" />
    <node id="OUTPATIENT ACP" />
    <node id="HEALTHCARE DELIVERY" />
    <node id="INPATIENT ACP" />
    <node id="PAUL HUMPHREYS" />
    <node id="EXTENDING OURSELVES" />
    <node id="COMPUTATIONAL METHODS" />
    <node id="MONTE CARLO METHODS" />
    <node id="PSYCHOSIS-SPECTRUM DISORDER" />
    <node id="BIPOLAR AFFECTIVE DISORDER" />
    <node id="COCHRANE-Q ANALYSIS" />
    <node id="DIGITAL EXCLUSION" />
    <node id="DIGITAL HEALTH LITERACY" />
    <node id="ENBS" />
    <node id="CANCER TECHNOLOGY APPRAISAL" />
    <node id="PEMBROLIZUMAB PLUS AXITINIB" />
    <node id="ADVANCED RENAL CELL CARCINOMA" />
    <node id="CUSHING SYNDROME" />
    <node id="CUSHING DISEASE" />
    <node id="PITUITARY TUMOR" />
    <node id="ADRENAL STEROIDOGENESIS INHIBITORS" />
    <node id="GLUCOCORTICOID RECEPTOR BLOCKERS" />
    <node id="BILATERAL ADRENALECTOMY" />
    <node id="PROTEIN CATABOLISM" />
    <node id="IMMUNOSUPPRESSION" />
    <node id="WEIGHT GAIN" />
    <node id="NEUROCOGNITIVE CHANGES" />
    <node id="MOOD DISORDERS" />
    <node id="MEXICAN AMERICANS" />
    <node id="US-BORN LATINOS" />
    <node id="FOREIGN-BORN LATINOS" />
    <node id="MULTIETHNIC COHORT STUDY" />
    <node id="DECISION-ANALYTIC MODELS" />
    <node id="GUIDELINES" />
    <node id="ECONOMIC EVALUATION METHODOLOGY" />
    <node id="VACCINATION INTENTION" />
    <node id="HEALTH WORKERS" />
    <node id="TRUSTWORTHY PHYSICIAN" />
    <node id="UNTRUSTWORTHY PHYSICIAN" />
    <node id="POSITIVE FRAMING" />
    <node id="NEGATIVE FRAMING" />
    <node id="KIDNEY TUMORS" />
    <node id="2.5D MFFAU-NET" />
    <node id="KITS19" />
    <node id="KITS21" />
    <node id="JAPAN ADJUVANT STUDY GROUP OF PANCREATIC CANCER 01" />
    <node id="S-1" />
    <node id="BOARD-CERTIFIED INSTITUTIONS" />
    <node id="STANDARD-DURATION GROUP" />
    <node id="LONGER DURATION GROUP" />
    <node id="POSTOPERATIVE RECURRENCE-FREE SURVIVAL" />
    <node id="CERVICAL CANCER INCIDENCE" />
    <node id="CERVICAL CANCER MORTALITY" />
    <node id="CANCER CARE INEQUITIES" />
    <node id="NHS HEALTH CHECK PROGRAMME" />
    <node id="PEER REVIEW SYSTEM" />
    <node id="AUTHORS" />
    <node id="PREPRINTS" />
    <node id="PHARMACOLOGICAL INTERVENTIONS" />
    <node id="OBSERVATIONAL STUDY DESIGNS" />
    <node id="RANDOMISED STUDY DESIGNS" />
    <node id="PSYCHOSOCIAL FACTORS AND CANCER INCIDENCE (PSY-CA) CONSORTIUM" />
    <node id="COHORTS" />
    <node id="SMOKING-RELATED CANCERS" />
    <node id="ALCOHOL-RELATED CANCERS" />
    <node id="MHAMFD" />
    <node id="AHIN" />
    <node id="AGES-REYKJAVIK STUDY" />
    <node id="ELASTIC NET REGRESSION" />
    <node id="ELASTIC NET COX REGRESSION" />
    <node id="PRINCESS MARGARET CANCER CENTER" />
    <node id="HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)" />
    <node id="SMOKING CESSATION" />
    <node id="LONG-TERM ABSTINENCE" />
    <node id="CURRENT SMOKERS" />
    <node id="FORMER SMOKERS" />
    <node id="CARDIOGRAPH" />
    <node id="GENOMICS HUB" />
    <node id="COST-EFFECTIVENESS STUDIES" />
    <node id="HUILE" />
    <node id="PROMIS-GH" />
    <node id="EQ5DLE" />
    <node id="PROMIS" />
    <node id="PROPR" />
    <node id="MODIFIED RANKIN SCALE" />
    <node id="OUTPATIENT CLINIC" />
    <node id="ISCHEMIC STROKE" />
    <node id="SUBARACHNOID HEMORRHAGE" />
    <node id="HUI-3" />
    <node id="QUEST" />
    <node id="CONNECT FOR CANCER PREVENTION STUDY" />
    <node id="WHO DIRECTOR-GENERAL" />
    <node id="SCREENING COVERAGE" />
    <node id="CISNET-CERVICAL MODELS" />
    <node id="REGRET THEORY" />
    <node id="HYBRID THEORY" />
    <node id="DUAL PROCESSING THEORY" />
    <node id="MEDICAL DECISION-MAKING" />
    <node id="DECISION THRESHOLDS" />
    <node id="SYSTEMATIC SCOPING REVIEW" />
    <node id="HUMAN SCREENING" />
    <node id="AUTOMATED SCREENING" />
    <node id="PC-12 CELLS" />
    <node id="ALFALFA APP" />
    <node id="CHICTR1900024455" />
    <node id="QUALITY-ADJUSTED LIFE-YEAR" />
    <node id="IMPACT MATRICES" />
    <node id="COST-CONSEQUENCE ANALYSIS" />
    <node id="RESIDENTIAL AGED-CARE FACILITIES" />
    <node id="PHYSICIANS REACTIONS TO UNCERTAINTY SCALE" />
    <node id="IMMEDIATE ASSESSMENT AND ANTIBIOTICS SCALE" />
    <node id="CLINICAL TOLERANCE OF UNCERTAINTY" />
    <node id="RESIDENT/FAMILY MEMBERS" />
    <node id="FORMAL CONSENSUS METHOD" />
    <node id="GUIDELINE COMMITTEE" />
    <node id="HEALTHCARE COMMITTEE MEMBERS" />
    <node id="CENTRE FOR NEW ART AND MEDIA (ZKM)" />
    <node id="KARLSRUHE" />
    <node id="ICONOCLASH" />
    <node id="ART &amp; LANGUAGE" />
    <node id="WILL BAUMEISTER" />
    <node id="CHRISTIAN BOLTANSKI" />
    <node id="DANIEL BUREN" />
    <node id="LUCAS CRANACH" />
    <node id="MAX DEAN" />
    <node id="MARCEL DUCHAMP" />
    <node id="ALBRECHT DURER" />
    <node id="LUCIO FONTANA" />
    <node id="FRANCISCO GOYA" />
    <node id="HANS HAACKE" />
    <node id="RICHARD HAMILTON" />
    <node id="YOUNG HAY" />
    <node id="ARATA ISOZAKI" />
    <node id="ASGER JORN" />
    <node id="MARTIN KIPPENBERGER" />
    <node id="IMI KNOEBEL" />
    <node id="KOMAR &amp; MELAMID" />
    <node id="JOSEPH KOSUTH" />
    <node id="GORDON MATTA-CLARK" />
    <node id="TRACEY MOFFA" />
    <node id="NAM JUNE PAIK" />
    <node id="SIGMAR POLKE" />
    <node id="STEPHEN PRINA" />
    <node id="MAN RAY" />
    <node id="SOPHIE RISTELHUEBER" />
    <node id="HIROSHI SUGIMOTO" />
    <node id="INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS AND OUTCOMES RESEARCH" />
    <node id="SOCIETY FOR MEDICAL DECISION MAKING" />
    <node id="CHECKLIST" />
    <node id="ISPOR-SMDM TASK FORCE" />
    <node id="DISCRETE EVENT SIMULATION STUDIES" />
    <node id="HEALTH ECONOMIC EVALUATION" />
    <node id="HEALTHCARE-RELATED DISCRETE EVENT SIMULATION" />
    <node id="TNM-8-N" />
    <node id="OSCC" />
    <node id="POSTCHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION (PCRPLND)" />
    <node id="NECROSIS (NEC)" />
    <node id="TERATOMA (TER)" />
    <node id="ANTERIOR GRADIENT PROTEIN 2 HOMOLOG (AGR2)" />
    <node id="KERATIN, TYPE I CYTOSKELETAL 19 (KRT19)" />
    <node id="MESSENGER RNA (MRNA)" />
    <node id="NANOSTRING PANEL" />
    <node id="PROTEINS" />
    <node id="PROTEOMICS" />
    <node id="IMMUNOHISTOCHEMISTRY (IHC)" />
    <node id="VANCOMYCIN DOSING STUDY" />
    <node id="ROCHESTER, MN" />
    <node id="CRITICAL CARE PHARMACISTS" />
    <node id="BMT SURVIVOR STUDY" />
    <node id="BEERS CRITERIA" />
    <node id="US TRANSPLANT CENTERS" />
    <node id="CHRONIC GRAFT VERSUS HOST DISEASE" />
    <node id="HEMATOLOGIC MALIGNANCIES" />
    <node id="BLOOD OR MARROW TRANSPLANTATION" />
    <node id="LOW-MOLECULAR-WEIGHT HEPARIN" />
    <node id="MATERNAL MORBIDITY" />
    <node id="MATERNAL DEATH" />
    <node id="DASH-TOP" />
    <node id="APPLIED CLINICAL RESEARCH IN HEALTH SCIENCES" />
    <node id="STUDENTS" />
    <node id="SYSTEMATIC REVIEW TOOLBOX" />
    <node id="NESTEDKNOWLEDGE" />
    <node id="SWIFT-ACTIVESCREENER" />
    <node id="LIVING REVIEWS" />
    <node id="LIVING RAPID REVIEWS" />
    <node id="EVIDENCE MAPS" />
    <node id="RACISM" />
    <node id="ADVERSE HEALTH OUTCOMES" />
    <node id="NON-HISPANIC WHITE SURVIVORS" />
    <node id="HISTORICALLY MARGINALIZED RACIAL/ETHNIC GROUPS" />
    <node id="DATA MANAGEMENT SYSTEM FOR DIABETES CLINICAL TRIALS" />
    <node id="DIABETES CLINICAL TRIALS" />
    <node id="ARTIFICIAL INTELLIGENCE MODEL" />
    <node id="OBSTETRIC CESAREAN SECTION" />
    <node id="CANADIAN EQ-5D-5L VALUATION STUDY" />
    <node id="MULTIPLE IMPUTATION (MI)" />
    <node id="CANADIAN GENERAL PUBLIC" />
    <node id="WOMEN WITH BREAST CANCER" />
    <node id="CARDIOMETABOLIC HEALTH" />
    <node id="PHYSICAL PERFORMANCE" />
    <node id="EMOTIONAL HEALTH" />
    <node id="INACTIVE-UNHEALTHY-DIET PROFILE" />
    <node id="ACTIVE-SEDENTARY-UNHEALTHY-DIET PROFILE" />
    <node id="DUTCH NATIONAL INTENSIVE CARE EVALUATION (NICE) REGISTRY" />
    <node id="FEBRUARY 27, 2020" />
    <node id="NOVEMBER 23, 2021" />
    <node id="WILLINGNESS-TO-PAY ESTIMATES" />
    <node id="PREFERENCE STABILITY" />
    <node id="PAYMENT-CARD CONTINGENT VALUATION METHOD" />
    <node id="SCALE AND POLISH" />
    <node id="GENERATIVE ARTIFICIAL INTELLIGENCE" />
    <node id="ACADEMIC RESEARCH" />
    <node id="SYSTEMATIC LITERATURE REVIEW" />
    <node id="REDS" />
    <node id="INFORMATION CONFLICT" />
    <node id="FEMALE PARTICIPANTS" />
    <node id="ADVANCED LOW-GRADE OVARIAN CARCINOMA" />
    <node id="ANTIHORMONAL THERAPY" />
    <node id="SIGNAL TRANSDUCTION PATHWAY" />
    <node id="AUSTRALIAN LIVING EVIDENCE CONSORTIUM" />
    <node id="NATIONAL INSTITUTE OF HEALTH AND CARE EXCELLENCE" />
    <node id="INFECTIOUS DISEASES SOCIETY OF AMERICA" />
    <node id="US GRADING OF RECOMMENDATIONS, ASSESSMENT, DEVELOPMENT AND EVALUATIONS NETWORK" />
    <node id="TIGRAY" />
    <node id="SMS TEXT MESSAGE-BASED HEALTH EDUCATION" />
    <node id="PARENTS OF CHILDREN LESS THAN 2 YEARS OF AGE" />
    <node id="NUTRITION EXPERTS" />
    <node id="EXPECTANT COUPLES" />
    <node id="BLAST PHASE" />
    <node id="RUX-MF STUDY" />
    <node id="PHILADELPHIA CHROMOSOME (PH)-LIKE B-ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)" />
    <node id="MULTIPLEX REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION" />
    <node id="NCOUNTER NANOSTRING" />
    <node id="FLUORESCENCE IN SITU HYBRIDIZATION" />
    <node id="FLOW CYTOMETRY-MINIMAL RESIDUAL DISEASE (MRD) ASSAY" />
    <node id="CRLF2, IGJ, CEACAM6, MUC4, SPATS2L, NRXN3" />
    <node id="ECONOMIC SCIENCE" />
    <node id="BOOK" />
    <node id="ECONOMISTS" />
    <node id="SCIENCE STUDIES SCHOLARS" />
    <node id="H2O AUTOML" />
    <node id="RAHMANI K" />
    <node id="MORGER A" />
    <node id="DILMEGANI C" />
    <node id="DEFAULT RANDOM FOREST" />
    <node id="STACKED ENSEMBLES" />
    <node id="UK TERTIARY CARE HOSPITALS" />
    <node id="NURSE-LED REMOTE POSTOPERATIVE MONITORING" />
    <node id="NCT05069103" />
    <node id="DIGITAL HEALTH" />
    <node id="REMOTE POSTOPERATIVE MONITORING" />
    <node id="YOUNG ADULT SURVIVORS OF CHILDHOOD CANCER" />
    <node id="LONELINESS" />
    <node id="SUICIDAL IDEATION" />
    <node id="HEAVY/RISKY ALCOHOL CONSUMPTION" />
    <node id="NEW-ONSET GRADE 2-4 CHRONIC CONDITIONS" />
    <node id="ORBITAL RHABDOMYOSARCOMA" />
    <node id="LOW-RISK ORMS" />
    <node id="NON-LOW-RISK ORMS" />
    <node id="RECURRENT ORMS" />
    <node id="MICRORNA-371A-3P" />
    <node id="CRC-AIM" />
    <node id="UKFSST" />
    <node id="DNN" />
    <node id="CANCER REGISTRY DATABASE" />
    <node id="NATIONAL HEALTH INSURANCE RESEARCH DATABASE" />
    <node id="NATIONAL DEATH REGISTRY" />
    <node id="CURATIVE CRC RESECTION" />
    <node id="CANCER-SPECIFIC SURVIVAL" />
    <node id="STAGE I-III DISEASE" />
    <node id="MEXICO SIMSMOKE" />
    <node id="NONDALY SMOKING" />
    <node id="DAILY SMOKING" />
    <node id="AI DIFFERENTIAL DIAGNOSIS APPLICATION" />
    <node id="CROHN'S DISEASE" />
    <node id="INTESTINAL TUBERCULOSIS" />
    <node id="TEXTCNN" />
    <node id="DEBIASED TEXTCNN" />
    <node id="LONG-TERM CANCER SURVIVORS" />
    <node id="CANCER-FREE CONTROLS" />
    <node id="BASELINE" />
    <node id="CLINICAL DECISION SUPPORT SYSTEM FOR YOUTH DEPRESSION (CDSS-YD)" />
    <node id="BEHAVIORAL HEALTH PROVIDERS" />
    <node id="MACHINE LEARNING BASED CLINICAL DECISION SUPPORT SYSTEMS (CDSSS)" />
    <node id="YOUTH DEPRESSION" />
    <node id="EMERGENCY MEDICAL SERVICES" />
    <node id="NEUROLOGISTS" />
    <node id="NATIONAL INSTITUTES OF HEALTH STROKE SCALE" />
    <node id="STROKE PATIENTS" />
    <node id="REGIONAL STROKE CENTER" />
    <node id="VIDEO CONSULTATION" />
    <node id="AMBULANCE TEAMS" />
    <node id="SIMULATED PATIENTS" />
    <node id="MICHOICE" />
    <node id="DECISION SUPPORT TOOLS" />
    <node id="AH" />
    <node id="CHEMOPREVENTION" />
    <node id="LCIS" />
    <node id="ADVANCED PRACTICE PROVIDERS" />
    <node id="WOMEN WITH HIGH-RISK BREAST LESIONS" />
    <node id="NATIONAL CAMPAIGN" />
    <node id="SURVEY OF ENDOSCOPIC CAPACITY" />
    <node id="HOSPITAL FOR TROPICAL DISEASES" />
    <node id="HO CHI MINH CITY" />
    <node id="VIETNAM" />
    <node id="DENGUE" />
    <node id="DIGITAL CLINICAL DECISION-SUPPORT SYSTEMS (CDSS)" />
    <node id="SEASONALITY" />
    <node id="TIME TO RECURRENCE" />
    <node id="CONSORT GROUP" />
    <node id="LEARNING HEALTH SYSTEM" />
    <node id="INTERNET OF FAIR DATA &amp; SERVICES" />
    <node id="PERSONOMICS" />
    <node id="GUIDELINE DEVELOPMENT" />
    <node id="DISSEMINATION" />
    <node id="IMPLEMENTATION STRATEGIES" />
    <node id="METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS" />
    <node id="GLOBAL HEALTH" />
    <node id="SABR-BRIDGE" />
    <node id="SABR" />
    <node id="THORACIC ONCOLOGY TEAMS" />
    <node id="LUNG MALIGNANCY" />
    <node id="TELEMEDICINE TECHNOLOGY" />
    <node id="OVID" />
    <node id="IEEE XPLORE" />
    <node id="TELECONSULTATION" />
    <node id="TELEVISIT" />
    <node id="TELEREHABILITATION" />
    <edge source="DISCRETE CHOICE EXPERIMENTS" target="SWING WEIGHTING WITH DIRECT RATING" />
    <edge source="DISCRETE CHOICE EXPERIMENTS" target="EQ-5D-5L HEALTH STATE VALUATION STUDIES" />
    <edge source="DISCRETE CHOICE EXPERIMENTS" target="ONLINE RESPONDENTS" />
    <edge source="DISCRETE CHOICE EXPERIMENTS" target="FACE-TO-FACE SCREENED RESPONDENTS" />
    <edge source="DISCRETE CHOICE EXPERIMENTS" target="ONLINE PANELS" />
    <edge source="ITALY" target="BELGIUM" />
    <edge source="ITALY" target="CLINICAL TRIAL" />
    <edge source="ITALY" target="DIGITAL PROFESSIONALISM" />
    <edge source="ITALY" target="AVALON" />
    <edge source="ITALY" target="ITALIAN PATIENTS" />
    <edge source="BELGIUM" target="THE RESEARCH ETHICS COMMITTEE UZ/KU LEUVEN" />
    <edge source="COHEN'S WEIGHTED KAPPA" target="DIRICHLET REGRESSION" />
    <edge source="NORTH CAROLINA" target="CANCER INFORMATION AND POPULATION HEALTH RESOURCE" />
    <edge source="NORTH CAROLINA" target="AREA HEALTH EDUCATION CENTER" />
    <edge source="NORTH CAROLINA" target="MENINGIOMA CONSORTIUM" />
    <edge source="TREATMENT DELAY" target="BLACK PATIENTS" />
    <edge source="TREATMENT DELAY" target="NON-BLACK PATIENTS" />
    <edge source="BLACK PATIENTS" target="NON-BLACK PATIENTS" />
    <edge source="BLACK PATIENTS" target="LEIBOVICH PROGNOSTIC MODEL" />
    <edge source="BLACK PATIENTS" target="EGFR" />
    <edge source="BLACK PATIENTS" target="CLINICAL TRIALS" />
    <edge source="BLACK PATIENTS" target="PACIFIC TRIAL" />
    <edge source="BLACK PATIENTS" target="DURVALUMAB" />
    <edge source="BLACK PATIENTS" target="NUTRITION CARE" />
    <edge source="NON-BLACK PATIENTS" target="DURVALUMAB" />
    <edge source="AMERICAN SOCIETY OF CLINICAL ONCOLOGY" target="ACADEMIC ONCOLOGY" />
    <edge source="AMERICAN SOCIETY OF CLINICAL ONCOLOGY" target="INDUSTRY" />
    <edge source="AMERICAN SOCIETY OF CLINICAL ONCOLOGY" target="UNITED STATES" />
    <edge source="AMERICAN SOCIETY OF CLINICAL ONCOLOGY" target="SURVEY" />
    <edge source="AMERICAN SOCIETY OF CLINICAL ONCOLOGY" target="EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY" />
    <edge source="AMERICAN SOCIETY OF CLINICAL ONCOLOGY" target="GERMAN INSTITUTE FOR QUALITY AND EFFICIENCY IN HEALTH CARE" />
    <edge source="AMERICAN SOCIETY OF CLINICAL ONCOLOGY" target="TRAUMA-INFORMED CARE" />
    <edge source="AMERICAN SOCIETY OF CLINICAL ONCOLOGY" target="COVID-19 VACCINE" />
    <edge source="AMERICAN SOCIETY OF CLINICAL ONCOLOGY" target="PATIENTS WITH CANCER" />
    <edge source="ACADEMIC ONCOLOGY" target="INDUSTRY" />
    <edge source="ACADEMIC ONCOLOGY" target="COLLABORATIVE RELATIONSHIPS" />
    <edge source="ACADEMIC ONCOLOGY" target="MENTORSHIP" />
    <edge source="INDUSTRY" target="COLLABORATIVE RELATIONSHIPS" />
    <edge source="INDUSTRY" target="EXPERIMENTAL PHYSICISTS" />
    <edge source="UNITED STATES" target="CANCER" />
    <edge source="UNITED STATES" target="NATIONAL CENTER FOR HEALTH STATISTICS" />
    <edge source="UNITED STATES" target="FLORIDA" />
    <edge source="UNITED STATES" target="PREDIABETES" />
    <edge source="UNITED STATES" target="CRC-PREVENT" />
    <edge source="UNITED STATES" target="ALCOHOL USE DISORDER" />
    <edge source="UNITED STATES" target="DIGITAL HEALTH TECHNOLOGIES" />
    <edge source="UNITED STATES" target="DISEASE EXPENDITURE PROJECT" />
    <edge source="UNITED STATES" target="KIDNEY CANCER" />
    <edge source="UNITED STATES" target="CORONAVIRUS DISEASE 2019" />
    <edge source="UNITED STATES" target="ALL OF US" />
    <edge source="UNITED STATES" target="US DIABETES, OBESITY, CARDIOVASCULAR DISEASE MICROSIMULATION (DOC-M) MODEL" />
    <edge source="UNITED STATES" target="DIGITAL MAMMOGRAPHY" />
    <edge source="UNITED STATES" target="COVID-19 PANDEMIC" />
    <edge source="UNITED STATES" target="ACTIV-6 PLATFORM" />
    <edge source="UNITED STATES" target="PROLIFIC.CO" />
    <edge source="UNITED STATES" target="CLINICAL PREDICTION MODELS (CPMS)" />
    <edge source="UNITED STATES" target="COVID-19" />
    <edge source="UNITED STATES" target="2019 ASCCP GUIDELINES" />
    <edge source="UNITED STATES" target="ONTOLOGY RESEARCH" />
    <edge source="UNITED STATES" target="E-CIGARETTE USE" />
    <edge source="UNITED STATES" target="SCREENING MAMMOGRAPHY" />
    <edge source="UNITED STATES" target="MAJOR DEPRESSIVE DISORDER" />
    <edge source="UNITED STATES" target="LARGE LANGUAGE MODELS" />
    <edge source="UNITED STATES" target="RISK STRATIFICATION ALGORITHM" />
    <edge source="UNITED STATES" target="HPV VACCINATION STUDY" />
    <edge source="UNITED STATES" target="CORONAVIRUS DISEASE 2019 (COVID-19) PANDEMIC" />
    <edge source="UNITED STATES" target="HISPANIC POPULATIONS" />
    <edge source="UNITED STATES" target="NON-HISPANIC WHITE INDIVIDUALS" />
    <edge source="UNITED STATES" target="US COVID-19 TRENDS AND IMPACT SURVEY" />
    <edge source="UNITED STATES" target="COUNTY-LEVEL VACCINATION COVERAGE" />
    <edge source="UNITED STATES" target="US PREVENTIVE SERVICES TASK FORCE" />
    <edge source="UNITED STATES" target="NATIONAL HEALTH INTERVIEW SURVEY" />
    <edge source="UNITED STATES" target="ADVANCE DIRECTIVE" />
    <edge source="UNITED STATES" target="CHILDREN'S ONCOLOGY GROUP" />
    <edge source="UNITED STATES" target="GLIOBLASTOMA" />
    <edge source="UNITED STATES" target="PREVEST" />
    <edge source="UNITED STATES" target="BRAIN TUMORS" />
    <edge source="UNITED STATES" target="EBV(-)M-PTLD" />
    <edge source="UNITED STATES" target="CERVICAL CANCER" />
    <edge source="UNITED STATES" target="INTERNATIONAL REGISTRY FOR MEN WITH ADVANCED PROSTATE CANCER" />
    <edge source="UNITED STATES" target="BREAST CANCER" />
    <edge source="UNITED STATES" target="CANCER MORTALITY STUDY" />
    <edge source="UNITED STATES" target="CHRONIC MYELOID LEUKEMIA" />
    <edge source="UNITED STATES" target="SEER DATABASE" />
    <edge source="UNITED STATES" target="PH-POSITIVE CML" />
    <edge source="UNITED STATES" target="ADVANCED NON-SMALL CELL LUNG CANCER" />
    <edge source="UNITED STATES" target="DIABETIC FOOT ULCER" />
    <edge source="UNITED STATES" target="LYME DISEASE" />
    <edge source="UNITED STATES" target="ROPEGINTERFERON ALFA-2B" />
    <edge source="UNITED STATES" target="PATIENTS" />
    <edge source="UNITED STATES" target="CLINICAL TRIAL SCREENING FRAMEWORK" />
    <edge source="UNITED STATES" target="CHINESE PHARMACEUTICAL MARKET" />
    <edge source="UNITED STATES" target="CLINICAL TRIALS" />
    <edge source="UNITED STATES" target="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK" />
    <edge source="UNITED STATES" target="GEISINGER" />
    <edge source="UNITED STATES" target="HYPERTENSION" />
    <edge source="UNITED STATES" target="TRANS-CATHETER VALVE THERAPIES REGISTRY" />
    <edge source="UNITED STATES" target="MR SUCCESS" />
    <edge source="UNITED STATES" target="ISRAEL" />
    <edge source="UNITED STATES" target="KAISER PERMANENTE SOUTHERN CALIFORNIA" />
    <edge source="UNITED STATES" target="AYA CANCER SURVIVORS" />
    <edge source="UNITED STATES" target="NATIONAL ALZHEIMER&#8217;S COORDINATING CENTER" />
    <edge source="UNITED STATES" target="ALZHEIMER&#8217;S DISEASE NEUROIMAGING INITIATIVE" />
    <edge source="UNITED STATES" target="ASIAN IMMIGRANT POPULATIONS" />
    <edge source="UNITED STATES" target="HISPANIC IMMIGRANT POPULATIONS" />
    <edge source="UNITED STATES" target="CHINESE AMERICANS" />
    <edge source="UNITED STATES" target="JAPANESE AMERICANS" />
    <edge source="UNITED STATES" target="KOREAN AMERICANS" />
    <edge source="UNITED STATES" target="AMERICAN PARTICIPANTS" />
    <edge source="UNITED STATES" target="PEDIATRIC CANCER CENTERS" />
    <edge source="UNITED STATES" target="NEUROBLASTOMA" />
    <edge source="UNITED STATES" target="MEXICAN AMERICANS" />
    <edge source="UNITED STATES" target="BLACK WOMEN" />
    <edge source="UNITED STATES" target="CISNET-CERVICAL MODELS" />
    <edge source="UNITED STATES" target="CRC-AIM" />
    <edge source="UNITED STATES" target="SABR-BRIDGE" />
    <edge source="SURVEY" target="BLACK WOMEN" />
    <edge source="SURVEY" target="FOCUS GROUPS" />
    <edge source="SURVEY" target="HOSPITAL MANAGERS" />
    <edge source="SURVEY" target="DECISION SUPPORT SYSTEM IMPLEMENTATION" />
    <edge source="SURVEY" target="GOODREPORTS.ORG" />
    <edge source="COLLABORATIVE RELATIONSHIPS" target="PHARMACEUTICAL COMPANIES" />
    <edge source="COLLABORATIVE RELATIONSHIPS" target="BIOTECHNOLOGY COMPANIES" />
    <edge source="COLLABORATIVE RELATIONSHIPS" target="OMIC COMPANIES" />
    <edge source="COLLABORATIVE RELATIONSHIPS" target="MEDICAL DEVICE COMPANIES" />
    <edge source="US NATIONAL LUNG SCREENING TRIAL" target="DUTCH-BELGIAN NELSON" />
    <edge source="US NATIONAL LUNG SCREENING TRIAL" target="ITALUNG" />
    <edge source="US NATIONAL LUNG SCREENING TRIAL" target="COSMOS" />
    <edge source="US NATIONAL LUNG SCREENING TRIAL" target="BIOLOGICAL EFFECTS OF IONIZING RADIATION, REPORT VII" />
    <edge source="US NATIONAL LUNG SCREENING TRIAL" target="UNITED STATES PREVENTIVE SERVICES TASK FORCE" />
    <edge source="US NATIONAL LUNG SCREENING TRIAL" target="AMERICAN CANCER SOCIETY" />
    <edge source="ITALUNG" target="BIOLOGICAL EFFECTS OF IONIZING RADIATION, REPORT VII" />
    <edge source="COSMOS" target="BIOLOGICAL EFFECTS OF IONIZING RADIATION, REPORT VII" />
    <edge source="ATHENS" target="GREECE" />
    <edge source="ATHENS" target="PWUD" />
    <edge source="ATHENS" target="FOCUS GROUP DISCUSSIONS" />
    <edge source="GREECE" target="PWUD" />
    <edge source="PWUD" target="TELEHEALTH" />
    <edge source="PWUD" target="FOCUS GROUP DISCUSSIONS" />
    <edge source="PWUD" target="INTERNET" />
    <edge source="TELEHEALTH" target="POLICYMAKERS" />
    <edge source="TELEHEALTH" target="ONLINE MEDICAL CONSULTATION" />
    <edge source="TELEHEALTH" target="IN-PERSON CONSULTATION" />
    <edge source="INTERNET" target="UGANDA" />
    <edge source="INTERNET" target="BIGRU" />
    <edge source="INTERNET" target="MEDICAL INDUSTRY" />
    <edge source="INTERNET" target="COVID-19 PANDEMIC" />
    <edge source="INTERNET" target="DIGITAL HEALTH LITERACY" />
    <edge source="POLICYMAKERS" target="DIGITAL MENTAL HEALTH APPS STUDY" />
    <edge source="POLICYMAKERS" target="NATIONAL CANCER CONTROL PLANS" />
    <edge source="POLICYMAKERS" target="CANCER PATIENTS" />
    <edge source="POLICYMAKERS" target="CANCER SURVIVORS" />
    <edge source="POLICYMAKERS" target="CAPACITY-BUILDING EBM TRAINING" />
    <edge source="POLICYMAKERS" target="HEALTH INFORMATION TECHNOLOGIES" />
    <edge source="NATIONAL CANCER INSTITUTE" target="BASAL CELL CARCINOMAS" />
    <edge source="NATIONAL CANCER INSTITUTE" target="CUTANEOUS SQUAMOUS CELL CARCINOMAS" />
    <edge source="NATIONAL CANCER INSTITUTE" target="INTERNATIONAL REGISTRY FOR MEN WITH ADVANCED PROSTATE CANCER (IRONMAN)" />
    <edge source="NATIONAL CANCER INSTITUTE" target="US FOOD AND DRUG ADMINISTRATION" />
    <edge source="NATIONAL CANCER INSTITUTE" target="SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAM" />
    <edge source="NATIONAL CANCER INSTITUTE" target="CANNABIS USE" />
    <edge source="NATIONAL CANCER INSTITUTE" target="HEAD AND NECK SQUAMOUS CELL CARCINOMA" />
    <edge source="NATIONAL CANCER INSTITUTE" target="RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA" />
    <edge source="NATIONAL CANCER INSTITUTE" target="CENTRAL BRAIN TUMOR REGISTRY OF THE UNITED STATES" />
    <edge source="NATIONAL CANCER INSTITUTE" target="UNITED STATES CANCER STATISTICS" />
    <edge source="NATIONAL CANCER INSTITUTE" target="CANCER PREVENTION STUDY II" />
    <edge source="NATIONAL CANCER INSTITUTE" target="BLACK MEN" />
    <edge source="NATIONAL CANCER INSTITUTE" target="SMOKING HISTORY GENERATOR" />
    <edge source="NATIONAL CANCER INSTITUTE" target="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK" />
    <edge source="BASAL CELL CARCINOMAS" target="CUTANEOUS SQUAMOUS CELL CARCINOMAS" />
    <edge source="PARKINSON'S DISEASE" target="ARTIFICIAL INTELLIGENCE" />
    <edge source="PARKINSON'S DISEASE" target="CONVOLUTIONAL NEURAL NETWORKS" />
    <edge source="PARKINSON'S DISEASE" target="RANDOM FOREST" />
    <edge source="PARKINSON'S DISEASE" target="LOGISTIC REGRESSION" />
    <edge source="PARKINSON'S DISEASE" target="SUPPORT VECTOR MACHINE" />
    <edge source="PARKINSON'S DISEASE" target="EXTREME BOOT CLASSIFIER" />
    <edge source="PARKINSON'S DISEASE" target="VOTING CLASSIFIER" />
    <edge source="PARKINSON'S DISEASE" target="PRO" />
    <edge source="PARKINSON'S DISEASE" target="SMARTPHONE-BASED SELF-MANAGEMENT PLATFORM" />
    <edge source="PARKINSON'S DISEASE" target="MALE PATIENTS" />
    <edge source="PARKINSON'S DISEASE" target="FEMALE PATIENTS" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="CONGENITAL ANOMALIES" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="YOLO8" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="CLINICAL DECISION SUPPORT SYSTEM" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="DERMOSCOPY ELEMENTS OF VISUALS ONTOLOGY (DEVO)" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="DERMOSCOPIC ANALYSIS" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="PREDICTIVE ALGORITHMS" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="HEALTH PROFESSIONS' STUDENTS" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="KNOWLEDGE, ATTITUDES, AND PRACTICES (KAP)" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="ELECTRONIC MEDICAL DATA" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="NON-COMMUNICABLE DISEASES" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="EFFICIENTNETB2" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="LARGE LANGUAGE MODELS" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="PERSONALISED MEDICINE" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="HEALTHCARE SYSTEMS" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="DOCTOR-PATIENT RELATIONSHIPS" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="EMPATHY AND COMPASSION" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="SHARED DECISION-MAKING" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="TRUST RELATIONSHIPS" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="CLINICAL PRACTICE GUIDELINES" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="PAJO MODEL" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="ACUTE MYOCARDIAL INFARCTION" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="ADVANCED RWE" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="HEALTHCARE" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="COVID-19 PANDEMIC" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="NON-MELANOMA SKIN CANCER" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="SCOPUS" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="PUBMED" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="SCIENCEDIRECT" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="SPRINGERLINK" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="DIMENSIONS" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="EVIDENCE-BASED MEDICINE" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="AUTOMATED LITERATURE SCREENING" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="LYMPHATIC CANCER" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="MEDLINE" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="EMBASE" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="IEEE" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="COCHRANE" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="PROSPERO" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="PYTHON" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="IMPLEMENTATION SCIENCE" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="CARDIOVASCULAR CARE" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="HEALTHCARE PROVIDERS" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="PATIENTS" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="SYSTEMATIC REVIEW" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="SWEDISH TRAUMA REGISTRY" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="LOGISTIC REGRESSION" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="RANDOM FOREST" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="XGBOOST" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="SUPPORT VECTOR MACHINE" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="ARTIFICIAL NEURAL NETWORK" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="NEW INJURY SEVERITY SCORE" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="TRAUMA" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="MOTOR VEHICLE CRASHES" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="FIELD TRIAGE" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="EVIDENCE REVIEWS" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="STUDY SCREENING" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="INFECTION CONTROL" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="PEER REVIEW WORKFLOW" />
    <edge source="ARTIFICIAL INTELLIGENCE" target="ETHICAL CONCERNS" />
    <edge source="CONVOLUTIONAL NEURAL NETWORKS" target="DEEP-LEARNING ALGORITHM" />
    <edge source="CONVOLUTIONAL NEURAL NETWORKS" target="MACHINE LEARNING" />
    <edge source="RANDOM FOREST" target="ENSEMBLE LEARNING" />
    <edge source="RANDOM FOREST" target="WATERBORNE DISEASE POLLUTION STUDY" />
    <edge source="RANDOM FOREST" target="CLINICAL DECISION SUPPORT SYSTEM" />
    <edge source="RANDOM FOREST" target="CESAREAN SECTION-INDUCED POSTPARTUM HEMORRHAGE" />
    <edge source="RANDOM FOREST" target="MACHINE LEARNING" />
    <edge source="RANDOM FOREST" target="SEPSIS" />
    <edge source="RANDOM FOREST" target="MATERNAL, NEWBORN, AND CHILD HEALTHCARE CONTINUUM" />
    <edge source="RANDOM FOREST" target="SUCCESSFUL AGING" />
    <edge source="RANDOM FOREST" target="SUICIDE RISK FACTORS" />
    <edge source="RANDOM FOREST" target="MACHINE LEARNING MODELS" />
    <edge source="RANDOM FOREST" target="CHRONIC HEART FAILURE" />
    <edge source="RANDOM FOREST" target="PREMATURE CORONARY ARTERY DISEASE" />
    <edge source="RANDOM FOREST" target="TAICHUNG VETERANS GENERAL HOSPITAL" />
    <edge source="RANDOM FOREST" target="FINANCIAL BALANCE" />
    <edge source="RANDOM FOREST" target="ELASTIC-NET ORDINAL REGRESSION" />
    <edge source="RANDOM FOREST" target="SUPPORT VECTOR MACHINE" />
    <edge source="RANDOM FOREST" target="ORDINAL LOGISTIC REGRESSION" />
    <edge source="RANDOM FOREST" target="PROLONGED INTERMITTENT RENAL REPLACEMENT THERAPY" />
    <edge source="RANDOM FOREST" target="THIRD AFFILIATED HOSPITAL OF ANHUI MEDICAL UNIVERSITY" />
    <edge source="RANDOM FOREST" target="TREE-BASED ENSEMBLE LEARNING" />
    <edge source="RANDOM FOREST" target="LOWER EXTREMITY ARTERIAL DISEASE" />
    <edge source="RANDOM FOREST" target="SHAP (SHAPLEY ADDITIVE EXPLANATIONS)" />
    <edge source="RANDOM FOREST" target="COVID-19" />
    <edge source="RANDOM FOREST" target="POLYPHARMACY" />
    <edge source="RANDOM FOREST" target="MACHINE LEARNING ALGORITHMS" />
    <edge source="RANDOM FOREST" target="LOGISTIC TENSOR REGRESSION" />
    <edge source="RANDOM FOREST" target="ACUTE MYELOID LEUKEMIA" />
    <edge source="RANDOM FOREST" target="NSCLC" />
    <edge source="RANDOM FOREST" target="ARTIFICIAL NEURAL NETWORK" />
    <edge source="RANDOM FOREST" target="UNDER-FIVE MORTALITY" />
    <edge source="RANDOM FOREST" target="RADIOFREQUENCY ABLATION" />
    <edge source="RANDOM FOREST" target="HEMORRHAGE" />
    <edge source="RANDOM FOREST" target="NON-LACTATING MASTITIS" />
    <edge source="RANDOM FOREST" target="BMI" />
    <edge source="RANDOM FOREST" target="AGITATION CLASSIFIER" />
    <edge source="RANDOM FOREST" target="GASTRIC STROMAL TUMORS" />
    <edge source="LOGISTIC REGRESSION" target="MATERNAL, NEWBORN, AND CHILD HEALTHCARE CONTINUUM" />
    <edge source="LOGISTIC REGRESSION" target="CHRONIC HEART FAILURE" />
    <edge source="LOGISTIC REGRESSION" target="CHD GROUP" />
    <edge source="LOGISTIC REGRESSION" target="NON-CHD GROUP" />
    <edge source="LOGISTIC REGRESSION" target="PCOS" />
    <edge source="LOGISTIC REGRESSION" target="AUTOMATED MACHINE LEARNING" />
    <edge source="LOGISTIC REGRESSION" target="TAICHUNG VETERANS GENERAL HOSPITAL" />
    <edge source="LOGISTIC REGRESSION" target="CODERS" />
    <edge source="LOGISTIC REGRESSION" target="PROBABILITY CALIBRATIONS" />
    <edge source="LOGISTIC REGRESSION" target="NOMOGRAM" />
    <edge source="LOGISTIC REGRESSION" target="MACHINE LEARNING MODELS" />
    <edge source="LOGISTIC REGRESSION" target="PREDICTION MODELLING" />
    <edge source="LOGISTIC REGRESSION" target="MACHINE LEARNING METHODS" />
    <edge source="LOGISTIC REGRESSION" target="GASTRIC CANCER" />
    <edge source="LOGISTIC REGRESSION" target="BEH&#199;ET&#8217;S DISEASE" />
    <edge source="LOGISTIC REGRESSION" target="EXTREME GRADIENT BOOSTING" />
    <edge source="LOGISTIC REGRESSION" target="NSCLC" />
    <edge source="LOGISTIC REGRESSION" target="GRAPH NEURAL NETWORK" />
    <edge source="LOGISTIC REGRESSION" target="ED REVISIT PREDICTION" />
    <edge source="LOGISTIC REGRESSION" target="PURE" />
    <edge source="LOGISTIC REGRESSION" target="MALE BREAST CANCER" />
    <edge source="LOGISTIC REGRESSION" target="GRADIENT BOOSTING DECISION TREES" />
    <edge source="LOGISTIC REGRESSION" target="MULTILAYER PERCEPTRON" />
    <edge source="LOGISTIC REGRESSION" target="IN-HOSPITAL MORTALITY STUDY" />
    <edge source="LOGISTIC REGRESSION" target="UNDER-FIVE MORTALITY" />
    <edge source="LOGISTIC REGRESSION" target="LIGHT GRADIENT BOOSTING" />
    <edge source="LOGISTIC REGRESSION" target="GASTRIC STROMAL TUMORS" />
    <edge source="LOGISTIC REGRESSION" target="FEDERATED LEARNING" />
    <edge source="LOGISTIC REGRESSION" target="AGES-REYKJAVIK STUDY" />
    <edge source="LOGISTIC REGRESSION" target="MACHINE LEARNING" />
    <edge source="LOGISTIC REGRESSION" target="HEALTHCARE-RELATED DISCRETE EVENT SIMULATION" />
    <edge source="SUPPORT VECTOR MACHINE" target="TEHRAN LIPID AND GLUCOSE STUDY" />
    <edge source="SUPPORT VECTOR MACHINE" target="CLINICAL DECISION SUPPORT SYSTEM" />
    <edge source="SUPPORT VECTOR MACHINE" target="MATERNAL, NEWBORN, AND CHILD HEALTHCARE CONTINUUM" />
    <edge source="SUPPORT VECTOR MACHINE" target="SUCCESSFUL AGING" />
    <edge source="SUPPORT VECTOR MACHINE" target="Z-SCORE ADAPTATION" />
    <edge source="SUPPORT VECTOR MACHINE" target="CHD GROUP" />
    <edge source="SUPPORT VECTOR MACHINE" target="PCOS" />
    <edge source="SUPPORT VECTOR MACHINE" target="TAICHUNG VETERANS GENERAL HOSPITAL" />
    <edge source="SUPPORT VECTOR MACHINE" target="THIRD AFFILIATED HOSPITAL OF ANHUI MEDICAL UNIVERSITY" />
    <edge source="SUPPORT VECTOR MACHINE" target="ACUTE MYOCARDIAL INFARCTION" />
    <edge source="SUPPORT VECTOR MACHINE" target="EXPERIMENT 2" />
    <edge source="SUPPORT VECTOR MACHINE" target="CHILD ABUSE AND NEGLECT" />
    <edge source="SUPPORT VECTOR MACHINE" target="NATURAL LANGUAGE PROCESSING" />
    <edge source="SUPPORT VECTOR MACHINE" target="LOGISTIC TENSOR REGRESSION" />
    <edge source="SUPPORT VECTOR MACHINE" target="NSCLC" />
    <edge source="SUPPORT VECTOR MACHINE" target="IN-HOSPITAL MORTALITY STUDY" />
    <edge source="SUPPORT VECTOR MACHINE" target="UNDER-FIVE MORTALITY" />
    <edge source="SUPPORT VECTOR MACHINE" target="MACHINE LEARNING" />
    <edge source="COVID-19" target="NATURAL LANGUAGE PROCESSING" />
    <edge source="COVID-19" target="PUBLIC HEALTH RESEARCH" />
    <edge source="COVID-19" target="NATURALNESS PREFERENCE SCALE" />
    <edge source="COVID-19" target="TECLISTAMAB" />
    <edge source="COVID-19" target="MAJESTEC-1 STUDY" />
    <edge source="COVID-19" target="CORRECTIONAL FACILITIES" />
    <edge source="COVID-19" target="COVID HOTLINE" />
    <edge source="COVID-19" target="NURSING TRIAGE" />
    <edge source="COVID-19" target="EMERGENCY DEPARTMENT" />
    <edge source="COVID-19" target="CHARLSON COMORBIDITY INDEX" />
    <edge source="COVID-19" target="RAPID ANTIGEN TEST" />
    <edge source="COVID-19" target="ACTIV-6 PLATFORM" />
    <edge source="COVID-19" target="FLUVOXAMINE" />
    <edge source="COVID-19" target="SARS-COV-2" />
    <edge source="COVID-19" target="NETHERLANDS" />
    <edge source="COVID-19" target="CLINICAL PREDICTION MODELS (CPMS)" />
    <edge source="COVID-19" target="ABATACEPT" />
    <edge source="COVID-19" target="CENICRIVIROC" />
    <edge source="COVID-19" target="INFLIXIMAB" />
    <edge source="COVID-19" target="VISION TRANSFORMER" />
    <edge source="COVID-19" target="COVID-19 VACCINE" />
    <edge source="COVID-19" target="VISUAL TRANSFORMER" />
    <edge source="COVID-19" target="CONVOLUTIONAL NEURAL NETWORKS (CNNS)" />
    <edge source="COVID-19" target="VIDEO SWIN TRANSFORMERS" />
    <edge source="COVID-19" target="CT SCAN IMAGES" />
    <edge source="COVID-19" target="CLINICAL DATA" />
    <edge source="COVID-19" target="HOSPITALIZATION RATES" />
    <edge source="COVID-19" target="MORTALITY RISKS" />
    <edge source="COVID-19" target="DEEP-LEARNING-BASED SCHEMES" />
    <edge source="COVID-19" target="3D DATA FUSION" />
    <edge source="COVID-19" target="CONVENTIONAL CLASSIFIERS" />
    <edge source="COVID-19" target="CLINICAL OUTCOMES" />
    <edge source="COVID-19" target="WUHAN" />
    <edge source="COVID-19" target="XGBOOST MODEL" />
    <edge source="COVID-19" target="BIO MED CENTRAL LTD." />
    <edge source="COVID-19" target="GOVERNMENTS" />
    <edge source="COVID-19" target="COMMUNITIES" />
    <edge source="COVID-19" target="COUNTRIES" />
    <edge source="COVID-19" target="GOVERNMENTAL INTERVENTION" />
    <edge source="COVID-19" target="PAXLOVID" />
    <edge source="COVID-19" target="CHINESE GOVERNMENT" />
    <edge source="COVID-19" target="SHANGHAI" />
    <edge source="COVID-19" target="JULY-SEPTEMBER WAVE" />
    <edge source="COVID-19" target="OCT-DEC WAVE" />
    <edge source="COVID-19" target="UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER" />
    <edge source="COVID-19" target="MACHINE LEARNING MODELS" />
    <edge source="COVID-19" target="MECHANICAL VENTILATION" />
    <edge source="COVID-19" target="30-DAY MORTALITY" />
    <edge source="COVID-19" target="RUSSIAN FEDERATION" />
    <edge source="COVID-19" target="SIR MODEL" />
    <edge source="COVID-19" target="GAUTENG PROVINCE" />
    <edge source="COVID-19" target="PUBLIC HEALTH DECISION- AND POLICY-MAKERS" />
    <edge source="COVID-19" target="VIRUS HOT-SPOTS" />
    <edge source="COVID-19" target="GERMANY" />
    <edge source="COVID-19" target="UNITED KINGDOM" />
    <edge source="COVID-19" target="COVID INTERFACE TERMINOLOGY" />
    <edge source="COVID-19" target="US" />
    <edge source="COVID-19" target="DEMOCRATIC PARTY" />
    <edge source="COVID-19" target="VACCINATION" />
    <edge source="COVID-19" target="HOMEOSTASIS IMBALANCE PROCESS ONTOLOGY (HOIP)" />
    <edge source="COVID-19" target="ELECTRONIC HEALTH RECORDS" />
    <edge source="COVID-19" target="MACHINE LEARNING" />
    <edge source="COVID-19" target="DEEP LEARNING" />
    <edge source="COVID-19" target="SILENT HYPOXEMIA" />
    <edge source="COVID-19" target="PHYSICIANS" />
    <edge source="COVID-19" target="DUTCH NATIONAL INTENSIVE CARE EVALUATION (NICE) REGISTRY" />
    <edge source="COVID-19" target="ICU" />
    <edge source="COVID-19" target="FEBRUARY 27, 2020" />
    <edge source="COVID-19" target="NOVEMBER 23, 2021" />
    <edge source="COVID-19" target="ACTIV-6" />
    <edge source="COVID-19" target="SABR-BRIDGE" />
    <edge source="NATURAL LANGUAGE PROCESSING" target="SYSTEMATIC REVIEWS" />
    <edge source="NATURAL LANGUAGE PROCESSING" target="PRE-TRAINED LANGUAGE MODELS" />
    <edge source="NATURAL LANGUAGE PROCESSING" target="SWEDISH CLINICAL BERT MODELS" />
    <edge source="NATURAL LANGUAGE PROCESSING" target="GPT-3" />
    <edge source="NATURAL LANGUAGE PROCESSING" target="ELECTRONIC HEALTH RECORDS" />
    <edge source="NATURAL LANGUAGE PROCESSING" target="CLINICAL VOCABULARY" />
    <edge source="NATURAL LANGUAGE PROCESSING" target="WORD EMBEDDINGS" />
    <edge source="NATURAL LANGUAGE PROCESSING" target="MACHINE LEARNING" />
    <edge source="NATURAL LANGUAGE PROCESSING" target="CHILD ABUSE AND NEGLECT" />
    <edge source="NATURAL LANGUAGE PROCESSING" target="BIOMEDICAL LITERATURE SURVEY" />
    <edge source="NATURAL LANGUAGE PROCESSING" target="REGER" />
    <edge source="NATURAL LANGUAGE PROCESSING" target="TEXT CLASSIFICATION" />
    <edge source="NATURAL LANGUAGE PROCESSING" target="NATURAL LANGUAGE CLASSIFIER" />
    <edge source="INTEGRASE STRAND TRANSFER INHIBITOR (INSTI)" target="US FOOD AND DRUG ADMINISTRATION" />
    <edge source="INTEGRASE STRAND TRANSFER INHIBITOR (INSTI)" target="NORTH AMERICAN AIDS COHORT COLLABORATION ON RESEARCH AND DESIGN" />
    <edge source="INTEGRASE STRAND TRANSFER INHIBITOR (INSTI)" target="HIV CARE" />
    <edge source="INTEGRASE STRAND TRANSFER INHIBITOR (INSTI)" target="RACIAL AND ETHNIC DIFFERENCES" />
    <edge source="INTEGRASE STRAND TRANSFER INHIBITOR (INSTI)" target="TREATMENT GUIDELINES" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="MIRVETUXIMAB" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="GLUCAGON-LIKE PEPTIDE RECEPTOR 1 AGONISTS" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="TIRZEPATIDE" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="PHENTERMINE-TOPIRAMATE" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="NALTREXONE-BUPROPION" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="ORLISTAT" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="PROSTATE CANCER STUDIES" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="BREAST CANCER STUDIES" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="POPULATION ASSESSMENT OF TOBACCO AND HEALTH STUDY" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="ONCOLOGY TRIALS" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="GLP-1 RECEPTOR AGONISTS" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="CONJUGATED EQUINE ESTROGENS (CEE)" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="BAZEDOXIFENE" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="FDA MANDATE" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="BRAF V600E MUTATIONS" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="TRAK FUSIONS" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="LOXO-TRK" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="SCOUT" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="NAVIGATE" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="STARTRK" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="VE-BASKET" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="ROAR BASKET" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="LIBRETTO-001" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="ARROW" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="FIGHT-203" />
    <edge source="US FOOD AND DRUG ADMINISTRATION" target="NATIONAL CANCER INSTITUTE-MOLECULAR ANALYSIS FOR THERAPY CHOICE" />
    <edge source="NORTH AMERICAN AIDS COHORT COLLABORATION ON RESEARCH AND DESIGN" target="HIV CARE" />
    <edge source="NORTH AMERICAN AIDS COHORT COLLABORATION ON RESEARCH AND DESIGN" target="CLINICAL SITES" />
    <edge source="HIV CARE" target="ART" />
    <edge source="HIV CARE" target="TREATMENT GUIDELINES" />
    <edge source="ART" target="NDW" />
    <edge source="INTENSIVE CARE UNIT" target="ELECTRONIC HEALTH RECORDS" />
    <edge source="INTENSIVE CARE UNIT" target="MACHINE LEARNING MODELS" />
    <edge source="INTENSIVE CARE UNIT" target="ACUTE RESPIRATORY FAILURE" />
    <edge source="INTENSIVE CARE UNIT" target="AGITATION CLASSIFIER" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="KNOWLEDGE GRAPH" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="HYPERLEDGER-FABRIC" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="LONG SHORT TERM MEMORY NEURAL NETWORKS" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="FUZZY LOGIC" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="EMERGENCY CLINICIANS" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="DIGITAL HEALTHCARE SERVICES" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="PATIENT" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="PERSIAN LANGUAGE" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="HEART FAILURE" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="MULTIMORBIDITY" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="DEPRESSION" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="MACHINE LEARNING METHODS" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="MEDMGF" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="GOVERNMENT AGENCIES" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="HEALTHCARE BODIES" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="HEALTH PROFESSIONALS" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="REAL-WORLD EVIDENCE" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="TRADITIONAL RWE" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="ADVANCED RWE" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="SOCIAL AND BEHAVIORAL DETERMINANTS OF HEALTH" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="CHILD ABUSE AND NEGLECT" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="LOGISTIC TENSOR REGRESSION" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="DE-IDENTIFICATION PIPELINE" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="NHS" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="INTEROPERABILITY" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="CLINICAL PREDICTION MODELS" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="MULTIPLE SCLEROSIS" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="DEEP LEARNING" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="COVID INTERFACE TERMINOLOGY" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="REAL-WORLD DATA" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="INDIANA" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="HEALTH SYSTEM IN THE US" />
    <edge source="ELECTRONIC HEALTH RECORDS" target="PHYSICIANS" />
    <edge source="MACHINE LEARNING MODELS" target="PREDICTIVE MODEL" />
    <edge source="MACHINE LEARNING MODELS" target="SEVERE ACUTE RESPIRATORY INFECTION" />
    <edge source="MACHINE LEARNING MODELS" target="AIRWAY STENOSIS" />
    <edge source="MACHINE LEARNING MODELS" target="RANDOM FOREST ALGORITHM" />
    <edge source="MACHINE LEARNING MODELS" target="FAST TRACK" />
    <edge source="MACHINE LEARNING MODELS" target="IRCCS OSPEDALE GALEAZZI-SANT&#8217;AMBROGIO" />
    <edge source="MACHINE LEARNING MODELS" target="EXPLAINABLE AI" />
    <edge source="MACHINE LEARNING MODELS" target="CAUTIOUS PREDICTION" />
    <edge source="MACHINE LEARNING MODELS" target="PATIENT-REPORTED OUTCOME MEASURES" />
    <edge source="MACHINE LEARNING MODELS" target="Z-SCORE ADAPTATION" />
    <edge source="MACHINE LEARNING MODELS" target="SHAP VALUE" />
    <edge source="MACHINE LEARNING MODELS" target="PERMUTATION IMPORTANCE" />
    <edge source="MACHINE LEARNING MODELS" target="PARTIAL DEPENDENCE PLOTS" />
    <edge source="MACHINE LEARNING MODELS" target="CHRONIC HEART FAILURE" />
    <edge source="MACHINE LEARNING MODELS" target="HIGH BLOOD PRESSURE" />
    <edge source="MACHINE LEARNING MODELS" target="ACCURACY" />
    <edge source="MACHINE LEARNING MODELS" target="PRECISION" />
    <edge source="MACHINE LEARNING MODELS" target="RECALL" />
    <edge source="MACHINE LEARNING MODELS" target="F1 SCORE" />
    <edge source="MACHINE LEARNING MODELS" target="MEDICAL INFORMATION MART FOR INTENSIVE CARE (MIMIC)-IV" />
    <edge source="MACHINE LEARNING MODELS" target="KIDNEY DISEASE IMPROVING GLOBAL OUTCOME (KDIGO)" />
    <edge source="MACHINE LEARNING MODELS" target="EXTREME GRADIENT BOOSTING (XGB)" />
    <edge source="MACHINE LEARNING MODELS" target="BIOMED CENTRAL LTD." />
    <edge source="MACHINE LEARNING MODELS" target="ACUTE KIDNEY INJURY (AKI)" />
    <edge source="MACHINE LEARNING MODELS" target="BASELINE SERUM CREATININE (SCR)" />
    <edge source="MACHINE LEARNING MODELS" target="FALSE POSITIVE (FP) EVENTS" />
    <edge source="MACHINE LEARNING MODELS" target="ACUTE MYOCARDIAL INFARCTION" />
    <edge source="MACHINE LEARNING MODELS" target="EUROPEAN SOCIETY OF CARDIOLOGY" />
    <edge source="MACHINE LEARNING MODELS" target="EMERGENCY DEPARTMENT" />
    <edge source="MACHINE LEARNING MODELS" target="ARTIFICIAL NEURAL NETWORKS" />
    <edge source="MACHINE LEARNING MODELS" target="CONVOLUTIONAL NEURAL NETWORK" />
    <edge source="MACHINE LEARNING MODELS" target="MORTALITY PREDICTION MODELS" />
    <edge source="MACHINE LEARNING MODELS" target="MARKOV MODEL" />
    <edge source="MACHINE LEARNING MODELS" target="UNDER-FIVE MORTALITY" />
    <edge source="MACHINE LEARNING MODELS" target="OBSTRUCTIVE SLEEP APNEA" />
    <edge source="KNOWLEDGE GRAPH" target="PREDICTIVE MODEL" />
    <edge source="KNOWLEDGE GRAPH" target="BREAST CANCER DIAGNOSIS" />
    <edge source="KNOWLEDGE GRAPH" target="CHINESE BREAST CANCER MAMMOGRAPHY REPORTS" />
    <edge source="KNOWLEDGE GRAPH" target="BILSTM-HIGHWAY-CRF MODEL" />
    <edge source="KNOWLEDGE GRAPH" target="NEO4J GRAPH DATA PLATFORM" />
    <edge source="KNOWLEDGE GRAPH" target="BIOMED CENTRAL LTD." />
    <edge source="MIMIC-III" target="BIOMEDICAL ONTOLOGIES" />
    <edge source="MIMIC-III" target="ARDSFLAG" />
    <edge source="MIMIC-III" target="ICU" />
    <edge source="MIMIC-III" target="MULTIPLE IMPUTATION" />
    <edge source="MIMIC-III" target="NYHA FUNCTIONAL CLASSIFICATION" />
    <edge source="MIMIC-III" target="PERCEIVER" />
    <edge source="MIMIC-III" target="SEPSIS" />
    <edge source="MIMIC-III" target="LATENT SEMANTIC INDEXING" />
    <edge source="MIMIC-III" target="KAMPNET" />
    <edge source="MIMIC-III" target="NHS TAYSIDE" />
    <edge source="PREDICTIVE MODEL" target="ADVANCED CARE PLANNING (ACP)" />
    <edge source="PREDICTIVE MODEL" target="ELECTRONIC HEALTH RECORD" />
    <edge source="TL;DR DATASET" target="REDDIT" />
    <edge source="TL;DR DATASET" target="CNN/DM" />
    <edge source="ROUGE" target="HUMAN PREFERENCES" />
    <edge source="ROUGE" target="CHATGPT" />
    <edge source="ROUGE" target="BERTSUM" />
    <edge source="ROUGE" target="BART" />
    <edge source="ROUGE" target="GPT-3.5" />
    <edge source="HUMAN PREFERENCES" target="REINFORCEMENT LEARNING SYSTEMS" />
    <edge source="HUMAN PREFERENCES" target="HUMAN OVERSIGHT" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="DENTAL CARIES" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="PERIODONTAL DISEASE" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="MEDLINE" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="COCHRANE DATABASE OF SYSTEMATIC REVIEWS" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="LATENT TUBERCULOSIS INFECTION" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="PROSTATE CANCER SCREENING" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="HIV" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="FAMILIAL HYPERCHOLESTEROLEMIA" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="MULTIFACTORIAL DYSLIPIDEMIA" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="ORAL HEALTH CONDITIONS" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="SKIN CANCER" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="HYPERTENSIVE DISORDERS OF PREGNANCY" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="LUNG SCREENING RECOMMENDATION EXPANSION 2021" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="LUNG CANCER MODELS" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="LUNG CANCER SCREENING" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="MAJOR DEPRESSIVE DISORDER" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="SCREENING FOR DEPRESSION" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="SCREENING FOR SUICIDE RISK" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="SKIN CANCER SCREENING PROGRAMS" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="EMBASE" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="FOLIC ACID SUPPLEMENTATION" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="ANXIETY DISORDERS SCREENING" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="COLORECTAL CANCER SCREENING" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="US" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="PROSTATE, LUNG, COLORECTAL AND OVARIAN CANCER SCREENING TRIAL" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="NATIONAL LUNG SCREENING TRIAL" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="NATIONAL HEALTH INTERVIEW SURVEY" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="LIFE YEARS FROM SCREENING-CT" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="GESTATIONAL DIABETES MELLITUS SCREENING" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE" target="LDCT SCREENING" />
    <edge source="MEDLINE" target="CUMULATIVE INDEX TO NURSING AND ALLIED HEALTH LITERATURE" />
    <edge source="MEDLINE" target="WEB OF SCIENCE" />
    <edge source="MEDLINE" target="EMBASE" />
    <edge source="MEDLINE" target="PRISMA GUIDELINE" />
    <edge source="MEDLINE" target="CHATGPT" />
    <edge source="MEDLINE" target="CANCER PREVENTION RECOMMENDATIONS" />
    <edge source="MEDLINE" target="WORD EMBEDDINGS" />
    <edge source="MEDLINE" target="UMLS" />
    <edge source="MEDLINE" target="SEMREP" />
    <edge source="MEDLINE" target="DISCRETE CHOICE EXPERIMENT" />
    <edge source="MEDLINE" target="SYSTEMATIC REVIEW AND META-ANALYSIS" />
    <edge source="MEDLINE" target="FAMILY MEDICINE DEPARTMENTS" />
    <edge source="MEDLINE" target="COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS" />
    <edge source="MEDLINE" target="PRIMARY HYPERTENSION" />
    <edge source="MEDLINE" target="SECONDARY HYPERTENSION" />
    <edge source="MEDLINE" target="AI METHODS" />
    <edge source="MEDLINE" target="GEFAPIXANT" />
    <edge source="MEDLINE" target="LIVING SYSTEMATIC REVIEW" />
    <edge source="MEDLINE" target="INFECTIOUS DISEASE MODELLING" />
    <edge source="MEDLINE" target="ORTHOSTATIC HYPOTENSION" />
    <edge source="MEDLINE" target="STANDING HYPOTENSION" />
    <edge source="MEDLINE" target="PRISMA" />
    <edge source="MEDLINE" target="CARDIOVASCULAR DISEASE (CVD)" />
    <edge source="MEDLINE" target="CINAHL" />
    <edge source="MEDLINE" target="MEDRXIV" />
    <edge source="MEDLINE" target="BIORXIV" />
    <edge source="MEDLINE" target="ARXIV" />
    <edge source="MEDLINE" target="CHD MODELLING STUDIES" />
    <edge source="MEDLINE" target="HEALTH DISPARITIES AND MINORITY HEALTH" />
    <edge source="MEDLINE" target="GENERALIZED ANXIETY DISORDER (GAD)" />
    <edge source="MEDLINE" target="CANCER RESEARCH" />
    <edge source="MEDLINE" target="SCOPUS" />
    <edge source="MEDLINE" target="PROQUEST" />
    <edge source="MEDLINE" target="LONG-TERM CARE FACILITIES" />
    <edge source="COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS" target="GEFAPIXANT" />
    <edge source="COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS" target="ANAPLASTIC LYMPHOMA KINASE (ALK)-MUTATED NON-SMALL CELL LUNG CANCER (NSCLC)" />
    <edge source="COCHRANE DATABASE OF SYSTEMATIC REVIEWS" target="ROBOTREVIEWER" />
    <edge source="COCHRANE DATABASE OF SYSTEMATIC REVIEWS" target="ML MODEL" />
    <edge source="COCHRANE DATABASE OF SYSTEMATIC REVIEWS" target="EXPERIENCED REVIEWERS" />
    <edge source="SCOPUS" target="EVIDENCE SYNTHESIS PROJECT" />
    <edge source="SCOPUS" target="CHILD AND YOUTH MULTIMORBIDITY" />
    <edge source="SCOPUS" target="PRISMA GUIDELINE" />
    <edge source="SCOPUS" target="VIRTUAL REALITY REHABILITATION" />
    <edge source="SCOPUS" target="CANCER PREVENTION RECOMMENDATIONS" />
    <edge source="SCOPUS" target="ONTOLOGY RESEARCH" />
    <edge source="SCOPUS" target="FOLLICULAR LYMPHOMA" />
    <edge source="SCOPUS" target="ARKSEY AND O'MALLEY" />
    <edge source="SCOPUS" target="SUICIDE RISK FACTORS" />
    <edge source="SCOPUS" target="SYSTEMATIC REVIEW AND META-ANALYSIS" />
    <edge source="SCOPUS" target="FAMILY MEDICINE DEPARTMENTS" />
    <edge source="SCOPUS" target="DATA QUALITY IN HEALTH INFORMATION SYSTEMS" />
    <edge source="SCOPUS" target="HEART FAILURE" />
    <edge source="SCOPUS" target="ESOPHAGEAL CANCER" />
    <edge source="SCOPUS" target="HYPERTENSION MANAGEMENT STUDY" />
    <edge source="SCOPUS" target="PRECISION MEDICINE" />
    <edge source="SCOPUS" target="VIRTUAL REALITY" />
    <edge source="SCOPUS" target="BARRIERS AND FACILITATORS REVIEW" />
    <edge source="SCOPUS" target="PROQUEST" />
    <edge source="SCOPUS" target="LONG-TERM CARE FACILITIES" />
    <edge source="SCOPUS" target="TELEMEDICINE TECHNOLOGY" />
    <edge source="EVIDENCE SYNTHESIS PROJECT" target="OPENALEX" />
    <edge source="IMMUNE CHECKPOINT INHIBITORS" target="ADVANCED MELANOMA" />
    <edge source="IMMUNE CHECKPOINT INHIBITORS" target="IMMUNE-RELATED ADVERSE EVENTS" />
    <edge source="IMMUNE CHECKPOINT INHIBITORS" target="ICI GASTRITIS" />
    <edge source="IMMUNE CHECKPOINT INHIBITORS" target="ICI ENTERITIS" />
    <edge source="IMMUNE CHECKPOINT INHIBITORS" target="ICI COLITIS" />
    <edge source="IMMUNE CHECKPOINT INHIBITORS" target="CANCER PATIENTS" />
    <edge source="IMMUNE CHECKPOINT INHIBITORS" target="ACUTE MYOCARDITIS" />
    <edge source="ADVANCED MELANOMA" target="CIRCULATING TUMOR DNA" />
    <edge source="ADVANCED MELANOMA" target="ANTI-PROGRAMMED DEATH 1 MONOTHERAPY" />
    <edge source="ADVANCED MELANOMA" target="ANTI-CTLA-4 THERAPY" />
    <edge source="ADVANCED MELANOMA" target="VITAMIN D3" />
    <edge source="ADVANCED MELANOMA" target="ANTI-PD-1 IMMUNOTHERAPY" />
    <edge source="CIRCULATING TUMOR DNA" target="COHORT A" />
    <edge source="CIRCULATING TUMOR DNA" target="COHORT B" />
    <edge source="CIRCULATING TUMOR DNA" target="COHORT C" />
    <edge source="ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY" target="AYAS" />
    <edge source="ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY" target="NON-AYAS" />
    <edge source="ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY" target="PUBMED" />
    <edge source="AYAS" target="LEUKEMIA" />
    <edge source="AYAS" target="BREAST CANCER" />
    <edge source="AYAS" target="LYMPHOMA" />
    <edge source="AYAS" target="COLORECTAL CANCER" />
    <edge source="AYAS" target="CENTRAL NERVOUS SYSTEM CANCER" />
    <edge source="AYAS" target="MELANOMA" />
    <edge source="AYAS" target="SARCOMA" />
    <edge source="AYAS" target="SARCOMAS" />
    <edge source="AYAS" target="SURVSARC" />
    <edge source="PUBMED" target="ALCOHOL USE DISORDER" />
    <edge source="PUBMED" target="CHILD AND YOUTH MULTIMORBIDITY" />
    <edge source="PUBMED" target="SNOMED CT" />
    <edge source="PUBMED" target="PRISMA GUIDELINE" />
    <edge source="PUBMED" target="SEPSIS" />
    <edge source="PUBMED" target="CLINICAL DECISION SUPPORT SYSTEMS (CDSS)" />
    <edge source="PUBMED" target="VIRTUAL REALITY REHABILITATION" />
    <edge source="PUBMED" target="TELEMEDICINE" />
    <edge source="PUBMED" target="FOLLICULAR LYMPHOMA" />
    <edge source="PUBMED" target="ALZHEIMER'S DISEASE" />
    <edge source="PUBMED" target="DJANGO" />
    <edge source="PUBMED" target="SUICIDE RISK FACTORS" />
    <edge source="PUBMED" target="PAJO MODEL" />
    <edge source="PUBMED" target="ANAPLASTIC LYMPHOMA KINASE (ALK)-MUTATED NON-SMALL CELL LUNG CANCER (NSCLC)" />
    <edge source="PUBMED" target="DATA QUALITY IN HEALTH INFORMATION SYSTEMS" />
    <edge source="PUBMED" target="HEART FAILURE" />
    <edge source="PUBMED" target="MACHINE LEARNING" />
    <edge source="PUBMED" target="SYSTEMATIC REVIEW" />
    <edge source="PUBMED" target="ANTIBODY-DRUG CONJUGATES" />
    <edge source="PUBMED" target="ESOPHAGEAL CANCER" />
    <edge source="PUBMED" target="CPAP" />
    <edge source="PUBMED" target="HYPERTENSION MANAGEMENT STUDY" />
    <edge source="PUBMED" target="PRECISION MEDICINE" />
    <edge source="PUBMED" target="VIRTUAL REALITY" />
    <edge source="PUBMED" target="MEDICATION ADMINISTRATION CLINICAL DECISION SUPPORT SYSTEMS" />
    <edge source="PUBMED" target="GLOBAL CANCER SURGERY" />
    <edge source="PUBMED" target="BARRIERS AND FACILITATORS REVIEW" />
    <edge source="PUBMED" target="RCT" />
    <edge source="PUBMED" target="CCT" />
    <edge source="PUBMED" target="MACHINE LEARNING IN MENTAL HEALTH RESEARCH" />
    <edge source="PUBMED" target="TELEMEDICINE TECHNOLOGY" />
    <edge source="LEUKEMIA" target="BONE MARROW" />
    <edge source="LEUKEMIA" target="CYTOCHROME P450 ENZYMES" />
    <edge source="LEUKEMIA" target="ASCIMINIB" />
    <edge source="LEUKEMIA" target="BREXUCABTAGENE AUTOLEUCEL" />
    <edge source="LEUKEMIA" target="ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN" />
    <edge source="LEUKEMIA" target="NON-HODGKIN LYMPHOMA" />
    <edge source="BREAST CANCER" target="CHINA" />
    <edge source="BREAST CANCER" target="PROGESTERONE RECEPTOR" />
    <edge source="BREAST CANCER" target="CENTRAL NERVOUS SYSTEM" />
    <edge source="BREAST CANCER" target="HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2" />
    <edge source="BREAST CANCER" target="IMMUNOTHERAPY" />
    <edge source="BREAST CANCER" target="BONE MARROW" />
    <edge source="BREAST CANCER" target="CYP3A4" />
    <edge source="BREAST CANCER" target="HER2-LOW" />
    <edge source="BREAST CANCER" target="HRQOL" />
    <edge source="BREAST CANCER" target="OBESITY" />
    <edge source="BREAST CANCER" target="CALORIC RESTRICTION" />
    <edge source="BREAST CANCER" target="COMBINED EXERCISE + CALORIC RESTRICTION" />
    <edge source="BREAST CANCER" target="PHYSICAL ACTIVITY + CALORIC RESTRICTION" />
    <edge source="BREAST CANCER" target="RESISTANCE EXERCISE" />
    <edge source="BREAST CANCER" target="MULTIMODAL EXERCISE AND DIET PROGRAMS" />
    <edge source="BREAST CANCER" target="WOMEN" />
    <edge source="BREAST CANCER" target="ADCS" />
    <edge source="BREAST CANCER" target="BCDR-F03" />
    <edge source="BREAST CANCER" target="WDBC" />
    <edge source="BREAST CANCER" target="GSE10810" />
    <edge source="BREAST CANCER" target="GSE15852" />
    <edge source="BREAST CANCER" target="CANCER PREVENTION RECOMMENDATIONS" />
    <edge source="BREAST CANCER" target="WORLD CANCER RESEARCH FUND/AMERICAN INSTITUTE FOR CANCER RESEARCH" />
    <edge source="BREAST CANCER" target="IGF2BP3" />
    <edge source="BREAST CANCER" target="BRAIN METASTASIS" />
    <edge source="BREAST CANCER" target="MAMMOGRAPHY SCREENING" />
    <edge source="BREAST CANCER" target="BREAST CANCER MORTALITY" />
    <edge source="BREAST CANCER" target="SCREENING WOMEN &#8805; 75 YEARS OLD" />
    <edge source="BREAST CANCER" target="MHEALTH" />
    <edge source="BREAST CANCER" target="CHEMOTHERAPY" />
    <edge source="BREAST CANCER" target="MODEL GE" />
    <edge source="BREAST CANCER" target="SKELETAL MUSCLE DECONDITIONING" />
    <edge source="BREAST CANCER" target="EXERCISE CAPACITY" />
    <edge source="BREAST CANCER" target="RACE/ETHNICITY" />
    <edge source="BREAST CANCER" target="SURVIVAL" />
    <edge source="BREAST CANCER" target="PATHWAYS STUDY" />
    <edge source="BREAST CANCER" target="ALCOHOL CONSUMPTION" />
    <edge source="BREAST CANCER" target="CARDIOVASCULAR DISEASE" />
    <edge source="BREAST CANCER" target="LOUISIANA" />
    <edge source="BREAST CANCER" target="BLACK WOMEN" />
    <edge source="BREAST CANCER" target="SCREENING BREAST MRI" />
    <edge source="BREAST CANCER" target="DNA DAMAGE RESPONSE" />
    <edge source="BREAST CANCER" target="THE CANCER GENOME ATLAS" />
    <edge source="BREAST CANCER" target="ORAL ANTICOAGULANT" />
    <edge source="BREAST CANCER" target="INTELLECTUAL OR DEVELOPMENTAL DISABILITIES (IDD)" />
    <edge source="BREAST CANCER" target="STAGE IV CANCER" />
    <edge source="BREAST CANCER" target="ATRIAL FIBRILLATION" />
    <edge source="BREAST CANCER" target="NEOADJUVANT CHEMOTHERAPY" />
    <edge source="BREAST CANCER" target="KENTUCKY CANCER REGISTRY" />
    <edge source="BREAST CANCER" target="DEPRESSION" />
    <edge source="BREAST CANCER" target="BRCA1/2 MUTATIONS" />
    <edge source="BREAST CANCER" target="HER2/NEU-POSITIVE BC" />
    <edge source="BREAST CANCER" target="BC CLINICIANS" />
    <edge source="BREAST CANCER" target="ONCOLOGY TEAM" />
    <edge source="BREAST CANCER" target="WEIGHT MANAGEMENT" />
    <edge source="BREAST CANCER" target="CENTERS FOR DISEASE CONTROL AND PREVENTION" />
    <edge source="BREAST CANCER" target="NATIONAL CENTER FOR HEALTH STATISTICS" />
    <edge source="BREAST CANCER" target="NORTHEAST" />
    <edge source="BREAST CANCER" target="SOUTH" />
    <edge source="BREAST CANCER" target="NON-HISPANIC WHITE WOMEN" />
    <edge source="BREAST CANCER" target="NON-HISPANIC ASIAN OR PACIFIC ISLANDER WOMEN" />
    <edge source="BREAST CANCER" target="WOMEN AGED 45 TO 64" />
    <edge source="BREAST CANCER" target="WOMEN AGED 65 OR OLDER" />
    <edge source="BREAST CANCER" target="ALBERTA MOVING BEYOND BREAST CANCER (AMBER) COHORT STUDY" />
    <edge source="BREAST CANCER" target="YOUNG WOMEN'S BREAST CANCER STUDY" />
    <edge source="BREAST CANCER" target="CONTRALATERAL PROPHYLACTIC MASTECTOMY" />
    <edge source="BREAST CANCER" target="LUMPECTOMY" />
    <edge source="BREAST CANCER" target="SINGLE MASTECTOMY" />
    <edge source="BREAST CANCER" target="DOUBLE MASTECTOMY" />
    <edge source="BREAST CANCER" target="NEGATIVE AFFECT" />
    <edge source="BREAST CANCER" target="ADABOOST ALGORITHM" />
    <edge source="BREAST CANCER" target="LOGISTIC REGRESSION (LR)" />
    <edge source="BREAST CANCER" target="RANDOM FOREST (RF)" />
    <edge source="BREAST CANCER" target="SUPPORT VECTOR CLASSIFICATION (SVC)" />
    <edge source="BREAST CANCER" target="EXTREME GRADIENT BOOSTING (XGBOOST)" />
    <edge source="BREAST CANCER" target="GRADIENT BOOSTING DECISION TREE (GBDT)" />
    <edge source="BREAST CANCER" target="DECISION TREE" />
    <edge source="BREAST CANCER" target="MULTILAYER PERCEPTRON (MLP)" />
    <edge source="BREAST CANCER" target="LINEAR DISCRIMINANT ANALYSIS (LDA)" />
    <edge source="BREAST CANCER" target="ADAPTIVE BOOSTING (ADABOOST)" />
    <edge source="BREAST CANCER" target="GAUSSIAN NAIVE BAYES (GAUSSIANNB)" />
    <edge source="BREAST CANCER" target="LIGHT GRADIENT BOOSTING MACHINE (LIGHTGBM)" />
    <edge source="BREAST CANCER" target="ANTIBODY-DRUG CONJUGATES" />
    <edge source="BREAST CANCER" target="VIRTUAL REALITY" />
    <edge source="BREAST CANCER" target="SYSTEMATIC REVIEW" />
    <edge source="BREAST CANCER" target="CANCER SURVIVORS" />
    <edge source="BREAST CANCER" target="US MILITARY" />
    <edge source="BREAST CANCER" target="WOMEN'S HEALTH ACCELEROMETRY COLLABORATION" />
    <edge source="BREAST CANCER" target="PHYSICAL ACTIVITY" />
    <edge source="BREAST CANCER" target="ANXIETY" />
    <edge source="BREAST CANCER" target="LONG-TERM CANCER SURVIVORS" />
    <edge source="COLORECTAL CANCER" target="CONGRESSIONAL DISTRICT" />
    <edge source="COLORECTAL CANCER" target="HRQOL" />
    <edge source="COLORECTAL CANCER" target="PERITONEUM" />
    <edge source="COLORECTAL CANCER" target="SURGERY" />
    <edge source="COLORECTAL CANCER" target="CANCER PREVENTION RECOMMENDATIONS" />
    <edge source="COLORECTAL CANCER" target="SURVEILLANCE COLONOSCOPY" />
    <edge source="COLORECTAL CANCER" target="ORAL ANTICOAGULANT" />
    <edge source="COLORECTAL CANCER" target="INTELLECTUAL OR DEVELOPMENTAL DISABILITIES (IDD)" />
    <edge source="COLORECTAL CANCER" target="STAGE IV CANCER" />
    <edge source="COLORECTAL CANCER" target="ATRIAL FIBRILLATION" />
    <edge source="COLORECTAL CANCER" target="CANCER THERAPY EVALUATION PROGRAM STUDY 9557" />
    <edge source="COLORECTAL CANCER" target="COLONOSCOPY" />
    <edge source="COLORECTAL CANCER" target="US" />
    <edge source="COLORECTAL CANCER" target="MARKOV MODELING" />
    <edge source="COLORECTAL CANCER" target="MULTIMODAL CRC SCREENING POLICIES" />
    <edge source="COLORECTAL CANCER" target="CANCER SURVIVORS" />
    <edge source="COLORECTAL CANCER" target="UNITED KINGDOM FLEXIBLE SIGMOIDOSCOPY SCREENING TRIAL" />
    <edge source="COLORECTAL CANCER" target="US MILITARY" />
    <edge source="COLORECTAL CANCER" target="ULCERATIVE COLITIS" />
    <edge source="COLORECTAL CANCER" target="DEPRESSION" />
    <edge source="COLORECTAL CANCER" target="ANXIETY" />
    <edge source="COLORECTAL CANCER" target="DIABETES" />
    <edge source="COLORECTAL CANCER" target="CURATIVE CRC RESECTION" />
    <edge source="COLORECTAL CANCER" target="COHORT STUDY" />
    <edge source="COLORECTAL CANCER" target="LONG-TERM CANCER SURVIVORS" />
    <edge source="MELANOMA" target="SKIN CANCER" />
    <edge source="MELANOMA" target="BRAF-TARGETED THERAPY" />
    <edge source="MELANOMA" target="IMMUNE CHECKPOINT INHIBITION" />
    <edge source="MELANOMA" target="GERMANY" />
    <edge source="MELANOMA" target="SKIN CANCER SCREENING PROGRAMS" />
    <edge source="MELANOMA" target="ITALIAN COHORT STUDY" />
    <edge source="MELANOMA" target="SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS DATABASE" />
    <edge source="MELANOMA" target="CLARK LEVEL II" />
    <edge source="MELANOMA" target="BRESLOW THICKNESS" />
    <edge source="MELANOMA" target="OVERDIAGNOSIS" />
    <edge source="MELANOMA" target="STAGE I LESIONS" />
    <edge source="MELANOMA" target="VERY-LOW RISK OF DEATH" />
    <edge source="MELANOMA" target="HIGH-RISK PATIENTS" />
    <edge source="ST. JUDE LIFETIME COHORT STUDY" target="ADULT SURVIVORS OF CHILDHOOD CANCER" />
    <edge source="ST. JUDE LIFETIME COHORT STUDY" target="CHILDHOOD CANCER SURVIVORS" />
    <edge source="ST. JUDE LIFETIME COHORT STUDY" target="CARDIOMETABOLIC HEALTH" />
    <edge source="ST. JUDE LIFETIME COHORT STUDY" target="PHYSICAL PERFORMANCE" />
    <edge source="ST. JUDE LIFETIME COHORT STUDY" target="EMOTIONAL HEALTH" />
    <edge source="ADULT SURVIVORS OF CHILDHOOD CANCER" target="NUTRITION GUIDELINES" />
    <edge source="NATURALNESS PREFERENCE SCALE" target="AMAZON MECHANICAL TURK" />
    <edge source="NATURALNESS PREFERENCE SCALE" target="STUDY 1" />
    <edge source="NATURALNESS PREFERENCE SCALE" target="STUDY 2" />
    <edge source="NATURALNESS PREFERENCE SCALE" target="STUDY 3" />
    <edge source="STUDY 1" target="POLITICALLY LIBERAL PARTICIPANTS" />
    <edge source="STUDY 1" target="POLITICALLY CONSERVATIVE PARTICIPANTS" />
    <edge source="STUDY 1" target="GENERAL PRACTITIONERS" />
    <edge source="STUDY 1" target="DECISION SUPPORT SYSTEM" />
    <edge source="STUDY 1" target="UNIVERSITY HOSPITAL" />
    <edge source="STUDY 1" target="STUDY 2" />
    <edge source="STUDY 1" target="UROLOGICAL OUTPATIENTS" />
    <edge source="STUDY 1" target="CLINICAL DECISION SUPPORT SYSTEM FOR YOUTH DEPRESSION (CDSS-YD)" />
    <edge source="STUDY 1" target="ADOLESCENTS" />
    <edge source="STUDY 1" target="PARENTS" />
    <edge source="STUDY 1" target="BEHAVIORAL HEALTH PROVIDERS" />
    <edge source="STUDY 2" target="PROVIDER INCLUSIVITY SIGNALING" />
    <edge source="STUDY 2" target="GENERAL PRACTITIONERS" />
    <edge source="STUDY 2" target="DECISION SUPPORT SYSTEM" />
    <edge source="STUDY 2" target="BLADDER CANCER PATIENTS" />
    <edge source="STUDY 2" target="AMERICAN PARTICIPANTS" />
    <edge source="STUDY 2" target="CANADIAN PARTICIPANTS" />
    <edge source="STUDY 2" target="CHINESE PARTICIPANTS" />
    <edge source="STUDY 2" target="NATURALNESS BIAS" />
    <edge source="STUDY 2" target="CLINICAL DECISION SUPPORT SYSTEM FOR YOUTH DEPRESSION (CDSS-YD)" />
    <edge source="STUDY 2" target="BEHAVIORAL HEALTH PROVIDERS" />
    <edge source="STUDY 3" target="PROVIDER INCLUSIVITY SIGNALING" />
    <edge source="EVSI" target="ITS" />
    <edge source="EVSI" target="DISCRETE SAMPLING METHOD" />
    <edge source="EVSI" target="INTERPOLATED ITS METHOD" />
    <edge source="EVSI" target="ENBS" />
    <edge source="EVSI" target="CANCER TECHNOLOGY APPRAISAL" />
    <edge source="DISCRETE SAMPLING METHOD" target="INTERPOLATED ITS METHOD" />
    <edge source="CORONARY ARTERY CALCIUM SCORE" target="MACHINE LEARNING" />
    <edge source="CORONARY ARTERY CALCIUM SCORE" target="MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS" />
    <edge source="CORONARY ARTERY CALCIUM SCORE" target="ROTTERDAM STUDY" />
    <edge source="CORONARY ARTERY CALCIUM SCORE" target="CHD RISK PREDICTION" />
    <edge source="CORONARY ARTERY CALCIUM SCORE" target="TRADITIONAL RISK FACTORS" />
    <edge source="MACHINE LEARNING" target="PRECISION MEDICINE" />
    <edge source="MACHINE LEARNING" target="CORONARY HEART DISEASE RISK-PREDICTION MODEL" />
    <edge source="MACHINE LEARNING" target="METABOLOMICS" />
    <edge source="MACHINE LEARNING" target="LUNG CANCER" />
    <edge source="MACHINE LEARNING" target="SOUTHERN TAIWAN HOSPITAL" />
    <edge source="MACHINE LEARNING" target="EMERGENCY DEPARTMENT OVERCROWDING" />
    <edge source="MACHINE LEARNING" target="ENSEMBLE LEARNING" />
    <edge source="MACHINE LEARNING" target="CLINICAL MEDICINE" />
    <edge source="MACHINE LEARNING" target="DIABETES PREDICTION" />
    <edge source="MACHINE LEARNING" target="MEDICAL DOMAIN KNOWLEDGE" />
    <edge source="MACHINE LEARNING" target="ML PIPELINE" />
    <edge source="MACHINE LEARNING" target="CESAREAN SECTION-INDUCED POSTPARTUM HEMORRHAGE" />
    <edge source="MACHINE LEARNING" target="PANCREATIC DUCTAL ADENOCARCINOMA" />
    <edge source="MACHINE LEARNING" target="GITHUB" />
    <edge source="MACHINE LEARNING" target="BIOMEDICAL RESEARCH" />
    <edge source="MACHINE LEARNING" target="CARDIOVASCULAR DISEASES" />
    <edge source="MACHINE LEARNING" target="FERNET ENCRYPTION ALGORITHM" />
    <edge source="MACHINE LEARNING" target="LGBM ALGORITHM" />
    <edge source="MACHINE LEARNING" target="LIME ANALYSIS" />
    <edge source="MACHINE LEARNING" target="MATERNAL, NEWBORN, AND CHILD HEALTHCARE CONTINUUM" />
    <edge source="MACHINE LEARNING" target="SYSTEMATIC REVIEWS" />
    <edge source="MACHINE LEARNING" target="SEPSIS" />
    <edge source="MACHINE LEARNING" target="EXTREME GRADIENT BOOSTING" />
    <edge source="MACHINE LEARNING" target="SYSTEMATIC REVIEW AND META-ANALYSIS" />
    <edge source="MACHINE LEARNING" target="TRAINING SET" />
    <edge source="MACHINE LEARNING" target="VALIDATION SET" />
    <edge source="MACHINE LEARNING" target="OPHTHALMOLOGISTS" />
    <edge source="MACHINE LEARNING" target="CORNEAL REFRACTIVE SURGERY" />
    <edge source="MACHINE LEARNING" target="SUICIDE ATTEMPTS" />
    <edge source="MACHINE LEARNING" target="SUICIDE RISK PREDICTION" />
    <edge source="MACHINE LEARNING" target="NON-SMALL CELL LUNG CANCER" />
    <edge source="MACHINE LEARNING" target="PARTICLE FILTERING" />
    <edge source="MACHINE LEARNING" target="PARAMETER ESTIMATION" />
    <edge source="MACHINE LEARNING" target="NSCLC RISK ASSESSMENT MODEL" />
    <edge source="MACHINE LEARNING" target="NOMOGRAMS" />
    <edge source="MACHINE LEARNING" target="HOSPITAL OPERATIONS MANAGEMENT" />
    <edge source="MACHINE LEARNING" target="PROLONGED DISORDERS OF CONSCIOUSNESS" />
    <edge source="MACHINE LEARNING" target="COMA RECOVERY SCALE-REVISED" />
    <edge source="MACHINE LEARNING" target="MUSIC THERAPY ASSESSMENT TOOL FOR AWARENESS IN DISORDERS OF CONSCIOUSNESS" />
    <edge source="MACHINE LEARNING" target="PROLONGED INTERMITTENT RENAL REPLACEMENT THERAPY" />
    <edge source="MACHINE LEARNING" target="CARDIOVASCULAR DISEASE" />
    <edge source="MACHINE LEARNING" target="LITERATURE REVIEW" />
    <edge source="MACHINE LEARNING" target="COMPUTATIONAL TOOLS" />
    <edge source="MACHINE LEARNING" target="METAMODELS" />
    <edge source="MACHINE LEARNING" target="SUPPORT VECTOR REGRESSION" />
    <edge source="MACHINE LEARNING" target="ARTIFICIAL NEURAL NETWORK" />
    <edge source="MACHINE LEARNING" target="CAUSAL INFERENCE" />
    <edge source="MACHINE LEARNING" target="INDIVIDUALIZED TREATMENT EFFECTS" />
    <edge source="MACHINE LEARNING" target="HEALTH TECHNOLOGY ASSESSMENT" />
    <edge source="MACHINE LEARNING" target="OBSERVATIONAL DATA" />
    <edge source="MACHINE LEARNING" target="TIME-VARYING CONFOUNDING" />
    <edge source="MACHINE LEARNING" target="TIME-TO-EVENT OUTCOMES" />
    <edge source="MACHINE LEARNING" target="ACUTE MYOCARDIAL INFARCTION" />
    <edge source="MACHINE LEARNING" target="SYSTEMATIC REVIEW" />
    <edge source="MACHINE LEARNING" target="RAPID SCOPING REVIEW" />
    <edge source="MACHINE LEARNING" target="SEASONAL VARIATION" />
    <edge source="MACHINE LEARNING" target="HYPERPARAMETER OPTIMIZATION" />
    <edge source="MACHINE LEARNING" target="AUROC" />
    <edge source="MACHINE LEARNING" target="AUPRC" />
    <edge source="MACHINE LEARNING" target="SYNTHETIC MINORITY OVER-SAMPLING TECHNIQUE (SMOTE)" />
    <edge source="MACHINE LEARNING" target="DECISION TREES" />
    <edge source="MACHINE LEARNING" target="GRADIENT BOOSTING" />
    <edge source="MACHINE LEARNING" target="XGBOOST" />
    <edge source="MACHINE LEARNING" target="LIGHTGBM" />
    <edge source="MACHINE LEARNING" target="MULTILAYER PERCEPTRONS (MLP)" />
    <edge source="MACHINE LEARNING" target="SUPPORT VECTOR MACHINES (SVM)" />
    <edge source="MACHINE LEARNING" target="SEQUENTIAL HALVING AND CLASSIFICATION (SHAC)" />
    <edge source="MACHINE LEARNING" target="ASCVD" />
    <edge source="MACHINE LEARNING" target="ML-BASED ANN MODEL" />
    <edge source="MACHINE LEARNING" target="ELECTRONIC MEDICAL RECORDS" />
    <edge source="MACHINE LEARNING" target="INDEX SYSTEM" />
    <edge source="MACHINE LEARNING" target="BRONCHOPULMONARY DYSPLASIA" />
    <edge source="MACHINE LEARNING" target="BIOMEDICAL LITERATURE SURVEY" />
    <edge source="MACHINE LEARNING" target="PERITONEAL DIALYSIS" />
    <edge source="MACHINE LEARNING" target="CATBOOST" />
    <edge source="MACHINE LEARNING" target="SHAPLEY ADDITIVE EXPLANATION" />
    <edge source="MACHINE LEARNING" target="PYTHON 3.8.3" />
    <edge source="MACHINE LEARNING" target="GASTRIC CANCER" />
    <edge source="MACHINE LEARNING" target="TRAUMATIC BRAIN INJURIES" />
    <edge source="MACHINE LEARNING" target="EMBASE.COM" />
    <edge source="MACHINE LEARNING" target="COCHRANE" />
    <edge source="MACHINE LEARNING" target="WEB OF SCIENCE" />
    <edge source="MACHINE LEARNING" target="PROBAST" />
    <edge source="MACHINE LEARNING" target="GCS SCORE" />
    <edge source="MACHINE LEARNING" target="CT CLASSIFICATION" />
    <edge source="MACHINE LEARNING" target="PUPIL SIZE/LIGHT REFLEX" />
    <edge source="MACHINE LEARNING" target="GLUCOSE" />
    <edge source="MACHINE LEARNING" target="SYSTOLIC BLOOD PRESSURE" />
    <edge source="MACHINE LEARNING" target="ESOPHAGEAL CANCER" />
    <edge source="MACHINE LEARNING" target="COMPUTER VISION" />
    <edge source="MACHINE LEARNING" target="PURE" />
    <edge source="MACHINE LEARNING" target="SEPSIS-ASSOCIATED ACUTE KIDNEY INJURY" />
    <edge source="MACHINE LEARNING" target="SHAPLEY ADDITIVE EXPLANATIONS" />
    <edge source="MACHINE LEARNING" target="NATURAL LANGUAGE CLASSIFIER" />
    <edge source="MACHINE LEARNING" target="BLOOD CULTURE PREDICTION INDEX (BCPI)" />
    <edge source="MACHINE LEARNING" target="DIABETES" />
    <edge source="MACHINE LEARNING" target="INFECTION CONTROL" />
    <edge source="MACHINE LEARNING" target="COGNITIVE DECLINE" />
    <edge source="MACHINE LEARNING" target="COMPUTATIONAL TEXT PHENOTYPING" />
    <edge source="MACHINE LEARNING" target="LIME" />
    <edge source="MACHINE LEARNING" target="DEEP LEARNING" />
    <edge source="MACHINE LEARNING" target="CLASSICAL ML" />
    <edge source="MACHINE LEARNING" target="AGES-REYKJAVIK STUDY" />
    <edge source="MACHINE LEARNING" target="COX REGRESSION" />
    <edge source="MACHINE LEARNING" target="ELASTIC NET REGRESSION" />
    <edge source="MACHINE LEARNING" target="ELASTIC NET COX REGRESSION" />
    <edge source="PRECISION MEDICINE" target="GENOMICS-BASED CLINICAL DIAGNOSIS" />
    <edge source="PRECISION MEDICINE" target="DATA DISPERSION" />
    <edge source="PRECISION MEDICINE" target="PRECISION ONCOLOGY" />
    <edge source="PRECISION MEDICINE" target="PRECISION MEDICINE FOR CHILDREN WITH CANCER (PRISM)" />
    <edge source="PRECISION MEDICINE" target="CHILDHOOD CANCER" />
    <edge source="PRECISION MEDICINE" target="PERSONALIZED DIABETES RISK INFORMATION" />
    <edge source="PRECISION MEDICINE" target="DOCTOR-PATIENT RELATIONSHIP" />
    <edge source="PRECISION MEDICINE" target="WEB OF SCIENCE" />
    <edge source="PRECISION MEDICINE" target="SOCIAL SCIENCE PREMIUM COLLECTION" />
    <edge source="PRECISION MEDICINE" target="CANCER CARE" />
    <edge source="PRECISION MEDICINE" target="GENETICS" />
    <edge source="PRECISION MEDICINE" target="CLINICAL GENETICS" />
    <edge source="HYPERTENSIVE PATIENTS" target="OBSTRUCTIVE CORONARY ARTERY DISEASE" />
    <edge source="OBSTRUCTIVE CORONARY ARTERY DISEASE" target="EXTREME GRADIENT BOOSTING" />
    <edge source="OBSTRUCTIVE CORONARY ARTERY DISEASE" target="CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY" />
    <edge source="EXTREME GRADIENT BOOSTING" target="XGBOOST" />
    <edge source="EXTREME GRADIENT BOOSTING" target="MEDICAL INFORMATION MART FOR INTENSIVE CARE IV" />
    <edge source="EXTREME GRADIENT BOOSTING" target="LIME" />
    <edge source="EXTREME GRADIENT BOOSTING" target="SHAPLEY ADDITIVE EXPLANATION" />
    <edge source="EXTREME GRADIENT BOOSTING" target="SOFA SCORE" />
    <edge source="EXTREME GRADIENT BOOSTING" target="SIMPLIFIED ACUTE PHYSIOLOGY SCORE II" />
    <edge source="EXTREME GRADIENT BOOSTING" target="MIMIC III" />
    <edge source="EXTREME GRADIENT BOOSTING" target="CONDITIONAL GENERATIVE ADVERSARIAL NEURAL NETWORK" />
    <edge source="EXTREME GRADIENT BOOSTING" target="TAICHUNG VETERANS GENERAL HOSPITAL" />
    <edge source="EXTREME GRADIENT BOOSTING" target="THIRD AFFILIATED HOSPITAL OF ANHUI MEDICAL UNIVERSITY" />
    <edge source="EXTREME GRADIENT BOOSTING" target="BEH&#199;ET&#8217;S DISEASE" />
    <edge source="EXTREME GRADIENT BOOSTING" target="CARDIAC EFFUSION/TAMPONADE" />
    <edge source="EXTREME GRADIENT BOOSTING" target="LIGHT GRADIENT BOOSTING" />
    <edge source="EXTREME GRADIENT BOOSTING" target="H2O AUTOML" />
    <edge source="CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY" target="DUAL-SOURCE COMPUTED TOMOGRAPHY" />
    <edge source="CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY" target="SWEDISH CARDIOPULMONARY BIOIMAGE STUDY" />
    <edge source="XGBOOST" target="ORNITHINE" />
    <edge source="XGBOOST" target="PALMITOYLCARNITINE" />
    <edge source="XGBOOST" target="NEW ZEALAND" />
    <edge source="XGBOOST" target="CVD EVENTS" />
    <edge source="XGBOOST" target="DIABETES" />
    <edge source="XGBOOST" target="SUICIDE RISK FACTORS" />
    <edge source="XGBOOST" target="DIABETIC PERIPHERAL NEUROPATHY" />
    <edge source="XGBOOST" target="HEMATOMA EXPANSION" />
    <edge source="XGBOOST" target="SMOTE" />
    <edge source="XGBOOST" target="CT IMAGE EXTRACTION" />
    <edge source="XGBOOST" target="SMOKER COVID-19 PATIENTS" />
    <edge source="XGBOOST" target="ACUTE MYELOID LEUKEMIA" />
    <edge source="XGBOOST" target="HF-LAB9" />
    <edge source="XGBOOST" target="GRAPH NEURAL NETWORK" />
    <edge source="XGBOOST" target="ED REVISIT PREDICTION" />
    <edge source="XGBOOST" target="PURE" />
    <edge source="XGBOOST" target="IN-HOSPITAL MORTALITY STUDY" />
    <edge source="XGBOOST" target="CRGNB" />
    <edge source="XGBOOST" target="NON-LACTATING MASTITIS" />
    <edge source="XGBOOST" target="INTRAOPERATIVE DISCHARGE" />
    <edge source="XGBOOST" target="QATAR BIOBANK" />
    <edge source="R" target="TIME-INDEPENDENT CSTMS" />
    <edge source="R" target="PREDTOOLS" />
    <edge source="R" target="MSMPLUS" />
    <edge source="R" target="STUDY I" />
    <edge source="R" target="ENBS" />
    <edge source="TIME-INDEPENDENT CSTMS" target="COHORT STATE-TRANSITION MODEL" />
    <edge source="TIME-INDEPENDENT CSTMS" target="PROBABILISTIC SENSITIVITY ANALYSIS" />
    <edge source="COHORT STATE-TRANSITION MODEL" target="DECISION MODELS" />
    <edge source="DECISION MODELS" target="COST-EFFECTIVENESS ANALYSIS" />
    <edge source="DECISION MODELS" target="VALUE OF INFORMATION (VOI)" />
    <edge source="DECISION MODELS" target="1-WAY SENSITIVITY ANALYSIS (OWSA)" />
    <edge source="DECISION MODELS" target="DISTRIBUTIONAL COST-EFFECTIVENESS ANALYSIS (DCEA)" />
    <edge source="DECISION MODELS" target="PROBABILISTIC SENSITIVITY ANALYSIS (PSA)" />
    <edge source="DECISION MODELS" target="ONCOLOGY CASE STUDY" />
    <edge source="DECISION MODELS" target="R CODE" />
    <edge source="DECISION MODELS" target="THE AUTHOR(S) 2024" />
    <edge source="PROBABILISTIC SENSITIVITY ANALYSIS" target="COST-EFFECTIVENESS ANALYSIS" />
    <edge source="COST-EFFECTIVENESS ANALYSIS" target="SCREENING MAMMOGRAPHY" />
    <edge source="COST-EFFECTIVENESS ANALYSIS" target="QUALITY-ADJUSTED LIFE-YEARS (QALYS)" />
    <edge source="COST-EFFECTIVENESS ANALYSIS" target="SENSITIVITY ANALYSIS" />
    <edge source="COST-EFFECTIVENESS ANALYSIS" target="HONG KONG PUBLIC INSTITUTION" />
    <edge source="COST-EFFECTIVENESS ANALYSIS" target="MARKOV DISEASE TRANSITION MODEL" />
    <edge source="CANCER" target="WOMEN OF COLOR" />
    <edge source="CANCER" target="CLARKE ET AL." />
    <edge source="CANCER" target="HRQOL" />
    <edge source="CANCER" target="CANNABIS USE" />
    <edge source="CANCER" target="WORLD CANCER RESEARCH FUND/AMERICAN INSTITUTE FOR CANCER RESEARCH" />
    <edge source="CANCER" target="HEPATOSPLENOMEGALY" />
    <edge source="CANCER" target="MACROGLOSSIA" />
    <edge source="CANCER" target="EXTRACELLULAR VESICLES" />
    <edge source="CANCER" target="ATRIAL FIBRILLATION" />
    <edge source="CANCER" target="CLINICAL PRACTICE RESEARCH DATALINK" />
    <edge source="CANCER" target="ORAL ANTICOAGULANT" />
    <edge source="CANCER" target="INTELLECTUAL OR DEVELOPMENTAL DISABILITIES (IDD)" />
    <edge source="CANCER" target="BLEEDING" />
    <edge source="CANCER" target="DEEP LEARNING" />
    <edge source="CANCER" target="CHINA" />
    <edge source="CANCER" target="CHINA HEALTH AND RETIREMENT LONGITUDINAL STUDY" />
    <edge source="CANCER" target="SLEEP DURATION" />
    <edge source="CANCER" target="WOMEN" />
    <edge source="CANCER" target="MEN" />
    <edge source="CANCER" target="TELEMEDICINE" />
    <edge source="CANCER" target="IN-PERSON CLINIC VISITS" />
    <edge source="CANCER" target="TOBACCO USE" />
    <edge source="CANCER" target="NEIGHBORHOOD SOCIOECONOMIC DISADVANTAGE (NSD)" />
    <edge source="CANCER" target="HEALTH DISPARITIES AND MINORITY HEALTH" />
    <edge source="RHODE ISLAND" target="BREAST AND CERVICAL CANCER SCREENING" />
    <edge source="BREAST AND CERVICAL CANCER SCREENING" target="WOMEN OF COLOR" />
    <edge source="US" target="LATENT TUBERCULOSIS INFECTION" />
    <edge source="US" target="SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS DATABASE" />
    <edge source="US" target="CANCER DIAGNOSIS" />
    <edge source="US" target="ACORN" />
    <edge source="US" target="CLINICAL TRIAL" />
    <edge source="US" target="HEPATITIS C VIRUS" />
    <edge source="US" target="HPV" />
    <edge source="US" target="HIV" />
    <edge source="US" target="ACUTE MYOCARDIAL INFARCTION" />
    <edge source="US" target="INTERNATIONAL REGISTRY FOR MEN WITH ADVANCED PROSTATE CANCER (IRONMAN)" />
    <edge source="US" target="PUBLIC HEALTH POLICY MAKERS" />
    <edge source="US" target="PUBLIC HEALTH LEADERS" />
    <edge source="US" target="HEALTHCARE PROVIDERS" />
    <edge source="US" target="IMMIGRANTS" />
    <edge source="US" target="AUTISM SPECTRUM DISORDER" />
    <edge source="US" target="MATERNAL MORTALITY" />
    <edge source="US" target="NCT03269994" />
    <edge source="US" target="DOOR-IN-DOOR-OUT TIME" />
    <edge source="US" target="ACADEMIC MEDICINE" />
    <edge source="US" target="INVOLUNTARY DISPLACEMENT" />
    <edge source="US" target="CANCER DISPARITIES" />
    <edge source="US" target="2021-2022 INFLUENZA SEASON" />
    <edge source="US" target="NCT02582957" />
    <edge source="US" target="NON-US SUBSETS" />
    <edge source="US" target="NCT04593940" />
    <edge source="US" target="NATIONAL ALZHEIMER'S COORDINATING CENTER" />
    <edge source="US" target="ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE" />
    <edge source="US" target="CENTERS FOR DISEASE CONTROL AND PREVENTION" />
    <edge source="US" target="BLACK POPULATION" />
    <edge source="US" target="WHITE POPULATION" />
    <edge source="US" target="FAMILIAL HYPERCHOLESTEROLEMIA" />
    <edge source="US" target="MULTIFACTORIAL DYSLIPIDEMIA" />
    <edge source="US" target="MODEL GE" />
    <edge source="US" target="NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY" />
    <edge source="US" target="WOMEN'S HEALTH INITIATIVE" />
    <edge source="US" target="HEALTH INEQUITIES" />
    <edge source="US" target="MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS" />
    <edge source="US" target="AUTISM DIAGNOSIS STUDY" />
    <edge source="US" target="HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)" />
    <edge source="US" target="ACTIV-6" />
    <edge source="US" target="GEISINGER MYCODE COMMUNITY HEALTH INITIATIVE" />
    <edge source="US" target="CHILDHOOD CANCER" />
    <edge source="US" target="PRIMARY CARE PRACTICE-BASED RESEARCH NETWORKS" />
    <edge source="US" target="CHRONIC OBSTRUCTIVE PULMONARY DISEASE" />
    <edge source="US" target="CHRONIC KIDNEY DISEASE" />
    <edge source="US" target="CARDIOVASCULAR RISK FACTORS STUDY" />
    <edge source="US" target="HYPERTENSION" />
    <edge source="US" target="DIABETES" />
    <edge source="US" target="OBESITY" />
    <edge source="US" target="HYPERLIPIDEMIA" />
    <edge source="US" target="DIABETIC RETINOPATHY" />
    <edge source="US" target="GET WITH THE GUIDELINES-STROKE PROGRAM" />
    <edge source="US" target="KIDS' INPATIENT DATABASE" />
    <edge source="US" target="BLACK MEN" />
    <edge source="US" target="CYSTIC FIBROSIS" />
    <edge source="US" target="FRAMINGHAM OFFSPRING" />
    <edge source="US" target="ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC)" />
    <edge source="US" target="MULTI-ETHNIC STUDY FOR ATHEROSCLEROSIS (MESA)" />
    <edge source="US" target="REASONS FOR GEOGRAPHICAL AND RACIAL DIFFERENCES IN STROKE (REGARDS)" />
    <edge source="US" target="DEMOCRATIC PARTY" />
    <edge source="US" target="COVID-19 PANDEMIC" />
    <edge source="US" target="NATIONAL HOSPITAL AMBULATORY MEDICAL CARE SURVEY" />
    <edge source="US" target="MENTAL HEALTH-RELATED ED VISITS" />
    <edge source="US" target="CRYOSTAT-2" />
    <edge source="US" target="HEALTH AND RETIREMENT STUDY" />
    <edge source="US" target="RISK-COMMUNICATION APPROACHES STUDY" />
    <edge source="US" target="AFRICAN AMERICAN" />
    <edge source="US" target="BIPOLAR DISORDER" />
    <edge source="US" target="ACUTE SINUSITIS" />
    <edge source="US" target="GENETIC EPIDEMIOLOGY OF COPD COHORT" />
    <edge source="US" target="HOSPITALS" />
    <edge source="US" target="HEALTH SYSTEM IN THE US" />
    <edge source="US" target="MACHINE LEARNING IN MENTAL HEALTH RESEARCH" />
    <edge source="HEPATOBILIARY CANCER RESEARCH" target="IMMUNOTHERAPEUTICS" />
    <edge source="HEPATOBILIARY CANCER RESEARCH" target="CHECKPOINT INHIBITORS" />
    <edge source="GERM CELL TUMOR EPIDEMIOLOGY STUDY" target="GERM CELL TUMORS (GCTS)" />
    <edge source="GERM CELL TUMORS (GCTS)" target="GENETIC OVERLAP BETWEEN ANOMALIES AND CANCER IN KIDS STUDY" />
    <edge source="GERM CELL TUMORS (GCTS)" target="BIRTH DEFECTS" />
    <edge source="GERM CELL TUMORS (GCTS)" target="SYNDROMIC DEFECTS" />
    <edge source="GERM CELL TUMORS (GCTS)" target="NONSYNDROMIC DEFECTS" />
    <edge source="GERM CELL TUMORS (GCTS)" target="POSTCHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION (PCRPLND)" />
    <edge source="GERM CELL TUMORS (GCTS)" target="MICRORNA-371A-3P" />
    <edge source="DEEP REINFORCEMENT LEARNING" target="SEPSIS" />
    <edge source="SEPSIS" target="DEEP INVERSE REINFORCEMENT LEARNING" />
    <edge source="SEPSIS" target="INTENSIVE CARE UNIT (ICU)" />
    <edge source="SEPSIS" target="MIMIC-III DATABASE" />
    <edge source="SEPSIS" target="EXTREME GRADIENT BOOSTING (XGBOOST)" />
    <edge source="SEPSIS" target="EXTRA TREE" />
    <edge source="SEPSIS" target="LOGISTIC REGRESSION (LR)" />
    <edge source="SEPSIS" target="SMOTE-TOMEK LINK" />
    <edge source="SEPSIS" target="SHAPLEY ADDITIVE EXPLANATIONS" />
    <edge source="SEPSIS" target="EMBASE" />
    <edge source="SEPSIS" target="COCHRANE" />
    <edge source="SEPSIS" target="WEB OF SCIENCE" />
    <edge source="SEPSIS" target="PROBAST" />
    <edge source="SEPSIS" target="SNOWFLAKE" />
    <edge source="SEPSIS" target="LIGHT GRADIENT BOOSTING MACHINE" />
    <edge source="SEPSIS" target="HOSPITAL LENGTH OF STAY" />
    <edge source="SEPSIS" target="CONTINUOUS RENAL REPLACEMENT THERAPY" />
    <edge source="SEPSIS" target="MIMIC III" />
    <edge source="SEPSIS" target="TRANSFER LEARNING" />
    <edge source="SEPSIS" target="MEDICAL INFORMATION MART FOR INTENSIVE CARE IV" />
    <edge source="SEPSIS" target="ICU" />
    <edge source="SEPSIS" target="DELTA SERUM PHOSPHATE" />
    <edge source="SEPSIS" target="IN-HOSPITAL MORTALITY" />
    <edge source="SEPSIS" target="28-DAY MORTALITY" />
    <edge source="SEPSIS" target="MIMIC-IV DATABASE" />
    <edge source="SEPSIS" target="SEQUENTIAL ORGAN FAILURE ASSESSMENT (SOFA) SCORE" />
    <edge source="DEEP INVERSE REINFORCEMENT LEARNING" target="MIMIC-III DATASET" />
    <edge source="SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS DATABASE" target="CANCER DIAGNOSIS" />
    <edge source="SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS DATABASE" target="IPSILATERAL BREAST TUMOR RECURRENCE (IBTR)" />
    <edge source="CANCER DIAGNOSIS" target="SUICIDE" />
    <edge source="CANCER DIAGNOSIS" target="OHIO" />
    <edge source="CANCER DIAGNOSIS" target="GEORGIA" />
    <edge source="CANCER DIAGNOSIS" target="MEDICAID EXPANSION" />
    <edge source="CANCER DIAGNOSIS" target="DIABETES MELLITUS" />
    <edge source="AMERICAN JOINT COMMITTEE ON CANCER" target="OUTCOME PREDICTION MODELS" />
    <edge source="AMERICAN JOINT COMMITTEE ON CANCER" target="INTERNATIONAL UNION AGAINST CANCER" />
    <edge source="AMERICAN JOINT COMMITTEE ON CANCER" target="VERSION 9 AJCC STAGING SYSTEM" />
    <edge source="AMERICAN JOINT COMMITTEE ON CANCER" target="ANAL CANCER" />
    <edge source="AMERICAN JOINT COMMITTEE ON CANCER" target="TUMOR MITOTIC RATE (TMR)" />
    <edge source="AMERICAN JOINT COMMITTEE ON CANCER" target="TNM-8-N" />
    <edge source="ALBERTA" target="ALBERTA CANCER REGISTRY" />
    <edge source="ALBERTA" target="CANADIAN CENSUS" />
    <edge source="ALBERTA" target="SOCIOECONOMIC STATUS" />
    <edge source="ALBERTA" target="ALBERTA PROSTATE CANCER RESEARCH INITIATIVE" />
    <edge source="ALBERTA CANCER REGISTRY" target="SOCIOECONOMIC STATUS" />
    <edge source="CANADIAN CENSUS" target="SOCIOECONOMIC STATUS" />
    <edge source="SOCIOECONOMIC STATUS" target="CHILDREN'S ONCOLOGY GROUP" />
    <edge source="SOCIOECONOMIC STATUS" target="ADOLESCENT AND YOUNG ADULT PATIENTS" />
    <edge source="SOCIOECONOMIC STATUS" target="NON-HISPANIC BLACKS" />
    <edge source="ACORN" target="CEFEPIME" />
    <edge source="ACORN" target="PIPERACILLIN-TAZOBACTAM" />
    <edge source="CONSOLIDATED STANDARDS OF REPORTING TRIALS" target="PREFERRED REPORTING ITEMS FOR SYSTEMATIC REVIEWS AND META-ANALYSES" />
    <edge source="CONSOLIDATED STANDARDS OF REPORTING TRIALS" target="QUALITY OF REPORTING OF META-ANALYSIS" />
    <edge source="CONSOLIDATED STANDARDS OF REPORTING TRIALS" target="TRANSPARENT REPORTING OF EVALUATIONS WITH NONRANDOMIZED DESIGNS" />
    <edge source="CONSOLIDATED STANDARDS OF REPORTING TRIALS" target="META-ANALYSIS OF OBSERVATIONAL STUDIES IN EPIDEMIOLOGY" />
    <edge source="CONSOLIDATED STANDARDS OF REPORTING TRIALS" target="STRENGTHENING THE REPORTING OF OBSERVATIONAL STUDIES IN EPIDEMIOLOGY" />
    <edge source="CONSOLIDATED STANDARDS OF REPORTING TRIALS" target="RCT ABSTRACTS" />
    <edge source="CONSOLIDATED STANDARDS OF REPORTING TRIALS" target="GENERATIVE PRE-TRAINED TRANSFORMER 4" />
    <edge source="CONSOLIDATED STANDARDS OF REPORTING TRIALS" target="RCTS IN PLASTIC SURGERY" />
    <edge source="CONSOLIDATED STANDARDS OF REPORTING TRIALS" target="CONSORT GROUP" />
    <edge source="CONSOLIDATED STANDARDS OF REPORTING TRIALS" target="EQUATOR NETWORK" />
    <edge source="PREFERRED REPORTING ITEMS FOR SYSTEMATIC REVIEWS AND META-ANALYSES" target="QUALITY OF REPORTING OF META-ANALYSIS" />
    <edge source="PREFERRED REPORTING ITEMS FOR SYSTEMATIC REVIEWS AND META-ANALYSES" target="TRANSPARENT REPORTING OF EVALUATIONS WITH NONRANDOMIZED DESIGNS" />
    <edge source="PREFERRED REPORTING ITEMS FOR SYSTEMATIC REVIEWS AND META-ANALYSES" target="META-ANALYSIS OF OBSERVATIONAL STUDIES IN EPIDEMIOLOGY" />
    <edge source="PREFERRED REPORTING ITEMS FOR SYSTEMATIC REVIEWS AND META-ANALYSES" target="STRENGTHENING THE REPORTING OF OBSERVATIONAL STUDIES IN EPIDEMIOLOGY" />
    <edge source="PREFERRED REPORTING ITEMS FOR SYSTEMATIC REVIEWS AND META-ANALYSES" target="PRISMA 2020" />
    <edge source="PREFERRED REPORTING ITEMS FOR SYSTEMATIC REVIEWS AND META-ANALYSES" target="SYSTEMATIC REVIEW AND META-ANALYSIS" />
    <edge source="QUALITY OF REPORTING OF META-ANALYSIS" target="TRANSPARENT REPORTING OF EVALUATIONS WITH NONRANDOMIZED DESIGNS" />
    <edge source="QUALITY OF REPORTING OF META-ANALYSIS" target="META-ANALYSIS OF OBSERVATIONAL STUDIES IN EPIDEMIOLOGY" />
    <edge source="QUALITY OF REPORTING OF META-ANALYSIS" target="STRENGTHENING THE REPORTING OF OBSERVATIONAL STUDIES IN EPIDEMIOLOGY" />
    <edge source="TRANSPARENT REPORTING OF EVALUATIONS WITH NONRANDOMIZED DESIGNS" target="META-ANALYSIS OF OBSERVATIONAL STUDIES IN EPIDEMIOLOGY" />
    <edge source="TRANSPARENT REPORTING OF EVALUATIONS WITH NONRANDOMIZED DESIGNS" target="STRENGTHENING THE REPORTING OF OBSERVATIONAL STUDIES IN EPIDEMIOLOGY" />
    <edge source="META-ANALYSIS OF OBSERVATIONAL STUDIES IN EPIDEMIOLOGY" target="STRENGTHENING THE REPORTING OF OBSERVATIONAL STUDIES IN EPIDEMIOLOGY" />
    <edge source="CUMULATIVE INDEX TO NURSING AND ALLIED HEALTH LITERATURE" target="WEB OF SCIENCE" />
    <edge source="CUMULATIVE INDEX TO NURSING AND ALLIED HEALTH LITERATURE" target="EMBASE" />
    <edge source="WEB OF SCIENCE" target="EMBASE" />
    <edge source="WEB OF SCIENCE" target="PRISMA GUIDELINE" />
    <edge source="WEB OF SCIENCE" target="VIRTUAL REALITY REHABILITATION" />
    <edge source="WEB OF SCIENCE" target="CANCER PREVENTION RECOMMENDATIONS" />
    <edge source="WEB OF SCIENCE" target="TELEMEDICINE" />
    <edge source="WEB OF SCIENCE" target="FOLLICULAR LYMPHOMA" />
    <edge source="WEB OF SCIENCE" target="ARKSEY AND O'MALLEY" />
    <edge source="WEB OF SCIENCE" target="DISCRETE CHOICE EXPERIMENT" />
    <edge source="WEB OF SCIENCE" target="SUICIDE RISK FACTORS" />
    <edge source="WEB OF SCIENCE" target="SYSTEMATIC REVIEW AND META-ANALYSIS" />
    <edge source="WEB OF SCIENCE" target="FAMILY MEDICINE DEPARTMENTS" />
    <edge source="WEB OF SCIENCE" target="PRISMA-SCR" />
    <edge source="WEB OF SCIENCE" target="PRIMARY HYPERTENSION" />
    <edge source="WEB OF SCIENCE" target="SECONDARY HYPERTENSION" />
    <edge source="WEB OF SCIENCE" target="GEFAPIXANT" />
    <edge source="WEB OF SCIENCE" target="INFECTIOUS DISEASE MODELLING" />
    <edge source="WEB OF SCIENCE" target="ANTIBODY-DRUG CONJUGATES" />
    <edge source="WEB OF SCIENCE" target="ESOPHAGEAL CANCER" />
    <edge source="WEB OF SCIENCE" target="HYPERTENSION MANAGEMENT STUDY" />
    <edge source="WEB OF SCIENCE" target="VIRTUAL REALITY" />
    <edge source="WEB OF SCIENCE" target="RCT" />
    <edge source="WEB OF SCIENCE" target="CCT" />
    <edge source="WEB OF SCIENCE" target="TELEMEDICINE TECHNOLOGY" />
    <edge source="EMBASE" target="ALCOHOL USE DISORDER" />
    <edge source="EMBASE" target="CHILD AND YOUTH MULTIMORBIDITY" />
    <edge source="EMBASE" target="PRISMA GUIDELINE" />
    <edge source="EMBASE" target="CHATGPT" />
    <edge source="EMBASE" target="CLINICAL DECISION SUPPORT SYSTEMS (CDSS)" />
    <edge source="EMBASE" target="CANCER PREVENTION RECOMMENDATIONS" />
    <edge source="EMBASE" target="TELEMEDICINE" />
    <edge source="EMBASE" target="FOLLICULAR LYMPHOMA" />
    <edge source="EMBASE" target="ARKSEY AND O'MALLEY" />
    <edge source="EMBASE" target="DISCRETE CHOICE EXPERIMENT" />
    <edge source="EMBASE" target="SYSTEMATIC REVIEW AND META-ANALYSIS" />
    <edge source="EMBASE" target="FAMILY MEDICINE DEPARTMENTS" />
    <edge source="EMBASE" target="PRISMA-SCR" />
    <edge source="EMBASE" target="PRIMARY HYPERTENSION" />
    <edge source="EMBASE" target="SECONDARY HYPERTENSION" />
    <edge source="EMBASE" target="AI METHODS" />
    <edge source="EMBASE" target="GEFAPIXANT" />
    <edge source="EMBASE" target="LIVING SYSTEMATIC REVIEW" />
    <edge source="EMBASE" target="ANAPLASTIC LYMPHOMA KINASE (ALK)-MUTATED NON-SMALL CELL LUNG CANCER (NSCLC)" />
    <edge source="EMBASE" target="ORTHOSTATIC HYPOTENSION" />
    <edge source="EMBASE" target="STANDING HYPOTENSION" />
    <edge source="EMBASE" target="PRISMA" />
    <edge source="EMBASE" target="SYSTEMATIC REVIEW" />
    <edge source="EMBASE" target="ANTIBODY-DRUG CONJUGATES" />
    <edge source="EMBASE" target="CARDIOVASCULAR DISEASE (CVD)" />
    <edge source="EMBASE" target="CPAP" />
    <edge source="EMBASE" target="CINAHL" />
    <edge source="EMBASE" target="MEDRXIV" />
    <edge source="EMBASE" target="BIORXIV" />
    <edge source="EMBASE" target="ARXIV" />
    <edge source="EMBASE" target="CHD MODELLING STUDIES" />
    <edge source="EMBASE" target="MEDICATION ADMINISTRATION CLINICAL DECISION SUPPORT SYSTEMS" />
    <edge source="EMBASE" target="RCT" />
    <edge source="EMBASE" target="CCT" />
    <edge source="EMBASE" target="CANCER RESEARCH" />
    <edge source="EMBASE" target="MACHINE LEARNING IN MENTAL HEALTH RESEARCH" />
    <edge source="EMBASE" target="LONG-TERM CARE FACILITIES" />
    <edge source="EMBASE" target="TELEMEDICINE TECHNOLOGY" />
    <edge source="THIOREDOXIN-INTERACTING PROTEIN" target="CALCIUM CHANNEL BLOCKERS" />
    <edge source="VERAPAMIL" target="TYPE 1 DIABETES" />
    <edge source="VERAPAMIL" target="CLINICAL TRIAL" />
    <edge source="CLINICAL TRIAL" target="MEROPENEM" />
    <edge source="CLINICAL TRIAL" target="CROATIA" />
    <edge source="CLINICAL TRIAL" target="KAZAKHSTAN" />
    <edge source="CLINICAL TRIAL" target="RUSSIA" />
    <edge source="CLINICAL TRIAL" target="ALPELISIB" />
    <edge source="CLINICAL TRIAL" target="US FETAL THERAPY CENTERS" />
    <edge source="CLINICAL TRIAL" target="NCT03101891" />
    <edge source="CLINICAL TRIAL" target="ARDS" />
    <edge source="CLINICAL TRIAL" target="VV-ECMO" />
    <edge source="CLINICAL TRIAL" target="FRANCE" />
    <edge source="CLINICAL TRIAL" target="NON-US SUBSETS" />
    <edge source="CLINICAL TRIAL" target="PSILOCYBIN-ASSISTED GROUP THERAPY" />
    <edge source="CLINICAL TRIAL" target="COMMUNITY CANCER CENTER" />
    <edge source="CLINICAL TRIAL" target="INTENSIVE DIABETES MANAGEMENT" />
    <edge source="CLINICAL TRIAL" target="STANDARD CARE" />
    <edge source="CLINICAL TRIAL" target="NCT04233034" />
    <edge source="CLINICAL TRIAL" target="BEMPEDOIC ACID" />
    <edge source="CLINICAL TRIAL" target="STATIN-INTOLERANT PATIENTS" />
    <edge source="CLINICAL TRIAL" target="PRIMARY PREVENTION PATIENTS" />
    <edge source="CLINICAL TRIAL" target="CARDIOVASCULAR OUTCOMES" />
    <edge source="CLINICAL TRIAL" target="NCT02993406" />
    <edge source="CLINICAL TRIAL" target="ALL-CAUSE MORTALITY" />
    <edge source="ETP-ALL" target="TP53" />
    <edge source="ETP-ALL" target="STEM CELL TRANSPLANTATION" />
    <edge source="TP53" target="ACUTE MYELOID LEUKEMIA" />
    <edge source="TP53" target="LUAD" />
    <edge source="TP53" target="PD-(L)1 INHIBITORS" />
    <edge source="TP53" target="PROGRESSION-FREE SURVIVAL" />
    <edge source="TP53" target="TP53 VARIANT ALLELE FREQUENCY" />
    <edge source="STEM CELL TRANSPLANTATION" target="AHOPCA-ALL REC 2014 PROTOCOL" />
    <edge source="LMICS" target="DEVELOPMENTAL MOTOR DISORDERS REGISTRY SYSTEM" />
    <edge source="DEVELOPMENTAL MOTOR DISORDERS REGISTRY SYSTEM" target="UNIVERSITY PHYSICAL NETWORK" />
    <edge source="DEVELOPMENTAL MOTOR DISORDERS REGISTRY SYSTEM" target="ASP.NET FRAMEWORK" />
    <edge source="DEVELOPMENTAL MOTOR DISORDERS REGISTRY SYSTEM" target="VISUAL STUDIO 2018" />
    <edge source="DEVELOPMENTAL MOTOR DISORDERS REGISTRY SYSTEM" target="C# PROGRAMMING LANGUAGE" />
    <edge source="DEVELOPMENTAL MOTOR DISORDERS REGISTRY SYSTEM" target="NET 4.5 TECHNOLOGY PLATFORM" />
    <edge source="PEKING UNION MEDICAL COLLEGE HOSPITAL" target="RIDGE CLASSIFIER" />
    <edge source="PEKING UNION MEDICAL COLLEGE HOSPITAL" target="ALLGENEIC BLOOD TRANSFUSION" />
    <edge source="PEKING UNION MEDICAL COLLEGE HOSPITAL" target="CHINESE ACADEMY OF MEDICAL SCIENCES" />
    <edge source="PEKING UNION MEDICAL COLLEGE HOSPITAL" target="CORNEAL REFRACTIVE SURGERY" />
    <edge source="PEKING UNION MEDICAL COLLEGE HOSPITAL" target="FEDERATED LEARNING" />
    <edge source="PEKING UNION MEDICAL COLLEGE HOSPITAL" target="AI DIFFERENTIAL DIAGNOSIS APPLICATION" />
    <edge source="PEKING UNION MEDICAL COLLEGE HOSPITAL" target="ELECTRONIC HEALTH RECORD" />
    <edge source="RIDGE CLASSIFIER" target="ALLGENEIC BLOOD TRANSFUSION" />
    <edge source="RIDGE CLASSIFIER" target="SHAPLEY ADDITIVE EXPLANATIONS" />
    <edge source="ALLGENEIC BLOOD TRANSFUSION" target="AMERICAN SOCIETY OF ANESTHESIOLOGISTS" />
    <edge source="ALLGENEIC BLOOD TRANSFUSION" target="HIP SURGERY" />
    <edge source="SHAPLEY ADDITIVE EXPLANATIONS" target="MACHINE LEARNING ALGORITHMS" />
    <edge source="SHAPLEY ADDITIVE EXPLANATIONS" target="RANDOM SURVIVAL FOREST" />
    <edge source="SHAPLEY ADDITIVE EXPLANATIONS" target="AUTOMATED MACHINE LEARNING" />
    <edge source="SHAPLEY ADDITIVE EXPLANATIONS" target="NON-LACTATING MASTITIS" />
    <edge source="SHAPLEY ADDITIVE EXPLANATIONS" target="OBSTRUCTIVE SLEEP APNEA" />
    <edge source="SHAPLEY ADDITIVE EXPLANATIONS" target="STACKING ENSEMBLE MODEL" />
    <edge source="AMERICAN SOCIETY OF ANESTHESIOLOGISTS" target="POSTOPERATIVE INFECTIOUS COMPLICATIONS" />
    <edge source="SWEDISH PHYSICIANS" target="EVIDENCE-BASED MEDICINE" />
    <edge source="EVIDENCE-BASED MEDICINE" target="SWEDISH NURSES" />
    <edge source="EVIDENCE-BASED MEDICINE" target="SWEDISH OCCUPATIONAL THERAPISTS" />
    <edge source="EVIDENCE-BASED MEDICINE" target="SWEDISH DENTISTS" />
    <edge source="EVIDENCE-BASED MEDICINE" target="SWEDISH DENTAL HYGIENISTS" />
    <edge source="EVIDENCE-BASED MEDICINE" target="BIOMEDICAL RESEARCH" />
    <edge source="EVIDENCE-BASED MEDICINE" target="SHARED DECISION-MAKING" />
    <edge source="KOMFO ANOKYE TEACHING HOSPITAL" target="GHANA" />
    <edge source="KOMFO ANOKYE TEACHING HOSPITAL" target="ELECTRONIC HEALTH RECORDS (EHRS)" />
    <edge source="GHANA" target="ELECTRONIC HEALTH RECORDS (EHRS)" />
    <edge source="GHANA" target="SICKLE PAN AFRICA RESEARCH CONSORTIUM (SPARCO)" />
    <edge source="GHANA" target="ELECTRONIC HEALTH RECORD SYSTEMS" />
    <edge source="GHANA" target="MAY TO JUNE 2023" />
    <edge source="ELECTRONIC HEALTH RECORDS (EHRS)" target="CLINICAL DECISION SUPPORT SYSTEMS (CDSS)" />
    <edge source="ELECTRONIC HEALTH RECORDS (EHRS)" target="COVID-19 PANDEMIC" />
    <edge source="ELECTRONIC HEALTH RECORDS (EHRS)" target="COVID INTERFACE TERMINOLOGY (CIT)" />
    <edge source="KERMAN" target="USABILITY EVALUATION" />
    <edge source="KERMAN" target="CORONARY ANGIOGRAPHY" />
    <edge source="KERMAN" target="HOSPITALS IN KERMAN" />
    <edge source="KERMAN" target="IRAN" />
    <edge source="USABILITY EVALUATION" target="SHAHID BEHESHTI HOSPITAL" />
    <edge source="USABILITY EVALUATION" target="AFZALIPOUR HOSPITAL" />
    <edge source="JOHNS HOPKINS HOSPITALS" target="HUMAN PAPILLOMAVIRUS (HPV)" />
    <edge source="HUMAN PAPILLOMAVIRUS (HPV)" target="MOUNT SINAI ICAHN SCHOOL OF MEDICINE" />
    <edge source="HUMAN PAPILLOMAVIRUS (HPV)" target="ISRAEL" />
    <edge source="HPV16" target="OROPHARYNGEAL CANCER" />
    <edge source="PORTUGUESE ACADEMIC COMMUNITY" target="DIGITAL MENTAL HEALTH APPS STUDY" />
    <edge source="DIGITAL MENTAL HEALTH APPS STUDY" target="UNIVERSITY OF PORTO" />
    <edge source="DIGITAL MENTAL HEALTH APPS STUDY" target="PORTO" />
    <edge source="DIGITAL MENTAL HEALTH APPS STUDY" target="DIGITAL MENTAL HEALTH APPS" />
    <edge source="DIGITAL MENTAL HEALTH APPS STUDY" target="RESEARCHERS" />
    <edge source="RESEARCHERS" target="SYSTEMATIC REVIEWS" />
    <edge source="RESEARCHERS" target="ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (ADNI)" />
    <edge source="RESEARCHERS" target="BIOMEDICAL DATA" />
    <edge source="RESEARCHERS" target="EPIDEMIOLOGISTS" />
    <edge source="RESEARCHERS" target="REPORTING GUIDELINES" />
    <edge source="NANCY CARTWRIGHT" target="SIMULACRUM ACCOUNT" />
    <edge source="NANCY CARTWRIGHT" target="ENTITY REALISM" />
    <edge source="NANCY CARTWRIGHT" target="PHILOSOPHICAL ESSAYS" />
    <edge source="MIDWEST" target="APPALACHIA" />
    <edge source="SOUTH" target="EAST COAST" />
    <edge source="SOUTH" target="SOUTHERN BORDER" />
    <edge source="CONGRESSIONAL DISTRICT" target="LUNG CANCER" />
    <edge source="CONGRESSIONAL DISTRICT" target="FEMALE BREAST CANCER" />
    <edge source="CONGRESSIONAL DISTRICT" target="PROSTATE CANCER" />
    <edge source="LUNG CANCER" target="PLASMA METABOLITES" />
    <edge source="LUNG CANCER" target="METABOLOMICS" />
    <edge source="LUNG CANCER" target="BONE MARROW" />
    <edge source="LUNG CANCER" target="CYP3A4" />
    <edge source="LUNG CANCER" target="HRQOL" />
    <edge source="LUNG CANCER" target="SOUTH DAKOTA" />
    <edge source="LUNG CANCER" target="US PREVENTIVE SERVICES TASK FORCE (USPSTF)" />
    <edge source="LUNG CANCER" target="PLCOM2012" />
    <edge source="LUNG CANCER" target="MONUMENT HEALTH CANCER CARE INSTITUTE" />
    <edge source="LUNG CANCER" target="LUNG SCREENING RECOMMENDATION EXPANSION 2021" />
    <edge source="LUNG CANCER" target="CANCER PREVENTION RECOMMENDATIONS" />
    <edge source="LUNG CANCER" target="TSCE MODEL" />
    <edge source="LUNG CANCER" target="INDETERMINATE PULMONARY NODULES (IPNS)" />
    <edge source="LUNG CANCER" target="ORAL ANTICOAGULANT" />
    <edge source="LUNG CANCER" target="INTELLECTUAL OR DEVELOPMENTAL DISABILITIES (IDD)" />
    <edge source="LUNG CANCER" target="ATRIAL FIBRILLATION" />
    <edge source="LUNG CANCER" target="SECOND PRIMARY LUNG CANCER (SPLC)" />
    <edge source="LUNG CANCER" target="GO2 FOR LUNG CANCER" />
    <edge source="LUNG CANCER" target="CANCER SURVIVORS" />
    <edge source="LUNG CANCER" target="US MILITARY" />
    <edge source="LUNG CANCER" target="DEPRESSION" />
    <edge source="LUNG CANCER" target="ANXIETY" />
    <edge source="PROSTATE CANCER" target="BONE MARROW" />
    <edge source="PROSTATE CANCER" target="CYP3A4" />
    <edge source="PROSTATE CANCER" target="DATABASEIII" />
    <edge source="PROSTATE CANCER" target="DATABASEDII" />
    <edge source="PROSTATE CANCER" target="BLACK MEN" />
    <edge source="PROSTATE CANCER" target="WHITE MEN" />
    <edge source="PROSTATE CANCER" target="VETERANS" />
    <edge source="PROSTATE CANCER" target="PSA SCREENING" />
    <edge source="PROSTATE CANCER" target="MULTIVARIABLE LOGISTIC REGRESSION MODELS" />
    <edge source="PROSTATE CANCER" target="PROSTATE-SPECIFIC ANTIGEN" />
    <edge source="PROSTATE CANCER" target="CANCER PREVENTION RECOMMENDATIONS" />
    <edge source="PROSTATE CANCER" target="PROSTATE CANCER GRADING" />
    <edge source="PROSTATE CANCER" target="PROSTATE SUBTYPING CLASSIFIER" />
    <edge source="PROSTATE CANCER" target="LUMINAL DIFFERENTIATED" />
    <edge source="PROSTATE CANCER" target="LUMINAL PROLIFERATING" />
    <edge source="PROSTATE CANCER" target="BASAL IMMUNE" />
    <edge source="PROSTATE CANCER" target="BASAL NEUROENDOCRINE" />
    <edge source="PROSTATE CANCER" target="ORAL ANTICOAGULANT" />
    <edge source="PROSTATE CANCER" target="ATRIAL FIBRILLATION" />
    <edge source="PROSTATE CANCER" target="UROLOGISTS" />
    <edge source="PROSTATE CANCER" target="RADIATION VAULTS" />
    <edge source="PROSTATE CANCER" target="INTENSITY-MODULATED RADIATION THERAPY (IMRT)" />
    <edge source="PROSTATE CANCER" target="UROLOGY PRACTICES" />
    <edge source="PROSTATE CANCER" target="ELECTRONIC NOSE TECHNOLOGY" />
    <edge source="PROSTATE CANCER" target="NEURAL NETWORK" />
    <edge source="PROSTATE CANCER" target="INDIGENOUS PEOPLES" />
    <edge source="PROSTATE CANCER" target="ALBERTA PROSTATE CANCER RESEARCH INITIATIVE" />
    <edge source="PROSTATE CANCER" target="ANDROGEN DEPRIVATION THERAPY" />
    <edge source="PROSTATE CANCER" target="RADIATION THERAPY" />
    <edge source="PROSTATE CANCER" target="AFRICAN AMERICAN MEN" />
    <edge source="PROSTATE CANCER" target="CAUCASIANS" />
    <edge source="PROSTATE CANCER" target="CHEMOKINE ASSAY" />
    <edge source="PROSTATE CANCER" target="IMMUNOHISTOCHEMISTRY" />
    <edge source="PROSTATE CANCER" target="PRECISION ONCOLOGY" />
    <edge source="PROSTATE CANCER" target="CHARLES HUGGINS" />
    <edge source="PROSTATE CANCER" target="CANCER SURVIVORS" />
    <edge source="PROSTATE CANCER" target="US MILITARY" />
    <edge source="PROSTATE CANCER" target="DEPRESSION" />
    <edge source="PROSTATE CANCER" target="ANXIETY" />
    <edge source="PROSTATE CANCER" target="LONG-TERM CANCER SURVIVORS" />
    <edge source="PROSTATE CANCER SCREENING" target="AFRICAN AMERICAN MEN" />
    <edge source="PROSTATE CANCER SCREENING" target="NON-HISPANIC WHITE MEN" />
    <edge source="PROSTATE CANCER SCREENING" target="BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM" />
    <edge source="AFRICAN AMERICAN MEN" target="NON-HISPANIC WHITE MEN" />
    <edge source="AFRICAN AMERICAN MEN" target="SYSTEMIC RACISM" />
    <edge source="AFRICAN AMERICAN MEN" target="EDUCATION LEVEL" />
    <edge source="AFRICAN AMERICAN MEN" target="CXCL2" />
    <edge source="AFRICAN AMERICAN MEN" target="CXCL5" />
    <edge source="AFRICAN AMERICAN MEN" target="CCL23" />
    <edge source="BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM" target="CANNABIS USE" />
    <edge source="BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM" target="SIBLINGS OF CHILDHOOD CANCER SURVIVORS" />
    <edge source="BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM" target="CANCER SURVIVORS" />
    <edge source="SYSTEMIC RACISM" target="PROSTATE-SPECIFIC ANTIGEN (PSA) SCREENING" />
    <edge source="EDUCATION LEVEL" target="PROSTATE-SPECIFIC ANTIGEN (PSA) SCREENING" />
    <edge source="INCOME" target="PROSTATE-SPECIFIC ANTIGEN (PSA) SCREENING" />
    <edge source="HEPATITIS C VIRUS" target="MEDICAID" />
    <edge source="HEPATITIS C VIRUS" target="BLACK INDIVIDUALS" />
    <edge source="HEPATITIS C VIRUS" target="WHITE INDIVIDUALS" />
    <edge source="HEPATITIS C VIRUS" target="AMERICAN INDIAN/ALASKA NATIVE" />
    <edge source="HEPATITIS C VIRUS" target="HISPANIC" />
    <edge source="HEPATITIS C VIRUS" target="METAMODELS" />
    <edge source="HEPATITIS C VIRUS" target="MICROSIMULATION MODEL" />
    <edge source="MEDICAID" target="BLACK INDIVIDUALS" />
    <edge source="MEDICAID" target="WHITE INDIVIDUALS" />
    <edge source="MEDICAID" target="LOUISIANA" />
    <edge source="MEDICAID" target="AFFORDABLE CARE ACT (ACA)" />
    <edge source="MEDICAID" target="PEDIATRIC MENTAL HEALTH HOSPITALIZATIONS" />
    <edge source="BLACK INDIVIDUALS" target="STROKE" />
    <edge source="BLACK INDIVIDUALS" target="FRAMINGHAM STROKE MODEL" />
    <edge source="BLACK INDIVIDUALS" target="REGARDS SELF-REPORT MODEL" />
    <edge source="BLACK INDIVIDUALS" target="POOLED COHORT EQUATIONS" />
    <edge source="WHITE INDIVIDUALS" target="STROKE" />
    <edge source="WHITE INDIVIDUALS" target="FRAMINGHAM STROKE MODEL" />
    <edge source="WHITE INDIVIDUALS" target="REGARDS SELF-REPORT MODEL" />
    <edge source="WHITE INDIVIDUALS" target="POOLED COHORT EQUATIONS" />
    <edge source="HISPANIC" target="MATERNAL MORTALITY" />
    <edge source="HISPANIC" target="DILATED CARDIOMYOPATHY" />
    <edge source="HISPANIC" target="ENDOMETRIAL CANCER" />
    <edge source="MIMIC III" target="ASSOCIATION OF ADVANCEMENT OF MEDICAL INSTRUMENTATION" />
    <edge source="MIMIC III" target="BRITISH HYPERTENSION SOCIETY" />
    <edge source="MIMIC III" target="DEEP LEARNING MODEL" />
    <edge source="HPV" target="HPV VACCINATION" />
    <edge source="HPV" target="CERVICAL CANCER SCREENING" />
    <edge source="HPV VACCINATION" target="PSYCHOSOCIAL CONSTRUCTS" />
    <edge source="HPV VACCINATION" target="PROVIDER RECOMMENDATION" />
    <edge source="HPV VACCINATION" target="POSITIVE HPV VACCINE ATTITUDES" />
    <edge source="HPV VACCINATION" target="CERVICAL CANCER" />
    <edge source="CERVICAL CANCER SCREENING" target="COLPOSCOPY" />
    <edge source="CERVICAL CANCER SCREENING" target="HISPANIC POPULATIONS" />
    <edge source="CERVICAL CANCER SCREENING" target="NON-HISPANIC WHITE INDIVIDUALS" />
    <edge source="FLORIDA" target="DUCTAL CARCINOMA IN SITU (DCIS)" />
    <edge source="MARTINIQUE" target="CARIBBEAN BLACKS" />
    <edge source="CARIBBEAN BLACKS" target="GUADELOUPE" />
    <edge source="CARIBBEAN BLACKS" target="ENDOMETRIAL CANCER" />
    <edge source="CARIBBEAN BLACKS" target="NON-HISPANIC BLACKS (NHB)" />
    <edge source="ENDOMETRIAL CANCER" target="NON-HISPANIC BLACKS (NHB)" />
    <edge source="ENDOMETRIAL CANCER" target="NON-HISPANIC WHITES (NHW)" />
    <edge source="ENDOMETRIAL CANCER" target="CANCER PREVENTION RECOMMENDATIONS" />
    <edge source="ENDOMETRIAL CANCER" target="MMR" />
    <edge source="ENDOMETRIAL CANCER" target="MSI" />
    <edge source="ENDOMETRIAL CANCER" target="LYNCH SYNDROME" />
    <edge source="ENDOMETRIAL CANCER" target="IMMUNOHISTOCHEMISTRY" />
    <edge source="ENDOMETRIAL CANCER" target="NEXT-GENERATION SEQUENCING" />
    <edge source="ENDOMETRIAL CANCER" target="DIGITAL SPATIAL TRANSCRIPTOMICS" />
    <edge source="ENDOMETRIAL CANCER" target="MEMORIAL SLOAN KETTERING CANCER CENTER" />
    <edge source="ENDOMETRIAL CANCER" target="ASHKENAZI JEWISH" />
    <edge source="ENDOMETRIAL CANCER" target="BLACK/AFRICAN AMERICAN" />
    <edge source="ENDOMETRIAL CANCER" target="AFRICAN" />
    <edge source="ENDOMETRIAL CANCER" target="NON-HISPANIC WHITE/EUROPEAN" />
    <edge source="ENDOMETRIAL CANCER" target="ASIAN" />
    <edge source="ENDOMETRIAL CANCER" target="CANCER PREDISPOSITION GENES" />
    <edge source="NON-HISPANIC BLACKS (NHB)" target="NON-HISPANIC WHITES (NHW)" />
    <edge source="EPIRRETINAL MEMBRANE" target="STYLEGAN2" />
    <edge source="EPIRRETINAL MEMBRANE" target="HEALTHCARE CENTER" />
    <edge source="STYLEGAN2" target="EFFICIENTNETB0" />
    <edge source="EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY" target="GERMAN INSTITUTE FOR QUALITY AND EFFICIENCY IN HEALTH CARE" />
    <edge source="NORWAY" target="CRLM" />
    <edge source="NORWAY" target="LIVER TRANSPLANTATION" />
    <edge source="NORWAY" target="BREAST CANCER SCREENING PROGRAMS" />
    <edge source="NORWAY" target="GESTATIONAL DIABETES MELLITUS SCREENING" />
    <edge source="NORWAY" target="HOSPITALS" />
    <edge source="CRLM" target="LIVER TRANSPLANTATION" />
    <edge source="ERASMUS MEDICAL CENTER" target="INVASIVE LOBULAR CARCINOMA" />
    <edge source="INVASIVE LOBULAR CARCINOMA" target="CHEMOTHERAPY" />
    <edge source="INVASIVE LOBULAR CARCINOMA" target="ADJUVANT ENDOCRINE THERAPY" />
    <edge source="CHEMOTHERAPY" target="BREAST CANCER SURVIVORS" />
    <edge source="CHEMOTHERAPY" target="PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ ALL)" />
    <edge source="CHEMOTHERAPY" target="CANCER INSTITUTE" />
    <edge source="CHEMOTHERAPY" target="ACUTE MYELOID LEUKEMIA" />
    <edge source="CHEMOTHERAPY" target="NEOADJUVANT CHEMOIMMUNOTHERAPY" />
    <edge source="CHEMOTHERAPY" target="EWING SARCOMA" />
    <edge source="CHEMOTHERAPY" target="SKELETAL MUSCLE DECONDITIONING" />
    <edge source="CHEMOTHERAPY" target="EXERCISE CAPACITY" />
    <edge source="CHEMOTHERAPY" target="CHILDHOOD CANCER" />
    <edge source="CHEMOTHERAPY" target="NON-HODGKIN LYMPHOMA" />
    <edge source="INTEGRATIVE THEORETICAL FRAMEWORK" target="STUDY" />
    <edge source="STUDY" target="GOODREPORTS.ORG" />
    <edge source="STUDY" target="STEREOTACTIC BODY RADIATION THERAPY" />
    <edge source="STUDY" target="SPINAL INSTABILITY NEOPLASTIC SCORE" />
    <edge source="STUDY" target="EASTERN COOPERATIVE ONCOLOGY GROUP" />
    <edge source="STUDY" target="INSTITUTION ONE" />
    <edge source="STUDY" target="INSTITUTION TWO" />
    <edge source="STUDY" target="OVERALL SURVIVAL" />
    <edge source="CHINA" target="CAR-BASED IMMUNOTHERAPY" />
    <edge source="CHINA" target="FUDAN TINNITUS RELIEVING SYSTEM" />
    <edge source="CHINA" target="GLOBAL BURDEN OF DISEASE STUDY" />
    <edge source="CHINA" target="TOBACCO USE" />
    <edge source="CHINA" target="T-DXD" />
    <edge source="CHINA" target="NEURAL NETWORK-BASED MODEL" />
    <edge source="CHINA" target="JUPITER-02" />
    <edge source="CHINA" target="HEPATOCELLULAR CARCINOMA" />
    <edge source="CHINA" target="WOMEN WITH EPILEPSY OF CHILD-BEARING AGE ONTOLOGY" />
    <edge source="CHINA" target="NATIONAL LONGITUDINAL COHORT OF HEMATOLOGICAL DISEASES IN CHINA" />
    <edge source="CHINA" target="LARGE LANGUAGE MODELS" />
    <edge source="CHINA" target="NATIONAL FREE PRECONCEPTION HEALTH EXAMINATION PROJECT" />
    <edge source="CHINA" target="LYMPHOMA STUDY" />
    <edge source="CHINA" target="CANCER SCREENING PROGRAM IN URBAN CHINA" />
    <edge source="CHINA" target="CHINESE CHILDREN'S CANCER GROUP" />
    <edge source="CHINA" target="CHINA HEALTH AND RETIREMENT LONGITUDINAL STUDY" />
    <edge source="CHINA" target="WANG" />
    <edge source="CHINA" target="ANTIBIOTIC OVERPRESCRIPTION" />
    <edge source="CHINA" target="OCULAR FUNDUS DISEASES" />
    <edge source="CHINA" target="ASCVD" />
    <edge source="CHINA" target="CHINESE GOVERNMENT" />
    <edge source="CHINA" target="SHANGHAI" />
    <edge source="CHINA" target="BORDER REOPENING" />
    <edge source="CHINA" target="FORWARD HEAD POSTURE DETECTION STUDY" />
    <edge source="CHINA" target="SICHUAN" />
    <edge source="CHINA" target="JAPAN" />
    <edge source="CHINA" target="GASTRIC CANCER" />
    <edge source="CHINA" target="CHINESE PHARMACEUTICAL MARKET" />
    <edge source="CHINA" target="ANTICANCER DRUGS" />
    <edge source="CHINA" target="DRUG APPROVAL" />
    <edge source="CHINA" target="CHENGDU" />
    <edge source="CHINA" target="GANSU PROVINCIAL HOSPITAL" />
    <edge source="CHINA" target="BAYESIAN MODELS" />
    <edge source="CHINA" target="RISPERIDONE" />
    <edge source="CHINA" target="NATIONAL CLAIMS DATABASE" />
    <edge source="CHINA" target="CHINESE PARTICIPANTS" />
    <edge source="CHINA" target="ALFALFA APP" />
    <edge source="CAR-BASED IMMUNOTHERAPY" target="T CELLS" />
    <edge source="CAR-BASED IMMUNOTHERAPY" target="NATURAL KILLER CELLS" />
    <edge source="CAR-BASED IMMUNOTHERAPY" target="MACROPHAGES" />
    <edge source="CAR-BASED IMMUNOTHERAPY" target="TUMOR ANTIGENS" />
    <edge source="CAR-BASED IMMUNOTHERAPY" target="IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT" />
    <edge source="CAR-BASED IMMUNOTHERAPY" target="CLINICAL TRIALS" />
    <edge source="CLINICAL TRIALS" target="EGFR" />
    <edge source="CLINICAL TRIALS" target="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK" />
    <edge source="CLINICAL TRIALS" target="EE GAP" />
    <edge source="CLINICAL TRIALS" target="ANTIBODY-DRUG CONJUGATES" />
    <edge source="CLINICAL TRIALS" target="CANCER PATIENTS" />
    <edge source="CLINICAL TRIALS" target="CHINESE PHARMACEUTICAL MARKET" />
    <edge source="DESIGN SCIENCE RESEARCH METHODOLOGY" target="FUZZY CLASSIFIER ALGORITHM" />
    <edge source="DESIGN SCIENCE RESEARCH METHODOLOGY" target="INFOM&#211;VEL" />
    <edge source="FUZZY CLASSIFIER ALGORITHM" target="DECISION MODEL AND NOTATION" />
    <edge source="EMERGENCY DEPARTMENTS" target="HEALTHCARE" />
    <edge source="HEALTHCARE" target="ONCOLOGY DEPARTMENTS" />
    <edge source="HEALTHCARE" target="PSYCHIATRY DEPARTMENTS" />
    <edge source="HEALTHCARE" target="INTERNET OF THINGS" />
    <edge source="HEALTHCARE" target="PATIENT DATA" />
    <edge source="HEALTHCARE" target="COVID-19 PANDEMIC" />
    <edge source="HEALTHCARE" target="LARGE LANGUAGE MODELS" />
    <edge source="THYMIC EPITHELIAL TUMORS" target="IMMUNOTHERAPIES" />
    <edge source="THYMIC EPITHELIAL TUMORS" target="IMMUNE CHECKPOINT BLOCKADE" />
    <edge source="THYMIC EPITHELIAL TUMORS" target="THYMUS" />
    <edge source="THYMIC EPITHELIAL TUMORS" target="SURGERY" />
    <edge source="THYMIC EPITHELIAL TUMORS" target="TREATMENT" />
    <edge source="IMMUNOTHERAPIES" target="CLINICAL STUDIES" />
    <edge source="IMMUNOTHERAPIES" target="RENAL CELL CARCINOMA" />
    <edge source="IMMUNOTHERAPIES" target="ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TYROSINE KINASE INHIBITORS" />
    <edge source="IMMUNE CHECKPOINT BLOCKADE" target="THYMOMA" />
    <edge source="IMMUNE CHECKPOINT BLOCKADE" target="THYMIC CARCINOMA" />
    <edge source="IMMUNE CHECKPOINT BLOCKADE" target="IMMUNE-RELATED ADVERSE EVENTS" />
    <edge source="SURGERY" target="INTRA-ABDOMINAL CHEMOTHERAPY" />
    <edge source="SURGERY" target="ATRIAL FIBRILLATION AND FLUTTER (AF)" />
    <edge source="SURGERY" target="INDETERMINATE PULMONARY NODULES (IPNS)" />
    <edge source="SURGERY" target="IMMUNOTHERAPY" />
    <edge source="SURGERY" target="COMPLICATIONS" />
    <edge source="SURGERY" target="SABR-BRIDGE" />
    <edge source="THYMOMA" target="PARANEOPLASTIC AUTOIMMUNE DISORDERS" />
    <edge source="IMMUNE-RELATED ADVERSE EVENTS" target="IMMUNOSUPPRESSIVE AGENTS" />
    <edge source="IMMUNE-RELATED ADVERSE EVENTS" target="SYSTEMIC STEROIDS" />
    <edge source="SARCOPENIA" target="MULTIPLE MYELOMA" />
    <edge source="SARCOPENIA" target="MACHINE LEARNING-BASED CONVOLUTIONAL NEURAL NETWORK ALGORITHM" />
    <edge source="MULTIPLE MYELOMA" target="FLUORESCENCE IN SITU HYBRIDIZATION (FISH) CYTOGENETICS" />
    <edge source="MULTIPLE MYELOMA" target="TECLISTAMAB" />
    <edge source="MULTIPLE MYELOMA" target="BONE MARROW" />
    <edge source="MULTIPLE MYELOMA" target="CYTOCHROME P450 ENZYMES" />
    <edge source="MULTIPLE MYELOMA" target="AUTOLOGOUS STEM CELL TRANSPLANT" />
    <edge source="MULTIPLE MYELOMA" target="EASTERN COOPERATIVE ONCOLOGY GROUP" />
    <edge source="MULTIPLE MYELOMA" target="REVISED INTERNATIONAL STAGING SYSTEM" />
    <edge source="MULTIPLE MYELOMA" target="US-BASED COMMUNITY ONCOLOGY PRACTICES" />
    <edge source="MULTIPLE MYELOMA" target="EARLY RELAPSE" />
    <edge source="MULTIPLE MYELOMA" target="INTERNATIONAL STAGING SYSTEM" />
    <edge source="MULTIPLE MYELOMA" target="AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION" />
    <edge source="MULTIPLE MYELOMA" target="MINIMAL RESIDUAL DISEASE" />
    <edge source="MULTIPLE MYELOMA" target="VERY GOOD PARTIAL RESPONSE" />
    <edge source="MULTIPLE MYELOMA" target="COMPLETE RESPONSE" />
    <edge source="MULTIPLE MYELOMA" target="SINGLE-CENTER STUDY" />
    <edge source="MULTIPLE MYELOMA" target="HIGH-RISK CYTOGENETIC ABNORMALITIES" />
    <edge source="MULTIPLE MYELOMA" target="PROGRESSION-FREE SURVIVAL" />
    <edge source="MULTIPLE MYELOMA" target="CHINESE NATIONAL MEDICAL CENTER" />
    <edge source="MULTIPLE MYELOMA" target="MULTIPLE MYELOMA RESEARCH FOUNDATION" />
    <edge source="MULTIPLE MYELOMA" target="1Q GAIN/AMPLIFICATION" />
    <edge source="DEEP LEARNING-BASED SEGMENTATION" target="CLINICAL COMPUTED TOMOGRAPHY (CT) IMAGES" />
    <edge source="L3 VERTEBRAE" target="SKELETAL MUSCLE INDEX" />
    <edge source="LORUNDROSTAT" target="NCT05001945" />
    <edge source="NCT05001945" target="CLINICALTRIALS.GOV" />
    <edge source="CLINICALTRIALS.GOV" target="PARADISE" />
    <edge source="CLINICALTRIALS.GOV" target="NCT03866174" />
    <edge source="CLINICALTRIALS.GOV" target="NCT04437511" />
    <edge source="CLINICALTRIALS.GOV" target="NCT04593940" />
    <edge source="CLINICALTRIALS.GOV" target="AUTISM DIAGNOSIS STUDY" />
    <edge source="CLINICALTRIALS.GOV" target="ANAPLASTIC LYMPHOMA KINASE (ALK)-MUTATED NON-SMALL CELL LUNG CANCER (NSCLC)" />
    <edge source="CLINICALTRIALS.GOV" target="ACTIVITY COACH" />
    <edge source="CLINICALTRIALS.GOV" target="HY-PER TRIAL" />
    <edge source="CLINICALTRIALS.GOV" target="CPAP" />
    <edge source="CLINICALTRIALS.GOV" target="NCT02145351" />
    <edge source="CLINICALTRIALS.GOV" target="LETERMOVIR" />
    <edge source="CLINICALTRIALS.GOV" target="NCT04281784" />
    <edge source="CLINICALTRIALS.GOV" target="BREAST CANCER SCREENING STUDY" />
    <edge source="CLINICALTRIALS.GOV" target="ACTIV-6" />
    <edge source="SCIENTIFIC PRACTICE" target="EPISTEMIC ARTIFACTS" />
    <edge source="EPISTEMIC ARTIFACTS" target="WORKING SCIENTISTS" />
    <edge source="EPISTEMIC ARTIFACTS" target="SEMANTIC CONCEPTION OF MODELS" />
    <edge source="LANGUAGE&#8208;TECHNOLOGICAL ARTIFACT" target="PARSER" />
    <edge source="HIV" target="ANTIRETROVIRAL THERAPY (ART)" />
    <edge source="HIV" target="SARS-COV-2 PANDEMIC" />
    <edge source="HIV" target="MONKEYPOX VIRUS OUTBREAK" />
    <edge source="ACUTE MYOCARDIAL INFARCTION" target="CANADA" />
    <edge source="ACUTE MYOCARDIAL INFARCTION" target="ENGLAND" />
    <edge source="ACUTE MYOCARDIAL INFARCTION" target="THE NETHERLANDS" />
    <edge source="ACUTE MYOCARDIAL INFARCTION" target="TAIWAN" />
    <edge source="ACUTE MYOCARDIAL INFARCTION" target="ISRAEL" />
    <edge source="ACUTE MYOCARDIAL INFARCTION" target="STEMI" />
    <edge source="ACUTE MYOCARDIAL INFARCTION" target="NSTEMI" />
    <edge source="ACUTE MYOCARDIAL INFARCTION" target="PORTUGAL" />
    <edge source="ACUTE MYOCARDIAL INFARCTION" target="STOCHASTIC GRADIENT DESCENT" />
    <edge source="ACUTE MYOCARDIAL INFARCTION" target="SMOTE" />
    <edge source="ACUTE MYOCARDIAL INFARCTION" target="PORTUGUESE HOSPITAL" />
    <edge source="ACUTE MYOCARDIAL INFARCTION" target="HEART FAILURE" />
    <edge source="ACUTE MYOCARDIAL INFARCTION" target="COHORT 1" />
    <edge source="ACUTE MYOCARDIAL INFARCTION" target="COHORT 2" />
    <edge source="CANADA" target="NCT03269994" />
    <edge source="CANADA" target="ONTOLOGY RESEARCH" />
    <edge source="CANADA" target="DECEASED ORGAN DONATION" />
    <edge source="CANADA" target="BLACK COMMUNITIES IN CANADA" />
    <edge source="CANADA" target="POHEM:NEUROLOGICAL" />
    <edge source="CANADA" target="ALZHEIMER'S AND RELATED DEMENTIAS" />
    <edge source="CANADA" target="ONTARIO" />
    <edge source="CANADA" target="MANITOBA" />
    <edge source="CANADA" target="ADVANCED NON-SMALL CELL LUNG CANCER" />
    <edge source="CANADA" target="CANADIAN YOUTH" />
    <edge source="CANADA" target="FIND TMF" />
    <edge source="CANADA" target="IMPACT-AF" />
    <edge source="CANADA" target="BAYESIAN MODELS" />
    <edge source="CANADA" target="CANADIAN EQ-5D-5L VALUATION STUDY" />
    <edge source="CANADA" target="SABR-BRIDGE" />
    <edge source="ENGLAND" target="BREAST CANCER SCREENING PROGRAMS" />
    <edge source="ENGLAND" target="ENGLISH PRIMARY CARE DATABASE" />
    <edge source="ENGLAND" target="DEMENTIA STUDY" />
    <edge source="ENGLAND" target="NATIONAL HEALTH SERVICE (NHS)" />
    <edge source="ENGLAND" target="LONDON" />
    <edge source="ENGLAND" target="COVID-19 PANDEMIC" />
    <edge source="ENGLAND" target="NHS HEALTH CHECK PROGRAMME" />
    <edge source="THE NETHERLANDS" target="STEMI" />
    <edge source="THE NETHERLANDS" target="HAGAZIEKENHUIS" />
    <edge source="THE NETHERLANDS" target="BAYESIAN MODELS" />
    <edge source="STEMI" target="ISRAEL" />
    <edge source="TAIWAN" target="SOUTHERN TAIWAN HOSPITAL" />
    <edge source="TAIWAN" target="JUPITER-02" />
    <edge source="TAIWAN" target="TAIWAN BIOBANK" />
    <edge source="TAIWAN" target="EMERGENCY DEPARTMENT (ED)" />
    <edge source="TAIWAN" target="TERTIARY MEDICAL CENTER" />
    <edge source="ISRAEL" target="TELEMEDICINE" />
    <edge source="ISRAEL" target="ULTRA-ORTHODOX COMMUNITY" />
    <edge source="ISRAEL" target="WEB-BASED DECISION AID" />
    <edge source="ISRAEL" target="JEWISH ULTRA-ORTHODOX COMMUNITY" />
    <edge source="ISRAEL" target="BRCA1/2" />
    <edge source="ISRAEL" target="ADLIFE" />
    <edge source="ISRAEL" target="CLALIT HEALTH SERVICES" />
    <edge source="ISRAEL" target="AYA CANCER SURVIVORS" />
    <edge source="AUSTRALIAN HEALTHCARE SECTOR" target="CYBERSECURITY ATTACKS" />
    <edge source="AUSTRALIAN HEALTHCARE SECTOR" target="FOCUS GROUP" />
    <edge source="CYBERSECURITY ATTACKS" target="FOCUS GROUP" />
    <edge source="ANTI-CTLA-4 THERAPY" target="ANTI-PD-1 THERAPY" />
    <edge source="PRIVATE EQUITY" target="US HOSPITALS" />
    <edge source="PRIVATE EQUITY" target="HOSPITAL-ACQUIRED CONDITIONS" />
    <edge source="US HOSPITALS" target="MEDICARE" />
    <edge source="US HOSPITALS" target="GENOMIC MEDICINE FOR ILL NEONATES AND INFANTS (GEMINI) STUDY" />
    <edge source="US HOSPITALS" target="JUMPSTART GUIDE" />
    <edge source="US HOSPITALS" target="DARTMOUTH ATLAS PROJECT" />
    <edge source="HOSPITAL-ACQUIRED CONDITIONS" target="CENTERS FOR MEDICARE &amp; MEDICAID SERVICES" />
    <edge source="HOSPITAL-ACQUIRED CONDITIONS" target="HOSPITALIZATIONS" />
    <edge source="MEDICARE" target="21ST CENTURY CURES ACT" />
    <edge source="MEDICARE" target="MEDICARE ADVANTAGE" />
    <edge source="MEDICARE" target="ESRD" />
    <edge source="MEDICARE" target="SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS-MEDICARE" />
    <edge source="MEDICARE" target="E/M PAYMENT POLICY CHANGE" />
    <edge source="MEDICARE" target="CDK4/6 INHIBITORS" />
    <edge source="MEDICARE" target="CALIFORNIA" />
    <edge source="MEDICARE" target="NEW JERSEY" />
    <edge source="MEDICARE" target="NEW YORK" />
    <edge source="MEDICARE" target="TEXAS" />
    <edge source="MEDICARE" target="UROLOGY PRACTICES" />
    <edge source="MEDICARE" target="CANCER PREVENTION STUDY II" />
    <edge source="MEDICARE" target="HEALTH SYSTEMS" />
    <edge source="MEDICARE" target="BLACK MEN" />
    <edge source="CENTERS FOR MEDICARE &amp; MEDICAID SERVICES" target="E/M PAYMENT POLICY CHANGE" />
    <edge source="CENTERS FOR MEDICARE &amp; MEDICAID SERVICES" target="HEALTH SYSTEMS" />
    <edge source="HOSPITALIZATIONS" target="CHRONIC KIDNEY DISEASE" />
    <edge source="CAREGIVERS" target="CLINICAL TEAM MEMBERS" />
    <edge source="CAREGIVERS" target="PATIENTS" />
    <edge source="CAREGIVERS" target="CAPACITY INSTRUMENT" />
    <edge source="CAREGIVERS" target="STA PROGRAM" />
    <edge source="CAREGIVERS" target="HOMECARE NURSES" />
    <edge source="CAREGIVERS" target="OLDER ADULTS" />
    <edge source="CAREGIVERS" target="DEMENTIA PATIENTS" />
    <edge source="CAREGIVERS" target="JAPANESE TRANSCRIBED INTERVIEWS" />
    <edge source="CAREGIVERS" target="LATENT NEEDS" />
    <edge source="CAREGIVERS" target="PATIENTS-CAREGIVER DYAD DECISION-MAKING STUDY" />
    <edge source="CAREGIVERS" target="DECISION-MAKING ROLE PREFERENCES" />
    <edge source="CAREGIVERS" target="DYADIC DISCORDANCE" />
    <edge source="CAREGIVERS" target="LONGSHI SCALE" />
    <edge source="CAREGIVERS" target="WECHAT" />
    <edge source="CAREGIVERS" target="PHYSICIAN REVIEWERS" />
    <edge source="CAREGIVERS" target="OUTPATIENT MEDICATION ERRORS" />
    <edge source="CLINICAL TEAM MEMBERS" target="CAPACITY INSTRUMENT" />
    <edge source="PATIENTS" target="PANCREATECTOMY" />
    <edge source="PATIENTS" target="MEDICAL CROWDSOURCING COMPETITIONS" />
    <edge source="PATIENTS" target="ONLINE PLATFORM" />
    <edge source="PATIENTS" target="SURGEONS" />
    <edge source="PATIENTS" target="CLINICAL DECISION SUPPORT SYSTEM (CDSS)" />
    <edge source="PATIENTS" target="PHYSIOTHERAPISTS" />
    <edge source="PATIENTS" target="PATIENT DECISION AID (PTDA)" />
    <edge source="PATIENTS" target="JOINT REPLACEMENT SURGERY" />
    <edge source="PATIENTS" target="HIP AND KNEE OSTEOARTHRITIS" />
    <edge source="PATIENTS" target="DISCORDANT CARE" />
    <edge source="PATIENTS" target="DECISION AIDS" />
    <edge source="PATIENTS" target="COLORECTAL CANCER SCREENING" />
    <edge source="PATIENTS" target="TRIAL" />
    <edge source="PATIENTS" target="TECLISTAMAB" />
    <edge source="PATIENTS" target="CYTOKINE RELEASE SYNDROME" />
    <edge source="PATIENTS" target="TOCILIZUMAB" />
    <edge source="PATIENTS" target="ULTRASOUND-GUIDED RADIOFREQUENCY ABLATION" />
    <edge source="PATIENTS" target="T1A GROUP" />
    <edge source="PATIENTS" target="T1B GROUP" />
    <edge source="PATIENTS" target="OUTPATIENT SERVICE" />
    <edge source="PATIENTS" target="SENIOR DOCTORS" />
    <edge source="PATIENTS" target="ASSOCIATE SENIOR DOCTORS" />
    <edge source="PATIENTS" target="BRCA1/2 MUTATIONS" />
    <edge source="PATIENTS" target="HER2/NEU-POSITIVE BC" />
    <edge source="PATIENTS" target="EMERGENCY DEPARTMENT" />
    <edge source="PATIENTS" target="URGENT CARE" />
    <edge source="PATIENTS" target="CARE PARTNERS" />
    <edge source="PATIENTS" target="FEBRUARY 2022" />
    <edge source="PATIENTS" target="INTRAOPERATIVE BLOOD TRANSFUSION" />
    <edge source="PATIENTS" target="INTRACRANIAL ANEURYSM SURGERY" />
    <edge source="PATIENTS" target="DECISION-MAKING" />
    <edge source="PATIENTS" target="COPING" />
    <edge source="PATIENTS" target="PLEURAL EFFUSION" />
    <edge source="PATIENTS" target="ONVACT" />
    <edge source="PATIENTS" target="ONCOLOGISTS" />
    <edge source="PATIENTS" target="GENERAL PRACTITIONERS" />
    <edge source="PATIENTS" target="ENCOUNTER DECISION AIDS" />
    <edge source="PATIENTS" target="PATIENTS-CAREGIVER DYAD DECISION-MAKING STUDY" />
    <edge source="PATIENTS" target="DECISION-MAKING ROLE PREFERENCES" />
    <edge source="PATIENTS" target="DYADIC DISCORDANCE" />
    <edge source="PATIENTS" target="BLOOD GLUCOSE" />
    <edge source="PATIENTS" target="DATA-DRIVEN INDIVIDUALIZED APPROACH" />
    <edge source="PATIENTS" target="REPORTING GUIDELINES" />
    <edge source="PATIENTS" target="BREASTCHOICE" />
    <edge source="PATIENTS" target="CLINICIANS" />
    <edge source="PATIENTS" target="PHYSICIANS" />
    <edge source="PATIENTS" target="ATRIAL FIBRILLATION" />
    <edge source="PATIENTS" target="INFORMED DECISION MAKING" />
    <edge source="PATIENTS" target="INSURANCE INFORMATION DISCLOSURE" />
    <edge source="PATIENTS" target="PHARMACEUTICAL DISCOUNT DISCLOSURE" />
    <edge source="PATIENTS" target="PROVIDERS" />
    <edge source="PATIENTS" target="AI-ENABLED MEDICAL DEVICES" />
    <edge source="PATIENTS" target="SHARED DECISION-MAKING" />
    <edge source="PATIENTS" target="POSTCHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION (PCRPLND)" />
    <edge source="PATIENTS" target="DISCOVERY COHORT" />
    <edge source="PATIENTS" target="VALIDATION COHORT" />
    <edge source="PATIENTS" target="RUXOLITINIB" />
    <edge source="PATIENTS" target="RUX-MF STUDY" />
    <edge source="PATIENTS" target="ANEMIA" />
    <edge source="PATIENTS" target="UK TERTIARY CARE HOSPITALS" />
    <edge source="PATIENTS" target="REMOTE POSTOPERATIVE MONITORING" />
    <edge source="PATIENTS" target="DECISION SUPPORT TOOLS" />
    <edge source="PATIENTS" target="CHEMOPREVENTION" />
    <edge source="SWEDEN" target="SWEDISH NATIONAL MEDICAL BIRTH REGISTER" />
    <edge source="SWEDEN" target="SWEDISH CARDIOPULMONARY BIOIMAGE STUDY" />
    <edge source="SWEDEN" target="BREAST CANCER SCREENING PROGRAMS" />
    <edge source="SWEDEN" target="DIGITAL PROFESSIONALISM" />
    <edge source="SWEDEN" target="RED BLOOD CELL TRANSFUSION" />
    <edge source="SWEDEN" target="STHLM3" />
    <edge source="SWEDEN" target="PROSTATA MODEL" />
    <edge source="SWEDISH NATIONAL MEDICAL BIRTH REGISTER" target="SWEDISH CARDIOPULMONARY BIOIMAGE STUDY" />
    <edge source="PROGESTERONE RECEPTOR" target="ESTROGEN RECEPTOR" />
    <edge source="PROGESTERONE RECEPTOR" target="KI67" />
    <edge source="PROGESTERONE RECEPTOR" target="ENDOCRINE THERAPY" />
    <edge source="PROGESTERONE RECEPTOR" target="LUMINAL BREAST CANCER" />
    <edge source="PROGESTERONE RECEPTOR" target="CORE NEEDLE BIOPSIES" />
    <edge source="PROGESTERONE RECEPTOR" target="TUMOR GRADE" />
    <edge source="PROGESTERONE RECEPTOR" target="NODE STAGE" />
    <edge source="ESTROGEN RECEPTOR" target="ENDOCRINE THERAPY" />
    <edge source="ESTROGEN RECEPTOR" target="ADVANCED LOW-GRADE OVARIAN CARCINOMA" />
    <edge source="ENDOCRINE THERAPY" target="EARLY-STAGE BREAST CANCER" />
    <edge source="EVIDENCE BRIEFS FOR POLICY" target="STEP" />
    <edge source="STEP" target="EQUATOR NETWORK" />
    <edge source="STEP" target="STEP WORKING GROUP" />
    <edge source="EQUATOR NETWORK" target="STEP WORKING GROUP" />
    <edge source="EQUATOR NETWORK" target="HEALTH RESEARCH" />
    <edge source="EQUATOR NETWORK" target="UK EQUATOR CENTRE" />
    <edge source="EQUATOR NETWORK" target="YOUNG RESEARCHER PHYSICIANS" />
    <edge source="EQUATOR NETWORK" target="DAVID MOHER" />
    <edge source="CORONARY HEART DISEASE RISK-PREDICTION MODEL" target="PEOPLE LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS" />
    <edge source="CORONARY HEART DISEASE RISK-PREDICTION MODEL" target="ELECTRONIC MEDICAL RECORDS" />
    <edge source="CORONARY HEART DISEASE RISK-PREDICTION MODEL" target="LIGHT GRADIENT-BOOSTING MACHINE" />
    <edge source="ELECTRONIC MEDICAL RECORDS" target="CLINICAL PATHWAYS" />
    <edge source="ELECTRONIC MEDICAL RECORDS" target="TEMPORAL TOPIC MODEL" />
    <edge source="ELECTRONIC MEDICAL RECORDS" target="SYSTEMATIC REVIEW AND META-ANALYSIS" />
    <edge source="ELECTRONIC MEDICAL RECORDS" target="NON-SMALL CELL LUNG CANCER" />
    <edge source="ELECTRONIC MEDICAL RECORDS" target="NSCLC RISK ASSESSMENT MODEL" />
    <edge source="ELECTRONIC MEDICAL RECORDS" target="DIAGNOSTIC INTELLIGENT DECISION SUPPORT PLATFORM" />
    <edge source="ELECTRONIC MEDICAL RECORDS" target="SOFTLEXICON-GLOVE-WORD2VEC MODEL" />
    <edge source="ELECTRONIC MEDICAL RECORDS" target="INDEX SYSTEM" />
    <edge source="ELECTRONIC MEDICAL RECORDS" target="KAMPNET" />
    <edge source="ELECTRONIC MEDICAL RECORDS" target="BREAST CANCER DIAGNOSIS" />
    <edge source="ELECTRONIC MEDICAL RECORDS" target="INTRAOPERATIVE BLEEDING" />
    <edge source="ELECTRONIC MEDICAL RECORDS" target="GENERAL PRACTICES" />
    <edge source="LIGHT GRADIENT-BOOSTING MACHINE" target="SHAPLEY ADDITIVE EXPLANATION" />
    <edge source="SHAPLEY ADDITIVE EXPLANATION" target="MACHINE LEARNING PREDICTIVE MODELS" />
    <edge source="SHARED DECISION MAKING (SDM)" target="ONCOLOGIST" />
    <edge source="SHARED DECISION MAKING (SDM)" target="OPTION12" />
    <edge source="SHARED DECISION MAKING (SDM)" target="4SDM" />
    <edge source="SHARED DECISION MAKING (SDM)" target="RANDOMIZED CLINICAL TRIAL" />
    <edge source="SHARED DECISION MAKING (SDM)" target="STROKE PREVENTION TRIAL" />
    <edge source="ONCOLOGIST" target="NEUROBLASTOMA" />
    <edge source="ONCOLOGIST" target="PARENTS" />
    <edge source="ONCOLOGIST" target="PROGNOSTIC DISCLOSURE" />
    <edge source="RANDOMIZED CLINICAL TRIAL" target="GOALS-OF-CARE DISCUSSIONS" />
    <edge source="DIABETES MELLITUS" target="PEMBROLIZUMAB" />
    <edge source="DIABETES MELLITUS" target="METASTATIC NON-SMALL CELL LUNG CANCER" />
    <edge source="DIABETES MELLITUS" target="NSCLC PATIENTS" />
    <edge source="DIABETES MELLITUS" target="BEVACIZUMAB" />
    <edge source="DIABETES MELLITUS" target="HYPERTENSION" />
    <edge source="DIABETES MELLITUS" target="LONG-TERM CANCER SURVIVORS" />
    <edge source="PEMBROLIZUMAB" target="MACCABI HEALTHCARE SERVICES" />
    <edge source="PEMBROLIZUMAB" target="TERTIARY CENTER" />
    <edge source="PEMBROLIZUMAB" target="NSCLC PATIENTS" />
    <edge source="PEMBROLIZUMAB" target="IMMUNE CHECKPOINT INHIBITION" />
    <edge source="PEMBROLIZUMAB" target="FOOD AND DRUG ADMINISTRATION" />
    <edge source="PEMBROLIZUMAB" target="SELINEXOR" />
    <edge source="PEMBROLIZUMAB" target="METASTATIC NON-SMALL CELL LUNG CANCER" />
    <edge source="PEMBROLIZUMAB" target="NCT02419495" />
    <edge source="PEMBROLIZUMAB" target="OCTREOTIDE" />
    <edge source="METASTATIC NON-SMALL CELL LUNG CANCER" target="SELINEXOR" />
    <edge source="METASTATIC NON-SMALL CELL LUNG CANCER" target="NCT02419495" />
    <edge source="METASTATIC NON-SMALL CELL LUNG CANCER" target="ANTI-PD-1/PD-L1 THERAPY" />
    <edge source="METASTATIC NON-SMALL CELL LUNG CANCER" target="NUCLEAR EXPORT PROTEINS" />
    <edge source="VIRTUAL REALITY TO OBSERVE ONCOLOGY DATA MODELS (VROOM)" target="VIRTUAL REALITY (VR)" />
    <edge source="VIRTUAL REALITY TO OBSERVE ONCOLOGY DATA MODELS (VROOM)" target="CLINICIANS" />
    <edge source="VIRTUAL REALITY TO OBSERVE ONCOLOGY DATA MODELS (VROOM)" target="GENETIC SCIENTISTS" />
    <edge source="VIRTUAL REALITY TO OBSERVE ONCOLOGY DATA MODELS (VROOM)" target="BIOINFORMATICS" />
    <edge source="VIRTUAL REALITY TO OBSERVE ONCOLOGY DATA MODELS (VROOM)" target="DATA ANALYSTS" />
    <edge source="CLINICIANS" target="GENETIC SCIENTISTS" />
    <edge source="CLINICIANS" target="NATIONAL CANCER CONTROL PLANS" />
    <edge source="CLINICIANS" target="RA PRO DASHBOARD" />
    <edge source="CLINICIANS" target="RA PATIENTS" />
    <edge source="CLINICIANS" target="CANCER PATIENTS" />
    <edge source="CLINICIANS" target="CANCER SURVIVORS" />
    <edge source="CLINICIANS" target="PATIENT DECISION AID (PTDA)" />
    <edge source="CLINICIANS" target="JOINT REPLACEMENT SURGERY" />
    <edge source="CLINICIANS" target="ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (ADNI)" />
    <edge source="CLINICIANS" target="BIOMEDICAL DATA" />
    <edge source="CLINICIANS" target="TUFTS MEDICINE HEALTHCARE SYSTEM" />
    <edge source="CLINICIANS" target="STUDY 1644" />
    <edge source="CLINICIANS" target="BREASTCHOICE" />
    <edge source="CLINICIANS" target="LARGE LANGUAGE MODELS" />
    <edge source="CLINICIANS" target="ETHICAL CONCERNS" />
    <edge source="CLINICIANS" target="HOSPITAL FOR TROPICAL DISEASES" />
    <edge source="CLINICIANS" target="DIGITAL CLINICAL DECISION-SUPPORT SYSTEMS (CDSS)" />
    <edge source="BIOINFORMATICS" target="DATA ANALYSTS" />
    <edge source="BIOINFORMATICS" target="OPEN BIOMEDICAL ONTOLOGIES" />
    <edge source="BIOINFORMATICS" target="HEALTHCARE BIG DATA" />
    <edge source="BIOINFORMATICS" target="DEEP NEURAL NETWORKS" />
    <edge source="PLWH" target="NIVOLOMAB" />
    <edge source="PLWH" target="KAPOSI SARCOMA" />
    <edge source="PLWH" target="CLINICALTRIALS.GOV IDENTIFIER: NCT02408861" />
    <edge source="NIVOLOMAB" target="KAPOSI SARCOMA" />
    <edge source="NIVOLOMAB" target="CHECKMATE-017" />
    <edge source="NIVOLOMAB" target="CHECKMATE-057" />
    <edge source="NIVOLOMAB" target="PRIMARY CNS LYMPHOMA" />
    <edge source="SMILOW CANCER HOSPITAL" target="ONCOLOGY HOSPITALISTS" />
    <edge source="SMILOW CANCER HOSPITAL" target="ONCOLOGISTS" />
    <edge source="ONCOLOGY HOSPITALISTS" target="INPATIENT HOSPICE" />
    <edge source="ONCOLOGY HOSPITALISTS" target="ONCOLOGISTS" />
    <edge source="ONCOLOGISTS" target="ONVACT" />
    <edge source="HOSPICE TRANSITIONS" target="ADVANCED CANCER" />
    <edge source="HOSPICE TRANSITIONS" target="GOALS OF CARE DISCUSSIONS" />
    <edge source="ADVANCED CANCER" target="GOALS OF CARE DISCUSSIONS" />
    <edge source="ADVANCED CANCER" target="SCREENING ULTRASOUND" />
    <edge source="ADVANCED CANCER" target="SCREENING MAMMOGRAM" />
    <edge source="NATIONAL CANCER CONTROL PLANS" target="ZIMBABWE" />
    <edge source="NATIONAL CANCER CONTROL PLANS" target="ZAMBIA" />
    <edge source="NATIONAL CANCER CONTROL PLANS" target="UGANDA" />
    <edge source="NATIONAL CANCER CONTROL PLANS" target="PUBLIC HEALTH ADVOCATES" />
    <edge source="ZIMBABWE" target="ZAMBIA" />
    <edge source="ZIMBABWE" target="UGANDA" />
    <edge source="ZAMBIA" target="UGANDA" />
    <edge source="UGANDA" target="SICKLE PAN AFRICA RESEARCH CONSORTIUM (SPARCO)" />
    <edge source="UGANDA" target="MULAGO NATIONAL REFERRAL HOSPITAL" />
    <edge source="UGANDA" target="JINJA REGIONAL REFERRAL HOSPITAL" />
    <edge source="UGANDA" target="MBALE REGIONAL REFERRAL HOSPITAL" />
    <edge source="UGANDA" target="LIRA REGIONAL REFERRAL HOSPITAL" />
    <edge source="UGANDA" target="FAMILY PLANNING SELF-CARE INTERVENTIONS" />
    <edge source="UGANDA" target="COVID-19 PANDEMIC" />
    <edge source="UGANDA" target="MINISTRY OF HEALTH" />
    <edge source="UGANDA" target="TRADITIONAL MEDIA" />
    <edge source="UGANDA" target="HEALTHCARE PROVIDERS" />
    <edge source="UGANDA" target="SCIENTIFIC ARTICLES" />
    <edge source="UGANDA" target="NORTHERN UGANDA" />
    <edge source="UGANDA" target="INSTITUTION REVIEW BOARD" />
    <edge source="UGANDA" target="STATA" />
    <edge source="UGANDA" target="PEARSON CHI-SQUARE" />
    <edge source="UGANDA" target="FISHER&#8217;S EXACT TEST" />
    <edge source="OBJECTIVES" target="METHODS" />
    <edge source="METHODS" target="INFORMATION SOURCES" />
    <edge source="INFORMATION SOURCES" target="SEARCH" />
    <edge source="SEARCH" target="SELECTION OF SOURCES OF EVIDENCE" />
    <edge source="SELECTION OF SOURCES OF EVIDENCE" target="DATA CHARTING PROCESS" />
    <edge source="DATA CHARTING PROCESS" target="SYNTHESIS OF RESULTS" />
    <edge source="SYNTHESIS OF RESULTS" target="DISCUSSION" />
    <edge source="DISCUSSION" target="LIMITATIONS" />
    <edge source="DISCUSSION" target="CONCLUSIONS" />
    <edge source="AUCKLAND" target="NEW ZEALAND" />
    <edge source="AUCKLAND" target="PUBLIC HOSPITALS IN AUCKLAND" />
    <edge source="NEW ZEALAND" target="CVD EVENTS" />
    <edge source="NEW ZEALAND" target="DIABETES" />
    <edge source="NEW ZEALAND" target="SURVIVORSHIP CARE PLANS" />
    <edge source="WORLD HEALTH ORGANIZATION" target="SEVERE ACUTE RESPIRATORY INFECTION" />
    <edge source="WORLD HEALTH ORGANIZATION" target="STEPWISE APPROACH TO NCD RISK FACTOR SURVEILLANCE" />
    <edge source="WORLD HEALTH ORGANIZATION" target="57 COUNTRIES" />
    <edge source="WORLD HEALTH ORGANIZATION" target="COVID-19 PANDEMIC" />
    <edge source="WORLD HEALTH ORGANIZATION" target="NCD PREVENTION AND MANAGEMENT INTERVENTIONS" />
    <edge source="WORLD HEALTH ORGANIZATION" target="EASTERN SUB-SAHARAN AFRICA" />
    <edge source="WORLD HEALTH ORGANIZATION" target="SOUTH-EAST ASIA" />
    <edge source="WORLD HEALTH ORGANIZATION" target="INTERNATIONAL LOW GRADE GLIOMA REGISTRY" />
    <edge source="WORLD HEALTH ORGANIZATION" target="CERVICAL CANCER" />
    <edge source="WORLD HEALTH ORGANIZATION" target="WHO DIRECTOR-GENERAL" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEMS (CDSS)" target="AI2" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEMS (CDSS)" target="COMMUNITY MENTAL HEALTH CLINIC" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEMS (CDSS)" target="CINAHL" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEMS (CDSS)" target="COCHRANE LIBRARY" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEMS (CDSS)" target="EVIDENCE PROJECT" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEMS (CDSS)" target="PROSPERO" />
    <edge source="NON-ADHERENCE EVENTS" target="FOLLOW-UP" />
    <edge source="FOLLOW-UP" target="BASELINE" />
    <edge source="ELECTRONIC ASTHMA MANAGEMENT SYSTEM" target="THEORETICAL DOMAINS FRAMEWORK" />
    <edge source="ELECTRONIC ASTHMA MANAGEMENT SYSTEM" target="GUIDELINE IMPLEMENTATION WITH DECISION SUPPORT" />
    <edge source="ELECTRONIC ASTHMA MANAGEMENT SYSTEM" target="TORONTO" />
    <edge source="THEORETICAL DOMAINS FRAMEWORK" target="GUIDELINE IMPLEMENTATION WITH DECISION SUPPORT" />
    <edge source="TORONTO" target="CLINICAL TEXT CORPUS" />
    <edge source="MIRVETUXIMAB" target="PLATINUM-RESISTANT OVARIAN CANCER" />
    <edge source="PLATINUM-RESISTANT OVARIAN CANCER" target="POLY(ADP-RIBOSE) POLYMERASE INHIBITOR" />
    <edge source="POLY(ADP-RIBOSE) POLYMERASE INHIBITOR" target="PLATINUM-SENSITIVE OVARIAN CARCINOMA" />
    <edge source="POLY(ADP-RIBOSE) POLYMERASE INHIBITOR" target="CARCINOSARCOMA" />
    <edge source="POLY(ADP-RIBOSE) POLYMERASE INHIBITOR" target="CLEAR CELL CARCINOMA" />
    <edge source="MICROSIMULATION MODELS" target="HEALTH POLICY" />
    <edge source="MICROSIMULATION MODELS" target="COLORECTAL CANCER SCREENING" />
    <edge source="MICROSIMULATION MODELS" target="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK" />
    <edge source="MICROSIMULATION MODELS" target="UNITED KINGDOM FLEXIBLE SIGMOIDOSCOPY SCREENING TRIAL" />
    <edge source="FAMILIAL HYPERCHOLESTEROLEMIA" target="MYOCARDIAL INFARCTION" />
    <edge source="FAMILIAL HYPERCHOLESTEROLEMIA" target="STROKE" />
    <edge source="FAMILIAL HYPERCHOLESTEROLEMIA" target="STATINS" />
    <edge source="FAMILIAL HYPERCHOLESTEROLEMIA" target="RCT" />
    <edge source="FAMILIAL HYPERCHOLESTEROLEMIA" target="ENGLISH-LANGUAGE RANDOMIZED CLINICAL TRIALS" />
    <edge source="FAMILIAL HYPERCHOLESTEROLEMIA" target="PEDIATRIC DYSLIPIDEMIA" />
    <edge source="MYOCARDIAL INFARCTION" target="MULTIFACTORIAL DYSLIPIDEMIA" />
    <edge source="MYOCARDIAL INFARCTION" target="CARDIOVASCULAR DISEASE (CVD)" />
    <edge source="MYOCARDIAL INFARCTION" target="CARDIOVASCULAR OUTCOMES" />
    <edge source="STROKE" target="MULTIFACTORIAL DYSLIPIDEMIA" />
    <edge source="STROKE" target="VIRTUAL REALITY REHABILITATION" />
    <edge source="STROKE" target="ATRIAL FIBRILLATION" />
    <edge source="STROKE" target="GERMANY" />
    <edge source="STROKE" target="CARDIOVASCULAR DISEASE (CVD)" />
    <edge source="STROKE" target="FRAMINGHAM OFFSPRING" />
    <edge source="STROKE" target="ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC)" />
    <edge source="STROKE" target="MULTI-ETHNIC STUDY FOR ATHEROSCLEROSIS (MESA)" />
    <edge source="STROKE" target="REASONS FOR GEOGRAPHICAL AND RACIAL DIFFERENCES IN STROKE (REGARDS)" />
    <edge source="STROKE" target="FRAMINGHAM STROKE MODEL" />
    <edge source="STROKE" target="REGARDS SELF-REPORT MODEL" />
    <edge source="STROKE" target="POOLED COHORT EQUATIONS" />
    <edge source="STROKE" target="CARDIOVASCULAR OUTCOMES" />
    <edge source="MULTIFACTORIAL DYSLIPIDEMIA" target="RCT" />
    <edge source="MULTIFACTORIAL DYSLIPIDEMIA" target="US COHORT STUDIES" />
    <edge source="MULTIFACTORIAL DYSLIPIDEMIA" target="BEHAVIORAL COUNSELING TRIALS" />
    <edge source="COVID-19 PANDEMIC" target="HEALTHCARE ESTABLISHMENT" />
    <edge source="COVID-19 PANDEMIC" target="SARS-COV-2 VACCINES" />
    <edge source="COVID-19 PANDEMIC" target="UK" />
    <edge source="COVID-19 PANDEMIC" target="SARS-COV-2" />
    <edge source="COVID-19 PANDEMIC" target="INFECTIOUS DISEASE MODELLING" />
    <edge source="COVID-19 PANDEMIC" target="INFLUENZA VIRUS INFECTIONS" />
    <edge source="COVID-19 PANDEMIC" target="U.S. COVID-19 SCENARIO MODELING HUB" />
    <edge source="COVID-19 PANDEMIC" target="ICU" />
    <edge source="COVID-19 PANDEMIC" target="FLANDERS" />
    <edge source="COVID-19 PANDEMIC" target="TELEMEDICINE" />
    <edge source="COVID-19 PANDEMIC" target="PUBLIC HEALTH" />
    <edge source="COVID-19 PANDEMIC" target="INFECTIOUS DISEASE" />
    <edge source="COVID-19 PANDEMIC" target="POLICY MODELLING" />
    <edge source="COVID-19 PANDEMIC" target="FAMILY MEDICINE DEPARTMENTS" />
    <edge source="COVID-19 PANDEMIC" target="BLACK WOMEN" />
    <edge source="COVID-19 PANDEMIC" target="CANCER CLINICAL TRIAL" />
    <edge source="COVID-19 PANDEMIC" target="INFECTIOUS DISEASE MODELS" />
    <edge source="COVID-19 PANDEMIC" target="ADVANCE DIRECTIVE" />
    <edge source="COVID-19 PANDEMIC" target="ADVANCE DECISION TO REFUSE TREATMENT (ADRT)" />
    <edge source="COVID-19 PANDEMIC" target="POLICY MAKERS" />
    <edge source="COVID-19 PANDEMIC" target="ORGANIZATIONS THAT DESIGN TEMPLATES FOR ADVANCE CARE PLANNING" />
    <edge source="COVID-19 PANDEMIC" target="MEDICATION DELIVERY SYSTEM" />
    <edge source="COVID-19 PANDEMIC" target="MYCHART" />
    <edge source="COVID-19 PANDEMIC" target="REHAB-AMD" />
    <edge source="COVID-19 PANDEMIC" target="LIVING SYSTEMATIC REVIEWS" />
    <edge source="COVID-19 PANDEMIC" target="TANYA OBAT" />
    <edge source="COVID-19 PANDEMIC" target="GLOBAL BURDEN OF DISEASES, INJURIES, AND RISK FACTORS STUDY (GBD)" />
    <edge source="COVID-19 PANDEMIC" target="FOOD AND DRUG ADMINISTRATION" />
    <edge source="COVID-19 PANDEMIC" target="MONOCLONAL ANTIBODIES" />
    <edge source="COVID-19 PANDEMIC" target="PUBLIC HEALTH CRISIS RESPONSES" />
    <edge source="COVID-19 PANDEMIC" target="CRC SCREENING" />
    <edge source="COVID-19 PANDEMIC" target="PSYCHOSIS-SPECTRUM DISORDER" />
    <edge source="COVID-19 PANDEMIC" target="BIPOLAR AFFECTIVE DISORDER" />
    <edge source="COVID-19 PANDEMIC" target="COCHRANE-Q ANALYSIS" />
    <edge source="COVID-19 PANDEMIC" target="DIGITAL EXCLUSION" />
    <edge source="COVID-19 PANDEMIC" target="DIGITAL HEALTH LITERACY" />
    <edge source="COVID-19 PANDEMIC" target="LIVING SYSTEMATIC REVIEW" />
    <edge source="COVID-19 PANDEMIC" target="UK TERTIARY CARE HOSPITALS" />
    <edge source="COVID-19 PANDEMIC" target="NURSE-LED REMOTE POSTOPERATIVE MONITORING" />
    <edge source="COVID-19 PANDEMIC" target="DIGITAL HEALTH" />
    <edge source="COVID-19 PANDEMIC" target="TELEMEDICINE TECHNOLOGY" />
    <edge source="COVID INTERFACE TERMINOLOGY (CIT)" target="SNOMED CT" />
    <edge source="COVID INTERFACE TERMINOLOGY (CIT)" target="CORONAVIRUS INFECTIOUS DISEASE ONTOLOGY (CIDO)" />
    <edge source="SNOMED CT" target="PEGASUS" />
    <edge source="SNOMED CT" target="UNIFIED MEDICAL LANGUAGE SYSTEM" />
    <edge source="SNOMED CT" target="MARCH 2021 US EDITION OF SNOMED CT" />
    <edge source="SNOMED CT" target="COVID INTERFACE TERMINOLOGY" />
    <edge source="SNOMED CT" target="RESOURCE DESCRIPTION FRAMEWORK" />
    <edge source="MERATIVE MARKETSCAN" target="METASTATIC PROSTATE CANCER" />
    <edge source="METASTATIC PROSTATE CANCER" target="DOCETAXEL" />
    <edge source="METASTATIC PROSTATE CANCER" target="ABIRATERONE ACETATE" />
    <edge source="BELANTAMAB MAFODOTIN" target="DREAMM-2" />
    <edge source="DOCETAXEL" target="ABIRATERONE ACETATE" />
    <edge source="DOCETAXEL" target="LUMINAL PROLIFERATING" />
    <edge source="DOCETAXEL" target="METASTATIC CASTRATE SENSITIVE PROSTATE CANCER" />
    <edge source="DOCETAXEL" target="CHECKMATE-017" />
    <edge source="DOCETAXEL" target="CHECKMATE-057" />
    <edge source="ABIRATERONE ACETATE" target="STAMPEDE" />
    <edge source="MICROSIMULATION FRAMEWORK" target="DISCRETE-TIME STATE TRANSITION MODEL" />
    <edge source="ANTIRETROVIRAL THERAPY (ART)" target="VIROLOGICAL FAILURE" />
    <edge source="CABOTEGRAVIR" target="RILPIVIRINE" />
    <edge source="PREDIABETES" target="DIABETES" />
    <edge source="PREDIABETES" target="CARDIOVASCULAR EVENTS" />
    <edge source="PREDIABETES" target="MORTALITY" />
    <edge source="PREDIABETES" target="METFORMIN" />
    <edge source="PREDIABETES" target="LIFESTYLE MODIFICATION" />
    <edge source="DIABETES" target="CVD EVENTS" />
    <edge source="DIABETES" target="MEXICAN AMERICAN ADULTS" />
    <edge source="DIABETES" target="MEALS" />
    <edge source="DIABETES" target="EXERCISES" />
    <edge source="DIABETES" target="ARTIFICIAL BETA-CELL SYSTEMS" />
    <edge source="DIABETES" target="DUAL ENERGY X-RAY ABSORPTIOMETRY" />
    <edge source="DIABETES" target="RECURSIVE FEATURE ELIMINATION" />
    <edge source="DIABETES" target="SHAP" />
    <edge source="DIABETES" target="OVERALL SURVIVAL" />
    <edge source="DIABETES" target="DISEASE-FREE SURVIVAL" />
    <edge source="DIABETES" target="CANCER-SPECIFIC SURVIVAL" />
    <edge source="DIABETES" target="CURATIVE CRC RESECTION" />
    <edge source="DIABETES" target="TIME TO RECURRENCE" />
    <edge source="CARDIOVASCULAR EVENTS" target="MAJOR DEPRESSIVE DISORDER" />
    <edge source="CARDIOVASCULAR EVENTS" target="WEEKEND WARRIOR" />
    <edge source="CARDIOVASCULAR EVENTS" target="ACTIVE REGULAR" />
    <edge source="CARDIOVASCULAR EVENTS" target="INACTIVE" />
    <edge source="MORTALITY" target="TIME FROM DIAGNOSIS TO TREATMENT" />
    <edge source="MORTALITY" target="MAJOR DEPRESSIVE DISORDER" />
    <edge source="MORTALITY" target="REBOA" />
    <edge source="MORTALITY" target="STANDARD CARE" />
    <edge source="MORTALITY" target="CANCER SCREENING" />
    <edge source="INTERNATIONAL REGISTRY FOR MEN WITH ADVANCED PROSTATE CANCER (IRONMAN)" target="CANCER JOURNAL" />
    <edge source="INTERNATIONAL REGISTRY FOR MEN WITH ADVANCED PROSTATE CANCER (IRONMAN)" target="BLACK MEN" />
    <edge source="INTERNATIONAL REGISTRY FOR MEN WITH ADVANCED PROSTATE CANCER (IRONMAN)" target="WHITE MEN" />
    <edge source="BLACK MEN" target="WHITE MEN" />
    <edge source="BLACK MEN" target="PSA SCREENING" />
    <edge source="BLACK MEN" target="FIRST PROSTATE BIOPSY" />
    <edge source="BLACK MEN" target="SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS-MEDICARE" />
    <edge source="BLACK MEN" target="MINORITY-SERVING HOSPITAL" />
    <edge source="BLACK MEN" target="SURGEON" />
    <edge source="BLACK MEN" target="FACILITY" />
    <edge source="WHITE MEN" target="FIRST PROSTATE BIOPSY" />
    <edge source="WHITE MEN" target="AFRICAN AMERICAN/BLACK MEN" />
    <edge source="COMPUTATIONAL SCIENCE" target="COMPUTER SIMULATIONS" />
    <edge source="COMPUTATIONAL SCIENCE" target="PHILOSOPHICAL ACCOUNT" />
    <edge source="COMPUTATIONAL SCIENCE" target="SCIENTIFIC INSTRUMENTS" />
    <edge source="COMPUTATIONAL SCIENCE" target="EMPIRICISM" />
    <edge source="COMPUTATIONAL SCIENCE" target="EPISTEMOLOGY" />
    <edge source="COMPUTATIONAL SCIENCE" target="SELECTIVE REALISM" />
    <edge source="COMPUTATIONAL SCIENCE" target="NEW EMPIRICISM" />
    <edge source="COMPUTATIONAL SCIENCE" target="PROPERTIES" />
    <edge source="COMPUTER SIMULATIONS" target="PHILOSOPHY OF SCIENCE" />
    <edge source="COMPUTER SIMULATIONS" target="PHILOSOPHERS OF SCIENCE" />
    <edge source="COMPUTER SIMULATIONS" target="SCIENTIFIC THEORIES" />
    <edge source="SCIENTIFIC METHODS" target="COMPUTATIONAL TEMPLATES" />
    <edge source="SCIENTIFIC METHODS" target="TECHNOLOGY" />
    <edge source="COMPUTATIONAL TEMPLATES" target="TECHNOLOGY" />
    <edge source="DRUG-DRUG SIMILARITY" target="JACCARD SIMILARITY MEASURE" />
    <edge source="DRUG-DRUG SIMILARITY" target="COMPUTATIONAL METHOD" />
    <edge source="DRUG-DRUG SIMILARITY" target="DRUG THERAPY SIMILARITY" />
    <edge source="DRUG-DRUG SIMILARITY" target="PATIENT SIMILARITY" />
    <edge source="DRUG-DRUG SIMILARITY" target="TREATMENT MODALITIES" />
    <edge source="CLARKE ET AL." target="DEFENSIVE INFORMATION PROCESSING" />
    <edge source="BREAST CANCER SCREENING PROGRAMS" target="LOGISTIC REGRESSION MODELS" />
    <edge source="LOGISTIC REGRESSION MODELS" target="MRI-TARGETED PROSTATE BIOPSY" />
    <edge source="LOGISTIC REGRESSION MODELS" target="SYSTEMATIC BIOPSY" />
    <edge source="LOGISTIC REGRESSION MODELS" target="ADVERSE PATHOLOGY" />
    <edge source="PUBLIC HEALTH POLICY MAKERS" target="MEXICO" />
    <edge source="MEXICO" target="PUBLIC HEALTH LEADERS" />
    <edge source="MEXICO" target="HEALTHCARE PROVIDERS" />
    <edge source="MEXICO" target="IMMIGRANTS" />
    <edge source="MEXICO" target="TECSALUD HOSPITALS MONTERREY" />
    <edge source="MEXICO" target="MONTERREY" />
    <edge source="MEXICO" target="GERMANY" />
    <edge source="MEXICO" target="MEXICAN AMERICANS" />
    <edge source="MEXICO" target="MEXICO SIMSMOKE" />
    <edge source="MEXICO" target="TOBACCO CONTROL POLICIES" />
    <edge source="MEXICO" target="NONDALY SMOKING" />
    <edge source="MEXICO" target="DAILY SMOKING" />
    <edge source="HEALTHCARE PROVIDERS" target="RAPID REVIEWS" />
    <edge source="HEALTHCARE PROVIDERS" target="IMPLEMENTATION INTERVENTIONS" />
    <edge source="HEALTHCARE PROVIDERS" target="HEALTH SYSTEM" />
    <edge source="HEALTHCARE PROVIDERS" target="AI-ENABLED MEDICAL DEVICES" />
    <edge source="COLOSENSE" target="CRC-PREVENT" />
    <edge source="DALIAN" target="LIAONING PROVINCE" />
    <edge source="LIAONING PROVINCE" target="PREMATURE CORONARY ARTERY DISEASE" />
    <edge source="YOUTH HEALTH REPORT SYSTEM" target="YOUTH HEALTH CLINIC" />
    <edge source="YOUTH HEALTH REPORT SYSTEM" target="HEALTHCARE PROFESSIONALS" />
    <edge source="YOUTH HEALTH REPORT SYSTEM" target="YOUTH PARTICIPANTS" />
    <edge source="YOUTH HEALTH CLINIC" target="HEALTHCARE PROFESSIONALS" />
    <edge source="YOUTH HEALTH CLINIC" target="YOUTH PARTICIPANTS" />
    <edge source="HEALTHCARE PROFESSIONALS" target="INFORMATION AND COMMUNICATION TECHNOLOGIES (ICTS)" />
    <edge source="HEALTHCARE PROFESSIONALS" target="VIRTUAL REALITY DEMENTIA DIAGNOSIS TOOLS" />
    <edge source="HEALTHCARE PROFESSIONALS" target="EBM" />
    <edge source="HEALTHCARE PROFESSIONALS" target="CAPACITY-BUILDING EBM TRAINING" />
    <edge source="HEALTHCARE PROFESSIONALS" target="TECHNICAL SUPPORT" />
    <edge source="HEALTHCARE PROFESSIONALS" target="INTERNET ACCESS" />
    <edge source="HEALTHCARE PROFESSIONALS" target="UK TERTIARY CARE HOSPITALS" />
    <edge source="HEALTHCARE PROFESSIONALS" target="REMOTE POSTOPERATIVE MONITORING" />
    <edge source="AUTISM SPECTRUM DISORDER" target="AUTISM DIAGNOSTIC OBSERVATION SCHEDULE-SECOND EDITION" />
    <edge source="AUTISM SPECTRUM DISORDER" target="AUTISM DIAGNOSTIC INTERVIEW" />
    <edge source="AUTISM SPECTRUM DISORDER" target="EARLY START DENVER MODEL" />
    <edge source="AUTISM SPECTRUM DISORDER" target="RISPERIDONE" />
    <edge source="AUTISM SPECTRUM DISORDER" target="ARIPIPRAZOLE" />
    <edge source="RISPERIDONE" target="GENERALIZED LINEAR MODEL" />
    <edge source="RISPERIDONE" target="SUPERLEARNER" />
    <edge source="RISPERIDONE" target="CHILDREN AND TEENAGERS" />
    <edge source="RISPERIDONE" target="MANIA" />
    <edge source="ARIPIPRAZOLE" target="BIPOLAR DISORDER" />
    <edge source="CHATGPT" target="HEALTH CARE SYSTEM" />
    <edge source="CHATGPT" target="MEDICAL ONCOLOGY" />
    <edge source="CHATGPT" target="OPENAI" />
    <edge source="CHATGPT" target="MICROSOFT BING AI" />
    <edge source="CHATGPT" target="PEYRONIE DISEASE" />
    <edge source="CHATGPT" target="OXFORD CENTRE FOR EVIDENCE-BASED MEDICINE" />
    <edge source="CHATGPT" target="CINAHL" />
    <edge source="CHATGPT" target="MEDRXIV" />
    <edge source="CHATGPT" target="BIORXIV" />
    <edge source="CHATGPT" target="ARXIV" />
    <edge source="CHATGPT" target="METEOR" />
    <edge source="CHATGPT" target="G-EVAL" />
    <edge source="CHATGPT" target="MULTIMEDQA" />
    <edge source="CHATGPT" target="GPT-3" />
    <edge source="CHATGPT" target="BART" />
    <edge source="CHATGPT" target="GPT-3.5" />
    <edge source="CHATGPT" target="BERTSCORE" />
    <edge source="CHATGPT" target="CBCT" />
    <edge source="CHATGPT" target="DENTAL DISEASES" />
    <edge source="CHATGPT" target="NEOPLASTIC/CYSTIC DISEASES" />
    <edge source="CHATGPT" target="EXPERT REVIEWERS" />
    <edge source="CHATGPT" target="PATHOLOGICAL DIAGNOSIS" />
    <edge source="CHATGPT" target="GPT-4.0" />
    <edge source="HEALTH CARE SYSTEM" target="PUBLIC HEALTH SURVEILLANCE" />
    <edge source="MEDICAL ONCOLOGY" target="BREAST CARE" />
    <edge source="J. NIEHANS" target="MODEL-BUILDING ERA" />
    <edge source="MODEL-BUILDING ERA" target="SIMULATION ERA" />
    <edge source="SIMULATION ERA" target="NUCLEAR PHYSICS" />
    <edge source="PAINKILLERS STUDY" target="PARTICIPANTS" />
    <edge source="PAINKILLERS STUDY" target="GRAPHICAL REPRESENTATION" />
    <edge source="PAINKILLERS STUDY" target="NUMERICAL REPRESENTATION" />
    <edge source="PAINKILLERS STUDY" target="EXPERIMENT" />
    <edge source="PAINKILLERS STUDY" target="UNDERGRADUATE STUDENTS" />
    <edge source="PARTICIPANTS" target="GRAPHICAL REPRESENTATION" />
    <edge source="PARTICIPANTS" target="NUMERICAL REPRESENTATION" />
    <edge source="PARTICIPANTS" target="DIETARY SODIUM STUDY" />
    <edge source="PARTICIPANTS" target="HIGH-SODIUM DIET" />
    <edge source="PARTICIPANTS" target="LOW-SODIUM DIET" />
    <edge source="PARTICIPANTS" target="COPD SELF-MANAGEMENT APPLICATION" />
    <edge source="PARTICIPANTS" target="COPD" />
    <edge source="GRAPHICAL REPRESENTATION" target="GRAPH LITERACY" />
    <edge source="NUMERICAL REPRESENTATION" target="NUMERACY" />
    <edge source="NUMERICAL REPRESENTATION" target="GRAPHICAL REPRESENTATION FORMATS" />
    <edge source="NUMERICAL REPRESENTATION" target="COGNITIVE PROCESSES" />
    <edge source="EXPERIMENT" target="NO CHOICE CONDITION" />
    <edge source="EXPERIMENT" target="CHOICE CONDITION" />
    <edge source="EXPERIMENT" target="UNDERGRADUATE STUDENTS" />
    <edge source="EXPERIMENT" target="SIMULATION" />
    <edge source="GRAPH LITERACY" target="COGNITIVE PROCESSES" />
    <edge source="GRAPH LITERACY" target="RISK-COMMUNICATION APPROACHES STUDY" />
    <edge source="NUMERACY" target="COGNITIVE PROCESSES" />
    <edge source="NUMERACY" target="NATURAL FREQUENCIES FORMAT" />
    <edge source="NUMERACY" target="BAYESIAN INFERENCE" />
    <edge source="NUMERACY" target="RISK-COMMUNICATION APPROACHES STUDY" />
    <edge source="TP53-ALTERED MYELODYSPLASTIC SYNDROME" target="TP53-ALTERED ACUTE MYELOID LEUKEMIA" />
    <edge source="LIVING SYSTEMATIC REVIEW" target="TRAINEES" />
    <edge source="LIVING SYSTEMATIC REVIEW" target="PRISMA" />
    <edge source="LIVING SYSTEMATIC REVIEW" target="THE COCHRANE LIBRARY" />
    <edge source="LIVING SYSTEMATIC REVIEW" target="RAYYAN" />
    <edge source="LIVING SYSTEMATIC REVIEW" target="MICROSOFT WORD" />
    <edge source="LIVING SYSTEMATIC REVIEW" target="SCOPING REVIEW" />
    <edge source="LIVING SYSTEMATIC REVIEW" target="PHARMACOLOGICAL INTERVENTIONS" />
    <edge source="LIVING SYSTEMATIC REVIEW" target="OBSERVATIONAL STUDY DESIGNS" />
    <edge source="LIVING SYSTEMATIC REVIEW" target="RANDOMISED STUDY DESIGNS" />
    <edge source="TRAINEES" target="EXPERIENTIAL EVIDENCE-BASED MEDICINE EDUCATION" />
    <edge source="TRAINEES" target="INTERNATIONAL COLLABORATION" />
    <edge source="FUDAN TINNITUS RELIEVING SYSTEM" target="SHANGHAI" />
    <edge source="FUDAN TINNITUS RELIEVING SYSTEM" target="JIANGSU" />
    <edge source="FUDAN TINNITUS RELIEVING SYSTEM" target="ZHEJIANG" />
    <edge source="FUDAN TINNITUS RELIEVING SYSTEM" target="GUANGDONG" />
    <edge source="FUDAN TINNITUS RELIEVING SYSTEM" target="SHANDONG" />
    <edge source="FUDAN TINNITUS RELIEVING SYSTEM" target="MAY 2018" />
    <edge source="SHANGHAI" target="CHINESE GOVERNMENT" />
    <edge source="SHANGHAI" target="ERDOS RENYL NETWORK" />
    <edge source="SHANGHAI" target="SEIRS MODEL" />
    <edge source="SHANGHAI" target="JULY-SEPTEMBER WAVE" />
    <edge source="SHANGHAI" target="OCT-DEC WAVE" />
    <edge source="SHANGHAI" target="LIGHT GRADIENT BOOSTING" />
    <edge source="BREAST CANCER SURVEILLANCE CONSORTIUM" target="SECOND BREAST CANCER" />
    <edge source="BREAST CANCER SURVEILLANCE CONSORTIUM" target="AMERICAN JOINT COMMISSION ON CANCER" />
    <edge source="BREAST CANCER SURVEILLANCE CONSORTIUM" target="SCREENING ULTRASOUND" />
    <edge source="BREAST CANCER SURVEILLANCE CONSORTIUM" target="SCREENING MAMMOGRAM" />
    <edge source="BREAST CANCER SURVEILLANCE CONSORTIUM" target="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK" />
    <edge source="SECOND BREAST CANCER" target="ER-NEGATIVE BREAST CANCER" />
    <edge source="SECOND BREAST CANCER" target="ER-POSITIVE BREAST CANCER" />
    <edge source="TECLISTAMAB" target="MAJESTEC-1 STUDY" />
    <edge source="TECLISTAMAB" target="CLINICAL TRIAL REGISTRATION NCT03145181/NCT04557098" />
    <edge source="TECLISTAMAB" target="PNEUMOCYSTIS JIROVECII PNEUMONIA" />
    <edge source="TECLISTAMAB" target="RESPIRATORY INFECTIONS" />
    <edge source="TECLISTAMAB" target="VIRAL INFECTIONS" />
    <edge source="TECLISTAMAB" target="GASTROINTESTINAL INFECTIONS" />
    <edge source="TECLISTAMAB" target="CYTOKINE RELEASE SYNDROME" />
    <edge source="MAJESTEC-1 STUDY" target="PHASE 1/2" />
    <edge source="MASS SPECTROMETRY" target="MACHINE LEARNING TECHNIQUES" />
    <edge source="MASS SPECTROMETRY" target="PROSTATE-RELATED DISEASES" />
    <edge source="MACHINE LEARNING TECHNIQUES" target="PROSTATE-RELATED DISEASES" />
    <edge source="MACHINE LEARNING TECHNIQUES" target="GITHUB" />
    <edge source="PROSTATE-RELATED DISEASES" target="PROSTATE DATASETS" />
    <edge source="GITHUB" target="DREAMER" />
    <edge source="SOUTHERN TAIWAN HOSPITAL" target="ENSEMBLE LEARNING" />
    <edge source="ENSEMBLE LEARNING" target="MULTI-LAYER PERCEPTRON" />
    <edge source="ENSEMBLE LEARNING" target="LIVER DISEASE" />
    <edge source="ENSEMBLE LEARNING" target="GRADIENT BOOSTING" />
    <edge source="BREAST CANCER SURVIVORS" target="NONCANCER CONTROLS" />
    <edge source="BREAST CANCER SURVIVORS" target="HORVATH" />
    <edge source="BREAST CANCER SURVIVORS" target="EXTRINSIC EPIGENETIC AGE (EEA)" />
    <edge source="BREAST CANCER SURVIVORS" target="GRIMAGE" />
    <edge source="BREAST CANCER SURVIVORS" target="DUNEDIN PACE OF AGING" />
    <edge source="BREAST CANCER SURVIVORS" target="INTERLEUKIN-6 (IL-6)" />
    <edge source="BREAST CANCER SURVIVORS" target="NEUROCOGNITION STUDY" />
    <edge source="NONCANCER CONTROLS" target="NEUROCOGNITION STUDY" />
    <edge source="EPIGENETIC AGING" target="FUNCTIONAL OUTCOMES" />
    <edge source="DUTCH CHILDHOOD CANCER SURVIVOR STUDY" target="CHILDHOOD CANCER SURVIVORS" />
    <edge source="DUTCH CHILDHOOD CANCER SURVIVOR STUDY" target="NETHERLANDS" />
    <edge source="DUTCH CHILDHOOD CANCER SURVIVOR STUDY" target="SIBLING CONTROL GROUP" />
    <edge source="DUTCH CHILDHOOD CANCER SURVIVOR STUDY" target="30-YEAR MCC" />
    <edge source="CHILDHOOD CANCER SURVIVORS" target="ROSENBERG SELF-ESTEEM SCALE" />
    <edge source="CHILDHOOD CANCER SURVIVORS" target="HOSPITAL ANXIETY AND DEPRESSION SCALE" />
    <edge source="CHILDHOOD CANCER SURVIVORS" target="DISTRESS THERMOMETER" />
    <edge source="CHILDHOOD CANCER SURVIVORS" target="SELF-RATING SCALE FOR POST-TRAUMATIC STRESS DISORDER" />
    <edge source="CHILDHOOD CANCER SURVIVORS" target="SHORT FORM-36" />
    <edge source="CHILDHOOD CANCER SURVIVORS" target="SIBLINGS OF CHILDHOOD CANCER SURVIVORS" />
    <edge source="CHILDHOOD CANCER SURVIVORS" target="CHILDREN'S HOSPITAL IN HELSINKI" />
    <edge source="CHILDHOOD CANCER SURVIVORS" target="FINNISH NATIONAL REGISTRIES" />
    <edge source="CHILDHOOD CANCER SURVIVORS" target="HEMATOPOIETIC STEM CELL THERAPY" />
    <edge source="CHILDHOOD CANCER SURVIVORS" target="TESTICULAR RADIATION" />
    <edge source="CHILDHOOD CANCER SURVIVORS" target="SIBLING CONTROL GROUP" />
    <edge source="CHILDHOOD CANCER SURVIVORS" target="DCCSS LATER" />
    <edge source="CHILDHOOD CANCER SURVIVORS" target="RISK STRATIFICATIONS" />
    <edge source="CHILDHOOD CANCER SURVIVORS" target="CHILDREN'S ONCOLOGY GROUP" />
    <edge source="CHILDHOOD CANCER SURVIVORS" target="SURVIVORSHIP CARE PLANS" />
    <edge source="CHILDHOOD CANCER SURVIVORS" target="CANCER SURVIVORS" />
    <edge source="CHILDHOOD CANCER SURVIVORS" target="PARENT PROXIES" />
    <edge source="CHILDHOOD CANCER SURVIVORS" target="INACTIVE-UNHEALTHY-DIET PROFILE" />
    <edge source="CHILDHOOD CANCER SURVIVORS" target="ACTIVE-SEDENTARY-UNHEALTHY-DIET PROFILE" />
    <edge source="CHILDHOOD CANCER SURVIVORS" target="CARDIOMETABOLIC HEALTH" />
    <edge source="CHILDHOOD CANCER SURVIVORS" target="PHYSICAL PERFORMANCE" />
    <edge source="CHILDHOOD CANCER SURVIVORS" target="EMOTIONAL HEALTH" />
    <edge source="NETHERLANDS" target="CLINICAL PREDICTION MODELS (CPMS)" />
    <edge source="NETHERLANDS" target="DIGITAL PROFESSIONALISM" />
    <edge source="NETHERLANDS" target="ROTTERDAM STUDY" />
    <edge source="NETHERLANDS" target="HEALTH TECHNOLOGY ASSESSMENT" />
    <edge source="NETHERLANDS" target="DUTCH CHILDHOOD CANCER SURVIVOR STUDY LATER" />
    <edge source="NETHERLANDS" target="PROOF OF PRINCIPLE STUDY" />
    <edge source="NETHERLANDS" target="HOSPITALS" />
    <edge source="NETHERLANDS" target="DUTCH NATIONAL INTENSIVE CARE EVALUATION (NICE) REGISTRY" />
    <edge source="HOSPITAL ANXIETY AND DEPRESSION SCALE" target="CAR-T" />
    <edge source="DESMOID TUMORS" target="CTNNB1 GENE" />
    <edge source="DESMOID TUMORS" target="APC GENE" />
    <edge source="TIGECYCLINE" target="HYPOFIBRINOGENEMIA" />
    <edge source="TIGECYCLINE" target="XGBOOST MODEL" />
    <edge source="TIGECYCLINE" target="RANDOM SURVIVAL FOREST" />
    <edge source="XGBOOST MODEL" target="RANDOM SURVIVAL FOREST" />
    <edge source="XGBOOST MODEL" target="ROC CURVE" />
    <edge source="XGBOOST MODEL" target="CALIBRATION CURVE" />
    <edge source="XGBOOST MODEL" target="DECISION CURVE ANALYSIS" />
    <edge source="XGBOOST MODEL" target="CLINICAL IMPACT CURVE ANALYSIS" />
    <edge source="XGBOOST MODEL" target="SHAPELY ADDITIVE EXPLANATIONS (SHAP)" />
    <edge source="XGBOOST MODEL" target="INVASIVE MICROPAPILLARY CARCINOMA" />
    <edge source="RANDOM SURVIVAL FOREST" target="SURVIVAL ANALYSIS" />
    <edge source="RANDOM SURVIVAL FOREST" target="YOUNG BREAST CANCER" />
    <edge source="RANDOM SURVIVAL FOREST" target="COX REGRESSION MODEL" />
    <edge source="RANDOM SURVIVAL FOREST" target="IRAN" />
    <edge source="RANDOM SURVIVAL FOREST" target="COX PROPORTIONAL HAZARDS MODEL" />
    <edge source="RANDOM SURVIVAL FOREST" target="NAFLD" />
    <edge source="RANDOM SURVIVAL FOREST" target="FBS" />
    <edge source="RANDOM SURVIVAL FOREST" target="DEPRESSION" />
    <edge source="RANDOM SURVIVAL FOREST" target="AFTERNOON SLEEP" />
    <edge source="ROC CURVE" target="MACHINE LEARNING PREDICTION METHODS" />
    <edge source="ROC CURVE" target="TEST TRADEOFF CURVE" />
    <edge source="ROC CURVE" target="LASSO REGRESSION" />
    <edge source="ROC CURVE" target="HOSMER&#8211;LEMESHOW TEST" />
    <edge source="ROC CURVE" target="GASTRIC STROMAL TUMORS" />
    <edge source="ROC CURVE" target="METACOGNITIVE SENSITIVITY" />
    <edge source="DECISION CURVE ANALYSIS" target="YOUNG BREAST CANCER" />
    <edge source="DECISION CURVE ANALYSIS" target="AUTOMATED MACHINE LEARNING" />
    <edge source="CORRECTIONAL FACILITIES" target="COMMUNITY" />
    <edge source="CORRECTIONAL FACILITIES" target="MAGNIFICATION-REFLECTION DYNAMIC" />
    <edge source="CORRECTIONAL FACILITIES" target="CORRECTIONAL STAFF" />
    <edge source="COMMUNITY" target="MAGNIFICATION-REFLECTION DYNAMIC" />
    <edge source="ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS" target="NONPROLIFERATIVE DIABETIC RETINOPATHY" />
    <edge source="NONPROLIFERATIVE DIABETIC RETINOPATHY" target="AFLIBERCEPT" />
    <edge source="NONPROLIFERATIVE DIABETIC RETINOPATHY" target="EARLY TREATMENT DIABETIC RETINOPATHY STUDY" />
    <edge source="AFLIBERCEPT" target="DIABETIC MACULAR EDEMA" />
    <edge source="AFLIBERCEPT" target="SHAM" />
    <edge source="AFLIBERCEPT" target="CLINICAL SITES IN THE US AND CANADA" />
    <edge source="AFLIBERCEPT" target="ANTIPLATELET TRIALISTS' COLLABORATION" />
    <edge source="GIERE" target="UNIVERSITY OF CHICAGO PRESS" />
    <edge source="GIERE" target="RICHARD LEVINS" />
    <edge source="GIERE" target="MODEL-BASED SCIENCE" />
    <edge source="GIERE" target="SUPPES" />
    <edge source="UNIVERSITY OF CHICAGO PRESS" target="CHICAGO" />
    <edge source="VON THUNEN" target="VON THUNEN'S ECONOMIC MODEL" />
    <edge source="VON THUNEN'S ECONOMIC MODEL" target="ISOLATED STATE" />
    <edge source="PAKISTAN" target="AYUB MEDICAL HOSPITAL" />
    <edge source="PAKISTAN" target="WATERBORNE DISEASE POLLUTION STUDY" />
    <edge source="AYUB MEDICAL HOSPITAL" target="WATERBORNE DISEASE POLLUTION STUDY" />
    <edge source="GLOBAL BURDEN OF DISEASE STUDY" target="DISEASE EXPENDITURE PROJECT" />
    <edge source="GLOBAL BURDEN OF DISEASE STUDY" target="GASTRIC CANCER" />
    <edge source="TOBACCO USE" target="HYPERTENSION" />
    <edge source="TOBACCO USE" target="NEIGHBORHOOD SOCIOECONOMIC DISADVANTAGE (NSD)" />
    <edge source="TOBACCO USE" target="HEAD AND NECK SQUAMOUS CELL CARCINOMA" />
    <edge source="ELISABETH LLOYD" target="EVOLUTIONARY BIOLOGY" />
    <edge source="FINANCIAL TOXICITY" target="CANCER TREATMENT" />
    <edge source="CANCER TREATMENT" target="NETWORK META-ANALYSIS" />
    <edge source="CANCER TREATMENT" target="TIME-TO-EVENT OUTCOMES" />
    <edge source="CANCER TREATMENT" target="CANNABIS USE" />
    <edge source="CANCER TREATMENT" target="FERTILITY PRESERVATION" />
    <edge source="SMART WATCHERS" target="ELASTIC WATCHERS" />
    <edge source="SMART WATCHERS" target="APACHE NIFI" />
    <edge source="SMART WATCHERS" target="ELECTRONIC PATIENT RECORD (EPR) FRONT-END" />
    <edge source="INTERNET OF THINGS" target="LIGHTWEIGHT CRYPTOGRAPHY" />
    <edge source="INTERNET OF THINGS" target="RECTANGLE" />
    <edge source="LIGHTWEIGHT CRYPTOGRAPHY" target="PATIENT DATA" />
    <edge source="RECTANGLE" target="RASPBERRY PI 3" />
    <edge source="PATIENT DATA" target="TEMPORAL ANALYSIS" />
    <edge source="PATIENT DATA" target="GRAPH NEURAL NETWORKS" />
    <edge source="BLACK WOMEN" target="BREAST CANCER SURVIVORSHIP" />
    <edge source="BLACK WOMEN" target="HEALTH CARE PROVIDERS" />
    <edge source="BLACK WOMEN" target="FOCUS GROUPS" />
    <edge source="BLACK WOMEN" target="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK" />
    <edge source="BLACK WOMEN" target="DIGITAL BREAST TOMOSYNTHESIS" />
    <edge source="BLACK WOMEN" target="COMMUNITY OUTREACH INITIATIVES" />
    <edge source="BLACK WOMEN" target="NORTHEAST COMMUNITIES" />
    <edge source="BLACK WOMEN" target="LOUISIANA" />
    <edge source="BLACK WOMEN" target="BREAST MRI" />
    <edge source="BLACK WOMEN" target="SCREENING BREAST MRI" />
    <edge source="BLACK WOMEN" target="ACADEMIC MEDICAL CENTER" />
    <edge source="BLACK WOMEN" target="MAMMOGRAPHY COMPLETION" />
    <edge source="BLACK WOMEN" target="BREAST CANCER DISPARITIES" />
    <edge source="BLACK WOMEN" target="SCREENING MAMMOGRAPHY" />
    <edge source="BLACK WOMEN" target="CERVICAL CANCER INCIDENCE" />
    <edge source="BLACK WOMEN" target="CERVICAL CANCER MORTALITY" />
    <edge source="BLACK WOMEN" target="MICROSIMULATION MODEL" />
    <edge source="BLACK WOMEN" target="CANCER CARE INEQUITIES" />
    <edge source="OBESITY" target="CARDIOVASCULAR DISEASE" />
    <edge source="OBESITY" target="TYPE 2 DIABETES" />
    <edge source="OBESITY" target="HYPERTENSION" />
    <edge source="OBESITY" target="E1900" />
    <edge source="OBESITY" target="E3999" />
    <edge source="OBESITY" target="ACUTE MYELOID LEUKEMIA (AML)" />
    <edge source="OBESITY" target="SYSTEMS SCIENCE" />
    <edge source="OBESITY" target="GERMANY" />
    <edge source="OBESITY" target="CANCER SURVIVORS" />
    <edge source="CARDIOVASCULAR DISEASE" target="IBRUTINIB" />
    <edge source="CARDIOVASCULAR DISEASE" target="UCI REPOSITORY" />
    <edge source="CARDIOVASCULAR DISEASE" target="XLSTAT SOFTWARE" />
    <edge source="CARDIOVASCULAR DISEASE" target="CVD RISK FACTORS" />
    <edge source="CARDIOVASCULAR DISEASE" target="CHILDHOOD CANCER" />
    <edge source="CARDIOVASCULAR DISEASE" target="NEURAL NET" />
    <edge source="CARDIOVASCULAR DISEASE" target="ORTHOSTATIC HYPOTENSION" />
    <edge source="CARDIOVASCULAR DISEASE" target="STANDING HYPOTENSION" />
    <edge source="CARDIOVASCULAR DISEASE" target="AYA CANCER SURVIVORS" />
    <edge source="CARDIOVASCULAR DISEASE" target="SOCIODEMOGRAPHIC FACTORS" />
    <edge source="CARDIOVASCULAR DISEASE" target="MODIFIABLE RISK FACTORS" />
    <edge source="CARDIOVASCULAR DISEASE" target="MACHINE LEARNING CLASSIFIERS" />
    <edge source="CARDIOVASCULAR DISEASE" target="OMICS DATA" />
    <edge source="CARDIOVASCULAR DISEASE" target="HYPERTENSION" />
    <edge source="TYPE 2 DIABETES" target="PROLIFIC.CO" />
    <edge source="TYPE 2 DIABETES" target="PRIMARY CARE PHYSICIANS" />
    <edge source="TYPE 2 DIABETES" target="GERMANY" />
    <edge source="TYPE 2 DIABETES" target="GLOBAL DIETARY DATABASE" />
    <edge source="TYPE 2 DIABETES" target="LATIN AMERICA AND THE CARIBBEAN" />
    <edge source="TYPE 2 DIABETES" target="SUB-SAHARAN AFRICA" />
    <edge source="TYPE 2 DIABETES" target="SSB" />
    <edge source="TYPE 2 DIABETES" target="2020" />
    <edge source="HYPERTENSION" target="CARDIOVASCULAR, RENAL, AND METABOLIC (CRM) CONDITIONS" />
    <edge source="HYPERTENSION" target="BEVACIZUMAB" />
    <edge source="HYPERTENSION" target="IBRUTINIB" />
    <edge source="HYPERTENSION" target="PATIENTS WITH CLL" />
    <edge source="HYPERTENSION" target="CHRONIC KIDNEY DISEASE" />
    <edge source="HYPERTENSION" target="BOSTON MEDICAL CENTER" />
    <edge source="HYPERTENSION" target="BLACK ADULTS" />
    <edge source="HYPERTENSION" target="MEXICAN AMERICAN ADULTS" />
    <edge source="HYPERTENSION" target="OTHER HISPANIC ADULTS" />
    <edge source="HYPERTENSION" target="AMERICAN HEART ASSOCIATION" />
    <edge source="HYPERTENSION" target="NUTRITION CARE" />
    <edge source="HYPERTENSION" target="CUSHING SYNDROME" />
    <edge source="ACUTE LYMPHOBLASTIC LEUKEMIA" target="IKZF3" />
    <edge source="ACUTE LYMPHOBLASTIC LEUKEMIA" target="MACHINE LEARNING ALGORITHMS" />
    <edge source="ACUTE LYMPHOBLASTIC LEUKEMIA" target="ARTIFICIAL NEURAL NETWORKS" />
    <edge source="ACUTE LYMPHOBLASTIC LEUKEMIA" target="BAGGING ALGORITHMS" />
    <edge source="ACUTE LYMPHOBLASTIC LEUKEMIA" target="BOOSTING ALGORITHMS" />
    <edge source="ACUTE LYMPHOBLASTIC LEUKEMIA" target="RANDOM FOREST ALGORITHMS" />
    <edge source="ACUTE LYMPHOBLASTIC LEUKEMIA" target="BONE MARROW TRANSPLANTATION" />
    <edge source="ACUTE LYMPHOBLASTIC LEUKEMIA" target="TCF3::PBX1" />
    <edge source="IKZF3" target="MLLT1" />
    <edge source="IKZF3" target="TAF1" />
    <edge source="IKZF3" target="POLR2A" />
    <edge source="IKZF3" target="RAD21" />
    <edge source="BOGEN" target="WOODWARD" />
    <edge source="LEIBOVICH PROGNOSTIC MODEL" target="RENAL CELL CARCINOMA" />
    <edge source="RENAL CELL CARCINOMA" target="KOREAN RENAL CELL CARCINOMA DATABASE" />
    <edge source="RENAL CELL CARCINOMA" target="CHRONIC KIDNEY DISEASE" />
    <edge source="RENAL CELL CARCINOMA" target="ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TYROSINE KINASE INHIBITORS" />
    <edge source="RENAL CELL CARCINOMA" target="MEMORIAL SLOAN KETTERING-INTEGRATED MUTATION PROFILING OF ACTIONABLE CANCER TARGETS" />
    <edge source="RENAL CELL CARCINOMA" target="AFRICAN ANCESTRY" />
    <edge source="RENAL CELL CARCINOMA" target="EAST ASIAN ANCESTRY" />
    <edge source="RENAL CELL CARCINOMA" target="EUROPEAN ANCESTRY" />
    <edge source="RENAL CELL CARCINOMA" target="NATIVE AMERICAN ANCESTRY" />
    <edge source="RENAL CELL CARCINOMA" target="SOUTH ASIAN ANCESTRY" />
    <edge source="RENAL CELL CARCINOMA" target="ADMIXED ANCESTRY" />
    <edge source="RENAL CELL CARCINOMA" target="THE CANCER GENOME ATLAS" />
    <edge source="QUANTUM SPHERICAL FUZZY M-SWARA TECHNIQUE" target="ANTIDEPRESSANT DRUGS" />
    <edge source="TEHRAN" target="TEHRAN LIPID AND GLUCOSE STUDY" />
    <edge source="TEHRAN LIPID AND GLUCOSE STUDY" target="GRADIENT BOOSTING MODEL" />
    <edge source="TEHRAN LIPID AND GLUCOSE STUDY" target="SUPER LEARNER" />
    <edge source="TEHRAN LIPID AND GLUCOSE STUDY" target="COX PROPORTIONAL HAZARD MODEL" />
    <edge source="GRADIENT BOOSTING MODEL" target="CORONARY ARTERY DISEASE (CAD)" />
    <edge source="CLINICAL MEDICINE" target="DIABETES PREDICTION" />
    <edge source="MEDICAL DOMAIN KNOWLEDGE" target="ML PIPELINE" />
    <edge source="IMMUNOTHERAPY" target="COMBINATION IMMUNOTHERAPY TREATMENTS" />
    <edge source="IMMUNOTHERAPY" target="EXTENSIVE-STAGE SMALL CELL LUNG CANCER" />
    <edge source="IMMUNOTHERAPY" target="BRAIN METASTASES" />
    <edge source="IMMUNOTHERAPY" target="TUMOR IMMUNE MICROENVIRONMENT" />
    <edge source="IMMUNOTHERAPY" target="UBIQUITIN-PROTEASOME SYSTEM" />
    <edge source="IMMUNOTHERAPY" target="HEAD AND NECK SQUAMOUS CELL CARCINOMA" />
    <edge source="IMMUNOTHERAPY" target="NEOADJUVANT IMMUNE CHECKPOINT INHIBITORS (NICI)" />
    <edge source="GENOMIC MEDICINE FOR ILL NEONATES AND INFANTS (GEMINI) STUDY" target="GENOMIC SEQUENCING" />
    <edge source="GENOMIC MEDICINE FOR ILL NEONATES AND INFANTS (GEMINI) STUDY" target="TARGETED NEONATAL GENE-SEQUENCING TEST" />
    <edge source="GENOMIC SEQUENCING" target="TARGETED NEONATAL GENE-SEQUENCING TEST" />
    <edge source="FRANCE" target="NCT04653597" />
    <edge source="FRANCE" target="RENNES UNIVERSITY HOSPITAL" />
    <edge source="FRANCE" target="FRENCH UNIVERSITY HOSPITAL" />
    <edge source="SURGICAL ONCOLOGY" target="BREAST CARE" />
    <edge source="BREAST CARE" target="SENTINEL LYMPH NODE BIOPSY" />
    <edge source="BREAST CARE" target="BREAST CONSERVATION" />
    <edge source="BREAST CARE" target="GENETICS" />
    <edge source="BREAST CARE" target="FERTILITY" />
    <edge source="SENTINEL LYMPH NODE BIOPSY" target="INDOCYANINE GREEN" />
    <edge source="SURGEONS" target="METRICS SYSTEM" />
    <edge source="SURGEONS" target="ONCOLOGIC PROBLEM" />
    <edge source="SURGEONS" target="VASCULAR PROBLEM" />
    <edge source="SURGEONS" target="CLINICALTRIALS.GOV IDENTIFIER: NCT02623335" />
    <edge source="METRICS SYSTEM" target="SURVEILLANCE TRACKING SYSTEM" />
    <edge source="OHIO" target="MEDICAID EXPANSION" />
    <edge source="OHIO" target="TURNING THE PAGE ON BREAST CANCER" />
    <edge source="MEDICAID EXPANSION" target="GEORGIA" />
    <edge source="GEORGIA" target="GERMLINE GENETIC TESTING" />
    <edge source="GEORGIA" target="SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS REGISTRIES" />
    <edge source="ENGLISH NATIONAL HEALTH SERVICE" target="RECTAL CANCER SURGERY" />
    <edge source="RECTAL CANCER SURGERY" target="CANCER SURGERY CENTER" />
    <edge source="WEARABLE DEVICES" target="ELDERLY CARE INSTITUTIONS" />
    <edge source="WEARABLE DEVICES" target="TECHNOLOGY ACCEPTANCE MODEL" />
    <edge source="WEARABLE DEVICES" target="VALUE ATTITUDE BEHAVIOUR MODEL" />
    <edge source="WEARABLE DEVICES" target="STRUCTURAL EQUATION MODELLING" />
    <edge source="WEARABLE DEVICES" target="FUZZY SET QUALITATIVE COMPARATIVE ANALYSIS" />
    <edge source="WEARABLE DEVICES" target="PERCEIVED USEFULNESS" />
    <edge source="WEARABLE DEVICES" target="PERCEIVED RELIABILITY" />
    <edge source="WEARABLE DEVICES" target="SELF-PERCEIVED AGEING" />
    <edge source="WEARABLE DEVICES" target="HEALTH PROMOTION" />
    <edge source="WEARABLE DEVICES" target="PERCEIVED EASE OF USE" />
    <edge source="M&amp;S STANDARDS DEVELOPMENT" target="INTELLECTUAL PROPERTY" />
    <edge source="M&amp;S STANDARDS DEVELOPMENT" target="TECHNOLOGICAL INNOVATION" />
    <edge source="M&amp;S STANDARDS DEVELOPMENT" target="ECONOMIC COMPETITIVENESS" />
    <edge source="TECHNOLOGICAL INNOVATION" target="ECONOMIC COMPETITIVENESS" />
    <edge source="MENTAL HEALTH QUALITY OF LIFE QUESTIONNAIRE (MHQOL)" target="DUTCH VALUE SET" />
    <edge source="MENTAL HEALTH QUALITY OF LIFE QUESTIONNAIRE (MHQOL)" target="DUTCH ADULT POPULATION" />
    <edge source="IMMUNE-CHECKPOINT INHIBITORS (ICIS)" target="NON-SMALL-CELL LUNG CANCER" />
    <edge source="NON-SMALL-CELL LUNG CANCER" target="NETWORK META-ANALYSIS" />
    <edge source="TGF-&#914;" target="EXTRACELLULAR VESICLES (EVS)" />
    <edge source="TGF-&#914;" target="PLASMA SAMPLES" />
    <edge source="EXTRACELLULAR VESICLES (EVS)" target="PLASMA SAMPLES" />
    <edge source="LOW-GRADE SEROUS OVARIAN CARCINOMA" target="PLATINUM-BASED CHEMOTHERAPY" />
    <edge source="LOW-GRADE SEROUS OVARIAN CARCINOMA" target="BEVACIZUMAB" />
    <edge source="LOW-GRADE SEROUS OVARIAN CARCINOMA" target="COMPREHENSIVE CANCER CENTER" />
    <edge source="LOW-GRADE SEROUS OVARIAN CARCINOMA" target="RESPONSE EVALUATION CRITERIA IN SOLID TUMORS (RECIST) V1.1" />
    <edge source="BEVACIZUMAB" target="ATEZOLIZUMAB" />
    <edge source="BEVACIZUMAB" target="ADVANCED HEPATOCELLULAR CARCINOMA" />
    <edge source="BEVACIZUMAB" target="VEGF INHIBITION" />
    <edge source="MONARCHE TRIAL" target="ABEMACICLIB" />
    <edge source="MONARCHE TRIAL" target="NATIONAL CANCER DATABASE" />
    <edge source="NATIONAL CANCER DATABASE" target="LOBAR RESECTION" />
    <edge source="NATIONAL CANCER DATABASE" target="SUBLOBAR RESECTION" />
    <edge source="NATIONAL CANCER DATABASE" target="LOBECTOMY" />
    <edge source="NATIONAL CANCER DATABASE" target="SINONASAL CANCER" />
    <edge source="NATIONAL CANCER DATABASE" target="VERSION 9 AJCC STAGING SYSTEM" />
    <edge source="NATIONAL CANCER DATABASE" target="ADJUVANT RADIATION THERAPY" />
    <edge source="SEOUL NATIONAL UNIVERSITY HOSPITAL" target="SEOUL" />
    <edge source="SEOUL NATIONAL UNIVERSITY HOSPITAL" target="CLINICAL TRIAL NO. NCT02487901" />
    <edge source="SEOUL" target="ACADEMIC MEDICAL CENTER" />
    <edge source="SEOUL" target="TERTIARY REFERRAL HOSPITAL" />
    <edge source="SEOUL" target="KOREA" />
    <edge source="JAPANESE ORTHOPEDIC ASSOCIATION" target="LONG SHORT-TERM MEMORY (LSTM)" />
    <edge source="LONG SHORT-TERM MEMORY (LSTM)" target="THYROID CANCER" />
    <edge source="LONG SHORT-TERM MEMORY (LSTM)" target="ENSEMBLE LEARNING MODEL" />
    <edge source="OLDER ADULTS" target="HEALTH MONITORING SYSTEMS" />
    <edge source="OLDER ADULTS" target="STA PROGRAM" />
    <edge source="OLDER ADULTS" target="SMART-VEST" />
    <edge source="OLDER ADULTS" target="CANCER PREVENTION STUDY II" />
    <edge source="HEALTH MONITORING SYSTEMS" target="INFORMATION AND COMMUNICATION TECHNOLOGIES (ICTS)" />
    <edge source="ACTIVITIES OF DAILY LIVING (ADLS)" target="CONCEPTUAL MODEL" />
    <edge source="PENILE SQUAMOUS CELL CARCINOMA" target="HUMAN PAPILLOMAVIRUS" />
    <edge source="PENILE SQUAMOUS CELL CARCINOMA" target="CARIS LIFE SCIENCES" />
    <edge source="PENILE SQUAMOUS CELL CARCINOMA" target="NEXT-GENERATION SEQUENCING" />
    <edge source="PENILE SQUAMOUS CELL CARCINOMA" target="IMMUNE-CHECKPOINT INHIBITORS" />
    <edge source="PENILE SQUAMOUS CELL CARCINOMA" target="PROGRAMMED DEATH LIGAND 1" />
    <edge source="PENILE SQUAMOUS CELL CARCINOMA" target="MICROSATELLITE INSTABILITY" />
    <edge source="PENILE SQUAMOUS CELL CARCINOMA" target="TUMOR MUTATIONAL BURDEN" />
    <edge source="PENILE SQUAMOUS CELL CARCINOMA" target="WHOLE-EXOME SEQUENCING" />
    <edge source="HUMAN PAPILLOMAVIRUS" target="PROGRAMMED CELL DEATH PROTEIN 1 INHIBITOR-BASED COMBINATION THERAPY" />
    <edge source="HUMAN PAPILLOMAVIRUS" target="GLDC" />
    <edge source="HUMAN PAPILLOMAVIRUS" target="CYP4F12" />
    <edge source="HUMAN PAPILLOMAVIRUS" target="RAGE" />
    <edge source="HUMAN PAPILLOMAVIRUS" target="PI3K/AKT" />
    <edge source="HUMAN PAPILLOMAVIRUS" target="HEAD AND NECK SQUAMOUS CELL CARCINOMA" />
    <edge source="HUMAN PAPILLOMAVIRUS" target="SINONASAL CANCER" />
    <edge source="HUMAN PAPILLOMAVIRUS" target="CERVICAL CANCER" />
    <edge source="SCREENING ULTRASOUND" target="INTERVAL INVASIVE CANCER" />
    <edge source="SCREENING MAMMOGRAM" target="INTERVAL INVASIVE CANCER" />
    <edge source="PHYSICAL ACTIVITY" target="HEALTHCARE NEED" />
    <edge source="PHYSICAL ACTIVITY" target="HYBRID MICRO-SIMULATION LIFETABLE MODEL" />
    <edge source="PHYSICAL ACTIVITY" target="DISEASE INCIDENCE" />
    <edge source="PHYSICAL ACTIVITY" target="LONGEVITY" />
    <edge source="PHYSICAL ACTIVITY" target="DEMENTIA" />
    <edge source="PHYSICAL ACTIVITY" target="CANCER SURVIVORS" />
    <edge source="PHYSICAL ACTIVITY" target="VECTOR MAGNITUDE COUNTS" />
    <edge source="PHYSICAL ACTIVITY" target="LIGHT PHYSICAL ACTIVITY" />
    <edge source="PHYSICAL ACTIVITY" target="MODERATE-TO-VIGOROUS PHYSICAL ACTIVITY" />
    <edge source="PHYSICAL ACTIVITY" target="TOTAL PHYSICAL ACTIVITY" />
    <edge source="HEALTHCARE NEED" target="HYBRID MICRO-SIMULATION LIFETABLE MODEL" />
    <edge source="HEALTHCARE NEED" target="COMPARATIVE RISK ASSESSMENT (CRA) METHODS" />
    <edge source="HEALTHCARE NEED" target="LONGEVITY" />
    <edge source="HEALTHCARE NEED" target="DISEASE INCIDENCE" />
    <edge source="HEALTHCARE NEED" target="DEMENTIA" />
    <edge source="HYBRID MICRO-SIMULATION LIFETABLE MODEL" target="COMPARATIVE RISK ASSESSMENT (CRA) METHODS" />
    <edge source="DEMENTIA" target="AGES-REYKJAVIK STUDY" />
    <edge source="MYELOFIBROSIS" target="JANUS KINASE INHIBITOR MONOTHERAPY" />
    <edge source="MYELOFIBROSIS" target="RUXOLITINIB" />
    <edge source="MYELOFIBROSIS" target="B-CELL LYMPHOMA PROTEIN BCL-EXTRA LARGE" />
    <edge source="MYELOFIBROSIS" target="NAVITOCLAX" />
    <edge source="MYELOFIBROSIS" target="PLACEBO/BAT" />
    <edge source="MYELOFIBROSIS" target="JAK INHIBITOR RUXOLITINIB" />
    <edge source="MYELOFIBROSIS" target="CANCER CENTER" />
    <edge source="MYELOFIBROSIS" target="MYELOPROLIFERATIVE NEOPLASMS" />
    <edge source="MYELOFIBROSIS" target="BLAST PHASE" />
    <edge source="MYELOFIBROSIS" target="ANEMIA" />
    <edge source="RUXOLITINIB" target="COMFORT-I" />
    <edge source="RUXOLITINIB" target="COMFORT-II" />
    <edge source="RUXOLITINIB" target="RUX-MF RETROSPECTIVE STUDY" />
    <edge source="RUXOLITINIB" target="DYNAMIC INTERNATIONAL PROGNOSTIC SCORE SYSTEM" />
    <edge source="RUXOLITINIB" target="MYELOFIBROSIS SECONDARY TO POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA PROGNOSTIC MODEL" />
    <edge source="RUXOLITINIB" target="CYTOPENIC MYELOFIBROSIS" />
    <edge source="RUXOLITINIB" target="RUX-MF STUDY" />
    <edge source="DNA" target="MESSENGER RNA" />
    <edge source="DNA" target="DNA SEQUENCING" />
    <edge source="DNA" target="RNA SEQUENCING" />
    <edge source="DNA" target="RONALD GIERE" />
    <edge source="DNA SEQUENCING" target="RNA SEQUENCING" />
    <edge source="DNA SEQUENCING" target="ACUTE MYELOID LEUKEMIA" />
    <edge source="DNA SEQUENCING" target="COX PROPORTIONAL HAZARDS REGRESSION MODELS" />
    <edge source="DNA SEQUENCING" target="SMALL CELL LUNG CANCER" />
    <edge source="RNA SEQUENCING" target="INTRAHEPATIC CHOLANGIOCARCINOMA" />
    <edge source="FUNCTIONOMICS" target="INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH (ICF)" />
    <edge source="FUNCTIONOMICS" target="FAIR PRINCIPLES" />
    <edge source="FUNCTIONOMICS" target="LEARNING HEALTH SYSTEM" />
    <edge source="FAIR PRINCIPLES" target="MEDICAL DATA INTEGRATION CENTER (MEDIC)" />
    <edge source="CHRONIC MYELOID LEUKEMIA" target="EUROPEAN LEUKEMIANET" />
    <edge source="CHRONIC MYELOID LEUKEMIA" target="CLINICALTRIALS.GOV IDENTIFIER NCT04384848" />
    <edge source="CHRONIC MYELOID LEUKEMIA" target="BCR::ABL1 TYROSINE KINASE INHIBITORS" />
    <edge source="CHRONIC MYELOID LEUKEMIA" target="PHILADELPHIA CHROMOSOME" />
    <edge source="CHRONIC MYELOID LEUKEMIA" target="SEER DATABASE" />
    <edge source="CHRONIC MYELOID LEUKEMIA" target="BARIATRIC SURGERY" />
    <edge source="EUROPEAN LEUKEMIANET" target="ACUTE MYELOID LEUKEMIA" />
    <edge source="BONE MARROW" target="CYTOCHROME P450 ENZYMES" />
    <edge source="BONE MARROW" target="CYP3A4" />
    <edge source="BONE MARROW" target="HEMATOPOIETIC STEM CELLS" />
    <edge source="CYTOCHROME P450 ENZYMES" target="HEMATOPOIETIC STEM CELLS" />
    <edge source="CYP3A4" target="CLARITHROMYCIN" />
    <edge source="MULTILEVEL NETWORK META-REGRESSION (ML-NMR)" target="NETWORK META-ANALYSIS (NMA)" />
    <edge source="MULTILEVEL NETWORK META-REGRESSION (ML-NMR)" target="PSOBEST REGISTRY" />
    <edge source="MULTILEVEL NETWORK META-REGRESSION (ML-NMR)" target="PROSPECT COHORT STUDY" />
    <edge source="MULTILEVEL NETWORK META-REGRESSION (ML-NMR)" target="CHIRICOZZI 2019 COHORT STUDY" />
    <edge source="MULTILEVEL NETWORK META-REGRESSION (ML-NMR)" target="PLAQUE PSORIASIS" />
    <edge source="MULTILEVEL NETWORK META-REGRESSION (ML-NMR)" target="AGGREGATE DATA (AGD)" />
    <edge source="MULTILEVEL NETWORK META-REGRESSION (ML-NMR)" target="INDIVIDUAL PATIENT DATA (IPD)" />
    <edge source="NETWORK META-ANALYSIS (NMA)" target="INDIRECT COMPARISONS" />
    <edge source="ORAL ANTICOAGULANTS" target="ATRIAL FIBRILLATION" />
    <edge source="ORAL ANTICOAGULANTS" target="SHARED DECISION MAKING" />
    <edge source="ATRIAL FIBRILLATION" target="CLINICAL PRACTICE RESEARCH DATALINK" />
    <edge source="ATRIAL FIBRILLATION" target="ORAL ANTICOAGULANT" />
    <edge source="ATRIAL FIBRILLATION" target="ELDERLY PATIENTS" />
    <edge source="ATRIAL FIBRILLATION" target="HEMATOLOGICAL CANCER" />
    <edge source="ATRIAL FIBRILLATION" target="RADIOFREQUENCY ABLATION" />
    <edge source="ATRIAL FIBRILLATION" target="TRANSFORMER ALGORITHM" />
    <edge source="ATRIAL FIBRILLATION" target="ALFALFA APP" />
    <edge source="SHARED DECISION MAKING" target="PATIENT DECISION AID" />
    <edge source="SHARED DECISION MAKING" target="OUTPATIENT CARDIOLOGY CLINIC" />
    <edge source="SHARED DECISION MAKING" target="ENCOUNTER DECISION AIDS" />
    <edge source="DENTAL CARIES UTILITY INDEX" target="AUSTRALIA" />
    <edge source="DENTAL CARIES UTILITY INDEX" target="DISCRETE CHOICE EXPERIMENT" />
    <edge source="DENTAL CARIES UTILITY INDEX" target="VISUAL ANALOGUE SCALE" />
    <edge source="AUSTRALIA" target="OMICRON WAVE" />
    <edge source="AUSTRALIA" target="AUSTRALIA NEW ZEALAND CLINICAL TRIAL REGISTRY" />
    <edge source="AUSTRALIA" target="BREAST CANCER SCREENING AND CARE STUDY" />
    <edge source="AUSTRALIA" target="CHOOSING WISELY" />
    <edge source="AUSTRALIA" target="PRECISION MEDICINE FOR CHILDREN WITH CANCER (PRISM)" />
    <edge source="AUSTRALIA" target="DECISION AID" />
    <edge source="AUSTRALIA" target="BETTERING THE EVALUATION AND CARE OF HEALTH PROGRAM" />
    <edge source="AUSTRALIA" target="FIND TMF" />
    <edge source="AUSTRALIA" target="SURVIVORSHIP CARE PLANS" />
    <edge source="AUSTRALIA" target="VICTORIA" />
    <edge source="DISCRETE CHOICE EXPERIMENT" target="CANCER SCREENING" />
    <edge source="DISCRETE CHOICE EXPERIMENT" target="PSYCINFO" />
    <edge source="DISCRETE CHOICE EXPERIMENT" target="HMIC" />
    <edge source="DISCRETE CHOICE EXPERIMENT" target="ECONLIT" />
    <edge source="DISCRETE CHOICE EXPERIMENT" target="LANCAR AND LOUVIERE FRAMEWORK" />
    <edge source="DISCRETE CHOICE EXPERIMENT" target="HEREDITARY CANCER SYNDROMES" />
    <edge source="DISCRETE CHOICE EXPERIMENT" target="TRAUMA CENTERS" />
    <edge source="DISCRETE CHOICE EXPERIMENT" target="EMS PRACTITIONERS" />
    <edge source="DISCRETE CHOICE EXPERIMENT" target="PUBLIC HEALTH PROFESSIONALS" />
    <edge source="DISCRETE CHOICE EXPERIMENT" target="UK WOMEN" />
    <edge source="DISCRETE CHOICE EXPERIMENT" target="BREAST SCREENING PROGRAM" />
    <edge source="DISCRETE CHOICE EXPERIMENT" target="BEST-WORST SCALING" />
    <edge source="DISCRETE CHOICE EXPERIMENT" target="STATA 16" />
    <edge source="PROVENT STUDY" target="TIXAGEVIMAB-CILGAVIMAB" />
    <edge source="TIXAGEVIMAB-CILGAVIMAB" target="ANTI-CD20 MONOCLONAL ANTIBODIES" />
    <edge source="TIXAGEVIMAB-CILGAVIMAB" target="B-NON-HODGKIN LYMPHOMA" />
    <edge source="TIXAGEVIMAB-CILGAVIMAB" target="SARS-COV-2" />
    <edge source="TIXAGEVIMAB-CILGAVIMAB" target="HEMATOLOGICAL DISEASES" />
    <edge source="TIXAGEVIMAB-CILGAVIMAB" target="BONE MARROW TRANSPLANT" />
    <edge source="TIXAGEVIMAB-CILGAVIMAB" target="MYELOPROLIFERATIVE DISORDERS" />
    <edge source="TIXAGEVIMAB-CILGAVIMAB" target="AUTOIMMUNE DISEASES" />
    <edge source="B-NON-HODGKIN LYMPHOMA" target="EBV(-)M-PTLD" />
    <edge source="SARS-COV-2" target="LYMPHOPROLIFERATIVE DISORDERS" />
    <edge source="SARS-COV-2" target="PASC" />
    <edge source="SARS-COV-2" target="U.S. COVID-19 SCENARIO MODELING HUB" />
    <edge source="SARS-COV-2" target="ISLET AUTOIMMUNITY" />
    <edge source="SARS-COV-2" target="ACTIV-6" />
    <edge source="JAPANESE MEDICAL INSTITUTIONS" target="CLINICAL RESEARCH COORDINATORS" />
    <edge source="JAPANESE MEDICAL INSTITUTIONS" target="JAPAN" />
    <edge source="CLINICAL RESEARCH COORDINATORS" target="SHARED DECISION-MAKING" />
    <edge source="JAPAN" target="FORENSIC PSYCHIATRY DATABASE" />
    <edge source="JAPAN" target="ADVANCED HEPATOCELLULAR CARCINOMA" />
    <edge source="JAPAN" target="GASTRIC CANCER" />
    <edge source="JAPAN" target="KAMPO MEDICINE" />
    <edge source="JAPAN" target="SHARED DECISION-MAKING" />
    <edge source="JAPAN" target="BAYESIAN MODELS" />
    <edge source="SHARED DECISION-MAKING" target="SHARED DECISION-MAKING QUESTIONNAIRE FOR DOCTORS" />
    <edge source="SHARED DECISION-MAKING" target="THEORY OF PLANNED BEHAVIOUR" />
    <edge source="SHARED DECISION-MAKING" target="PATIENT DECISION AIDS" />
    <edge source="SHARED DECISION-MAKING" target="FINNISH PENSIONERS&#8217; FEDERATION" />
    <edge source="SHARED DECISION-MAKING" target="RENAL REPLACEMENT TREATMENT" />
    <edge source="SHARED DECISION-MAKING" target="NEPHROLOGY MEDICAL TEAM" />
    <edge source="SHARED DECISION-MAKING" target="BRIEF ILLNESS PERCEPTION QUESTIONNAIRE" />
    <edge source="SHARED DECISION-MAKING" target="BREAST CANCER CARE" />
    <edge source="SHARED DECISION-MAKING" target="PRISM" />
    <edge source="SHARED DECISION-MAKING" target="BIOMED CENTRAL LTD." />
    <edge source="SHARED DECISION-MAKING" target="SCOPING REVIEW" />
    <edge source="SHARED DECISION-MAKING" target="HEALTHCARE DELIVERY SETTINGS" />
    <edge source="SHARED DECISION-MAKING" target="CLINICAL TEAM" />
    <edge source="SHARED DECISION-MAKING" target="ORGANISATIONAL SUPPORT" />
    <edge source="SHARED DECISION-MAKING" target="REGULATORY PROVISIONS" />
    <edge source="SHARED DECISION-MAKING" target="PHYSIOTHERAPY" />
    <edge source="SHARED DECISION-MAKING" target="PHYSIOTHERAPISTS" />
    <edge source="SHARED DECISION-MAKING" target="DECISIONAL CONFLICT SCALE" />
    <edge source="SHARED DECISION-MAKING" target="HEALTH CARE PROFESSIONALS" />
    <edge source="MATERNAL MORTALITY" target="AMERICAN INDIAN AND ALASKA NATIVE" />
    <edge source="MATERNAL MORTALITY" target="BLACK" />
    <edge source="MATERNAL MORTALITY" target="ASIAN, NATIVE HAWAIIAN, OR OTHER PACIFIC ISLANDER" />
    <edge source="MATERNAL MORTALITY" target="WHITE" />
    <edge source="AMERICAN INDIAN AND ALASKA NATIVE" target="HEALTH INEQUITIES" />
    <edge source="BLACK" target="HEALTH INEQUITIES" />
    <edge source="IRAN" target="PLT" />
    <edge source="IRAN" target="PLT-APHERESIS" />
    <edge source="IRAN" target="RBC" />
    <edge source="IRAN" target="LR-RBC" />
    <edge source="IRAN" target="FFP" />
    <edge source="IRAN" target="ISFAHAN COHORT STUDY" />
    <edge source="IRAN" target="DENTAL SERVICES UTILIZATION STUDY" />
    <edge source="IRAN" target="TEHRAN UNIVERSITY OF MEDICAL SCIENCE" />
    <edge source="IRAN" target="CANCER INSTITUTE" />
    <edge source="IRAN" target="PREGNANT WOMEN" />
    <edge source="IRAN" target="DIGITAL PROFESSIONALISM" />
    <edge source="IRAN" target="GASTRIC CANCER" />
    <edge source="IRAN" target="AYATOLLAH TALLEGHANI HOSPITAL" />
    <edge source="IRAN" target="IRAN-PREMATURE CORONARY ARTERY DISEASE STUDY" />
    <edge source="IRAN" target="BURN CENTER" />
    <edge source="IRAN" target="POLYPHARMACY" />
    <edge source="IRAN" target="SMARTPHONE-BASED APP" />
    <edge source="IRAN" target="E-PRESCRIBING" />
    <edge source="IRAN" target="MINISTRY OF HEALTH" />
    <edge source="IRAN" target="MASHHAD UNIVERSITY OF MEDICAL SCIENCES" />
    <edge source="IRAN" target="HOSPITALS IN KERMAN" />
    <edge source="IRAN" target="PERSIAN CONDITION-SPECIFIC EHEALTH LITERACY SCALE FOR DIABETES (PERSIAN CEHLS-D)" />
    <edge source="IRAN" target="COX PROPORTIONAL HAZARDS MODEL" />
    <edge source="IRAN" target="IRAN ELECTRONIC HEALTH RECORD SYSTEM (SEPAS)" />
    <edge source="PLT" target="LSTM MODEL" />
    <edge source="PLT-APHERESIS" target="LSTM MODEL" />
    <edge source="RBC" target="LSTM MODEL" />
    <edge source="LR-RBC" target="LSTM MODEL" />
    <edge source="FFP" target="LSTM MODEL" />
    <edge source="DATABASEIII" target="DATABASEDII" />
    <edge source="DATABASEIII" target="CERVICAL CANCER" />
    <edge source="DATABASEDII" target="CERVICAL CANCER" />
    <edge source="CERVICAL CANCER" target="HUMAN PAPILLOMAVIRUS VACCINE" />
    <edge source="CERVICAL CANCER" target="US MILITARY" />
    <edge source="CERVICAL CANCER" target="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK" />
    <edge source="CERVICAL CANCER" target="SCREENING COVERAGE" />
    <edge source="ALCOHOL USE DISORDER" target="COCHRANE LIBRARY" />
    <edge source="ALCOHOL USE DISORDER" target="COCHRANE CENTRAL TRIALS REGISTRY" />
    <edge source="ALCOHOL USE DISORDER" target="PSYCINFO" />
    <edge source="ALCOHOL USE DISORDER" target="CINAHL" />
    <edge source="ALCOHOL USE DISORDER" target="ACAMPROSATE" />
    <edge source="ALCOHOL USE DISORDER" target="NALTREXONE" />
    <edge source="COCHRANE LIBRARY" target="PRISMA GUIDELINE" />
    <edge source="COCHRANE LIBRARY" target="FOLLICULAR LYMPHOMA" />
    <edge source="COCHRANE LIBRARY" target="PRIMARY HYPERTENSION" />
    <edge source="COCHRANE LIBRARY" target="SECONDARY HYPERTENSION" />
    <edge source="COCHRANE LIBRARY" target="GENERALIZED ANXIETY DISORDER (GAD)" />
    <edge source="COCHRANE LIBRARY" target="VIRTUAL REALITY" />
    <edge source="COCHRANE LIBRARY" target="TELEMEDICINE TECHNOLOGY" />
    <edge source="PSYCINFO" target="CHILD AND YOUTH MULTIMORBIDITY" />
    <edge source="PSYCINFO" target="HEART FAILURE" />
    <edge source="CINAHL" target="MEDRXIV" />
    <edge source="CINAHL" target="BIORXIV" />
    <edge source="CINAHL" target="ARXIV" />
    <edge source="CINAHL" target="MEDICATION ADMINISTRATION CLINICAL DECISION SUPPORT SYSTEMS" />
    <edge source="CINAHL" target="LONG-TERM CARE FACILITIES" />
    <edge source="DIGITAL HEALTH TECHNOLOGIES" target="WEB-DELPHI" />
    <edge source="DIGITAL HEALTH TECHNOLOGIES" target="UNITED KINGDOM" />
    <edge source="DIGITAL HEALTH TECHNOLOGIES" target="GERMANY" />
    <edge source="UNITED KINGDOM" target="20% TAX ON SUGAR SWEETENED DRINKS" />
    <edge source="UNITED KINGDOM" target="ONTOLOGY RESEARCH" />
    <edge source="UNITED KINGDOM" target="ADVANCE DECISION TO REFUSE TREATMENT (ADRT)" />
    <edge source="UNITED KINGDOM" target="WESTERN EUROPE" />
    <edge source="UNITED KINGDOM" target="EBV(-)M-PTLD" />
    <edge source="UNITED KINGDOM" target="GERMANY" />
    <edge source="UNITED KINGDOM" target="SOFT DRINKS INDUSTRY LEVY" />
    <edge source="UNITED KINGDOM" target="UNITED KINGDOM FLEXIBLE SIGMOIDOSCOPY SCREENING TRIAL" />
    <edge source="UNITED KINGDOM" target="UKFSST" />
    <edge source="GERMANY" target="PRIMARY VACCINATION" />
    <edge source="GERMANY" target="BOOSTER VACCINATION" />
    <edge source="GERMANY" target="SKIN CANCER SCREENING PROGRAMS" />
    <edge source="GERMANY" target="SYMPTOM CHECKER APPLICATIONS" />
    <edge source="GERMANY" target="IMPACT NCD GERMANY" />
    <edge source="GERMANY" target="CARDIOMETABOLIC DISEASES" />
    <edge source="GERMANY" target="CORONARY HEART DISEASE" />
    <edge source="GERMANY" target="UNIVERSITY HOSPITAL T&#220;BINGEN" />
    <edge source="GERMANY" target="TRS DEMONSTRATOR" />
    <edge source="GERMANY" target="PSORIASIS" />
    <edge source="GERMANY" target="ADVANCED NON-SMALL CELL LUNG CANCER" />
    <edge source="GERMANY" target="NEPHROLOGISTS" />
    <edge source="GERMANY" target="ADLIFE" />
    <edge source="GERMANY" target="BAYESIAN MODELS" />
    <edge source="GERMANY" target="PATIENT DECISION AIDS" />
    <edge source="GERMANY" target="CENTRE FOR NEW ART AND MEDIA (ZKM)" />
    <edge source="FIRST-TIME ANTERIOR SHOULDER DISLOCATION (FTASD)" target="PATIENT PREFERENCES" />
    <edge source="PATIENT PREFERENCES" target="PATIENT-PROVIDER COMMUNICATION" />
    <edge source="PATIENT PREFERENCES" target="CLINICAL PRACTICE GUIDELINES" />
    <edge source="ICONIC MODELS" target="ASTRONOMY" />
    <edge source="ICONIC MODELS" target="PHYSICS" />
    <edge source="ICONIC MODELS" target="BIOLOGY" />
    <edge source="ICONIC MODELS" target="CHEMISTRY" />
    <edge source="ICONIC MODELS" target="PSYCHOLOGY" />
    <edge source="PHYSICS" target="THEORETICAL PHYSICS" />
    <edge source="BIOLOGY" target="MOLECULAR BIOLOGY" />
    <edge source="BIOLOGY" target="THEORETICAL BIOLOGY" />
    <edge source="BIOLOGY" target="CELL BIOLOGY" />
    <edge source="ACADEMIC MEDICAL CENTER" target="SOUTH KOREA" />
    <edge source="ACADEMIC MEDICAL CENTER" target="ARX" />
    <edge source="ACADEMIC MEDICAL CENTER" target="EMERGENCY DEPARTMENT LENGTH OF STAY" />
    <edge source="ACADEMIC MEDICAL CENTER" target="MYCOSIS FUNGOIDES" />
    <edge source="ACADEMIC MEDICAL CENTER" target="WHITE WOMEN" />
    <edge source="SOUTH KOREA" target="KOREAN NATIONAL HEALTH INSURANCE" />
    <edge source="SOUTH KOREA" target="CANCER SCREENING" />
    <edge source="SOUTH KOREA" target="OCTOBER 2022" />
    <edge source="SOUTH KOREA" target="PUBLIC PRE-HOSPITAL CARE SYSTEM" />
    <edge source="SOUTH KOREA" target="PREDICTION MODEL" />
    <edge source="PRISMA 2020" target="LSR" />
    <edge source="LSR" target="LITERATURE SURVEILLANCE" />
    <edge source="LSR" target="SCOPING REVIEW" />
    <edge source="SCOPING REVIEW" target="ARKSEY AND O'MALLEY" />
    <edge source="SCOPING REVIEW" target="LEVAC ET AL." />
    <edge source="SCOPING REVIEW" target="CHILD AND YOUTH MULTIMORBIDITY" />
    <edge source="SCOPING REVIEW" target="POSTGRADUATE FAMILY MEDICINE TRAINING" />
    <edge source="SCOPING REVIEW" target="DIGITAL LEARNING TOOLS" />
    <edge source="SCOPING REVIEW" target="PRISMA 2020 EXTENSION" />
    <edge source="SCOPING REVIEW" target="METHODOLOGICAL QUALITY" />
    <edge source="SCOPING REVIEW" target="RISK OF BIAS" />
    <edge source="SCOPING REVIEW" target="MICROSOFT EXCEL 2013" />
    <edge source="SCOPING REVIEW" target="SYSTEMATIC SEARCH" />
    <edge source="SCOPING REVIEW" target="EVIDENCE SYNTHESIS" />
    <edge source="SCOPING REVIEW" target="HEALTH CARE" />
    <edge source="SCOPING REVIEW" target="LLMS" />
    <edge source="SCOPING REVIEW" target="STANDARDIZED EVALUATION FRAMEWORK" />
    <edge source="SCOPING REVIEW" target="EVIDENCE GAPS" />
    <edge source="ONLINE MEDICAL CONSULTATION" target="IN-PERSON CONSULTATION" />
    <edge source="ONLINE MEDICAL CONSULTATION" target="EDUCATIONAL ACUTE-CARE HOSPITAL IN JAPAN" />
    <edge source="ONLINE MEDICAL CONSULTATION" target="PHYSICIAN" />
    <edge source="ONLINE MEDICAL CONSULTATION" target="PATIENTS' FAMILIES" />
    <edge source="IN-PERSON CONSULTATION" target="EDUCATIONAL ACUTE-CARE HOSPITAL IN JAPAN" />
    <edge source="IN-PERSON CONSULTATION" target="PHYSICIAN" />
    <edge source="IN-PERSON CONSULTATION" target="PATIENTS' FAMILIES" />
    <edge source="PHYSICIAN" target="PATIENTS' FAMILIES" />
    <edge source="PHYSICIAN" target="CAREGIVER" />
    <edge source="PHYSICIAN" target="PATIENT" />
    <edge source="PHYSICIAN" target="TREATMENT DECISION-MAKING" />
    <edge source="PHYSICIAN" target="PROSTATE CANCER CONSULTATIONS" />
    <edge source="PHYSICIAN" target="AGGRESSIVE TREATMENT" />
    <edge source="PHYSICIAN" target="NONAGGRESSIVE TREATMENT" />
    <edge source="PHYSICIAN" target="MULTIDISCIPLINARY PROVIDERS" />
    <edge source="PHYSICIAN" target="CODERS" />
    <edge source="PHYSICIAN" target="COVID-19 VACCINE" />
    <edge source="PHYSICIAN" target="EXPERIMENT 3" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="ETNK1 MUTATION" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="NOTCH MUTATIONS" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="NOVEL TARGETED THERAPIES" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="CYTOGENETIC/MOLECULAR TESTING" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="CR2" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="VENETOCLAX" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="IDH2" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="NPM1" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="OLDER/UNFIT PATIENTS" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="TRAINING COHORT" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="VALIDATION GROUP" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="CHRONIC MYELOMONOCYTIC LEUKEMIA" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="CLADRIBINE" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="LOW-DOSE CYTARABINE" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="HYPOMETHYLATING AGENTS" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="RETROSPECTIVE CHART REVIEW" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="DNM1" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="MEIS1" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="SUSD3" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="CANCER GENOME ATLAS" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="MACHINE-LEARNING TOOLS" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="LASSO" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="SVM-RFE" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="HYPERLEUKOCYTOSIS" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="INSTITUTIONAL PROTOCOLS" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="CHILDREN WITH AML" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="ALLENEOGENEIC HEMATOPOIETIC CELL TRANSPLANT" />
    <edge source="ACUTE MYELOID LEUKEMIA" target="FLT3" />
    <edge source="ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION" target="MYELODYSPLASTIC SYNDROME" />
    <edge source="ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION" target="MYELOPROLIFERATIVE NEOPLASM" />
    <edge source="ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION" target="REDUCED-INTENSITY CONDITIONING" />
    <edge source="ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION" target="MYELOABLATIVE CONDITIONING" />
    <edge source="ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION" target="ACUTE GRAFT-VERSUS-HOST DISEASE" />
    <edge source="ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION" target="CYTOGENETIC RISK" />
    <edge source="ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION" target="SUBSEQUENT SOLID CANCERS" />
    <edge source="ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION" target="GRAFT-VERSUS-HOST DISEASE" />
    <edge source="ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION" target="HLA-DPB1" />
    <edge source="ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION" target="HLA-A" />
    <edge source="ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION" target="HLA-B" />
    <edge source="ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION" target="HLA-C" />
    <edge source="ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION" target="HLA-DRB1/3/4/5" />
    <edge source="ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION" target="HLA-DQB1" />
    <edge source="ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION" target="MINIMAL RESIDUAL DISEASE" />
    <edge source="ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION" target="MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS" />
    <edge source="MYELODYSPLASTIC SYNDROME" target="ETNK1 MUTATION" />
    <edge source="MYELOPROLIFERATIVE NEOPLASM" target="ETNK1 MUTATION" />
    <edge source="PRIMARY VACCINATION" target="BOOSTER VACCINATION" />
    <edge source="VACCINATION MANDATES" target="MONETARY INCENTIVES" />
    <edge source="HER2-LOW" target="TRASTUZUMAB DERUXTECAN" />
    <edge source="BENDAMUSTINE HYDROCHLORIDE" target="INDOLENT NON-HODGKIN LYMPHOMA" />
    <edge source="BENDAMUSTINE HYDROCHLORIDE" target="CHINESE CORPORATION" />
    <edge source="BENDAMUSTINE HYDROCHLORIDE" target="RITUXIMAB" />
    <edge source="RITUXIMAB" target="R/R INDOLENT NON-HODGKIN LYMPHOMA" />
    <edge source="RITUXIMAB" target="FOLLICULAR LYMPHOMA" />
    <edge source="RITUXIMAB" target="CD19-TARGETING CAR T CELLS" />
    <edge source="DISEASE EXPENDITURE PROJECT" target="INSTITUTE FOR HEALTH METRICS AND EVALUATION" />
    <edge source="KIDNEY CANCER" target="TARGETED THERAPIES" />
    <edge source="SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAM" target="GENERAL US POPULATION" />
    <edge source="21ST CENTURY CURES ACT" target="MEDICARE ADVANTAGE" />
    <edge source="MEDICARE ADVANTAGE" target="ESRD" />
    <edge source="ONCOTYPEDX" target="RSCLIN" />
    <edge source="ONCOTYPEDX" target="STAGE I-III HR+/HER2- BREAST CANCER" />
    <edge source="RSCLIN" target="NATIONAL CANCER DATA BASE" />
    <edge source="RSCLIN" target="STAGE I-III HR+/HER2- BREAST CANCER" />
    <edge source="ARKSEY AND O'MALLEY" target="CHILD AND YOUTH MULTIMORBIDITY" />
    <edge source="ARKSEY AND O'MALLEY" target="PUBMED/MEDLINE" />
    <edge source="ARKSEY AND O'MALLEY" target="ERIC" />
    <edge source="ARKSEY AND O'MALLEY" target="GOOGLE SCHOLAR" />
    <edge source="ARKSEY AND O'MALLEY" target="LEVAC ET AL" />
    <edge source="ARKSEY AND O'MALLEY" target="LEVAC ET AL." />
    <edge source="CHILD AND YOUTH MULTIMORBIDITY" target="LEVAC ET AL." />
    <edge source="CHILD AND YOUTH MULTIMORBIDITY" target="MULTIMORBIDITY" />
    <edge source="MULTIMORBIDITY" target="HEART FAILURE" />
    <edge source="MULTIMORBIDITY" target="HEALTHCARE SYSTEMS" />
    <edge source="MULTIMORBIDITY" target="CANCER SURVIVORS" />
    <edge source="ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT)" target="PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ ALL)" />
    <edge source="PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ ALL)" target="TYROSINE KINASE INHIBITORS (TKIS)" />
    <edge source="PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ ALL)" target="COMPLETE MOLECULAR REMISSION (CMR)" />
    <edge source="COMPLETE MOLECULAR REMISSION (CMR)" target="PONATINIB" />
    <edge source="COMPLETE MOLECULAR REMISSION (CMR)" target="IMATINIB" />
    <edge source="IMATINIB" target="ITALIAN PATIENTS" />
    <edge source="IMATINIB" target="FRONTLINE TREATMENT" />
    <edge source="CARBOHYDRATE ANTIGEN 19-9 (CA 19-9)" target="INTRAHEPATIC CHOLANGIOCARCINOMA (ICCA)" />
    <edge source="CARBOHYDRATE ANTIGEN 19-9 (CA 19-9)" target="PROGRESSION-FREE SURVIVAL (PFS)" />
    <edge source="CARBOHYDRATE ANTIGEN 19-9 (CA 19-9)" target="OVERALL SURVIVAL (OS)" />
    <edge source="INTRAHEPATIC CHOLANGIOCARCINOMA (ICCA)" target="RESPONSE EVALUATION CRITERIA IN SOLID TUMORS VERSION 1.1" />
    <edge source="PROGRESSION-FREE SURVIVAL (PFS)" target="IMMUNE-CHECKPOINT INHIBITOR (ICI)" />
    <edge source="PROGRESSION-FREE SURVIVAL (PFS)" target="DEL(1P13.3)" />
    <edge source="PROGRESSION-FREE SURVIVAL (PFS)" target="1Q21 GAIN" />
    <edge source="PROGRESSION-FREE SURVIVAL (PFS)" target="1Q21 AMP" />
    <edge source="OVERALL SURVIVAL (OS)" target="IMMUNE-CHECKPOINT INHIBITOR (ICI)" />
    <edge source="OVERALL SURVIVAL (OS)" target="DEL(1P13.3)" />
    <edge source="OVERALL SURVIVAL (OS)" target="1Q21 GAIN" />
    <edge source="OVERALL SURVIVAL (OS)" target="1Q21 AMP" />
    <edge source="OVERALL SURVIVAL (OS)" target="GLIOMAS" />
    <edge source="OVERALL SURVIVAL (OS)" target="SHORT-TERM SURVIVAL" />
    <edge source="OVERALL SURVIVAL (OS)" target="MEDIUM-TERM SURVIVAL" />
    <edge source="OVERALL SURVIVAL (OS)" target="LONG-TERM SURVIVAL" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEM" target="PHYSICIANS" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEM" target="ACUTE POSTOPERATIVE ENDOPHTHALMITIS" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEM" target="DECISION TREE CLASSIFIER" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEM" target="K-NEAREST NEIGHBORS" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEM" target="INFORMATION SYSTEM FOR CLINICAL CONCEPT SEARCHING" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEM" target="TENSORFLOW" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEM" target="TENSORFLOW RANKING" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEM" target="LEARNING-TO-RANK" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEM" target="INFORMATION RETRIEVAL" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEM" target="INTERNISTS" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEM" target="GENERAL PRACTITIONERS" />
    <edge source="PHYSICIANS" target="ACUTE POSTOPERATIVE ENDOPHTHALMITIS" />
    <edge source="PHYSICIANS" target="DERMOSCOPY ELEMENTS OF VISUALS ONTOLOGY (DEVO)" />
    <edge source="PHYSICIANS" target="DERMOSCOPIC ANALYSIS" />
    <edge source="PHYSICIANS" target="SMARTPHONE APPLICATION" />
    <edge source="PHYSICIANS" target="TRACHEOSTOMY AND PROLONGED MECHANICAL VENTILATION DECISION MAKING" />
    <edge source="PHYSICIANS" target="SURROGATE DECISION MAKERS" />
    <edge source="PHYSICIANS" target="PATIENTS WITH METASTATIC CANCER" />
    <edge source="PHYSICIANS" target="CANCER CLINICAL TRIAL" />
    <edge source="PHYSICIANS" target="US HEALTH CARE WORKERS" />
    <edge source="PHYSICIANS" target="CHILD ABUSE AND NEGLECT" />
    <edge source="PHYSICIANS" target="HEALTH SYSTEMS" />
    <edge source="PHYSICIANS" target="MEDICARE BENEFICIARIES" />
    <edge source="PHYSICIANS" target="E-PRESCRIBING" />
    <edge source="PHYSICIANS" target="URMIA UNIVERSITY OF MEDICAL SCIENCES" />
    <edge source="PHYSICIANS" target="ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK CALCULATOR" />
    <edge source="PHYSICIANS" target="RISK SCORE CALCULATORS" />
    <edge source="PHYSICIANS" target="OUTPATIENT COMMUNITY-BASED CLINICAL SETTINGS" />
    <edge source="PHYSICIANS" target="VERILOGUE POINT-OF-PRACTICE DATABASE" />
    <edge source="PHYSICIANS" target="DOAC PRESCRIPTION" />
    <edge source="PHYSICIANS" target="WARFARIN PRESCRIPTION" />
    <edge source="PHYSICIANS" target="INFORMED DECISION MAKING" />
    <edge source="PHYSICIANS" target="FINANCIAL COSTS" />
    <edge source="PHYSICIANS" target="PATIENT DECISION AIDS" />
    <edge source="PHYSICIANS" target="CHEMOPREVENTION" />
    <edge source="PHYSICIANS" target="DECISION SUPPORT TOOLS" />
    <edge source="ACUTE POSTOPERATIVE ENDOPHTHALMITIS" target="OPHTHALMOLOGISTS" />
    <edge source="K-NEAREST NEIGHBORS" target="MRI BRAIN IMAGES" />
    <edge source="OPHTHALMOLOGISTS" target="CORNEAL REFRACTIVE SURGERY" />
    <edge source="ISRUC-SLEEP SUBGROUP1" target="MULTI-MODAL POLYSOMNOGRAPHY" />
    <edge source="MULTI-MODAL POLYSOMNOGRAPHY" target="SLEEP-EDF" />
    <edge source="MULTI-MODAL POLYSOMNOGRAPHY" target="PHYSIO BANK CAP SLEEP DATABASE" />
    <edge source="MULTI-MODAL POLYSOMNOGRAPHY" target="ADA BOOST WITH RANDOM FOREST" />
    <edge source="MULTI-MODAL POLYSOMNOGRAPHY" target="RELIEFF" />
    <edge source="MORSE FALL SCALE" target="FALL EVENTS" />
    <edge source="MORSE FALL SCALE" target="MACHINE LEARNING MODEL" />
    <edge source="FALL EVENTS" target="CEREBROVASCULAR SPECIALTY HOSPITAL" />
    <edge source="FALL EVENTS" target="MACHINE LEARNING MODEL" />
    <edge source="MACHINE LEARNING MODEL" target="INTRAOPERATIVE BLOOD TRANSFUSION" />
    <edge source="MACHINE LEARNING MODEL" target="K-NEAREST NEIGHBOR" />
    <edge source="MACHINE LEARNING MODEL" target="RANGER" />
    <edge source="MACHINE LEARNING MODEL" target="EXTREMELY GRADIENT BOOSTING MODEL" />
    <edge source="COMPUTER SIMULATION" target="EXPERIMENTAL MEASUREMENT" />
    <edge source="COMPUTER SIMULATION" target="RED GIANT STAR" />
    <edge source="COMPUTER SIMULATION" target="PHILOSOPHY OF SCIENCE" />
    <edge source="COMPUTER SIMULATION" target="TRADITIONAL EXPERIMENTATION" />
    <edge source="COMPUTER SIMULATION" target="PHYSICAL SCIENCES" />
    <edge source="COMPUTER SIMULATION" target="BIOLOGICAL SCIENCES" />
    <edge source="COMPUTER SIMULATION" target="SOCIAL SCIENCES" />
    <edge source="COMPUTER SIMULATION" target="CELLULAR AUTOMATA" />
    <edge source="COMPUTER SIMULATION" target="NANOSCIENCE" />
    <edge source="STA PROGRAM" target="SMART-VEST" />
    <edge source="STA PROGRAM" target="HOMECARE NURSES" />
    <edge source="EQUIPE" target="HRQOL" />
    <edge source="EQUIPE" target="EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER" />
    <edge source="EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER" target="CANTO" />
    <edge source="EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER" target="SURVSARC" />
    <edge source="EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER" target="ISF" />
    <edge source="EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER" target="QUALITY OF LIFE QUESTIONNAIRE CORE 30" />
    <edge source="EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER" target="HEALTH ECONOMICS RESEARCHERS" />
    <edge source="MEMORIAL SLOAN KETTERING CANCER CENTER" target="ALPELISIB" />
    <edge source="MEMORIAL SLOAN KETTERING CANCER CENTER" target="MRI-TARGETED PROSTATE BIOPSY" />
    <edge source="MEMORIAL SLOAN KETTERING CANCER CENTER" target="SYSTEMATIC BIOPSY" />
    <edge source="ALPELISIB" target="HYPERGLYCEMIA" />
    <edge source="ALPELISIB" target="FULVESTRANT" />
    <edge source="HYPERGLYCEMIA" target="CUSHING SYNDROME" />
    <edge source="AMERICAN COLLEGE OF SURGEONS NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM" target="NCT03269994" />
    <edge source="PROSPERO" target="SCIBERT" />
    <edge source="PROSPERO" target="METAMAP" />
    <edge source="PROSPERO" target="SYSTEMATIC REVIEWS" />
    <edge source="PROSPERO" target="TRIAL REGISTRATIONS" />
    <edge source="PROSPERO" target="TRIAL ARTICLES" />
    <edge source="PROSPERO" target="CRD42023464746" />
    <edge source="PROSPERO" target="SYSTEMATIC REVIEW" />
    <edge source="PROSPERO" target="CANCER RESEARCH" />
    <edge source="SCIBERT" target="PICO" />
    <edge source="METAMAP" target="PICO" />
    <edge source="SYSTEMATIC REVIEWS" target="TRIAL REGISTRATIONS" />
    <edge source="SYSTEMATIC REVIEWS" target="TRIAL ARTICLES" />
    <edge source="SYSTEMATIC REVIEWS" target="AUTOMATION" />
    <edge source="SYSTEMATIC REVIEWS" target="MACHINE LEARNING METHODS" />
    <edge source="SYSTEMATIC REVIEWS" target="MACHINE LEARNING TOOLS" />
    <edge source="SYSTEMATIC REVIEWS" target="TITLE AND ABSTRACT SCREENING" />
    <edge source="SYSTEMATIC REVIEWS" target="INTERNATIONAL COLLABORATION FOR THE AUTOMATION OF SYSTEMATIC REVIEWS" />
    <edge source="SYSTEMATIC REVIEWS" target="TEXT MINING" />
    <edge source="SYSTEMATIC REVIEWS" target="LATENT DIRICHLET ALLOCATION" />
    <edge source="SYSTEMATIC REVIEWS" target="HELIMINTH DATASET" />
    <edge source="SYSTEMATIC REVIEWS" target="WILSON DISEASE DATASET" />
    <edge source="SYSTEMATIC REVIEWS" target="AUTOMATED SCREENING METHODOLOGY" />
    <edge source="SYSTEMATIC REVIEWS" target="AI METHODS" />
    <edge source="SYSTEMATIC REVIEWS" target="EVIDENCE SYNTHESIS" />
    <edge source="SYSTEMATIC REVIEWS" target="SYSTEMATIC REVIEWERS" />
    <edge source="SYSTEMATIC REVIEWS" target="ARTIFICIAL INTELLIGENCE TOOLS" />
    <edge source="SYSTEMATIC REVIEWS" target="ACADEMIC WRITING" />
    <edge source="SYSTEMATIC REVIEWS" target="RESEARCH SYNTHESIS" />
    <edge source="SYSTEMATIC REVIEWS" target="EVIDENCE-BASED PRACTICE" />
    <edge source="SYSTEMATIC REVIEWS" target="ELECTRONIC DATABASES" />
    <edge source="SYSTEMATIC REVIEWS" target="SOFTWARE REPOSITORIES" />
    <edge source="SYSTEMATIC REVIEWS" target="META-ANALYSES" />
    <edge source="SYSTEMATIC REVIEWS" target="RESEARCH SCREENER" />
    <edge source="SYSTEMATIC REVIEWS" target="COCHRANE" />
    <edge source="SYSTEMATIC REVIEWS" target="BIOMEDICAL LITERATURE SURVEY" />
    <edge source="SYSTEMATIC REVIEWS" target="GENERALIZED ANXIETY DISORDER (GAD)" />
    <edge source="TRIAL REGISTRATIONS" target="TRIAL ARTICLES" />
    <edge source="BONE MARROW TRANSPLANT SURVIVOR STUDY" target="BMT SURVIVORS" />
    <edge source="BMT SURVIVORS" target="TRANSPLANT CENTERS" />
    <edge source="BMT SURVIVORS" target="CHRONIC GRAFT-VS-HOST DISEASE" />
    <edge source="ELECTRONIC PATIENT-REPORTED OUTCOMES" target="ELECTRONIC HEALTH REPORT FORM" />
    <edge source="ELECTRONIC HEALTH REPORT FORM" target="SWEDISH YOUTH HEALTH CLINICS" />
    <edge source="ELECTRONIC HEALTH REPORT FORM" target="EXPERT PANEL" />
    <edge source="ELECTRONIC HEALTH REPORT FORM" target="YOUNG PEOPLE" />
    <edge source="SWEDISH YOUTH HEALTH CLINICS" target="YOUNG PEOPLE" />
    <edge source="EXPERT PANEL" target="DELPHI METHOD" />
    <edge source="EXPERT PANEL" target="SENSITIVITY OUTCOME INDEX SYSTEM" />
    <edge source="EXPERT PANEL" target="HOME NURSING" />
    <edge source="MEDICAL CROWDSOURCING COMPETITIONS" target="DOCTORS" />
    <edge source="MEDICAL CROWDSOURCING COMPETITIONS" target="ONLINE PLATFORM" />
    <edge source="DOCTORS" target="ONLINE PLATFORM" />
    <edge source="DOCTORS" target="PATIENT" />
    <edge source="INFERTILITY" target="MOBILE PHONE-BASED APPLICATION" />
    <edge source="MOBILE PHONE-BASED APPLICATION" target="NUTRITION SPECIALISTS" />
    <edge source="MOBILE PHONE-BASED APPLICATION" target="INFERTILITY SPECIALISTS" />
    <edge source="MOBILE PHONE-BASED APPLICATION" target="PANEL OF EXPERTS" />
    <edge source="SIMULTANEOUS MAXIMUM ACCEPTABLE RISK THRESHOLDS" target="MAXIMUM ACCEPTABLE RISK" />
    <edge source="DIFFUSE LARGE B-CELL LYMPHOMA" target="LONCASTUXIMAB TESIRINE-LPYL" />
    <edge source="DIFFUSE LARGE B-CELL LYMPHOMA" target="EPSTEIN-BARR VIRUS" />
    <edge source="DIFFUSE LARGE B-CELL LYMPHOMA" target="TET2" />
    <edge source="DIFFUSE LARGE B-CELL LYMPHOMA" target="LILRB1" />
    <edge source="DIFFUSE LARGE B-CELL LYMPHOMA" target="PCLO" />
    <edge source="DIFFUSE LARGE B-CELL LYMPHOMA" target="GSE10846" />
    <edge source="DIFFUSE LARGE B-CELL LYMPHOMA" target="GSE53786" />
    <edge source="DIFFUSE LARGE B-CELL LYMPHOMA" target="EBV(-)M-PTLD" />
    <edge source="ASPIRIN" target="ATHEROSCLEROTIC CARDIOVASCULAR DISEASE" />
    <edge source="ASPIRIN" target="LOW-INCOME COUNTRIES" />
    <edge source="ASPIRIN" target="LOWER-MIDDLE-INCOME COUNTRIES" />
    <edge source="ASPIRIN" target="UPPER-MIDDLE-INCOME COUNTRIES" />
    <edge source="ASPIRIN" target="HIGH-INCOME COUNTRIES" />
    <edge source="ASPIRIN" target="WORLDWIDE" />
    <edge source="ASPIRIN" target="CVD" />
    <edge source="ASPIRIN" target="LEFT VENTRICULAR ASSIST DEVICES" />
    <edge source="LOW-INCOME COUNTRIES" target="CVD" />
    <edge source="LOW-INCOME COUNTRIES" target="HEART FAILURE STUDY" />
    <edge source="LOWER-MIDDLE-INCOME COUNTRIES" target="CVD" />
    <edge source="LOWER-MIDDLE-INCOME COUNTRIES" target="HEART FAILURE STUDY" />
    <edge source="UPPER-MIDDLE-INCOME COUNTRIES" target="CVD" />
    <edge source="UPPER-MIDDLE-INCOME COUNTRIES" target="HEART FAILURE STUDY" />
    <edge source="HIGH-INCOME COUNTRIES" target="CVD" />
    <edge source="HIGH-INCOME COUNTRIES" target="HEART FAILURE STUDY" />
    <edge source="HIGH-INCOME COUNTRIES" target="ONCOLOGY RANDOMIZED CONTROLLED TRIALS" />
    <edge source="HIGH-INCOME COUNTRIES" target="LOW-MIDDLE/UPPER-MIDDLE INCOME COUNTRIES" />
    <edge source="CVD" target="CARDIOVASCULAR RISK" />
    <edge source="CVD" target="DECISION TREE" />
    <edge source="CVD" target="DESCRIPTIVE FOREST" />
    <edge source="OPENAI" target="GPT-3" />
    <edge source="OPENAI" target="INSTRUCTGPT" />
    <edge source="OPENAI" target="GPT-3.5" />
    <edge source="OPENAI" target="GPT-4" />
    <edge source="MICROSOFT BING AI" target="PEYRONIE DISEASE" />
    <edge source="BARON AND KENNY APPROACH" target="STRUCTURAL EQUATION MODELING" />
    <edge source="CANTO" target="CHEMOTHERAPY DOSE-REDUCTIONS" />
    <edge source="CANTO" target="POSTCHEMOTHERAPY-TOXICITIES" />
    <edge source="HL7 FHIR" target="CDA" />
    <edge source="HL7 FHIR" target="HIPAA" />
    <edge source="HL7 FHIR" target="SNOMED-CT" />
    <edge source="HL7 FHIR" target="SOA" />
    <edge source="HL7 FHIR" target="RIM" />
    <edge source="HL7 FHIR" target="XML" />
    <edge source="HL7 FHIR" target="API" />
    <edge source="HL7 FHIR" target="JAVA" />
    <edge source="HL7 FHIR" target="SQL" />
    <edge source="HL7 FHIR" target="RDF" />
    <edge source="HL7 FHIR" target="ADLIFE" />
    <edge source="TURING MACHINE" target="COMPUTER" />
    <edge source="COMPUTER" target="PRACTITIONERS" />
    <edge source="PRACTITIONERS" target="ELECTRONIC DIGITAL COMPUTERS" />
    <edge source="ARDSFLAG" target="BERLIN DEFINITION" />
    <edge source="FORENSIC PSYCHIATRY DATABASE" target="MEDICAL TREATMENT AND SUPERVISION ACT (MTSA)" />
    <edge source="THE FEBS JOURNAL" target="SCIENTIFIC COMMUNITY" />
    <edge source="SCIENTIFIC COMMUNITY" target="LITERATURE REVIEWS" />
    <edge source="SCIENTIFIC COMMUNITY" target="RESEARCH" />
    <edge source="LITERATURE REVIEWS" target="REVIEW ARTICLES" />
    <edge source="RESEARCH" target="PREDICTIVE ALGORITHMS" />
    <edge source="CVD EVENTS" target="PATHWAYS STUDY" />
    <edge source="CORONAVIRUS DISEASE 2019" target="NORTH AMERICAN ASSOCIATION OF CENTRAL CANCER REGISTRIES" />
    <edge source="CORONAVIRUS DISEASE 2019" target="APRIL 2020" />
    <edge source="CORONAVIRUS DISEASE 2019" target="ASIANS/PACIFIC ISLANDERS" />
    <edge source="CORONAVIRUS DISEASE 2019" target="NOVEL CORONAVIRUS" />
    <edge source="CORONAVIRUS DISEASE 2019" target="GOVERNMENTS" />
    <edge source="PROGRAM VERIFICATION" target="ALGORITHMS" />
    <edge source="PROGRAM VERIFICATION" target="PROGRAMS" />
    <edge source="CESAREAN SECTION-INDUCED POSTPARTUM HEMORRHAGE" target="SHIJIAZHUANG OBSTETRICS AND GYNECOLOGY HOSPITAL" />
    <edge source="COMBINATION IMMUNOTHERAPY TREATMENTS" target="PRECISION-DRIVEN APPROACH" />
    <edge source="ITALIAN SPECIALIZED CENTERS" target="HEMOGLOBINOPATHIES STUDY" />
    <edge source="HEMOGLOBINOPATHIES STUDY" target="HEPATOCELLULAR CARCINOMA (HCC)" />
    <edge source="HEPATOCELLULAR CARCINOMA (HCC)" target="TRANSFUSION-DEPENDENT &#914;-THALASSEMIA" />
    <edge source="BPPV" target="AI-BASED METHODS" />
    <edge source="BPPV" target="MULTIMODAL DEEP LEARNING DIAGNOSTIC MODEL" />
    <edge source="BPPV" target="HOSPITAL" />
    <edge source="HOSPITAL" target="ACUTE PANCREATITIS" />
    <edge source="HOSPITAL" target="OUTPATIENT SERVICE" />
    <edge source="HOSPITAL" target="INTRACRANIAL ANEURYSM SURGERY" />
    <edge source="PANCREATIC DUCTAL ADENOCARCINOMA" target="S-1" />
    <edge source="QIAGEN INGENUITY PATHWAY ANALYSIS" target="GENEMANIA" />
    <edge source="RNASEQ DATA" target="PUBLIC REPOSITORIES" />
    <edge source="RNASEQ DATA" target="RANDOM FOREST MODEL" />
    <edge source="RANDOM FOREST MODEL" target="CROSS-VALIDATION" />
    <edge source="RANDOM FOREST MODEL" target="GANSU MEDICAL MEDIATION COMMITTEE" />
    <edge source="RANDOM FOREST MODEL" target="LGA BIRTHS" />
    <edge source="RANDOM FOREST MODEL" target="CRGNB" />
    <edge source="WOMEN" target="SLEEP DURATION" />
    <edge source="WOMEN" target="HEALTH INFORMATION TECHNOLOGIES" />
    <edge source="SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS" target="RANDOMIZED CONTROLLED TRIALS" />
    <edge source="SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS" target="MAY 2022" />
    <edge source="RANDOMIZED CONTROLLED TRIALS" target="NETWORK META-ANALYSIS" />
    <edge source="RANDOMIZED CONTROLLED TRIALS" target="J ORTHOP SPORTS PHYS THER" />
    <edge source="RANDOMIZED CONTROLLED TRIALS" target="EARLY-MID CAREER RESEARCHERS" />
    <edge source="RANDOMIZED CONTROLLED TRIALS" target="SENIOR RESEARCHERS" />
    <edge source="MAY 2022" target="CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH" />
    <edge source="PRIME" target="NCD SCENARIO MODELS" />
    <edge source="SHARED DECISION MAKING PROCESS" target="MONTREAL COGNITIVE ASSESSMENT TEST" />
    <edge source="SHARED DECISION MAKING PROCESS" target="SURE SCALE" />
    <edge source="SHARED DECISION MAKING PROCESS" target="ELECTIVE SURGERY" />
    <edge source="ICU" target="ANTI-THROMBOTIC THERAPY" />
    <edge source="ICU" target="RBC TRANSFUSION" />
    <edge source="ICU" target="HEMOGLOBIN THRESHOLDS" />
    <edge source="ICU" target="SEQUENTIAL ORGAN FAILURE ASSESSMENT" />
    <edge source="ICU" target="INFECTIVE ENDOCARDITIS" />
    <edge source="ICU" target="NOMOGRAM" />
    <edge source="MULTIPLE IMPUTATION" target="SHORT-TERM MORTALITY" />
    <edge source="MULTIPLE IMPUTATION" target="MID-NET&#174;" />
    <edge source="MULTIPLE IMPUTATION" target="SCENARIO 1" />
    <edge source="MULTIPLE IMPUTATION" target="SCENARIO 2" />
    <edge source="DEEP NEURAL NETWORKS" target="SHORT-TERM MORTALITY" />
    <edge source="DEEP NEURAL NETWORKS" target="TRANSFORMER MODEL" />
    <edge source="DEEP NEURAL NETWORKS" target="BROAD LEARNING SYSTEM" />
    <edge source="SHORT-TERM MORTALITY" target="PENALIZED REGRESSION" />
    <edge source="SHORT-TERM MORTALITY" target="STATISTICAL LEARNING APPROACHES" />
    <edge source="RONALD GIERE" target="ENLIGHTENMENT" />
    <edge source="RONALD GIERE" target="UNIVERSE" />
    <edge source="EXTREME GRADIENT BOOSTING (XGBOOST)" target="HEMODIALYSIS STUDY" />
    <edge source="LOGISTIC REGRESSION (LR)" target="AI-AIDED DIAGNOSTIC SYSTEM" />
    <edge source="BRUNO LATOUR" target="ROGER GUILLEMIN" />
    <edge source="ROGER GUILLEMIN" target="SALK INSTITUTE" />
    <edge source="PHILOSOPHERS" target="SCIENTISTS" />
    <edge source="SCIENTISTS" target="MODELS" />
    <edge source="UNITY OF SCIENCE" target="ORDER OF THINGS" />
    <edge source="UNITY OF SCIENCE" target="METAPHYSICS" />
    <edge source="INNBC DAPP" target="BNB SMART CHAIN" />
    <edge source="INNBC DAPP" target="AES ENCRYPTION" />
    <edge source="COLORECTAL CANCER SCREENING" target="DEFENSIVE INFORMATION PROCESSING (DIP)" />
    <edge source="COLORECTAL CANCER SCREENING" target="FECAL IMMUNOCHEMICAL TEST (FIT)" />
    <edge source="COLORECTAL CANCER SCREENING" target="FECAL OCCULT BLOOD TESTING" />
    <edge source="COLORECTAL CANCER SCREENING" target="FECAL IMMUNOCHEMICAL TESTING" />
    <edge source="COLORECTAL CANCER SCREENING" target="MULTITARGET STOOL DNA TESTING" />
    <edge source="COLORECTAL CANCER SCREENING" target="FLEXIBLE SIGMOIDOSCOPY" />
    <edge source="COLORECTAL CANCER SCREENING" target="COMPUTED TOMOGRAPHIC COLONOGRAPHY" />
    <edge source="COLORECTAL CANCER SCREENING" target="COLONOSCOPY" />
    <edge source="COLORECTAL CANCER SCREENING" target="CRC SCREENING STRATEGIES" />
    <edge source="COLORECTAL CANCER SCREENING" target="HISPANIC POPULATIONS" />
    <edge source="COLORECTAL CANCER SCREENING" target="NON-HISPANIC WHITE INDIVIDUALS" />
    <edge source="DEFENSIVE INFORMATION PROCESSING (DIP)" target="MCQUEEN DIP MEASURE" />
    <edge source="CARDIOVASCULAR DISEASES" target="ISFAHAN COHORT STUDY" />
    <edge source="CARDIOVASCULAR DISEASES" target="WORLD CANCER RESEARCH FUND/AMERICAN INSTITUTE FOR CANCER RESEARCH" />
    <edge source="CARDIOVASCULAR DISEASES" target="CHRONIC KIDNEY DISEASE" />
    <edge source="CARDIOVASCULAR DISEASES" target="GLOBAL DIETARY DATABASE" />
    <edge source="CARDIOVASCULAR DISEASES" target="LATIN AMERICA AND THE CARIBBEAN" />
    <edge source="CARDIOVASCULAR DISEASES" target="SUB-SAHARAN AFRICA" />
    <edge source="CARDIOVASCULAR DISEASES" target="SSB" />
    <edge source="CARDIOVASCULAR DISEASES" target="2020" />
    <edge source="ISFAHAN COHORT STUDY" target="BAYESIAN ADDITIVE REGRESSION TREES" />
    <edge source="ISFAHAN COHORT STUDY" target="MISSFOREST" />
    <edge source="ISFAHAN COHORT STUDY" target="RECURSIVE FEATURE ELIMINATION" />
    <edge source="ISFAHAN COHORT STUDY" target="QUADRATIC DISCRIMINANT ANALYSIS" />
    <edge source="ISFAHAN COHORT STUDY" target="DECISION TREES" />
    <edge source="TP53-RELATED CANCER SYNDROME" target="SWEDISH TP53 STUDY" />
    <edge source="TP53-RELATED CANCER SYNDROME" target="WHOLE-BODY MRI" />
    <edge source="SWEDISH TP53 STUDY" target="WHOLE-BODY MRI" />
    <edge source="AMERICAN HEART ASSOCIATION" target="GET WITH THE GUIDELINES-STROKE REGISTRY" />
    <edge source="AMERICAN HEART ASSOCIATION" target="GET WITH THE GUIDELINES-STROKE PROGRAM" />
    <edge source="GET WITH THE GUIDELINES-STROKE REGISTRY" target="DOOR-IN-DOOR-OUT TIME" />
    <edge source="DOOR-IN-DOOR-OUT TIME" target="NATIONAL INSTITUTES OF HEALTH" />
    <edge source="NATIONAL INSTITUTES OF HEALTH" target="FACULTY MEMBERS" />
    <edge source="NATIONAL INSTITUTES OF HEALTH" target="COMMON DATA ELEMENTS REPOSITORY" />
    <edge source="NATIONAL INSTITUTES OF HEALTH" target="PCOS" />
    <edge source="GENOMICS-BASED CLINICAL DIAGNOSIS" target="GENETICISTS" />
    <edge source="GENETICISTS" target="DATA DISPERSION" />
    <edge source="CLINVAR" target="ONCOLOGY" />
    <edge source="CLINVAR" target="CARDIOLOGY" />
    <edge source="ONCOLOGY" target="ENSEMBL" />
    <edge source="ONCOLOGY" target="GWAS CATALOG" />
    <edge source="ONCOLOGY" target="LOVD" />
    <edge source="ONCOLOGY" target="CIVIC" />
    <edge source="ONCOLOGY" target="CARDIODB" />
    <edge source="CARDIOLOGY" target="ENSEMBL" />
    <edge source="CARDIOLOGY" target="GWAS CATALOG" />
    <edge source="CARDIOLOGY" target="LOVD" />
    <edge source="CARDIOLOGY" target="CIVIC" />
    <edge source="CARDIOLOGY" target="CARDIODB" />
    <edge source="IMMUNE-CHECKPOINT BLOCKADE THERAPY" target="TRIPLE-NEGATIVE BREAST CANCER" />
    <edge source="TRIPLE-NEGATIVE BREAST CANCER" target="TYPE-I PROTEIN ARGININE METHYLTRANSFERASES" />
    <edge source="TYPE-I PROTEIN ARGININE METHYLTRANSFERASES" target="SINGLE-CELL TRANSCRIPTOMIC ANALYSIS" />
    <edge source="TUMOR MICROENVIRONMENT" target="MS023" />
    <edge source="TUMOR MICROENVIRONMENT" target="CD8 T-CELL" />
    <edge source="TUMOR MICROENVIRONMENT" target="INTRAHEPATIC CHOLANGIOCARCINOMA" />
    <edge source="MS023" target="ANTI-PROGRAMMED CELL DEATH PROTEIN 1 ANTIBODY" />
    <edge source="MS023" target="SYNGENEIC MURINE MODEL" />
    <edge source="CD8 T-CELL" target="SINGLE-CELL T-CELL RECEPTOR SEQUENCING" />
    <edge source="T-DXD" target="ADCS" />
    <edge source="ADCS" target="EXPERTS IN CHINA" />
    <edge source="PREDICTIVE ALGORITHMS" target="ONLINE CALCULATORS" />
    <edge source="PREDICTIVE ALGORITHMS" target="BLACK BOX MACHINE LEARNING METHODS" />
    <edge source="PREDICTIVE ALGORITHMS" target="JOURNALS" />
    <edge source="PREDICTIVE ALGORITHMS" target="FUNDERS" />
    <edge source="PREDICTIVE ALGORITHMS" target="CLINICAL GUIDELINES" />
    <edge source="PREDICTIVE ALGORITHMS" target="EXTERNAL VALIDATION" />
    <edge source="BLACK BOX MACHINE LEARNING METHODS" target="ALGORITHM IMPLEMENTATION" />
    <edge source="CLINICAL GUIDELINES" target="FERTILITY PRESERVATION" />
    <edge source="COMFORT-I" target="COMFORT-II" />
    <edge source="LEFT VENTRICULAR ASSIST DEVICES" target="VITAMIN K ANTAGONISTS" />
    <edge source="LEFT VENTRICULAR ASSIST DEVICES" target="INTERNATIONAL STUDY" />
    <edge source="VITAMIN K ANTAGONISTS" target="ENDOVASCULAR THROMBECTOMY" />
    <edge source="VITAMIN K ANTAGONISTS" target="ACUTE ISCHEMIC STROKE" />
    <edge source="INTERNATIONAL STUDY" target="CLINICALTRIALS.GOV IDENTIFIER: NCT04069156" />
    <edge source="MYCOSIS FUNGOIDES" target="T-CELL RECEPTOR GENE REARRANGEMENT" />
    <edge source="MYCOSIS FUNGOIDES" target="FLOW CYTOMETRY" />
    <edge source="MYCOSIS FUNGOIDES" target="LACTATE DEHYDROGENASE" />
    <edge source="FLOW CYTOMETRY" target="INTRAHEPATIC CHOLANGIOCARCINOMA" />
    <edge source="SPANISH POPULATION" target="GOMPERTZ DISTRIBUTION" />
    <edge source="SPANISH POPULATION" target="WEIBULL DISTRIBUTION" />
    <edge source="SPANISH POPULATION" target="LOG-NORMAL DISTRIBUTION" />
    <edge source="DENTAL SERVICES UTILIZATION STUDY" target="CRISP-DM" />
    <edge source="DENTAL SERVICES UTILIZATION STUDY" target="RAPIDMINER" />
    <edge source="VIRTUAL REALITY DEMENTIA DIAGNOSIS TOOLS" target="PRIMARY HEALTHCARE ORGANIZATIONS" />
    <edge source="NCCN/FACT BLADDER SYMPTOM INDEX-18" target="JAVELIN BLADDER 100" />
    <edge source="NCCN/FACT BLADDER SYMPTOM INDEX-18" target="EUROQOL-5D UTILITY INDEX" />
    <edge source="NCCN/FACT BLADDER SYMPTOM INDEX-18" target="EASTERN COOPERATIVE ONCOLOGY GROUP" />
    <edge source="JAVELIN BLADDER 100" target="AVELUMAB" />
    <edge source="EASTERN COOPERATIVE ONCOLOGY GROUP" target="HEAD AND NECK SQUAMOUS CELL CARCINOMA" />
    <edge source="EASTERN COOPERATIVE ONCOLOGY GROUP" target="KRAS-POSITIVE NSCLC" />
    <edge source="EASTERN COOPERATIVE ONCOLOGY GROUP" target="METASTATIC UVEAL MELANOMA" />
    <edge source="AVELUMAB" target="MERKEL CELL CARCINOMA" />
    <edge source="AVELUMAB" target="FDG-PET/CT" />
    <edge source="AVELUMAB" target="RECURRENCE-FREE SURVIVAL" />
    <edge source="AVELUMAB" target="NOVEMBER 2017 TO FEBRUARY 2022" />
    <edge source="RA PRO DASHBOARD" target="RA PATIENTS" />
    <edge source="RA PRO DASHBOARD" target="ECOLOGICAL MODEL OF HEALTH" />
    <edge source="DISTILLERSR" target="MAY 2020 RELEASE" />
    <edge source="DISTILLERSR" target="CANCER RESEARCH" />
    <edge source="DISTILLERSR" target="SYSTEMATIC REVIEW TOOLBOX" />
    <edge source="DISTILLERSR" target="LIVING REVIEWS" />
    <edge source="PSILOCYBIN" target="MAJOR DEPRESSIVE DISORDER" />
    <edge source="PSILOCYBIN" target="NIACIN" />
    <edge source="PSILOCYBIN" target="MONTGOMERY-ASBERG DEPRESSION RATING SCALE" />
    <edge source="PSILOCYBIN" target="SHEEHAN DISABILITY SCALE" />
    <edge source="UK" target="SCIENTIFIC ADVISORY GROUP FOR EMERGENCIES (SAGE)" />
    <edge source="UK" target="DIGITAL PROFESSIONALISM" />
    <edge source="UK" target="COMA RECOVERY SCALE-REVISED" />
    <edge source="UK" target="MUSIC THERAPY ASSESSMENT TOOL FOR AWARENESS IN DISORDERS OF CONSCIOUSNESS" />
    <edge source="UK" target="EUROQOL 5-DIMENSION (EQ-5D)" />
    <edge source="UK" target="CARDIOVASCULAR DISEASE (CVD)" />
    <edge source="UK" target="HEALTH INFORMATICS COLLABORATIVE" />
    <edge source="UK" target="NOVEL HEALTHCARE TECHNOLOGIES" />
    <edge source="UK" target="CRYOSTAT-2" />
    <edge source="UK" target="ADLIFE" />
    <edge source="UK" target="HOSPITALS" />
    <edge source="UK" target="COVID-19 VACCINE" />
    <edge source="UK" target="EXPERIMENT 3" />
    <edge source="INFECTIOUS DISEASE MODELLING" target="PRISMA" />
    <edge source="INFECTIOUS DISEASE MODELLING" target="MEDRXIV" />
    <edge source="INFECTIOUS DISEASE MODELLING" target="BIORXIV" />
    <edge source="SCIENTIFIC ADVISORY GROUP FOR EMERGENCIES (SAGE)" target="SPI-M-O (SCIENTIFIC PANDEMIC INFLUENZA GROUP ON MODELLING-OPERATIONAL)" />
    <edge source="SCIENTIFIC ADVISORY GROUP FOR EMERGENCIES (SAGE)" target="UK GOVERNMENT" />
    <edge source="SPI-M-O (SCIENTIFIC PANDEMIC INFLUENZA GROUP ON MODELLING-OPERATIONAL)" target="UK GOVERNMENT" />
    <edge source="JANUARY 2020" target="JULY 2020" />
    <edge source="CALIFORNIA" target="INSURANCE GENDER NONDISCRIMINATION ACT" />
    <edge source="CALIFORNIA" target="WASHINGTON" />
    <edge source="CALIFORNIA" target="ARIZONA" />
    <edge source="CALIFORNIA" target="GERMLINE GENETIC TESTING" />
    <edge source="CALIFORNIA" target="SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS REGISTRIES" />
    <edge source="CALIFORNIA" target="DUCTAL CARCINOMA IN SITU (DCIS)" />
    <edge source="CALIFORNIA" target="MENINGIOMA CONSORTIUM" />
    <edge source="CALIFORNIA" target="CALIFORNIA CANCER REGISTRY" />
    <edge source="CALIFORNIA" target="KIDNEY CANCER STUDY" />
    <edge source="NATIONAL INSTITUTE OF HEALTH" target="ALL OF US" />
    <edge source="ALL OF US" target="ADVERSE DRUG EVENTS" />
    <edge source="ADVERSE DRUG EVENTS" target="SELECTIVE SEROTONIN REUPTAKE INHIBITOR" />
    <edge source="ADVERSE DRUG EVENTS" target="MEDICATION ADMINISTRATION CLINICAL DECISION SUPPORT SYSTEMS" />
    <edge source="OLDER WOMEN WITH BREAST CANCER" target="TOXICITY-RELATED HOSPITALIZATION" />
    <edge source="OLDER WOMEN WITH BREAST CANCER" target="GERIATRIC ASSESSMENT" />
    <edge source="OLDER WOMEN WITH BREAST CANCER" target="FALL HISTORY" />
    <edge source="TOXICITY-RELATED HOSPITALIZATION" target="FALL HISTORY" />
    <edge source="US DIABETES, OBESITY, CARDIOVASCULAR DISEASE MICROSIMULATION (DOC-M) MODEL" target="NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES)" />
    <edge source="US DIABETES, OBESITY, CARDIOVASCULAR DISEASE MICROSIMULATION (DOC-M) MODEL" target="MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS" />
    <edge source="US DIABETES, OBESITY, CARDIOVASCULAR DISEASE MICROSIMULATION (DOC-M) MODEL" target="PRODUCE PRESCRIPTION PROGRAM" />
    <edge source="MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS" target="POLYGENIC RISK SCORE" />
    <edge source="ETNK1 MUTATION" target="MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM" />
    <edge source="ETNK1 MUTATION" target="ASXL1 MUTATION" />
    <edge source="ETNK1 MUTATION" target="TET2 MUTATION" />
    <edge source="ETNK1 MUTATION" target="EZH2 MUTATION" />
    <edge source="ETNK1 MUTATION" target="RUNX1 MUTATION" />
    <edge source="ETNK1 MUTATION" target="SRSF2 MUTATION" />
    <edge source="ATHENA COVID-19 FEASIBILITY STUDY" target="QUEENSLAND" />
    <edge source="ATHENA COVID-19 FEASIBILITY STUDY" target="QUEENSLAND HEALTH" />
    <edge source="FACULTY MEMBERS" target="MINORITIZED GROUPS" />
    <edge source="ACADEMIC MEDICINE" target="MINORITIZED GROUPS" />
    <edge source="TANZANIA" target="SICKLE PAN AFRICA RESEARCH CONSORTIUM (SPARCO)" />
    <edge source="TANZANIA" target="MATERNAL, NEWBORN, AND CHILD HEALTHCARE CONTINUUM" />
    <edge source="EASTERN COOPERATIVE ONCOLOGY GROUP-AMERICAN COLLEGE OF RADIOLOGY IMAGING NETWORK" target="E1900" />
    <edge source="EASTERN COOPERATIVE ONCOLOGY GROUP-AMERICAN COLLEGE OF RADIOLOGY IMAGING NETWORK" target="E3999" />
    <edge source="ACUTE MYELOID LEUKEMIA (AML)" target="TEXAS CANCER REGISTRY" />
    <edge source="ACUTE MYELOID LEUKEMIA (AML)" target="ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)" />
    <edge source="ACUTE MYELOID LEUKEMIA (AML)" target="KMT2A-REARRANGED AML" />
    <edge source="CAROL BENNETT" target="COLLEAGUES" />
    <edge source="FDA" target="510(K) PATHWAY" />
    <edge source="FDA" target="CLASS I RECALL" />
    <edge source="FDA" target="DEVICES@FDA" />
    <edge source="510(K) PATHWAY" target="CLASS I RECALL" />
    <edge source="510(K) PATHWAY" target="REGULATORY INTELLIGENCE PLATFORM" />
    <edge source="HYPERLEDGER-FABRIC" target="EMERGENCY CLINICIANS" />
    <edge source="HYPERLEDGER-FABRIC" target="BLOCKCHAIN NETWORK" />
    <edge source="EMERGENCY CLINICIANS" target="PATIENT" />
    <edge source="PATIENT" target="BLOCKCHAIN NETWORK" />
    <edge source="PATIENT" target="CAREGIVER" />
    <edge source="PATIENT" target="TREATMENT DECISION-MAKING" />
    <edge source="CNN-RES" target="NEUROSCIENCE CENTER OF TABRIZ UNIVERSITY OF MEDICAL SCIENCES" />
    <edge source="CNN-RES" target="SPES 2015" />
    <edge source="CNN-RES" target="MRI" />
    <edge source="NEUROSCIENCE CENTER OF TABRIZ UNIVERSITY OF MEDICAL SCIENCES" target="TABRIZ" />
    <edge source="MRI" target="TAMOXIFEN" />
    <edge source="MRI" target="AGES-REYKJAVIK STUDY" />
    <edge source="COCHRANE RAPID REVIEWS METHODS GROUP" target="RAPID REVIEWS" />
    <edge source="COCHRANE RAPID REVIEWS METHODS GROUP" target="COCHRANE" />
    <edge source="RAPID REVIEWS" target="COCHRANE" />
    <edge source="RAPID REVIEWS" target="POLICY MAKERS" />
    <edge source="VAN FRAASSEN" target="SCIENTIFIC REALISM" />
    <edge source="VAN FRAASSEN" target="HACKING" />
    <edge source="VAN FRAASSEN" target="DA COSTA" />
    <edge source="VAN FRAASSEN" target="FRENCH" />
    <edge source="PASC" target="RECOVER" />
    <edge source="RECOVER" target="WASHINGTON, DC" />
    <edge source="RECOVER" target="PUERTO RICO" />
    <edge source="INVOLUNTARY DISPLACEMENT" target="SUBSTANCE USE DISORDER" />
    <edge source="INVOLUNTARY DISPLACEMENT" target="OVERDOSE MORTALITY" />
    <edge source="INVOLUNTARY DISPLACEMENT" target="SERIOUS INJECTION-RELATED INFECTIONS" />
    <edge source="INVOLUNTARY DISPLACEMENT" target="MEDICATIONS FOR OPIOID USE DISORDER" />
    <edge source="CENTERS FOR DISEASE CONTROL AND PREVENTION" target="NATIONAL HIV BEHAVIORAL SURVEILLANCE" />
    <edge source="GRAVES DISEASE" target="HYPERTHYROIDISM" />
    <edge source="HYPERTHYROIDISM" target="TOXIC NODULES" />
    <edge source="HYPERTHYROIDISM" target="THYROTOXICOSIS" />
    <edge source="THYROTOXICOSIS" target="THYROIDITIS" />
    <edge source="CRUZR" target="ANDROID" />
    <edge source="CRUZR" target="WEBSOCKET" />
    <edge source="CRUZR" target="GOOGLE CLOUD" />
    <edge source="CRUZR" target="HEALTHCARE USE CASES" />
    <edge source="CRUZR" target="ANDROID TABLET" />
    <edge source="ANDROID" target="PEPPER" />
    <edge source="WEBSOCKET" target="PEPPER" />
    <edge source="WEBSOCKET" target="PYTHON" />
    <edge source="GOOGLE CLOUD" target="CLOUD SERVICES" />
    <edge source="PYTHON" target="GUROBI SOLVER ENGINE" />
    <edge source="PYTHON" target="CONSTRAINED OPTIMIZATION" />
    <edge source="PYTHON" target="UNIVERSITY OF GONDAR COMPREHENSIVE AND SPECIALIZED HOSPITAL" />
    <edge source="NHS" target="SOUTH WEST OF ENGLAND" />
    <edge source="NHS" target="LONDON" />
    <edge source="NHS" target="YORKSHIRE" />
    <edge source="NHS" target="WELSH AMBULANCE SERVICES" />
    <edge source="NHS" target="INTEROPERABILITY" />
    <edge source="LONDON" target="THIRD MEETING OF ICASR" />
    <edge source="FACEBOOK'S PROPHET" target="ARIMA" />
    <edge source="LAB2CLEAN" target="R FUNCTIONS" />
    <edge source="LAB2CLEAN" target="ELECTRONIC MEDICAL RECORD DATABASES" />
    <edge source="LAB2CLEAN" target="CLINICAL LABORATORY DATA" />
    <edge source="CLINICAL LABORATORY DATA" target="MACHINE LEARNING MODELS IN HEALTHCARE" />
    <edge source="CLINICAL LABORATORY DATA" target="CLINICAL RESEARCH" />
    <edge source="MACHINE LEARNING MODELS IN HEALTHCARE" target="CLINICAL RESEARCH" />
    <edge source="REPORTING GUIDELINES" target="STUDY DESIGNS" />
    <edge source="REPORTING GUIDELINES" target="MODELLING STUDIES" />
    <edge source="REPORTING GUIDELINES" target="POPULATION MODELLING" />
    <edge source="REPORTING GUIDELINES" target="JOURNAL EDITORS" />
    <edge source="REPORTING GUIDELINES" target="PUBLISHERS" />
    <edge source="REPORTING GUIDELINES" target="SOCIETY AT LARGE" />
    <edge source="EMERGENCY DEPARTMENT" target="CANADIAN YOUTH" />
    <edge source="CHARLSON COMORBIDITY INDEX" target="CALIFORNIA CANCER REGISTRY" />
    <edge source="CMEIE DATASET" target="CHINESE-ROBERTA-CRF MODEL" />
    <edge source="ACTIVE LEARNING" target="DISTANT SUPERVISION" />
    <edge source="ACTIVE LEARNING" target="RELATION EXTRACTION" />
    <edge source="ACTIVE LEARNING" target="SYSTEMATIC REVIEW" />
    <edge source="ACTIVE LEARNING" target="REVIEWERS" />
    <edge source="ACTIVE LEARNING" target="WORKFLOW" />
    <edge source="ACTIVE LEARNING" target="WORK SAVED OVER SAMPLING (WSS)" />
    <edge source="ACTIVE LEARNING" target="AVERAGE TIME TO DISCOVERY (ATD)" />
    <edge source="ACTIVE LEARNING" target="SIMULATION STUDY" />
    <edge source="ACTIVE LEARNING" target="RECALL" />
    <edge source="ACTIVE LEARNING" target="PRISMA GUIDELINES" />
    <edge source="ACTIVE LEARNING" target="RDAL-CHECKLIST" />
    <edge source="DISTANT SUPERVISION" target="RELATION EXTRACTION" />
    <edge source="RELATION EXTRACTION" target="MEDICAL RESEARCH" />
    <edge source="RELATION EXTRACTION" target="UNSTRUCTURED TEXTS" />
    <edge source="MEDICAL RESEARCH" target="OUTLIER DETECTION" />
    <edge source="PERSIAN LANGUAGE" target="PERTO" />
    <edge source="PERTO" target="F1-SCORE" />
    <edge source="CANCER DISPARITIES" target="ANTHROPOGENIC CLIMATE CHANGE" />
    <edge source="MACHINE LEARNING METHODS" target="DEPRESSION" />
    <edge source="MACHINE LEARNING METHODS" target="PRISMA PROCESS" />
    <edge source="MACHINE LEARNING METHODS" target="PREDICTION MODELLING" />
    <edge source="MACHINE LEARNING METHODS" target="CHILD ABUSE AND NEGLECT" />
    <edge source="NEURAL NETWORK-BASED MODEL" target="OTORHINOLARYNGOLOGY" />
    <edge source="NEURAL NETWORK-BASED MODEL" target="PEDIATRICS" />
    <edge source="NEURAL NETWORK-BASED MODEL" target="HYBRID MODEL" />
    <edge source="MACHINE LEARNING ALGORITHMS" target="AMYOTROPHIC LATERAL SCLEROSIS" />
    <edge source="MACHINE LEARNING ALGORITHMS" target="POLYPHARMACY" />
    <edge source="MACHINE LEARNING ALGORITHMS" target="AUTOMATIC CLASSIFIER" />
    <edge source="MACHINE LEARNING ALGORITHMS" target="GASTRIC STROMAL TUMORS" />
    <edge source="ARTIFICIAL NEURAL NETWORKS" target="FUZZY EXPERT SYSTEM" />
    <edge source="ARTIFICIAL NEURAL NETWORKS" target="EDDIE" />
    <edge source="NYHA FUNCTIONAL CLASSIFICATION" target="CNN-LSTM-SE MODEL" />
    <edge source="LOBAR RESECTION" target="SUBLOBAR RESECTION" />
    <edge source="LOBAR RESECTION" target="LOBECTOMY" />
    <edge source="SUBLOBAR RESECTION" target="LOBECTOMY" />
    <edge source="LOBECTOMY" target="ATRIAL FIBRILLATION AND FLUTTER (AF)" />
    <edge source="GENERAL PRACTITIONERS" target="NATIONAL HEALTH SERVICE" />
    <edge source="GENERAL PRACTITIONERS" target="AI DIAGNOSIS ASSISTANT WEB APPLICATION" />
    <edge source="GENERAL PRACTITIONERS" target="DECISION FATIGUE" />
    <edge source="GENERAL PRACTITIONERS" target="ANTIBIOTICS" />
    <edge source="GENERAL PRACTITIONERS" target="STATINS" />
    <edge source="GENERAL PRACTITIONERS" target="OSTEOPOROSIS MEDICATIONS" />
    <edge source="GENERAL PRACTITIONERS" target="BENZODIAZEPINES" />
    <edge source="GENERAL PRACTITIONERS" target="OPIOIDS" />
    <edge source="GENERAL PRACTITIONERS" target="SHARED DECISION-MAKING SUPPORT TRAINING" />
    <edge source="GENERAL PRACTITIONERS" target="ENCOUNTER DECISION AIDS" />
    <edge source="GENERAL PRACTITIONERS" target="DECISION SUPPORT SYSTEM" />
    <edge source="GENERAL PRACTITIONERS" target="DIAGNOSTIC ERRORS" />
    <edge source="GENERAL PRACTITIONERS" target="VIRTUAL GROUPS" />
    <edge source="GENERAL PRACTITIONERS" target="COLLECTIVE INTELLIGENCE" />
    <edge source="NATIONAL HEALTH SERVICE" target="BREAST SCREENING PROGRAM" />
    <edge source="NATIONAL HEALTH SERVICE" target="NHS HEALTH CHECK PROGRAMME" />
    <edge source="NATIONAL HEALTH SERVICE" target="RANDOMIZED CONTROLLED TRIAL" />
    <edge source="AI DIAGNOSIS ASSISTANT WEB APPLICATION" target="BERT+CNN HYBRID ARCHITECTURE" />
    <edge source="COMPLAINT SYMPTOMS INTEGRATION METHOD" target="INTEGRATION DATASET" />
    <edge source="INTEGRATION DATASET" target="SYMPTOM DOT SEPARATING METHOD" />
    <edge source="INTEGRATION DATASET" target="BERT+CNN HYBRID ARCHITECTURE" />
    <edge source="BERT+CNN HYBRID ARCHITECTURE" target="NEUROLOGICAL DISEASES" />
    <edge source="ROME CRITERIA" target="FGID" />
    <edge source="ROME CRITERIA" target="PURE CLUSTERS" />
    <edge source="ROME CRITERIA" target="FGIDS" />
    <edge source="FGID" target="GI SYMPTOMS" />
    <edge source="FGID" target="PSYCHOLOGICAL FACTORS" />
    <edge source="FGID" target="UNSUPERVISED MACHINE LEARNING ALGORITHM" />
    <edge source="FGID" target="CROSS-SECTIONAL STUDY" />
    <edge source="PURE CLUSTERS" target="GI SYMPTOMS" />
    <edge source="GI SYMPTOMS" target="FGIDS" />
    <edge source="GI SYMPTOMS" target="UNSUPERVISED MACHINE LEARNING ALGORITHM" />
    <edge source="GI SYMPTOMS" target="NON-PURE CLUSTERS" />
    <edge source="PSYCHOLOGICAL FACTORS" target="NEW CLUSTERS" />
    <edge source="PSYCHOLOGICAL FACTORS" target="FGIDS" />
    <edge source="PSYCHOLOGICAL FACTORS" target="UNSUPERVISED MACHINE LEARNING ALGORITHM" />
    <edge source="UNSUPERVISED MACHINE LEARNING ALGORITHM" target="FGIDS" />
    <edge source="CROSS-SECTIONAL STUDY" target="FGIDS" />
    <edge source="NEW CLUSTERS" target="NON-PURE CLUSTERS" />
    <edge source="NEW CLUSTERS" target="RE-CLUSTERING" />
    <edge source="NON-PURE CLUSTERS" target="RE-CLUSTERING" />
    <edge source="2021-2022 INFLUENZA SEASON" target="A(H3N2) VIRUS" />
    <edge source="GUROBI SOLVER ENGINE" target="CONSTRAINED OPTIMIZATION" />
    <edge source="CONSTRAINED OPTIMIZATION" target="HEALTH APPLICATIONS" />
    <edge source="STEREOTACTIC BODY RADIOTHERAPY (SBRT)" target="MAGNETIC RESONANCE-GUIDED DAILY ADAPTIVE SBRT (MRG-A-SBRT)" />
    <edge source="STEREOTACTIC BODY RADIOTHERAPY (SBRT)" target="COMPUTED TOMOGRAPHY-GUIDED NON-ADAPTIVE PROSTATE SBRT (CT-SBRT)" />
    <edge source="PRISMA GUIDELINES" target="META-ANALYSIS" />
    <edge source="META-ANALYSIS" target="MEDLINE (PUBMED)" />
    <edge source="META-ANALYSIS" target="GOOGLE SCHOLAR" />
    <edge source="META-ANALYSIS" target="TIME FROM DIAGNOSIS TO TREATMENT" />
    <edge source="META-ANALYSIS" target="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK" />
    <edge source="META-ANALYSIS" target="HORMONE RECEPTOR&#8211;POSITIVE BREAST CANCER" />
    <edge source="META-ANALYSIS" target="NUDGES" />
    <edge source="META-ANALYSIS" target="SYSTEMATIC REVIEW" />
    <edge source="META-ANALYSIS" target="SIMULATING INDIVIDUAL-LEVEL TRIAL DATA" />
    <edge source="META-ANALYSIS" target="GENERALIZED ANXIETY DISORDER (GAD)" />
    <edge source="GOOGLE SCHOLAR" target="PRISMA-SCR" />
    <edge source="GOOGLE SCHOLAR" target="DATA QUALITY IN HEALTH INFORMATION SYSTEMS" />
    <edge source="GOOGLE SCHOLAR" target="SYSTEMATIC REVIEW" />
    <edge source="GOOGLE SCHOLAR" target="MACHINE LEARNING IN MENTAL HEALTH RESEARCH" />
    <edge source="GOOGLE SCHOLAR" target="TELEMEDICINE TECHNOLOGY" />
    <edge source="NRG/RADIATION THERAPY ONCOLOGY GROUP" target="RTOG 9406" />
    <edge source="NRG/RADIATION THERAPY ONCOLOGY GROUP" target="RTOG 0126" />
    <edge source="L4-L5" target="L5" />
    <edge source="DIGITAL MAMMOGRAPHY" target="NATIVE AMERICAN WOMEN" />
    <edge source="DIGITAL MAMMOGRAPHY" target="RURAL RESIDENTS" />
    <edge source="DIGITAL MAMMOGRAPHY" target="US WOMEN" />
    <edge source="POLIO ANTIVIRAL DRUGS" target="POLIO ERADICATION" />
    <edge source="POLIO ERADICATION" target="ORAL POLIOVIRUS VACCINE" />
    <edge source="POLIO ERADICATION" target="SABIN OPV" />
    <edge source="POLIO ERADICATION" target="IMMUNODEFICIENCY-RELATED VACCINE-DERIVED POLIOVIRUS" />
    <edge source="AIRWAY STENOSIS" target="LUNG TRANSPLANTATION" />
    <edge source="AIRWAY STENOSIS" target="LOGISTIC REGRESSION MODEL" />
    <edge source="LOGISTIC REGRESSION MODEL" target="LGA BIRTHS" />
    <edge source="LOGISTIC REGRESSION MODEL" target="MACHINE LEARNING APPROACHES" />
    <edge source="RANDOM FOREST ALGORITHM" target="EPILEPSY" />
    <edge source="NCT02582957" target="TRAUMA PATIENTS" />
    <edge source="TRAUMA PATIENTS" target="ACUTE RESPIRATORY DISTRESS SYNDROME" />
    <edge source="U.S. COVID-19 SCENARIO MODELING HUB" target="EPIDEMIC" />
    <edge source="EPIDEMIC" target="VACCINATION CAMPAIGN" />
    <edge source="EPIDEMIC" target="MC-SEIRSV MODEL" />
    <edge source="EPIDEMIC" target="NPI" />
    <edge source="EPIDEMIC" target="VACCINATION" />
    <edge source="EPIDEMIC" target="COMMUNITY TRANSMISSION" />
    <edge source="EPIDEMIC" target="HOUSEHOLD TRANSMISSION" />
    <edge source="NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY" target="DEEP CONVOLUTIONAL AUTOENCODERS" />
    <edge source="NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY" target="SECONDHAND SMOKE" />
    <edge source="NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY" target="CANCER SURVIVORS" />
    <edge source="NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY" target="CARDIOVASCULAR RISK FACTORS STUDY" />
    <edge source="DEEP CONVOLUTIONAL AUTOENCODERS" target="K-MEANS ALGORITHM" />
    <edge source="EARLY-MORNING MOVERS" target="HIGHEST ACTIVITY" />
    <edge source="EARLY-MORNING MOVERS" target="LOWEST ACTIVITY" />
    <edge source="HIGHEST ACTIVITY" target="LOWEST ACTIVITY" />
    <edge source="LOWEST ACTIVITY" target="LEAST SEDENTARY MOVERS" />
    <edge source="CATARACT SURGERY" target="MAIN SURGEON" />
    <edge source="CNN" target="LSTM" />
    <edge source="CNN" target="PCOS" />
    <edge source="LSTM" target="DEEP LEARNING-BASED NLP" />
    <edge source="LSTM" target="AGITATION CLASSIFIER" />
    <edge source="CATARACT-101" target="TIMELSTM" />
    <edge source="CATARACT-101" target="RSDNET" />
    <edge source="CATARACT-101" target="CATANET" />
    <edge source="SOUTH DAKOTA" target="MONUMENT HEALTH CANCER CARE INSTITUTE" />
    <edge source="US PREVENTIVE SERVICES TASK FORCE (USPSTF)" target="GENITAL HERPES" />
    <edge source="SCOPING REVIEWS" target="EVIDENCE SYNTHESIS" />
    <edge source="SCOPING REVIEWS" target="JBI SCOPING REVIEW METHODOLOGY GROUP" />
    <edge source="SCOPING REVIEWS" target="PRISMA-SCR" />
    <edge source="EVIDENCE SYNTHESIS" target="AI METHODS" />
    <edge source="EVIDENCE SYNTHESIS" target="JBI SCOPING REVIEW METHODOLOGY GROUP" />
    <edge source="PHILOSOPHY OF SCIENCE" target="ROBUSTNESS" />
    <edge source="PHILOSOPHY OF SCIENCE" target="2004 PSA MEETING" />
    <edge source="PHILOSOPHY OF SCIENCE" target="NANOSCIENCE" />
    <edge source="PHILOSOPHY OF SCIENCE" target="SCIENTIFIC THEORIES" />
    <edge source="NETWORK META-ANALYSIS" target="TRI-STATE MARKOV MODEL" />
    <edge source="NETWORK META-ANALYSIS" target="EVIDENCE BASE" />
    <edge source="NETWORK META-ANALYSIS" target="TOPSIS" />
    <edge source="NETWORK META-ANALYSIS" target="VIKOR" />
    <edge source="NETWORK META-ANALYSIS" target="PROMETHEE" />
    <edge source="NETWORK META-ANALYSIS" target="ANALYTIC HIERARCHY PROCESS" />
    <edge source="NETWORK META-ANALYSIS" target="ENTROPY METHOD" />
    <edge source="TRI-STATE MARKOV MODEL" target="PARAMETRIC SURVIVAL FUNCTIONS" />
    <edge source="TRI-STATE MARKOV MODEL" target="FRACTIONAL POLYNOMIALS" />
    <edge source="OVERALL SURVIVAL" target="PROGRESSION-FREE SURVIVAL" />
    <edge source="OVERALL SURVIVAL" target="TIME FROM DIAGNOSIS TO TREATMENT" />
    <edge source="OVERALL SURVIVAL" target="ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION" />
    <edge source="OVERALL SURVIVAL" target="EWING SARCOMA" />
    <edge source="OVERALL SURVIVAL" target="OVARIAN CANCER" />
    <edge source="OVERALL SURVIVAL" target="ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)" />
    <edge source="OVERALL SURVIVAL" target="ANAL SQUAMOUS CELL CARCINOMA" />
    <edge source="OVERALL SURVIVAL" target="BRCA1/2 MUTATIONS" />
    <edge source="OVERALL SURVIVAL" target="KAPLAN-MEIER METHOD" />
    <edge source="OVERALL SURVIVAL" target="ADJUVANT RADIATION THERAPY" />
    <edge source="OVERALL SURVIVAL" target="COMPLETE REMISSION" />
    <edge source="OVERALL SURVIVAL" target="DISEASE-FREE SURVIVAL" />
    <edge source="OVERALL SURVIVAL" target="SPINAL METASTASES" />
    <edge source="OVERALL SURVIVAL" target="POSTOPERATIVE RECURRENCE-FREE SURVIVAL" />
    <edge source="PROGRESSION-FREE SURVIVAL" target="CAR T-CELL THERAPY" />
    <edge source="PROGRESSION-FREE SURVIVAL" target="OVARIAN CANCER" />
    <edge source="PROGRESSION-FREE SURVIVAL" target="PD-(L)1 INHIBITORS" />
    <edge source="PROGRESSION-FREE SURVIVAL" target="SIGNAL TRANSDUCTION PATHWAY" />
    <edge source="CANCER SCREENING" target="UK POPULATION" />
    <edge source="CANCER SCREENING" target="PHENOTYPIC RISK PREDICTION MODELS" />
    <edge source="CANCER SCREENING" target="POLYGENIC RISK PREDICTION MODELS" />
    <edge source="CANCER SCREENING" target="5-YEAR SURVIVAL RATES" />
    <edge source="CANCER SCREENING" target="INCIDENCE" />
    <edge source="CANCER SCREENING" target="LAYPEOPLE" />
    <edge source="CANCER SCREENING" target="EARLY DETECTION" />
    <edge source="CANCER SCREENING" target="MATHEMATICAL MODELING" />
    <edge source="HEART FAILURE-A CONTROLLED TRIAL INVESTIGATING OUTCOMES OF EXERCISE TRAINING (HF-ACTION)" target="NOMOGRAM MODEL" />
    <edge source="NOMOGRAM MODEL" target="AMERICAN POPULATION" />
    <edge source="MACHINE LEARNING TOOLS" target="AUTOMATED SIMULATION" />
    <edge source="MACHINE LEARNING TOOLS" target="SEMI-AUTOMATED SIMULATION" />
    <edge source="MACHINE LEARNING TOOLS" target="SYSTEMATIC REVIEWERS" />
    <edge source="TRAUMA-INFORMED CARE" target="SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ASSOCIATION" />
    <edge source="SIMULATION" target="ORGANIZATIONAL SYSTEMS" />
    <edge source="SIMULATION" target="PROCESSES" />
    <edge source="SIMULATION" target="DECISION-MAKERS" />
    <edge source="SIMULATION" target="AUTHOR" />
    <edge source="SIMULATION" target="ECONOMICS" />
    <edge source="SWEDISH QUALITY REGISTER FOR EAR SURGERY" target="SWEDISH OTOSURGICAL SOCIETY" />
    <edge source="HEALTH PROFESSIONS' STUDENTS" target="JORDAN" />
    <edge source="HEALTH PROFESSIONS' STUDENTS" target="ONLINE QUESTIONNAIRE" />
    <edge source="KNOWLEDGE, ATTITUDES, AND PRACTICES (KAP)" target="QUANTILE REGRESSION MODELS" />
    <edge source="JORDAN" target="MEDICATION DELIVERY SYSTEM" />
    <edge source="SAN FRANCISCO BAY-DELTA MODEL" target="LOTKA-VOLTERRA MODEL" />
    <edge source="SAN FRANCISCO BAY-DELTA MODEL" target="SCHELLING'S SEGREGATION MODEL" />
    <edge source="LOTKA-VOLTERRA MODEL" target="SCHELLING'S SEGREGATION MODEL" />
    <edge source="POPULATION ASSESSMENT OF TOBACCO AND HEALTH STUDY" target="CANCER SURVIVORS" />
    <edge source="CANCER SURVIVORS" target="CANNABIS USE" />
    <edge source="CANCER SURVIVORS" target="CANNABIS USE FOR MEDICAL PURPOSES" />
    <edge source="CANCER SURVIVORS" target="MEDICAL EXPENDITURE PANEL SURVEY" />
    <edge source="CANCER SURVIVORS" target="CANCER PATIENTS" />
    <edge source="CANCER SURVIVORS" target="EMPLOYERS" />
    <edge source="CANCER SURVIVORS" target="SECONDHAND SMOKE" />
    <edge source="CANCER SURVIVORS" target="SHARED DECISION-MAKING SUPPORT TRAINING" />
    <edge source="CANCER SURVIVORS" target="CANCER PREVENTION STUDY II" />
    <edge source="CANCER SURVIVORS" target="COMORBIDITY TRAJECTORIES" />
    <edge source="CANCER SURVIVORS" target="SMOKING" />
    <edge source="CANCER SURVIVORS" target="ADULT CANCER SURVIVORS" />
    <edge source="CANCER SURVIVORS" target="CANCER-RELATED FOLLOW-UP CARE" />
    <edge source="CANCER SURVIVORS" target="DISCRIMINATION" />
    <edge source="CANCER SURVIVORS" target="DEFICIT ACCUMULATION INDEX" />
    <edge source="CANCER SURVIVORS" target="RACISM" />
    <edge source="CHOLANGIOCARCINOMA" target="BILIARY TRACT" />
    <edge source="CHOLANGIOCARCINOMA" target="ADJUVANT RADIATION THERAPY" />
    <edge source="CHOLANGIOCARCINOMA" target="ADJUVANT CAPECITABINE" />
    <edge source="BCDR-F03" target="GENERALIZED FISHER SCORE" />
    <edge source="WDBC" target="GENERALIZED FISHER SCORE" />
    <edge source="GSE10810" target="GENERALIZED FISHER SCORE" />
    <edge source="GSE15852" target="GENERALIZED FISHER SCORE" />
    <edge source="MORTON NEUROMA" target="PLANTAR FASCIITIS" />
    <edge source="MORTON NEUROMA" target="ACHILLES TENDINOPATHY" />
    <edge source="PLANTAR FASCIITIS" target="ACHILLES TENDINOPATHY" />
    <edge source="PUBLIC HEALTH" target="SYSTEMS SCIENCE" />
    <edge source="PUBLIC HEALTH" target="GLOBAL PANDEMICS" />
    <edge source="PUBLIC HEALTH" target="GLOBAL LEADERS" />
    <edge source="PUBLIC HEALTH" target="COMMUNITIES" />
    <edge source="PUBLIC HEALTH" target="SIMULATION MODELLING" />
    <edge source="PUBLIC HEALTH" target="COMPLEX SYSTEMS MODELS" />
    <edge source="SYSTEMS SCIENCE" target="SYSTEM DYNAMICS" />
    <edge source="SYSTEMS SCIENCE" target="NETWORK ANALYSIS" />
    <edge source="SYSTEMS SCIENCE" target="AGENT-BASED MODELING" />
    <edge source="SYSTEMS SCIENCE" target="INFECTIOUS DISEASE" />
    <edge source="SYSTEMS SCIENCE" target="TOBACCO CONTROL" />
    <edge source="NETWORK ANALYSIS" target="MAYO CLINIC STUDY OF AGING" />
    <edge source="NETWORK ANALYSIS" target="DEMENTIA ONSET" />
    <edge source="AGENT-BASED MODELING" target="COMPUTATIONAL METHODS" />
    <edge source="CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH" target="HIGH-RISK MULTIPLE MYELOMA" />
    <edge source="CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH" target="ALLENEOGENEIC HEMATOPOIETIC CELL TRANSPLANT" />
    <edge source="CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH" target="2013-2019" />
    <edge source="HIGH-RISK MULTIPLE MYELOMA" target="LENALIDOMIDE" />
    <edge source="HIGH-RISK MULTIPLE MYELOMA" target="BORTEZOMIB" />
    <edge source="LENALIDOMIDE" target="BORTEZOMIB" />
    <edge source="E3311" target="NRG HN002" />
    <edge source="CHECKMATE 651" target="JUPITER-02" />
    <edge source="CHECKMATE 651" target="NIVOLUMAB" />
    <edge source="CHECKMATE 651" target="IPILIMUMAB" />
    <edge source="CHECKMATE 651" target="CETUXIMAB" />
    <edge source="JUPITER-02" target="SINGAPORE" />
    <edge source="JUPITER-02" target="TORIPALIMAB" />
    <edge source="JUPITER-02" target="GEMCITABINE" />
    <edge source="JUPITER-02" target="CISPLATIN" />
    <edge source="NIVOLUMAB" target="IPILIMUMAB" />
    <edge source="NIVOLUMAB" target="IMMUNE CHECKPOINT INHIBITION" />
    <edge source="NIVOLUMAB" target="VENETOCLAX" />
    <edge source="SINGAPORE" target="SINGHEALTH-DUKE-GLAXOSMITHKLINE COPD AND ASTHMA REAL-WORLD EVIDENCE (SDG-CARE) COLLABORATION" />
    <edge source="SINGAPORE" target="TREATMENT DECISION-MAKING" />
    <edge source="SINGAPORE" target="PATIENTS-CAREGIVER DYAD DECISION-MAKING STUDY" />
    <edge source="TORIPALIMAB" target="GEMCITABINE" />
    <edge source="TORIPALIMAB" target="CISPLATIN" />
    <edge source="MATERNAL, NEWBORN, AND CHILD HEALTHCARE CONTINUUM" target="DEMOCRATIC REPUBLIC OF CONGO" />
    <edge source="MATERNAL, NEWBORN, AND CHILD HEALTHCARE CONTINUUM" target="KENYA" />
    <edge source="MATERNAL, NEWBORN, AND CHILD HEALTHCARE CONTINUUM" target="EAST AFRICAN COMMUNITY" />
    <edge source="MATERNAL, NEWBORN, AND CHILD HEALTHCARE CONTINUUM" target="DECISION TREE" />
    <edge source="MATERNAL, NEWBORN, AND CHILD HEALTHCARE CONTINUUM" target="ARTIFICIAL NEURAL NETWORK" />
    <edge source="KENYA" target="NDW" />
    <edge source="KENYA" target="KENYA HEALTH INFORMATION SYSTEM" />
    <edge source="DECISION TREE" target="CHRONIC HEART FAILURE" />
    <edge source="DECISION TREE" target="NSCLC" />
    <edge source="DECISION TREE" target="GRAPH NEURAL NETWORK" />
    <edge source="DECISION TREE" target="ED REVISIT PREDICTION" />
    <edge source="DECISION TREE" target="PURE" />
    <edge source="ARTIFICIAL NEURAL NETWORK" target="CHD GROUP" />
    <edge source="ARTIFICIAL NEURAL NETWORK" target="PROBABILITY CALIBRATIONS" />
    <edge source="ARTIFICIAL NEURAL NETWORK" target="IRAN-PREMATURE CORONARY ARTERY DISEASE STUDY" />
    <edge source="ARTIFICIAL NEURAL NETWORK" target="UNDER-FIVE MORTALITY" />
    <edge source="EGFR" target="CKD-EPI" />
    <edge source="EGFR" target="MDRD" />
    <edge source="CAR-T" target="FUNCTIONAL ASSESSMENT OF CANCER THERAPY-GENERAL" />
    <edge source="CAR-T" target="POST-TRAUMATIC STRESS CHECKLIST" />
    <edge source="CAR-T" target="PROGNOSTIC AWARENESS IMPACT SCALE" />
    <edge source="NEW SOUTH WALES" target="BREAST CANCER SCREENING AND CARE STUDY" />
    <edge source="BREAST CANCER SCREENING AND CARE STUDY" target="BREASTSCREEN" />
    <edge source="BREAST CANCER SCREENING AND CARE STUDY" target="MENTAL HEALTH SERVICE" />
    <edge source="BREAST CANCER SCREENING AND CARE STUDY" target="POPULATION CANCER REGISTER" />
    <edge source="BREAST CANCER SCREENING AND CARE STUDY" target="WOMEN WITH MENTAL HEALTH CONDITIONS" />
    <edge source="MENTAL HEALTH SERVICE" target="WOMEN WITH MENTAL HEALTH CONDITIONS" />
    <edge source="BRCA1" target="BRCA2" />
    <edge source="BRCA1" target="KAPLAN-MEIER METHOD" />
    <edge source="BRCA1" target="OVARIAN CANCER" />
    <edge source="BRCA1" target="PANCREATICOBILIARY CANCER" />
    <edge source="BRCA2" target="KAPLAN-MEIER METHOD" />
    <edge source="BRCA2" target="OVARIAN CANCER" />
    <edge source="BRCA2" target="PANCREATICOBILIARY CANCER" />
    <edge source="KAPLAN-MEIER METHOD" target="ITALIAN COHORT STUDY" />
    <edge source="KAPLAN-MEIER METHOD" target="LEUKEMIA-FREE SURVIVAL" />
    <edge source="KAPLAN-MEIER METHOD" target="ADJUVANT RADIATION THERAPY" />
    <edge source="KAPLAN-MEIER METHOD" target="ADVANCED HEPATOCELLULAR CARCINOMA (AD-HCC)" />
    <edge source="DONANEMAB" target="ALZHEIMER DISEASE" />
    <edge source="DONANEMAB" target="MULTICENTER TRIAL" />
    <edge source="MULTICENTER TRIAL" target="NCT04437511" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEM (CDSS)" target="PHYSIOTHERAPISTS" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEM (CDSS)" target="NORWEGIAN PHYSIOTHERAPY PRIMARY HEALTHCARE SECTOR" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEM (CDSS)" target="MUSCULOSKELETAL PAIN DISORDERS" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEM (CDSS)" target="RANDOMISED CONTROLLED TRIAL" />
    <edge source="NORWEGIAN PHYSIOTHERAPY PRIMARY HEALTHCARE SECTOR" target="OCTOBER AND NOVEMBER 2020" />
    <edge source="NATIONAL HEALTH INTERVIEW SURVEY" target="LGB AYACS" />
    <edge source="NATIONAL HEALTH INTERVIEW SURVEY" target="LGB INDIVIDUALS WITHOUT A HISTORY OF CANCER" />
    <edge source="NATIONAL HEALTH INTERVIEW SURVEY" target="HETEROSEXUAL AYACS" />
    <edge source="NATIONAL HEALTH INTERVIEW SURVEY" target="SIBLINGS OF CHILDHOOD CANCER SURVIVORS" />
    <edge source="NATIONAL HEALTH INTERVIEW SURVEY" target="HISPANIC POPULATIONS" />
    <edge source="NATIONAL HEALTH INTERVIEW SURVEY" target="NON-HISPANIC WHITE INDIVIDUALS" />
    <edge source="NATIONAL HEALTH INTERVIEW SURVEY" target="PROSTATE, LUNG, COLORECTAL AND OVARIAN CANCER SCREENING TRIAL" />
    <edge source="NATIONAL HEALTH INTERVIEW SURVEY" target="NATIONAL LUNG SCREENING TRIAL" />
    <edge source="NATIONAL HEALTH INTERVIEW SURVEY" target="LIFE YEARS FROM SCREENING-CT" />
    <edge source="NATIONAL HEALTH INTERVIEW SURVEY" target="CANCER MORTALITY STUDY" />
    <edge source="NATIONAL HEALTH INTERVIEW SURVEY" target="MEDICAL EXPENDITURE PANEL SURVEY" />
    <edge source="LGB AYACS" target="LGB INDIVIDUALS WITHOUT A HISTORY OF CANCER" />
    <edge source="LGB AYACS" target="HETEROSEXUAL AYACS" />
    <edge source="INTERNATIONAL COLLABORATION FOR THE AUTOMATION OF SYSTEMATIC REVIEWS" target="VIENNA" />
    <edge source="TEXT MINING" target="BIOMEDICAL STUDIES" />
    <edge source="COCHRANE" target="ROBOTREVIEWER" />
    <edge source="COCHRANE" target="GESTATIONAL DIABETES MELLITUS SCREENING" />
    <edge source="COCHRANE" target="ANTIBODY-DRUG CONJUGATES" />
    <edge source="COCHRANE" target="RCT" />
    <edge source="COCHRANE" target="CCT" />
    <edge source="SYSTEMATIC REVIEW AND META-ANALYSIS" target="AUGUST 9TH, 2022" />
    <edge source="SYSTEMATIC REVIEW AND META-ANALYSIS" target="QUALITY ASSESSMENT OF DIAGNOSTIC ACCURACY STUDIES-2" />
    <edge source="SYSTEMATIC REVIEW AND META-ANALYSIS" target="ADMINISTRATIVE DATABASES" />
    <edge source="SWEDISH CLINICAL BERT MODELS" target="PSEUDONYMIZATION" />
    <edge source="CLINICAL DOMAIN" target="PSEUDONYMIZATION" />
    <edge source="POLICY MAKERS" target="GLOBAL BURDEN OF DISEASES, INJURIES, AND RISK FACTORS STUDY (GBD)" />
    <edge source="POLICY MAKERS" target="ORGANIZATIONS THAT DESIGN TEMPLATES FOR ADVANCE CARE PLANNING" />
    <edge source="POLICY MAKERS" target="HEALTH TECHNOLOGY ASSESSMENT" />
    <edge source="POLICY MAKERS" target="HTA EXPERTS" />
    <edge source="POLICY MAKERS" target="BARRIERS" />
    <edge source="POLICY MAKERS" target="FACILITATORS" />
    <edge source="FACEBOOK" target="GERM CELL TUMOR SURVIVOR SISTERS FACEBOOK GROUP" />
    <edge source="FACEBOOK" target="TWITTER" />
    <edge source="TWITTER" target="LYME DISEASE" />
    <edge source="TWITTER" target="BERTWEET" />
    <edge source="ANTI-THROMBOTIC THERAPY" target="DEEP LEARNING ALGORITHM" />
    <edge source="ANTI-THROMBOTIC THERAPY" target="THROMBOSIS" />
    <edge source="ANTI-THROMBOTIC THERAPY" target="BLEEDING" />
    <edge source="DEEP LEARNING ALGORITHM" target="PREDICTION MODEL" />
    <edge source="BLEEDING" target="ORAL ANTICOAGULANT" />
    <edge source="PREDICTION MODEL" target="RESEARCH STUDY" />
    <edge source="PREDICTION MODEL" target="NATIONAL EMERGENCY DEPARTMENT INFORMATION SYSTEM" />
    <edge source="PREDICTION MODEL" target="PUBLIC PRE-HOSPITAL CARE SYSTEM" />
    <edge source="PREDICTION MODEL" target="CARDIOVASCULAR EMERGENCY DISEASES" />
    <edge source="PREDICTION MODEL" target="MACHINE LEARNING ALGORITHM" />
    <edge source="PREDICTION MODEL" target="INAPPROPRIATE HOSPITAL TRANSFER" />
    <edge source="BIO MED CENTRAL LTD." target="SPRINGER NATURE" />
    <edge source="BIO MED CENTRAL LTD." target="CLINICAL DECISION SUPPORT INTERVENTION" />
    <edge source="BIO MED CENTRAL LTD." target="LYME DISEASE" />
    <edge source="BIO MED CENTRAL LTD." target="BASQUE COUNTRY" />
    <edge source="BIO MED CENTRAL LTD." target="LIGHT GRADIENT BOOSTING" />
    <edge source="SPRINGER NATURE" target="BIOMED CENTRAL LTD." />
    <edge source="OUR BREAST HEALTH: THE ACCESS PROJECT" target="BLACK SEXUAL MINORITY WOMEN" />
    <edge source="OUR BREAST HEALTH: THE ACCESS PROJECT" target="COMMUNITY-BASED ORGANIZATIONS" />
    <edge source="BLACK SEXUAL MINORITY WOMEN" target="COMMUNITY-BASED ORGANIZATIONS" />
    <edge source="PRECISION ONCOLOGY" target="NON-SMALL CELL LUNG CANCER" />
    <edge source="PRECISION ONCOLOGY" target="KRASG12C" />
    <edge source="PRECISION ONCOLOGY" target="EXON 20 INSERTIONS" />
    <edge source="PRECISION ONCOLOGY" target="RET MUTATIONS" />
    <edge source="PRECISION ONCOLOGY" target="ANTIBODY DRUG CONJUGATES" />
    <edge source="NON-SMALL CELL LUNG CANCER" target="EPIDERMAL GROWTH FACTOR RECEPTOR" />
    <edge source="NON-SMALL CELL LUNG CANCER" target="ANAPLASTIC LYMPHOMA KINASE" />
    <edge source="NON-SMALL CELL LUNG CANCER" target="NEOADJUVANT IMMUNOTHERAPY" />
    <edge source="NON-SMALL CELL LUNG CANCER" target="NEOADJUVANT CHEMOIMMUNOTHERAPY" />
    <edge source="EPIDERMAL GROWTH FACTOR RECEPTOR" target="TYROSINE KINASE INHIBITORS" />
    <edge source="EPIDERMAL GROWTH FACTOR RECEPTOR" target="HSP90" />
    <edge source="ANAPLASTIC LYMPHOMA KINASE" target="TYROSINE KINASE INHIBITORS" />
    <edge source="TYROSINE KINASE INHIBITORS" target="BARIATRIC SURGERY" />
    <edge source="CHRONIC KIDNEY DISEASE" target="NEPHRECTOMY" />
    <edge source="CHRONIC KIDNEY DISEASE" target="GRADIENT BOOST ALGORITHM" />
    <edge source="CHRONIC KIDNEY DISEASE" target="DIALYSIS" />
    <edge source="CHRONIC KIDNEY DISEASE" target="CHRONIC KIDNEY DISEASE EPIDEMIOLOGY COLLABORATION" />
    <edge source="CHRONIC KIDNEY DISEASE" target="KIDNEY FAILURE" />
    <edge source="CHRONIC KIDNEY DISEASE" target="HEART FAILURE" />
    <edge source="CHRONIC KIDNEY DISEASE" target="APP + OUTPATIENT FOLLOW-UP" />
    <edge source="CHRONIC KIDNEY DISEASE" target="TRADITIONAL OUTPATIENT FOLLOW-UP" />
    <edge source="CHRONIC KIDNEY DISEASE" target="CDSS" />
    <edge source="PLEUROPULMONARY BLASTOMA" target="INTERNATIONAL PPB/DICER1 REGISTRY" />
    <edge source="HEPATOCELLULAR CARCINOMA" target="CHRONIC HEPATITIS B VIRUS INFECTION" />
    <edge source="HEPATOCELLULAR CARCINOMA" target="PRE-S2 GENE DELETION MUTATION" />
    <edge source="HEPATOCELLULAR CARCINOMA" target="MONOCYTE CHEMOATTRACTANT PROTEIN-1" />
    <edge source="HEPATOCELLULAR CARCINOMA" target="LIVER RESECTION" />
    <edge source="HEPATOCELLULAR CARCINOMA" target="RANDOM SURVIVAL FOREST MODEL" />
    <edge source="HEPATOCELLULAR CARCINOMA" target="DEEP LEARNING" />
    <edge source="HEPATOCELLULAR CARCINOMA" target="NONALCOHOLIC FATTY LIVER DISEASE" />
    <edge source="HEPATOCELLULAR CARCINOMA" target="MAGNESIUM" />
    <edge source="HEPATOCELLULAR CARCINOMA" target="MEXICAN AMERICANS" />
    <edge source="HEPATOCELLULAR CARCINOMA" target="US-BORN LATINOS" />
    <edge source="HEPATOCELLULAR CARCINOMA" target="FOREIGN-BORN LATINOS" />
    <edge source="PRE-S2 GENE DELETION MUTATION" target="MONOCYTE CHEMOATTRACTANT PROTEIN-1" />
    <edge source="RANDOMIZED CONTROLLED TRIAL" target="REAL-WORLD EVIDENCE" />
    <edge source="RANDOMIZED CONTROLLED TRIAL" target="ELECTRONIC HEALTH RECORD-INTEGRATED CPR" />
    <edge source="RANDOMIZED CONTROLLED TRIAL" target="PRIMARY CARE SETTINGS" />
    <edge source="RANDOMIZED CONTROLLED TRIAL" target="ALFALFA APP" />
    <edge source="RANDOMIZED CONTROLLED TRIAL" target="CHICTR1900024455" />
    <edge source="RANDOMIZED CONTROLLED TRIAL" target="WILLINGNESS-TO-PAY ESTIMATES" />
    <edge source="RANDOMIZED CONTROLLED TRIAL" target="SCALE AND POLISH" />
    <edge source="REAL-WORLD EVIDENCE" target="MIGRAINE" />
    <edge source="METASTATIC COLORECTAL CANCER" target="ANTIANGIOGENIC TREATMENTS" />
    <edge source="JOHNS HOPKINS HOSPITAL" target="QUALITY METRIC REPORTING" />
    <edge source="JOHNS HOPKINS HOSPITAL" target="BALTIMORE" />
    <edge source="BALTIMORE" target="BALTIMORE REGIONAL HOUSING PARTNERSHIP" />
    <edge source="LUNG CANCER CLINICAL GUIDELINES" target="NEVER-SMOKERS" />
    <edge source="NEVER-SMOKERS" target="LUNG CANCER DIAGNOSTICIANS" />
    <edge source="LUNG CANCER DIAGNOSTICIANS" target="MODEL OF PATHWAYS TO TREATMENT" />
    <edge source="LUNG CANCER DIAGNOSTICIANS" target="HEMOPTYSIS" />
    <edge source="ELECTROCARDIOGRAM (ECG)" target="NESTED LONG SHORT-TERM MEMORY (NESTED LSTM)" />
    <edge source="ELECTROCARDIOGRAM (ECG)" target="SUDDEN CARDIAC DEATH" />
    <edge source="NESTED LONG SHORT-TERM MEMORY (NESTED LSTM)" target="SUDDEN CARDIAC DEATH" />
    <edge source="ACTIV-6 PLATFORM" target="FLUVOXAMINE" />
    <edge source="FLUVOXAMINE" target="ACTIV-6" />
    <edge source="CLINICAL PRACTICE RESEARCH DATALINK (CPRD) AURUM" target="ENGLISH PRIMARY CARE DATABASE" />
    <edge source="DEPRESSION" target="MENTAL HEALTH (MH) CONDITIONS" />
    <edge source="DEPRESSION" target="WESTERN EDUCATED INDUSTRIALISED RICH DEMOCRATIC" />
    <edge source="DEPRESSION" target="GASTRIC CANCER SURGERY" />
    <edge source="DEPRESSION" target="MOBILE-BASED SELF-CARE APPLICATION" />
    <edge source="DEPRESSION" target="PATIENTS WITH DEPRESSION AND ANXIETY" />
    <edge source="DEPRESSION" target="PSYCHOSOCIAL FACTORS AND CANCER INCIDENCE (PSY-CA) CONSORTIUM" />
    <edge source="DEPRESSION" target="SMOKING-RELATED CANCERS" />
    <edge source="DEPRESSION" target="ALCOHOL-RELATED CANCERS" />
    <edge source="DEPRESSION" target="LONELINESS" />
    <edge source="MENTAL HEALTH (MH) CONDITIONS" target="PTSD" />
    <edge source="MENTAL HEALTH (MH) CONDITIONS" target="SCHIZOPHRENIA" />
    <edge source="MENTAL HEALTH (MH) CONDITIONS" target="BIPOLAR DISORDER" />
    <edge source="MENTAL HEALTH (MH) CONDITIONS" target="EATING DISORDERS" />
    <edge source="BIPOLAR DISORDER" target="LITHIUM" />
    <edge source="BIPOLAR DISORDER" target="VALPROATE" />
    <edge source="BIPOLAR DISORDER" target="LAMOTRIGINE" />
    <edge source="BIPOLAR DISORDER" target="QUETIAPINE" />
    <edge source="BIPOLAR DISORDER" target="ASENAPINE" />
    <edge source="BIPOLAR DISORDER" target="LURASIDONE" />
    <edge source="BIPOLAR DISORDER" target="CARIPRAZINE" />
    <edge source="INTERNATIONAL UNION AGAINST CANCER" target="TNM-8-N" />
    <edge source="NOTCH MUTATIONS" target="T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA" />
    <edge source="NOTCH MUTATIONS" target="EUROPEAN LEUKEMIA NET 2017" />
    <edge source="FIFTH HOSPITAL OF SHANXI MEDICAL UNIVERSITY" target="SHANXI" />
    <edge source="BPS/IC" target="HYDRODISTENTION SURGERY" />
    <edge source="BPS/IC" target="CD117" />
    <edge source="BPS/IC" target="P2X3R" />
    <edge source="BPS/IC" target="NGF" />
    <edge source="BPS/IC" target="TRKA" />
    <edge source="BPS/IC" target="AGE" />
    <edge source="LUNG CANCER SCREENING" target="PRIMARY CARE PROVIDERS" />
    <edge source="LUNG CANCER SCREENING" target="QUALITY IMPROVEMENT PROJECT" />
    <edge source="LUNG CANCER SCREENING" target="LUNG-RADS" />
    <edge source="LUNG CANCER SCREENING" target="TRANSIT DESERTS" />
    <edge source="LUNG CANCER SCREENING" target="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK" />
    <edge source="LUNG CANCER SCREENING" target="SOJOURN TIMES" />
    <edge source="LUNG CANCER SCREENING" target="STAGE-SPECIFIC SENSITIVITIES" />
    <edge source="LUNG CANCER SCREENING" target="SCREENING-INDUCED LUNG CANCER MORTALITY REDUCTIONS" />
    <edge source="LUNG CANCER SCREENING" target="PERSONALIZED SCREENING RECOMMENDATIONS" />
    <edge source="CANNABIS USE" target="CANNABIS USE DISORDER" />
    <edge source="CANNABIS USE" target="PAIN" />
    <edge source="CANNABIS USE" target="SLEEP PROBLEMS" />
    <edge source="CANNABIS USE" target="ANXIETY" />
    <edge source="CANNABIS USE" target="NAUSEA/VOMITING" />
    <edge source="CANNABIS USE" target="HEADACHES" />
    <edge source="CANNABIS USE" target="MUSCLE SPASMS" />
    <edge source="CANNABIS USE" target="INDIVIDUALS WITHOUT A HISTORY OF CANCER" />
    <edge source="ANXIETY" target="RISK SCORE CALCULATORS" />
    <edge source="ANXIETY" target="MOBILE-BASED SELF-CARE APPLICATION" />
    <edge source="ANXIETY" target="PATIENTS WITH DEPRESSION AND ANXIETY" />
    <edge source="ANXIETY" target="PSYCHOSOCIAL FACTORS AND CANCER INCIDENCE (PSY-CA) CONSORTIUM" />
    <edge source="ANXIETY" target="SMOKING-RELATED CANCERS" />
    <edge source="ANXIETY" target="ALCOHOL-RELATED CANCERS" />
    <edge source="ANXIETY" target="NURSES" />
    <edge source="ANXIETY" target="LONELINESS" />
    <edge source="TEHRAN UNIVERSITY OF MEDICAL SCIENCE" target="CANCER INSTITUTE" />
    <edge source="CANCER INSTITUTE" target="METASTASIS" />
    <edge source="LORRAINE DASTON" target="PETER GALISON" />
    <edge source="REPRESENTATIONS" target="THE IMAGE OF OBJECTIVITY" />
    <edge source="THE IMAGE OF OBJECTIVITY" target="THE REGENTS OF THE UNIVERSITY OF CALIFORNIA" />
    <edge source="ELECTRONIC MEDICAL DATA" target="NON-COMMUNICABLE DISEASES" />
    <edge source="NON-COMMUNICABLE DISEASES" target="MENTAL HEALTH DISORDERS" />
    <edge source="MNCLCDA" target="CIRCRNAS" />
    <edge source="MEDICAL INFORMATION MART FOR INTENSIVE CARE IV" target="ACUTE RESPIRATORY FAILURE" />
    <edge source="LIME" target="DEEP LEARNING" />
    <edge source="ARDS" target="VV-ECMO" />
    <edge source="PSA SCREENING" target="VETERANS" />
    <edge source="PERCEIVER" target="PHYSIONET-2012 CHALLENGE" />
    <edge source="PERCEIVER" target="CONTINUOUS PATIENT STATE MODELS" />
    <edge source="CONTINUOUS PATIENT STATE MODELS" target="NEURAL ORDINARY DIFFERENTIAL EQUATIONS" />
    <edge source="CONTINUOUS PATIENT STATE MODELS" target="ELECTRONIC HEALTH RECORD" />
    <edge source="ELECTRONIC HEALTH RECORD" target="DIAGNOSIS SUPPORT SYSTEMS" />
    <edge source="ELECTRONIC HEALTH RECORD" target="HUMAN PHENOTYPE ONTOLOGY" />
    <edge source="ELECTRONIC HEALTH RECORD" target="SJ&#214;GREN&#8217;S DISEASE" />
    <edge source="ELECTRONIC HEALTH RECORD" target="ELECTRONIC DENTAL RECORD" />
    <edge source="ELECTRONIC HEALTH RECORD" target="GRAPH NEURAL NETWORK" />
    <edge source="ELECTRONIC HEALTH RECORD" target="RECURRENT NEURAL NETWORK" />
    <edge source="ELECTRONIC HEALTH RECORD" target="GOALS-OF-CARE DISCUSSIONS" />
    <edge source="ELECTRONIC HEALTH RECORD" target="LEARNING HEALTH SYSTEM" />
    <edge source="LUNG SCREENING RECOMMENDATION EXPANSION 2021" target="SCREENING BENEFITS" />
    <edge source="LUNG SCREENING RECOMMENDATION EXPANSION 2021" target="SCREENING HARMS" />
    <edge source="SCREENING BENEFITS" target="SCREENING HARMS" />
    <edge source="SCREENING HARMS" target="CRC SCREENING STRATEGIES" />
    <edge source="TAIWAN BIOBANK" target="CORONARY ARTERY DISEASE (CAD)" />
    <edge source="MEDRXIV" target="BIORXIV" />
    <edge source="MEDRXIV" target="ARXIV" />
    <edge source="BIORXIV" target="ARXIV" />
    <edge source="MULTIMEDQA" target="HEALTHSEARCHQA" />
    <edge source="MULTIMEDQA" target="FLAN-PALM" />
    <edge source="MULTIMEDQA" target="MEDQA" />
    <edge source="MULTIMEDQA" target="MEDMCQA" />
    <edge source="MULTIMEDQA" target="PUBMEDQA" />
    <edge source="MULTIMEDQA" target="MMLU" />
    <edge source="MULTIMEDQA" target="CLINICAL APPLICATIONS" />
    <edge source="MULTIMEDQA" target="HUMAN EVALUATION" />
    <edge source="NANCY NERSESSIAN" target="CREATING SCIENTIFIC CONCEPTS" />
    <edge source="WALSH ET AL." target="THREE DIFFERENT CENTERS" />
    <edge source="OPENAI GPT-4" target="GPT-4-TURBO" />
    <edge source="OPENAI GPT-4" target="GPT-4-VISION" />
    <edge source="OPENAI GPT-4" target="SPORTS MEDICINE AND EXERCISE SCIENCE CLINICAL TRIAL REPORTS" />
    <edge source="GPT-4-TURBO" target="TRAIN DATASET" />
    <edge source="GPT-4-TURBO" target="TEST DATASET" />
    <edge source="GPT-4-VISION" target="TEST DATASET" />
    <edge source="SPORTS MEDICINE AND EXERCISE SCIENCE CLINICAL TRIAL REPORTS" target="META LLAMA2" />
    <edge source="META LLAMA2" target="LLAMA 2 70B" />
    <edge source="LLAMA 2 70B" target="TRAIN DATASET" />
    <edge source="LLAMA 2 70B" target="TEST DATASET" />
    <edge source="LLAMA 2 70B" target="FINE-TUNING" />
    <edge source="TRAIN DATASET" target="HYPERPARAMETER TUNING" />
    <edge source="TRAIN DATASET" target="FINE-TUNING" />
    <edge source="TRAIN DATASET" target="OPENAI GPT-3.5" />
    <edge source="TRAIN DATASET" target="HYPERPARAMETER AND MODEL FINE-TUNING" />
    <edge source="TEST DATASET" target="OPENAI GPT-3.5" />
    <edge source="TEST DATASET" target="MODEL PERFORMANCE ASSESSMENT" />
    <edge source="HYPERPARAMETER TUNING" target="PROBABILITY THRESHOLD MOVING" />
    <edge source="HEART FAILURE" target="PHYSICAL INACTIVITY" />
    <edge source="HEART FAILURE" target="SEDENTARY LIFESTYLE" />
    <edge source="HEART FAILURE" target="CARDIOLOGISTS" />
    <edge source="HEART FAILURE" target="LOGISTIC TENSOR REGRESSION" />
    <edge source="HEART FAILURE" target="HYPOTENSION" />
    <edge source="HEART FAILURE" target="PULMONARY HEART DISEASE" />
    <edge source="HEART FAILURE" target="MITRAL REGURGITATION" />
    <edge source="HEART FAILURE" target="ATHEROSCLEROTIC HEART DISEASE" />
    <edge source="HEART FAILURE" target="FAMILY CAREGIVERS" />
    <edge source="HEART FAILURE" target="LEFT VENTRICULAR ASSIST DEVICE (LVAD)" />
    <edge source="HEART FAILURE" target="ISCHEMIC HEART DISEASE" />
    <edge source="HEART FAILURE" target="DXLR MODEL" />
    <edge source="HEART FAILURE" target="CARDIOVASCULAR DISEASE (CVD)" />
    <edge source="HEART FAILURE" target="COHORT 1" />
    <edge source="HEART FAILURE" target="HF-LAB9" />
    <edge source="HEALTHCARE SYSTEMS" target="COVID-19 GLOBAL PANDEMIC" />
    <edge source="INTRODUCTION PART I" target="PART II" />
    <edge source="INTRODUCTION PART I" target="PART III" />
    <edge source="INTRODUCTION PART I" target="NOMOLOGICAL MACHINES" />
    <edge source="PART II" target="PART III" />
    <edge source="PART II" target="ARISTOTELIAN NATURES" />
    <edge source="PART II" target="SOCIO-ECONOMIC MACHINES" />
    <edge source="PART II" target="PROBABILITY MACHINES" />
    <edge source="PART II" target="PLURALISM" />
    <edge source="PART III" target="BRIDGE PRINCIPLES" />
    <edge source="PRALSETINIB" target="ARROW TRIAL" />
    <edge source="PRALSETINIB" target="CHINESE PATIENTS" />
    <edge source="PRALSETINIB" target="RET" />
    <edge source="PRALSETINIB" target="NSCLC" />
    <edge source="ARROW TRIAL" target="CHINESE PATIENTS" />
    <edge source="ARROW TRIAL" target="NCT03037385" />
    <edge source="ARROW TRIAL" target="NSCLC" />
    <edge source="NSCLC" target="PACIFIC TRIAL" />
    <edge source="NSCLC" target="FRAMINGHAM HEART STUDY" />
    <edge source="NSCLC" target="LAROTRECTINIB" />
    <edge source="NSCLC" target="GENETIC VARIATIONS" />
    <edge source="NSCLC" target="DNA METHYLATION" />
    <edge source="NSCLC" target="TWO-STAGE CASE-CONTROL DESIGN" />
    <edge source="NSCLC" target="FIXED-EFFECT META-ANALYSIS" />
    <edge source="NSCLC" target="MULTI-OMICS FUNCTIONAL ANNOTATION" />
    <edge source="NSCLC" target="NEURAL NETWORK" />
    <edge source="NSCLC" target="NAIVE BAYES" />
    <edge source="NSCLC" target="TONGUE FEATURE" />
    <edge source="NSCLC" target="TUMOR MARKER" />
    <edge source="NSCLC" target="PD-1/PD-L1 IMMUNE CHECKPOINT" />
    <edge source="NSCLC" target="PD-(L)1 INHIBITORS" />
    <edge source="ASYSD" target="ENDNOTE" />
    <edge source="ASYSD" target="SYSTEMATIC REVIEW ASSISTANT DEDUPLICATION MODULE" />
    <edge source="ASYSD" target="BIOMEDICAL REVIEWS" />
    <edge source="UK NATIONAL HEALTH SERVICE" target="SEPTIC SHOCK TRIAL" />
    <edge source="SEPTIC SHOCK TRIAL" target="EU CLINICAL TRIALS REGISTER" />
    <edge source="SEPTIC SHOCK TRIAL" target="ISRCTN" />
    <edge source="SEPTIC SHOCK TRIAL" target="LANDIOLOL" />
    <edge source="SEPTIC SHOCK TRIAL" target="NOREPINEPHRINE" />
    <edge source="SEPTIC SHOCK TRIAL" target="SEQUENTIAL ORGAN FAILURE ASSESSMENT (SOFA) SCORE" />
    <edge source="BRAZIL" target="SMARTPHONE APPLICATION" />
    <edge source="BRAZIL" target="REMOTE GERIATRIC ASSESSMENT AND IMPLEMENTATION PROGRAM" />
    <edge source="SMARTPHONE APPLICATION" target="CENTRO UNIVERSIT&#193;RIO CHRISTUS" />
    <edge source="SMARTPHONE APPLICATION" target="SYSTEM USABILITY SCALE" />
    <edge source="SMARTPHONE APPLICATION" target="EGE-UNET" />
    <edge source="SMARTPHONE APPLICATION" target="DHA(C3AE)" />
    <edge source="SMARTPHONE APPLICATION" target="DEEP LEARNING" />
    <edge source="SYSTEM USABILITY SCALE" target="TANYA OBAT" />
    <edge source="TIME FROM DIAGNOSIS TO TREATMENT" target="COMPLETE REMISSION" />
    <edge source="COMPLETE REMISSION" target="PROLONGED TDT" />
    <edge source="COMPLETE REMISSION" target="BASELINE BONE MARROW BLAST PERCENTAGE" />
    <edge source="COMPLETE REMISSION" target="MINIMAL/MEASURABLE RESIDUAL DISEASE RESPONSE" />
    <edge source="COMPLETE REMISSION" target="DISEASE-FREE SURVIVAL" />
    <edge source="PROLONGED TDT" target="OLDER AGE" />
    <edge source="PROLONGED TDT" target="LOWER PROLIFERATION BURDEN" />
    <edge source="LASSO" target="PROPOSED METHOD" />
    <edge source="LASSO" target="XG BOOST" />
    <edge source="PROPOSED METHOD" target="RSF-VS" />
    <edge source="PROPOSED METHOD" target="SCAD" />
    <edge source="PROPOSED METHOD" target="COXBOOST" />
    <edge source="PROPOSED METHOD" target="COXPH" />
    <edge source="PROPOSED METHOD" target="RSF" />
    <edge source="PROPOSED METHOD" target="DEEPHIT NN" />
    <edge source="EPILEPSY" target="ELECTROENCEPHALOGRAM (EEG)" />
    <edge source="EPILEPSY" target="CONVOLUTIONAL NEURAL NETWORK (CNN)" />
    <edge source="EPILEPSY" target="EEG" />
    <edge source="ELECTROENCEPHALOGRAM (EEG)" target="DISCRETE WAVELET TRANSFORM (DWT)" />
    <edge source="CONVOLUTIONAL NEURAL NETWORK (CNN)" target="DEEPVAQ" />
    <edge source="CONVOLUTIONAL NEURAL NETWORK (CNN)" target="VISION TRANSFORMER (VIT)" />
    <edge source="BONN EEG DATASETS" target="NEW DELHI DATASETS" />
    <edge source="PRESCRIPTION DRUG OVERDOSE" target="CLINICAL DECISION SUPPORT INTERVENTION" />
    <edge source="CLINICAL DECISION SUPPORT INTERVENTION" target="LARGE MULTI-CENTER HEALTHCARE SYSTEM" />
    <edge source="CHOOSING WISELY" target="ANZCTR376477" />
    <edge source="BERNIE STUDY" target="EUROPEAN PAEDIATRIC SOFT TISSUE SARCOMA STUDY GROUP" />
    <edge source="EUROPEAN PAEDIATRIC SOFT TISSUE SARCOMA STUDY GROUP" target="MTS 2008 STUDY" />
    <edge source="PEDIATRIC HEMATOLOGY-ONCOLOGY ASSOCIATION OF CENTRAL AMERICA (AHOPCA)" target="AHOPCA-ALL REC 2014 PROTOCOL" />
    <edge source="AHOPCA-ALL REC 2014 PROTOCOL" target="CENTRAL AMERICA" />
    <edge source="AHOPCA-ALL REC 2014 PROTOCOL" target="ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)" />
    <edge source="ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)" target="HEMATOPOIETIC CELL TRANSPLANTATION" />
    <edge source="ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)" target="PHILADELPHIA CHROMOSOME-POSITIVE ALL" />
    <edge source="ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)" target="LEUKEMIA-FREE SURVIVAL (LFS)" />
    <edge source="ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)" target="TEXAS CANCER REGISTRY" />
    <edge source="VALUE-OF-INFORMATION METHODOLOGY" target="EXPECTED VALUE OF PERFECT INFORMATION (EVPI)" />
    <edge source="EXPECTED VALUE OF PERFECT INFORMATION (EVPI)" target="BOOTSTRAP-BASED METHODS" />
    <edge source="EXPECTED VALUE OF PERFECT INFORMATION (EVPI)" target="ASYMPTOTIC METHODS" />
    <edge source="FRAUD, WASTE, AND ABUSE (FWA)" target="HEALTHCARE CLAIMS" />
    <edge source="HEALTHCARE CLAIMS" target="UNSUPERVISED MACHINE LEARNING" />
    <edge source="UNSUPERVISED MACHINE LEARNING" target="DEEP AUTOENCODERS" />
    <edge source="DEEP AUTOENCODERS" target="DENSITY-BASED CLUSTERING MODEL" />
    <edge source="IPSILATERAL BREAST TUMOR RECURRENCE (IBTR)" target="REPEAT SENTINEL LYMPH NODE BIOPSY (RSLNB)" />
    <edge source="IPSILATERAL BREAST TUMOR RECURRENCE (IBTR)" target="AXILLARY LYMPH NODE DISSECTION (ALND)" />
    <edge source="REPEAT SENTINEL LYMPH NODE BIOPSY (RSLNB)" target="AXILLARY LYMPH NODE DISSECTION (ALND)" />
    <edge source="BRAIN TUMORS" target="3D CONVOLUTIONAL NEURAL NETWORKS" />
    <edge source="BRAIN TUMORS" target="VISION TRANSFORMER" />
    <edge source="BRAIN TUMORS" target="SWIN UNET3D" />
    <edge source="BRAIN TUMORS" target="MAGNETIC RESONANCE IMAGING" />
    <edge source="BRAIN TUMORS" target="CANCER BURDEN" />
    <edge source="VISION TRANSFORMER" target="VIRAL PNEUMONIA" />
    <edge source="VISION TRANSFORMER" target="BACTERIAL PNEUMONIA" />
    <edge source="VISION TRANSFORMER" target="MIDDLE EAST RESPIRATORY SYNDROME" />
    <edge source="VISION TRANSFORMER" target="SEVERE ACUTE RESPIRATORY SYNDROME" />
    <edge source="VISION TRANSFORMER" target="TUBERCULOSIS" />
    <edge source="VISION TRANSFORMER" target="RADAM" />
    <edge source="VISION TRANSFORMER" target="NADAM" />
    <edge source="SWIN UNET3D" target="BRATS2021" />
    <edge source="SWIN UNET3D" target="BRATS2018" />
    <edge source="AMERICAN SOCIETY FOR COLPOSCOPY AND CERVICAL PATHOLOGY" target="2019 ASCCP GUIDELINES" />
    <edge source="2019 ASCCP GUIDELINES" target="OBSTETRICS AND GYNECOLOGY PHYSICIANS" />
    <edge source="2019 ASCCP GUIDELINES" target="FAMILY MEDICINE PHYSICIANS" />
    <edge source="2019 ASCCP GUIDELINES" target="INTERNAL MEDICINE PHYSICIANS" />
    <edge source="HIGH-DOSE METHOTREXATE" target="PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA" />
    <edge source="HIGH-DOSE METHOTREXATE" target="XGBOOST ALGORITHM" />
    <edge source="HIGH-DOSE METHOTREXATE" target="NEUROTOXICITY" />
    <edge source="HIGH-DOSE METHOTREXATE" target="TEXAS CHILDREN'S CANCER CENTER" />
    <edge source="HIGH-DOSE METHOTREXATE" target="LATINO CHILDREN" />
    <edge source="XGBOOST ALGORITHM" target="SMOTE" />
    <edge source="XGBOOST ALGORITHM" target="DIAGNOSTIC INTELLIGENT DECISION SUPPORT PLATFORM" />
    <edge source="SMOTE" target="CONVOLUTIONAL NEURAL NETWORK" />
    <edge source="VIRTUAL REALITY REHABILITATION" target="IEEE" />
    <edge source="VIRTUAL REALITY REHABILITATION" target="PSYCNET" />
    <edge source="IEEE" target="ESOPHAGEAL CANCER" />
    <edge source="IEEE" target="HYPERTENSION MANAGEMENT STUDY" />
    <edge source="IEEE" target="VIRTUAL REALITY" />
    <edge source="DA COSTA" target="FRENCH" />
    <edge source="DA COSTA" target="OXFORD" />
    <edge source="FRENCH" target="SAATSI" />
    <edge source="FRENCH" target="OXFORD" />
    <edge source="DEEPVAQ" target="HEMODIALYSIS PATIENTS" />
    <edge source="DEEPVAQ" target="PHOTOPLETHYSMOGRAPHY (PPG) SENSORS" />
    <edge source="DEEPVAQ" target="ULTRASOUND DILUTION TECHNIQUE (UDT)" />
    <edge source="DEEPVAQ" target="DEEP LEARNING" />
    <edge source="HEMODIALYSIS PATIENTS" target="VASCULAR ACCESS (VA)" />
    <edge source="DEEP LEARNING" target="FEATURE SELECTION" />
    <edge source="DEEP LEARNING" target="CLINICAL PRACTICE" />
    <edge source="DEEP LEARNING" target="AUTOMATED MACHINE LEARNING" />
    <edge source="DEEP LEARNING" target="WASSERSTEIN TABULAR GENERATIVE ADVERSARIAL NETWORK" />
    <edge source="DEEP LEARNING" target="DEEP FNN" />
    <edge source="DEEP LEARNING" target="HEALTHCARE SYSTEM" />
    <edge source="DEEP LEARNING" target="DRUG DEVELOPMENT SECTORS" />
    <edge source="DEEP LEARNING" target="GENE EXPRESSION DATASETS" />
    <edge source="DEEP LEARNING" target="MICROARRAY GENE EXPRESSION DATASETS" />
    <edge source="DEEP LEARNING" target="BIOMEDICAL LITERATURE SURVEY" />
    <edge source="DEEP LEARNING" target="MULTIPLE SCLEROSIS" />
    <edge source="DEEP LEARNING" target="NEUROIMAGING DATA" />
    <edge source="DEEP LEARNING" target="CLINICAL NOTES" />
    <edge source="DEEP LEARNING" target="MEDICAL INSTITUTIONS" />
    <edge source="DEEP LEARNING" target="HYBRID RESUNET MODEL" />
    <edge source="DEEP LEARNING" target="CLASSICAL ML" />
    <edge source="DEEP LEARNING" target="STYLEGANV2-ADA" />
    <edge source="DEEP LEARNING" target="BRAIN TUMOR CLASSIFICATION" />
    <edge source="DEEP LEARNING" target="H2O AUTOML" />
    <edge source="TECHNETIUM-99" target="INDOCYANINE GREEN" />
    <edge source="TECHNETIUM-99" target="BLUE DYE" />
    <edge source="TECHNETIUM-99" target="PEDIATRIC PATIENTS" />
    <edge source="INDOCYANINE GREEN" target="BLUE DYE" />
    <edge source="INDOCYANINE GREEN" target="PEDIATRIC PATIENTS" />
    <edge source="INDOCYANINE GREEN" target="YOUNG ADULT POPULATION" />
    <edge source="AMERICAN RADIUM SOCIETY" target="APPROPRIATE USE CRITERIA" />
    <edge source="APPROPRIATE USE CRITERIA" target="LIVER METASTASES" />
    <edge source="RICHARD LEVINS" target="MICHAEL WEISBERG" />
    <edge source="RICHARD LEVINS" target="WIMSATT" />
    <edge source="RICHARD LEVINS" target="POPULATION BIOLOGY" />
    <edge source="RICHARD LEVINS" target="MODEL-BASED SCIENCE" />
    <edge source="MICHAEL WEISBERG" target="STANFORD" />
    <edge source="POPULATION BIOLOGY" target="POPULATION GENETICS" />
    <edge source="POPULATION BIOLOGY" target="POPULATION ECOLOGY" />
    <edge source="POPULATION BIOLOGY" target="MATHEMATICAL BIOGEOGRAPHY" />
    <edge source="CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS" target="CHEERS 2022" />
    <edge source="CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS" target="HEALTH ECONOMIC EVALUATIONS" />
    <edge source="CHEERS 2022" target="HEALTH TECHNOLOGY ASSESSMENT BODIES" />
    <edge source="CHEERS 2022" target="PEER REVIEWED JOURNALS" />
    <edge source="TAIWAN PEDIATRIC ONCOLOGY GROUP" target="TPOG-ALL-2013" />
    <edge source="TAIWAN PEDIATRIC ONCOLOGY GROUP" target="TPOG-ALL-2002" />
    <edge source="TPOG-ALL-2013" target="TPOG-ALL-2002" />
    <edge source="TPOG-ALL-2013" target="ETV6-RUNX1" />
    <edge source="TPOG-ALL-2013" target="BCR-ABL1" />
    <edge source="TPOG-ALL-2013" target="DUX4-REARRANGED" />
    <edge source="TPOG-ALL-2013" target="ZNF384-REARRANGED" />
    <edge source="TPOG-ALL-2013" target="MEF2D-REARRANGED" />
    <edge source="TPOG-ALL-2013" target="PAX5ALT" />
    <edge source="TPOG-ALL-2013" target="KMT2A-REARRANGED" />
    <edge source="TPOG-ALL-2013" target="T-CELL ALL" />
    <edge source="US CITIES" target="DIETARY SODIUM STUDY" />
    <edge source="DIETARY SODIUM STUDY" target="CLINICALTRIALS.GOV IDENTIFIER: NCT04258332" />
    <edge source="DIETARY SODIUM STUDY" target="HIGH-SODIUM DIET" />
    <edge source="DIETARY SODIUM STUDY" target="LOW-SODIUM DIET" />
    <edge source="HIGH-SODIUM DIET" target="LOW-SODIUM DIET" />
    <edge source="SCIENCE" target="MEASUREMENT" />
    <edge source="SCIENCE" target="MATHEMATICAL PHYSICS" />
    <edge source="SCIENCE" target="LOGICAL POSITIVISM" />
    <edge source="MEASUREMENT" target="MATHEMATICAL PHYSICS" />
    <edge source="GPT-3" target="INSTRUCTGPT" />
    <edge source="GPT-3" target="BERTSUM" />
    <edge source="GPT-3" target="BART" />
    <edge source="GPT-3" target="GPT-3.5" />
    <edge source="REMAP-CAP" target="IL-6 RECEPTOR ANTAGONISTS" />
    <edge source="REMAP-CAP" target="ANTIPLATELET AGENTS" />
    <edge source="REMAP-CAP" target="THERAPEUTIC ANTICOAGULATION" />
    <edge source="REMAP-CAP" target="CONVALESCENT PLASMA" />
    <edge source="REMAP-CAP" target="LOPINAVIR-RITONAVIR" />
    <edge source="REMAP-CAP" target="HYDROXYCHLOROQUINE" />
    <edge source="REMAP-CAP" target="CORTICOSTEROIDS" />
    <edge source="CORTICOSTEROIDS" target="ACUTE MYOCARDITIS" />
    <edge source="NEUROPSI" target="WILCOXON PAIRED SIGNED-RANK TEST" />
    <edge source="BIOMED CENTRAL LTD." target="ESOPHAGEAL SQUAMOUS CELL CARCINOMA" />
    <edge source="BIOMED CENTRAL LTD." target="BMC MEDICAL INFORMATICS AND DECISION MAKING" />
    <edge source="&quot;THE STRUCTURE OF SCIENTIFIC REVOLUTIONS&quot;" target="&quot;THOMAS KUHN&quot;" />
    <edge source="&quot;THE STRUCTURE OF SCIENTIFIC REVOLUTIONS&quot;" target="&quot;IAN HACKING&quot;" />
    <edge source="&quot;THE STRUCTURE OF SCIENTIFIC REVOLUTIONS&quot;" target="&quot;1962&quot;" />
    <edge source="CANNABIS" target="CANCER PAIN" />
    <edge source="CANNABIS" target="MINORITIZED RACIAL IDENTITIES" />
    <edge source="CANNABIS" target="OPIOID RISK MITIGATION STRATEGIES" />
    <edge source="CANNABIS" target="PREGNANCY OUTCOMES" />
    <edge source="PROTICNN-BILSTM" target="BAYESIAN OPTIMISATION" />
    <edge source="PROTICNN-BILSTM" target="PDB-14,189" />
    <edge source="NEXT-GENERATION SEQUENCING" target="MMR" />
    <edge source="WHOLE-EXOME SEQUENCING" target="PARAFFIN TUMOR SAMPLES" />
    <edge source="TRACHEOSTOMY AND PROLONGED MECHANICAL VENTILATION DECISION MAKING" target="SURROGATE DECISION MAKERS" />
    <edge source="CILIOPATHIES" target="DIAGNOSIS SUPPORT SYSTEMS" />
    <edge source="DIAGNOSIS SUPPORT SYSTEMS" target="ORPHANET" />
    <edge source="HUMAN PHENOTYPE ONTOLOGY" target="CLINICAL DEEP PHENOTYPING" />
    <edge source="HUMAN PHENOTYPE ONTOLOGY" target="PHENOTYPE ANNOTATION" />
    <edge source="WORLD CANCER RESEARCH FUND" target="AMERICAN INSTITUTE FOR CANCER RESEARCH" />
    <edge source="WORLD CANCER RESEARCH FUND" target="CANCER PREVENTION RECOMMENDATIONS" />
    <edge source="AMERICAN INSTITUTE FOR CANCER RESEARCH" target="CANCER PREVENTION RECOMMENDATIONS" />
    <edge source="CANCER PREVENTION RECOMMENDATIONS" target="PANCREATIC CANCER" />
    <edge source="CANCER PREVENTION RECOMMENDATIONS" target="CHRONIC LYMPHOCYTIC LEUKEMIA" />
    <edge source="PANCREATIC CANCER" target="XG-BOOST" />
    <edge source="CHRONIC LYMPHOCYTIC LEUKEMIA" target="BRUTON TYROSINE KINASE INHIBITORS" />
    <edge source="CHRONIC LYMPHOCYTIC LEUKEMIA" target="BCL2 INHIBITION" />
    <edge source="CHRONIC LYMPHOCYTIC LEUKEMIA" target="ANTI-CD20 ANTIBODIES" />
    <edge source="CHRONIC LYMPHOCYTIC LEUKEMIA" target="FRONTLINE TREATMENT LANDSCAPE" />
    <edge source="CHRONIC LYMPHOCYTIC LEUKEMIA" target="RANDOMIZED TRIALS" />
    <edge source="CHRONIC LYMPHOCYTIC LEUKEMIA" target="PHASE 2 AND 3 STUDIES" />
    <edge source="CHRONIC LYMPHOCYTIC LEUKEMIA" target="STANDARD OF CARE" />
    <edge source="CHRONIC LYMPHOCYTIC LEUKEMIA" target="ONGOING STUDIES" />
    <edge source="CHRONIC LYMPHOCYTIC LEUKEMIA" target="FUTURE PLANNED TRIALS" />
    <edge source="CHRONIC LYMPHOCYTIC LEUKEMIA" target="IBRUTINIB" />
    <edge source="CHRONIC LYMPHOCYTIC LEUKEMIA" target="ACALABRUTINIB" />
    <edge source="CHRONIC LYMPHOCYTIC LEUKEMIA" target="ZANUBRUTINIB" />
    <edge source="CHRONIC LYMPHOCYTIC LEUKEMIA" target="VENETOCLAX" />
    <edge source="CHRONIC LYMPHOCYTIC LEUKEMIA" target="PITOBRUTINIB" />
    <edge source="CHRONIC LYMPHOCYTIC LEUKEMIA" target="IDELALISIB" />
    <edge source="CHRONIC LYMPHOCYTIC LEUKEMIA" target="DUVELISIB" />
    <edge source="CHRONIC LYMPHOCYTIC LEUKEMIA" target="LISOCABTAGENE MARALEUCEL" />
    <edge source="CHRONIC LYMPHOCYTIC LEUKEMIA" target="ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT" />
    <edge source="MICROFOUNDATIONAL SIMULATION" target="TWEAKING" />
    <edge source="TELEMEDICINE-ASSISTED STRUCTURED SMBG" target="TRADITIONAL BGM" />
    <edge source="TELEMEDICINE-ASSISTED STRUCTURED SMBG" target="CHINESE CLINICAL TRIAL REGISTRY" />
    <edge source="CHINESE CLINICAL TRIAL REGISTRY" target="CHONGQING MEDICAL UNIVERSITY" />
    <edge source="ISLET AUTOIMMUNITY" target="PRIMARY ORAL INSULIN TRIAL" />
    <edge source="PRIMARY ORAL INSULIN TRIAL" target="EUROPE" />
    <edge source="EUROPE" target="GENERAL DATA PROTECTION REGULATION" />
    <edge source="EUROPE" target="CORONAVIRUS DISEASE 2019 (COVID-19) PANDEMIC" />
    <edge source="EUROPE" target="PANCARESURFUP" />
    <edge source="EUROPE" target="PH-POSITIVE CML" />
    <edge source="GRAPHICAL REPRESENTATION FORMATS" target="COGNITIVE PROCESSES" />
    <edge source="GRAPHICAL REPRESENTATION FORMATS" target="TIME PRESSURE" />
    <edge source="COGNITIVE PROCESSES" target="INCONSISTENT REPRESENTATION" />
    <edge source="COGNITIVE PROCESSES" target="CONSISTENT REPRESENTATION" />
    <edge source="PAUL EDWARDS" target="A VAST MACHINE" />
    <edge source="A VAST MACHINE" target="GLOBAL WARMING" />
    <edge source="GLOBAL WARMING" target="METEOROLOGY" />
    <edge source="NURSES' HEALTH STUDY" target="LOW-CARBOHYDRATE DIETS" />
    <edge source="LOW-CARBOHYDRATE DIETS" target="NURSES' HEALTH STUDY II" />
    <edge source="LOW-CARBOHYDRATE DIETS" target="BREAST CANCER DIAGNOSIS" />
    <edge source="PART I" target="COMPLEXITY" />
    <edge source="COMPLEXITY" target="CONSTITUTIVE COMPLEXITY" />
    <edge source="COMPLEXITY" target="DYNAMIC COMPLEXITY" />
    <edge source="COMPLEXITY" target="EVOLVED DIVERSITY" />
    <edge source="PLURALISM" target="LAWS" />
    <edge source="PLURALISM" target="DISUNITY" />
    <edge source="REVISED INTERNATIONAL STAGING SYSTEM" target="INTERNATIONAL STAGING SYSTEM" />
    <edge source="WILLIAM BECHTEL" target="ROBERT RICHARDSON" />
    <edge source="WILLIAM BECHTEL" target="DISCOVERING COMPLEXITY" />
    <edge source="ROBERT RICHARDSON" target="DISCOVERING COMPLEXITY" />
    <edge source="DISCOVERING COMPLEXITY" target="MIT PRESS" />
    <edge source="COMMISSION BIAS" target="EMOTIONAL SENSITIVITY TO PROBABILITIES (ESP)" />
    <edge source="EMOTIONAL SENSITIVITY TO PROBABILITIES (ESP)" target="POSSIBILITY PROBABILITY QUESTIONNAIRE (PPQ)" />
    <edge source="COMPUTATIONAL MODELS" target="INFECTIOUS DISEASES" />
    <edge source="COMPUTATIONAL MODELS" target="REPRODUCIBILITY GUIDELINES" />
    <edge source="COMPUTATIONAL MODELS" target="SCIENTIFIC COMMUNITIES" />
    <edge source="INFECTIOUS DISEASES" target="EPIDEMIC PROCESS" />
    <edge source="EUROPEAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION" target="ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION" />
    <edge source="ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION" target="MATCHED SIBLING DONOR" />
    <edge source="ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION" target="MATCHED UNRELATED DONOR" />
    <edge source="ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION" target="MISMATCHED UNRELATED DONOR" />
    <edge source="ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION" target="HAPLOIDENTICAL DONOR" />
    <edge source="ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION" target="CORD BLOOD" />
    <edge source="ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION" target="GVHD" />
    <edge source="ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION" target="LEUKEMIA-FREE SURVIVAL" />
    <edge source="ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION" target="NONRELAPSE MORTALITY" />
    <edge source="NORTH CAROLINA CENTRAL CANCER REGISTRY" target="SOCIETY FOR ASSISTED REPRODUCTIVE TECHNOLOGY" />
    <edge source="FERTILITY PRESERVATION" target="CAYA" />
    <edge source="FERTILITY PRESERVATION" target="US STATES" />
    <edge source="FERTILITY PRESERVATION" target="CANCER CARE CONTINUUM" />
    <edge source="FERTILITY PRESERVATION" target="FEMALE RISK ESTIMATION TOOLS" />
    <edge source="FERTILITY PRESERVATION" target="MATURE OOCYTE/EMBRYO CRYOPRESERVATION" />
    <edge source="FERTILITY PRESERVATION" target="OVARIAN TISSUE CRYOPRESERVATION" />
    <edge source="FERTILITY PRESERVATION" target="OVARIAN SUPPRESSION WITH GNRH AGONISTS" />
    <edge source="FERTILITY PRESERVATION" target="IN VITRO OOCYTE MATURATION" />
    <edge source="FERTILITY PRESERVATION" target="GYNECOLOGIC CANCERS" />
    <edge source="FERTILITY PRESERVATION" target="SPERM CRYOPRESERVATION" />
    <edge source="FERTILITY PRESERVATION" target="HEALTH INSURERS" />
    <edge source="MEDICAL EXPENDITURE PANEL SURVEY" target="CANCER PATIENTS" />
    <edge source="CANCER PATIENTS" target="EMPLOYERS" />
    <edge source="CANCER PATIENTS" target="PSILOCYBIN-ASSISTED GROUP THERAPY" />
    <edge source="CANCER PATIENTS" target="GASTRIC BIOPSIES" />
    <edge source="CANCER PATIENTS" target="GLUCOCORTICOIDS" />
    <edge source="CANCER PATIENTS" target="SHARED DECISION-MAKING SUPPORT TRAINING" />
    <edge source="CANCER PATIENTS" target="CLINICAL TRIAL SCREENING FRAMEWORK" />
    <edge source="CANCER PATIENTS" target="PATIENT DECISION AIDS" />
    <edge source="CANCER PATIENTS" target="SWEDISH CANCER REGISTRY" />
    <edge source="CANCER PATIENTS" target="CANCER COHORTS" />
    <edge source="CANCER PATIENTS" target="TELEMEDICINE TECHNOLOGY" />
    <edge source="CANCER PATIENTS" target="TELECONSULTATION" />
    <edge source="CANCER PATIENTS" target="TELEVISIT" />
    <edge source="CANCER PATIENTS" target="TELEREHABILITATION" />
    <edge source="VACCINE ADVERSE EVENTS REPORTING SYSTEM" target="MEDICAL DICTIONARY FOR REGULATORY ACTIVITIES" />
    <edge source="VACCINE ADVERSE EVENTS REPORTING SYSTEM" target="GUILLAIN-BARR&#201; SYNDROME" />
    <edge source="VACCINE ADVERSE EVENTS REPORTING SYSTEM" target="INFLUENZA VACCINATION" />
    <edge source="MEDICAL DICTIONARY FOR REGULATORY ACTIVITIES" target="GUILLAIN-BARR&#201; SYNDROME" />
    <edge source="MEDICAL DICTIONARY FOR REGULATORY ACTIVITIES" target="INFLUENZA VACCINATION" />
    <edge source="GUILLAIN-BARR&#201; SYNDROME" target="SYSTEM ORGAN CLASS" />
    <edge source="GUILLAIN-BARR&#201; SYNDROME" target="LOWEST LEVEL TERMS" />
    <edge source="SYSTEM ORGAN CLASS" target="LOWEST LEVEL TERMS" />
    <edge source="PRENATAL GENETIC SCREENS" target="DIAGNOSTIC TESTS" />
    <edge source="SHARED DECISION-MAKING (SDM) INSTRUMENT" target="NEST" />
    <edge source="SHARED DECISION-MAKING (SDM) INSTRUMENT" target="OPTION SCALE" />
    <edge source="TSCE MODEL" target="CARET" />
    <edge source="GERMLINE GENETIC TESTING" target="LOGISTIC REGRESSION MODELING" />
    <edge source="VISION TRANSFORMER (VIT)" target="ORTHODONTISTS" />
    <edge source="VISION TRANSFORMER (VIT)" target="EFFICIENTNETV2_S" />
    <edge source="MICHAEL LYNCH" target="BOSTON UNIVERSITY" />
    <edge source="STEVE WOOLGAR" target="BRUNEL UNIVERSITY" />
    <edge source="BRUNEL UNIVERSITY" target="UXBRIDGE" />
    <edge source="FLUORIDE SUPPLEMENTS" target="FLUORIDE GELS" />
    <edge source="FLUORIDE SUPPLEMENTS" target="FLUORIDE VARNISH" />
    <edge source="FLUORIDE SUPPLEMENTS" target="RESIN-BASED SEALANTS" />
    <edge source="FLUORIDE GELS" target="FLUORIDE VARNISH" />
    <edge source="FLUORIDE GELS" target="RESIN-BASED SEALANTS" />
    <edge source="FLUORIDE VARNISH" target="RESIN-BASED SEALANTS" />
    <edge source="ONTOLOGY RESEARCH" target="PROJECT MANAGEMENT" />
    <edge source="ONTOLOGY RESEARCH" target="KNOWLEDGE MANAGEMENT" />
    <edge source="ONTOLOGY RESEARCH" target="BUILDING INFORMATION MODELING" />
    <edge source="ONTOLOGY RESEARCH" target="COMPLIANCE CONTROL" />
    <edge source="ONTOLOGY RESEARCH" target="SCIENTOMETRIC ANALYSIS" />
    <edge source="ONTOLOGY RESEARCH" target="CRITICAL REVIEW" />
    <edge source="ONTOLOGY RESEARCH" target="DOMAIN ONTOLOGY" />
    <edge source="ONTOLOGY RESEARCH" target="INDUSTRY FOUNDATION CLASSES" />
    <edge source="ONTOLOGY RESEARCH" target="AUTOMATED COMPLIANCE CHECKING" />
    <edge source="CLINICAL PATHWAYS" target="TEMPORAL TOPIC MODEL" />
    <edge source="CLINICAL PATHWAYS" target="INTELLIGENT HEALTHCARE SERVICES" />
    <edge source="CLINICAL PATHWAYS" target="CLINICAL DECISION SUPPORT SYSTEMS (CDSSS)" />
    <edge source="TEMPORAL TOPIC MODEL" target="EXPERIMENTAL RESEARCH" />
    <edge source="AOTEAROA NEW ZEALAND" target="PATIENT PERCEPTIONS STUDY" />
    <edge source="PATIENT PERCEPTIONS STUDY" target="HEALTH SERVICES" />
    <edge source="WORD EMBEDDINGS" target="WORD EVOLUTION" />
    <edge source="UMLS" target="SMART CARE SYSTEM" />
    <edge source="UMLS" target="ORDO" />
    <edge source="UMLS" target="SEMEHR" />
    <edge source="GRIMM ET AL" target="MODELING INFECTIOUS DISEASES IN HEALTHCARE NETWORK" />
    <edge source="MODELING INFECTIOUS DISEASES IN HEALTHCARE NETWORK" target="AGENT-BASED MODELS" />
    <edge source="MULTIDRUG-RESISTANT ORGANISMS" target="HEALTHCARE-ASSOCIATED INFECTIONS" />
    <edge source="HEALTHCARE-ASSOCIATED INFECTIONS" target="ELECTRONIC SURVEILLANCE SYSTEM" />
    <edge source="HEALTHCARE-ASSOCIATED INFECTIONS" target="KNOWLEDGE-BASED HEALTHCARE-ASSOCIATED INFECTIONS SURVEILLANCE SYSTEM (KBHAIS)" />
    <edge source="USA" target="DIABETES INCIDENCE" />
    <edge source="USA" target="DIABETES MORTALITY" />
    <edge source="USA" target="THYROID CANCER" />
    <edge source="USA" target="DIGITAL PROFESSIONALISM" />
    <edge source="USA" target="COMA RECOVERY SCALE-REVISED" />
    <edge source="USA" target="MUSIC THERAPY ASSESSMENT TOOL FOR AWARENESS IN DISORDERS OF CONSCIOUSNESS" />
    <edge source="CANCER DIAGNOSIS IN PREGNANCY" target="MULTIMODALITY IMAGING" />
    <edge source="CANCER DIAGNOSIS IN PREGNANCY" target="IONIZING RADIATION IMAGING" />
    <edge source="CANCER DIAGNOSIS IN PREGNANCY" target="NOVEL ANTICANCER THERAPIES" />
    <edge source="CANCER DIAGNOSIS IN PREGNANCY" target="MULTIDISCIPLINARY MANAGEMENT" />
    <edge source="MULTIMODALITY IMAGING" target="IONIZING RADIATION IMAGING" />
    <edge source="MULTIMODALITY IMAGING" target="NOVEL ANTICANCER THERAPIES" />
    <edge source="NOVEL ANTICANCER THERAPIES" target="MULTIDISCIPLINARY MANAGEMENT" />
    <edge source="VENOUS THROMBOEMBOLISM" target="CANCER-ASSOCIATED THROMBOSIS" />
    <edge source="VENOUS THROMBOEMBOLISM" target="CLOTCATCHER" />
    <edge source="VENOUS THROMBOEMBOLISM" target="INTERNATIONAL CLASSIFICATION OF DISEASES" />
    <edge source="VENOUS THROMBOEMBOLISM" target="LOW-MOLECULAR-WEIGHT HEPARIN" />
    <edge source="VENOUS THROMBOEMBOLISM" target="MATERNAL MORBIDITY" />
    <edge source="VENOUS THROMBOEMBOLISM" target="MATERNAL DEATH" />
    <edge source="CANCER-ASSOCIATED THROMBOSIS" target="LOW MOLECULAR WEIGHT HEPARINS" />
    <edge source="CANCER-ASSOCIATED THROMBOSIS" target="DIRECT ORAL ANTICOAGULANTS" />
    <edge source="INFLIXIMAB" target="ULCERATIVE COLITIS" />
    <edge source="NCT04593940" target="LATIN AMERICA" />
    <edge source="SUCCESSFUL AGING" target="ADAPTIVE NEURO-FUZZY INFERENCE SYSTEM" />
    <edge source="SUCCESSFUL AGING" target="MULTILAYER PERCEPTRON" />
    <edge source="SUCCESSFUL AGING" target="DECISION SUPPORT SYSTEM" />
    <edge source="MULTILAYER PERCEPTRON" target="MRI BRAIN IMAGES" />
    <edge source="MULTILAYER PERCEPTRON" target="CLINICAL PREDICTION MODELS" />
    <edge source="MICHAEL POLANYI" target="THOMAS KUHN" />
    <edge source="MICHAEL POLANYI" target="KARL POPPER" />
    <edge source="MICHAEL POLANYI" target="THE TACIT DIMENSION" />
    <edge source="ALZHEIMER'S DISEASE" target="NATIONAL ALZHEIMER'S COORDINATING CENTER" />
    <edge source="ALZHEIMER'S DISEASE" target="ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE" />
    <edge source="ALZHEIMER'S DISEASE" target="WORD2VEC" />
    <edge source="ALZHEIMER'S DISEASE" target="BIOWORDVEC" />
    <edge source="ALZHEIMER'S DISEASE" target="NATURAL LANGUAGE PROCESSING PIPELINE" />
    <edge source="ALZHEIMER'S DISEASE" target="ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (ADNI)" />
    <edge source="ALZHEIMER'S DISEASE" target="ALZHEIMER&#8217;S DISEASE NEUROIMAGING INITIATIVE" />
    <edge source="ALZHEIMER'S DISEASE" target="NATIONAL ALZHEIMER&#8217;S COORDINATING CENTER" />
    <edge source="ALZHEIMER'S DISEASE" target="EXTREME GRADIENT BOOSTING-SHAPLEY ADDITIVE EXPLANATIONS" />
    <edge source="NATIONAL ALZHEIMER'S COORDINATING CENTER" target="ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE" />
    <edge source="NATIONAL ALZHEIMER'S COORDINATING CENTER" target="COMMON DATA ELEMENTS REPOSITORY" />
    <edge source="ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE" target="COMMON DATA ELEMENTS REPOSITORY" />
    <edge source="WORD2VEC" target="BIGRU" />
    <edge source="FAST TRACK" target="HIP AND KNEE ARTHROPLASTY" />
    <edge source="PATIENT-REPORTED OUTCOME MEASURES" target="NATIONAL HEALTH SERVICE (NHS)" />
    <edge source="LIGHT GRADIENT BOOSTING MACHINE" target="HOSPITAL LENGTH OF STAY" />
    <edge source="LIGHT GRADIENT BOOSTING MACHINE" target="THIRD AFFILIATED HOSPITAL OF ANHUI MEDICAL UNIVERSITY" />
    <edge source="ADOLESCENTS AND YOUNG ADULTS (AYAS)" target="AYA ONCOLOGY" />
    <edge source="ADOLESCENTS AND YOUNG ADULTS (AYAS)" target="MULTICOMPONENT PROGRAMS" />
    <edge source="AYA ONCOLOGY" target="TRANSACTIONAL MODEL OF STRESS AND COPING" />
    <edge source="MULTICOMPONENT PROGRAMS" target="EHEALTH MODALITIES" />
    <edge source="IGF2BP3" target="BRAIN METASTASIS" />
    <edge source="IGF2BP3" target="PD-1 CHECKPOINT PATHWAY" />
    <edge source="IGF2BP3" target="HER2-HER3 SIGNALING" />
    <edge source="IGF2BP3" target="EPITHELIAL-MESENCHYMAL TRANSITION" />
    <edge source="UK BIOBANK" target="DEMENTIA STUDY" />
    <edge source="UK BIOBANK" target="POISSON REGRESSION ANALYSIS" />
    <edge source="UK BIOBANK" target="DIFFERENTIALLY PRIVATE GENERATIVE MODELLING" />
    <edge source="UK BIOBANK" target="ASSESSMENT CENTERS" />
    <edge source="UK BIOBANK" target="COLLABORATIVE LEARNING" />
    <edge source="UK BIOBANK" target="WEEKEND WARRIOR" />
    <edge source="UK BIOBANK" target="ACTIVE REGULAR" />
    <edge source="UK BIOBANK" target="INACTIVE" />
    <edge source="UK BIOBANK" target="VENOUS THROMBOEMBOLISM (VTE)" />
    <edge source="UK BIOBANK" target="BRITISH" />
    <edge source="UK BIOBANK" target="IRISH" />
    <edge source="DEMENTIA STUDY" target="SCOTLAND" />
    <edge source="DEMENTIA STUDY" target="WALES" />
    <edge source="WOMEN WITH EPILEPSY OF CHILD-BEARING AGE ONTOLOGY" target="ONLINE QUESTION AND ANSWER SYSTEM" />
    <edge source="EXPERIMENTAL PHYSICISTS" target="MODERN TECHNOLOGY" />
    <edge source="EXPERIMENTAL PHYSICISTS" target="MICROPHYSICS" />
    <edge source="EXPERIMENTAL PHYSICISTS" target="TRADING ZONES" />
    <edge source="EXPERIMENTAL PHYSICISTS" target="AUTHOR" />
    <edge source="MODERN TECHNOLOGY" target="MICROPHYSICS" />
    <edge source="MODERN TECHNOLOGY" target="TRADING ZONES" />
    <edge source="TRADING ZONES" target="AUTHOR" />
    <edge source="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK" target="US WOMEN" />
    <edge source="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK" target="US COHORT STUDIES" />
    <edge source="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK" target="REGISTRY" />
    <edge source="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK" target="CLAIMS DATA" />
    <edge source="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK" target="BREAST CANCER MODELING" />
    <edge source="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK" target="STATISTICAL MODELS" />
    <edge source="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK" target="BREAST CANCER SCREENING" />
    <edge source="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK" target="BREAST CANCER TREATMENT" />
    <edge source="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK" target="NATURAL-HISTORY MODELING" />
    <edge source="US WOMEN" target="DIGITAL BREAST TOMOSYNTHESIS" />
    <edge source="MAMMOGRAPHY SCREENING" target="BREAST CANCER MORTALITY" />
    <edge source="MAMMOGRAPHY SCREENING" target="ACE-ITS PROGRAM" />
    <edge source="MMIR" target="MULTIMODAL HISTOLOGY IMAGE REGISTRATION" />
    <edge source="MULTIMODAL HISTOLOGY IMAGE REGISTRATION" target="HISTOLOGY" />
    <edge source="MULTIMODAL HISTOLOGY IMAGE REGISTRATION" target="MICROSCOPY MODALITIES" />
    <edge source="US MULTI-SOCIETY TASK FORCE" target="SURVEILLANCE COLONOSCOPY" />
    <edge source="SURVEILLANCE COLONOSCOPY" target="MASS GENERAL BRIGHAM COLONOSCOPY COHORT" />
    <edge source="SURVEILLANCE COLONOSCOPY" target="COLORECTAL POLYPECTOMY" />
    <edge source="SURVEILLANCE COLONOSCOPY" target="HIGH-RISK POLYPS" />
    <edge source="SYSTEMATIC REVIEW" target="TELEMEDICINE" />
    <edge source="SYSTEMATIC REVIEW" target="PATIENT SATISFACTION" />
    <edge source="SYSTEMATIC REVIEW" target="SUICIDE RISK FACTORS" />
    <edge source="SYSTEMATIC REVIEW" target="MEDICAL LIBRARIAN" />
    <edge source="SYSTEMATIC REVIEW" target="DECEMBER 4, 2020" />
    <edge source="SYSTEMATIC REVIEW" target="APRIL 14, 2023" />
    <edge source="SYSTEMATIC REVIEW" target="IEEE XPLORE DIGITAL LIBRARY" />
    <edge source="SYSTEMATIC REVIEW" target="ACM DIGITAL LIBRARY" />
    <edge source="SYSTEMATIC REVIEW" target="QUADAS-2" />
    <edge source="SYSTEMATIC REVIEW" target="LINGO3G" />
    <edge source="SYSTEMATIC REVIEW" target="HUMAN RESEARCHER" />
    <edge source="SYSTEMATIC REVIEW" target="VIRTUAL REALITY" />
    <edge source="SYSTEMATIC REVIEW" target="FEBRUARY 6, 2022" />
    <edge source="SYSTEMATIC REVIEW" target="GROUP 6" />
    <edge source="SYSTEMATIC REVIEW" target="TECH MINING" />
    <edge source="SYSTEMATIC REVIEW" target="HUMAN SCREENING" />
    <edge source="SYSTEMATIC REVIEW" target="AUTOMATED SCREENING" />
    <edge source="SYSTEMATIC REVIEW" target="MACHINE LEARNING ALGORITHM" />
    <edge source="SYSTEMATIC REVIEW" target="PC-12 CELLS" />
    <edge source="SYSTEMATIC REVIEW" target="DIGITAL HEALTH INTERVENTIONS" />
    <edge source="REVIEWERS" target="PEER REVIEW WORKFLOW" />
    <edge source="REVIEWERS" target="PEER REVIEW SYSTEM" />
    <edge source="REVIEWERS" target="AUTOMATED SCREENING TOOLS" />
    <edge source="HUMANS" target="MACHINES" />
    <edge source="MACHINES" target="LABORATORIES" />
    <edge source="SCIENTIFIC REPRESENTATION" target="SIMILARITY" />
    <edge source="SCIENTIFIC REPRESENTATION" target="ISOMORPHISM" />
    <edge source="PATIENTS WITH METASTATIC CANCER" target="FAMILY CAREGIVERS" />
    <edge source="PATIENTS WITH METASTATIC CANCER" target="JOINT DECISION MAKING" />
    <edge source="PATIENTS WITH METASTATIC CANCER" target="PATIENT-LED DECISION MAKING" />
    <edge source="FAMILY CAREGIVERS" target="DECISION-MAKING" />
    <edge source="FAMILY CAREGIVERS" target="COPING" />
    <edge source="JOINT DECISION MAKING" target="QUALITY OF LIFE" />
    <edge source="JOINT DECISION MAKING" target="QUALITY OF CARE" />
    <edge source="PATIENT-LED DECISION MAKING" target="QUALITY OF LIFE" />
    <edge source="PATIENT-LED DECISION MAKING" target="QUALITY OF CARE" />
    <edge source="QUALITY OF CARE" target="FINANCIAL BALANCE" />
    <edge source="E-CIGARETTE USE" target="AFRICAN AMERICAN CANCER SURVIVOR POPULATION" />
    <edge source="DETROIT RESEARCH ON CANCER SURVIVORS" target="AFRICAN AMERICAN CANCER SURVIVOR POPULATION" />
    <edge source="LEUKEMIA TRIAL" target="NICE TSD 21.1" />
    <edge source="LEUKEMIA TRIAL" target="EXPERT OPINION" />
    <edge source="EXPERT OPINION" target="BAYESIAN METHOD" />
    <edge source="EXPERT OPINION" target="FREQUENTIST APPROACH" />
    <edge source="BAYESIAN METHOD" target="FREQUENTIST APPROACH" />
    <edge source="ECOACH" target="SPARQL" />
    <edge source="ECOACH" target="PMDATA" />
    <edge source="ECOACH" target="MOX2-5" />
    <edge source="ECOACH" target="GRADIENT BOOST (GB) CLASSIFIER" />
    <edge source="ECOACH" target="HERMIT REASONER" />
    <edge source="ECOACH" target="AI" />
    <edge source="ECOACH" target="RESIDUAL ERROR MINIMIZATION (REM)" />
    <edge source="ECOACH" target="NA&#207;VE-BASED INTERVAL PREDICTION" />
    <edge source="ECOACH" target="ENSEMBLE MULTI-CLASS CLASSIFICATION" />
    <edge source="ECOACH" target="TIME-SERIES PREDICTION" />
    <edge source="PMDATA" target="ADASYN" />
    <edge source="MOX2-5" target="ADASYN" />
    <edge source="GLOBAL BURDEN OF DISEASE" target="DISABILITY-ADJUSTED LIFE YEAR" />
    <edge source="GRANULOSA CELL TUMOR-SURVIVOR SISTERS" target="GCT-SS FACEBOOK GROUP" />
    <edge source="GRANULOSA CELL TUMOR-SURVIVOR SISTERS" target="GCT" />
    <edge source="GCT-SS FACEBOOK GROUP" target="GCT" />
    <edge source="GCT" target="JUVENILE GCT" />
    <edge source="GCT" target="ADULT GCT" />
    <edge source="JUVENILE GCT" target="ADULT GCT" />
    <edge source="TELEMEDICINE" target="JOANNA BRIGGS INSTITUTE" />
    <edge source="TELEMEDICINE" target="UNIVERSITY OF PENNSYLVANIA" />
    <edge source="TELEMEDICINE" target="IN-PERSON CLINIC VISITS" />
    <edge source="TELEMEDICINE" target="ADVANCE CARE PLANNING" />
    <edge source="TELEMEDICINE" target="UNPLANNED HOSPITALIZATIONS" />
    <edge source="TELEMEDICINE" target="IN-PERSON VISITS" />
    <edge source="TELEMEDICINE" target="MAXQDA 18" />
    <edge source="TELEMEDICINE" target="CHI-SQUARE TESTS" />
    <edge source="TELEMEDICINE" target="DESCRIPTIVE STATISTICS" />
    <edge source="JOANNA BRIGGS INSTITUTE" target="CRITICAL APPRAISAL TOOL FOR ANALYTICAL CROSS-SECTIONAL STUDIES" />
    <edge source="JOANNA BRIGGS INSTITUTE" target="EBM" />
    <edge source="JOANNA BRIGGS INSTITUTE" target="PRISMA-SCR" />
    <edge source="BERTRAND RUSSELL" target="CARNAP" />
    <edge source="BERTRAND RUSSELL" target="PUTNAM" />
    <edge source="BERTRAND RUSSELL" target="PICTURE THEORY OF SCIENCE" />
    <edge source="CARNAP" target="PUTNAM" />
    <edge source="CARNAP" target="PICTURE THEORY OF SCIENCE" />
    <edge source="PUTNAM" target="PICTURE THEORY OF SCIENCE" />
    <edge source="PUTNAM" target="QUINE" />
    <edge source="PUTNAM" target="HACKING" />
    <edge source="PICTURE THEORY OF SCIENCE" target="BILDTHEORIE" />
    <edge source="BONE MARROW TRANSPLANTATION" target="CHRONIC HEALTH CONDITIONS" />
    <edge source="BONE MARROW TRANSPLANTATION" target="ACUTE MYELOID LEUKEMIA/MYELODYSPLASTIC SYNDROME" />
    <edge source="BONE MARROW TRANSPLANTATION" target="CHILDHOOD" />
    <edge source="CHRONIC HEALTH CONDITIONS" target="TOTAL BODY IRRADIATION" />
    <edge source="CHRONIC HEALTH CONDITIONS" target="GRAFT-VERSUS-HOST DISEASE" />
    <edge source="CHRONIC HEALTH CONDITIONS" target="SURVIVORS" />
    <edge source="GRAFT-VERSUS-HOST DISEASE" target="CYCLOPHOSPHAMIDE" />
    <edge source="SURVIVORS" target="SIBLINGS" />
    <edge source="SIBLINGS" target="FEMALE SURVIVORS" />
    <edge source="SIBLINGS" target="CHILDHOOD CANCER SURVIVOR STUDY" />
    <edge source="SIBLINGS" target="LONELINESS" />
    <edge source="FOLLICULAR LYMPHOMA" target="OBINUTUZUMAB" />
    <edge source="OBINUTUZUMAB" target="VENETOCLAX" />
    <edge source="DECO-MOM" target="CHUNCHEON" />
    <edge source="DECO-MOM" target="GONGJU" />
    <edge source="DECO-MOM" target="KCT0007725" />
    <edge source="POLICY MODELLING" target="GLOBAL LEADERS" />
    <edge source="POLICY MODELLING" target="COMMUNITIES" />
    <edge source="COMMUNITIES" target="GOVERNMENTS" />
    <edge source="COMMUNITIES" target="COMMUNICATION STRATEGY" />
    <edge source="PHYSICAL SCIENCES" target="MODELLING AND SIMULATION" />
    <edge source="BIOLOGICAL SCIENCES" target="INTEGRATIVE PLURALISM" />
    <edge source="POST-ERCP PANCREATITIS" target="CHINESE TERTIARY HOSPITAL" />
    <edge source="POST-ERCP PANCREATITIS" target="LASSO REGRESSION" />
    <edge source="POST-ERCP PANCREATITIS" target="R SHINY PACKAGE" />
    <edge source="POST-ERCP PANCREATITIS" target="WEB SERVER" />
    <edge source="POST-ERCP PANCREATITIS" target="ERCP" />
    <edge source="POST-ERCP PANCREATITIS" target="NON-ELDERLY PATIENTS" />
    <edge source="POST-ERCP PANCREATITIS" target="COMMON BILE DUCT STONES" />
    <edge source="LASSO REGRESSION" target="PURE" />
    <edge source="LASSO REGRESSION" target="MIMIC IV" />
    <edge source="NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION" target="GENE EXPRESSION OMNIBUS" />
    <edge source="GENE EXPRESSION OMNIBUS" target="DLBCL" />
    <edge source="CIBERSORT" target="R SOFTWARE" />
    <edge source="R SOFTWARE" target="LASSO REGRESSION MODEL" />
    <edge source="GSE10846" target="GSE53786" />
    <edge source="LOGICAL POSITIVISM" target="OBSERVATION-SENTENCES" />
    <edge source="LOGICAL POSITIVISM" target="CORRESPONDENCE RULES" />
    <edge source="OBSERVATION-SENTENCES" target="OBSERVATIONAL VOCABULARY" />
    <edge source="CORRESPONDENCE RULES" target="THEORETICAL VOCABULARY" />
    <edge source="OBSERVATIONAL VOCABULARY" target="THEORETICAL VOCABULARY" />
    <edge source="THYROID CANCER" target="GATED RECURRENT UNITS (GRUS)" />
    <edge source="THYROID CANCER" target="BI-DIRECTIONAL LSTM (BI-LSTM)" />
    <edge source="THYROID CANCER" target="INDEPENDENT SET TEST (IST)" />
    <edge source="THYROID CANCER" target="ENSEMBLE LEARNING MODEL" />
    <edge source="GATED RECURRENT UNITS (GRUS)" target="ENSEMBLE LEARNING MODEL" />
    <edge source="BI-DIRECTIONAL LSTM (BI-LSTM)" target="ENSEMBLE LEARNING MODEL" />
    <edge source="INDEPENDENT SET TEST (IST)" target="ENSEMBLE LEARNING MODEL" />
    <edge source="ENSEMBLE LEARNING MODEL" target="ASIA.ENSEMBL.ORG" />
    <edge source="ENSEMBLE LEARNING MODEL" target="INTOGEN.ORG" />
    <edge source="ENSEMBLE LEARNING MODEL" target="SELF-CONSISTENCY TEST (SCT)" />
    <edge source="ENSEMBLE LEARNING MODEL" target="10-FOLD CROSS-VALIDATION TEST (10-FCVT)" />
    <edge source="ENSEMBLE LEARNING MODEL" target="HAHN MOMENTS" />
    <edge source="ENSEMBLE LEARNING MODEL" target="CENTRAL MOMENTS" />
    <edge source="ENSEMBLE LEARNING MODEL" target="RAW MOMENTS" />
    <edge source="ASIA.ENSEMBL.ORG" target="INTOGEN.ORG" />
    <edge source="HEPATITIS D VIRUS" target="HEPATITIS B VIRUS" />
    <edge source="HEPATITIS D VIRUS" target="INTERFERON ALFA" />
    <edge source="HEPATITIS D VIRUS" target="BULEVIRTIDE" />
    <edge source="HEPATITIS D VIRUS" target="LONAFARNIB" />
    <edge source="SCREENING MAMMOGRAPHY" target="QUALITY-ADJUSTED LIFE-YEARS (QALYS)" />
    <edge source="SCREENING MAMMOGRAPHY" target="WOMEN OLDER THAN 40 YEARS" />
    <edge source="SCREENING MAMMOGRAPHY" target="U.S. GUIDELINES" />
    <edge source="SCREENING MAMMOGRAPHY" target="WHITE WOMEN" />
    <edge source="NATIONAL POISON DATA SYSTEM" target="RSTI" />
    <edge source="NATIONAL POISON DATA SYSTEM" target="ACUTE ACETAMINOPHEN EXPOSURE" />
    <edge source="RSTI" target="DECISION TREE ALGORITHM" />
    <edge source="ACUTE ACETAMINOPHEN EXPOSURE" target="DECISION TREE ALGORITHM" />
    <edge source="NATURAL LANGUAGE PROCESSING PIPELINE" target="DJANGO" />
    <edge source="THE AUTHOR(S)" target="ORIGINAL ARTICLE" />
    <edge source="THE AUTHOR(S)" target="EQ. 1" />
    <edge source="THE AUTHOR(S)" target="CORRECTION" />
    <edge source="ORIGINAL ARTICLE" target="EQ. 1" />
    <edge source="PERSONAL HEALTH RECORDS" target="ELECTRONIC HEALTH" />
    <edge source="PERSONAL HEALTH RECORDS" target="INTEGRATED PHR" />
    <edge source="PERSONAL HEALTH RECORDS" target="SELF-CARE" />
    <edge source="INTEGRATED PHR" target="DELPHI TECHNIQUE" />
    <edge source="INTEGRATED PHR" target="HEALTHCARE ORGANIZATIONS" />
    <edge source="INTEGRATED PHR" target="SECURITY REQUIREMENTS" />
    <edge source="DELPHI TECHNIQUE" target="QUESTIONNAIRE" />
    <edge source="DELPHI TECHNIQUE" target="EXPERTS" />
    <edge source="SECURITY REQUIREMENTS" target="LITERATURE REVIEW" />
    <edge source="EXPERTS" target="DELPHI PANELS" />
    <edge source="EXPERTS" target="OPIOID MANAGEMENT STRATEGIES" />
    <edge source="PROFESSIONAL MEDICAL ORGANIZATIONS" target="POSTPARTUM CARE" />
    <edge source="POSTPARTUM CARE" target="NEW YORK CITY" />
    <edge source="POSTPARTUM CARE" target="OREGON" />
    <edge source="POSTPARTUM CARE" target="LOW-INCOME IMMIGRANTS" />
    <edge source="POSTPARTUM CARE" target="NONIMMIGRANTS" />
    <edge source="POSTPARTUM CARE" target="19 STATES" />
    <edge source="PREGNANCY RISK ASSESSMENT MONITORING SYSTEM" target="NEW YORK CITY" />
    <edge source="NEW YORK CITY" target="LOW-INCOME IMMIGRANTS" />
    <edge source="LOW-INCOME IMMIGRANTS" target="19 STATES" />
    <edge source="BERTSUM" target="BART" />
    <edge source="BERTSUM" target="BERTSCORE" />
    <edge source="BART" target="BERTSCORE" />
    <edge source="GPT-3.5" target="BERTSCORE" />
    <edge source="GPT-3.5" target="AZURE" />
    <edge source="GPT-3.5" target="ICD-9" />
    <edge source="BAYESIAN APPROACH" target="DIRICHLET PROCESS MIXTURE MODEL" />
    <edge source="BAYESIAN APPROACH" target="TYPE 2 DIABETES SECOND-LINE THERAPIES" />
    <edge source="BAYESIAN APPROACH" target="UK EQ-5D-3L VALUATION STUDY" />
    <edge source="BAYESIAN APPROACH" target="POSTERIOR DISTRIBUTIONS" />
    <edge source="DIRICHLET PROCESS MIXTURE MODEL" target="TYPE 2 DIABETES SECOND-LINE THERAPIES" />
    <edge source="ERIC" target="FAMILY MEDICINE DEPARTMENTS" />
    <edge source="COVID PANDEMIC" target="SMARTWATCHES" />
    <edge source="COVID PANDEMIC" target="H2O AUTOML" />
    <edge source="SMARTWATCHES" target="HEALTHCARE SECTOR" />
    <edge source="SMARTWATCHES" target="AI-HOSPITAL ASSISTANTS" />
    <edge source="CHATEXTRACT" target="CHATGPT-4" />
    <edge source="CHATEXTRACT" target="MATERIALS DATA" />
    <edge source="CHATEXTRACT" target="CRITICAL COOLING RATES OF METALLIC GLASSES" />
    <edge source="CHATEXTRACT" target="YIELD STRENGTHS OF HIGH ENTROPY ALLOYS" />
    <edge source="CHATGPT-4" target="LIKERT SCALE" />
    <edge source="TRANSFER LEARNING" target="MACHINE LEARNING CLASSIFIERS" />
    <edge source="MULTI-CANCER EARLY DETECTION TEST" target="NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE" />
    <edge source="MULTI-CANCER EARLY DETECTION TEST" target="CANCER SIGNAL ORIGIN" />
    <edge source="MULTI-CANCER EARLY DETECTION TEST" target="POSITIVE PREDICTIVE VALUE" />
    <edge source="MULTI-CANCER EARLY DETECTION TEST" target="RESIDUAL CURRENT CANCER RISK" />
    <edge source="NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE" target="SURVINT" />
    <edge source="AREN0532" target="WILMS TUMOR" />
    <edge source="WILMS TUMOR" target="AREN03B2" />
    <edge source="WILMS TUMOR" target="VINCRISTINE/DACTINOMYCIN/DOXORUBICIN (DD4A)" />
    <edge source="WILMS TUMOR" target="BECKWITH-WIEDEMANN SYNDROME" />
    <edge source="WILMS TUMOR" target="INTERNATIONAL SOCIETY OF PAEDIATRIC ONCOLOGY" />
    <edge source="WILMS TUMOR" target="UK CHILDREN'S CANCER AND LEUKAEMIA GROUP" />
    <edge source="WILMS TUMOR" target="GESELLSCHAFT F&#220;R P&#196;DIATRISCHE ONKOLOGIE UND H&#196;MATOLOGIE" />
    <edge source="WILMS TUMOR" target="CHILDHOOD CANCER" />
    <edge source="WILMS TUMOR" target="NON-HODGKIN LYMPHOMA" />
    <edge source="SUICIDE RISK FACTORS" target="SID" />
    <edge source="SUICIDE RISK FACTORS" target="NEURAL NETWORK" />
    <edge source="SUICIDE RISK FACTORS" target="COX" />
    <edge source="SUICIDE RISK FACTORS" target="SUICIDE RISK PREDICTION" />
    <edge source="NEURAL NETWORK" target="ELECTRONIC NOSE TECHNOLOGY" />
    <edge source="NEURAL NETWORK" target="BENIGN PROSTATIC HYPERPLASIA" />
    <edge source="DEMENTIA PATIENTS" target="JAPANESE TRANSCRIBED INTERVIEWS" />
    <edge source="DEMENTIA PATIENTS" target="LATENT NEEDS" />
    <edge source="LATENT NEEDS" target="SOCIETAL DECISION MAKING" />
    <edge source="Z-SCORE ADAPTATION" target="NAIVE BAYES" />
    <edge source="Z-SCORE ADAPTATION" target="SOCIETAL DECISION MAKING" />
    <edge source="NAIVE BAYES" target="CHRONIC HEART FAILURE" />
    <edge source="NAIVE BAYES" target="PROLONGED INTERMITTENT RENAL REPLACEMENT THERAPY" />
    <edge source="NAIVE BAYES" target="PROBABILITY CALIBRATIONS" />
    <edge source="NAIVE BAYES" target="LOGISTIC TENSOR REGRESSION" />
    <edge source="NAIVE BAYES" target="TF-IDF" />
    <edge source="FIRST AFFILIATED HOSPITAL OF KUNMING MEDICAL UNIVERSITY" target="KUNMING" />
    <edge source="CHRONIC HEART FAILURE" target="RANDOM FOREST CLASSIFIER" />
    <edge source="CHRONIC HEART FAILURE" target="EXTREME GRADIENT BOOST" />
    <edge source="CHRONIC HEART FAILURE" target="K-NEAREST NEIGHBOR" />
    <edge source="CHRONIC HEART FAILURE" target="ADLIFE" />
    <edge source="RANDOM FOREST CLASSIFIER" target="VIROLOGICAL FAILURE" />
    <edge source="RANDOM FOREST CLASSIFIER" target="FOOD FREQUENCY QUESTIONNAIRES" />
    <edge source="RANDOM FOREST CLASSIFIER" target="MEASUREMENT ERROR" />
    <edge source="RANDOM FOREST CLASSIFIER" target="DIABETIC KIDNEY DISEASE" />
    <edge source="RANDOM FOREST CLASSIFIER" target="MACHINE LEARNING ALGORITHM" />
    <edge source="K-NEAREST NEIGHBOR" target="PROLONGED INTERMITTENT RENAL REPLACEMENT THERAPY" />
    <edge source="BRAF-TARGETED THERAPY" target="DABRAFENIB" />
    <edge source="BRAF-TARGETED THERAPY" target="TRAMETINIB" />
    <edge source="DABRAFENIB" target="CANCER THERAPY EVALUATION PROGRAM STUDY 9557" />
    <edge source="DABRAFENIB" target="AT13387" />
    <edge source="DABRAFENIB" target="TRAMETINIB" />
    <edge source="DABRAFENIB" target="BRAF" />
    <edge source="TRAMETINIB" target="CANCER THERAPY EVALUATION PROGRAM STUDY 9557" />
    <edge source="TRAMETINIB" target="AT13387" />
    <edge source="TRAMETINIB" target="MEK" />
    <edge source="NEOADJUVANT IMMUNOTHERAPY" target="PROGRAMMED DEATH-1" />
    <edge source="NEOADJUVANT IMMUNOTHERAPY" target="PROGRAMMED CELL DEATH LIGAND-1" />
    <edge source="NEOADJUVANT IMMUNOTHERAPY" target="CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED ANTIGEN-4" />
    <edge source="NEOADJUVANT IMMUNOTHERAPY" target="PRISMA" />
    <edge source="NEOADJUVANT IMMUNOTHERAPY" target="MOOSE" />
    <edge source="NEOADJUVANT IMMUNOTHERAPY" target="PICOD" />
    <edge source="PRISMA" target="CENTRAL" />
    <edge source="PRISMA" target="YOUNG ADULT CANCER SURVIVORS" />
    <edge source="PRISMA" target="YOUNG RESEARCHER PHYSICIANS" />
    <edge source="BLACK POPULATION" target="WHITE POPULATION" />
    <edge source="BLACK POPULATION" target="HEART DISEASE" />
    <edge source="HEART DISEASE" target="RISK SCORE CALCULATORS" />
    <edge source="MEDMGF" target="FOCAL LOSS" />
    <edge source="MEDMGF" target="GRAPHICAL CONVOLUTIONAL NETWORK" />
    <edge source="MEDMGF" target="SYNTHETIC MINORITY OVERSAMPLING TECHNIQUE" />
    <edge source="MEDMGF" target="PEDIATRIC SEPSIS DATASET" />
    <edge source="WALTON" target="MIMESIS AS MAKE-BELIEVE" />
    <edge source="MIMESIS AS MAKE-BELIEVE" target="HARVARD UNIVERSITY PRESS" />
    <edge source="HARVARD UNIVERSITY PRESS" target="CAMBRIDGE/MA" />
    <edge source="PREGNANT WOMEN" target="MHEALTH" />
    <edge source="PREGNANT WOMEN" target="OBSTETRICS AND GYNECOLOGY CLINIC" />
    <edge source="PREGNANT WOMEN" target="SOCIAL MEDIA" />
    <edge source="SPSS" target="MHEALTH" />
    <edge source="SPSS" target="CEPHALOMETRIC ANALYSIS" />
    <edge source="SPSS" target="IRAN-PREMATURE CORONARY ARTERY DISEASE STUDY" />
    <edge source="MHEALTH" target="NVIVO 11" />
    <edge source="MHEALTH" target="POSITIVE WEIGHT CONTROLLERS" />
    <edge source="MHEALTH" target="PATIENTS INACTIVE DUE TO FATIGUE" />
    <edge source="MHEALTH" target="YOUNG PATIENTS WHO AVOIDED COMMUNICATION" />
    <edge source="MHEALTH" target="OVERWEIGHT PATIENTS WITH TREATMENT PRIORITY" />
    <edge source="MHEALTH" target="PATIENTS WHO ENGAGED IN IRREGULAR EXERCISE" />
    <edge source="MHEALTH" target="USER RETENTION" />
    <edge source="MHEALTH" target="ENGAGEMENT" />
    <edge source="MHEALTH" target="USER PERSONA" />
    <edge source="SOCIAL MEDIA" target="BEHAVIOURAL CHANGE MODELS" />
    <edge source="FAMILY MEDICINE DEPARTMENTS" target="EDUCATION SOURCE" />
    <edge source="FAMILY MEDICINE DEPARTMENTS" target="OSF REGISTRIES" />
    <edge source="POSTGRADUATE FAMILY MEDICINE TRAINING" target="DIGITAL LEARNING TOOLS" />
    <edge source="NSCLC RISK ASSESSMENT MODEL" target="EMPIRICAL ANALYSIS EXPERIMENT" />
    <edge source="PARTICLE FILTERING" target="PARAMETER ESTIMATION" />
    <edge source="PARTICLE FILTERING" target="POSTOPERATIVE SURVIVAL RISK ASSESSMENT MODEL" />
    <edge source="PARAMETER ESTIMATION" target="POSTOPERATIVE SURVIVAL RISK ASSESSMENT MODEL" />
    <edge source="MEDICAL MAXIMIZING ORIENTATION" target="LOW-VALUE CARE" />
    <edge source="MEDICAL MAXIMIZING ORIENTATION" target="THYROID ULTRASONOGRAPHY" />
    <edge source="MEDICAL MAXIMIZING ORIENTATION" target="RISK PERCEPTION" />
    <edge source="MEDICAL MAXIMIZING ORIENTATION" target="KNOWLEDGE" />
    <edge source="THYROID ULTRASONOGRAPHY" target="SOUTH KOREAN WOMEN" />
    <edge source="RISK PERCEPTION" target="KNOWLEDGE" />
    <edge source="REBOA" target="UK TRAUMA CENTERS" />
    <edge source="REBOA" target="ISRCTN16184981" />
    <edge source="REBOA" target="EXSANQUINATING HEMORRHAGE" />
    <edge source="EXSANQUINATING HEMORRHAGE" target="STANDARD CARE" />
    <edge source="TERTIARY REFERRAL HOSPITAL" target="TNM 7TH EDITION" />
    <edge source="KOREA" target="KOREAN NATIONAL HEALTH INSURANCE DATABASE" />
    <edge source="KOREA" target="NATIONAL CANCER CENTER, KOREA" />
    <edge source="KOREA" target="NON-SMALL CELL LUNG CANCER (NSCLC)" />
    <edge source="KOREA" target="BAYESIAN MODELS" />
    <edge source="KOREAN NATIONAL HEALTH INSURANCE DATABASE" target="TNM 7TH EDITION" />
    <edge source="BATTERMAN" target="ASYMPTOTIC REASONING" />
    <edge source="BATTERMAN" target="WILSON" />
    <edge source="BATTERMAN" target="BELOT" />
    <edge source="ASYMPTOTIC REASONING" target="UNIVERSAL BEHAVIOUR" />
    <edge source="ROBOTREVIEWER" target="MONASH RESEARCH OFFICE" />
    <edge source="ROBOTREVIEWER" target="COVIENCE" />
    <edge source="ROBOTREVIEWER" target="SYSTEMATIC REVIEWERS" />
    <edge source="ROBOTREVIEWER" target="COCHRANE RISK OF BIAS TOOL" />
    <edge source="ROBOTREVIEWER" target="ML MODEL" />
    <edge source="ROBOTREVIEWER" target="TRIAL REPORT" />
    <edge source="ROBOTREVIEWER" target="RISK OF BIAS ASSESSMENT" />
    <edge source="ROBOTREVIEWER" target="EXPERIENCED REVIEWERS" />
    <edge source="MONASH RESEARCH OFFICE" target="TRIAL" />
    <edge source="SYSTEMATIC REVIEWERS" target="TRIAL" />
    <edge source="TRIAL" target="RISK-OF-BIAS ASSESSMENTS" />
    <edge source="TRIAL" target="DECISION AIDS" />
    <edge source="UNIVERSITY COLLEGE LONDON" target="MONASH UNIVERSITY" />
    <edge source="ELECTRONIC HEALTH RECORD SYSTEMS" target="HEALTH PROFESSIONALS" />
    <edge source="ELECTRONIC HEALTH RECORD SYSTEMS" target="MAY TO JUNE 2023" />
    <edge source="ELECTRONIC HEALTH RECORD SYSTEMS" target="PROOF OF PRINCIPLE STUDY" />
    <edge source="HEALTH PROFESSIONALS" target="MAY TO JUNE 2023" />
    <edge source="HEALTH PROFESSIONALS" target="REFLECTIVE PRACTICE" />
    <edge source="HEALTH PROFESSIONALS" target="LONGSHI SCALE" />
    <edge source="HEALTH PROFESSIONALS" target="WECHAT" />
    <edge source="SNOMED&#8212;CT" target="SMART CARE SYSTEM" />
    <edge source="GERMAN POPULATION" target="ICON ARRAYS" />
    <edge source="GERMAN POPULATION" target="ONLINE EXPERIMENT" />
    <edge source="ICON ARRAYS" target="CARDIOVASCULAR RISK" />
    <edge source="ICON ARRAYS" target="ONLINE EXPERIMENT" />
    <edge source="ATEZOLIZUMAB" target="ADVANCED HEPATOCELLULAR CARCINOMA" />
    <edge source="ATEZOLIZUMAB" target="ES-SCLC" />
    <edge source="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK (CISNET)" target="SCREENING WOMEN &#8805; 75 YEARS OLD" />
    <edge source="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK (CISNET)" target="SIMCRC" />
    <edge source="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK (CISNET)" target="MISCAN-COLON" />
    <edge source="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK (CISNET)" target="CRC-SPIN" />
    <edge source="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK (CISNET)" target="BAYESIAN ALGORITHM" />
    <edge source="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK (CISNET)" target="LATIN HYPERCUBE SAMPLING" />
    <edge source="CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK (CISNET)" target="HAMILTONIAN MONTE CARLO" />
    <edge source="SCREENING WOMEN &#8805; 75 YEARS OLD" target="U.S. WOMEN BORN IN 1940" />
    <edge source="SCREENING WOMEN &#8805; 75 YEARS OLD" target="MICROSIMULATION MODELING" />
    <edge source="SCREENING WOMEN &#8805; 75 YEARS OLD" target="SHARED DECISION-MAKING (SDM)" />
    <edge source="SCREENING WOMEN &#8805; 75 YEARS OLD" target="FAMILY HISTORY" />
    <edge source="SCREENING WOMEN &#8805; 75 YEARS OLD" target="BREAST DENSITY" />
    <edge source="SCREENING WOMEN &#8805; 75 YEARS OLD" target="PRIOR BIOPSY" />
    <edge source="MOZAMBIQUE" target="INFOM&#211;VEL" />
    <edge source="MOZAMBIQUE" target="MOBILE HEALTH" />
    <edge source="MOZAMBIQUE" target="ANTIRETROVIRAL TREATMENT" />
    <edge source="INFOM&#211;VEL" target="COMMUNITY HEALTH WORKERS" />
    <edge source="INFOM&#211;VEL" target="COMMCAREHQ.ORG" />
    <edge source="INFOM&#211;VEL" target="UNITED NATIONS" />
    <edge source="COMMUNITY HEALTH WORKERS" target="ELECTRONIC COMMUNITY HEALTH INFORMATION SYSTEM" />
    <edge source="POISSON REGRESSION ANALYSIS" target="DIFFERENTIALLY PRIVATE GENERATIVE MODELLING" />
    <edge source="DIFFERENTIALLY PRIVATE GENERATIVE MODELLING" target="ASSESSMENT CENTERS" />
    <edge source="COLLABORATIVE LEARNING" target="PRIVACY-PRESERVING COLLABORATIVE LEARNING" />
    <edge source="COOPERATIVE OSTEOSARCOMA STUDY GROUP" target="OSTEOSARCOMA" />
    <edge source="CANTATA-D" target="CANTATA-D2" />
    <edge source="CANTATA-D" target="UK PRIMARY CARE" />
    <edge source="CANTATA-D" target="SGLT2-INHIBITOR" />
    <edge source="CANTATA-D" target="DPP4-INHIBITOR" />
    <edge source="CANTATA-D2" target="UK PRIMARY CARE" />
    <edge source="CANTATA-D2" target="SGLT2-INHIBITOR" />
    <edge source="CANTATA-D2" target="DPP4-INHIBITOR" />
    <edge source="UK PRIMARY CARE" target="CLINICAL PRACTICE RESEARCH DATALINK" />
    <edge source="SGLT2-INHIBITOR" target="DPP4-INHIBITOR" />
    <edge source="PACIFIC TRIAL" target="DURVALUMAB" />
    <edge source="DURVALUMAB" target="ES-SCLC" />
    <edge source="STEREOTACTIC BODY RADIATION THERAPY (SBRT)" target="NON-SMALL CELL LUNG CANCER (NSCLC)" />
    <edge source="NON-SMALL CELL LUNG CANCER (NSCLC)" target="PI3K-AKT-MTOR" />
    <edge source="NON-SMALL CELL LUNG CANCER (NSCLC)" target="PI3K ACTIVITY SIGNATURE" />
    <edge source="NON-SMALL CELL LUNG CANCER (NSCLC)" target="CLARIOM D ASSAY" />
    <edge source="NON-SMALL CELL LUNG CANCER (NSCLC)" target="KAPLAN-MEIER CURVES" />
    <edge source="NON-SMALL CELL LUNG CANCER (NSCLC)" target="COX REGRESSIONS" />
    <edge source="NON-SMALL CELL LUNG CANCER (NSCLC)" target="NATIONAL CANCER CENTER, KOREA" />
    <edge source="NON-SMALL CELL LUNG CANCER (NSCLC)" target="CARDIOVASCULAR (CV) EVENTS" />
    <edge source="NON-SMALL CELL LUNG CANCER (NSCLC)" target="VIMENTIN" />
    <edge source="NON-SMALL CELL LUNG CANCER (NSCLC)" target="IMMUNE-CHECKPOINT INHIBITOR (ICI)" />
    <edge source="NON-SMALL CELL LUNG CANCER (NSCLC)" target="MULTICENTER STUDY" />
    <edge source="EXERCISE STRESS ECG" target="HFQRS ANALYSIS" />
    <edge source="CHD GROUP" target="NON-CHD GROUP" />
    <edge source="CHD GROUP" target="XGBOOST CLASSIFIER" />
    <edge source="CHD GROUP" target="LIGHTGBM CLASSIFIER" />
    <edge source="CHD GROUP" target="RANDOMFOREST CLASSIFIER" />
    <edge source="STATINS" target="OBSERVATIONAL STUDIES" />
    <edge source="STATINS" target="RCT" />
    <edge source="RCT" target="STROKE SURVIVORS" />
    <edge source="ENGLISH-LANGUAGE RANDOMIZED CLINICAL TRIALS" target="LIPID SCREENING" />
    <edge source="LAROTRECTINIB" target="TRK FUSION SARCOMAS" />
    <edge source="LAROTRECTINIB" target="NTRK GENE FUSIONS" />
    <edge source="LAROTRECTINIB" target="RECIST V1.1" />
    <edge source="LAROTRECTINIB" target="ADVERSE EVENTS" />
    <edge source="LAROTRECTINIB" target="TREATMENT-EMERGENT ADVERSE EVENTS" />
    <edge source="DNA METHYLATION" target="MODILM" />
    <edge source="INTERNATIONAL SOCIETY OF UROLOGICAL PATHOLOGISTS" target="ISUP PATHOLOGISTS" />
    <edge source="INTERNATIONAL SOCIETY OF UROLOGICAL PATHOLOGISTS" target="PATHOLOGY RESIDENTS" />
    <edge source="ISUP PATHOLOGISTS" target="PROSTATE CANCER GRADING" />
    <edge source="PATHOLOGY RESIDENTS" target="PROSTATE CANCER GRADING" />
    <edge source="PROSTATE CANCER GRADING" target="HISTOLOGIC CASES" />
    <edge source="EFFICIENTNETB2" target="BD-BRAINTUMOR" />
    <edge source="EFFICIENTNETB2" target="BRAIN-TUMOR-DETECTION" />
    <edge source="EFFICIENTNETB2" target="BRAIN-MRI-IMAGES-FOR-BRAIN-TUMOR-DETECTION" />
    <edge source="MODELS" target="EXPERIMENTS" />
    <edge source="MODELS" target="WORLD" />
    <edge source="CLINICAL PRACTICE" target="AI-DRIVEN SELECTION SUPPORT SYSTEM" />
    <edge source="CLINICAL PRACTICE" target="MACHINE LEARNING BASED CLINICAL DECISION SUPPORT SYSTEMS (CDSSS)" />
    <edge source="ONCOLOGY TRIALS" target="SEER" />
    <edge source="ONCOLOGY TRIALS" target="RANDOM-EFFECTS META-ANALYSIS" />
    <edge source="EUROPEAN PAEDIATRIC SOFT TISSUE SARCOMA STUDY GROUP (EPSSG)" target="INDIVIDUAL PATIENTS" />
    <edge source="INDIVIDUAL PATIENTS" target="INDIVIDUAL RADIOLOGISTS" />
    <edge source="INDIVIDUAL PATIENTS" target="INDIVIDUAL NODULES" />
    <edge source="COVID-19 VACCINE" target="PATIENTS WITH CANCER" />
    <edge source="PATIENTS WITH CANCER" target="SEVERE ACUTE RESPIRATORY SYNDROME-CORONAVIRUS 2" />
    <edge source="DENMARK" target="TRANS STUDY" />
    <edge source="DENMARK" target="DANISH HEALTH AUTHORITY" />
    <edge source="DENMARK" target="BREAST CANCER SCREENING" />
    <edge source="DENMARK" target="RED BLOOD CELL TRANSFUSION" />
    <edge source="DENMARK" target="ADLIFE" />
    <edge source="TRANS STUDY" target="TRANSGENDER INDIVIDUALS" />
    <edge source="TRANS STUDY" target="NONTRANSGENDER INDIVIDUALS" />
    <edge source="TRANSGENDER INDIVIDUALS" target="NONTRANSGENDER INDIVIDUALS" />
    <edge source="RCT ABSTRACTS" target="GENERATIVE PRE-TRAINED TRANSFORMER 4" />
    <edge source="RCT ABSTRACTS" target="PLASTIC SURGERY JOURNALS" />
    <edge source="RCT ABSTRACTS" target="RCTS IN PLASTIC SURGERY" />
    <edge source="EWING SARCOMA" target="LOCAL RECURRENCE-FREE SURVIVAL" />
    <edge source="EWING SARCOMA" target="METASTASIS-FREE SURVIVAL" />
    <edge source="EWING SARCOMA" target="EVENT-FREE SURVIVAL" />
    <edge source="EWING SARCOMA" target="INTERNATIONAL INSTITUTIONS" />
    <edge source="EVENT-FREE SURVIVAL" target="BARIATRIC SURGERY" />
    <edge source="FOOD AND DRUG ADMINISTRATION" target="ASCIMINIB" />
    <edge source="FOOD AND DRUG ADMINISTRATION" target="BREXUCABTAGENE AUTOLEUCEL" />
    <edge source="FOOD AND DRUG ADMINISTRATION" target="ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN" />
    <edge source="FOOD AND DRUG ADMINISTRATION" target="ENFORTUMAB VEDOTIN" />
    <edge source="FOOD AND DRUG ADMINISTRATION" target="SACITUZUMAB GOVITECAN" />
    <edge source="FOOD AND DRUG ADMINISTRATION" target="TISOTUMAB VEDOTIN" />
    <edge source="FOOD AND DRUG ADMINISTRATION" target="VALUE-OF-INFORMATION (VOI) APPROACH" />
    <edge source="FOOD AND DRUG ADMINISTRATION" target="CUMULATIVE META-ANALYSIS" />
    <edge source="FOOD AND DRUG ADMINISTRATION" target="REFERENCE STANDARD RETROSPECTIVE VOI ANALYSIS" />
    <edge source="AUTOMATED SCREENING METHODOLOGY" target="SIMULATION STUDY" />
    <edge source="CYCLIN E1 (CCNE1)" target="HIGH-GRADE SEROUS CARCINOMA (HGSC)" />
    <edge source="CYCLIN E1 (CCNE1)" target="OVARIAN TUMOR TISSUE ANALYSIS CONSORTIUM" />
    <edge source="PEDIATRIC DYSLIPIDEMIA" target="LIPID SCREENING" />
    <edge source="WEBCEPH" target="CEPHALOMETRIC ANALYSIS" />
    <edge source="CEPHALOMETRIC ANALYSIS" target="CEPHX" />
    <edge source="CEPHALOMETRIC ANALYSIS" target="AI-DRIVEN TOOLS" />
    <edge source="CEPHALOMETRIC ANALYSIS" target="ORTHODONTIC DIAGNOSIS" />
    <edge source="CEPHALOMETRIC ANALYSIS" target="MANUAL METHOD" />
    <edge source="CEPHALOMETRIC ANALYSIS" target="INTRA-GROUP COMPARISON" />
    <edge source="CEPHALOMETRIC ANALYSIS" target="INTER-GROUP COMPARISON" />
    <edge source="MMR" target="MSI" />
    <edge source="MMR" target="LYNCH SYNDROME" />
    <edge source="MMR" target="MLH1" />
    <edge source="MMR" target="PMS2" />
    <edge source="MMR" target="MSH6" />
    <edge source="MMR" target="IMMUNOHISTOCHEMISTRY" />
    <edge source="MMR" target="DIGITAL SPATIAL TRANSCRIPTOMICS" />
    <edge source="IMMUNOHISTOCHEMISTRY" target="SIGNAL TRANSDUCTION PATHWAY" />
    <edge source="EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER" target="EORTC QLQ-NHL-HG29" />
    <edge source="EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER" target="EORTC QLQ-NHL-LG20" />
    <edge source="EORTC QLQ-NHL-HG29" target="HEALTH-RELATED QUALITY OF LIFE" />
    <edge source="EORTC QLQ-NHL-LG20" target="HEALTH-RELATED QUALITY OF LIFE" />
    <edge source="HEALTH-RELATED QUALITY OF LIFE" target="NON-HODGKIN LYMPHOMA" />
    <edge source="HEALTH-RELATED QUALITY OF LIFE" target="REMOTE GERIATRIC ASSESSMENT AND IMPLEMENTATION PROGRAM" />
    <edge source="HEALTH-RELATED QUALITY OF LIFE" target="QUALITY-ADJUSTED LIFE-YEAR LOSS" />
    <edge source="HEALTH-RELATED QUALITY OF LIFE" target="ECONOMIC EVALUATIONS" />
    <edge source="NON-HODGKIN LYMPHOMA" target="HODGKIN LYMPHOMA" />
    <edge source="NON-HODGKIN LYMPHOMA" target="BONE SARCOMA" />
    <edge source="NON-HODGKIN LYMPHOMA" target="RADIOTHERAPY" />
    <edge source="UNIVERSITY OF GONDAR COMPREHENSIVE AND SPECIALIZED HOSPITAL" target="VIROLOGICAL FAILURE" />
    <edge source="UNIVERSITY OF GONDAR COMPREHENSIVE AND SPECIALIZED HOSPITAL" target="UNIVERSITY OF GONDAR" />
    <edge source="VIROLOGICAL FAILURE" target="MACHINE LEARNING PREDICTIVE ALGORITHMS" />
    <edge source="VIROLOGICAL FAILURE" target="CD4 COUNT" />
    <edge source="INFORMATION SYSTEM FOR CLINICAL CONCEPT SEARCHING" target="CLINICAL CONCEPT TAGGING" />
    <edge source="INFORMATION SYSTEM FOR CLINICAL CONCEPT SEARCHING" target="PATIENT ALLERGIES" />
    <edge source="BECKWITH-WIEDEMANN SYNDROME" target="HEPATOBLASTOMA" />
    <edge source="HEPATOBLASTOMA" target="BDNCO" />
    <edge source="TEXAS" target="TEXAS BIRTH DEFECTS REGISTRY" />
    <edge source="TEXAS" target="TEXAS CANCER REGISTRY" />
    <edge source="TEXAS" target="DUCTAL CARCINOMA IN SITU (DCIS)" />
    <edge source="TEXAS" target="MENINGIOMA CONSORTIUM" />
    <edge source="TEXAS BIRTH DEFECTS REGISTRY" target="TEXAS CANCER REGISTRY" />
    <edge source="TEXAS CANCER REGISTRY" target="CHILDHOOD LEUKEMIA STUDY" />
    <edge source="USER PERSONA" target="QUESTIONNAIRE SURVEY" />
    <edge source="CHINESE DIABETES MELLITUS ONTOLOGY" target="T5 MODEL" />
    <edge source="CHINESE DIABETES MELLITUS ONTOLOGY" target="CHINESE CLINICAL PRACTICE GUIDELINES" />
    <edge source="CHINESE DIABETES MELLITUS ONTOLOGY" target="EXPERT CONSENSUS" />
    <edge source="CHINESE DIABETES MELLITUS ONTOLOGY" target="HOSPITAL INFORMATION SYSTEM DATABASE" />
    <edge source="CHINESE DIABETES MELLITUS ONTOLOGY" target="SEMANTIC WEB RULE LANGUAGE" />
    <edge source="CHINESE DIABETES MELLITUS ONTOLOGY" target="CHINESE NATURAL LANGUAGE MEDICAL QUESTION ANSWERING" />
    <edge source="EQ-5D-5L" target="CTTO" />
    <edge source="EQ-5D-5L" target="POLISH VALUATION STUDY" />
    <edge source="EQ-5D-5L" target="EUROQOL VALUATION TECHNOLOGY" />
    <edge source="EQ-5D-5L" target="INDIA" />
    <edge source="EQ-5D-5L" target="EQ-VT DESIGN" />
    <edge source="EQ-5D-5L" target="BAYESIAN MODELS" />
    <edge source="EQ-5D-5L" target="CALE MODEL" />
    <edge source="EQ-5D-5L" target="HEALTH UTILITIES" />
    <edge source="EQ-5D-5L" target="CANADIAN EQ-5D-5L VALUATION STUDY" />
    <edge source="EQ-5D-5L" target="MULTIPLE IMPUTATION (MI)" />
    <edge source="CTTO" target="POLISH VALUATION STUDY" />
    <edge source="NLP RESEARCHERS" target="RECOGNIZING TEXTUAL ENTAILMENT (RTE)" />
    <edge source="RECOGNIZING TEXTUAL ENTAILMENT (RTE)" target="NATURAL LANGUAGE UNDERSTANDING" />
    <edge source="RECOGNIZING TEXTUAL ENTAILMENT (RTE)" target="MACHINE TRANSLATION" />
    <edge source="RECOGNIZING TEXTUAL ENTAILMENT (RTE)" target="SEMANTIC SEARCH" />
    <edge source="RECOGNIZING TEXTUAL ENTAILMENT (RTE)" target="INFORMATION EXTRACTION" />
    <edge source="AUSTRALIANS" target="SECONDARY USE OF ELECTRONIC HEALTH DATA" />
    <edge source="SIBLINGS OF CHILDHOOD CANCER SURVIVORS" target="FINANCIAL HARDSHIP" />
    <edge source="SIBLINGS OF CHILDHOOD CANCER SURVIVORS" target="GENERAL POPULATION" />
    <edge source="SIBLINGS OF CHILDHOOD CANCER SURVIVORS" target="MEDICAL BILLS" />
    <edge source="SIBLINGS OF CHILDHOOD CANCER SURVIVORS" target="NUTRITIOUS FOODS" />
    <edge source="SIBLINGS OF CHILDHOOD CANCER SURVIVORS" target="MEDICAL CARE" />
    <edge source="SIBLINGS OF CHILDHOOD CANCER SURVIVORS" target="PRESCRIPTION MEDICATIONS" />
    <edge source="SIBLINGS OF CHILDHOOD CANCER SURVIVORS" target="DENTAL CARE" />
    <edge source="GENERAL POPULATION" target="AYA CANCER SURVIVORS" />
    <edge source="GENERAL POPULATION" target="TANYA OBAT" />
    <edge source="GENERAL POPULATION" target="LONELINESS" />
    <edge source="PCOS" target="KAGGLE" />
    <edge source="PCOS" target="VGG16" />
    <edge source="PCOS" target="NA&#207;VE BAYES" />
    <edge source="NA&#207;VE BAYES" target="UNDER-FIVE MORTALITY" />
    <edge source="BERT MODELS" target="HAGAZIEKENHUIS" />
    <edge source="BERT MODELS" target="MEDROBERTA.NL-HAGA" />
    <edge source="BERT MODELS" target="CLINICALBERT" />
    <edge source="BERT MODELS" target="PATIENT LIFESTYLE CLASSIFICATION" />
    <edge source="MEDROBERTA.NL-HAGA" target="PATIENT LIFESTYLE CLASSIFICATION" />
    <edge source="CLINICALBERT" target="PATIENT LIFESTYLE CLASSIFICATION" />
    <edge source="CLINICALBERT" target="MEDICAL IMAGE PROTOCOL ASSIGNMENT" />
    <edge source="CLINICALBERT" target="RADIOLIST" />
    <edge source="PATIENT LIFESTYLE CLASSIFICATION" target="DUTCH BERT MODELS" />
    <edge source="PATIENT LIFESTYLE CLASSIFICATION" target="ENGLISH BERT MODELS" />
    <edge source="YOUNG BREAST CANCER" target="SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS" />
    <edge source="YOUNG BREAST CANCER" target="TIANJIN MEDICAL UNIVERSITY CANCER INSTITUTE AND HOSPITAL" />
    <edge source="YOUNG BREAST CANCER" target="LEAST ABSOLUTE SHRINKAGE AND SELECTION OPERATOR" />
    <edge source="COX REGRESSION MODEL" target="CURB-65" />
    <edge source="COX REGRESSION MODEL" target="BLOOD CULTURE PREDICTION INDEX (BCPI)" />
    <edge source="COX REGRESSION MODEL" target="IN-HOSPITAL MORTALITY" />
    <edge source="NEURAL TUBE DEFECTS" target="FOLIC ACID SUPPLEMENTATION" />
    <edge source="MODELE PARFAIT" target="PHOTOGRAPHIE" />
    <edge source="BRUTON TYROSINE KINASE INHIBITORS" target="IBRUTINIB" />
    <edge source="BRUTON TYROSINE KINASE INHIBITORS" target="ACALABRUTINIB" />
    <edge source="BRUTON TYROSINE KINASE INHIBITORS" target="ZANUBRUTINIB" />
    <edge source="BCL2 INHIBITION" target="VENETOCLAX" />
    <edge source="IBRUTINIB" target="CARDIOVASCULAR TOXICITIES" />
    <edge source="IBRUTINIB" target="PATIENTS WITH CLL" />
    <edge source="IBRUTINIB" target="BRUTON TYROSINE KINASE INHIBITOR" />
    <edge source="ACALABRUTINIB" target="BRUTON TYROSINE KINASE INHIBITOR" />
    <edge source="ZANUBRUTINIB" target="BRUTON TYROSINE KINASE INHIBITOR" />
    <edge source="VENETOCLAX" target="B-CELL LEUKEMIA/LYMPHOMA 2 INHIBITOR" />
    <edge source="VENETOCLAX" target="AVALON" />
    <edge source="VENETOCLAX" target="VIALE-A" />
    <edge source="VENETOCLAX" target="HYPOMETHYLATING AGENTS" />
    <edge source="VENETOCLAX" target="DECITABINE" />
    <edge source="VENETOCLAX" target="AZACITIDINE" />
    <edge source="VENETOCLAX" target="PD-1 INHIBITION" />
    <edge source="STAGE I INTERMEDIATE-RISK WILMS TUMOR" target="STAGE I EPITHELIAL TYPE WILMS TUMOR" />
    <edge source="STAGE I INTERMEDIATE-RISK WILMS TUMOR" target="STAGE I STROMAL TYPE WILMS TUMOR" />
    <edge source="STAGE I EPITHELIAL TYPE WILMS TUMOR" target="OTHER INTERMEDIATE-RISK WILMS TUMOR" />
    <edge source="STAGE I STROMAL TYPE WILMS TUMOR" target="OTHER INTERMEDIATE-RISK WILMS TUMOR" />
    <edge source="KOREAN NATIONAL HEALTH INSURANCE" target="CRC SURVIVORS" />
    <edge source="CRC SURVIVORS" target="POLYPHARMACY" />
    <edge source="POLYPHARMACY" target="NATIONAL CENTER FOR HEALTH INSURANCE RESEARCH" />
    <edge source="POLYPHARMACY" target="KHUZESTAN" />
    <edge source="POLYPHARMACY" target="HEALTH INSURANCE CLAIMS DATA" />
    <edge source="MARYLAND" target="MARYLAND MULTI-DRUG RESISTANT ORGANISM PREVENTION COLLABORATIVE" />
    <edge source="MARYLAND MULTI-DRUG RESISTANT ORGANISM PREVENTION COLLABORATIVE" target="ACUTE CARE HOSPITALS" />
    <edge source="MARYLAND MULTI-DRUG RESISTANT ORGANISM PREVENTION COLLABORATIVE" target="LONG-TERM CARE FACILITIES" />
    <edge source="ACUTE CARE HOSPITALS" target="LONG-TERM CARE FACILITIES" />
    <edge source="LONG-TERM CARE FACILITIES" target="METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS" />
    <edge source="LONG-TERM CARE FACILITIES" target="ANTIMICROBIAL RESISTANCE" />
    <edge source="LONG-TERM CARE FACILITIES" target="GLOBAL HEALTH" />
    <edge source="ACINETOBACTER BAUMANNII" target="CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII (CRAB)" />
    <edge source="ACINETOBACTER BAUMANNII" target="CANDIDA AURIS" />
    <edge source="ACINETOBACTER BAUMANNII" target="MECHANICAL VENTILATION" />
    <edge source="ACINETOBACTER BAUMANNII" target="SURVEILLANCE CULTURES" />
    <edge source="CANDIDA AURIS" target="MARYLAND DEPARTMENT OF HEALTH" />
    <edge source="CANDIDA AURIS" target="MECHANICAL VENTILATION" />
    <edge source="CANDIDA AURIS" target="SURVEILLANCE CULTURES" />
    <edge source="2D CONVOLUTIONAL NEURAL NETWORK" target="MRI BRAIN IMAGES" />
    <edge source="2D CONVOLUTIONAL NEURAL NETWORK" target="AUTO-ENCODER NETWORK" />
    <edge source="MRI BRAIN IMAGES" target="AUTO-ENCODER NETWORK" />
    <edge source="ATRIAL FIBRILLATION AND FLUTTER (AF)" target="PNEUMONECTOMY" />
    <edge source="CEREBROVASCULAR DISEASE (CEVD)" target="SYSTEMIC THERAPY" />
    <edge source="LARGE LANGUAGE MODELS" target="GENERATIVE PRE-TRAINED TRANSFORMER-2" />
    <edge source="LARGE LANGUAGE MODELS" target="CALGARY" />
    <edge source="LARGE LANGUAGE MODELS" target="EMERGENCY MEDICINE" />
    <edge source="LARGE LANGUAGE MODELS" target="CLINICAL DECISION-MAKING" />
    <edge source="LARGE LANGUAGE MODELS" target="EFFICIENCY, WORKFLOW, AND INFORMATION MANAGEMENT" />
    <edge source="LARGE LANGUAGE MODELS" target="RISKS, ETHICS, AND TRANSPARENCY" />
    <edge source="LARGE LANGUAGE MODELS" target="EDUCATION AND COMMUNICATION" />
    <edge source="LARGE LANGUAGE MODELS" target="DELIBERATE THEN GENERATE" />
    <edge source="LARGE LANGUAGE MODELS" target="GPT-4.0" />
    <edge source="LARGE LANGUAGE MODELS" target="ALIGNMENT EVALUATIONS" />
    <edge source="LARGE LANGUAGE MODELS" target="IMITATION LEARNING" />
    <edge source="LARGE LANGUAGE MODELS" target="BINARY DISCRIMINATION" />
    <edge source="LARGE LANGUAGE MODELS" target="RANKED PREFERENCE MODELING" />
    <edge source="LARGE LANGUAGE MODELS" target="PREFERENCE MODEL PRE-TRAINING" />
    <edge source="LARGE LANGUAGE MODELS" target="ETHICAL CONCERNS" />
    <edge source="CALGARY" target="NEOADJUVANT CHEMOTHERAPY" />
    <edge source="NEOADJUVANT CHEMOTHERAPY" target="DEEP LEARNING RADIOMICS NOMOGRAM" />
    <edge source="NEOADJUVANT CHEMOTHERAPY" target="HER2-POSITIVE BREAST CANCER" />
    <edge source="NEOADJUVANT CHEMOTHERAPY" target="UPFRONT SURGERY" />
    <edge source="STEPWISE APPROACH TO NCD RISK FACTOR SURVEILLANCE" target="HIGH BLOOD PRESSURE" />
    <edge source="HIGH BLOOD PRESSURE" target="NONCOMMUNICABLE DISEASES" />
    <edge source="ACCURACY" target="DATA QUALITY IN HEALTH INFORMATION SYSTEMS" />
    <edge source="ACCURACY" target="SURVIVAL PREDICTIONS" />
    <edge source="PRECISION" target="SURVIVAL PREDICTIONS" />
    <edge source="RECALL" target="SURVIVAL PREDICTIONS" />
    <edge source="F1 SCORE" target="GRAPH NEURAL NETWORK" />
    <edge source="F1 SCORE" target="RECURRENT NEURAL NETWORK" />
    <edge source="CLINICAL DECISION-MAKING" target="LLMS" />
    <edge source="PRISMA-SCR" target="OVID MEDLINE" />
    <edge source="PRISMA-SCR" target="JBI SCOPING REVIEW METHODOLOGY GROUP" />
    <edge source="PRISMA-SCR" target="OPEN SCIENCE FRAMEWORK" />
    <edge source="HEAD AND NECK SQUAMOUS CELL CARCINOMA" target="NEOADJUVANT IMMUNE CHECKPOINT INHIBITORS (NICI)" />
    <edge source="HEAD AND NECK SQUAMOUS CELL CARCINOMA" target="FREE FLAP RECONSTRUCTION" />
    <edge source="HEAD AND NECK SQUAMOUS CELL CARCINOMA" target="TRANSORAL ROBOTIC SURGERY (TORS)" />
    <edge source="HEAD AND NECK SQUAMOUS CELL CARCINOMA" target="PRINCESS MARGARET CANCER CENTER" />
    <edge source="HEAD AND NECK SQUAMOUS CELL CARCINOMA" target="SMOKING CESSATION" />
    <edge source="HEAD AND NECK SQUAMOUS CELL CARCINOMA" target="FORMER SMOKERS" />
    <edge source="HEAD AND NECK SQUAMOUS CELL CARCINOMA" target="CURRENT SMOKERS" />
    <edge source="RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA" target="HPV-POSITIVE DISEASE" />
    <edge source="RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA" target="HPV-NEGATIVE DISEASE" />
    <edge source="RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA" target="OLIGOMETASTATIC DISEASE" />
    <edge source="RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA" target="POLYMETASTATIC DISEASE" />
    <edge source="WORLD" target="MODEL" />
    <edge source="INDETERMINATE PULMONARY NODULES (IPNS)" target="CHEST COMPUTED TOMOGRAPHY (CT)" />
    <edge source="INDETERMINATE PULMONARY NODULES (IPNS)" target="POSITRON EMISSION TOMOGRAPHY (PET)/PET-CT" />
    <edge source="INDETERMINATE PULMONARY NODULES (IPNS)" target="BRONCHOSCOPY" />
    <edge source="INDETERMINATE PULMONARY NODULES (IPNS)" target="NEEDLE BIOPSY" />
    <edge source="INDETERMINATE PULMONARY NODULES (IPNS)" target="INTERNATIONAL CLASSIFICATION OF DISEASES (ICD)" />
    <edge source="INDETERMINATE PULMONARY NODULES (IPNS)" target="POISSON REGRESSION MODELS" />
    <edge source="INDETERMINATE PULMONARY NODULES (IPNS)" target="STAGE REDISTRIBUTION" />
    <edge source="INTERNATIONAL CLASSIFICATION OF DISEASES (ICD)" target="MEDICAL DICTIONARY FOR REGULATORY ACTIVITIES (MEDDRA)" />
    <edge source="INTERNATIONAL CLASSIFICATION OF DISEASES (ICD)" target="UNIFIED MEDICAL LANGUAGE SYSTEM (UMLS)" />
    <edge source="INTERNATIONAL CLASSIFICATION OF DISEASES (ICD)" target="OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP COMMON DATA MODEL (OMOP CDM)" />
    <edge source="INTERNATIONAL CLASSIFICATION OF DISEASES (ICD)" target="MAPPING STATUS" />
    <edge source="INTERNATIONAL CLASSIFICATION OF DISEASES (ICD)" target="MAPPING STATISTICS" />
    <edge source="INTERNATIONAL CLASSIFICATION OF DISEASES (ICD)" target="QUALITY ANALYSIS" />
    <edge source="INTERNATIONAL CLASSIFICATION OF DISEASES (ICD)" target="MAPPING COVERAGE" />
    <edge source="COM-B MODEL" target="PRIME THEORY" />
    <edge source="GEORGETOWN UNIVERSITY-ALBERT EINSTEIN COLLEGE OF MEDICINE" target="MODEL GE" />
    <edge source="MODEL GE" target="CISNET" />
    <edge source="CISNET" target="CRC SCREENING" />
    <edge source="CISNET" target="CRC-AIM" />
    <edge source="CAR T-CELL THERAPY" target="LARGE B CELL LYMPHOMAS" />
    <edge source="CAR T-CELL THERAPY" target="18 F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY" />
    <edge source="CAR T-CELL THERAPY" target="DEUVILLE SCORE" />
    <edge source="CAR T-CELL THERAPY" target="STANDARDIZED UPTAKE VALUE" />
    <edge source="CAR T-CELL THERAPY" target="SINGLE-CENTER PROSPECTIVE STUDY" />
    <edge source="CAR T-CELL THERAPY" target="PARTIAL RESPONSE" />
    <edge source="CAR T-CELL THERAPY" target="STABLE DISEASE" />
    <edge source="ACUTE KIDNEY INJURY" target="ACUTE PANCREATITIS" />
    <edge source="ACUTE KIDNEY INJURY" target="AUTOMATED MACHINE LEARNING" />
    <edge source="ACUTE KIDNEY INJURY" target="MEDICAL INFORMATION MART FOR INTENSIVE CARE-IV" />
    <edge source="ACUTE KIDNEY INJURY" target="KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES" />
    <edge source="ACUTE KIDNEY INJURY" target="ELECTRONIC INTENSIVE CARE UNIT DATABASE" />
    <edge source="ACUTE KIDNEY INJURY" target="COLOMBIAN OPEN HEALTH DATABASE" />
    <edge source="ACUTE KIDNEY INJURY" target="LIPOPROTEIN METABOLISM DISORDERS" />
    <edge source="ACUTE KIDNEY INJURY" target="ESSENTIAL HYPERTENSION" />
    <edge source="ACUTE KIDNEY INJURY" target="FLUID, ELECTROLYTE, AND ACID-BASE BALANCE DISORDERS" />
    <edge source="ACUTE KIDNEY INJURY" target="HEART-KIDNEY CROSSTALK" />
    <edge source="ACUTE KIDNEY INJURY" target="LUNG-KIDNEY CROSSTALK" />
    <edge source="AUTOMATED MACHINE LEARNING" target="LASSO ALGORITHM" />
    <edge source="AUTOMATED MACHINE LEARNING" target="RECEIVER OPERATING CHARACTERISTIC CURVES" />
    <edge source="AUTOMATED MACHINE LEARNING" target="LOCALLY INTERPRETABLE MODEL-AGNOSTIC EXPLANATIONS" />
    <edge source="DANISH HEALTH AUTHORITY" target="BREAST CANCER SCREENING" />
    <edge source="BREAST CANCER SCREENING" target="DANISH WOMEN" />
    <edge source="BREAST CANCER SCREENING" target="MAMMOGRAPHY SCREENING INVITATION" />
    <edge source="BREAST CANCER SCREENING" target="HISPANIC POPULATIONS" />
    <edge source="BREAST CANCER SCREENING" target="NON-HISPANIC WHITE INDIVIDUALS" />
    <edge source="BREAST CANCER SCREENING" target="TURNING THE PAGE ON BREAST CANCER" />
    <edge source="BREAST CANCER SCREENING" target="OVERDIAGNOSIS" />
    <edge source="DANISH WOMEN" target="MAMMOGRAPHY SCREENING INVITATION" />
    <edge source="DANISH WOMEN" target="CENTRAL DENMARK REGION" />
    <edge source="DANISH WOMEN" target="BREAST CANCER SCREENING STUDY" />
    <edge source="DANISH WOMEN" target="HYPOTHETICAL BREAST CANCER SCREENING" />
    <edge source="DANISH WOMEN" target="INFORMED DECISION MAKING" />
    <edge source="INDIA" target="POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH" />
    <edge source="INDIA" target="NIL RATAN SIRCAR MEDICAL COLLEGE AND HOSPITAL" />
    <edge source="INDIA" target="PHILADELPHIA-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA" />
    <edge source="POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH" target="CHANDIGARH" />
    <edge source="NIL RATAN SIRCAR MEDICAL COLLEGE AND HOSPITAL" target="KOLKATA" />
    <edge source="SCS BTT" target="SUSOKA" />
    <edge source="SCS BTT" target="SHINE &amp; LAL" />
    <edge source="SCS BTT" target="MCV &#8804; 80 FL" />
    <edge source="ALBINISM" target="MOBILE HEALTH APPLICATION" />
    <edge source="MOBILE HEALTH APPLICATION" target="MICROSOFT VISIO 2021" />
    <edge source="MOBILE HEALTH APPLICATION" target="MOBILE APPLICATION USABILITY QUESTIONNAIRE (MAUQ)" />
    <edge source="2022" target="MHEALTH APPLICATION" />
    <edge source="2022" target="HYPERTENSION MANAGEMENT STUDY" />
    <edge source="MHEALTH APPLICATION" target="PATIENTS WITH ALBINISM" />
    <edge source="DUTCH CHILDHOOD CANCER SURVIVOR LATER STUDY" target="CHILDHOOD CANCER SURVIVORS (CCSS)" />
    <edge source="DUTCH CHILDHOOD CANCER SURVIVOR LATER STUDY" target="MALE SIBLINGS" />
    <edge source="CHILDHOOD CANCER SURVIVORS (CCSS)" target="MALE SIBLINGS" />
    <edge source="CHILDHOOD CANCER SURVIVORS (CCSS)" target="DUTCH CHILDHOOD CANCER SURVIVOR STUDY LATER" />
    <edge source="MALE SIBLINGS" target="DUTCH CHILDHOOD CANCER SURVIVOR STUDY LATER" />
    <edge source="SINGHEALTH-DUKE-GLAXOSMITHKLINE COPD AND ASTHMA REAL-WORLD EVIDENCE (SDG-CARE) COLLABORATION" target="SINGHEALTH COPD AND ASTHMA DATA MART (SCDM)" />
    <edge source="BURKINA FASO" target="DIGITAL HEALTH INTERVENTIONS" />
    <edge source="BURKINA FASO" target="NATIONAL HEALTH INFORMATION SYSTEM" />
    <edge source="BURKINA FASO" target="HEALTHCARE INFORMATION MANAGERS" />
    <edge source="BURKINA FASO" target="SOFTWARE DEVELOPERS" />
    <edge source="BURKINA FASO" target="PRIVATE SECTOR" />
    <edge source="DIGITAL HEALTH INTERVENTIONS" target="NATIONAL HEALTH INFORMATION SYSTEM" />
    <edge source="DIGITAL HEALTH INTERVENTIONS" target="TECHNICAL AND FINANCIAL PARTNERS" />
    <edge source="DIGITAL HEALTH INTERVENTIONS" target="PRIVATE SECTOR" />
    <edge source="DIGITAL HEALTH INTERVENTIONS" target="ECONOMIC EVALUATIONS" />
    <edge source="SOFTWARE DEVELOPERS" target="REHAB-AMD" />
    <edge source="SOFTWARE DEVELOPERS" target="AMD PATIENTS" />
    <edge source="SOFTWARE DEVELOPERS" target="HEALTHCARE PRACTITIONERS" />
    <edge source="CONGRESS" target="MATHEMATICAL THEORY OF GROUPS" />
    <edge source="MATHEMATICAL THEORY OF GROUPS" target="SET THEORY" />
    <edge source="DECEASED ORGAN DONATION" target="CENTRE HOSPITALIER DE L'UNIVERSIT&#201; DE MONTR&#201;AL" />
    <edge source="DECEASED ORGAN DONATION" target="SUBSTITUTE DECISION-MAKERS" />
    <edge source="DECEASED ORGAN DONATION" target="NCT03850847" />
    <edge source="PEDIATRIC CNS TUMORS" target="RADIATION THERAPY" />
    <edge source="PEDIATRIC CNS TUMORS" target="SOCIAL COGNITION" />
    <edge source="PEDIATRIC CNS TUMORS" target="ADULT SURVIVORS" />
    <edge source="RADIATION THERAPY" target="INFRATENTORIAL TUMORS" />
    <edge source="RADIATION THERAPY" target="SUPRATENTORIAL TUMORS" />
    <edge source="RADIATION THERAPY" target="CHILDHOOD CANCER" />
    <edge source="RADIATION THERAPY" target="ANDROGEN DEPRIVATION THERAPY" />
    <edge source="SOCIAL COGNITION" target="SOCIAL ADJUSTMENT" />
    <edge source="SOCIAL COGNITION" target="EXECUTIVE FUNCTIONING" />
    <edge source="SOCIAL COGNITION" target="NONVERBAL REASONING" />
    <edge source="SOCIAL COGNITION" target="FULL-TIME EMPLOYMENT" />
    <edge source="SOCIAL COGNITION" target="COLLEGE EDUCATION" />
    <edge source="INFRATENTORIAL TUMORS" target="CRANIOSPINAL IRRADIATION" />
    <edge source="BLACK COMMUNITIES IN CANADA" target="CANCER RESEARCH" />
    <edge source="CANCER RESEARCH" target="FEDERAL AND PROVINCIAL GOVERNMENTS" />
    <edge source="CANCER RESEARCH" target="UNIVERSITIES" />
    <edge source="CANCER RESEARCH" target="THE COCHRANE LIBRARY" />
    <edge source="CANCER RESEARCH" target="ABSTRACKR" />
    <edge source="CANCER RESEARCH" target="ROBOTANALYST" />
    <edge source="CANCER RESEARCH" target="EPPI-REVIEWER" />
    <edge source="WOMEN'S HEALTH INITIATIVE" target="LIVER CANCER INCIDENCE" />
    <edge source="WOMEN'S HEALTH INITIATIVE" target="CHRONIC LIVER DISEASE MORTALITY" />
    <edge source="WOMEN'S HEALTH INITIATIVE" target="POSTMENOPAUSAL WOMEN" />
    <edge source="LIVER CANCER INCIDENCE" target="SUGAR-SWEETENED BEVERAGES" />
    <edge source="LIVER CANCER INCIDENCE" target="ARTIFICIALLY SWEETENED BEVERAGES" />
    <edge source="CHRONIC LIVER DISEASE MORTALITY" target="SUGAR-SWEETENED BEVERAGES" />
    <edge source="CHRONIC LIVER DISEASE MORTALITY" target="ARTIFICIALLY SWEETENED BEVERAGES" />
    <edge source="M-HEALTH" target="INTERVENTION GROUP" />
    <edge source="M-HEALTH" target="HEALTH LITERACY INTERVENTION" />
    <edge source="INTERVENTION GROUP" target="CONTROL GROUP" />
    <edge source="PRIMARY HYPERTENSION" target="PUBMED CENTRAL" />
    <edge source="PRIMARY HYPERTENSION" target="QUALITY ASSESSMENT OF DIAGNOSTIC ACCURACY STUDIES TOOL" />
    <edge source="SECONDARY HYPERTENSION" target="PUBMED CENTRAL" />
    <edge source="SECONDARY HYPERTENSION" target="QUALITY ASSESSMENT OF DIAGNOSTIC ACCURACY STUDIES TOOL" />
    <edge source="PUBMED CENTRAL" target="MACHINE LEARNING ALGORITHM" />
    <edge source="EXTREME GRADIENT BOOSTING (XGB)" target="EXPLAINABLE AI (XAI)" />
    <edge source="ACUTE KIDNEY INJURY (AKI)" target="LIGHTGBM" />
    <edge source="BASELINE SERUM CREATININE (SCR)" target="MODIFICATION OF DIET IN RENAL DISEASE (MDRD) EQUATION" />
    <edge source="LUNG VOLUME REDUCTION SURGERY" target="EMPHYSEMA" />
    <edge source="LUNG VOLUME REDUCTION SURGERY" target="NATIONAL EMPHYSEMA TREATMENT TRIAL" />
    <edge source="EMPHYSEMA" target="NATIONAL EMPHYSEMA TREATMENT TRIAL" />
    <edge source="NATIONAL EMPHYSEMA TREATMENT TRIAL" target="MEDICAL THERAPY" />
    <edge source="THE CANCER GENOME ATLAS" target="SMAD4" />
    <edge source="THE CANCER GENOME ATLAS" target="LUAD" />
    <edge source="SMAD4" target="INTERNATIONAL CANCER GENOME CONSORTIUM" />
    <edge source="SMAD4" target="PANCREATIC ADENOCARCINOMA" />
    <edge source="DELTA SERUM PHOSPHATE" target="IN-HOSPITAL MORTALITY" />
    <edge source="DELTA SERUM PHOSPHATE" target="28-DAY MORTALITY" />
    <edge source="WESLEY C. SALMON" target="SCIENTIFIC EXPLANATION" />
    <edge source="WESLEY C. SALMON" target="EPISTEMIC CONCEPTION" />
    <edge source="WESLEY C. SALMON" target="MODAL CONCEPTION" />
    <edge source="WESLEY C. SALMON" target="ONTIC CONCEPTION" />
    <edge source="AI METHODS" target="CDSR" />
    <edge source="AI METHODS" target="EPISTEMONIKOS" />
    <edge source="CALIFORNIA CANCER REGISTRY" target="KIDNEY CANCER STUDY" />
    <edge source="KAPLAN-MEIER SURVIVAL ANALYSIS" target="COX REGRESSION ANALYSIS" />
    <edge source="COX REGRESSION ANALYSIS" target="INTRAHEPATIC CHOLANGIOCARCINOMA" />
    <edge source="AFRICAN AMERICAN/BLACK MEN" target="WHITE WOMEN" />
    <edge source="WHITE WOMEN" target="MAMMOGRAPHY COMPLETION" />
    <edge source="WHITE WOMEN" target="BREAST CANCER DISPARITIES" />
    <edge source="RACE/ETHNICITY" target="SURVIVAL" />
    <edge source="LIMESURVEY CLOUD" target="EVALUATION SAMPLE" />
    <edge source="EVALUATION SAMPLE" target="HEALTH REGISTRIES" />
    <edge source="GERMAN FUNDING INITIATIVE" target="HEALTH REGISTRIES" />
    <edge source="RADIATION EXPOSURE" target="LGA BIRTHS" />
    <edge source="SIR MODEL" target="PUBLIC HEALTH AUTHORITIES" />
    <edge source="SIR MODEL" target="VALUE OF INFORMATION" />
    <edge source="SIR MODEL" target="RUSSIAN FEDERATION" />
    <edge source="SIR MODEL" target="REGIONAL HEALTH AUTHORITIES" />
    <edge source="PUBLIC HEALTH AUTHORITIES" target="VACCINATION CAMPAIGN" />
    <edge source="PUBLIC HEALTH AUTHORITIES" target="VALUE OF INFORMATION" />
    <edge source="HER2-POSITIVE BREAST CANCER" target="SWEDISH NATIONAL BREAST CANCER REGISTER" />
    <edge source="HER2-POSITIVE BREAST CANCER" target="DANA-FARBER BRIGHAM CANCER CENTER" />
    <edge source="HER2-POSITIVE BREAST CANCER" target="HOSPITAL CLINIC OF BARCELONA" />
    <edge source="HER2-POSITIVE BREAST CANCER" target="HOSPITAL CLINICO OF VALENCIA" />
    <edge source="HER2-POSITIVE BREAST CANCER" target="UPFRONT SURGERY" />
    <edge source="SPD MODELS" target="EH MODELS" />
    <edge source="SPD MODELS" target="AKAIKE INFORMATION CRITERION" />
    <edge source="EH MODELS" target="GENERAL POPULATION MORTALITY" />
    <edge source="EH MODELS" target="AKAIKE INFORMATION CRITERION" />
    <edge source="EH MODELS" target="STAGE I CANCER" />
    <edge source="EH MODELS" target="STAGE II CANCER" />
    <edge source="EH MODELS" target="STAGE III CANCER" />
    <edge source="EH MODELS" target="STAGE IV CANCER" />
    <edge source="HONG KONG PUBLIC INSTITUTION" target="RHEUMATOID ARTHRITIS" />
    <edge source="RHEUMATOID ARTHRITIS" target="METHOTREXATE" />
    <edge source="RHEUMATOID ARTHRITIS" target="BIOSIMILAR INFLIXIMAB (CT-P13)" />
    <edge source="RHEUMATOID ARTHRITIS" target="BIOSIMILAR ADALIMUMAB (ABP-501)" />
    <edge source="RHEUMATOID ARTHRITIS" target="LEFLUNOMIDE" />
    <edge source="BIOSIMILAR INFLIXIMAB (CT-P13)" target="LEFLUNOMIDE" />
    <edge source="BIOSIMILAR ADALIMUMAB (ABP-501)" target="LEFLUNOMIDE" />
    <edge source="EAST CHINA" target="CORONARY ARTERY BYPASS GRAFTING (CABG)" />
    <edge source="LIGHTGBM" target="SHAPLEY ADDITIVE EXPLANATIONS (SHAP)" />
    <edge source="HLA-DPB1" target="PIRCHE" />
    <edge source="HLA-DPB1" target="HLAMATCHMAKER" />
    <edge source="CYCLOPHOSPHAMIDE" target="CD19-TARGETING CAR T CELLS" />
    <edge source="US PRIMARY CARE PHYSICIANS" target="SPECIALISTS" />
    <edge source="US PRIMARY CARE PHYSICIANS" target="E/M PAYMENT POLICY CHANGE" />
    <edge source="SPECIALISTS" target="E/M PAYMENT POLICY CHANGE" />
    <edge source="E/M PAYMENT POLICY CHANGE" target="FAMILY PRACTICE PHYSICIAN" />
    <edge source="E/M PAYMENT POLICY CHANGE" target="RADIOLOGIST" />
    <edge source="E/M PAYMENT POLICY CHANGE" target="DERMATOLOGY" />
    <edge source="E/M PAYMENT POLICY CHANGE" target="PSYCHIATRY" />
    <edge source="E/M PAYMENT POLICY CHANGE" target="GENERAL SURGERY" />
    <edge source="SINONASAL CANCER" target="HPV16/18" />
    <edge source="SINONASAL CANCER" target="HPV-NEGATIVE" />
    <edge source="HPV-NEGATIVE" target="HPV16/18-POSITIVE" />
    <edge source="HPV-NEGATIVE" target="OTHER HIGH-RISK HPV" />
    <edge source="HPV-NEGATIVE" target="LOW-RISK HPV" />
    <edge source="CHILDHOOD CANCER SURVIVOR STUDY" target="NEUROBLASTOMA SURVIVORS" />
    <edge source="CHILDHOOD CANCER SURVIVOR STUDY" target="SOCIETY FOR ASSISTED REPRODUCTIVE TECHNOLOGY CLINIC OUTCOME REPORTING SYSTEM" />
    <edge source="CHILDHOOD CANCER SURVIVOR STUDY" target="YOUNG ADULT SURVIVORS OF CHILDHOOD CANCER" />
    <edge source="NEUROBLASTOMA SURVIVORS" target="SIBLING CONTROLS" />
    <edge source="NEUROBLASTOMA SURVIVORS" target="NEUROCOGNITIVE QUESTIONNAIRE" />
    <edge source="NEUROBLASTOMA SURVIVORS" target="PLATINUM EXPOSURE" />
    <edge source="NEUROBLASTOMA SURVIVORS" target="HEARING LOSS" />
    <edge source="NEUROBLASTOMA SURVIVORS" target="CARDIOVASCULAR CONDITIONS" />
    <edge source="NEUROBLASTOMA SURVIVORS" target="NEUROLOGIC CONDITIONS" />
    <edge source="NEUROBLASTOMA SURVIVORS" target="RESPIRATORY CONDITIONS" />
    <edge source="GEFAPIXANT" target="VITALOJAK" />
    <edge source="GEFAPIXANT" target="LEICESTER COUGH QUESTIONNAIRE" />
    <edge source="GEFAPIXANT" target="GRADE" />
    <edge source="GEFAPIXANT" target="RANDOMIZED CLINICAL TRIALS" />
    <edge source="GEFAPIXANT" target="CHRONIC COUGH" />
    <edge source="GEFAPIXANT" target="TASTE-RELATED ADVERSE EVENTS" />
    <edge source="GEFAPIXANT" target="TREATMENT-RELATED ADVERSE EVENTS" />
    <edge source="RANDOMIZED CLINICAL TRIALS" target="HORMONAL THERAPY" />
    <edge source="PATHWAYS STUDY" target="ALCOHOL CONSUMPTION" />
    <edge source="PATHWAYS STUDY" target="WOMEN DIAGNOSED WITH STAGE I-IV BC" />
    <edge source="PATHWAYS STUDY" target="NORTHERN CALIFORNIA" />
    <edge source="ALCOHOL CONSUMPTION" target="BMI" />
    <edge source="ALCOHOL CONSUMPTION" target="WOMEN DIAGNOSED WITH STAGE I-IV BC" />
    <edge source="WOMEN DIAGNOSED WITH STAGE I-IV BC" target="BMI" />
    <edge source="BMI" target="NOMOGRAMS" />
    <edge source="LUMINAL DIFFERENTIATED" target="ANDROGEN RECEPTOR ACTIVITY" />
    <edge source="LUMINAL PROLIFERATING" target="BASAL IMMUNE" />
    <edge source="LUMINAL PROLIFERATING" target="BASAL NEUROENDOCRINE" />
    <edge source="LUMINAL PROLIFERATING" target="ANDROGEN RECEPTOR ACTIVITY" />
    <edge source="LUMINAL PROLIFERATING" target="MYC ACTIVITY" />
    <edge source="LUMINAL PROLIFERATING" target="HOMOLOGOUS RECOMBINATION DEFICIENCY" />
    <edge source="BASAL IMMUNE" target="BASAL NEUROENDOCRINE" />
    <edge source="BASAL IMMUNE" target="INTERFERON &#915; ACTIVITY" />
    <edge source="BASAL IMMUNE" target="IMMUNE INFILTRATION" />
    <edge source="BASAL IMMUNE" target="RADIOTHERAPY" />
    <edge source="BASAL NEUROENDOCRINE" target="NEUROENDOCRINE EXPRESSION PATTERNS" />
    <edge source="RADIOTHERAPY" target="ESOPHAGEAL SQUAMOUS CELL CARCINOMA" />
    <edge source="RADIOTHERAPY" target="ELDERLY ESCC PATIENTS" />
    <edge source="PREMATURE CORONARY ARTERY DISEASE" target="LASSO LOGISTIC REGRESSION" />
    <edge source="LASSO LOGISTIC REGRESSION" target="DEEP LEARNING MODEL" />
    <edge source="EGE-UNET" target="HEMOGLOBIN LEVEL PREDICTION" />
    <edge source="HEMOGLOBIN LEVEL PREDICTION" target="DHA(C3AE)" />
    <edge source="HEMOGLOBIN LEVEL PREDICTION" target="MOBILE MEDICAL SETTINGS" />
    <edge source="HEMOGLOBIN LEVEL PREDICTION" target="PERIOPERATIVE ENVIRONMENTS" />
    <edge source="SLAMS" target="ML CLASSIFIERS" />
    <edge source="ML CLASSIFIERS" target="PICTURE DESCRIPTION TASK" />
    <edge source="ML CLASSIFIERS" target="STORY RECALL TASK" />
    <edge source="ML CLASSIFIERS" target="PHONE-BASED RECORDINGS" />
    <edge source="ML CLASSIFIERS" target="WEB-BASED RECORDINGS" />
    <edge source="ML CLASSIFIERS" target="ACOUSTIC FEATURES" />
    <edge source="ML CLASSIFIERS" target="LINGUISTIC FEATURES" />
    <edge source="AZZOUNI" target="RAYO" />
    <edge source="PEACOCKE" target="JENKINS" />
    <edge source="EULER'S FORMULA" target="BLACK-SCHOLES MODEL" />
    <edge source="EULER'S FORMULA" target="SPEED OF SOUND" />
    <edge source="BLACK-SCHOLES MODEL" target="SPEED OF SOUND" />
    <edge source="CENTRES FOR MEDICARE AND MEDICAID SERVICES (CMS)" target="DE-SYNPUF" />
    <edge source="ASSOCIATION RULE MINING" target="UNSUPERVISED LEARNING TECHNIQUES" />
    <edge source="ASSOCIATION RULE MINING" target="FRAUD DETECTION METHODOLOGY" />
    <edge source="UNSUPERVISED LEARNING TECHNIQUES" target="CBLOF" />
    <edge source="UNSUPERVISED LEARNING TECHNIQUES" target="IF" />
    <edge source="UNSUPERVISED LEARNING TECHNIQUES" target="ECOD" />
    <edge source="UNSUPERVISED LEARNING TECHNIQUES" target="OCSVM" />
    <edge source="UNSUPERVISED LEARNING TECHNIQUES" target="FRAUD DETECTION METHODOLOGY" />
    <edge source="FRAUD DETECTION METHODOLOGY" target="ANOMALY DETECTION ALGORITHMS" />
    <edge source="INSURANCE INDUSTRY" target="HEALTHCARE PROGRAMS" />
    <edge source="DIFFERENCE AND REPETITION" target="DELEUZE" />
    <edge source="DIFFERENCE AND REPETITION" target="HEGEL" />
    <edge source="DIFFERENCE AND REPETITION" target="KIERKEGAARD" />
    <edge source="DIFFERENCE AND REPETITION" target="FREUD" />
    <edge source="DIFFERENCE AND REPETITION" target="ALTHUSSER" />
    <edge source="DIFFERENCE AND REPETITION" target="NIETZSCHE" />
    <edge source="DIFFERENCE AND REPETITION" target="WESTERN METAPHYSICS" />
    <edge source="DIFFERENCE AND REPETITION" target="MARX" />
    <edge source="DIFFERENCE AND REPETITION" target="EVENT" />
    <edge source="FREDERICK SUPPE" target="THE STRUCTURE OF SCIENTIFIC THEORIES" />
    <edge source="THE STRUCTURE OF SCIENTIFIC THEORIES" target="UNIVERSITY OF ILLINOIS PRESS" />
    <edge source="J. P. DAY" target="THE PHILOSOPHICAL QUARTERLY" />
    <edge source="HEALTH INEQUITIES" target="NATIVE HAWAIIAN AND OTHER PACIFIC ISLANDER" />
    <edge source="HEALTH INEQUITIES" target="MEDICAL EXPENDITURE PANEL SURVEY (MEPS)" />
    <edge source="HEALTH INEQUITIES" target="BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM (BRFSS)" />
    <edge source="HEALTH INEQUITIES" target="NATIONAL VITAL STATISTICS SYSTEM" />
    <edge source="HEALTH INEQUITIES" target="IPUMS AMERICAN COMMUNITY SURVEY" />
    <edge source="HEALTH INEQUITIES" target="FEDERAL POLICY MAKERS" />
    <edge source="HEALTH INEQUITIES" target="STATE POLICY MAKERS" />
    <edge source="HEALTH INEQUITIES" target="LOCAL POLICY MAKERS" />
    <edge source="PATIENT DECISION AIDS" target="PDAIN" />
    <edge source="PATIENT DECISION AIDS" target="MYOPIA" />
    <edge source="PATIENT DECISION AIDS" target="NON-PROFIT ORGANIZATIONS" />
    <edge source="PATIENT DECISION AIDS" target="QUALITY ASSESSMENT TOOL" />
    <edge source="PDAIN" target="IPDAS" />
    <edge source="PDAIN" target="CORNEAL SPECIALIST OPHTHALMOLOGISTS" />
    <edge source="PDAIN" target="HEALTH EDUCATION EXPERT" />
    <edge source="PDAIN" target="LASER CORRECTION" />
    <edge source="MYOPIA" target="LASER CORRECTION" />
    <edge source="METAVERSE" target="DIGITAL PROFESSIONALISM" />
    <edge source="METAVERSE" target="DIGITAL TWIN TECHNOLOGY" />
    <edge source="DIGITAL PROFESSIONALISM" target="POLAND" />
    <edge source="DIGITAL PROFESSIONALISM" target="ROMANIA" />
    <edge source="MAXQDA" target="VER BI GMBH" />
    <edge source="GLOBAL BURDEN OF DISEASES, INJURIES, AND RISK FACTORS STUDY (GBD)" target="PUBLIC" />
    <edge source="GLOBAL BURDEN OF DISEASES, INJURIES, AND RISK FACTORS STUDY (GBD)" target="2050" />
    <edge source="HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT" target="GENERAL DATA PROTECTION REGULATION" />
    <edge source="HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT" target="U.S." />
    <edge source="U.S." target="NATIONAL CAMPAIGN" />
    <edge source="GEMELLI GENERATOR - REAL WORLD DATA SANDBOX" target="DOCKER" />
    <edge source="GEMELLI GENERATOR - REAL WORLD DATA SANDBOX" target="IDENTITY AND ACCESS MANAGEMENT AGENT" />
    <edge source="GEMELLI GENERATOR - REAL WORLD DATA SANDBOX" target="BLOCKCHAIN-BASED NOTARISATION MODULE" />
    <edge source="DOCKER" target="DREAMER" />
    <edge source="SGM CANCER PATIENTS" target="SGM WELCOMING ENVIRONMENT" />
    <edge source="SGM CANCER PATIENTS" target="CANCER CARE STUDY" />
    <edge source="CANCER CARE STUDY" target="BIPOC" />
    <edge source="B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA" target="BLINATUMOMAB" />
    <edge source="B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA" target="DEXAMETHASONE" />
    <edge source="BLINATUMOMAB" target="DEXAMETHASONE" />
    <edge source="BLINATUMOMAB" target="RELAPSED/REFRACTORY B-ALL" />
    <edge source="BASELINE BONE MARROW BLAST PERCENTAGE" target="MINIMAL/MEASURABLE RESIDUAL DISEASE RESPONSE" />
    <edge source="CLIMATE MODEL" target="ENSEMBLE APPROACH" />
    <edge source="RISK STRATIFICATION ALGORITHM" target="OOPHORECTOMY" />
    <edge source="RISK STRATIFICATION ALGORITHM" target="CHILDREN'S HOSPITALS" />
    <edge source="OOPHORECTOMY" target="CHILDREN'S HOSPITALS" />
    <edge source="PATIENT DECISION AID (PTDA)" target="HIP AND KNEE OSTEOARTHRITIS" />
    <edge source="LYMPHOMA STUDY" target="ANN ARBOR STAGE" />
    <edge source="LYMPHOMA STUDY" target="LASSO REGRESSION ANALYSIS" />
    <edge source="LYMPHOMA STUDY" target="COX STEPWISE REGRESSION ANALYSIS" />
    <edge source="LYMPHOMA STUDY" target="NOMOGRAM" />
    <edge source="LYMPHOMA STUDY" target="WEB-BASED DYNAMIC NOMOGRAM" />
    <edge source="NOMOGRAM" target="CRITICAL RESPIRATORY EVENTS" />
    <edge source="NOMOGRAM" target="GRADE A TERTIARY HOSPITAL" />
    <edge source="NOMOGRAM" target="TRIPOD CHECKLIST" />
    <edge source="NOMOGRAM" target="BOOTSTRAPPING" />
    <edge source="NOMOGRAM" target="POST-ANESTHESIA CARE UNIT (PACU)" />
    <edge source="NOMOGRAM" target="XGB MODEL" />
    <edge source="NOMOGRAM" target="INFECTIVE ENDOCARDITIS" />
    <edge source="LOUISIANA" target="AFFORDABLE CARE ACT (ACA)" />
    <edge source="CDK4/6 INHIBITORS" target="SURVEY EPIDEMIOLOGY AND END RESULTS-MEDICARE DATABASE" />
    <edge source="CDK4/6 INHIBITORS" target="KAPLAN-MEIER METHODS" />
    <edge source="CDK4/6 INHIBITORS" target="COX REGRESSION MODELS" />
    <edge source="CDK4/6 INHIBITORS" target="HORMONE RECEPTOR-POSITIVE METASTATIC BREAST CANCER" />
    <edge source="CDK4/6 INHIBITORS" target="HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-2 NEGATIVE" />
    <edge source="CDK4/6 INHIBITORS" target="ENDROCRINE THERAPY" />
    <edge source="KAPLAN-MEIER METHODS" target="ANAL CANCER" />
    <edge source="KAPLAN-MEIER METHODS" target="VETERANS HEALTH ADMINISTRATION" />
    <edge source="COX REGRESSION MODELS" target="MULTISTATE REGISTRY-LINKAGE COHORT STUDY" />
    <edge source="GENITAL HERPES" target="HERPES SIMPLEX VIRUS TYPE 1 (HSV-1)" />
    <edge source="GENITAL HERPES" target="HERPES SIMPLEX VIRUS TYPE 2 (HSV-2)" />
    <edge source="GENITAL HERPES" target="NEONATAL HERPES INFECTION" />
    <edge source="CONCORDANCE" target="DISCORDANT CARE" />
    <edge source="CASTLE" target="MULLER" />
    <edge source="MULLER" target="HALDANE" />
    <edge source="MULLER" target="LEWONTIN" />
    <edge source="ROBUSTNESS" target="HEURISTICS" />
    <edge source="REDUCTIONISM" target="EMERGENCE" />
    <edge source="CANCER CLINICAL TRIAL" target="NURSES" />
    <edge source="CANCER CLINICAL TRIAL" target="HOSPITAL HEALTH SYSTEMS" />
    <edge source="CANCER CLINICAL TRIAL" target="ACADEMIC CENTERS" />
    <edge source="CANCER CLINICAL TRIAL" target="PROFESSIONAL SOCIETIES" />
    <edge source="CANCER CLINICAL TRIAL" target="ADVOCACY ORGANIZATIONS" />
    <edge source="CANCER CLINICAL TRIAL" target="INDUSTRY NETWORKS" />
    <edge source="NURSES" target="CHILD ABUSE AND NEGLECT" />
    <edge source="NURSES" target="SHARED DECISION-MAKING SUPPORT TRAINING" />
    <edge source="NURSES" target="RESIDENTIAL AGED-CARE FACILITIES" />
    <edge source="NURSES" target="PHYSICIANS REACTIONS TO UNCERTAINTY SCALE" />
    <edge source="NURSES" target="IMMEDIATE ASSESSMENT AND ANTIBIOTICS SCALE" />
    <edge source="NURSES" target="CLINICAL TOLERANCE OF UNCERTAINTY" />
    <edge source="NURSES" target="RESIDENT/FAMILY MEMBERS" />
    <edge source="PERITONEAL MESOTHELIOMA" target="GERMLINE MUTATIONS" />
    <edge source="PERITONEAL MESOTHELIOMA" target="BRCA1-ASSOCIATED PROTEIN 1 (BAP1)" />
    <edge source="PERITONEAL MESOTHELIOMA" target="CYTOREDUCTIVE SURGERIES" />
    <edge source="PERITONEAL MESOTHELIOMA" target="SURGICAL PROCEDURES" />
    <edge source="GERMLINE MUTATIONS" target="PROSPECTIVE STUDY" />
    <edge source="GERMLINE MUTATIONS" target="ROC ANALYSIS" />
    <edge source="RUX-MF RETROSPECTIVE STUDY" target="PRIMARY MYELOFIBROSIS" />
    <edge source="RUX-MF RETROSPECTIVE STUDY" target="SECONDARY MYELOFIBROSIS" />
    <edge source="CYTOPENIC MYELOFIBROSIS" target="THROMBOCYTOPENIA" />
    <edge source="CYTOPENIC MYELOFIBROSIS" target="ANEMIA" />
    <edge source="CYTOPENIC MYELOFIBROSIS" target="LEUKEMIC TRANSFORMATION" />
    <edge source="THROMBOCYTOPENIA" target="ANTIBODY-DRUG CONJUGATES" />
    <edge source="ANEMIA" target="BLAST PHASE" />
    <edge source="POLYGENIC RISK SCORE" target="ROTTERDAM STUDY" />
    <edge source="POLYGENIC RISK SCORE" target="CHD RISK PREDICTION" />
    <edge source="POLYGENIC RISK SCORE" target="TRADITIONAL RISK FACTORS" />
    <edge source="ROTTERDAM STUDY" target="ROTTERDAM" />
    <edge source="CHD RISK PREDICTION" target="TRADITIONAL RISK FACTORS" />
    <edge source="ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (ADNI)" target="BIOMEDICAL DATA" />
    <edge source="ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (ADNI)" target="COMPUTATIONAL ONTOLOGIES" />
    <edge source="BIOMEDICAL DATA" target="BIOTECHNOLOGY" />
    <edge source="BIOMEDICAL DATA" target="COMPUTER SCIENCE" />
    <edge source="AUTISM DIAGNOSIS STUDY" target="SPECIALTY AUTISM CLINICS" />
    <edge source="AUTISM DIAGNOSIS STUDY" target="EYE-TRACKING MEASUREMENT" />
    <edge source="AUTISM DIAGNOSIS STUDY" target="EXPERT CLINICAL DIAGNOSIS" />
    <edge source="AUTISM DIAGNOSIS STUDY" target="CHILDREN" />
    <edge source="AUTISM DIAGNOSIS STUDY" target="NCT03469986" />
    <edge source="CHILDREN" target="PRECISION MEDICINE FOR CHILDREN WITH CANCER TRIAL" />
    <edge source="CHILDREN" target="PARENTS" />
    <edge source="CHILDREN" target="ACUTE SINUSITIS" />
    <edge source="REMOTE GERIATRIC ASSESSMENT AND IMPLEMENTATION PROGRAM" target="BRAZILIAN CANCER CENTER" />
    <edge source="REMOTE GERIATRIC ASSESSMENT AND IMPLEMENTATION PROGRAM" target="FUNCTIONAL ASSESSMENT OF CANCER THERAPY - GENERAL" />
    <edge source="REMOTE GERIATRIC ASSESSMENT AND IMPLEMENTATION PROGRAM" target="GERIATRIC DEPRESSION SCALE" />
    <edge source="REMOTE GERIATRIC ASSESSMENT AND IMPLEMENTATION PROGRAM" target="INSTRUMENTAL ACTIVITIES OF DAILY LIVING" />
    <edge source="TAICHUNG VETERANS GENERAL HOSPITAL" target="FRIED'S FRAILTY PHENOTYPE" />
    <edge source="VANDERBILT UNIVERSITY MEDICAL CENTER" target="DUKE UNIVERSITY HEALTH SYSTEM" />
    <edge source="VANDERBILT UNIVERSITY MEDICAL CENTER" target="PREDICTION CALCULATORS" />
    <edge source="DUKE UNIVERSITY HEALTH SYSTEM" target="PREDICTION CALCULATORS" />
    <edge source="PREDICTION CALCULATORS" target="SPINE SURGERY" />
    <edge source="QUALITY OUTCOMES DATABASE" target="WEB-BASED PREDICTION CALCULATORS" />
    <edge source="WEB-BASED PREDICTION CALCULATORS" target="ORTHOPEDIC AND NEUROSURGERY HEALTH CARE PROVIDERS" />
    <edge source="WEB-BASED PREDICTION CALCULATORS" target="HEALTH CARE ADMINISTRATORS" />
    <edge source="WEB-BASED PREDICTION CALCULATORS" target="PATIENTS UNDERGOING ELECTIVE SPINE SURGERY" />
    <edge source="ORTHOPEDIC AND NEUROSURGERY HEALTH CARE PROVIDERS" target="SPINE SURGERY" />
    <edge source="SPINE SURGERY" target="PATIENTS UNDERGOING ELECTIVE SPINE SURGERY" />
    <edge source="HEALTH CARE ADMINISTRATORS" target="TUFTS MEDICINE HEALTHCARE SYSTEM" />
    <edge source="HEALTH CARE ADMINISTRATORS" target="STUDY 1644" />
    <edge source="UNIT NORMAL LOSS INTEGRAL" target="PREDTOOLS" />
    <edge source="UNIT NORMAL LOSS INTEGRAL" target="MONTE CARLO SIMULATIONS" />
    <edge source="UNIT NORMAL LOSS INTEGRAL" target="3-ARM CLINICAL TRIAL" />
    <edge source="UNIT NORMAL LOSS INTEGRAL" target="DECISION ANALYSIS" />
    <edge source="UNIT NORMAL LOSS INTEGRAL" target="RISK MODELING" />
    <edge source="MONTE CARLO SIMULATIONS" target="SIMULATING INDIVIDUAL-LEVEL TRIAL DATA" />
    <edge source="DECISION ANALYSIS" target="DASH-TOP" />
    <edge source="ESOPHAGEAL SQUAMOUS CELL CARCINOMA" target="CONCURRENT CHEMORADIOTHERAPY" />
    <edge source="ESOPHAGEAL SQUAMOUS CELL CARCINOMA" target="RESOLSTM-DEPTH" />
    <edge source="CONCURRENT CHEMORADIOTHERAPY" target="ELDERLY ESCC PATIENTS" />
    <edge source="ELDERLY ESCC PATIENTS" target="NOMOGRAMS" />
    <edge source="NOMOGRAMS" target="KAPLAN&#8211;MEIER CURVES" />
    <edge source="NOMOGRAMS" target="HISTOLOGIC GRADE" />
    <edge source="NOMOGRAMS" target="T STAGE" />
    <edge source="TAMOXIFEN" target="AROMATASE INHIBITORS" />
    <edge source="TAMOXIFEN" target="BREAST CANCER DEATH" />
    <edge source="TAMOXIFEN" target="INVASIVE BREAST CANCER" />
    <edge source="AROMATASE INHIBITORS" target="INVASIVE BREAST CANCER" />
    <edge source="AROMATASE INHIBITORS" target="BREAST CANCER DEATH" />
    <edge source="OLDER/UNFIT PATIENTS" target="INSTITUTION" />
    <edge source="TRAINING COHORT" target="INSTITUTION" />
    <edge source="VALIDATION GROUP" target="INSTITUTION" />
    <edge source="THERAPYSELECTOR" target="HEPATITIS C" />
    <edge source="DNA DAMAGE RESPONSE" target="FANCONI ANEMIA" />
    <edge source="DNA DAMAGE RESPONSE" target="PALB2" />
    <edge source="PALB2" target="PANCREATICOBILIARY CANCER" />
    <edge source="PARP3" target="MKI67" />
    <edge source="NATIONAL HEALTH SERVICE (NHS)" target="CORONARY ARTERY BYPASS GRAFT (CABG)" />
    <edge source="NATIONAL HEALTH SERVICE (NHS)" target="TOTAL HIP REPLACEMENT (THR)" />
    <edge source="NATIONAL HEALTH SERVICE (NHS)" target="HOSPITAL EPISODE STATISTICS" />
    <edge source="NATIONAL HEALTH SERVICE (NHS)" target="OFFICE FOR NATIONAL STATISTICS" />
    <edge source="CORONARY ARTERY BYPASS GRAFT (CABG)" target="TOTAL HIP REPLACEMENT (THR)" />
    <edge source="AMAZON'S MTURK" target="US PARTICIPANTS" />
    <edge source="US PARTICIPANTS" target="UNFAMILIAR FUNGAL DISEASE" />
    <edge source="FINNISH PHYSICIANS" target="DIGITALIZATION OF HEALTHCARE" />
    <edge source="FINNISH PHYSICIANS" target="TELECONSULTATIONS" />
    <edge source="FINNISH PHYSICIANS" target="INFORMATION SYSTEMS" />
    <edge source="DIGITALIZATION OF HEALTHCARE" target="TELECONSULTATIONS" />
    <edge source="DIGITALIZATION OF HEALTHCARE" target="INFORMATION SYSTEMS" />
    <edge source="TELEHEALTH SERVICES" target="BIDIRECTIONAL LONG SHORT-TERM MEMORY (BI-LSTM) NEURAL NETWORK" />
    <edge source="BIDIRECTIONAL LONG SHORT-TERM MEMORY (BI-LSTM) NEURAL NETWORK" target="CHARACTER EMBEDDING" />
    <edge source="CHARACTER EMBEDDING" target="CLINICAL CORPUS" />
    <edge source="CLINICAL CORPUS" target="MEDICAL DATASET" />
    <edge source="EXTRACELLULAR VESICLES" target="GLIOBLASTOMA" />
    <edge source="EXTRACELLULAR VESICLES" target="IMMUNE SYSTEM" />
    <edge source="EXTRACELLULAR VESICLES" target="CELL CYCLE" />
    <edge source="EXTRACELLULAR VESICLES" target="PROGRAMMED CELL DEATH" />
    <edge source="GLIOBLASTOMA" target="PLASMA-DERIVED EVS" />
    <edge source="GLIOBLASTOMA" target="SALIVA-DERIVED EVS" />
    <edge source="GLIOBLASTOMA" target="ALDOLASE A" />
    <edge source="GLIOBLASTOMA" target="14-3-3 PROTEIN &#917;" />
    <edge source="GLIOBLASTOMA" target="ENOYL COA HYDRATASE 1" />
    <edge source="GLIOBLASTOMA" target="TRANSMEMBRANE PROTEASE SERINE 11B" />
    <edge source="GLIOBLASTOMA" target="O'NEAL COMPREHENSIVE CANCER CENTER" />
    <edge source="GLIOBLASTOMA" target="AFRICAN AMERICAN" />
    <edge source="GLIOBLASTOMA" target="WHITE PATIENTS" />
    <edge source="MEDICAL DICTIONARY FOR REGULATORY ACTIVITIES (MEDDRA)" target="UNIFIED MEDICAL LANGUAGE SYSTEM (UMLS)" />
    <edge source="MEDICAL DICTIONARY FOR REGULATORY ACTIVITIES (MEDDRA)" target="OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP COMMON DATA MODEL (OMOP CDM)" />
    <edge source="MEDICAL DICTIONARY FOR REGULATORY ACTIVITIES (MEDDRA)" target="MAPPING STATUS" />
    <edge source="MEDICAL DICTIONARY FOR REGULATORY ACTIVITIES (MEDDRA)" target="MAPPING STATISTICS" />
    <edge source="MEDICAL DICTIONARY FOR REGULATORY ACTIVITIES (MEDDRA)" target="QUALITY ANALYSIS" />
    <edge source="MEDICAL DICTIONARY FOR REGULATORY ACTIVITIES (MEDDRA)" target="MAPPING COVERAGE" />
    <edge source="US KIDNEY ALLOCATION SYSTEM" target="SCIENTIFIC REGISTRY OF TRANSPLANT RECIPIENTS" />
    <edge source="US KIDNEY ALLOCATION SYSTEM" target="MICROSIMULATION MODEL" />
    <edge source="US KIDNEY ALLOCATION SYSTEM" target="OLDER CANDIDATES" />
    <edge source="US KIDNEY ALLOCATION SYSTEM" target="DECEASED DONOR KIDNEYS" />
    <edge source="SCIENTIFIC REGISTRY OF TRANSPLANT RECIPIENTS" target="MICROSIMULATION MODEL" />
    <edge source="OLDER CANDIDATES" target="DECEASED DONOR KIDNEYS" />
    <edge source="ARTIFICIAL VISCOSITY" target="COMPUTATIONAL FLUID DYNAMICS" />
    <edge source="MODEL BUILDING TECHNIQUES" target="SIMULATION MODELS" />
    <edge source="MODEL BUILDING TECHNIQUES" target="CREDIBILITY OF SIMULATION MODELS" />
    <edge source="SIMULATION MODELS" target="CREDIBILITY OF SIMULATION MODELS" />
    <edge source="NEURO-TTRANSFORM" target="EPLONTERSEN" />
    <edge source="NEURO-TTRANSFORM" target="NEURO-TTR" />
    <edge source="NEURO-TTRANSFORM" target="INOTERSEN" />
    <edge source="NEURO-TTRANSFORM" target="ATTRV AMYLOIDOSIS" />
    <edge source="NEURO-TTRANSFORM" target="COUTINHO STAGE 1 OR 2" />
    <edge source="NEURO-TTRANSFORM" target="15 COUNTRIES" />
    <edge source="EPLONTERSEN" target="CARDIAC ARRHYTHMIA" />
    <edge source="EPLONTERSEN" target="INTRACEREBRAL HEMORRHAGE" />
    <edge source="CARDIAC ARRHYTHMIA" target="ECG MACHINES" />
    <edge source="CARDIAC ARRHYTHMIA" target="CONGESTIVE HEART FAILURE" />
    <edge source="CARDIAC ARRHYTHMIA" target="NORMAL SINUS RHYTHM" />
    <edge source="INTRACEREBRAL HEMORRHAGE" target="STROKE SURVIVORS" />
    <edge source="LOW BACK PAIN" target="LUMBAR DISC HERNIATION" />
    <edge source="LOW BACK PAIN" target="LUMBAR SPINAL STENOSIS" />
    <edge source="LUMBAR DISC HERNIATION" target="DEEP LEARNING MODEL" />
    <edge source="LUMBAR SPINAL STENOSIS" target="DEEP LEARNING MODEL" />
    <edge source="DEEP LEARNING MODEL" target="DECOMPRESSION SURGERY" />
    <edge source="DEEP LEARNING MODEL" target="HOUSTON" />
    <edge source="DEEP LEARNING MODEL" target="HGB TESTS" />
    <edge source="DEEP LEARNING MODEL" target="HEALTHCARE COSTS" />
    <edge source="DEEP LEARNING MODEL" target="PATIENT OUTCOMES" />
    <edge source="ORAL ANTICOAGULANT" target="HEMATOLOGICAL CANCER" />
    <edge source="ORAL ANTICOAGULANT" target="ELDERLY PATIENTS" />
    <edge source="ELDERLY PATIENTS" target="CRITICAL RESPIRATORY EVENTS" />
    <edge source="MRI-TARGETED PROSTATE BIOPSY" target="SYSTEMATIC BIOPSY" />
    <edge source="MRI-TARGETED PROSTATE BIOPSY" target="PROSTATECTOMY" />
    <edge source="MRI-TARGETED PROSTATE BIOPSY" target="COX REGRESSION" />
    <edge source="MRI-TARGETED PROSTATE BIOPSY" target="HIGH-GRADE GROUP PROSTATE CANCER" />
    <edge source="SYSTEMATIC BIOPSY" target="PROSTATECTOMY" />
    <edge source="SYSTEMATIC BIOPSY" target="COX REGRESSION" />
    <edge source="SYSTEMATIC BIOPSY" target="HIGH-GRADE GROUP PROSTATE CANCER" />
    <edge source="COX REGRESSION" target="BIOCHEMICAL RECURRENCE" />
    <edge source="COX REGRESSION" target="AGES-REYKJAVIK STUDY" />
    <edge source="VERSION 9 AJCC STAGING SYSTEM" target="8TH EDITION AJCC STAGE GROUPS" />
    <edge source="VERSION 9 AJCC STAGING SYSTEM" target="ANAL CANCER" />
    <edge source="ANAL CANCER" target="COX PROPORTIONAL HAZARDS MODELS" />
    <edge source="COX PROPORTIONAL HAZARDS MODELS" target="ITALIAN COHORT STUDY" />
    <edge source="CARDIOVASCULAR TOXICITIES" target="PATIENTS WITH CLL" />
    <edge source="CYTOKINE RELEASE SYNDROME" target="TOCILIZUMAB" />
    <edge source="CYTOKINE RELEASE SYNDROME" target="AMERICAN SOCIETY FOR TRANSPLANTATION AND CELLULAR THERAPY" />
    <edge source="INTELLECTUAL OR DEVELOPMENTAL DISABILITIES (IDD)" target="METASTATIC CANCER" />
    <edge source="ONTARIO" target="MANITOBA" />
    <edge source="ONTARIO" target="MACHINE LEARNING ALGORITHM" />
    <edge source="ONTARIO" target="LUNG CANCER SCREENING POLICIES" />
    <edge source="TREATMENT DECISION-MAKING" target="CAREGIVER" />
    <edge source="TREATMENT DECISION-MAKING" target="FAMILY" />
    <edge source="CAREGIVER" target="OUTPATIENT CLINICS" />
    <edge source="CAREGIVER" target="FAMILY" />
    <edge source="COLONOSCOPY" target="MULTIMODAL CRC SCREENING POLICIES" />
    <edge source="CRC SCREENING STRATEGIES" target="LIFE-YEARS GAINED" />
    <edge source="CRC SCREENING STRATEGIES" target="SCREENING BURDEN" />
    <edge source="HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)" target="SODIUM-GLUCOSE COTRANSPORTER TYPE 2 INHIBITORS" />
    <edge source="HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)" target="FUROSEMIDE" />
    <edge source="HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)" target="TORSEMIDE" />
    <edge source="HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)" target="H2FPEF SCORE" />
    <edge source="SODIUM-GLUCOSE COTRANSPORTER TYPE 2 INHIBITORS" target="DAPAGLIFLOZIN" />
    <edge source="SODIUM-GLUCOSE COTRANSPORTER TYPE 2 INHIBITORS" target="EMPAGLIFLOZIN" />
    <edge source="DAPAGLIFLOZIN" target="QATAR BIOBANK" />
    <edge source="EBM" target="AFRICAN COUNTRIES" />
    <edge source="EBM" target="HEALTHCARE SETTINGS" />
    <edge source="EBM" target="MAXQDA10" />
    <edge source="EBM" target="HEALTHCARE MANAGERS" />
    <edge source="CAPACITY-BUILDING EBM TRAINING" target="GOVERNMENT" />
    <edge source="CAPACITY-BUILDING EBM TRAINING" target="DIFFERENCE-IN-DIFFERENCES ANALYSIS" />
    <edge source="CAPACITY-BUILDING EBM TRAINING" target="FIXED EFFECT PANEL-DATA REGRESSION MODEL" />
    <edge source="GOVERNMENT" target="MOBILE PHONES" />
    <edge source="CHILDREN'S HOSPITAL IN HELSINKI" target="HELSINKI" />
    <edge source="LIVER" target="KIDNEYS" />
    <edge source="KIDNEYS" target="HEART" />
    <edge source="KIDNEYS" target="BRAIN" />
    <edge source="KIDNEYS" target="LUNGS" />
    <edge source="KIDNEYS" target="GUT" />
    <edge source="DEEP LEARNING MODELS" target="EEG" />
    <edge source="DEEP LEARNING MODELS" target="BEAM" />
    <edge source="DEEP LEARNING MODELS" target="CHB-MIT DATASET" />
    <edge source="DEEP LEARNING MODELS" target="WHITE-BOX ATTACKS" />
    <edge source="BEAM" target="GPBEAM" />
    <edge source="BEAM" target="GPBEAM-DE" />
    <edge source="WHITE-BOX ATTACKS" target="GPBEAM" />
    <edge source="WHITE-BOX ATTACKS" target="GPBEAM-DE" />
    <edge source="GPBEAM" target="GPBEAM-DE" />
    <edge source="ENDOSONOGRAPHERS" target="DEEP-LEARNING RADIOMICS (DLR) MODEL" />
    <edge source="ENDOSONOGRAPHERS" target="ENDOSCOPIC ULTRASONOGRAPHY (EUS)" />
    <edge source="DEEP-LEARNING RADIOMICS (DLR) MODEL" target="PANCREATIC DUCTAL ADENOCARCINOMA (PDAC)" />
    <edge source="DEEP-LEARNING RADIOMICS (DLR) MODEL" target="ENDOSCOPIC ULTRASONOGRAPHY (EUS)" />
    <edge source="DEEP-LEARNING RADIOMICS (DLR) MODEL" target="JUNIOR ENDOSONOGRAPHER GROUP" />
    <edge source="DEEP-LEARNING RADIOMICS (DLR) MODEL" target="SENIOR ENDOSONOGRAPHER GROUP" />
    <edge source="PANCREATIC DUCTAL ADENOCARCINOMA (PDAC)" target="BRCA1/2" />
    <edge source="JUNIOR ENDOSONOGRAPHER GROUP" target="SENIOR ENDOSONOGRAPHER GROUP" />
    <edge source="COSMIC313" target="BELZUTIFAN" />
    <edge source="PEACE-1" target="ARASENS" />
    <edge source="VISION" target="THERAP" />
    <edge source="METASTATIC CASTRATE SENSITIVE PROSTATE CANCER" target="ANDROGEN-SIGNALING INHIBITORS" />
    <edge source="METASTATIC CASTRATE SENSITIVE PROSTATE CANCER" target="ANDROGEN DEPRIVATION THERAPY" />
    <edge source="METASTATIC CASTRATE RESISTANT PROSTATE CANCER" target="RADIOLIGAND THERAPY 177 LU-PSMA-617" />
    <edge source="ULTRASOUND-GUIDED RADIOFREQUENCY ABLATION" target="PAPILLARY THYROID CARCINOMA" />
    <edge source="ULTRASOUND-GUIDED RADIOFREQUENCY ABLATION" target="BIPOLAR RFA PROCEDURE" />
    <edge source="ULTRASOUND-GUIDED RADIOFREQUENCY ABLATION" target="VOLUME REDUCTION RATE" />
    <edge source="ULTRASOUND-GUIDED RADIOFREQUENCY ABLATION" target="COMPLETE DISAPPEARANCE RATE" />
    <edge source="ULTRASOUND-GUIDED RADIOFREQUENCY ABLATION" target="DELAYED SURGERY" />
    <edge source="PAPILLARY THYROID CARCINOMA" target="T1N0M0 PTC" />
    <edge source="PAPILLARY THYROID CARCINOMA" target="LYMPH NODE METASTASIS" />
    <edge source="PAPILLARY THYROID CARCINOMA" target="RECURRENT TUMOR" />
    <edge source="PAPILLARY THYROID CARCINOMA" target="PERSISTENT TUMOR" />
    <edge source="PAPILLARY THYROID CARCINOMA" target="DISTANT METASTASIS" />
    <edge source="T1A GROUP" target="T1B GROUP" />
    <edge source="CANCER THERAPY EVALUATION PROGRAM STUDY 9557" target="AT13387" />
    <edge source="CANCER THERAPY EVALUATION PROGRAM STUDY 9557" target="BRAF V600E-MUTANT SOLID TUMORS" />
    <edge source="AT13387" target="HSP90" />
    <edge source="BRAF V600E-MUTANT SOLID TUMORS" target="BRAF" />
    <edge source="BRAF" target="LOW-GRADE SEROUS OVARIAN CANCER" />
    <edge source="BRAF" target="PANCREATICOBILIARY CANCER" />
    <edge source="NDW" target="KHIS" />
    <edge source="NDW" target="EMRS" />
    <edge source="NDW" target="BIO-MED CENTRAL LTD" />
    <edge source="PROSTATE CANCER CONSULTATIONS" target="AGGRESSIVE TREATMENT" />
    <edge source="PROSTATE CANCER CONSULTATIONS" target="NONAGGRESSIVE TREATMENT" />
    <edge source="CORONAVIRUS DISEASE 2019 (COVID-19) PANDEMIC" target="EPIDEMIOLOGICAL MODELING" />
    <edge source="VISUAL TRANSFORMER" target="CONVOLUTIONAL NEURAL NETWORKS (CNNS)" />
    <edge source="VIDEO SWIN TRANSFORMERS" target="CT SCAN IMAGES" />
    <edge source="VIDEO SWIN TRANSFORMERS" target="CLINICAL DATA" />
    <edge source="CT SCAN IMAGES" target="CLINICAL DATA" />
    <edge source="CT SCAN IMAGES" target="3D DATA FUSION" />
    <edge source="CLINICAL DATA" target="3D DATA FUSION" />
    <edge source="CLINICAL DATA" target="SIAP" />
    <edge source="DEEP-LEARNING-BASED SCHEMES" target="3D DATA FUSION" />
    <edge source="DEEP-LEARNING-BASED SCHEMES" target="CONVENTIONAL CLASSIFIERS" />
    <edge source="SURGICAL SITE INFECTION" target="INTERNATIONAL ORGANIZATIONS" />
    <edge source="SURGICAL SITE INFECTION" target="ANTIBIOTIC PROPHYLAXIS" />
    <edge source="SURGICAL SITE INFECTION" target="CHLORHEXIDINE GLUCONATE" />
    <edge source="SURGICAL SITE INFECTION" target="ALCOHOL-BASED SKIN PREPARATION" />
    <edge source="SURGICAL SITE INFECTION" target="NEGATIVE PRESSURE WOUND THERAPY" />
    <edge source="SURGICAL SITE INFECTION" target="PERIOPERATIVE GLYCEMIC CONTROL" />
    <edge source="SURGICAL SITE INFECTION" target="DECOLONIZATION" />
    <edge source="CENTRAL CHINA" target="BI SYSTEM" />
    <edge source="2016&#8211;2019 ML-IDENTIFIED MEASURES" target="HUMANLY DECIDED MEASURES" />
    <edge source="2016&#8211;2019 ML-IDENTIFIED MEASURES" target="ANNUAL MEETING MINUTES" />
    <edge source="ALLAN FRANKLIN" target="SHERLOCK HOLMES STRATEGY" />
    <edge source="CLINICAL DECISION-SUPPORT SYSTEMS" target="COUNTERFACTUAL POLICY LEARNING" />
    <edge source="COUNTERFACTUAL POLICY LEARNING" target="BOOTSTRAP METHOD" />
    <edge source="COUNTERFACTUAL POLICY LEARNING" target="ADVERSARIAL LEARNING ALGORITHM" />
    <edge source="BDNCO" target="EMBRYONAL TUMORS" />
    <edge source="BDNCO" target="NEUROBLASTOMA" />
    <edge source="BDNCO" target="NEPHROBLASTOMA" />
    <edge source="INFORMATION TECHNOLOGY" target="EMERGENCY LABORATORY TESTING" />
    <edge source="DECEMBER 2021" target="OCTOBER 2021" />
    <edge source="OCTOBER 2021" target="MAY 2020" />
    <edge source="JANUARY 2021" target="SEPTEMBER 2021" />
    <edge source="JANUARY 2022" target="SEPTEMBER 2022" />
    <edge source="DEEP LEARNING RADIOMICS NOMOGRAM" target="HOSPITAL 1" />
    <edge source="DEEP LEARNING RADIOMICS NOMOGRAM" target="HOSPITAL 2" />
    <edge source="DEEP LEARNING RADIOMICS NOMOGRAM" target="DEEP LEARNING RADIOMICS" />
    <edge source="HISTORIANS" target="PHILOSOPHERS OF SCIENCE" />
    <edge source="PHILOSOPHERS OF SCIENCE" target="IDEALIZATION" />
    <edge source="THEORETICAL PHYSICS" target="MOLECULAR BIOLOGY" />
    <edge source="MOLECULAR BIOLOGY" target="X-RAY CRYSTALLOGRAPHY" />
    <edge source="MOLECULAR BIOLOGY" target="RHEINBERGER" />
    <edge source="MOLECULAR BIOLOGY" target="LABORATORY" />
    <edge source="MOLECULAR BIOLOGY" target="PHYSICISTS" />
    <edge source="HORMONAL THERAPY" target="DUCTAL CARCINOMA IN SITU (DCIS)" />
    <edge source="HORMONAL THERAPY" target="CONTRALATERAL INVASIVE BREAST CANCER (IBC)" />
    <edge source="DUCTAL CARCINOMA IN SITU (DCIS)" target="BREAST-CONSERVING SURGERY (BCS)" />
    <edge source="DUCTAL CARCINOMA IN SITU (DCIS)" target="RADIATION THERAPY (RT)" />
    <edge source="DUCTAL CARCINOMA IN SITU (DCIS)" target="MASTECTOMY" />
    <edge source="DUCTAL CARCINOMA IN SITU (DCIS)" target="NEW JERSEY" />
    <edge source="DUCTAL CARCINOMA IN SITU (DCIS)" target="NEW YORK" />
    <edge source="DUCTAL CARCINOMA IN SITU (DCIS)" target="CANCER CENTERS" />
    <edge source="DUCTAL CARCINOMA IN SITU (DCIS)" target="HEALTH SYSTEMS" />
    <edge source="DUCTAL CARCINOMA IN SITU (DCIS)" target="SINGLE SPECIALTY PRACTICES" />
    <edge source="DUCTAL CARCINOMA IN SITU (DCIS)" target="MULTISPECIALTY PRACTICES" />
    <edge source="BREAST-CONSERVING SURGERY (BCS)" target="RADIATION THERAPY (RT)" />
    <edge source="30-YEAR MCC" target="RISK STRATIFICATIONS" />
    <edge source="ACUTE RESPIRATORY FAILURE" target="RED BLOOD CELL DISTRIBUTION WIDTH TO ALBUMIN RATIO" />
    <edge source="AGENTS" target="MODEL" />
    <edge source="MODEL" target="PURPOSE" />
    <edge source="MODEL" target="COGNITIVE LINGUISTICS" />
    <edge source="DILATED CARDIOMYOPATHY" target="AFRICAN ANCESTRY" />
    <edge source="DILATED CARDIOMYOPATHY" target="EUROPEAN ANCESTRY" />
    <edge source="DILATED CARDIOMYOPATHY" target="NATIVE AMERICAN ANCESTRY" />
    <edge source="DILATED CARDIOMYOPATHY" target="TTN" />
    <edge source="DILATED CARDIOMYOPATHY" target="NON-HISPANIC BLACK" />
    <edge source="DILATED CARDIOMYOPATHY" target="NON-HISPANIC WHITE" />
    <edge source="AFRICAN ANCESTRY" target="TTN" />
    <edge source="EUROPEAN ANCESTRY" target="TTN" />
    <edge source="NORTH CYPRUS" target="NEU HOSPITAL" />
    <edge source="NEU HOSPITAL" target="INTERNAL MEDICINE DEPARTMENT" />
    <edge source="US COVID-19 TRENDS AND IMPACT SURVEY" target="AMERICAN COMMUNITY SURVEY" />
    <edge source="US COVID-19 TRENDS AND IMPACT SURVEY" target="COVID-19 VACCINATION" />
    <edge source="US COVID-19 TRENDS AND IMPACT SURVEY" target="POPULATION HEALTH MEASUREMENT" />
    <edge source="AMERICAN COMMUNITY SURVEY" target="POPULATION HEALTH MEASUREMENT" />
    <edge source="AMERICAN COMMUNITY SURVEY" target="NATIONAL DEATH INDEX" />
    <edge source="AMERICAN COMMUNITY SURVEY" target="COHORT STUDY" />
    <edge source="AMERICAN COMMUNITY SURVEY" target="US CENSUS" />
    <edge source="COVID-19 VACCINATION" target="EMERGENCY USE AUTHORIZATION" />
    <edge source="HEALTHCARE SYSTEM" target="LLMS" />
    <edge source="MEMORIAL SLOAN KETTERING-INTEGRATED MUTATION PROFILING OF ACTIONABLE CANCER TARGETS" target="MEMORIAL SLOAN KETTERING" />
    <edge source="MEMORIAL SLOAN KETTERING" target="YALE" />
    <edge source="MEMORIAL SLOAN KETTERING" target="METASTATIC UVEAL MELANOMA" />
    <edge source="PROSTATE, LUNG, COLORECTAL AND OVARIAN CANCER SCREENING TRIAL" target="NATIONAL LUNG SCREENING TRIAL" />
    <edge source="PROSTATE, LUNG, COLORECTAL AND OVARIAN CANCER SCREENING TRIAL" target="COX MODELS" />
    <edge source="NATIONAL LUNG SCREENING TRIAL" target="COX MODELS" />
    <edge source="NATIONAL LUNG SCREENING TRIAL" target="LDCT SCREENING" />
    <edge source="UROLOGY PRACTICES" target="RADIATION VAULTS" />
    <edge source="PITOBRUTINIB" target="BRUTON TYROSINE KINASE INHIBITOR" />
    <edge source="IDELALISIB" target="PHOSPHOINOSITIDE 3'-KINASE INHIBITOR" />
    <edge source="DUVELISIB" target="PHOSPHOINOSITIDE 3'-KINASE INHIBITOR" />
    <edge source="COMA RECOVERY SCALE-REVISED" target="IRELAND" />
    <edge source="MUSIC THERAPY ASSESSMENT TOOL FOR AWARENESS IN DISORDERS OF CONSCIOUSNESS" target="IRELAND" />
    <edge source="ZHONGSHAN HOSPITAL" target="CKD PREDICTION INTERPRETATION FRAMEWORK" />
    <edge source="ZHONGSHAN HOSPITAL" target="CHRONIC KIDNEY DISEASE (CKD)" />
    <edge source="CKD PREDICTION INTERPRETATION FRAMEWORK" target="ENSEMBLE MODEL" />
    <edge source="CKD PREDICTION INTERPRETATION FRAMEWORK" target="CHRONIC KIDNEY DISEASE (CKD)" />
    <edge source="CKD PREDICTION INTERPRETATION FRAMEWORK" target="MACHINE LEARNING CLASSIFIERS" />
    <edge source="CHRONIC KIDNEY DISEASE (CKD)" target="IMMUNE CHECKPOINT INHIBITORS (ICIS)" />
    <edge source="CHRONIC KIDNEY DISEASE (CKD)" target="IMMUNE-RELATED ADVERSE EVENTS (IRAES)" />
    <edge source="ENSEMBLE MODEL" target="LINEAR MODEL LOGISTIC REGRESSION (LR)" />
    <edge source="MACHINE LEARNING CLASSIFIERS" target="SEMI-SUPERVISED AUTOENCODERS" />
    <edge source="MACHINE LEARNING CLASSIFIERS" target="UNSUPERVISED AUTOENCODERS" />
    <edge source="SJ&#214;GREN&#8217;S DISEASE" target="INDIANA NETWORK FOR PATIENT CARE" />
    <edge source="SJ&#214;GREN&#8217;S DISEASE" target="INDIANA UNIVERSITY SCHOOL OF DENTISTRY" />
    <edge source="SJ&#214;GREN&#8217;S DISEASE" target="ELECTRONIC DENTAL RECORD" />
    <edge source="GASTRIC CANCER" target="AYATOLLAH TALLEGHANI HOSPITAL" />
    <edge source="GASTRIC CANCER" target="TUMOR STAGE" />
    <edge source="GASTRIC CANCER" target="HISTORY OF OTHER CANCERS" />
    <edge source="GASTRIC CANCER" target="LYMPHATIC INVASION" />
    <edge source="GASTRIC CANCER" target="TUMOR SITE" />
    <edge source="GASTRIC CANCER" target="TYPE OF TREATMENT" />
    <edge source="GASTRIC CANCER" target="BODY WEIGHT" />
    <edge source="GASTRIC CANCER" target="HISTOLOGICAL TYPE" />
    <edge source="GASTRIC CANCER" target="ADDICTION" />
    <edge source="GASTRIC CANCER" target="GRADIENT BOOSTING MACHINE" />
    <edge source="AYATOLLAH TALLEGHANI HOSPITAL" target="ABADAN" />
    <edge source="TUMOR-BASED NEXT-GENERATION SEQUENCING" target="OVARIAN CANCER" />
    <edge source="TUMOR-BASED NEXT-GENERATION SEQUENCING" target="HIGH-GRADE EPITHELIAL OVARIAN CARCINOMA" />
    <edge source="OVARIAN CANCER" target="AKT2" />
    <edge source="OVARIAN CANCER" target="TEMPORAL ANALYSIS" />
    <edge source="OVARIAN CANCER" target="GRAPH NEURAL NETWORKS" />
    <edge source="USPSTF" target="NATIONAL LUNG CANCER ROUNDTABLE" />
    <edge source="MEDICAL TREATMENT REIMBURSEMENT DECISIONS" target="BEHAVIORAL EXPERIMENT" />
    <edge source="MEDICAL TREATMENT REIMBURSEMENT DECISIONS" target="BEDSIDE LEVEL" />
    <edge source="MEDICAL TREATMENT REIMBURSEMENT DECISIONS" target="POLICY LEVEL" />
    <edge source="BEDSIDE LEVEL" target="POLICY LEVEL" />
    <edge source="BEDSIDE LEVEL" target="WITHDRAWING TREATMENT" />
    <edge source="BEDSIDE LEVEL" target="WITHHOLDING TREATMENT" />
    <edge source="POLICY LEVEL" target="WITHDRAWING TREATMENT" />
    <edge source="POLICY LEVEL" target="WITHHOLDING TREATMENT" />
    <edge source="WITHDRAWING TREATMENT" target="WITHHOLDING TREATMENT" />
    <edge source="CHILDREN'S ONCOLOGY GROUP" target="PEDIATRIC HEALTH INFORMATION SYSTEM" />
    <edge source="CHILDREN'S ONCOLOGY GROUP" target="PHASE 2/3 AND PHASE 3 TRIALS" />
    <edge source="CHILDREN'S ONCOLOGY GROUP" target="ADOLESCENT AND YOUNG ADULT PATIENTS" />
    <edge source="CHILDREN'S ONCOLOGY GROUP" target="NON-HISPANIC BLACKS" />
    <edge source="CHILDREN'S ONCOLOGY GROUP" target="NON-HISPANIC WHITES" />
    <edge source="CHILDREN'S ONCOLOGY GROUP" target="GERM CELL TUMOR TRIALS" />
    <edge source="CHILDREN'S ONCOLOGY GROUP" target="ZIP CODES WITH MEDIAN HOUSEHOLD INCOME &#8804;150% OF FEDERAL POVERTY LINE" />
    <edge source="CHILDREN'S ONCOLOGY GROUP" target="PEDIATRIC CLINICAL TRIALS" />
    <edge source="CHILDREN'S ONCOLOGY GROUP" target="ORBITAL RHABDOMYOSARCOMA" />
    <edge source="CHILDREN'S ONCOLOGY GROUP" target="LOW-RISK ORMS" />
    <edge source="CHILDREN'S ONCOLOGY GROUP" target="NON-LOW-RISK ORMS" />
    <edge source="CHILDREN'S ONCOLOGY GROUP" target="RECURRENT ORMS" />
    <edge source="US CENSUS BUREAU" target="SOCIAL DISORGANIZATION INDEX" />
    <edge source="SOCIAL DISORGANIZATION INDEX" target="SEPTIC SHOCK" />
    <edge source="SEPTIC SHOCK" target="SEPTIC SHOCK-ASSOCIATED DEATH" />
    <edge source="CVD RISK FACTORS" target="SEX DIFFERENCES" />
    <edge source="CVD RISK FACTORS" target="PRINCIPAL COMPONENT ANALYSIS" />
    <edge source="CVD RISK FACTORS" target="LATENT CLASS ANALYSIS" />
    <edge source="THIRD AFFILIATED HOSPITAL OF ANHUI MEDICAL UNIVERSITY" target="MGA-XGBOOST" />
    <edge source="THIRD AFFILIATED HOSPITAL OF ANHUI MEDICAL UNIVERSITY" target="COLORECTAL CANCER SURGERY" />
    <edge source="THIRD AFFILIATED HOSPITAL OF ANHUI MEDICAL UNIVERSITY" target="LINEAR REGRESSION" />
    <edge source="THIRD AFFILIATED HOSPITAL OF ANHUI MEDICAL UNIVERSITY" target="BP NEURAL NETWORK" />
    <edge source="MGA-XGBOOST" target="POSTOPERATIVE INFECTIOUS COMPLICATIONS" />
    <edge source="LINEAR REGRESSION" target="METAMODELS" />
    <edge source="FEMALE SURVIVORS" target="CRANIAL RADIATION THERAPY" />
    <edge source="FEMALE SURVIVORS" target="PELVIC RADIATION THERAPY" />
    <edge source="FEMALE SURVIVORS" target="ALKYLATOR EXPOSURE" />
    <edge source="ITALIAN COHORT STUDY" target="TUMOR MITOTIC RATE (TMR)" />
    <edge source="TUMOR MITOTIC RATE (TMR)" target="SENTINEL LYMPH-NODE BIOPSY" />
    <edge source="ACTIV-6" target="IVERMECTIN" />
    <edge source="ACTIV-6" target="PLACEBO" />
    <edge source="EVIDENCE-BASED PRACTICE" target="BEHAVIOUR CHANGE INTERVENTIONS" />
    <edge source="PAJO MODEL" target="BERT MODEL" />
    <edge source="PAJO MODEL" target="NECK PAIN" />
    <edge source="METAMODELS" target="QUALITY-ADJUSTED LIFE-YEARS" />
    <edge source="METAMODELS" target="INCREMENTAL COST-EFFECTIVENESS RATIO" />
    <edge source="METAMODELS" target="COST-EFFECTIVENESS ANALYSIS CURVE" />
    <edge source="METAMODELS" target="EXPECTED VALUE OF PERFECT INFORMATION" />
    <edge source="METAMODELS" target="ROOT MEAN SQUARED ERROR" />
    <edge source="METAMODELS" target="PEARSON&#8217;S R2" />
    <edge source="QUALITY-ADJUSTED LIFE-YEARS" target="GESTATIONAL DIABETES MELLITUS SCREENING" />
    <edge source="CAUSAL GRAPH LEARNING" target="META-LEARNING" />
    <edge source="CAUSAL GRAPH LEARNING" target="CLINICAL DECISION SUPPORT SYSTEMS" />
    <edge source="CAUSAL GRAPH LEARNING" target="STRUCTURAL HAMMING DISTANCE" />
    <edge source="CAUSAL GRAPH LEARNING" target="FALSE DISCOVERY RATE" />
    <edge source="META-LEARNING" target="BIOMEDICINE" />
    <edge source="CANADIAN TASK FORCE ON PREVENTIVE HEALTH CARE" target="ELECTRONIC CIGARETTES" />
    <edge source="HNC COMMUNICATION PLATFORM" target="HNC TREATMENT JOURNEY MAP" />
    <edge source="HNC COMMUNICATION PLATFORM" target="CANCER SURVIVOR STORIES" />
    <edge source="HNC COMMUNICATION PLATFORM" target="OPERATION CONSENT REDESIGN" />
    <edge source="HNC COMMUNICATION PLATFORM" target="NON-VERBAL COMMUNICATION TOOLKIT" />
    <edge source="HNC COMMUNICATION PLATFORM" target="DOCTOR-PATIENT RELATIONSHIP" />
    <edge source="HNC COMMUNICATION PLATFORM" target="ELECTRONIC HEALTH RECORD SYSTEM" />
    <edge source="HNC COMMUNICATION PLATFORM" target="SERVICE BLUEPRINT" />
    <edge source="DOCTOR-PATIENT RELATIONSHIP" target="CANCER CARE" />
    <edge source="CANCER SCREENING PROGRAM IN URBAN CHINA" target="BREAST CANCER RISK-PREDICTION MODEL" />
    <edge source="BREAST CANCER RISK-PREDICTION MODEL" target="WEB-BASED CALCULATOR" />
    <edge source="BREAST CANCER RISK-PREDICTION MODEL" target="URBAN CHINA" />
    <edge source="RESPONDENT-DRIVEN SAMPLING" target="WEBRDS" />
    <edge source="WEBRDS" target="YEMEN" />
    <edge source="WEBRDS" target="ODK" />
    <edge source="WEBRDS" target="YEMENI DIASPORA" />
    <edge source="WEBRDS" target="WHATSAPP" />
    <edge source="WEBRDS" target="SMS" />
    <edge source="WEBRDS" target="SURVEY UPTAKE" />
    <edge source="WEBRDS" target="LANGUAGE SUPPORT" />
    <edge source="WEBRDS" target="SURVEY LINKS" />
    <edge source="LOW-GRADE SEROUS OVARIAN CANCER" target="KRAS" />
    <edge source="LOW-GRADE SEROUS OVARIAN CANCER" target="MEK INHIBITORS" />
    <edge source="LOW-GRADE SEROUS OVARIAN CANCER" target="BRAF KINASE INHIBITORS" />
    <edge source="LOW-GRADE SEROUS OVARIAN CANCER" target="CDK 4/6 INHIBITORS" />
    <edge source="HEALTH RESEARCH" target="GOODREPORTS.ORG" />
    <edge source="CANADIAN TRIAGE AND ACUITY SCALE" target="MACHINE LEARNING ALGORITHM" />
    <edge source="MACHINE LEARNING ALGORITHM" target="GRADIENT BOOSTING REGRESSOR" />
    <edge source="MACHINE LEARNING ALGORITHM" target="VIRTUAL URGENT CARE" />
    <edge source="MACHINE LEARNING ALGORITHM" target="HIGH ACUITY" />
    <edge source="MACHINE LEARNING ALGORITHM" target="LOW ACUITY" />
    <edge source="MACHINE LEARNING ALGORITHM" target="ARTIFICIAL INTELLIGENCE TECHNOLOGY" />
    <edge source="MACHINE LEARNING ALGORITHM" target="ARTIFICIAL INTELLIGENCE MODEL" />
    <edge source="GEISINGER MYCODE COMMUNITY HEALTH INITIATIVE" target="VENOUS THROMBOEMBOLISM (VTE)" />
    <edge source="GEISINGER MYCODE COMMUNITY HEALTH INITIATIVE" target="UBA1" />
    <edge source="GEISINGER MYCODE COMMUNITY HEALTH INITIATIVE" target="GEISINGER" />
    <edge source="GEISINGER MYCODE COMMUNITY HEALTH INITIATIVE" target="EXOME SEQUENCING" />
    <edge source="VENOUS THROMBOEMBOLISM (VTE)" target="SEX CHROMOSOME ANEUPLOIDY" />
    <edge source="GOVERNMENTS" target="SOCIAL SCIENCE DISCIPLINES" />
    <edge source="GOVERNMENTS" target="COMMUNICATION STRATEGY" />
    <edge source="GOVERNMENTS" target="INFECTIOUS DISEASE SCIENTISTS" />
    <edge source="GOVERNMENTS" target="NOVEL CORONAVIRUS" />
    <edge source="GOVERNMENTS" target="DIAGNOSIS UNDERREPORTING STUDY" />
    <edge source="INFECTIOUS DISEASE MODELS" target="SOCIAL DETERMINANTS OF HEALTH" />
    <edge source="INFECTIOUS DISEASE MODELS" target="COMMUNITY TRANSMISSION" />
    <edge source="INFECTIOUS DISEASE MODELS" target="HOUSEHOLD TRANSMISSION" />
    <edge source="INFECTIOUS DISEASE MODELS" target="MC-SEIRSV MODEL" />
    <edge source="EPIDEMIOLOGISTS" target="LEGAL EPIDEMIOLOGY" />
    <edge source="INDIVIDUALIZED TREATMENT EFFECTS" target="HEALTH TECHNOLOGY ASSESSMENT" />
    <edge source="HEALTH TECHNOLOGY ASSESSMENT" target="OBSERVATIONAL DATA" />
    <edge source="HEALTH TECHNOLOGY ASSESSMENT" target="PHYSICIAN PREFERENCE ITEMS" />
    <edge source="HEALTH TECHNOLOGY ASSESSMENT" target="HTA EXPERTS" />
    <edge source="HEALTH TECHNOLOGY ASSESSMENT" target="BARRIERS" />
    <edge source="HEALTH TECHNOLOGY ASSESSMENT" target="FACILITATORS" />
    <edge source="HEALTH TECHNOLOGY ASSESSMENT" target="VALUE-OF-INFORMATION (VOI) APPROACH" />
    <edge source="HEALTH TECHNOLOGY ASSESSMENT" target="REFERENCE STANDARD RETROSPECTIVE VOI ANALYSIS" />
    <edge source="HEALTH TECHNOLOGY ASSESSMENT" target="DECISION-ANALYTIC MODELS" />
    <edge source="HEALTH TECHNOLOGY ASSESSMENT" target="GUIDELINES" />
    <edge source="OBSERVATIONAL DATA" target="DIAGNOSTIC ERROR" />
    <edge source="GLP-1 RECEPTOR AGONISTS" target="GOOGLE PATENTS" />
    <edge source="GLP-1 RECEPTOR AGONISTS" target="FDA APPROVAL" />
    <edge source="PITUITARY ADENOMAS" target="MACROADENOMAS" />
    <edge source="PITUITARY ADENOMAS" target="MICROADENOMAS" />
    <edge source="PITUITARY ADENOMAS" target="PROLACTINOMAS" />
    <edge source="PITUITARY ADENOMAS" target="SOMATOTROPINOMAS" />
    <edge source="PITUITARY ADENOMAS" target="CORTICOTROPINOMAS" />
    <edge source="PITUITARY ADENOMAS" target="TRANSSPHENOIDAL PITUITARY SURGERY" />
    <edge source="PROLACTINOMAS" target="BROMOCRIPTINE" />
    <edge source="PROLACTINOMAS" target="CABERGOLINE" />
    <edge source="ICI GASTRITIS" target="ICI ENTERITIS" />
    <edge source="ICI GASTRITIS" target="ICI COLITIS" />
    <edge source="ICI GASTRITIS" target="GASTRIC BIOPSIES" />
    <edge source="ICI GASTRITIS" target="GLUCOCORTICOIDS" />
    <edge source="MATTHEW H. NITECKI" target="ANTONI HOFFMAN" />
    <edge source="ANTONI HOFFMAN" target="DAVID M. RAUP" />
    <edge source="NLP-DRIVEN CDSS" target="NORWEGIAN HOSPITAL" />
    <edge source="NLP-DRIVEN CDSS" target="THE UNIFIED THEORY OF ACCEPTANCE AND USE OF TECHNOLOGY (UTAUT)" />
    <edge source="OSTEOARTHRITIS" target="MENISCAL TEARS" />
    <edge source="OSTEOARTHRITIS" target="KNEE JOINT REPLACEMENT" />
    <edge source="MENISCAL TEARS" target="MCMURRAY TEST" />
    <edge source="MENISCAL TEARS" target="CONSERVATIVE MANAGEMENT" />
    <edge source="PATELLOFEMORAL PAIN" target="MCMURRAY TEST" />
    <edge source="PATELLOFEMORAL PAIN" target="HIP AND KNEE STRENGTHENING EXERCISES" />
    <edge source="PATELLOFEMORAL PAIN" target="FOOT ORTHOSES" />
    <edge source="PATELLOFEMORAL PAIN" target="PATELLAR TAPING" />
    <edge source="EXERCISE THERAPY" target="KNEE OA" />
    <edge source="KNEE OA" target="WEIGHT LOSS" />
    <edge source="KNEE OA" target="EDUCATION AND SELF-MANAGEMENT PROGRAMS" />
    <edge source="KNEE OA" target="SURGICAL REFERRAL" />
    <edge source="AL-ZAHRA HOSPITAL" target="ISFAHAN" />
    <edge source="AL-ZAHRA HOSPITAL" target="SCENARIO 19" />
    <edge source="AL-ZAHRA HOSPITAL" target="SCENARIO 34" />
    <edge source="HEALTHCARE INDUSTRY" target="DATA ANALYTIC (DA)" />
    <edge source="HEALTHCARE INDUSTRY" target="DATA SCIENTISTS" />
    <edge source="HEALTHCARE INDUSTRY" target="MEDICAL PROVIDERS" />
    <edge source="DATA ANALYTIC (DA)" target="FUZZY ANALYTIC HIERARCHY PROCESS (FUZZY AHP)" />
    <edge source="DATA ANALYTIC (DA)" target="FUZZY TECHNIQUES FOR ORDER PREFERENCE BY SIMILARITY TO IDEAL SOLUTION (FUZZY TOPSIS)" />
    <edge source="CIRRHOSIS" target="WITHING'S BIOIMPEDANCE SCALE" />
    <edge source="CIRRHOSIS" target="CLIF-CONSORTIUM ACUTE DECOMPENSATION (CLIF-C AD) SCORES" />
    <edge source="CIRRHOSIS" target="CLINICAL FRAILTY SCORE (CFS)" />
    <edge source="CIRRHOSIS" target="IMMUNE CHECKPOINT INHIBITORS (ICIS)" />
    <edge source="WITHING'S BIOIMPEDANCE SCALE" target="REMOTE MONITORING" />
    <edge source="REMOTE MONITORING" target="DECOMPENSATED CIRRHOSIS" />
    <edge source="DECOMPENSATED CIRRHOSIS" target="NUTRITIONAL STATUS" />
    <edge source="AMERICAN CANCER SOCIETY CANCER ACTION NETWORK" target="2019 SUMMIT" />
    <edge source="ETHIOPIAN NATIONAL KIDNEY TRANSPLANTATION CENTER" target="ETHIOPIA" />
    <edge source="ETHIOPIAN NATIONAL KIDNEY TRANSPLANTATION CENTER" target="KIDNEY TRANSPLANT" />
    <edge source="ETHIOPIA" target="NORTH SHEWA ZONE" />
    <edge source="ETHIOPIA" target="ETHIOPIAN MINISTRY OF HEALTH" />
    <edge source="ETHIOPIA" target="CARDIAC SURGERY STUDY" />
    <edge source="ETHIOPIA" target="SUB-SAHARAN REGION" />
    <edge source="ETHIOPIA" target="ELECTRONIC COMMUNITY HEALTH INFORMATION SYSTEM" />
    <edge source="ETHIOPIA" target="TIGRAY" />
    <edge source="KIDNEY TRANSPLANT" target="GRAFT FAILURE" />
    <edge source="KIDNEY TRANSPLANT" target="CMV DISEASE" />
    <edge source="TREE-BASED ENSEMBLE LEARNING" target="BAGGED TREE" />
    <edge source="STACKING ENSEMBLE LEARNING" target="STOCHASTIC GRADIENT BOOSTING" />
    <edge source="PANCREATICOBILIARY CANCER" target="LIQUID BIOPSY" />
    <edge source="PANCREATICOBILIARY CANCER" target="ERBB2" />
    <edge source="PANCREATICOBILIARY CANCER" target="ATM" />
    <edge source="PANCREATICOBILIARY CANCER" target="NF1" />
    <edge source="PANCREATICOBILIARY CANCER" target="PIK3CA" />
    <edge source="PANCREATICOBILIARY CANCER" target="IDH1" />
    <edge source="PANCREATICOBILIARY CANCER" target="BILE" />
    <edge source="PANCREATICOBILIARY CANCER" target="PLASMA" />
    <edge source="BILE" target="PLASMA" />
    <edge source="WEST CHINA HOSPITAL" target="SICHUAN UNIVERSITY" />
    <edge source="WEST CHINA HOSPITAL" target="INTERNET OF MEDICAL THINGS (IOMT)" />
    <edge source="SICHUAN UNIVERSITY" target="INTERNET OF MEDICAL THINGS (IOMT)" />
    <edge source="INTERNET OF MEDICAL THINGS (IOMT)" target="COMPUTED TOMOGRAPHY (CT) EQUIPMENT" />
    <edge source="ANOMALIES" target="MEDICAL EQUIPMENT" />
    <edge source="ANOMALIES" target="MAINTENANCE" />
    <edge source="MEDICAL EQUIPMENT" target="MAINTENANCE" />
    <edge source="ADVANCED MACHINE LEARNING MODELS" target="INTERPRETABLE MACHINE LEARNING TOOLS" />
    <edge source="ADVANCED MACHINE LEARNING MODELS" target="MEDICAL DECISION MAKING" />
    <edge source="INTERPRETABLE MACHINE LEARNING TOOLS" target="INTERPRETABILITY" />
    <edge source="HOSPITAL READMISSION PREDICTION" target="TWO-STEP EXTRACTED REGRESSION TREE APPROACH" />
    <edge source="TWO-STEP EXTRACTED REGRESSION TREE APPROACH" target="NEURAL NETWORKS" />
    <edge source="TWO-STEP EXTRACTED REGRESSION TREE APPROACH" target="LARGE TEACHING HOSPITAL IN ASIA" />
    <edge source="TWO-STEP EXTRACTED REGRESSION TREE APPROACH" target="PREDICTION ACCURACY" />
    <edge source="TWO-STEP EXTRACTED REGRESSION TREE APPROACH" target="RISK FACTORS" />
    <edge source="DEBORAH MAYO" target="ERROR-STATISTICAL APPROACH" />
    <edge source="CHILDHOOD CANCER" target="CRANIAL IRRADIATION" />
    <edge source="CHILDHOOD CANCER" target="ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT" />
    <edge source="CHILDHOOD CANCER" target="ENDOCRINE DISORDERS" />
    <edge source="CHILDHOOD CANCER" target="SUBSEQUENT NEOPLASMS" />
    <edge source="CHILDHOOD CANCER" target="PRECISION MEDICINE FOR CHILDREN WITH CANCER (PRISM)" />
    <edge source="CHILDHOOD CANCER" target="PANCARESURFUP" />
    <edge source="CHINESE CHILDREN'S CANCER GROUP" target="ALL-2015 PROTOCOL" />
    <edge source="CHINESE CHILDREN'S CANCER GROUP" target="TCF3::PBX1" />
    <edge source="PD-(L)1 INHIBITORS" target="TP53 VARIANT ALLELE FREQUENCY" />
    <edge source="PD-(L)1 INHIBITORS" target="PD-1/PD-L1 IMMUNE CHECKPOINT" />
    <edge source="TP53 VARIANT ALLELE FREQUENCY" target="LOCAL COHORT" />
    <edge source="TP53 VARIANT ALLELE FREQUENCY" target="DISCOVERY COHORT" />
    <edge source="TP53 VARIANT ALLELE FREQUENCY" target="VALIDATION COHORT" />
    <edge source="DISCOVERY COHORT" target="NANOSTRING PANEL" />
    <edge source="DISCOVERY COHORT" target="PROTEOMICS" />
    <edge source="DISCOVERY COHORT" target="VALIDATION COHORT" />
    <edge source="VALIDATION COHORT" target="IMMUNOHISTOCHEMISTRY (IHC)" />
    <edge source="STOCHASTIC GRADIENT DESCENT" target="EXPERIMENT 1" />
    <edge source="STOCHASTIC GRADIENT DESCENT" target="EXPERIMENT 3" />
    <edge source="EXPERIMENT 1" target="CATBOOST ALGORITHM" />
    <edge source="EXPERIMENT 1" target="SELLA AREA" />
    <edge source="EXPERIMENT 3" target="CATBOOST ALGORITHM" />
    <edge source="EXPERIMENT 3" target="SELLA AREA" />
    <edge source="EXPERIMENT 2" target="CATBOOST ALGORITHM" />
    <edge source="EXPERIMENT 2" target="SELLA HEIGHT POSTERIOR" />
    <edge source="CORONARY ARTERY DISEASE" target="IRAN-PREMATURE CORONARY ARTERY DISEASE STUDY" />
    <edge source="CORONARY ARTERY DISEASE" target="CORONARY ANGIOGRAPHY" />
    <edge source="IRAN-PREMATURE CORONARY ARTERY DISEASE STUDY" target="RAZI HOSPITAL" />
    <edge source="RAZI HOSPITAL" target="BIRJAND" />
    <edge source="RAPID SCOPING REVIEW" target="LITERATURE SEARCH" />
    <edge source="LITERATURE SEARCH" target="GREY LITERATURE SEARCH" />
    <edge source="EXTENSIVE-STAGE SMALL CELL LUNG CANCER" target="ANTIPROGRAMMED DEATH LIGAND 1 THERAPY" />
    <edge source="BRAIN METASTASES" target="ANTIPROGRAMMED DEATH LIGAND 1 THERAPY" />
    <edge source="LOCAL TEXT REUSE DETECTION" target="PLAGIARISM DETECTION" />
    <edge source="LOCAL TEXT REUSE DETECTION" target="JOURNALISTS' USE OF PRESS RELEASES" />
    <edge source="LOCAL TEXT REUSE DETECTION" target="SCIENTISTS' CITATION OF EARLIER PAPERS" />
    <edge source="LOCAL TEXT REUSE DETECTION" target="CITATION LOCALIZATION DATASET" />
    <edge source="PHILADELPHIA-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA" target="CRLF2" />
    <edge source="PHILADELPHIA-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA" target="JAK2" />
    <edge source="PHILADELPHIA-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA" target="PHI-RACE CLASSIFIER" />
    <edge source="PHILADELPHIA-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA" target="DEVELOPING COUNTRIES" />
    <edge source="PHILADELPHIA-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA" target="PHILADELPHIA" />
    <edge source="CRLF2" target="PHILADELPHIA CHROMOSOME (PH)-LIKE B-ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)" />
    <edge source="ANAPLASTIC LYMPHOMA KINASE (ALK)-MUTATED NON-SMALL CELL LUNG CANCER (NSCLC)" target="LORLATINIB" />
    <edge source="ANAPLASTIC LYMPHOMA KINASE (ALK)-MUTATED NON-SMALL CELL LUNG CANCER (NSCLC)" target="ALECTINIB" />
    <edge source="ANAPLASTIC LYMPHOMA KINASE (ALK)-MUTATED NON-SMALL CELL LUNG CANCER (NSCLC)" target="ENSARTINIB" />
    <edge source="ANAPLASTIC LYMPHOMA KINASE (ALK)-MUTATED NON-SMALL CELL LUNG CANCER (NSCLC)" target="BRIGATINIB" />
    <edge source="ANAPLASTIC LYMPHOMA KINASE (ALK)-MUTATED NON-SMALL CELL LUNG CANCER (NSCLC)" target="CRIZOTINIB" />
    <edge source="ANAPLASTIC LYMPHOMA KINASE (ALK)-MUTATED NON-SMALL CELL LUNG CANCER (NSCLC)" target="CERITINIB" />
    <edge source="ANAPLASTIC LYMPHOMA KINASE (ALK)-MUTATED NON-SMALL CELL LUNG CANCER (NSCLC)" target="PEMETREXED-BASED CHEMOTHERAPY" />
    <edge source="ANAPLASTIC LYMPHOMA KINASE (ALK)-MUTATED NON-SMALL CELL LUNG CANCER (NSCLC)" target="INTERNATIONAL CONFERENCES" />
    <edge source="CAPTURE" target="US PRIMARY CARE" />
    <edge source="CAPTURE" target="COPD" />
    <edge source="COPD" target="GENETIC EPIDEMIOLOGY OF COPD COHORT" />
    <edge source="COPD" target="AIRWAY MUCUS PLUGS" />
    <edge source="COPD" target="SPIROMICS I" />
    <edge source="COPD" target="SPIROMICS II" />
    <edge source="COPD" target="SYMPTOMATIC TEPS" />
    <edge source="COPD" target="ASYMPTOMATIC TEPS" />
    <edge source="CHRONIC OBSTRUCTIVE PULMONARY DISEASE" target="ADLIFE" />
    <edge source="ACUTE RESPIRATORY INFECTIONS" target="ELECTRONIC HEALTH RECORD-INTEGRATED CPR" />
    <edge source="ELECTRONIC HEALTH RECORD-INTEGRATED CPR" target="CLINICAL PREDICTION RULES" />
    <edge source="ELECTRONIC HEALTH RECORD-INTEGRATED CPR" target="REGISTERED NURSE" />
    <edge source="PRIMARY CARE SETTINGS" target="CHILD ABUSE AND NEGLECT" />
    <edge source="NUDGES" target="PRESCRIBING DECISIONS" />
    <edge source="NUDGES" target="PUBLICATION BIAS" />
    <edge source="NUDGES" target="COST-EFFECTIVENESS" />
    <edge source="NUDGES" target="HEALTH AND SOCIAL SCIENCE DATABASES" />
    <edge source="NUDGES" target="OPIOID PRESCRIBING" />
    <edge source="NUDGES" target="ANTIBIOTIC PRESCRIBING" />
    <edge source="ANTIBIOTIC PRESCRIBING" target="RESIDENTIAL AGED-CARE FACILITIES" />
    <edge source="AMERICAN COLLEGE OF RADIOLOGY" target="BI-RADS" />
    <edge source="BI-RADS" target="TECSALUD HOSPITALS MONTERREY" />
    <edge source="TECSALUD HOSPITALS MONTERREY" target="BREAST RADIOLOGY DEPARTMENT" />
    <edge source="TECSALUD HOSPITALS MONTERREY" target="GOOGLE TRANSLATE" />
    <edge source="TECSALUD HOSPITALS MONTERREY" target="MONTERREY" />
    <edge source="BIOGPT" target="BERT" />
    <edge source="BERT" target="MEDICAL IMAGE PROTOCOL ASSIGNMENT" />
    <edge source="BERT" target="RADIOLIST" />
    <edge source="UBIQUITIN-PROTEASOME SYSTEM" target="UBIQUITINATION" />
    <edge source="UBIQUITIN-PROTEASOME SYSTEM" target="P53" />
    <edge source="UBIQUITIN-PROTEASOME SYSTEM" target="PHOSPHATASE AND TENSIN HOMOLOG (PTEN)" />
    <edge source="UBIQUITIN-PROTEASOME SYSTEM" target="MYC PROTEIN" />
    <edge source="LARGE LANGUAGE MODEL" target="OPENAI GPT-3.5" />
    <edge source="LARGE LANGUAGE MODEL" target="REPORTING GUIDELINE COMPLIANCE" />
    <edge source="OPENAI GPT-3.5" target="SPORTS MEDICINE CLINICAL TRIAL REPORTS" />
    <edge source="DIABETIC PERIPHERAL NEUROPATHY" target="DIABETIC FOOT ULCERS" />
    <edge source="DIABETIC PERIPHERAL NEUROPATHY" target="MACHINE LEARNING PREDICTIVE MODELS" />
    <edge source="DIABETIC PERIPHERAL NEUROPATHY" target="URINARY ALBUMIN-TO-CREATININE RATIO" />
    <edge source="DIABETIC PERIPHERAL NEUROPATHY" target="GLYCOSYLATED HEMOGLOBIN" />
    <edge source="DIABETIC PERIPHERAL NEUROPATHY" target="SERUM CREATININE" />
    <edge source="DIABETIC PERIPHERAL NEUROPATHY" target="CAROTID STENOSIS" />
    <edge source="DIABETIC PERIPHERAL NEUROPATHY" target="DECREASED SERUM ALBUMIN" />
    <edge source="DIABETIC PERIPHERAL NEUROPATHY" target="LOWER LYMPHOCYTE COUNT" />
    <edge source="DIABETIC FOOT ULCERS" target="LOWER EXTREMITY ARTERIAL DISEASE" />
    <edge source="MACHINE LEARNING PREDICTIVE MODELS" target="LOWER EXTREMITY ARTERIAL DISEASE" />
    <edge source="MACHINE LEARNING PREDICTIVE MODELS" target="PARTICLE SWARM OPTIMIZATION" />
    <edge source="URINARY ALBUMIN-TO-CREATININE RATIO" target="LOWER EXTREMITY ARTERIAL DISEASE" />
    <edge source="GLYCOSYLATED HEMOGLOBIN" target="LOWER EXTREMITY ARTERIAL DISEASE" />
    <edge source="SERUM CREATININE" target="LOWER EXTREMITY ARTERIAL DISEASE" />
    <edge source="CAROTID STENOSIS" target="LOWER EXTREMITY ARTERIAL DISEASE" />
    <edge source="LOWER EXTREMITY ARTERIAL DISEASE" target="ELEVATED NEUTROPHIL-TO-LYMPHOCYTE RATIO" />
    <edge source="LOWER EXTREMITY ARTERIAL DISEASE" target="HIGHER D-DIMER LEVELS" />
    <edge source="SIMULATION MODELLING" target="ENVIRONMENTAL CHALLENGES" />
    <edge source="SIMULATION MODELLING" target="SCIENTIFIC MODELLING COMMUNITIES" />
    <edge source="SIMULATION MODELLING" target="PARTICIPATORY MODELLING APPROACHES" />
    <edge source="SLEEP DURATION" target="MEN" />
    <edge source="DANISH HOSPITALS" target="ICD-10" />
    <edge source="SHAP" target="C-REACTIVE PROTEIN" />
    <edge source="SHAP" target="ESTIMATED GLOMERULAR FILTRATION" />
    <edge source="SHAP" target="EXTREME GRADIENT BOOSTING-SHAPLEY ADDITIVE EXPLANATIONS" />
    <edge source="THROMBOTIC DISEASES" target="ATHEROSCLEROTIC DISEASES" />
    <edge source="AUROC" target="CLINICAL PREDICTION MODELS" />
    <edge source="R-CHOP" target="DLBCL" />
    <edge source="DLBCL" target="CREB1" />
    <edge source="DLBCL" target="N4BP1" />
    <edge source="DLBCL" target="UBAP2" />
    <edge source="DLBCL" target="DEAF1" />
    <edge source="DLBCL" target="INTERNATIONAL PROGNOSTIC INDEX" />
    <edge source="DLBCL" target="HIGH-DENSITY ANTIGEN MICROARRAY" />
    <edge source="CREB1" target="N4BP1" />
    <edge source="SPLC-RAT" target="MAYO CLINIC" />
    <edge source="SPLC-RAT" target="NATIONAL COMPREHENSIVE CANCER NETWORK" />
    <edge source="SPLC-RAT" target="SECOND PRIMARY LUNG CANCER (SPLC)" />
    <edge source="SPLC-RAT" target="SPLC-RAT DEVELOPMENT COHORT" />
    <edge source="MAYO CLINIC" target="ROCHESTER, MINNESOTA" />
    <edge source="MAYO CLINIC" target="HFPEF" />
    <edge source="MAYO CLINIC" target="CDSS" />
    <edge source="MAYO CLINIC" target="VANCOMYCIN DOSING STUDY" />
    <edge source="MAYO CLINIC" target="ROCHESTER, MN" />
    <edge source="CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER (CKD-MBD)" target="MACHINE LEARNING PREDICTION METHODS" />
    <edge source="CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER (CKD-MBD)" target="SEQUENTIAL FORWARD FEATURE SELECTION" />
    <edge source="CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER (CKD-MBD)" target="CALCIUM ABNORMALITY" />
    <edge source="CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER (CKD-MBD)" target="PHOSPHORUS ABNORMALITY" />
    <edge source="CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER (CKD-MBD)" target="PTH ABNORMALITY" />
    <edge source="RABBIT ANTITHYMOCYTE GLOBULIN (ATG)" target="GRAFT-VERSUS-HOST DISEASE (GVHD)" />
    <edge source="RABBIT ANTITHYMOCYTE GLOBULIN (ATG)" target="HEMATOPOIETIC CELL TRANSPLANTATION" />
    <edge source="GRAFT-VERSUS-HOST DISEASE (GVHD)" target="POSTTRANSPLANT CYCLOPHOSPHAMIDE (PTCY)" />
    <edge source="HEMATOPOIETIC CELL TRANSPLANTATION" target="POSTTRANSPLANT CYCLOPHOSPHAMIDE (PTCY)" />
    <edge source="HEMATOPOIETIC CELL TRANSPLANTATION" target="MATCHED UNRELATED DONORS" />
    <edge source="WANG" target="ANTIBIOTIC OVERPRESCRIPTION" />
    <edge source="ANTIBIOTIC OVERPRESCRIPTION" target="DOCTOR-PATIENT INTERACTIONS" />
    <edge source="ANTIBIOTIC OVERPRESCRIPTION" target="HEALTH COMMUNICATION" />
    <edge source="ANTIBIOTIC OVERPRESCRIPTION" target="NON-PRESCRIBED ANTIBIOTICS USE" />
    <edge source="MIMIC-IV DATABASE" target="GOOGLE BIGQUERY" />
    <edge source="HEALTH SYSTEMS" target="INTERNAL REVENUE SERVICE" />
    <edge source="HEALTH SYSTEMS" target="2018 COMMERCIAL CLAIMS DATA" />
    <edge source="HEALTH SYSTEMS" target="HOSPITALS" />
    <edge source="IMMUNE CHECKPOINT INHIBITOR" target="MERKEL CELL CARCINOMA" />
    <edge source="IMMUNE CHECKPOINT INHIBITOR" target="PLATINUM-ETOPOSIDE" />
    <edge source="RECURRENCE-FREE SURVIVAL" target="BRCA1/2 MUTATIONS" />
    <edge source="THEORETICAL DOMAINS FRAMEWORK (TDF)" target="ACUTE LOW BACK PAIN MANAGEMENT" />
    <edge source="THEORETICAL DOMAINS FRAMEWORK (TDF)" target="PRIMARY CARE" />
    <edge source="THEORETICAL DOMAINS FRAMEWORK (TDF)" target="IMPLEMENTATION RESEARCH" />
    <edge source="THEORETICAL DOMAINS FRAMEWORK (TDF)" target="INTERVENTION DEVELOPMENT" />
    <edge source="ACUTE LOW BACK PAIN MANAGEMENT" target="SMALL GROUP WORKSHOPS" />
    <edge source="PRIMARY CARE" target="INTERVENTION DEVELOPMENT" />
    <edge source="PRIMARY CARE" target="GENERALIZED ANXIETY DISORDER (GAD)" />
    <edge source="OCULAR FUNDUS DISEASES" target="GLOBAL AGING" />
    <edge source="DIAGNOSTIC INTELLIGENT DECISION SUPPORT PLATFORM" target="JUNIOR DOCTORS" />
    <edge source="DIAGNOSTIC INTELLIGENT DECISION SUPPORT PLATFORM" target="EXPERIENCED DOCTORS" />
    <edge source="JUNIOR DOCTORS" target="EXPERIENCED DOCTORS" />
    <edge source="MULTIDISCIPLINARY SPANISH DIGESTIVE CANCER GROUP" target="CYP2D6" />
    <edge source="MULTIDISCIPLINARY SPANISH DIGESTIVE CANCER GROUP" target="GEMCAD COHORT" />
    <edge source="CYP2D6" target="ANAL SQUAMOUS CELL CARCINOMA" />
    <edge source="CYP2D6" target="DISEASE-FREE SURVIVAL" />
    <edge source="ANAL SQUAMOUS CELL CARCINOMA" target="5-FLUOROURACIL" />
    <edge source="ANAL SQUAMOUS CELL CARCINOMA" target="MITOMYCIN C" />
    <edge source="MIGRAINE" target="ADVANCED RWE" />
    <edge source="LIVING SYSTEMATIC REVIEWS" target="JOURNAL PUBLISHERS" />
    <edge source="LIVING SYSTEMATIC REVIEWS" target="HEALTHCARE POLICY" />
    <edge source="LIVING SYSTEMATIC REVIEWS" target="LIVING REVIEWS" />
    <edge source="COCHRANE REVIEW" target="OPEN SCIENCE FRAMEWORK" />
    <edge source="COCHRANE REVIEW" target="PAXLOVID" />
    <edge source="NIRMATRELVIR" target="RITONAVIR" />
    <edge source="RH IMMUNOGLOBULIN" target="FIRST-TRIMESTER ABORTION" />
    <edge source="RH IMMUNOGLOBULIN" target="RH SENSITIZATION" />
    <edge source="FIRST-TRIMESTER ABORTION" target="GESTATION" />
    <edge source="FIRST-TRIMESTER ABORTION" target="ABORTION CARE" />
    <edge source="FIRST-TRIMESTER ABORTION" target="MEDICATION ABORTION" />
    <edge source="FIRST-TRIMESTER ABORTION" target="PROCEDURAL ABORTION" />
    <edge source="HIGH-THROUGHPUT FLOW CYTOMETRY" target="MULTICENTER OBSERVATIONAL PROSPECTIVE COHORT STUDY" />
    <edge source="HIGH-DOSE CHEMOTHERAPY" target="GERM CELL TUMORS" />
    <edge source="HIGH-DOSE CHEMOTHERAPY" target="AMERICAN SPEECH-LANGUAGE-HEARING ASSOCIATION" />
    <edge source="WEB OF KNOWLEDGE" target="DATA QUALITY IN HEALTH INFORMATION SYSTEMS" />
    <edge source="DATA QUALITY IN HEALTH INFORMATION SYSTEMS" target="SCIENCE DIRECT" />
    <edge source="DATA QUALITY IN HEALTH INFORMATION SYSTEMS" target="EMERALD" />
    <edge source="DATA QUALITY IN HEALTH INFORMATION SYSTEMS" target="CONSISTENCY" />
    <edge source="DATA QUALITY IN HEALTH INFORMATION SYSTEMS" target="SECURITY" />
    <edge source="DATA QUALITY IN HEALTH INFORMATION SYSTEMS" target="TIMELINESS" />
    <edge source="DATA QUALITY IN HEALTH INFORMATION SYSTEMS" target="COMPLETENESS" />
    <edge source="DATA QUALITY IN HEALTH INFORMATION SYSTEMS" target="RELIABILITY" />
    <edge source="DATA QUALITY IN HEALTH INFORMATION SYSTEMS" target="ACCESSIBILITY" />
    <edge source="DATA QUALITY IN HEALTH INFORMATION SYSTEMS" target="OBJECTIVITY" />
    <edge source="DATA QUALITY IN HEALTH INFORMATION SYSTEMS" target="RELEVANCY" />
    <edge source="DATA QUALITY IN HEALTH INFORMATION SYSTEMS" target="UNDERSTANDABILITY" />
    <edge source="DATA QUALITY IN HEALTH INFORMATION SYSTEMS" target="NAVIGATION" />
    <edge source="DATA QUALITY IN HEALTH INFORMATION SYSTEMS" target="REPUTATION" />
    <edge source="DATA QUALITY IN HEALTH INFORMATION SYSTEMS" target="EFFICIENCY" />
    <edge source="DATA QUALITY IN HEALTH INFORMATION SYSTEMS" target="VALUE-ADDED" />
    <edge source="ACE-R" target="CHC MODEL" />
    <edge source="FUZZY EXPERT SYSTEM" target="EDDIE" />
    <edge source="EDDIE" target="TECHNOLOGY AGENCY OF THE CZECH REPUBLIC" />
    <edge source="MAURICIO SUAREZ" target="INTRODUCTION" />
    <edge source="ARTHUR FINE" target="THE NATURE OF FICTIONS IN SCIENCE" />
    <edge source="THE NATURE OF FICTIONS IN SCIENCE" target="JOSEPH ROUSE" />
    <edge source="THE NATURE OF FICTIONS IN SCIENCE" target="ANOUK BARBEROUSSE" />
    <edge source="THE NATURE OF FICTIONS IN SCIENCE" target="PASCAL LUDWIG" />
    <edge source="ANOUK BARBEROUSSE" target="PASCAL LUDWIG" />
    <edge source="CATHERINE ELGIN" target="THE EXPLANATORY POWER OF FICTIONS" />
    <edge source="THE EXPLANATORY POWER OF FICTIONS" target="ALISA BOKULICH" />
    <edge source="THE EXPLANATORY POWER OF FICTIONS" target="MARGARET MORRISON" />
    <edge source="CARSTEN HELD" target="FICTIONS IN THE PHYSICAL SCIENCES" />
    <edge source="FICTIONS IN THE PHYSICAL SCIENCES" target="ERIC WINSBERG" />
    <edge source="RACHEL ANKENY" target="FICTIONS IN THE SPECIAL SCIENCES" />
    <edge source="FICTIONS IN THE SPECIAL SCIENCES" target="TARJA KNUUTTILA" />
    <edge source="PAUL TELLER" target="FICTIONS AND REALISM" />
    <edge source="FICTIONS AND REALISM" target="RONALD N. GIERE" />
    <edge source="MINIMAL RESIDUAL DISEASE" target="NEXT-GENERATION FLOW CYTOMETRY" />
    <edge source="MINIMAL RESIDUAL DISEASE" target="MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS" />
    <edge source="INFORMAL CAREGIVERS" target="CHILDREN WITH BURN INJURIES" />
    <edge source="INFORMAL CAREGIVERS" target="E-HEALTH LITERACY" />
    <edge source="INFORMAL CAREGIVERS" target="MOBILE PHONE USAGE" />
    <edge source="INFORMAL CAREGIVERS" target="HEALTH CARE NEEDS" />
    <edge source="INFORMAL CAREGIVERS" target="ELECTRONIC HEALTH LITERACY" />
    <edge source="INFORMAL CAREGIVERS" target="MOBILE HEALTH (MHEALTH) INTERVENTIONS" />
    <edge source="INFORMAL CAREGIVERS" target="SDMMCC INTERVENTION" />
    <edge source="INFORMAL CAREGIVERS" target="OLDER ADULTS WITH MULTIPLE CHRONIC CONDITIONS" />
    <edge source="E-HEALTH LITERACY" target="MOBILE PHONE USAGE" />
    <edge source="MOBILE PHONE USAGE" target="MOBILE HEALTH (MHEALTH) INTERVENTIONS" />
    <edge source="ACUTE MYOCARDITIS" target="INFLUENZA" />
    <edge source="ACUTE MYOCARDITIS" target="CORONAVIRUS" />
    <edge source="ACUTE MYOCARDITIS" target="SYSTEMIC LUPUS ERYTHEMATOSUS" />
    <edge source="ACUTE MYOCARDITIS" target="SMALLPOX VACCINE" />
    <edge source="ACUTE MYOCARDITIS" target="MRNA COVID-19 VACCINES" />
    <edge source="ACUTE MYOCARDITIS" target="MYOCARDIUM" />
    <edge source="ACUTE MYOCARDITIS" target="TROPONINS" />
    <edge source="ACUTE MYOCARDITIS" target="ELECTROCARDIOGRAPHIC ST SEGMENTS" />
    <edge source="ACUTE MYOCARDITIS" target="ECHOCARDIOGRAPHIC WALL MOTION ABNORMALITIES" />
    <edge source="ACUTE MYOCARDITIS" target="CARDIAC MAGNETIC RESONANCE IMAGING" />
    <edge source="ACUTE MYOCARDITIS" target="ENDOMYOCARDIAL BIOPSY" />
    <edge source="ACUTE MYOCARDITIS" target="EXTRACORPOREAL LIFE SUPPORT" />
    <edge source="SYSTEMIC LUPUS ERYTHEMATOSUS" target="CD19-TARGETING CAR T CELLS" />
    <edge source="GUIDELINES INTERNATIONAL NETWORK" target="G-I-N PERFORMANCE MEASURES WORKING GROUP" />
    <edge source="SAMSUNG MEDICAL CENTER" target="DEEP LEARNING-BASED NLP" />
    <edge source="DEEP LEARNING-BASED NLP" target="BIOBERT" />
    <edge source="DEEP LEARNING-BASED NLP" target="BIDIRECTIONAL LSTM WITH CONDITIONAL RANDOM FIELDS" />
    <edge source="BIOBERT" target="TRANSFORMER MODEL" />
    <edge source="BIOBERT" target="BIOMEDICAL DOMAIN" />
    <edge source="BIOBERT" target="MEDICAL IMAGE PROTOCOL ASSIGNMENT" />
    <edge source="BIOBERT" target="RADIOLIST" />
    <edge source="GENERALIZED JOINT HYPER-MOBILITY" target="EHLERS-DANLOS SYNDROME" />
    <edge source="HYBRIDPOSENET" target="MOBILENET-V2" />
    <edge source="HYBRIDPOSENET" target="HYPERLSTM" />
    <edge source="ASCVD" target="ML-BASED ANN MODEL" />
    <edge source="ASCVD" target="ELECTROCARDIOGRAPH" />
    <edge source="ASCVD" target="ECHOCARDIOGRAPHY" />
    <edge source="ML-BASED ANN MODEL" target="PCE" />
    <edge source="ML-BASED ANN MODEL" target="CHINA-PAR" />
    <edge source="ACTIVITY COACH" target="NCT05235763" />
    <edge source="PHYSICAL INACTIVITY" target="SEDENTARY LIFESTYLE" />
    <edge source="GENOMIC TESTING" target="EARLY-STAGE BREAST CANCER" />
    <edge source="EARLY-STAGE BREAST CANCER" target="CHEMOENDOCRINE THERAPY" />
    <edge source="MEDICATION DELIVERY SYSTEM" target="MINISTRY OF HEALTH" />
    <edge source="MEDICATION DELIVERY SYSTEM" target="ELECTRONIC HEALTH SOLUTIONS" />
    <edge source="MEDICATION DELIVERY SYSTEM" target="MY HAKEEM APP" />
    <edge source="MINISTRY OF HEALTH" target="ELECTRONIC HEALTH SOLUTIONS" />
    <edge source="MINISTRY OF HEALTH" target="E-PRESCRIBING" />
    <edge source="MINISTRY OF HEALTH" target="TECHNICAL INFRASTRUCTURE" />
    <edge source="MINISTRY OF HEALTH" target="DENGUE" />
    <edge source="GEMINI" target="FLESCH READING EASE SCORE (FRES)" />
    <edge source="GEMINI" target="MODIFIED DISCERN SCALE" />
    <edge source="GEMINI" target="GLOBAL QUALITY SCALE (GQS)" />
    <edge source="MODIFIED DISCERN SCALE" target="COPILOT" />
    <edge source="GLOBAL QUALITY SCALE (GQS)" target="COPILOT" />
    <edge source="OUTPATIENT SERVICE" target="CPLEX" />
    <edge source="OUTPATIENT SERVICE" target="SENIOR DOCTORS" />
    <edge source="OUTPATIENT SERVICE" target="ASSOCIATE SENIOR DOCTORS" />
    <edge source="HYPERLIPIDEMIA" target="AYA CANCER SURVIVORS" />
    <edge source="INGUINAL HERNIA" target="INTESTINAL NECROSIS" />
    <edge source="INTESTINAL NECROSIS" target="BOWEL RESECTION SURGERY" />
    <edge source="LASSO REGRESSION MODEL" target="NOMOGRAM GRAPH" />
    <edge source="EQ-VT DESIGN" target="RMSE" />
    <edge source="EQ-VT DESIGN" target="MAE" />
    <edge source="VISUAL ELECTROPHYSIOLOGY" target="FLASH VISUAL EVOKED POTENTIAL" />
    <edge source="VISUAL ELECTROPHYSIOLOGY" target="ARTIFICIAL INTELLIGENCE ALGORITHM" />
    <edge source="MCAC-NET" target="RETINITIS PIGMENTOSA" />
    <edge source="MCAC-NET" target="FVEP DATASET" />
    <edge source="EASTERN COOPERATIVE GROUP" target="ES-SCLC" />
    <edge source="ES-SCLC" target="MAYO CLINIC HEALTH SYSTEM" />
    <edge source="ES-SCLC" target="PHASE 3 CLINICAL TRIALS" />
    <edge source="PATIENT-DETECTED BREAST CANCER" target="MAMMOGRAPHY-DETECTED BREAST CANCER" />
    <edge source="PATIENT-DETECTED BREAST CANCER" target="INSTITUTIONAL COHORT" />
    <edge source="MAMMOGRAPHY-DETECTED BREAST CANCER" target="INSTITUTIONAL COHORT" />
    <edge source="INSTITUTIONAL COHORT" target="PHYSICIAN-DETECTED BREAST CANCER" />
    <edge source="INSTITUTIONAL COHORT" target="1990-2019" />
    <edge source="CHINESE GOVERNMENT" target="ZERO-COVID POLICY" />
    <edge source="CHINESE GOVERNMENT" target="BORDER REOPENING" />
    <edge source="FLAN-PALM" target="PATHWAYS LANGUAGE MODEL" />
    <edge source="PATHWAYS LANGUAGE MODEL" target="MED-PALM" />
    <edge source="PATHWAYS LANGUAGE MODEL" target="INSTRUCTION PROMPT TUNING" />
    <edge source="MED-PALM" target="INSTRUCTION PROMPT TUNING" />
    <edge source="EORTC 26951 TRIAL" target="RTOG 9402 TRIAL" />
    <edge source="JUMPING DIAGNOSTIC ODDS RATIO SEQUENTIAL PATTERNS (JDORSP)" target="HEALTH-CARE DOMAIN" />
    <edge source="JUMPING DIAGNOSTIC ODDS RATIO SEQUENTIAL PATTERNS (JDORSP)" target="MEDICAL EXPERTS" />
    <edge source="HEALTH-CARE DOMAIN" target="PATTERN MINING TECHNIQUES" />
    <edge source="HEALTH-CARE DOMAIN" target="CLINICAL EVALUATION" />
    <edge source="CLINICAL EVALUATION" target="MULTIVARIATE SEQUENTIAL PATTERNS" />
    <edge source="TEMPORAL DIMENSION" target="MULTIVARIATE SEQUENTIAL PATTERNS" />
    <edge source="SYMPTOM CHECKER APPLICATIONS" target="HYPOCHONDRIA" />
    <edge source="SYMPTOM CHECKER APPLICATIONS" target="SELF-EFFICACY" />
    <edge source="SYMPTOM CHECKER APPLICATIONS" target="GERMAN CLINICAL TRIALS REGISTER" />
    <edge source="PREDICTIVE MODELING" target="MEDICINE" />
    <edge source="PREDICTIVE MODELING" target="HEALTHCARE SETTINGS" />
    <edge source="ULTRA-ORTHODOX COMMUNITY" target="WEB-BASED DECISION AID" />
    <edge source="WEB-BASED DECISION AID" target="MUSLIM-ARABS" />
    <edge source="WEB-BASED DECISION AID" target="HEBREW-SPEAKING PARENTS" />
    <edge source="WEB-BASED DECISION AID" target="YOUNG ADULTS" />
    <edge source="WEB-BASED DECISION AID" target="JEWISH ULTRA-ORTHODOX COMMUNITY" />
    <edge source="CENTRAL BRAIN TUMOR REGISTRY OF THE UNITED STATES" target="CENTER FOR DISEASE CONTROL AND PREVENTION" />
    <edge source="CENTER FOR DISEASE CONTROL AND PREVENTION" target="NATIONAL PROGRAM OF CANCER REGISTRIES" />
    <edge source="CENTER FOR DISEASE CONTROL AND PREVENTION" target="UNITED STATES CANCER STATISTICS" />
    <edge source="REGIONAL HEALTH AUTHORITIES" target="EPIDEMIC PROCESS" />
    <edge source="HY-PER TRIAL" target="FRENCH HOSPITALS" />
    <edge source="HY-PER TRIAL" target="NCT02201732" />
    <edge source="HY-PER TRIAL" target="VACUUM ASPIRATION" />
    <edge source="HY-PER TRIAL" target="HYSTEROSCOPY" />
    <edge source="3-D MODELS" target="WOODEN SHIPS" />
    <edge source="3-D MODELS" target="PLASTIC MOLECULES" />
    <edge source="3-D MODELS" target="WAX BODIES" />
    <edge source="3-D MODELS" target="PERSPEX ECONOMY" />
    <edge source="3-D MODELS" target="CORK MONUMENTS" />
    <edge source="3-D MODELS" target="PLASTER MATHEMATICS" />
    <edge source="3-D MODELS" target="CASTS OF DISEASES" />
    <edge source="3-D MODELS" target="HABITAT DIORAMAS" />
    <edge source="3-D MODELS" target="EXTINCT MONSTERS" />
    <edge source="META-ANALYSES" target="RESEARCH SCREENER" />
    <edge source="ACUTE PROMYELOCYTIC LEUKEMIA" target="RESNET-18" />
    <edge source="RESNET-18" target="INTERNATIONAL SOCIETY OF LABORATORY HEMATOLOGY" />
    <edge source="RESNET-18" target="RESOLSTM-DEPTH" />
    <edge source="TUFTS HEALTH SCIENCES INSTITUTIONAL REVIEW BOARD" target="STUDY 1644" />
    <edge source="STUDY 1644" target="TUFTS MEDICINE HEALTHCARE SYSTEM" />
    <edge source="TUFTS MEDICINE HEALTHCARE SYSTEM" target="TUFTS MEDICINE SENIOR VICE PRESIDENT OF ACADEMIC INTEGRATION" />
    <edge source="TUFTS MEDICINE HEALTHCARE SYSTEM" target="HOSPITAL EMPLOYEES" />
    <edge source="INDEX SYSTEM" target="DISEASE RISK PREDICTION" />
    <edge source="DELPHI METHOD" target="ANALYTIC HIERARCHY PROCESS" />
    <edge source="ANALYTIC HIERARCHY PROCESS" target="SENSITIVITY OUTCOME INDEX SYSTEM" />
    <edge source="BRCA1/2 MUTATIONS" target="HER2/NEU-POSITIVE BC" />
    <edge source="BRCA1/2 MUTATIONS" target="CLINICOPATHOLOGIC FEATURES" />
    <edge source="BRCA1/2 MUTATIONS" target="SURVIVAL RATES" />
    <edge source="HER2/NEU-POSITIVE BC" target="GERMLINE BRCA MUTATIONS" />
    <edge source="CLINICOPATHOLOGIC FEATURES" target="UNIVARIATE AND MULTIVARIABLE COX PROPORTIONAL HAZARDS REGRESSION MODELS" />
    <edge source="CLASSICAL PARTICLE MECHANICS" target="COLLISION MECHANICS" />
    <edge source="CLASSICAL PARTICLE MECHANICS" target="RELATIVISTIC COLLISION MECHANICS" />
    <edge source="CLASSICAL PARTICLE MECHANICS" target="LAGRANGIAN MECHANICS" />
    <edge source="COLLISION MECHANICS" target="RELATIVISTIC COLLISION MECHANICS" />
    <edge source="DALTONIAN STOICHIOMETRY" target="SIMPLE EQUILIBRIUM THERMODYNAMICS" />
    <edge source="SIMPLE EQUILIBRIUM THERMODYNAMICS" target="PURE EXCHANGE ECONOMICS" />
    <edge source="LUDWIG WITTGENSTEIN" target="PHILOSOPHICAL INVESTIGATIONS" />
    <edge source="PHILOSOPHICAL INVESTIGATIONS" target="GERMAN-ENGLISH VERSION" />
    <edge source="PHILOSOPHICAL INVESTIGATIONS" target="ANSCOMBE" />
    <edge source="PHILOSOPHICAL INVESTIGATIONS" target="PHILOSOPHY OF PSYCHOLOGY - A FRAGMENT" />
    <edge source="PHILOSOPHICAL INVESTIGATIONS" target="FOURTH EDITION" />
    <edge source="PHILOSOPHICAL INVESTIGATIONS" target="ENGLISH TRANSLATION" />
    <edge source="PHILOSOPHICAL INVESTIGATIONS" target="EDITORIAL ENDNOTES" />
    <edge source="TRANS AND GENDER-NONCONFORMING PATIENTS" target="PROVIDER INCLUSIVITY SIGNALING" />
    <edge source="TRANS AND GENDER-NONCONFORMING PATIENTS" target="HEALTH DISPARITIES" />
    <edge source="PROVIDER INCLUSIVITY SIGNALING" target="INCLUSIVITY IN HEALTH CARE" />
    <edge source="INCLUSIVITY IN HEALTH CARE" target="PATIENT-PROVIDER INTERACTIONS" />
    <edge source="INCLUSIVITY IN HEALTH CARE" target="BACKLASH" />
    <edge source="NEPHROLOGY MEDICAL TEAM" target="SOUTHERN TAIWAN" />
    <edge source="EBV(-)M-PTLD" target="PEDIATRIC MATURE B-NHL-SPECIFIC REGIMEN" />
    <edge source="EBV(-)M-PTLD" target="LOW-DOSE CYCLOPHOSPHAMIDE, PREDNISONE, AND RITUXIMAB" />
    <edge source="EUROPEAN HEALTH DATA SPACE" target="ELECTRONIC MEDICAL RECORD SYSTEM" />
    <edge source="ELECTRONIC MEDICAL RECORD SYSTEM" target="SURGICAL DEPARTMENTS" />
    <edge source="ELECTRONIC MEDICAL RECORD SYSTEM" target="DATA QUALITY" />
    <edge source="ELECTRONIC MEDICAL RECORD SYSTEM" target="IMPLEMENTATION PROCESS" />
    <edge source="DATA QUALITY" target="IMPLEMENTATION PROCESS" />
    <edge source="DATA QUALITY" target="MEDICAL AI" />
    <edge source="NORTH SHEWA ZONE" target="DISTRICT HEALTH OFFICE" />
    <edge source="DISTRICT HEALTH OFFICE" target="DATA-INFORMED PLATFORM FOR HEALTH" />
    <edge source="DATA-INFORMED PLATFORM FOR HEALTH" target="PERFORMANCE MONITORING TEAM" />
    <edge source="CATBOOST ALGORITHM" target="EXPERIMENT 4" />
    <edge source="EXPERIMENT 4" target="SELLA HEIGHT MEDIAN" />
    <edge source="CHRONIC MYELOMONOCYTIC LEUKEMIA" target="CLADRIBINE" />
    <edge source="CHRONIC MYELOMONOCYTIC LEUKEMIA" target="LOW-DOSE CYTARABINE" />
    <edge source="CHRONIC MYELOMONOCYTIC LEUKEMIA" target="HYPOMETHYLATING AGENTS" />
    <edge source="CHRONIC MYELOMONOCYTIC LEUKEMIA" target="INTERNATIONAL WORKING GROUP" />
    <edge source="CHRONIC MYELOMONOCYTIC LEUKEMIA" target="RETROSPECTIVE CHART REVIEW" />
    <edge source="HYPOMETHYLATING AGENTS" target="PD-1 INHIBITION" />
    <edge source="GULU CITY" target="FAMILY PLANNING SELF-CARE INTERVENTIONS" />
    <edge source="FAMILY PLANNING SELF-CARE INTERVENTIONS" target="MOBILE PHONES" />
    <edge source="FAMILY PLANNING SELF-CARE INTERVENTIONS" target="NORTHERN UGANDA" />
    <edge source="FAMILY PLANNING SELF-CARE INTERVENTIONS" target="SPSS SOFTWARE" />
    <edge source="MOBILE PHONES" target="HEALTHCARE PRACTITIONERS" />
    <edge source="MOBILE PHONES" target="HEALTH DEVELOPMENT PARTNERS" />
    <edge source="HEALTHCARE PRACTITIONERS" target="REHAB-AMD" />
    <edge source="CARE PARTNERS" target="FEBRUARY 2022" />
    <edge source="TRANSFORMER MODEL" target="MEDBERT" />
    <edge source="TRANSFORMER MODEL" target="MASSGENIE" />
    <edge source="MEDBERT" target="BIOMEDICAL DOMAIN" />
    <edge source="MASSGENIE" target="BIOMEDICAL DOMAIN" />
    <edge source="BIOMEDICAL DOMAIN" target="RDF" />
    <edge source="NATIONAL DEATH INDEX" target="COHORT STUDY" />
    <edge source="NATIONAL DEATH INDEX" target="VETERANS HEALTH ADMINISTRATION" />
    <edge source="NATIONAL DEATH INDEX" target="CANCER MORTALITY STUDY" />
    <edge source="COHORT STUDY" target="SUICIDE RISK" />
    <edge source="COHORT STUDY" target="ACUTE SINUSITIS" />
    <edge source="COHORT STUDY" target="PROPENSITY SCORE MATCHING" />
    <edge source="US HEALTH CARE WORKERS" target="REGISTERED NURSES" />
    <edge source="US HEALTH CARE WORKERS" target="HEALTH TECHNICIANS" />
    <edge source="US HEALTH CARE WORKERS" target="HEALTH CARE SUPPORT WORKERS" />
    <edge source="US HEALTH CARE WORKERS" target="SOCIAL/BEHAVIORAL HEALTH WORKERS" />
    <edge source="US HEALTH CARE WORKERS" target="NON-HEALTH CARE WORKERS" />
    <edge source="US HEALTH CARE WORKERS" target="SUICIDE RISK" />
    <edge source="NON-HEALTH CARE WORKERS" target="SUICIDE RISK" />
    <edge source="IMPACT NCD GERMANY" target="PRIMETIME" />
    <edge source="CORONARY HEART DISEASE" target="CHD POLICY MODELS" />
    <edge source="CORONARY HEART DISEASE" target="SIMULATION STUDIES" />
    <edge source="JAK INHIBITOR RUXOLITINIB" target="CANCER CENTER" />
    <edge source="AACTT FRAMEWORK" target="TACT FRAMEWORK" />
    <edge source="AACTT FRAMEWORK" target="FRENCH ET AL." />
    <edge source="IMPLEMENTATION INTERVENTIONS" target="HEALTH SYSTEM" />
    <edge source="PRECISION MEDICINE FOR CHILDREN WITH CANCER (PRISM)" target="PARENTS" />
    <edge source="PRECISION MEDICINE FOR CHILDREN WITH CANCER (PRISM)" target="ADOLESCENT PATIENTS" />
    <edge source="PARENTS" target="PISCF" />
    <edge source="PARENTS" target="PRECISION MEDICINE FOR CHILDREN WITH CANCER TRIAL" />
    <edge source="PARENTS" target="CLINICIAN" />
    <edge source="PARENTS" target="CHILDREN WITH ADVANCED CANCER" />
    <edge source="PARENTS" target="PROGNOSTIC DISCLOSURE" />
    <edge source="PARENTS" target="CLINICAL DECISION SUPPORT SYSTEM FOR YOUTH DEPRESSION (CDSS-YD)" />
    <edge source="PARENTS" target="ADOLESCENTS" />
    <edge source="PARENTS" target="BEHAVIORAL HEALTH PROVIDERS" />
    <edge source="ADOLESCENT PATIENTS" target="PISCF" />
    <edge source="DECISION AID" target="INTERNATIONAL PATIENT DECISION AID STANDARDS" />
    <edge source="DECISION AID" target="DECISIONAL CONFLICT SCALE" />
    <edge source="PERSONALIZED DIABETES RISK INFORMATION" target="RISK COMMUNICATION INTERVENTION" />
    <edge source="MOTIVATED REASONING" target="RISK SKEPTICISM" />
    <edge source="RISK SKEPTICISM" target="BAYESIAN UPDATING" />
    <edge source="RISK SKEPTICISM" target="PERSONAL RELEVANCE" />
    <edge source="SLEEP APNEA SYNDROME" target="POLYSOMNOGRAPHY" />
    <edge source="POLYSOMNOGRAPHY" target="MASSACHUSETTS GENERAL HOSPITAL" />
    <edge source="POLYSOMNOGRAPHY" target="OBSTRUCTIVE SLEEP APNEA" />
    <edge source="AUTOENCODER" target="ONE DIMENSIONAL CONVOLUTIONAL NEURAL NETWORK&#8212;LONG SHORT-TERM MEMORY (1D CNN-LSTM)" />
    <edge source="LONG-TERM SURVIVORS" target="FAECALIBACTERIUM PRAUSNITZII" />
    <edge source="LONG-TERM SURVIVORS" target="AKKERMANSIA MUCINIPHILA" />
    <edge source="LONG-TERM SURVIVORS" target="RUMINACOCCACEAE FAMILY" />
    <edge source="LONG-TERM SURVIVORS" target="ILLUMINA NEXTSEQ500" />
    <edge source="LONG-TERM SURVIVORS" target="PCA" />
    <edge source="LONG-TERM SURVIVORS" target="MICROBIOMESEQ" />
    <edge source="LONG-TERM SURVIVORS" target="PHYLOSEQ" />
    <edge source="ILLUMINA NEXTSEQ500" target="CONTROL PATIENTS" />
    <edge source="PCA" target="CONTROL PATIENTS" />
    <edge source="MICROBIOMESEQ" target="CONTROL PATIENTS" />
    <edge source="PHYLOSEQ" target="CONTROL PATIENTS" />
    <edge source="TP53-MUTATED ACUTE MYELOID LEUKEMIA" target="NON-HISPANIC WHITE PATIENTS" />
    <edge source="TP53-MUTATED ACUTE MYELOID LEUKEMIA" target="NON-HISPANIC BLACK PATIENTS" />
    <edge source="NON-HISPANIC WHITE PATIENTS" target="MULTICENTER RETROSPECTIVE STUDY" />
    <edge source="NON-HISPANIC WHITE PATIENTS" target="INTENSIVE CHEMOTHERAPY" />
    <edge source="NON-HISPANIC WHITE PATIENTS" target="ALLOGENEIC STEM CELL TRANSPLANTATION" />
    <edge source="NON-HISPANIC BLACK PATIENTS" target="MULTICENTER RETROSPECTIVE STUDY" />
    <edge source="NON-HISPANIC BLACK PATIENTS" target="LOW-INTENSITY CHEMOTHERAPY" />
    <edge source="NON-HISPANIC BLACK PATIENTS" target="BEST SUPPORTIVE CARE" />
    <edge source="EXPERIMENTAL ECONOMICS" target="PHILOSOPHER OF SCIENCE" />
    <edge source="PHILOSOPHER OF SCIENCE" target="INTEGRATIVE PLURALISM" />
    <edge source="HEMATOMA EXPANSION" target="SPONTANEOUS INTRACEREBRAL HEMORRHAGE" />
    <edge source="SPONTANEOUS INTRACEREBRAL HEMORRHAGE" target="CEREBRAL AMYLOID ANGIOPATHY" />
    <edge source="SPONTANEOUS INTRACEREBRAL HEMORRHAGE" target="RED BLOOD CELL TRANSFUSION" />
    <edge source="INTRAOPERATIVE BLOOD TRANSFUSION" target="INTRACRANIAL ANEURYSM SURGERY" />
    <edge source="INTRACRANIAL ANEURYSM SURGERY" target="JANUARY 2019 TO DECEMBER 2021" />
    <edge source="EE GAP" target="ROUTINE CLINICAL PRACTICE" />
    <edge source="TRAUMA CENTERS" target="EMS PRACTITIONERS" />
    <edge source="TRAUMA CENTERS" target="RURAL AREAS" />
    <edge source="TRAUMA CENTERS" target="TRIAGE" />
    <edge source="EMS PRACTITIONERS" target="TRIAGE" />
    <edge source="RURAL AREAS" target="HEALTH SYSTEM IN THE US" />
    <edge source="TRIAGE" target="PREGNANCY" />
    <edge source="PREGNANCY RISK ASSESSMENT MONITORING SYSTEM (PRAMS)" target="CARDIOVASCULAR HEALTH (CVH)" />
    <edge source="CARDIOVASCULAR HEALTH (CVH)" target="ADVERSE PREGNANCY OUTCOMES (APOS)" />
    <edge source="CARDIOVASCULAR HEALTH (CVH)" target="CARDIOVASCULAR DISEASE (CVD)" />
    <edge source="ADVERSE PREGNANCY OUTCOMES (APOS)" target="CARDIOVASCULAR DISEASE (CVD)" />
    <edge source="CARDIOVASCULAR DISEASE (CVD)" target="EUROQOL 5-DIMENSION (EQ-5D)" />
    <edge source="CARDIOVASCULAR DISEASE (CVD)" target="ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT (OECD)" />
    <edge source="CARDIOVASCULAR DISEASE (CVD)" target="PERIPHERAL ARTERIAL DISEASE" />
    <edge source="CARDIOVASCULAR DISEASE (CVD)" target="STABLE ANGINA" />
    <edge source="CARDIOVASCULAR DISEASE (CVD)" target="TRANSIENT ISCHEMIC ATTACK" />
    <edge source="CARDIOVASCULAR DISEASE (CVD)" target="UNSTABLE ANGINA" />
    <edge source="CONVOLUTIONAL NEURAL NETWORK" target="IQ-OTHNCCD" />
    <edge source="CONVOLUTIONAL NEURAL NETWORK" target="BIGRU" />
    <edge source="CONVOLUTIONAL NEURAL NETWORK" target="FEDERATED LEARNING" />
    <edge source="BIOMEDICAL RELATION EXTRACTION" target="SHORTEST DEPENDENCY PATHS" />
    <edge source="BIOMEDICAL RELATION EXTRACTION" target="RE CLASSIFIERS" />
    <edge source="SHORTEST DEPENDENCY PATHS" target="RE CLASSIFIERS" />
    <edge source="GESTATIONAL DIABETES MELLITUS SCREENING" target="UNIVERSAL SCREENING" />
    <edge source="GESTATIONAL DIABETES MELLITUS SCREENING" target="CURRENT GUIDELINES" />
    <edge source="GESTATIONAL DIABETES MELLITUS SCREENING" target="HIGH-RISK SCREENING" />
    <edge source="GESTATIONAL DIABETES MELLITUS SCREENING" target="NO SCREENING" />
    <edge source="GESTATIONAL DIABETES MELLITUS SCREENING" target="TYPE 2 DIABETES MELLITUS" />
    <edge source="GESTATIONAL DIABETES MELLITUS SCREENING" target="PERINATAL DEATH" />
    <edge source="TYPE 2 DIABETES MELLITUS" target="PREDIABETIC PATIENTS" />
    <edge source="TYPE 2 DIABETES MELLITUS" target="CUMULATIVE T2DM INCIDENCE" />
    <edge source="COST-EFFECTIVENESS PLANES" target="NET MONETARY BENEFIT LINES" />
    <edge source="NET MONETARY BENEFIT LINES" target="COST-EFFECTIVENESS ACCEPTABILITY CURVES" />
    <edge source="NET MONETARY BENEFIT LINES" target="EXPECTED LOSS CURVES" />
    <edge source="LATIN AMERICA AND THE CARIBBEAN" target="1990" />
    <edge source="1990" target="SUB-SAHARAN AFRICA" />
    <edge source="LATENT SEMANTIC INDEXING" target="ICD-9" />
    <edge source="GPT-4" target="AZURE" />
    <edge source="GPT-4" target="ICD-9" />
    <edge source="SOCIAL AND BEHAVIORAL DETERMINANTS OF HEALTH" target="MACHINE LEARNING APPROACHES" />
    <edge source="SIAP" target="SIAP-ALL" />
    <edge source="SIAP" target="ISR" />
    <edge source="SIAP" target="PYTHON 3.6" />
    <edge source="SIAP" target="TRADITIONAL CHINESE MEDICINE" />
    <edge source="SIAP" target="FORMULARY" />
    <edge source="SIAP-ALL" target="SIAP + ALL" />
    <edge source="SIAP-ALL" target="ISR" />
    <edge source="SIAP-ALL" target="PYTHON 3.6" />
    <edge source="ISR" target="SIAP + ALL" />
    <edge source="PYTHON 3.6" target="SIAP + ALL" />
    <edge source="NONINVASIVE PRENATAL TESTING" target="TRISOMY 21" />
    <edge source="NONINVASIVE PRENATAL TESTING" target="TREEAGE" />
    <edge source="PREDICTION MODELLING" target="PERITONITIS" />
    <edge source="PREDICTION MODELLING" target="DECISION CURVE ANALYSIS (DCA)" />
    <edge source="PERITONITIS" target="OPEN ABDOMEN TREATMENT" />
    <edge source="PERITONITIS" target="MORTALITY PREDICTION MODELS" />
    <edge source="MORTALITY PREDICTION MODELS" target="CALIBRATION BELTS" />
    <edge source="MORTALITY PREDICTION MODELS" target="RECEIVER OPERATING CHARACTERISTIC CURVE (AUROC)" />
    <edge source="MORTALITY PREDICTION MODELS" target="PRECISION RECALL CURVE (AUPRC)" />
    <edge source="MORTALITY PREDICTION MODELS" target="BRIER SCORE" />
    <edge source="LOGHMAN HAKIM HOSPITAL" target="HEMODIALYSIS STUDY" />
    <edge source="HEMODIALYSIS STUDY" target="HISTGRADIENT BOOSTING (HGB)" />
    <edge source="HEMODIALYSIS STUDY" target="K-NEAREST NEIGHBORS (KNN)" />
    <edge source="HEMODIALYSIS STUDY" target="ADAPTIVE BOOSTING (ADABOOST)" />
    <edge source="HEMODIALYSIS STUDY" target="MACHINE LEARNING PREDICTION MODEL" />
    <edge source="HEMODIALYSIS STUDY" target="POISONED PATIENTS" />
    <edge source="K-NEAREST NEIGHBORS (KNN)" target="SUPERVISED MACHINE LEARNING (ML)" />
    <edge source="MACHINE LEARNING PREDICTION MODEL" target="POISONED PATIENTS" />
    <edge source="SDMMCC INTERVENTION" target="GERIATRICIANS" />
    <edge source="SDMMCC INTERVENTION" target="OUTPATIENT GERIATRIC CLINICS" />
    <edge source="SDMMCC INTERVENTION" target="OPTIONMCC" />
    <edge source="SDMMCC INTERVENTION" target="OLDER ADULTS WITH MULTIPLE CHRONIC CONDITIONS" />
    <edge source="HUNGARY" target="RA HIP SURGERY" />
    <edge source="HUNGARY" target="AI-BASED MEDICAL IMAGE EVALUATION" />
    <edge source="RA HIP SURGERY" target="AI-BASED MEDICAL IMAGE EVALUATION" />
    <edge source="RA HIP SURGERY" target="EHEALS QUESTIONNAIRE" />
    <edge source="AI-BASED MEDICAL IMAGE EVALUATION" target="EHEALS QUESTIONNAIRE" />
    <edge source="12-LEAD ELECTROCARDIOGRAM (ECG)" target="DEEP-LEARNING ALGORITHM" />
    <edge source="DEEP-LEARNING ALGORITHM" target="BIDIRECTIONAL LONG SHORT-TERM MEMORY" />
    <edge source="CHILD ABUSE AND NEGLECT" target="U.S. ACADEMIC HEALTH CENTER" />
    <edge source="CHILD ABUSE AND NEGLECT" target="CHILD ABUSE EXPERTS" />
    <edge source="CHILD ABUSE AND NEGLECT" target="SOCIAL WORKERS" />
    <edge source="U.S. ACADEMIC HEALTH CENTER" target="PEDIATRIC PRIMARY CARE CLINICS" />
    <edge source="SCIENTIFIC DISCOURSE" target="AUTOMATIC CLASSIFIER" />
    <edge source="AUTOMATIC CLASSIFIER" target="CORPUS" />
    <edge source="ANTIMICROBIAL RESISTANCE" target="ARTIFICIAL INTELLIGENCE-BASED DECISION SUPPORT SYSTEMS" />
    <edge source="ANTIMICROBIAL RESISTANCE" target="ANTIMICROBIAL USE" />
    <edge source="ANTIMICROBIAL RESISTANCE" target="INFECTION CONTROL" />
    <edge source="ARTIFICIAL INTELLIGENCE-BASED DECISION SUPPORT SYSTEMS" target="HOSPITAL MANAGERS" />
    <edge source="ARTIFICIAL INTELLIGENCE-BASED DECISION SUPPORT SYSTEMS" target="HUMAN-ORGANIZATION-TECHNOLOGY-FIT MODEL" />
    <edge source="ARTIFICIAL INTELLIGENCE-BASED DECISION SUPPORT SYSTEMS" target="ANTIBIOTIC PRESCRIPTION" />
    <edge source="HOSPITAL MANAGERS" target="GERMAN HOSPITALS" />
    <edge source="GERMAN HOSPITALS" target="DECISION SUPPORT SYSTEM IMPLEMENTATION" />
    <edge source="IN-PERSON CLINIC VISITS" target="ADVANCE CARE PLANNING" />
    <edge source="IN-PERSON CLINIC VISITS" target="UNPLANNED HOSPITALIZATIONS" />
    <edge source="SURVSARC" target="AYA SARCOMA SURVIVORS" />
    <edge source="AYA SARCOMA SURVIVORS" target="ISF" />
    <edge source="SICKKIDS" target="STANFORDPEDS" />
    <edge source="SICKKIDS" target="STANFORDADULTS" />
    <edge source="SICKKIDS" target="DIAGNOSTIC CODES" />
    <edge source="SICKKIDS" target="CLINICAL PREDICTION MODELS" />
    <edge source="STANFORDPEDS" target="STANFORDADULTS" />
    <edge source="STANFORDPEDS" target="HYPERKALEMIA" />
    <edge source="STANFORDPEDS" target="NEUTROPENIA" />
    <edge source="STANFORDPEDS" target="DIAGNOSTIC CODES" />
    <edge source="STANFORDPEDS" target="CLINICAL PREDICTION MODELS" />
    <edge source="STANFORDADULTS" target="DIAGNOSTIC CODES" />
    <edge source="STANFORDADULTS" target="CLINICAL PREDICTION MODELS" />
    <edge source="DIAGNOSTIC CODES" target="CLINICAL PREDICTION MODELS" />
    <edge source="DIAGNOSTIC CODES" target="MULTICENTER NETWORK STUDIES" />
    <edge source="CLINICAL PREDICTION MODELS" target="LOGISTIC LASSO REGRESSION" />
    <edge source="CLINICAL PREDICTION MODELS" target="LONG SHORT-TERM MEMORY" />
    <edge source="CLINICAL PREDICTION MODELS" target="BOOTSTRAPPING" />
    <edge source="CLINICAL PREDICTION MODELS" target="RAPID INPATIENT DETERIORATION" />
    <edge source="CLINICAL PREDICTION MODELS" target="MISSING DATA STRATEGIES" />
    <edge source="NEUTROPENIA" target="ANTIBODY-DRUG CONJUGATES" />
    <edge source="NEUTROPENIA" target="VALGANCICLOVIR" />
    <edge source="NEUTROPENIA" target="LETERMOVIR" />
    <edge source="VITAMIN D3" target="ANTI-PD-1 IMMUNOTHERAPY" />
    <edge source="SPRINGER HANDBOOK" target="MODEL-BASED REASONING" />
    <edge source="1Q GAIN/AMPLIFICATION" target="AUTOGENOUS STEM CELL TRANSPLANTATION" />
    <edge source="HOUSTON" target="TEACHING HOSPITAL" />
    <edge source="COVID-19 GLOBAL PANDEMIC" target="IRANIAN POPULATION" />
    <edge source="IRANIAN POPULATION" target="SMOKER COVID-19 PATIENTS" />
    <edge source="IRANIAN POPULATION" target="SIX MEDICAL CENTERS" />
    <edge source="SMOKER COVID-19 PATIENTS" target="SIX MEDICAL CENTERS" />
    <edge source="BILCAP TRIAL" target="ADJUVANT RADIATION THERAPY" />
    <edge source="ADJUVANT RADIATION THERAPY" target="PROPENSITY SCORE MATCHING" />
    <edge source="ADJUVANT RADIATION THERAPY" target="MULTIVARIATE ANALYSIS" />
    <edge source="PROPENSITY SCORE MATCHING" target="COMPLICATIONS" />
    <edge source="PROPENSITY SCORE MATCHING" target="MID-NET&#174;" />
    <edge source="ESBENSHADE VANDERBILT MODELS" target="STEM CELL TRANSPLANT" />
    <edge source="STEM CELL TRANSPLANT" target="ESVANALLOSCT" />
    <edge source="STEM CELL TRANSPLANT" target="SINGLE INSTITUTION" />
    <edge source="STEM CELL TRANSPLANT" target="BLOODSTREAM INFECTIONS" />
    <edge source="OTTAWA HOSPITAL" target="PACLITAXEL" />
    <edge source="PACLITAXEL" target="H2RA" />
    <edge source="KUHN" target="HACKING" />
    <edge source="HACKING" target="FEYERABEND" />
    <edge source="HACKING" target="LAKATOS" />
    <edge source="HACKING" target="HIGH ENERGY PHYSICS" />
    <edge source="HACKING" target="MICROSCOPE IN CELL BIOLOGY" />
    <edge source="HIGH ENERGY PHYSICS" target="MODELS AS MEDIATORS" />
    <edge source="HIGH ENERGY PHYSICS" target="STANDARD MODEL" />
    <edge source="VIMENTIN" target="IMMUNE-CHECKPOINT INHIBITOR (ICI)" />
    <edge source="VIMENTIN" target="PROGRAMMED DEATH-LIGAND 1 (PD-L1)" />
    <edge source="VIMENTIN" target="TISSUE MICROARRAYS" />
    <edge source="IMMUNE-CHECKPOINT INHIBITOR (ICI)" target="OBJECTIVE RESPONSE RATE (ORR)" />
    <edge source="INTERNATIONAL REGISTRY FOR MEN WITH ADVANCED PROSTATE CANCER" target="ADVANCED PROSTATE CANCER" />
    <edge source="CANCER AUSTRALIA NATIONAL CANCER CONTROL INDICATORS" target="STUDY ENROLLMENT" />
    <edge source="STUDY ENROLLMENT" target="BLACK PARTICIPANTS" />
    <edge source="STUDY ENROLLMENT" target="WHITE PARTICIPANTS" />
    <edge source="STUDY ENROLLMENT" target="AGE AT ENROLLMENT" />
    <edge source="STUDY ENROLLMENT" target="DISEASE STATE AT ENROLLMENT" />
    <edge source="BLACK PARTICIPANTS" target="WHITE PARTICIPANTS" />
    <edge source="BRONCHOPULMONARY DYSPLASIA" target="GENERALIZED LINEAR MODELS" />
    <edge source="BRONCHOPULMONARY DYSPLASIA" target="NFE2L2" />
    <edge source="BRONCHOPULMONARY DYSPLASIA" target="GLS" />
    <edge source="BRONCHOPULMONARY DYSPLASIA" target="MONOCYTES" />
    <edge source="GENERALIZED LINEAR MODELS" target="GSE190215" />
    <edge source="GENERALIZED LINEAR MODELS" target="GSE188944" />
    <edge source="NFE2L2" target="GLS" />
    <edge source="NFE2L2" target="GSE108754" />
    <edge source="GLS" target="GSE108754" />
    <edge source="EXPLAINABLE NLP" target="HUMAN-ANNOTATED TEXTUAL EXPLANATIONS" />
    <edge source="EXPLAINABLE NLP" target="65 DATASETS" />
    <edge source="HUMAN-ANNOTATED TEXTUAL EXPLANATIONS" target="DATA AUGMENTATION" />
    <edge source="HUMAN-ANNOTATED TEXTUAL EXPLANATIONS" target="SUPERVISION" />
    <edge source="HUMAN-ANNOTATED TEXTUAL EXPLANATIONS" target="GROUND-TRUTH EVALUATION" />
    <edge source="LUNG ULTRASOUND" target="PLEURAL EFFUSION" />
    <edge source="PLEURAL EFFUSION" target="DEEP-LEARNING MODEL" />
    <edge source="PLEURAL EFFUSION" target="LUS EXPERTS" />
    <edge source="DEEP-LEARNING MODEL" target="LUS EXPERTS" />
    <edge source="DEEP-LEARNING MODEL" target="ALGORITHM" />
    <edge source="LUS EXPERTS" target="DICE SIMILARITY COEFFICIENT" />
    <edge source="ALGORITHM" target="DICE SIMILARITY COEFFICIENT" />
    <edge source="GAUTENG PROVINCE" target="SOUTH AFRICA" />
    <edge source="GAUTENG PROVINCE" target="FIRST WAVE OF COVID-19" />
    <edge source="GAUTENG PROVINCE" target="SECOND WAVE OF COVID-19" />
    <edge source="GAUTENG PROVINCE" target="VIRUS HOT-SPOTS" />
    <edge source="NOVEMBER 8, 2020" target="MARCH 5, 2005" />
    <edge source="ONCOLOGY RANDOMIZED CONTROLLED TRIALS" target="LOW-MIDDLE/UPPER-MIDDLE INCOME COUNTRIES" />
    <edge source="AFRICAN AMERICAN" target="WHITE PATIENTS" />
    <edge source="NETHERLANDS TRIAL REGISTRY" target="NL7335" />
    <edge source="ARTIFICIAL INTELLIGENCE IN HEALTHCARE" target="MEDICAL AI" />
    <edge source="MEDICAL AI" target="HEALTHCARE STAKEHOLDERS" />
    <edge source="MEDICAL AI" target="ETHICAL GOVERNANCE" />
    <edge source="MEDICAL AI" target="ALGORITHMIC BIAS" />
    <edge source="MEDICAL AI" target="OPACITY" />
    <edge source="MEDICAL AI" target="SAFETY AND SECURITY" />
    <edge source="MEDICAL AI" target="RESPONSIBILITY ATTRIBUTION" />
    <edge source="BC CLINICIANS" target="ONCOLOGY TEAM" />
    <edge source="BC CLINICIANS" target="HEALTHY WEIGHT COUNSELING" />
    <edge source="WEIGHT MANAGEMENT" target="HEALTHY WEIGHT COUNSELING" />
    <edge source="MEDICAL DIAGNOSIS" target="FEEDBACK LOOP" />
    <edge source="FEEDBACK LOOP" target="DIAGNOSTIC ERROR" />
    <edge source="DIAGNOSTIC ERROR" target="DISEASE ETIOLOGY" />
    <edge source="ORTHOSTATIC HYPOTENSION" target="ALL-CAUSE MORTALITY" />
    <edge source="ORTHOSTATIC HYPOTENSION" target="CENTRAL" />
    <edge source="ORTHOSTATIC HYPOTENSION" target="HYPERTENSION TRIAL PARTICIPANTS" />
    <edge source="ALL-CAUSE MORTALITY" target="STANDING HYPOTENSION" />
    <edge source="CENTRAL" target="STANDING HYPOTENSION" />
    <edge source="CENTRAL" target="CPAP" />
    <edge source="HYPERTENSION TRIAL PARTICIPANTS" target="STANDING HYPOTENSION" />
    <edge source="MARGINAL ZONE LYMPHOMAS" target="HISTOLOGIC TRANSFORMATION" />
    <edge source="HISTOLOGIC TRANSFORMATION" target="DIFFUSE LARGE B-CELL LYMPHOMAS" />
    <edge source="HISTOLOGIC TRANSFORMATION" target="TBL1XR1" />
    <edge source="TBL1XR1" target="PIM1" />
    <edge source="KAMPNET" target="GRAPH ATTENTION NETWORK" />
    <edge source="KAMPNET" target="GRAPH CONVOLUTIONAL NETWORK" />
    <edge source="FORWARD HEAD POSTURE DETECTION STUDY" target="EXTRA TREE CLASSIFIER" />
    <edge source="DIABETIC RETINOPATHY" target="MARKOV MODELING" />
    <edge source="SCREENING INTERVENTION" target="SIMULATION MODELING" />
    <edge source="SCREENING INTERVENTION" target="PREVENTIVE HEALTH INTERVENTION" />
    <edge source="SIMULATION MODELING" target="PREVENTIVE HEALTH INTERVENTION" />
    <edge source="SIMULATION MODELING" target="DISCRETE-EVENT SIMULATION" />
    <edge source="SIMULATION MODELING" target="CONTINUOUS SIMULATION" />
    <edge source="SIMULATION MODELING" target="AGENT-BASED SIMULATION" />
    <edge source="SIMULATION MODELING" target="MONTE-CARLO SIMULATION" />
    <edge source="MENOPAUSE" target="VASOMOTOR SYMPTOMS" />
    <edge source="MENOPAUSE" target="GENITOURINARY SYNDROME OF MENOPAUSE (GSM)" />
    <edge source="MENOPAUSE" target="PROBLEMATIC MENOPAUSE" />
    <edge source="VASOMOTOR SYMPTOMS" target="CONJUGATED EQUINE ESTROGENS (CEE)" />
    <edge source="VASOMOTOR SYMPTOMS" target="PAROXETINE" />
    <edge source="VASOMOTOR SYMPTOMS" target="VENLAFAXINE" />
    <edge source="GENITOURINARY SYNDROME OF MENOPAUSE (GSM)" target="VAGINAL PRASTERONE" />
    <edge source="GENITOURINARY SYNDROME OF MENOPAUSE (GSM)" target="ORAL OSPEMIFENE" />
    <edge source="CONJUGATED EQUINE ESTROGENS (CEE)" target="MEDROXYPROGESTERONE ACETATE (MPA)" />
    <edge source="SPATIAL MOLECULAR PROFILING" target="HUMAN HERPES SIMPLEX VIRUS INFECTION" />
    <edge source="SPATIAL MOLECULAR PROFILING" target="CYTO MODEL" />
    <edge source="SPATIAL MOLECULAR PROFILING" target="DEEP LEARNING-BASED CELL SEGMENTATION MODELS" />
    <edge source="CYTO MODEL" target="CELLPOSE" />
    <edge source="DEEP LEARNING-BASED CELL SEGMENTATION MODELS" target="IMMUNOFLUORESCENCE IMAGES" />
    <edge source="IMMUNOFLUORESCENCE IMAGES" target="SKIN TISSUE" />
    <edge source="REGER" target="CHINESE FERTILITY CENTER" />
    <edge source="REGER" target="ELECTRONIC MEDICAL RECORD" />
    <edge source="REGER" target="PREMATURE OVARIAN DECLINE" />
    <edge source="REGER" target="REGEXGENERATOR++" />
    <edge source="REGER" target="CHINESE REPRODUCTIVE EMRS" />
    <edge source="REGEXGENERATOR++" target="GENETIC PROGRAMMING" />
    <edge source="TURNING THE PAGE ON BREAST CANCER" target="COMMUNITY EVENTS" />
    <edge source="TURNING THE PAGE ON BREAST CANCER" target="TPBC WEBSITE" />
    <edge source="COMMUNITY EVENTS" target="TPBC WEBSITE" />
    <edge source="DEL(1P13.3)" target="1Q21 GAIN" />
    <edge source="DEL(1P13.3)" target="1Q21 AMP" />
    <edge source="DEL(1P13.3)" target="INTERNATIONAL STAGING SYSTEM (ISS) STAGE 3" />
    <edge source="DEL(1P13.3)" target="GENE EXPRESSION PROFILING (GEP)70 HIGH RISK" />
    <edge source="DEL(1P13.3)" target="AHCYL1 GENE" />
    <edge source="1Q21 GAIN" target="CKS1B LOCUS" />
    <edge source="1Q21 AMP" target="CKS1B LOCUS" />
    <edge source="NATURAL FREQUENCIES FORMAT" target="BAYESIAN INFERENCE" />
    <edge source="NATURAL FREQUENCIES FORMAT" target="CHORIONIC VILLUS SAMPLING TEST" />
    <edge source="BAYESIAN INFERENCE" target="SOUTH KOREAN ADULTS" />
    <edge source="BAYESIAN INFERENCE" target="STRICT ROUNDING" />
    <edge source="BAYESIAN INFERENCE" target="LOOSE ROUNDING" />
    <edge source="BAYESIAN INFERENCE" target="ABSOLUTE DEVIATION" />
    <edge source="BAYESIAN INFERENCE" target="50-SPLIT" />
    <edge source="SOUTH KOREAN ADULTS" target="WEB-BASED EXPERIMENTAL SURVEY" />
    <edge source="POPULATION GENETICS" target="POPULATION ECOLOGY" />
    <edge source="POPULATION GENETICS" target="MATHEMATICAL BIOGEOGRAPHY" />
    <edge source="POPULATION GENETICS" target="EVOLUTION" />
    <edge source="POPULATION ECOLOGY" target="MATHEMATICAL BIOGEOGRAPHY" />
    <edge source="POPULATION ECOLOGY" target="EVOLUTION" />
    <edge source="DEMOGRAPHIC TIME" target="EVOLUTIONARY TIME" />
    <edge source="MAGIC EVIDENCE ECOSYSTEM FOUNDATION" target="MAGICAPP" />
    <edge source="MAGIC EVIDENCE ECOSYSTEM FOUNDATION" target="BMJ RAPID RECOMMENDATIONS" />
    <edge source="ENCOUNTER DECISION AIDS" target="CLINICAL ENCOUNTERS" />
    <edge source="EQ-5D-5L HEALTH STATE VALUATION STUDIES" target="MOBILITY" />
    <edge source="EQ-5D-5L HEALTH STATE VALUATION STUDIES" target="ANXIETY/DEPRESSION" />
    <edge source="ONLINE RESPONDENTS" target="FACE-TO-FACE SCREENED RESPONDENTS" />
    <edge source="PROXIMAL POLICY OPTIMIZATION" target="TRUST REGION POLICY OPTIMIZATION" />
    <edge source="DISCRETE-EVENT SIMULATION" target="EVENT SCHEDULING" />
    <edge source="DISCRETE-EVENT SIMULATION" target="PROCESS INTERACTION" />
    <edge source="DISCRETE-EVENT SIMULATION" target="ACTIVITY SCANNING" />
    <edge source="DISCRETE-EVENT SIMULATION" target="SINGLE-SERVER QUEUEING SYSTEM" />
    <edge source="DISCRETE-EVENT SIMULATION" target="MULTIPLE-SERVER FINITE CAPACITY QUEUEING SYSTEM" />
    <edge source="AGENT-BASED SIMULATION" target="GAME OF LIFE MODEL" />
    <edge source="AGENT-BASED SIMULATION" target="VARIATION MODEL" />
    <edge source="AGENT-BASED SIMULATION" target="EMERGENT BEHAVIOR" />
    <edge source="CITATION BLOCK DETERMINATION" target="RESEARCH PAPER SUMMARISATION" />
    <edge source="CITATION BLOCK DETERMINATION" target="IDEA ATTRIBUTION" />
    <edge source="CITATION BLOCK DETERMINATION" target="SENTIMENT ANALYSIS" />
    <edge source="DE-IDENTIFICATION PIPELINE" target="PRODIGY" />
    <edge source="DE-IDENTIFICATION PIPELINE" target="BI-LSTM + CRF" />
    <edge source="DE-IDENTIFICATION PIPELINE" target="FRENCH DE-IDENTIFICATION DATASET" />
    <edge source="CHU DE RENNES" target="EHOP CLINICAL DATA WAREHOUSE" />
    <edge source="CHU DE RENNES" target="RENNES UNIVERSITY HOSPITAL" />
    <edge source="EHOP CLINICAL DATA WAREHOUSE" target="FRENCH DE-IDENTIFICATION DATASET" />
    <edge source="RENNES UNIVERSITY HOSPITAL" target="FRENCH DE-IDENTIFICATION DATASET" />
    <edge source="BI-LSTM + CRF" target="FLAIR + FASTTEXT" />
    <edge source="DEEP LEARNING-BASED MODELS" target="NAMED ENTITY RECOGNITION" />
    <edge source="LEAF CAF&#201;" target="SYDNEY" />
    <edge source="LEAF CAF&#201;" target="TELEPHONE INTERVIEW FOR COGNITIVE STATUS-MODIFIED (TICS-M)" />
    <edge source="GRADIENT BOOSTING MACHINE" target="OBSTRUCTIVE SLEEP APNEA" />
    <edge source="GRADIENT BOOSTING MACHINE" target="ONLINE CALCULATOR" />
    <edge source="GRADIENT BOOSTING MACHINE" target="GASTRIC STROMAL TUMORS" />
    <edge source="GRADIENT BOOSTING MACHINE" target="H2O AUTOML" />
    <edge source="CD19-TARGETING CAR T CELLS" target="ANTISYNTHETASE SYNDROME" />
    <edge source="CD19-TARGETING CAR T CELLS" target="FLUDARABINE" />
    <edge source="CD19-TARGETING CAR T CELLS" target="MYCOPHENOLATE MOFETIL" />
    <edge source="CD19-TARGETING CAR T CELLS" target="AZATHIOPRINE" />
    <edge source="UNIVERSITY HOSPITAL T&#220;BINGEN" target="T&#220;BINGEN" />
    <edge source="ENDOVASCULAR THROMBECTOMY" target="ACUTE ISCHEMIC STROKE" />
    <edge source="INTRAHEPATIC CHOLANGIOCARCINOMA" target="FOXP3" />
    <edge source="INTRAHEPATIC CHOLANGIOCARCINOMA" target="CD68" />
    <edge source="INTRAHEPATIC CHOLANGIOCARCINOMA" target="CD8&#913;" />
    <edge source="INTRAHEPATIC CHOLANGIOCARCINOMA" target="PD-L1" />
    <edge source="INTRAHEPATIC CHOLANGIOCARCINOMA" target="CLINICOPATHOLOGICAL CHARACTERISTICS" />
    <edge source="INTRAHEPATIC CHOLANGIOCARCINOMA" target="PROGNOSIS" />
    <edge source="INTRAHEPATIC CHOLANGIOCARCINOMA" target="MULTIPLEX IMMUNOFLUORESCENCE" />
    <edge source="TREGIII" target="RELAPSE-FREE SURVIVAL" />
    <edge source="PRIMARY ANGLE CLOSURE SUSPECT (PACS)" target="AI-AIDED DIAGNOSTIC SYSTEM" />
    <edge source="PRIMARY ANGLE CLOSURE SUSPECT (PACS)" target="ANTERIOR SEGMENT OPTICAL COHERENCE TOMOGRAPHY" />
    <edge source="AI-AIDED DIAGNOSTIC SYSTEM" target="RANDOM FOREST (RF)" />
    <edge source="AI-AIDED DIAGNOSTIC SYSTEM" target="CLASSIFICATION AND REGRESSION TREE (CART)" />
    <edge source="AI-AIDED DIAGNOSTIC SYSTEM" target="ALEXNET" />
    <edge source="AI-AIDED DIAGNOSTIC SYSTEM" target="VGG-16" />
    <edge source="AI-AIDED DIAGNOSTIC SYSTEM" target="EXPERIENCED OPHTHALMOLOGISTS" />
    <edge source="AI-AIDED DIAGNOSTIC SYSTEM" target="JUNIOR PHYSICIANS" />
    <edge source="AI-AIDED DIAGNOSTIC SYSTEM" target="CONVOLUTIONAL NEURAL NETWORKS (CNN)" />
    <edge source="RANDOM FOREST (RF)" target="SUPERVISED MACHINE LEARNING (ML)" />
    <edge source="RANDOM FOREST (RF)" target="EXTENSOR DIGITORUM (EXT)" />
    <edge source="RANDOM FOREST (RF)" target="ABDUCTOR POLLICIS BREVIS (APB)" />
    <edge source="RANDOM FOREST (RF)" target="TIBIALIS ANTERIOR (TA)" />
    <edge source="ALEXNET" target="ECG MACHINES" />
    <edge source="PRO" target="SMARTPHONE-BASED SELF-MANAGEMENT PLATFORM" />
    <edge source="PRO" target="MALE PATIENTS" />
    <edge source="PRO" target="FEMALE PATIENTS" />
    <edge source="MALE PATIENTS" target="FEMALE PATIENTS" />
    <edge source="MINDRAY MC-100I" target="ARTIFICIAL INTELLIGENCE (AI)" />
    <edge source="MINDRAY MC-100I" target="BLOOD SAMPLES" />
    <edge source="ARTIFICIAL INTELLIGENCE (AI)" target="JUNIOR TECHNOLOGISTS" />
    <edge source="ARTIFICIAL INTELLIGENCE (AI)" target="INTERMEDIATE TECHNOLOGISTS" />
    <edge source="ARTIFICIAL INTELLIGENCE (AI)" target="LEUKOCYTE DIFFERENTIATION" />
    <edge source="BLOOD SAMPLES" target="HEMATOLOGY ANALYZERS" />
    <edge source="LEUKOCYTE DIFFERENTIATION" target="PERIPHERAL LEUKOCYTES" />
    <edge source="US-MEXICO BORDER" target="TEXAS-MEXICO BORDER" />
    <edge source="US-MEXICO BORDER" target="CHILDREN WITH ALL" />
    <edge source="US-MEXICO BORDER" target="CHILDREN WITH AML" />
    <edge source="CHILDREN WITH ALL" target="CHILDHOOD LEUKEMIA STUDY" />
    <edge source="CHILDREN WITH AML" target="CHILDHOOD LEUKEMIA STUDY" />
    <edge source="INTEROPERABILITY" target="EPRESCRIBING SYSTEMS" />
    <edge source="INTEROPERABILITY" target="PATIENT SAFETY" />
    <edge source="INTEROPERABILITY" target="INTEGRATION &amp; CONTINUITY OF CARE" />
    <edge source="INTEROPERABILITY" target="OPTIMISING CARE PATHWAYS" />
    <edge source="INTEROPERABILITY" target="FULL PATIENT CARE SERVICES INTEROPERABILITY" />
    <edge source="CHIEF CLINICAL INFORMATION OFFICERS" target="NHS ENGLAND" />
    <edge source="BEH&#199;ET&#8217;S DISEASE" target="EGYPTIAN COLLEGE OF RHEUMATOLOGY" />
    <edge source="BEH&#199;ET&#8217;S DISEASE" target="VISION-THREATENING BEH&#199;ET&#8217;S DISEASE" />
    <edge source="VISION-THREATENING BEH&#199;ET&#8217;S DISEASE" target="MACHINE-LEARNING MODELS" />
    <edge source="MACHINE-LEARNING MODELS" target="SHAPLEY ADDITIVE EXPLANATION VALUE" />
    <edge source="PAN-EUROPEAN NETWORK FOR CARE OF SURVIVORS AFTER CHILDHOOD AND ADOLESCENT CANCER" target="PANCARESURFUP" />
    <edge source="MAGNESIUM" target="UNIVERSITY OF PITTSBURGH MEDICAL CENTER" />
    <edge source="RECOGNIZING TEXTUAL ENTAILMENT" target="NLP SYSTEMS" />
    <edge source="COPD SELF-MANAGEMENT APPLICATION" target="CLINICALTRIALS.GOV NCT03857061" />
    <edge source="COPD SELF-MANAGEMENT APPLICATION" target="SMARTPHONE" />
    <edge source="COPD SELF-MANAGEMENT APPLICATION" target="SMARTWATCH" />
    <edge source="ISCHEMIC HEART DISEASE" target="SICHUAN" />
    <edge source="ISCHEMIC HEART DISEASE" target="DXLR MODEL" />
    <edge source="DXLR MODEL" target="SHAPLEY ADDICTIVE EXPLANATIONS" />
    <edge source="SICHUAN" target="HOSPITAL DISCHARGE RECORDS" />
    <edge source="YALE" target="METASTATIC UVEAL MELANOMA" />
    <edge source="METASTATIC UVEAL MELANOMA" target="PRIMARY UVEAL MELANOMA" />
    <edge source="METASTATIC UVEAL MELANOMA" target="HEPATIC METASTASES" />
    <edge source="METASTATIC UVEAL MELANOMA" target="EXTRAHEPATIC-ONLY METASTASES" />
    <edge source="GO2 FOR LUNG CANCER" target="PATIENT-REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM SEXUAL FUNCTION AND SATISFACTION MEASURES" />
    <edge source="PATIENTS-CAREGIVER DYAD DECISION-MAKING STUDY" target="DECISION-MAKING ROLE PREFERENCES" />
    <edge source="PATIENTS-CAREGIVER DYAD DECISION-MAKING STUDY" target="DYADIC DISCORDANCE" />
    <edge source="PRECISION MEDICINE FOR CHILDREN WITH CANCER TRIAL" target="GERMLINE GENOME SEQUENCING" />
    <edge source="PRECISION MEDICINE FOR CHILDREN WITH CANCER TRIAL" target="CLINICIAN" />
    <edge source="GERMLINE GENOME SEQUENCING" target="CANCER PREDISPOSITION GENES" />
    <edge source="FDA MANDATE" target="NATIONAL INPATIENT SAMPLE" />
    <edge source="FDA MANDATE" target="ACUTE LIVER FAILURE STUDY GROUP" />
    <edge source="OPIOID TOXICITY" target="ACETAMINOPHEN" />
    <edge source="OPIOID TOXICITY" target="HOSPITALIZATION" />
    <edge source="OPIOID TOXICITY" target="ACUTE LIVER FAILURE" />
    <edge source="ACETAMINOPHEN" target="HOSPITALIZATION" />
    <edge source="ACETAMINOPHEN" target="ACUTE LIVER FAILURE" />
    <edge source="TRS DEMONSTRATOR" target="DERMATOLOGISTS" />
    <edge source="TRS DEMONSTRATOR" target="NATIONAL DERMATOLOGY CONFERENCE" />
    <edge source="TRS DEMONSTRATOR" target="SYSTEM USABILITY SCALE (SUS)" />
    <edge source="SYSTEM USABILITY SCALE (SUS)" target="FIND TMF" />
    <edge source="ALZHEIMER&#8217;S DISEASE NEUROIMAGING INITIATIVE" target="NATIONAL ALZHEIMER&#8217;S COORDINATING CENTER" />
    <edge source="ALZHEIMER&#8217;S DISEASE NEUROIMAGING INITIATIVE" target="ALZHEIMER&#8217;S DISEASE DATA ELEMENT ONTOLOGY" />
    <edge source="ALZHEIMER&#8217;S DISEASE NEUROIMAGING INITIATIVE" target="CROSS-COHORT QUERY SYSTEM" />
    <edge source="ALZHEIMER&#8217;S DISEASE NEUROIMAGING INITIATIVE" target="FAIR" />
    <edge source="NATIONAL ALZHEIMER&#8217;S COORDINATING CENTER" target="ALZHEIMER&#8217;S DISEASE DATA ELEMENT ONTOLOGY" />
    <edge source="NATIONAL ALZHEIMER&#8217;S COORDINATING CENTER" target="CROSS-COHORT QUERY SYSTEM" />
    <edge source="NATIONAL ALZHEIMER&#8217;S COORDINATING CENTER" target="FAIR" />
    <edge source="WORLD TRADE CENTER BOMBING" target="PUBLIC HEALTH SURVEILLANCE" />
    <edge source="PUBLIC HEALTH SURVEILLANCE" target="ELECTRONIC AND INFORMATION TECHNOLOGIES" />
    <edge source="PUBLIC HEALTH SURVEILLANCE" target="PUBLIC HEALTH WORKFORCE" />
    <edge source="POPULATION MODELLING" target="ECONOMIC EVALUATION STUDIES" />
    <edge source="TONGUE FEATURE" target="NON-ADVANCED NSCLC" />
    <edge source="TONGUE FEATURE" target="ADVANCED NSCLC" />
    <edge source="TUMOR MARKER" target="NON-ADVANCED NSCLC" />
    <edge source="TUMOR MARKER" target="ADVANCED NSCLC" />
    <edge source="MULTIMODAL CRC SCREENING POLICIES" target="MONTE CARLO SIMULATION FRAMEWORK" />
    <edge source="MULTIMODAL CRC SCREENING POLICIES" target="MARKOV MODEL" />
    <edge source="MULTIMODAL CRC SCREENING POLICIES" target="FECAL OCCULT BLOOD TEST" />
    <edge source="MULTIMODAL CRC SCREENING POLICIES" target="FECAL IMMUNOCHEMICAL TEST" />
    <edge source="ALBERTA MOVING BEYOND BREAST CANCER (AMBER) COHORT STUDY" target="ACTIGRAPH" />
    <edge source="ALBERTA MOVING BEYOND BREAST CANCER (AMBER) COHORT STUDY" target="ACTIVPAL" />
    <edge source="ALBERTA MOVING BEYOND BREAST CANCER (AMBER) COHORT STUDY" target="QUALITY OF LIFE (QOL)" />
    <edge source="ALBERTA MOVING BEYOND BREAST CANCER (AMBER) COHORT STUDY" target="FATIGUE" />
    <edge source="ACTIGRAPH" target="R SOJOURN PACKAGE" />
    <edge source="ACTIVPAL" target="PAL SOFTWARE" />
    <edge source="QUALITY OF LIFE (QOL)" target="FATIGUE" />
    <edge source="DENSENET121_448" target="NMLS DETECTION STUDY" />
    <edge source="NMLS DETECTION STUDY" target="MOBILENET_448" />
    <edge source="AUTOMATED LITERATURE SCREENING" target="HUMAN INVESTIGATORS" />
    <edge source="RSGP" target="ROBERTA" />
    <edge source="RSGP" target="CMEIE" />
    <edge source="ROBERTA" target="MEDICAL IMAGE PROTOCOL ASSIGNMENT" />
    <edge source="ROBERTA" target="RADIOLIST" />
    <edge source="FOOD FREQUENCY QUESTIONNAIRES" target="DIET-DISEASE RELATIONSHIPS" />
    <edge source="FOOD FREQUENCY QUESTIONNAIRES" target="MEASUREMENT ERROR" />
    <edge source="FOOD FREQUENCY QUESTIONNAIRES" target="UNDERREPORTING" />
    <edge source="MEALS" target="BLOOD GLUCOSE" />
    <edge source="MODEL TRAINING" target="MODEL SELECTION" />
    <edge source="MODEL SELECTION" target="BINARY CLASSIFIERS" />
    <edge source="LENVATINIB" target="PROGRAMMED CELL DEATH PROTEIN 1 (PD-1)" />
    <edge source="LENVATINIB" target="ADVANCED HEPATOCELLULAR CARCINOMA (AD-HCC)" />
    <edge source="PROGRAMMED CELL DEATH PROTEIN 1 (PD-1)" target="ADVANCED HEPATOCELLULAR CARCINOMA (AD-HCC)" />
    <edge source="ADVANCED HEPATOCELLULAR CARCINOMA (AD-HCC)" target="HEPATIC ARTERIAL INFUSION CHEMOTHERAPY (HAIC)" />
    <edge source="ADVANCED HEPATOCELLULAR CARCINOMA (AD-HCC)" target="APRIL 2016 TO SEPTEMBER 2021" />
    <edge source="ADVANCED HEPATOCELLULAR CARCINOMA (AD-HCC)" target="LOG-RANK TEST" />
    <edge source="ADVANCED HEPATOCELLULAR CARCINOMA (AD-HCC)" target="FORWARD STEPWISE COX REGRESSION MODEL" />
    <edge source="HOSPITALS" target="MEDICARE BENEFICIARIES" />
    <edge source="HOSPITALS" target="EPRESCRIBING SYSTEMS" />
    <edge source="SMARTPHONE-BASED APP" target="ANDROID STUDIO 3" />
    <edge source="SMARTPHONE-BASED APP" target="JAVA 8" />
    <edge source="SMARTPHONE-BASED APP" target="SQLITE" />
    <edge source="SMARTPHONE-BASED APP" target="USABILITY EVALUATION QUESTIONNAIRE" />
    <edge source="SMARTPHONE-BASED APP" target="USER SATISFACTION QUESTIONNAIRE (QUIS)" />
    <edge source="KIDS' INPATIENT DATABASE" target="CHILD AND ADOLESCENT MENTAL HEALTH DISORDERS CLASSIFICATION SYSTEM" />
    <edge source="PEDIATRIC MENTAL HEALTH HOSPITALIZATIONS" target="ATTEMPTED SUICIDE, SUICIDAL IDEATION, OR SELF-INJURY" />
    <edge source="CANCER REGISTRY SYSTEM" target="COGNITIVE WALKTHROUGH" />
    <edge source="CANCER REGISTRY SYSTEM" target="SPSS 22" />
    <edge source="SPSS 22" target="IRAN ELECTRONIC HEALTH RECORD SYSTEM (SEPAS)" />
    <edge source="ABSTRACKR" target="WORDSTAT" />
    <edge source="ABSTRACKR" target="QDA MINER" />
    <edge source="ABSTRACKR" target="CRD42018084123" />
    <edge source="WORDSTAT" target="QDA MINER" />
    <edge source="WORDSTAT" target="CRD42018084123" />
    <edge source="QDA MINER" target="CRD42018084123" />
    <edge source="REINFORCEMENT LEARNING SYSTEMS" target="ATARI GAMES" />
    <edge source="REINFORCEMENT LEARNING SYSTEMS" target="SIMULATED ROBOT LOCOMOTION" />
    <edge source="REINFORCEMENT LEARNING SYSTEMS" target="REAL-WORLD ENVIRONMENTS" />
    <edge source="REINFORCEMENT LEARNING SYSTEMS" target="HUMAN OVERSIGHT" />
    <edge source="BRATS 2020 CHALLENGE DATASET" target="SRI 24 ANATOMICAL ATLAS" />
    <edge source="BRATS 2020 CHALLENGE DATASET" target="3D CONVOLUTIONAL NEURAL NETWORK" />
    <edge source="BRATS 2020 CHALLENGE DATASET" target="TRANSVERSE TEMPORAL GYRUS" />
    <edge source="BRATS 2020 CHALLENGE DATASET" target="FUSIFORM" />
    <edge source="BRATS 2020 CHALLENGE DATASET" target="PALLADIUM" />
    <edge source="BRATS 2020 CHALLENGE DATASET" target="GLIOMAS" />
    <edge source="3D CONVOLUTIONAL NEURAL NETWORK" target="GRADIENT-WEIGHTED CLASS ACTIVATION MAPPING (GRAD-CAM)" />
    <edge source="3D CONVOLUTIONAL NEURAL NETWORK" target="GLIOMAS" />
    <edge source="NEUROPHYSIOLOGIST" target="MOTOR EVOKED POTENTIAL (MEP)" />
    <edge source="MOTOR EVOKED POTENTIAL (MEP)" target="SUPERVISED MACHINE LEARNING (ML)" />
    <edge source="MOTOR EVOKED POTENTIAL (MEP)" target="SUPRATENTORIAL SURGERY" />
    <edge source="SUPERVISED MACHINE LEARNING (ML)" target="LOGISTIC REGRESSION (LOGREG)" />
    <edge source="EXTENSOR DIGITORUM (EXT)" target="ABDUCTOR POLLICIS BREVIS (APB)" />
    <edge source="EXTENSOR DIGITORUM (EXT)" target="TIBIALIS ANTERIOR (TA)" />
    <edge source="HUMANISED MICE" target="CANCER STEM CELL RESEARCH" />
    <edge source="ANTIBODY-DRUG CONJUGATES" target="LYMPHOPENIA" />
    <edge source="ANTIBODY-DRUG CONJUGATES" target="NAUSEA" />
    <edge source="ANTIBODY-DRUG CONJUGATES" target="BLURRED VISION" />
    <edge source="ANTIBODY-DRUG CONJUGATES" target="PERIPHERAL NEUROPATHY" />
    <edge source="ANTIBODY-DRUG CONJUGATES" target="HYPOESTHESIA" />
    <edge source="ANTIBODY-DRUG CONJUGATES" target="FEBRILE NEUTROPENIA" />
    <edge source="JOURNAL EDITORS" target="PEER REVIEW SYSTEM" />
    <edge source="JOURNAL EDITORS" target="AUTOMATED SCREENING TOOLS" />
    <edge source="UK EQUATOR CENTRE" target="GOODREPORTS.ORG" />
    <edge source="GOODREPORTS.ORG" target="PARTNER JOURNAL" />
    <edge source="GOODREPORTS.ORG" target="GOODREPORTS TOOL DEVELOPMENT" />
    <edge source="GOODREPORTS.ORG" target="RANDOMISED TRIAL" />
    <edge source="PARTNER JOURNAL" target="RANDOM SAMPLE" />
    <edge source="COVID" target="COMMUNITY MEMBERS" />
    <edge source="COVID" target="HEALTH CARE PROFESSIONALS" />
    <edge source="COVID" target="OCCAM'S RAZOR" />
    <edge source="COVID" target="DIAGNOSTIC REASONING" />
    <edge source="COMMUNITY MEMBERS" target="HEALTH CARE PROFESSIONALS" />
    <edge source="COMMUNITY MEMBERS" target="HYPOTHETICAL SCENARIOS" />
    <edge source="HEALTH CARE PROFESSIONALS" target="HYPOTHETICAL SCENARIOS" />
    <edge source="HEALTH CARE PROFESSIONALS" target="MOBILE APPLICATIONS" />
    <edge source="DIAGNOSTIC REASONING" target="FLU" />
    <edge source="DIAGNOSTIC REASONING" target="MONONUCLEOSIS" />
    <edge source="DIAGNOSTIC REASONING" target="HYPOTHETICAL SCENARIOS" />
    <edge source="CANCER MORTALITY STUDY" target="NON-HISPANIC WHITE ADULTS" />
    <edge source="CANCER MORTALITY STUDY" target="NON-HISPANIC BLACK ADULTS" />
    <edge source="CANCER MORTALITY STUDY" target="ADULTS WITH A COLLEGE DEGREE" />
    <edge source="VIRTUAL GROUPS" target="COLLECTIVE INTELLIGENCE" />
    <edge source="LONG SHORT-TERM MEMORY" target="LIGHT GRADIENT BOOSTING" />
    <edge source="LONG SHORT-TERM MEMORY" target="RESOLSTM-DEPTH" />
    <edge source="MISSING DATA STRATEGIES" target="MEAN IMPUTATION" />
    <edge source="MISSING DATA STRATEGIES" target="NORMAL-VALUE IMPUTATION" />
    <edge source="MISSING DATA STRATEGIES" target="CONDITIONAL IMPUTATION" />
    <edge source="MISSING DATA STRATEGIES" target="CATEGORICAL ENCODING" />
    <edge source="MISSING DATA STRATEGIES" target="MISSINGNESS EMBEDDINGS" />
    <edge source="MISSING DATA STRATEGIES" target="LAST OBSERVATION CARRIED FORWARD" />
    <edge source="RED BLOOD CELL TRANSFUSION" target="BLOOD DONORS" />
    <edge source="RED BLOOD CELL TRANSFUSION" target="TRANSFUSION RECIPIENTS" />
    <edge source="BLOOD DONORS" target="TRANSFUSION RECIPIENTS" />
    <edge source="BROAD LEARNING SYSTEM" target="DAE-BLS" />
    <edge source="YOUNG WOMEN'S BREAST CANCER STUDY" target="NEONATAL INTENSIVE CARE UNIT" />
    <edge source="INSIGHTSLEEPNET" target="MESA" />
    <edge source="INSIGHTSLEEPNET" target="CFS" />
    <edge source="INSIGHTSLEEPNET" target="CAP" />
    <edge source="R CODE" target="THE AUTHOR(S) 2024" />
    <edge source="ESOPHAGEAL CANCER" target="WILEY" />
    <edge source="ESOPHAGEAL CANCER" target="ENDOSCOPIC IMAGES" />
    <edge source="ESOPHAGEAL CANCER" target="COMPUTED TOMOGRAPHY IMAGES" />
    <edge source="ESOPHAGEAL CANCER" target="WHITE LIGHT IMAGING" />
    <edge source="BCR::ABL1 TYROSINE KINASE INHIBITORS" target="PH-POSITIVE CML" />
    <edge source="PH-POSITIVE CML" target="SEER DATABASE" />
    <edge source="SEER DATABASE" target="XGB MODEL" />
    <edge source="SEER DATABASE" target="INVASIVE MICROPAPILLARY CARCINOMA" />
    <edge source="ECOG-ACRIN" target="CANCER PATIENT TOBACCO USE QUESTIONNAIRE (C-TUQ)" />
    <edge source="CANCER PATIENT TOBACCO USE QUESTIONNAIRE (C-TUQ)" target="AREA DEPRIVATION INDEX" />
    <edge source="JBI SCOPING REVIEW METHODOLOGY GROUP" target="SCOPING REVIEW PROTOCOL" />
    <edge source="JBI SCOPING REVIEW METHODOLOGY GROUP" target="JBI" />
    <edge source="JBI SCOPING REVIEW METHODOLOGY GROUP" target="JBI MANUAL FOR EVIDENCE SYNTHESIS" />
    <edge source="E-PRESCRIBING" target="URMIA UNIVERSITY OF MEDICAL SCIENCES" />
    <edge source="E-PRESCRIBING" target="TECHNICAL INFRASTRUCTURE" />
    <edge source="E-PRESCRIBING" target="SWOT MODEL" />
    <edge source="UNIVERSITY OF ALABAMA AT BIRMINGHAM" target="LILA" />
    <edge source="UNIVERSITY OF ALABAMA AT BIRMINGHAM" target="GI CANCERS" />
    <edge source="UNIVERSITY OF ALABAMA AT BIRMINGHAM" target="BIRMINGHAM" />
    <edge source="LILA" target="US DEPARTMENT OF AGRICULTURE ECONOMIC RESEARCH SERVICE" />
    <edge source="LILA" target="CARE FRAILTY INDEX" />
    <edge source="CPAP" target="OSA" />
    <edge source="CPAP" target="MACCE" />
    <edge source="CPAP" target="SAVE" />
    <edge source="CPAP" target="ISAACC" />
    <edge source="CPAP" target="RICCADSA" />
    <edge source="CPAP" target="CURRENT CONTROLLED TRIALS" />
    <edge source="CPAP" target="ISRCTN REGISTRY" />
    <edge source="CPAP" target="EUROPEAN UNION CLINICAL TRIALS DATABASE" />
    <edge source="BORDERLINE PERSONALITY DISORDER" target="DIALECTICAL BEHAVIOR THERAPY" />
    <edge source="BORDERLINE PERSONALITY DISORDER" target="PSYCHODYNAMIC THERAPY" />
    <edge source="BORDERLINE PERSONALITY DISORDER" target="ESCITALOPRAM" />
    <edge source="BORDERLINE PERSONALITY DISORDER" target="SERTRALINE" />
    <edge source="BORDERLINE PERSONALITY DISORDER" target="FLUOXETINE" />
    <edge source="BORDERLINE PERSONALITY DISORDER" target="QUETIAPINE" />
    <edge source="BORDERLINE PERSONALITY DISORDER" target="PROMETHAZINE" />
    <edge source="BORDERLINE PERSONALITY DISORDER" target="DIAZEPAM" />
    <edge source="BORDERLINE PERSONALITY DISORDER" target="LORAZEPAM" />
    <edge source="BORDERLINE PERSONALITY DISORDER" target="ANXIETY DISORDERS" />
    <edge source="BORDERLINE PERSONALITY DISORDER" target="SUBSTANCE USE DISORDERS" />
    <edge source="BORDERLINE PERSONALITY DISORDER" target="SUICIDAL BEHAVIOR" />
    <edge source="BORDERLINE PERSONALITY DISORDER" target="SELF-MUTILATION" />
    <edge source="BORDERLINE PERSONALITY DISORDER" target="CRISIS MANAGEMENT" />
    <edge source="BORDERLINE PERSONALITY DISORDER" target="GENETIC FACTORS" />
    <edge source="BORDERLINE PERSONALITY DISORDER" target="ADVERSE CHILDHOOD EXPERIENCES" />
    <edge source="FREE FLAP RECONSTRUCTION" target="TRANSORAL ROBOTIC SURGERY (TORS)" />
    <edge source="COMPLICATIONS" target="REGRESSION ANALYSIS" />
    <edge source="ADVANCED NON-SMALL CELL LUNG CANCER" target="FIRST LINE OF THERAPY (1LOT)" />
    <edge source="DIABETIC FOOT ULCER" target="BLACK PEOPLE" />
    <edge source="DIABETIC FOOT ULCER" target="HISPANIC PEOPLE" />
    <edge source="DIABETIC FOOT ULCER" target="NATIVE AMERICAN PEOPLE" />
    <edge source="DIABETIC FOOT ULCER" target="WHITE PEOPLE" />
    <edge source="HUMAN CELL ATLAS" target="GUT CELL ATLAS" />
    <edge source="GUT CELL ATLAS" target="GUT LINEAR MODEL" />
    <edge source="GUT CELL ATLAS" target="ILEUM" />
    <edge source="GUT CELL ATLAS" target="TRANSVERSE COLON" />
    <edge source="GUT CELL ATLAS" target="ILEO-CAECAL VALVE" />
    <edge source="GUT CELL ATLAS" target="HEPATIC FLEXURE" />
    <edge source="GUT CELL ATLAS" target="SMALL INTESTINE" />
    <edge source="GUT CELL ATLAS" target="LARGE INTESTINE" />
    <edge source="GUT CELL ATLAS" target="CT SCAN" />
    <edge source="US NATIONAL HEALTH INTERVIEW SURVEY" target="AYA CANCER SURVIVORS" />
    <edge source="AYA CANCER SURVIVORS" target="SOCIODEMOGRAPHIC FACTORS" />
    <edge source="AYA CANCER SURVIVORS" target="MODIFIABLE RISK FACTORS" />
    <edge source="AYA CANCER SURVIVORS" target="CLALIT HEALTH SERVICES" />
    <edge source="AYA CANCER SURVIVORS" target="KAISER PERMANENTE SOUTHERN CALIFORNIA" />
    <edge source="AYA CANCER SURVIVORS" target="CHRONIC CONDITIONS" />
    <edge source="AYA CANCER SURVIVORS" target="OSTEOPOROSIS" />
    <edge source="AYA CANCER SURVIVORS" target="CARDIOMYOPATHY" />
    <edge source="MYCHART" target="EPIC" />
    <edge source="MYCHART" target="LEBANON" />
    <edge source="MYCHART" target="MOBILE APPLICATION RATING SCALE" />
    <edge source="MYCHART" target="BIO MED CENTRAL LTD" />
    <edge source="CONTRALATERAL PROPHYLACTIC MASTECTOMY" target="NEGATIVE AFFECT" />
    <edge source="NEGATIVE AFFECT" target="DOUBLE MASTECTOMY" />
    <edge source="NEGATIVE AFFECT" target="NARRATIVE MANIPULATION" />
    <edge source="NEGATIVE AFFECT" target="CANCER RISK PERCEPTIONS" />
    <edge source="NARRATIVE MANIPULATION" target="CANCER RISK PERCEPTIONS" />
    <edge source="HYPERLEUKOCYTOSIS" target="LEUKAPHERESIS" />
    <edge source="HYPERLEUKOCYTOSIS" target="LD-CYTARABINE" />
    <edge source="HYPERLEUKOCYTOSIS" target="HYDROXYUREA" />
    <edge source="HYPERLEUKOCYTOSIS" target="PULMONARY COMPLICATIONS" />
    <edge source="HYPERLEUKOCYTOSIS" target="METABOLIC COMPLICATIONS" />
    <edge source="LEUKAPHERESIS" target="INFECTION" />
    <edge source="EQ-5D" target="QUALITY-ADJUSTED LIFE-YEAR LOSS" />
    <edge source="EQ-5D" target="COST-EFFECTIVENESS STUDIES" />
    <edge source="QUALITY-ADJUSTED LIFE-YEAR LOSS" target="INJURY EVENT" />
    <edge source="NATIONAL INSTITUTE OF HEALTH AND SOCIAL CARE RESEARCH" target="HEALTH INFORMATICS COLLABORATIVE" />
    <edge source="HEALTH INFORMATICS COLLABORATIVE" target="OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP" />
    <edge source="HEALTH INFORMATICS COLLABORATIVE" target="HEARING HEALTH" />
    <edge source="OMAHA CLASSIFICATION SYSTEM" target="HIP REPLACEMENT" />
    <edge source="HIP REPLACEMENT" target="HOME-BASED REHABILITATION" />
    <edge source="HIP REPLACEMENT" target="POPULATION AGING" />
    <edge source="HIP REPLACEMENT" target="PHYSICAL HEALTH-RELATED PROBLEMS" />
    <edge source="HOME-BASED REHABILITATION" target="REHABILITATION CARE" />
    <edge source="REHABILITATION CARE" target="PRECISION CARE" />
    <edge source="CRITICAL RESPIRATORY EVENTS" target="GENERAL ANESTHESIA" />
    <edge source="CRITICAL RESPIRATORY EVENTS" target="PERIOPERATIVE CARE" />
    <edge source="MCMASTER CHILDREN'S HOSPITAL" target="CHILD AND YOUTH MENTAL HEALTH PROGRAM" />
    <edge source="GRAPH NEURAL NETWORK" target="RECURRENT NEURAL NETWORK" />
    <edge source="GRAPH NEURAL NETWORK" target="ED REVISIT PREDICTION" />
    <edge source="RECURRENT NEURAL NETWORK" target="ED REVISIT PREDICTION" />
    <edge source="INTERNATIONAL COLLABORATION FOR AUTOMATION OF SYSTEMATIC REVIEWS" target="THIRD MEETING OF ICASR" />
    <edge source="LUNG CANCER SCREENING POLICIES" target="KEVIN TEN HAAF" />
    <edge source="SURGEON" target="FACILITY" />
    <edge source="LOUISE MAPLE-BROWN" target="CORRECTION ARTICLE" />
    <edge source="PURE" target="DEPARTMENT OF UROLOGY" />
    <edge source="PURE" target="RIDGE REGRESSION" />
    <edge source="PURE" target="BAGGED TREES" />
    <edge source="PURE" target="BOOSTED TREES" />
    <edge source="PURE" target="RANDOMFOREST" />
    <edge source="BALTIMORE REGIONAL HOUSING PARTNERSHIP" target="HOUSING MOBILITY PROGRAM" />
    <edge source="HOUSING MOBILITY PROGRAM" target="URECA" />
    <edge source="MSMPLUS" target="RSHINY" />
    <edge source="MSMPLUS" target="STATA" />
    <edge source="MSMPLUS" target="BREAST CANCER DATA BASE SWEDEN 2.0" />
    <edge source="MSMPLUS" target="STUDY II" />
    <edge source="STUDY II" target="PROSTATA MODEL" />
    <edge source="JOINT FRAILTY MODEL" target="COLON CANCER" />
    <edge source="JOINT FRAILTY MODEL" target="STUDY IV" />
    <edge source="STUDY IV" target="FLEXIBLE PARAMETRIC SURVIVAL MODELS" />
    <edge source="STUDY IV" target="PROSTATA MODEL" />
    <edge source="STUDY I" target="FLEXIBLE PARAMETRIC SURVIVAL MODELS" />
    <edge source="STUDY I" target="STHLM3" />
    <edge source="STUDY I" target="C++" />
    <edge source="FLEXIBLE PARAMETRIC SURVIVAL MODELS" target="STUDY III" />
    <edge source="STUDY III" target="PROSTATA MODEL" />
    <edge source="CYSTIC FIBROSIS" target="CFTR" />
    <edge source="CYSTIC FIBROSIS" target="F508DEL" />
    <edge source="CYSTIC FIBROSIS" target="IVACAFTOR" />
    <edge source="CYSTIC FIBROSIS" target="ELEXACAFTOR-TEZACAFTOR-IVACAFTOR" />
    <edge source="CYSTIC FIBROSIS" target="DORNASE ALFA" />
    <edge source="CYSTIC FIBROSIS" target="AZITHROMYCIN" />
    <edge source="CYSTIC FIBROSIS" target="TOBRAMYCIN" />
    <edge source="OMAHA PROBLEM CLASSIFICATION SYSTEM" target="SENSITIVITY OUTCOME INDEX SYSTEM" />
    <edge source="HOME NURSING" target="ELDERLY LIVER TRANSPLANT PATIENTS" />
    <edge source="GRAPH NEURAL NETWORKS" target="TEXT CLASSIFICATION" />
    <edge source="GRAPH NEURAL NETWORKS" target="GRAPH FUSION NETWORK" />
    <edge source="GRAPH NEURAL NETWORKS" target="TEMPORAL ANALYSIS" />
    <edge source="GRAPH NEURAL NETWORKS" target="SCIENTIFIC DATA" />
    <edge source="TEXT CLASSIFICATION" target="GRAPH FUSION NETWORK" />
    <edge source="GRAPH FUSION NETWORK" target="GRAPH LEARNING" />
    <edge source="GRAPH FUSION NETWORK" target="GRAPH CONVOLUTION" />
    <edge source="GRAPH FUSION NETWORK" target="GRAPH FUSION" />
    <edge source="XGB MODEL" target="SHAP FRAMEWORK" />
    <edge source="XGB MODEL" target="MALE BREAST CANCER" />
    <edge source="XGB MODEL" target="DELONG TEST" />
    <edge source="DELONG TEST" target="GASTRIC STROMAL TUMORS" />
    <edge source="BEHAVIOUR CHANGE INTERVENTIONS" target="FRAMEWORKS OF BEHAVIOUR CHANGE INTERVENTIONS" />
    <edge source="LDCT SCREENING" target="NOVEL TREATMENTS" />
    <edge source="CANADIAN PRIMARY CARE SENTINEL SURVEILLANCE NETWORK" target="INTERNATIONAL CLASSIFICATION OF DISEASES, NINTH REVISION, CLINICAL MODIFICATION" />
    <edge source="CANADIAN PRIMARY CARE SENTINEL SURVEILLANCE NETWORK" target="ANATOMICAL THERAPEUTIC CHEMICAL CLASSIFICATION" />
    <edge source="CANADIAN PRIMARY CARE SENTINEL SURVEILLANCE NETWORK" target="PROBLEMATIC MENOPAUSE" />
    <edge source="INTERNATIONAL CLASSIFICATION OF DISEASES, NINTH REVISION, CLINICAL MODIFICATION" target="PROBLEMATIC MENOPAUSE" />
    <edge source="ANATOMICAL THERAPEUTIC CHEMICAL CLASSIFICATION" target="PROBLEMATIC MENOPAUSE" />
    <edge source="NCD PREVENTION AND MANAGEMENT INTERVENTIONS" target="TOBACCO CONTROL POLICIES" />
    <edge source="NCD PREVENTION AND MANAGEMENT INTERVENTIONS" target="ALCOHOL CONTROL POLICIES" />
    <edge source="NCD PREVENTION AND MANAGEMENT INTERVENTIONS" target="CARDIOVASCULAR DISEASE TREATMENT" />
    <edge source="NCD PREVENTION AND MANAGEMENT INTERVENTIONS" target="CERVICAL CANCER TREATMENT" />
    <edge source="NCD PREVENTION AND MANAGEMENT INTERVENTIONS" target="EPILEPSY TREATMENT" />
    <edge source="TOBACCO CONTROL POLICIES" target="MEXICO SIMSMOKE" />
    <edge source="TOBACCO CONTROL POLICIES" target="NONDALY SMOKING" />
    <edge source="TOBACCO CONTROL POLICIES" target="DAILY SMOKING" />
    <edge source="ADABOOST ALGORITHM" target="SHAPLEY ADDITIVE EXPLANATION (SHAP)" />
    <edge source="ADABOOST ALGORITHM" target="CA125" />
    <edge source="ADABOOST ALGORITHM" target="CEA" />
    <edge source="ADABOOST ALGORITHM" target="FBG" />
    <edge source="ADABOOST ALGORITHM" target="TUMOR DIAMETER" />
    <edge source="RISK SCORE CALCULATORS" target="RESIDENTS" />
    <edge source="RISK SCORE CALCULATORS" target="ATTENDING PHYSICIANS" />
    <edge source="RISK SCORE CALCULATORS" target="RISK SCORE ESTIMATES" />
    <edge source="YOUNG ADULT CANCER SURVIVORS" target="SOCIAL ISOLATION" />
    <edge source="YOUNG ADULT CANCER SURVIVORS" target="SOCIAL CONNECTEDNESS" />
    <edge source="YOUNG ADULT CANCER SURVIVORS" target="PEER-REVIEWED ARTICLES" />
    <edge source="SOCIAL ISOLATION" target="CANCER-RELATED OUTCOMES" />
    <edge source="SOCIAL CONNECTEDNESS" target="CANCER-RELATED OUTCOMES" />
    <edge source="PEER-REVIEWED ARTICLES" target="DATABASE SEARCHES" />
    <edge source="CLINICAL SETTINGS" target="LLMS" />
    <edge source="LLMS" target="PATIENT NOTES" />
    <edge source="LLMS" target="BIASES IN TRAINING DATA" />
    <edge source="LLMS" target="ETHICAL, LEGAL, SOCIOECONOMIC, AND PRIVACY CONCERNS" />
    <edge source="PHYSICIAN PREFERENCE ITEMS" target="ITALIAN HOSPITAL ORTHOPEDISTS" />
    <edge source="PHYSICIAN PREFERENCE ITEMS" target="CLINICAL EVIDENCE" />
    <edge source="PHYSICIAN PREFERENCE ITEMS" target="QUALITY OF PRODUCTS" />
    <edge source="PHYSICIAN PREFERENCE ITEMS" target="COST" />
    <edge source="PHYSICIAN PREFERENCE ITEMS" target="RELATIONSHIP WITH SALES REPRESENTATIVE" />
    <edge source="BEST-WORST SCALING" target="STATA 16" />
    <edge source="BASQUE COUNTRY" target="JOHNS HOPKINS ADJUSTED CLINICAL GROUPS (ACG) SYSTEM" />
    <edge source="BASQUE COUNTRY" target="UNPLANNED HOSPITALIZATION" />
    <edge source="SIMULATING INDIVIDUAL-LEVEL TRIAL DATA" target="REAL-WORLD DATA (RWD)" />
    <edge source="SIMULATING INDIVIDUAL-LEVEL TRIAL DATA" target="SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS&#8211;MEDICARE DATA" />
    <edge source="SIMULATING INDIVIDUAL-LEVEL TRIAL DATA" target="KAPLAN-MEIER ESTIMATES" />
    <edge source="FLYBASE" target="MOUSE GENOME INFORMATICS" />
    <edge source="FLYBASE" target="WORMBASE" />
    <edge source="FLYBASE" target="THE ARABIDOPSIS INFORMATION RESOURCE" />
    <edge source="MOUSE GENOME INFORMATICS" target="WORMBASE" />
    <edge source="MOUSE GENOME INFORMATICS" target="THE ARABIDOPSIS INFORMATION RESOURCE" />
    <edge source="WORMBASE" target="THE ARABIDOPSIS INFORMATION RESOURCE" />
    <edge source="YOUNG RESEARCHER PHYSICIANS" target="CONSORT" />
    <edge source="YOUNG RESEARCHER PHYSICIANS" target="ARRIVE" />
    <edge source="YOUNG RESEARCHER PHYSICIANS" target="GRRAS" />
    <edge source="YOUNG RESEARCHER PHYSICIANS" target="SAMPL" />
    <edge source="BARRIERS" target="FACILITATORS" />
    <edge source="LONGSHI SCALE" target="WECHAT" />
    <edge source="LONGSHI SCALE" target="SECOND PEOPLE'S HOSPITAL OF SHENZHEN" />
    <edge source="LONGSHI SCALE" target="CLINICAL TRIAL REGISTER CENTER" />
    <edge source="LONGSHI SCALE" target="NCT05214638" />
    <edge source="WECHAT" target="AM-SAS" />
    <edge source="SECOND PEOPLE'S HOSPITAL OF SHENZHEN" target="SHENZHEN" />
    <edge source="SECOND PEOPLE'S HOSPITAL OF SHENZHEN" target="ETHICS COMMITTEE" />
    <edge source="ETHICS COMMITTEE" target="IMPLEMENTATION SCIENCE" />
    <edge source="SELINEXOR" target="NCT02419495" />
    <edge source="NUCLEAR EXPORT PROTEINS" target="TUMOR SUPPRESSOR PROTEINS" />
    <edge source="TANOM-HS" target="BIOPORTAL" />
    <edge source="JBI" target="INTERNATIONAL SCIENTIFIC COMMITTEE" />
    <edge source="MASHHAD UNIVERSITY OF MEDICAL SCIENCES" target="FAMILY PHYSICIAN PROGRAM" />
    <edge source="MASHHAD UNIVERSITY OF MEDICAL SCIENCES" target="SINA SYSTEM" />
    <edge source="MASHHAD UNIVERSITY OF MEDICAL SCIENCES" target="ELECTRONIC PATIENT REFERRAL SYSTEM" />
    <edge source="ELECTRONIC PATIENT REFERRAL SYSTEM" target="INTERNET INFRASTRUCTURE" />
    <edge source="ELECTRONIC PATIENT REFERRAL SYSTEM" target="APPOINTMENT SCHEDULING" />
    <edge source="ELECTRONIC PATIENT REFERRAL SYSTEM" target="INTERDEPARTMENTAL COORDINATION" />
    <edge source="ELECTRONIC PATIENT REFERRAL SYSTEM" target="RECORDING DEFINITIVE DIAGNOSIS CODES" />
    <edge source="ELECTRONIC PATIENT REFERRAL SYSTEM" target="FALSE REFERRALS" />
    <edge source="ELECTRONIC PATIENT REFERRAL SYSTEM" target="HEALTH INDICATORS" />
    <edge source="BREASTCHOICE" target="MIDWESTERN MEDICAL SPECIALTY CENTERS" />
    <edge source="BREASTCHOICE" target="AUGUST 2020 TO APRIL 2021" />
    <edge source="WEARABLE ELECTROCARDIOGRAM (ECG) SENSORS" target="CONVOLUTION NEURAL NETWORKS (CNN)" />
    <edge source="WEARABLE ELECTROCARDIOGRAM (ECG) SENSORS" target="PANDEMICS" />
    <edge source="WEARABLE ELECTROCARDIOGRAM (ECG) SENSORS" target="HEALTHCARE FACILITIES" />
    <edge source="CONVOLUTION NEURAL NETWORKS (CNN)" target="PANDEMICS" />
    <edge source="CONVOLUTION NEURAL NETWORKS (CNN)" target="DATABASE" />
    <edge source="DATABASE" target="CENTRALIZED SERVER" />
    <edge source="IDEALIZATION" target="SCIENTIFIC THEORIES" />
    <edge source="IDEALIZATION" target="REPRESENTATIONAL IDEALS" />
    <edge source="CERT" target="SPORTS AND EXERCISE MEDICINE JOURNALS" />
    <edge source="SPORTS AND EXERCISE MEDICINE JOURNALS" target="TIDIER" />
    <edge source="FIBROIDS" target="CONVERSATION AIDS" />
    <edge source="CONVERSATION AIDS" target="MORVILLE'S HONEYCOMB FRAMEWORK" />
    <edge source="CONVERSATION AIDS" target="FRAME" />
    <edge source="CONVERSATION AIDS" target="SPANISH TRANSLATIONS" />
    <edge source="CONVERSATION AIDS" target="DECEMBER 2018" />
    <edge source="IMPLEMENTATION PROJECT" target="UTERINE FIBROIDS" />
    <edge source="BRCA1/2" target="INTERNATIONAL CANCER OF THE PANCREAS SCREENING (CAPS)" />
    <edge source="BRCA1/2" target="AMERICAN COLLEGE OF GASTROENTEROLOGY (ACG)" />
    <edge source="XG-BOOST" target="AU-ROC" />
    <edge source="MYELOPROLIFERATIVE NEOPLASMS" target="POLYCYTHEMIA VERA" />
    <edge source="MYELOPROLIFERATIVE NEOPLASMS" target="ESSENTIAL THROMBOCYTHEMIA" />
    <edge source="POLYCYTHEMIA VERA" target="ROPEGINTERFERON ALFA-2B" />
    <edge source="POLYCYTHEMIA VERA" target="HEPCIDIN MIMESIS" />
    <edge source="ROPEGINTERFERON ALFA-2B" target="ESSENTIAL THROMBOCYTHEMIA" />
    <edge source="U.S. NATIONAL HEALTH INTERVIEW SURVEYS" target="1890 BIRTH COHORT" />
    <edge source="1890 BIRTH COHORT" target="SMOKING HISTORY GENERATOR" />
    <edge source="1890 BIRTH COHORT" target="TOBACCO CONTROL INTERVENTIONS" />
    <edge source="1890 BIRTH COHORT" target="CIGARETTE SMOKING INTERVENTION STRATEGIES" />
    <edge source="SMOKING HISTORY GENERATOR" target="MICRO-SIMULATION MODELS" />
    <edge source="MULTIPLE SCLEROSIS" target="EXPANDED DISABILITY STATUS SCALE" />
    <edge source="MULTIPLE SCLEROSIS" target="NEUROIMAGING DATA" />
    <edge source="MULTIPLE SCLEROSIS" target="CLINICAL NOTES" />
    <edge source="CLINICAL NOTES" target="COMPUTATIONAL TEXT PHENOTYPING" />
    <edge source="SCIENTIFIC COMPUTING" target="MODELLING AND SIMULATION" />
    <edge source="MODELLING AND SIMULATION" target="VERIFICATION AND VALIDATION" />
    <edge source="MODELLING AND SIMULATION" target="ENGINEERING" />
    <edge source="MODELLING AND SIMULATION" target="TECHNOLOGY AND INDUSTRY" />
    <edge source="MODELLING AND SIMULATION" target="ENVIRONMENTAL REGULATIONS AND SAFETY" />
    <edge source="MODELLING AND SIMULATION" target="PRODUCT AND PLANT SAFETY" />
    <edge source="MODELLING AND SIMULATION" target="FINANCIAL INVESTING" />
    <edge source="MODELLING AND SIMULATION" target="GOVERNMENTAL REGULATIONS" />
    <edge source="MODELLING AND SIMULATION" target="RESEARCHERS, PRACTITIONERS, AND DECISION MAKERS" />
    <edge source="PARTIAL DIFFERENTIAL AND INTEGRAL EQUATIONS" target="NUMERICAL SOLUTION" />
    <edge source="CHD MODELLING STUDIES" target="CHD POLICY MODELS" />
    <edge source="CHD POLICY MODELS" target="LIFE TABLE ANALYSES" />
    <edge source="CHD POLICY MODELS" target="MICRO-SIMULATION" />
    <edge source="CHD POLICY MODELS" target="CELL-BASED MODELS" />
    <edge source="QUALITY OF LIFE QUESTIONNAIRE CORE 30" target="EQ-5D-3L INDEX" />
    <edge source="HEALTH ECONOMICS RESEARCHERS" target="MAPPING STUDIES" />
    <edge source="HEALTH ECONOMICS RESEARCHERS" target="SAMPLE SIZE CALCULATION" />
    <edge source="MAPPING STUDIES" target="SAMPLE SIZE CALCULATION" />
    <edge source="IMPLEMENTATION SCIENCE" target="FIND TMF" />
    <edge source="GENERAL CIRCULATION MODELS" target="CLIMATE RESEARCH" />
    <edge source="MULTIDISCIPLINARY TEAMS (MDTS)" target="CLINICAL DECISION SUPPORT SYSTEMS (CDSSS)" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEMS (CDSSS)" target="MATHIJS P. HENDRIKS" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEMS (CDSSS)" target="KEES C. EBBEN" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEMS (CDSSS)" target="JANINE A. VAN TIL" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEMS (CDSSS)" target="AGNES JAGER" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEMS (CDSSS)" target="SABINE SIESLING" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEMS (CDSSS)" target="JIMMA HEALTH CENTER" />
    <edge source="SAN ANTONIO BREAST CANCER SYMPOSIUM" target="SAN ANTONIO, TX" />
    <edge source="SAN ANTONIO BREAST CANCER SYMPOSIUM" target="AACR" />
    <edge source="AACR" target="CANCER RES" />
    <edge source="EQ-5D-3L" target="UK EQ-5D-3L VALUATION STUDY" />
    <edge source="EQ-5D-3L" target="UTILITY SCORES" />
    <edge source="EQ-5D-3L" target="MAXIMUM ENDURABLE TIME (MET)" />
    <edge source="EQ-5D-3L" target="MONOTONICITY" />
    <edge source="UK EQ-5D-3L VALUATION STUDY" target="MARKOV CHAIN MONTE CARLO (MCMC)" />
    <edge source="UK EQ-5D-3L VALUATION STUDY" target="KULLBACK&#8211;LEIBLER (KL) DIVERGENCE" />
    <edge source="UK EQ-5D-3L VALUATION STUDY" target="BROYDEN&#8211;FLETCHER&#8211;GOLDFARB&#8211;SHANNO (BFGS) ALGORITHM" />
    <edge source="UK EQ-5D-3L VALUATION STUDY" target="HIERARCHICAL MODEL" />
    <edge source="UK EQ-5D-3L VALUATION STUDY" target="ECONOMIC EVALUATIONS" />
    <edge source="ECONOMIC EVALUATIONS" target="PRICE-THRESHOLD ANALYSES" />
    <edge source="ECONOMIC EVALUATIONS" target="QUALITY-ADJUSTED LIFE-YEAR" />
    <edge source="ECONOMIC EVALUATIONS" target="IMPACT MATRICES" />
    <edge source="ECONOMIC EVALUATIONS" target="COST-CONSEQUENCE ANALYSIS" />
    <edge source="POSTERIOR DISTRIBUTIONS" target="MIXTURES OF NORMAL DISTRIBUTIONS" />
    <edge source="ACE-ITS PROGRAM" target="NATIONAL INSTITUTE OF MINORITY HEALTH AND HEALTH DISPARITIES" />
    <edge source="ACE-ITS PROGRAM" target="PRACTICAL ROBUST IMPLEMENTATION AND SUSTAINABILITY MODEL" />
    <edge source="ACE-ITS PROGRAM" target="BLACK AND HISPANIC WOMEN" />
    <edge source="ACE-ITS PROGRAM" target="GENETIC COUNSELORS" />
    <edge source="ACE-ITS PROGRAM" target="COMMUNITY PARTNERS" />
    <edge source="ACE-ITS PROGRAM" target="GENETIC RISK ASSESSMENT" />
    <edge source="ACE-ITS PROGRAM" target="GENETIC COUNSELING/TESTING" />
    <edge source="DOAC PRESCRIPTION" target="INFORMED DECISION MAKING" />
    <edge source="WARFARIN PRESCRIPTION" target="INFORMED DECISION MAKING" />
    <edge source="INFORMED DECISION MAKING" target="HYPOTHETICAL BREAST CANCER SCREENING" />
    <edge source="CLINICAL DEEP PHENOTYPING" target="PHENOTYPE ANNOTATION" />
    <edge source="GPT-3.5-TURBO" target="GPT-4.0" />
    <edge source="GPT-4.0" target="IN-CONTEXT LEARNING" />
    <edge source="GPT-4.0" target="RARE DISORDERS FIELD" />
    <edge source="PUBLICATION ABSTRACTS" target="CLINICAL OBSERVATIONS" />
    <edge source="NOVEL HEALTHCARE TECHNOLOGIES" target="ONLINE SURVEY" />
    <edge source="NOVEL HEALTHCARE TECHNOLOGIES" target="GENERAL PRACTITIONER" />
    <edge source="NOVEL HEALTHCARE TECHNOLOGIES" target="LASER-BASED TOOL" />
    <edge source="NOVEL HEALTHCARE TECHNOLOGIES" target="VIRTUAL REALITY TOOL" />
    <edge source="NOVEL HEALTHCARE TECHNOLOGIES" target="NON-INVASIVE CONTINUOUS GLUCOSE MONITOR" />
    <edge source="NOVEL HEALTHCARE TECHNOLOGIES" target="MOBILE APP" />
    <edge source="HYPERTENSION MANAGEMENT STUDY" target="SPSS STATISTICS 24" />
    <edge source="INSURANCE INFORMATION DISCLOSURE" target="JANUARY 2023" />
    <edge source="JANUARY 2023" target="PHARMACEUTICAL DISCOUNT DISCLOSURE" />
    <edge source="PROVIDERS" target="CHEMOPREVENTION" />
    <edge source="PROVIDERS" target="DECISION SUPPORT TOOLS" />
    <edge source="MENTAL HEALTH-RELATED ED VISITS" target="SUICIDE-RELATED VISITS" />
    <edge source="MAXIMUM CARE HOSPITAL" target="MEDICAL DATA INTEGRATION CENTER (MEDIC)" />
    <edge source="STHLM3" target="PROSTATA MODEL" />
    <edge source="CHARLES HUGGINS" target="NOBEL PRIZE IN MEDICINE" />
    <edge source="CHARLES HUGGINS" target="TESTOSTERONE" />
    <edge source="CHARLES HUGGINS" target="ORCHIECTOMY" />
    <edge source="CRYOSTAT-2" target="CLINICALTRIALS.GOV IDENTIFIER: NCT04704869" />
    <edge source="CRYOSTAT-2" target="ISRCTN IDENTIFIER: ISRCTN14998314" />
    <edge source="HOMEOSTASIS IMBALANCE PROCESS ONTOLOGY (HOIP)" target="COVID-19 ONTOLOGY HARMONISATION WORKING GROUP" />
    <edge source="CLINICAL TRIAL SCREENING FRAMEWORK" target="PATIENT ELECTRONIC HEALTH RECORD" />
    <edge source="CLINICAL TRIAL SCREENING FRAMEWORK" target="REGIONAL TRIAL ELIGIBILITY SCREENING" />
    <edge source="CLINICAL TRIAL SCREENING FRAMEWORK" target="AUTOMATED REGIONAL SEARCH TOOL" />
    <edge source="PATIENT ELECTRONIC HEALTH RECORD" target="AUTOMATED REGIONAL SEARCH TOOL" />
    <edge source="FIND TMF" target="THEORIES, MODELS AND FRAMEWORKS (TMFS)" />
    <edge source="HFPEF" target="NCT02145351" />
    <edge source="HFPEF" target="PACEMAKER" />
    <edge source="HFPEF" target="KANSAS CITY CARDIOMYOPATHY QUESTIONNAIRE" />
    <edge source="REGULEM" target="UNIFIED PROTOCOL" />
    <edge source="DESCRIPTIVE FOREST" target="C4.5 TREE" />
    <edge source="DESCRIPTIVE FOREST" target="HEART FAILURE&#8211;PREDICTION DATASET" />
    <edge source="DESCRIPTIVE FOREST" target="HEART DISEASE HEALTH&#8211;INDICATORS DATASET" />
    <edge source="CARDIOVASCULAR CARE" target="AI-ENABLED MEDICAL DEVICES" />
    <edge source="AGE-RELATED MACULAR DEGENERATION" target="REHAB-AMD" />
    <edge source="REHAB-AMD" target="VISION REHABILITATION EXPERT" />
    <edge source="REHAB-AMD" target="AMD PATIENTS" />
    <edge source="VISION REHABILITATION EXPERT" target="AMD PATIENTS" />
    <edge source="IMPLEMENTATION SUPPORT TEAM" target="EXPERT RECOMMENDATIONS FOR IMPLEMENTING CHANGE" />
    <edge source="IMPLEMENTATION SUPPORT TEAM" target="PROCTOR ET AL.'S REPORTING FRAMEWORK" />
    <edge source="IMPLEMENTATION SUPPORT TEAM" target="CONSOLIDATED FRAMEWORK FOR IMPLEMENTATION RESEARCH" />
    <edge source="IMPLEMENTATION SUPPORT TEAM" target="FRAMEWORK FOR REPORTING ADAPTATIONS AND MODIFICATIONS-ENHANCED" />
    <edge source="IMPLEMENTATION SUPPORT TEAM" target="CLINICALTRIALS.GOV ID: NCT03607617" />
    <edge source="IMPLEMENTATION SUPPORT TEAM" target="COMMUNITY CLINICS" />
    <edge source="IMPLEMENTATION SUPPORT TEAM" target="FACILITATION-FOCUSED STRATEGY" />
    <edge source="IMPLEMENTATION SUPPORT TEAM" target="CLINIC-LEVEL STRATEGY ADDITION" />
    <edge source="IMPLEMENTATION SUPPORT TEAM" target="STUDY-LEVEL STRATEGY ADDITION" />
    <edge source="COMMUNITY CLINICS" target="SOCIAL DETERMINANTS OF HEALTH-RELATED ACTIVITIES" />
    <edge source="SURVIVORSHIP CARE PLANS" target="ADULT CANCER SURVIVORS" />
    <edge source="SURVIVORSHIP CARE PLANS" target="PARENT PROXIES" />
    <edge source="SURVIVORSHIP CARE PLANS" target="CANCER-RELATED FOLLOW-UP CARE" />
    <edge source="NIGERIA" target="2018 NIGERIA DEMOGRAPHIC AND HEALTH SURVEY" />
    <edge source="UNDER-FIVE MORTALITY" target="K-NEAREST NEIGHBOURHOOD" />
    <edge source="HEALTH AND RETIREMENT STUDY" target="LOW-WAGE EARNING" />
    <edge source="LOW-WAGE EARNING" target="EMPLOYMENT INSTABILITY" />
    <edge source="LOW-WAGE EARNING" target="COX PROPORTIONAL HAZARDS" />
    <edge source="LOW-WAGE EARNING" target="ADDITIVE HAZARDS REGRESSION MODELS" />
    <edge source="LOW-WAGE EARNING" target="FEDERAL POVERTY LINE" />
    <edge source="LOW-WAGE EARNING" target="MINIMUM WAGE LAWS" />
    <edge source="DRUG REPURPOSING" target="PROTEIN SEQUENCES" />
    <edge source="CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)" target="EXTREME OBESITY" />
    <edge source="CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)" target="AALL03N1" />
    <edge source="EXTREME OBESITY" target="ERYTHROCYTE THIOGUANINE NUCLEOTIDE (TGN) LEVELS" />
    <edge source="STEREOTACTIC BODY RADIATION THERAPY" target="SPINAL METASTASES" />
    <edge source="KAMPO MEDICINE" target="JAPANESE PHARMACOPOEIA" />
    <edge source="IBM WATSON" target="NATURAL LANGUAGE CLASSIFIER" />
    <edge source="NATURAL LANGUAGE CLASSIFIER" target="PHARMACISTS" />
    <edge source="NATURAL LANGUAGE CLASSIFIER" target="PHARMACY STUDENTS" />
    <edge source="NATURAL LANGUAGE CLASSIFIER" target="VALIDATION QUESTIONS" />
    <edge source="PHARMACISTS" target="TANYA OBAT" />
    <edge source="HEALTH DISPARITIES AND MINORITY HEALTH" target="HDMH MONITOR" />
    <edge source="HEALTH DISPARITIES AND MINORITY HEALTH" target="MENTAL HEALTH" />
    <edge source="HEALTH DISPARITIES AND MINORITY HEALTH" target="ENDOCRINE/METABOLIC DISORDERS" />
    <edge source="HEALTH DISPARITIES AND MINORITY HEALTH" target="HEARING CONDITIONS" />
    <edge source="HEALTH DISPARITIES AND MINORITY HEALTH" target="VISION CONDITIONS" />
    <edge source="HEALTH DISPARITIES AND MINORITY HEALTH" target="SKIN-RELATED CONDITIONS" />
    <edge source="FERMI" target="V-A THEORY" />
    <edge source="V-A THEORY" target="PARITY NONCONSERVATION" />
    <edge source="WORLD WAR II" target="BETA-DECAY THEORY" />
    <edge source="CRGNB" target="SVM" />
    <edge source="BARIATRIC SURGERY" target="CHRONIC MYELOID LEUKEMIA (CML)" />
    <edge source="BARIATRIC SURGERY" target="EARLY MOLECULAR RESPONSE" />
    <edge source="BARIATRIC SURGERY" target="COMPLETE CYTOGENETIC RESPONSE" />
    <edge source="BARIATRIC SURGERY" target="MAJOR MOLECULAR RESPONSE" />
    <edge source="BARIATRIC SURGERY" target="FAILURE-FREE SURVIVAL" />
    <edge source="FEDERATED LEARNING" target="CONTINUAL LEARNING FRAMEWORK" />
    <edge source="FEDERATED LEARNING" target="ACUTE PULMONARY THROMBOEMBOLISM" />
    <edge source="FEDERATED LEARNING" target="PULMONARY EMBOLISM SEVERITY INDEX" />
    <edge source="FEDERATED LEARNING" target="SIMPLIFIED PULMONARY EMBOLISM SEVERITY INDEX" />
    <edge source="FEDERATED LEARNING" target="MULTI LAYER PERCEPTRON" />
    <edge source="FEDERATED LEARNING" target="NONFED" />
    <edge source="CONTINUAL LEARNING FRAMEWORK" target="GENERATIVE ADVERSARIAL NETWORK" />
    <edge source="CONTINUAL LEARNING FRAMEWORK" target="ELECTROCARDIOGRAM DATASETS" />
    <edge source="CONTINUAL LEARNING FRAMEWORK" target="ARRHYTHMIA DETECTION MODEL" />
    <edge source="CONTINUAL LEARNING FRAMEWORK" target="SUPERVISED LEARNING METHODS" />
    <edge source="CONTINUAL LEARNING FRAMEWORK" target="FINETUNING APPROACHES" />
    <edge source="ELECTROCARDIOGRAM DATASETS" target="ARRHYTHMIA DETECTION MODEL" />
    <edge source="ALLENEOGENEIC HEMATOPOIETIC CELL TRANSPLANT" target="2013-2019" />
    <edge source="CLINICAL INTERVENTIONS" target="SURVIVAL PREDICTIONS" />
    <edge source="SURVIVAL PREDICTIONS" target="PREDICTION LATENCY" />
    <edge source="CHONGQING MEDICAL UNIVERSITY" target="POST-STROKE DEPRESSION" />
    <edge source="CHONGQING MEDICAL UNIVERSITY" target="LIVER FUNCTION TEST INDICES" />
    <edge source="CHONGQING MEDICAL UNIVERSITY" target="NANCHONG CENTRAL HOSPITAL" />
    <edge source="CHONGQING MEDICAL UNIVERSITY" target="AFFILIATED HOSPITAL OF SOUTHWEST MEDICAL UNIVERSITY" />
    <edge source="CHONGQING MEDICAL UNIVERSITY" target="HAIFU HOSPITAL" />
    <edge source="POST-STROKE DEPRESSION" target="LIVER FUNCTION TEST INDICES" />
    <edge source="POST-STROKE DEPRESSION" target="GBDT MODEL" />
    <edge source="RADIOFREQUENCY ABLATION" target="SINGLE MEDICAL CENTER" />
    <edge source="RADIOFREQUENCY ABLATION" target="TRANSFORMER ALGORITHM" />
    <edge source="PNEUMONIA" target="CURB-65" />
    <edge source="PNEUMONIA" target="BLOOD CULTURE PREDICTION INDEX (BCPI)" />
    <edge source="CURB-65" target="30-DAY MORTALITY RATE" />
    <edge source="BLOOD CULTURE PREDICTION INDEX (BCPI)" target="30-DAY MORTALITY RATE" />
    <edge source="VALGANCICLOVIR" target="LETERMOVIR" />
    <edge source="VALGANCICLOVIR" target="CYTOMEGALOVIRUS" />
    <edge source="VALGANCICLOVIR" target="MYELOSUPPRESSION" />
    <edge source="VALGANCICLOVIR" target="LEUKOPENIA" />
    <edge source="LETERMOVIR" target="EUDRACT" />
    <edge source="LETERMOVIR" target="CYTOMEGALOVIRUS" />
    <edge source="LETERMOVIR" target="LEUKOPENIA" />
    <edge source="LINGO3G" target="HUMAN RESEARCHER" />
    <edge source="OVERDIAGNOSIS" target="REDS" />
    <edge source="OVERDIAGNOSIS" target="INFORMATION CONFLICT" />
    <edge source="OVERDIAGNOSIS" target="FEMALE PARTICIPANTS" />
    <edge source="SHUGUANG HOSPITAL" target="SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE" />
    <edge source="SHUGUANG HOSPITAL" target="MAMMARY DEPARTMENT" />
    <edge source="TEST TRADEOFF CURVE" target="RISK PREDICTION" />
    <edge source="TEST TRADEOFF CURVE" target="BENEFIT-COST RATIO" />
    <edge source="TEST TRADEOFF CURVE" target="RISK THRESHOLD" />
    <edge source="RISK-COMMUNICATION APPROACHES STUDY" target="DISCRETE CHOICE EXPERIMENTS (DCES)" />
    <edge source="RISK-COMMUNICATION APPROACHES STUDY" target="HEALTH LITERACY" />
    <edge source="ROBERT AXELROD" target="THE EVOLUTION OF COOPERATION" />
    <edge source="ROBERT AXELROD" target="THE COMPLEXITY OF COOPERATION" />
    <edge source="THE EVOLUTION OF COOPERATION" target="THE COMPLEXITY OF COOPERATION" />
    <edge source="CHINESE PHARMACEUTICAL MARKET" target="CHINESE REGULATORY AGENCIES" />
    <edge source="ANTICANCER DRUGS" target="DRUG APPROVAL" />
    <edge source="EXPERIMENTAL SYSTEM" target="EXPERIMENTAL LANDSCAPE" />
    <edge source="SMALL CELL LUNG CANCER" target="PD1 BLOCKADE" />
    <edge source="SMALL CELL LUNG CANCER" target="IMMUNE CHECK POINT INHIBITORS" />
    <edge source="SMALL CELL LUNG CANCER" target="WHOLE TRANSCRIPTOMICS" />
    <edge source="SMALL CELL LUNG CANCER" target="CHEMOIMMUNOTHERAPY" />
    <edge source="SMALL CELL LUNG CANCER" target="RADIATION" />
    <edge source="CORONARY ANGIOGRAPHY" target="AP" />
    <edge source="SPSS 15" target="DAS" />
    <edge source="SPSS 15" target="KEARNEY-FLESCHER SELF-CARE SURVEY" />
    <edge source="PERSIAN CONDITION-SPECIFIC EHEALTH LITERACY SCALE FOR DIABETES (PERSIAN CEHLS-D)" target="TYPE 2 DIABETES MELLITUS (T2DM)" />
    <edge source="HYBRID RESUNET MODEL" target="ANT COLONY OPTIMIZATION (ACO)" />
    <edge source="HYBRID RESUNET MODEL" target="RESNET" />
    <edge source="HYBRID RESUNET MODEL" target="U-NET" />
    <edge source="HYBRID RESUNET MODEL" target="SKIN LESION SEGMENTATION" />
    <edge source="HYBRID RESUNET MODEL" target="SKIN LESION CLASSIFICATION" />
    <edge source="CONTROL PREFERENCE SCALE" target="SHARED DECISION-MAKING QUESTIONNAIRE (SDM-Q-9)" />
    <edge source="ORAL MUCOSITIS" target="SQUAMOUS CELL CARCINOMA" />
    <edge source="ORAL MUCOSITIS" target="LATENT GROUPS" />
    <edge source="ORAL MUCOSITIS" target="ILLUMINA" />
    <edge source="IMMUNE CHECKPOINT INHIBITORS (ICIS)" target="CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)" />
    <edge source="IMMUNE CHECKPOINT INHIBITORS (ICIS)" target="CONGESTIVE HEART FAILURE (CHF)" />
    <edge source="IMMUNE CHECKPOINT INHIBITORS (ICIS)" target="IMMUNE-RELATED ADVERSE EVENTS (IRAES)" />
    <edge source="IMMUNE CHECKPOINT INHIBITORS (ICIS)" target="AUTHORS' INSTITUTION" />
    <edge source="JANUARY 1, 2015" target="JANUARY 1, 2021" />
    <edge source="KMT2A-REARRANGED AML" target="DISSEMINATED INTRAVASCULAR COAGULATION" />
    <edge source="ELECTRONIC COMMUNITY HEALTH INFORMATION SYSTEM" target="HEALTH EXTENSION WORKERS" />
    <edge source="ELECTRONIC COMMUNITY HEALTH INFORMATION SYSTEM" target="REVISED TECHNOLOGY ACCEPTANCE MODEL" />
    <edge source="ELECTRONIC COMMUNITY HEALTH INFORMATION SYSTEM" target="SIX REGIONS OF ETHIOPIA" />
    <edge source="COX PROPORTIONAL HAZARDS MODEL" target="NAFLD" />
    <edge source="COX PROPORTIONAL HAZARDS MODEL" target="FBS" />
    <edge source="PREDIABETIC PATIENTS" target="SOUTHWEST IRAN" />
    <edge source="AGITATION CLASSIFIER" target="THRESHOLD" />
    <edge source="COMMUNITY-ACADEMIC PARTNERSHIP" target="COMMUNITY TASK FORCE" />
    <edge source="COMMUNITY TASK FORCE" target="BREAST CANCER DISPARITIES" />
    <edge source="BUFFALO, NEW YORK" target="BREAST CANCER DISPARITIES" />
    <edge source="HOSPITAL-INDUCED DELIRIUM" target="MULTIDISCIPLINARY TASK FORCE" />
    <edge source="HOSPITAL-INDUCED DELIRIUM" target="PROGNOSTIC MODELS" />
    <edge source="PROGNOSTIC MODELS" target="RETROSPECTIVE COHORT STUDY" />
    <edge source="RETROSPECTIVE COHORT STUDY" target="ADMINISTRATIVE AND ELECTRONIC HEALTH RECORDS" />
    <edge source="GENERALIZED ANXIETY DISORDER (GAD)" target="PSYCHINFO" />
    <edge source="GENERALIZED ANXIETY DISORDER (GAD)" target="GAD-2" />
    <edge source="GENERALIZED ANXIETY DISORDER (GAD)" target="GAD-7" />
    <edge source="GENERALIZED ANXIETY DISORDER (GAD)" target="ENGLISH-LANGUAGE ORIGINAL STUDIES" />
    <edge source="GENERALIZED ANXIETY DISORDER (GAD)" target="RCTS" />
    <edge source="OBSTRUCTIVE SLEEP APNEA" target="EPWORTH SLEEPINESS SCALE" />
    <edge source="OBSTRUCTIVE SLEEP APNEA" target="BERLIN QUESTIONNAIRE" />
    <edge source="INDONESIA" target="TANYA OBAT" />
    <edge source="INDONESIA" target="BAYESIAN MODELS" />
    <edge source="TANYA OBAT" target="BANDUNG CITY" />
    <edge source="DECISION-CURVE ANALYSIS" target="APSIII" />
    <edge source="DECISION-CURVE ANALYSIS" target="SAPSII" />
    <edge source="MODILM" target="GRAPH ATTENTION NETWORKS" />
    <edge source="MODILM" target="MULTILAYER PERCEPTRON NETWORKS" />
    <edge source="MODILM" target="VIEW CORRELATION DISCOVERY NETWORK" />
    <edge source="MODILM" target="COMPLEX DISEASES" />
    <edge source="MODILM" target="MULTI-OMICS DATA" />
    <edge source="MODILM" target="MIRNA EXPRESSION" />
    <edge source="MODILM" target="MRNA" />
    <edge source="MRNA" target="TCGA DATABASE" />
    <edge source="MRNA" target="MIRNA" />
    <edge source="MRNA" target="METHYLATION" />
    <edge source="VEXAS SYNDROME" target="UBA1" />
    <edge source="UBA1" target="GEISINGER" />
    <edge source="QATAR BIOBANK" target="RF" />
    <edge source="QATAR BIOBANK" target="T12" />
    <edge source="QATAR BIOBANK" target="TROCH" />
    <edge source="QATAR BIOBANK" target="TRUNK AREA" />
    <edge source="IMPACT-AF" target="NOVA SCOTIA" />
    <edge source="IMPACT-AF" target="COMPUTERIZED DECISION SUPPORT SYSTEM" />
    <edge source="SEMANTIC WEB COMMUNITY" target="RDF" />
    <edge source="RDF" target="HL7 RIM" />
    <edge source="RDF" target="CDISC CDASH" />
    <edge source="RDF" target="DCT" />
    <edge source="RDF" target="SIO" />
    <edge source="RDF" target="FOAF" />
    <edge source="RDF" target="ORDO" />
    <edge source="RDF" target="GRDDL" />
    <edge source="CHENGDU" target="CEREBROVASCULAR DISEASE" />
    <edge source="CEREBROVASCULAR DISEASE" target="STACKING ENSEMBLE MODEL" />
    <edge source="CEREBROVASCULAR DISEASE" target="HOSPITAL ADMISSIONS" />
    <edge source="STACKING ENSEMBLE MODEL" target="AIR QUALITY DATA" />
    <edge source="STACKING ENSEMBLE MODEL" target="METEOROLOGICAL DATA" />
    <edge source="HOSPITAL INFORMATION SYSTEMS" target="EMERGENCY QUERY PROGRAM" />
    <edge source="HOSPITAL INFORMATION SYSTEMS" target="EMERGENCY PRESCRIPTION SYSTEM" />
    <edge source="EMERGENCY PRESCRIPTION SYSTEM" target="MICROSOFT POWER PLATFORM" />
    <edge source="EMERGENCY PRESCRIPTION SYSTEM" target="MICROSOFT TEAMS" />
    <edge source="VIRTUAL REALITY" target="EFFECTIVE PUBLIC HEALTH PRACTICE PROJECT (EPHPP) TOOL" />
    <edge source="KOREAN NATIONAL HEALTH INSURANCE SERVICE" target="GASTRIC CANCER SURGERY" />
    <edge source="ECG MACHINES" target="RESNET 50" />
    <edge source="CONGESTIVE HEART FAILURE" target="NORMAL SINUS RHYTHM" />
    <edge source="MIT-BIH" target="PHYSIONET" />
    <edge source="PHYSIONET" target="BIDMC" />
    <edge source="MANUFACTURER" target="PAYER" />
    <edge source="MANUFACTURER" target="PRICE-THRESHOLD ANALYSES" />
    <edge source="MANUFACTURER" target="INDICATION-SPECIFIC PRICES" />
    <edge source="PAYER" target="PRICE-THRESHOLD ANALYSES" />
    <edge source="PAYER" target="REIMBURSEMENT DECISIONS" />
    <edge source="INDICATION-SPECIFIC PRICES" target="REIMBURSEMENT DECISIONS" />
    <edge source="MAXIMUM ENDURABLE TIME (MET)" target="QALY MODELS" />
    <edge source="MONOTONICITY" target="PREFERENCE REVERSALS" />
    <edge source="MONOTONICITY" target="TRANSITIVITY VIOLATIONS" />
    <edge source="QALY MODELS" target="PREFERENCE REVERSALS" />
    <edge source="LIGHT GRADIENT BOOSTING" target="CATHEPSIN B" />
    <edge source="LIGHT GRADIENT BOOSTING" target="ADA-BOOSTING OF DECISION TREE" />
    <edge source="LIGHT GRADIENT BOOSTING" target="MULTILAYER PERCEPTION" />
    <edge source="LIGHT GRADIENT BOOSTING" target="GRADIENT BOOSTING DECISION TREE" />
    <edge source="INTRAOPERATIVE BLEEDING" target="SURGICAL INPATIENTS" />
    <edge source="AM-SAS" target="ADENOMYOSIS" />
    <edge source="SWITZERLAND" target="CPR SURVIVAL RATES STUDY" />
    <edge source="CPR SURVIVAL RATES STUDY" target="SURVEY ON HEALTH, AGEING, AND RETIREMENT IN EUROPE (SHARE)" />
    <edge source="CKD MANAGEMENT CENTER" target="APP + OUTPATIENT FOLLOW-UP" />
    <edge source="CKD MANAGEMENT CENTER" target="TRADITIONAL OUTPATIENT FOLLOW-UP" />
    <edge source="APP + OUTPATIENT FOLLOW-UP" target="PHOSPHORUS" />
    <edge source="APP + OUTPATIENT FOLLOW-UP" target="SODIUM" />
    <edge source="APP + OUTPATIENT FOLLOW-UP" target="TRIGLYCERIDE" />
    <edge source="APP + OUTPATIENT FOLLOW-UP" target="HEMOGLOBIN" />
    <edge source="KNOWLEDGE-BASED HEALTHCARE-ASSOCIATED INFECTIONS SURVEILLANCE SYSTEM (KBHAIS)" target="GANSU PROVINCIAL HOSPITAL" />
    <edge source="EARLY DETECTION" target="SCREENING PROTOCOLS" />
    <edge source="BARRETT'S ESOPHAGUS" target="ESOPHAGEAL ADENOCARCINOMA" />
    <edge source="BARRETT'S ESOPHAGUS" target="GASTROESOPHAGEAL REFLUX DISEASE" />
    <edge source="ESOPHAGEAL ADENOCARCINOMA" target="U.S. CANCER REGISTRY" />
    <edge source="TOTAL PRODUCT LIFECYCLE MANAGEMENT" target="POST-MARKET SURVEILLANCE" />
    <edge source="EMBOLIZATION COILS" target="SOCIETY OF INTERVENTIONAL RADIOLOGY" />
    <edge source="EMBOLIZATION COILS" target="COOK MEDICAL" />
    <edge source="EMBOLIZATION COILS" target="COOK MEDICAL TORNADO" />
    <edge source="EMBOLIZATION COILS" target="NESTER" />
    <edge source="EMBOLIZATION COILS" target="MREYE" />
    <edge source="MEDICAL DEVICE MANUFACTURER" target="NON-PROFIT DATA INSTITUTE" />
    <edge source="EVIDENCE REVIEWS" target="STUDY SCREENING" />
    <edge source="MID-NET&#174;" target="SINGLE REGRESSION IMPUTATION" />
    <edge source="MID-NET&#174;" target="INVERSE PROBABILITY WEIGHTED METHOD" />
    <edge source="MID-NET&#174;" target="PROPENSITY SCORE WEIGHTING" />
    <edge source="MID-NET&#174;" target="REGRESSION ADJUSTMENT" />
    <edge source="SINGLE REGRESSION IMPUTATION" target="SCENARIO 1" />
    <edge source="SINGLE REGRESSION IMPUTATION" target="SCENARIO 2" />
    <edge source="INVERSE PROBABILITY WEIGHTED METHOD" target="SCENARIO 1" />
    <edge source="INVERSE PROBABILITY WEIGHTED METHOD" target="SCENARIO 2" />
    <edge source="ACUTE SINUSITIS" target="AMOXICILLIN-CLAVULANATE" />
    <edge source="ACUTE SINUSITIS" target="AMOXICILLIN" />
    <edge source="ACUTE SINUSITIS" target="ADOLESCENTS" />
    <edge source="AMOXICILLIN-CLAVULANATE" target="AMOXICILLIN" />
    <edge source="ADOLESCENTS" target="CLINICAL DECISION SUPPORT SYSTEM FOR YOUTH DEPRESSION (CDSS-YD)" />
    <edge source="ADOLESCENTS" target="BEHAVIORAL HEALTH PROVIDERS" />
    <edge source="MOBILE-BASED SELF-CARE APPLICATION" target="PATIENTS WITH DEPRESSION AND ANXIETY" />
    <edge source="AUTONOMY PREFERENCE INDEX" target="API-URO" />
    <edge source="API-URO" target="UROLOGICAL CANCER TREATMENTS" />
    <edge source="UROLOGICAL CANCER TREATMENTS" target="BLADDER CANCER PATIENTS" />
    <edge source="POPULATION HEALTH INTERVENTION RESEARCH" target="SIMULATION STUDIES" />
    <edge source="DIABETIC KIDNEY DISEASE" target="TYPE-2 DIABETES" />
    <edge source="DIABETIC KIDNEY DISEASE" target="XIANGYANG CENTRAL HOSPITAL" />
    <edge source="NATURAL-HISTORY MODELING" target="PERSONALIZED SCREENING RECOMMENDATIONS" />
    <edge source="NATURAL-HISTORY MODELING" target="CANCER EPIDEMIOLOGY" />
    <edge source="OMICS DATA" target="FINNISH PARTICIPANTS" />
    <edge source="NULLIPAROUS PREGNANCY OUTCOMES STUDY: MONITORING MOTHERS-TO-BE" target="US MEDICAL CENTERS" />
    <edge source="PREGNANCY OUTCOMES" target="PLACENTAL FUNCTION" />
    <edge source="PLACENTAL FUNCTION" target="CANNABIS EXPOSURE" />
    <edge source="CANNABIS EXPOSURE" target="FIRST TRIMESTER" />
    <edge source="CANNABIS EXPOSURE" target="ONGOING EXPOSURE" />
    <edge source="VALUE-OF-INFORMATION (VOI) APPROACH" target="REFERENCE STANDARD RETROSPECTIVE VOI ANALYSIS" />
    <edge source="CUMULATIVE META-ANALYSIS" target="REFERENCE STANDARD RETROSPECTIVE VOI ANALYSIS" />
    <edge source="AIRWAY MUCUS PLUGS" target="CHEST CT SCANS" />
    <edge source="MEDICATION ADMINISTRATION CLINICAL DECISION SUPPORT SYSTEMS" target="FAST HEALTHCARE INTEROPERABILITY RESOURCES" />
    <edge source="MEDICATION ADMINISTRATION CLINICAL DECISION SUPPORT SYSTEMS" target="PROQUEST" />
    <edge source="PROQUEST" target="TELEMEDICINE TECHNOLOGY" />
    <edge source="BMC MED INFORM DECIS MAK" target="CORRECTION" />
    <edge source="CORRECTION" target="PHAM ET AL." />
    <edge source="CORRECTION" target="BMC MEDICAL INFORMATICS AND DECISION MAKING" />
    <edge source="PRINCIPAL COMPONENT ANALYSIS (PCA)" target="MULTIPLE CO-INERTIA ANALYSIS (MCIA)" />
    <edge source="PRINCIPAL COMPONENT ANALYSIS (PCA)" target="DIMENSION REDUCTION" />
    <edge source="MULTIPLE CO-INERTIA ANALYSIS (MCIA)" target="T-DISTRIBUTED STOCHASTIC NEIGHBOR EMBEDDING (T-SNE)" />
    <edge source="MULTIPLE CO-INERTIA ANALYSIS (MCIA)" target="BAGPLOTS" />
    <edge source="MULTIPLE CO-INERTIA ANALYSIS (MCIA)" target="COMPUTED TOMOGRAPHY SCANS" />
    <edge source="MULTIPLE CO-INERTIA ANALYSIS (MCIA)" target="DIMENSION REDUCTION" />
    <edge source="DIMENSION REDUCTION" target="T-DISTRIBUTED STOCHASTIC NEIGHBOR EMBEDDING (T-SNE)" />
    <edge source="HIPPOCAMPAL AVOIDANCE" target="HIPPOCAMPUS" />
    <edge source="HIPPOCAMPAL AVOIDANCE" target="MEDULLOBLASTOMA" />
    <edge source="HIPPOCAMPAL AVOIDANCE" target="VMAT" />
    <edge source="HIPPOCAMPAL AVOIDANCE" target="IMPT" />
    <edge source="VMAT" target="IMPT" />
    <edge source="RESOLSTM-DEPTH" target="EXPERIENCED RADIOLOGIST" />
    <edge source="MEDICAL LIBRARY ASSOCIATION" target="GROUP 6" />
    <edge source="GROUP 6" target="TECH MINING" />
    <edge source="CDSS" target="REDCAP" />
    <edge source="CDSS" target="STATA SE 15.1" />
    <edge source="CDSS" target="EXCEL" />
    <edge source="CDSS" target="NEPHROLOGISTS" />
    <edge source="CDSS" target="CKD PROGRESSION PREDICTION" />
    <edge source="CDSS" target="IN-SILICO SIMULATIONS" />
    <edge source="CDSS" target="VANCOMYCIN DOSING STUDY" />
    <edge source="LANCET COMMISSION ON GLOBAL SURGERY" target="GLOBAL CANCER SURGERY" />
    <edge source="GLOBAL CANCER SURGERY" target="CORONAVIRUS DISEASE 2019 PANDEMIC" />
    <edge source="GLOBAL CANCER SURGERY" target="SWOT ANALYSIS" />
    <edge source="COULOMB'S LAW" target="ATOM" />
    <edge source="ATOM" target="NUCLEUS" />
    <edge source="ATOM" target="ELECTRON" />
    <edge source="NUCLEUS" target="ELECTRON" />
    <edge source="ADLIFE" target="SHARE APPROACH" />
    <edge source="ADLIFE" target="QUIS7 QUESTIONNAIRE" />
    <edge source="ADLIFE" target="SPAIN" />
    <edge source="ADLIFE" target="PATIENT EMPOWERMENT PROCESS" />
    <edge source="ADLIFE" target="PROMS" />
    <edge source="ADLIFE" target="CLINICAL PILOT STUDIES" />
    <edge source="GASTRIC STROMAL TUMORS" target="GANSU PROVINCE" />
    <edge source="GASTRIC STROMAL TUMORS" target="BIO-MED CENTRAL LTD." />
    <edge source="SIMCRC" target="ARTIFICIAL NEURAL NETWORKS (ANNS)" />
    <edge source="MISCAN-COLON" target="ARTIFICIAL NEURAL NETWORKS (ANNS)" />
    <edge source="MISCAN-COLON" target="NATIONAL CAMPAIGN" />
    <edge source="CRC-SPIN" target="ARTIFICIAL NEURAL NETWORKS (ANNS)" />
    <edge source="BIGRU" target="MANHATTAN DISTANCE" />
    <edge source="BIGRU" target="ATTENTION MECHANISM" />
    <edge source="BIGRU" target="ETHNIC MEDICINE" />
    <edge source="BIGRU" target="SIAMESE NETWORK" />
    <edge source="CHECKMATE-017" target="FLEXIBLE PARAMETRIC MODELS" />
    <edge source="CHECKMATE-017" target="MIXTURE CURE MODELS" />
    <edge source="FLEXIBLE PARAMETRIC MODELS" target="CHECKMATE-057" />
    <edge source="CHECKMATE-057" target="BAYESIAN MULTIPARAMETER EVIDENCE SYNTHESIS" />
    <edge source="PROTON RADIOTHERAPY" target="LEPTOMENINGEAL METASTASES" />
    <edge source="DELPHI PANELS" target="RAND/UCLA" />
    <edge source="OPIOID MANAGEMENT STRATEGIES" target="CANCER-RELATED PAIN" />
    <edge source="OPIOID MANAGEMENT STRATEGIES" target="BUCCAL/NALOXONE TRANSITION" />
    <edge source="CARDIOVASCULAR OUTCOMES" target="CORONARY REVASCULARIZATION" />
    <edge source="CARDIOVASCULAR OUTCOMES" target="CARDIOVASCULAR DEATH" />
    <edge source="BASKET TRIALS" target="CANCER THERAPY" />
    <edge source="BASKET TRIALS" target="NTRK FUSIONS" />
    <edge source="BASKET TRIALS" target="BRAF MUTATIONS" />
    <edge source="BASKET TRIALS" target="RET ALTERATIONS" />
    <edge source="BASKET TRIALS" target="FGFR1 ALTERATIONS" />
    <edge source="AFRICAN AMERICAN CANCER SURVIVORS" target="DISCRIMINATION" />
    <edge source="AFRICAN AMERICAN CANCER SURVIVORS" target="DEFICIT ACCUMULATION INDEX" />
    <edge source="DISCRIMINATION" target="DEFICIT ACCUMULATION INDEX" />
    <edge source="SPIROMICS I" target="SPIROMICS II" />
    <edge source="SPIROMICS I" target="TEPS" />
    <edge source="SPIROMICS I" target="SYMPTOMATIC TEPS" />
    <edge source="SPIROMICS I" target="ASYMPTOMATIC TEPS" />
    <edge source="SPIROMICS II" target="TEPS" />
    <edge source="SPIROMICS II" target="SYMPTOMATIC TEPS" />
    <edge source="SPIROMICS II" target="ASYMPTOMATIC TEPS" />
    <edge source="BAYESIAN MODELS" target="SPATIAL CORRELATION" />
    <edge source="BAYESIAN MODELS" target="PREDICTIVE PRECISION" />
    <edge source="CALE MODEL" target="PREDICTIVE PRECISION" />
    <edge source="PREDICTIVE PRECISION" target="ROOT MEAN SQUARED ERROR (RMSE)" />
    <edge source="GENERALIZED LINEAR MODEL" target="H2O AUTOML" />
    <edge source="HEALTH INFORMATION TECHNOLOGIES" target="BARRIERS AND FACILITATORS REVIEW" />
    <edge source="HEALTH INFORMATION TECHNOLOGIES" target="MANAGERS OF ORGANIZATIONS" />
    <edge source="HEALTH INFORMATION TECHNOLOGIES" target="DESIGNERS OF HEALTH SYSTEMS" />
    <edge source="BARRIERS AND FACILITATORS REVIEW" target="WEB OF SCIENCES" />
    <edge source="SOCIETY OF THORACIC SURGEONS" target="AMERICAN COLLEGE OF CARDIOLOGY" />
    <edge source="SOCIETY OF THORACIC SURGEONS" target="TRANS-CATHETER VALVE THERAPIES REGISTRY" />
    <edge source="AMERICAN COLLEGE OF CARDIOLOGY" target="TRANS-CATHETER VALVE THERAPIES REGISTRY" />
    <edge source="MITRACLIP" target="ABBOTT" />
    <edge source="MITRACLIP" target="DEGENERATIVE MITRAL REGURGITATION" />
    <edge source="DEGENERATIVE MITRAL REGURGITATION" target="TRANS-CATHETER MITRAL VALVE REPAIR" />
    <edge source="MR SUCCESS" target="TRANS-CATHETER MITRAL VALVE REPAIR" />
    <edge source="PANDORA'S BLACK BOX" target="LITERATURE" />
    <edge source="LITERATURE" target="CONTROVERSIES" />
    <edge source="CONTROVERSIES" target="RHETORIC" />
    <edge source="LABORATORIES" target="CENTRES OF CALCULATION" />
    <edge source="CENTRES OF CALCULATION" target="TRIBUNALS OF REASON" />
    <edge source="STRONGHOLDS" target="NETWORKS" />
    <edge source="PEDIATRIC CANCER CENTERS" target="CHILDREN WITH LEUKEMIA OR LYMPHOMA" />
    <edge source="PEDIATRIC CANCER CENTERS" target="MEDICATION ERRORS" />
    <edge source="CHILDREN WITH LEUKEMIA OR LYMPHOMA" target="OUTPATIENT MEDICATION ERRORS" />
    <edge source="CHILDREN WITH LEUKEMIA OR LYMPHOMA" target="HARM" />
    <edge source="MEDICATION ERRORS" target="HARM" />
    <edge source="PHYSICIAN REVIEWERS" target="OUTPATIENT MEDICATION ERRORS" />
    <edge source="PHYSICIAN REVIEWERS" target="IMPROVED COMMUNICATION" />
    <edge source="IMPROVED COMMUNICATION" target="HARM" />
    <edge source="INTERLEUKIN-6 (IL-6)" target="NEUROCOGNITION STUDY" />
    <edge source="SURVINT" target="PHASE III CLINICAL TRIALS" />
    <edge source="TRANSLATOR" target="OBJECTIVISM" />
    <edge source="STRUCTURES" target="HABITUS" />
    <edge source="HABITUS" target="SYMBOLIC POWER" />
    <edge source="PROOF OF PRINCIPLE STUDY" target="FAIR DATA PRINCIPLES" />
    <edge source="PROOF OF PRINCIPLE STUDY" target="PERSONAL HEALTH TRAIN (PHT)" />
    <edge source="EPRESCRIBING SYSTEMS" target="STAKEHOLDERS" />
    <edge source="EPRESCRIBING SYSTEMS" target="DIGITALLY ADVANCED HOSPITAL SITES" />
    <edge source="EPRESCRIBING SYSTEMS" target="ELECTRONIC HEALTH RECORD ENTERPRISE SYSTEMS" />
    <edge source="TCGA DATABASE" target="MIRNA" />
    <edge source="TCGA DATABASE" target="METHYLATION" />
    <edge source="TCGA DATABASE" target="DNASEQ" />
    <edge source="TCGA DATABASE" target="COPY NUMBER VARIATION" />
    <edge source="HARRELL'S C-INDEX" target="INTEGRATED BRIER SCORE" />
    <edge source="IRAN ELECTRONIC HEALTH RECORD SYSTEM (SEPAS)" target="DELONE AND MCLEAN MODEL" />
    <edge source="IRAN ELECTRONIC HEALTH RECORD SYSTEM (SEPAS)" target="HEALTH INFORMATION MANAGEMENT PERSONNEL" />
    <edge source="IRAN ELECTRONIC HEALTH RECORD SYSTEM (SEPAS)" target="SYSTEM QUALITY" />
    <edge source="IRAN ELECTRONIC HEALTH RECORD SYSTEM (SEPAS)" target="SEPAS BENEFITS" />
    <edge source="COCHRANE COLLABORATION" target="PRISMA STATEMENT" />
    <edge source="COCHRANE COLLABORATION" target="BEHAVIOURAL CHANGE MODELS" />
    <edge source="PRISMA STATEMENT" target="BEHAVIOURAL CHANGE MODELS" />
    <edge source="BEHAVIOURAL CHANGE MODELS" target="INFECTIOUS DISEASE TRANSMISSION" />
    <edge source="PHAM ET AL." target="BMC MEDICAL INFORMATICS AND DECISION MAKING" />
    <edge source="CHRONIC CONDITIONS" target="DEMENTIA ONSET" />
    <edge source="NUTRITION CARE" target="BLOOD PRESSURE CONTROL" />
    <edge source="NUTRITION CARE" target="LONGITUDINAL TARGETED MAXIMUM LIKELIHOOD ESTIMATION" />
    <edge source="BLOOD PRESSURE CONTROL" target="PREVENTIVE CARE VISITS" />
    <edge source="BLOOD PRESSURE CONTROL" target="PATIENT EDUCATION MATERIALS" />
    <edge source="INFECTION CONTROL" target="BIG DATA ANALYTICS" />
    <edge source="INTERNATIONAL LOW GRADE GLIOMA REGISTRY" target="LOWER GRADE GLIOMA" />
    <edge source="MENINGIOMA CONSORTIUM" target="CONNECTICUT" />
    <edge source="MENINGIOMA CONSORTIUM" target="MASSACHUSETTS" />
    <edge source="MENINGIOMA CONSORTIUM" target="MENINGIOMA" />
    <edge source="SEISMOCARDIOGRAPHY" target="ADAPTIVE BIDIRECTIONAL FILTERING" />
    <edge source="SEISMOCARDIOGRAPHY" target="WEARABLE SENSORS" />
    <edge source="ADAPTIVE BIDIRECTIONAL FILTERING" target="REDUNDANT MULTI-SCALE WAVELET DECOMPOSITION" />
    <edge source="ADAPTIVE BIDIRECTIONAL FILTERING" target="TIME-FREQUENCY MASKING" />
    <edge source="ADAPTIVE BIDIRECTIONAL FILTERING" target="NON-NEGATIVE MATRIX DECOMPOSITION" />
    <edge source="ADAPTIVE BIDIRECTIONAL FILTERING" target="ECG" />
    <edge source="ECG" target="TRANSFORMER ALGORITHM" />
    <edge source="CCT" target="STROKE SURVIVORS" />
    <edge source="STROKE SURVIVORS" target="MOBILE APPLICATIONS" />
    <edge source="STROKE SURVIVORS" target="HUILE" />
    <edge source="STROKE SURVIVORS" target="EQ5DLE" />
    <edge source="STROKE SURVIVORS" target="PROMIS" />
    <edge source="STROKE SURVIVORS" target="PROPR" />
    <edge source="STROKE SURVIVORS" target="MODIFIED RANKIN SCALE" />
    <edge source="STROKE SURVIVORS" target="OUTPATIENT CLINIC" />
    <edge source="STROKE SURVIVORS" target="ISCHEMIC STROKE" />
    <edge source="STROKE SURVIVORS" target="SUBARACHNOID HEMORRHAGE" />
    <edge source="MOBILE APPLICATIONS" target="TRUNK CONTROL ABILITY" />
    <edge source="MOBILE APPLICATIONS" target="FUGL-MEYER ASSESSMENT" />
    <edge source="MOBILE APPLICATIONS" target="LOW-DENSITY LIPOPROTEIN CHOLESTEROL" />
    <edge source="MOBILE APPLICATIONS" target="GLYCOSYLATED HAEMOGLOBIN A1C" />
    <edge source="MELANOMA PATHOLOGY STUDY" target="PATHOLOGISTS" />
    <edge source="PATHOLOGISTS" target="BREAST PATHOLOGY STUDY" />
    <edge source="PATHOLOGISTS" target="METACOGNITIVE SENSITIVITY" />
    <edge source="PATHOLOGISTS" target="METACOGNITION" />
    <edge source="METACOGNITIVE SENSITIVITY" target="SECONDARY DIAGNOSTIC ACTION" />
    <edge source="INTEGRATIVE SYSTEMS BIOLOGY" target="BIMODAL RESEARCHER" />
    <edge source="INTEGRATIVE SYSTEMS BIOLOGY" target="UNIMODAL MODELING STRATEGY" />
    <edge source="BIMODAL RESEARCHER" target="SYSTEMS BIOLOGY RESEARCH LABS" />
    <edge source="MAYO CLINIC STUDY OF AGING" target="MCI DIAGNOSIS" />
    <edge source="MAYO CLINIC STUDY OF AGING" target="DEMENTIA ONSET" />
    <edge source="MAYO CLINIC STUDY OF AGING" target="SEX-SPECIFIC IMPACT" />
    <edge source="MCI DIAGNOSIS" target="DEMENTIA ONSET" />
    <edge source="DEMENTIA ONSET" target="NEUROPSYCHIATRIC SYMPTOMS" />
    <edge source="DEMENTIA ONSET" target="SEX-SPECIFIC IMPACT" />
    <edge source="EPPI-REVIEWER" target="SYSTEMATIC REVIEW TOOLBOX" />
    <edge source="EPPI-REVIEWER" target="LIVING REVIEWS" />
    <edge source="COMPUTATIONAL TEXT PHENOTYPING" target="RARE DISEASES" />
    <edge source="RARE DISEASES" target="NLP" />
    <edge source="NLP" target="ICD CODES" />
    <edge source="VICTORIA" target="GENERAL PRACTICES" />
    <edge source="DIAGNOSIS UNDERREPORTING STUDY" target="AGENCIES" />
    <edge source="DIAGNOSIS UNDERREPORTING STUDY" target="CHRONIC DISEASES" />
    <edge source="DIAGNOSIS UNDERREPORTING STUDY" target="CLINICAL DECISION SUPPORT" />
    <edge source="RESOURCE ALLOCATION" target="POPULATION HEALTHCARE PLANNING" />
    <edge source="HEALTH ECONOMIC MODELERS" target="COMPLEX SYSTEMS MODELS" />
    <edge source="COMPLEX SYSTEMS MODELS" target="WORKING GROUP" />
    <edge source="MACHINE LEARNING IN MENTAL HEALTH RESEARCH" target="OCTOBER 2022 TO MARCH 2024" />
    <edge source="MACHINE LEARNING IN MENTAL HEALTH RESEARCH" target="IMMIGRANTS, REFUGEES, MIGRANTS, AND RACIAL AND ETHNIC MINORITIES" />
    <edge source="SWEDISH CANCER REGISTRY" target="PARAMETRIC MODELS" />
    <edge source="SWEDISH CANCER REGISTRY" target="SPLINE MODELS" />
    <edge source="PARAMETRIC MODELS" target="SPLINE MODELS" />
    <edge source="RELATIVE SURVIVAL FRAMEWORK" target="ALL-CAUSE SURVIVAL FRAMEWORK" />
    <edge source="ETHICAL CONCERNS" target="AI TOOL" />
    <edge source="CANADIAN-LED INTERNATIONAL STUDY" target="TERTIARY CARE CENTERS" />
    <edge source="CANADIAN-LED INTERNATIONAL STUDY" target="POSTOPERATIVE RADIATION THERAPY" />
    <edge source="CANADIAN-LED INTERNATIONAL STUDY" target="SALIVARY GLAND CANCER" />
    <edge source="CANADIAN-LED INTERNATIONAL STUDY" target="ACINIC CELL CARCINOMA" />
    <edge source="CANADIAN-LED INTERNATIONAL STUDY" target="MUCOEPIDERMOID CARCINOMA" />
    <edge source="POSTOPERATIVE RADIATION THERAPY" target="PAROTID GLAND" />
    <edge source="POSTOPERATIVE RADIATION THERAPY" target="SUBMANDIBULAR GLAND" />
    <edge source="KIDNEY CANCER STUDY" target="WWAS PLATFORM" />
    <edge source="KIDNEY CANCER STUDY" target="GROUNDWATER" />
    <edge source="KIDNEY CANCER STUDY" target="CHLORDANE" />
    <edge source="KIDNEY CANCER STUDY" target="DIELDRIN" />
    <edge source="KIDNEY CANCER STUDY" target="1,2-DICHLOROPROPANE" />
    <edge source="KIDNEY CANCER STUDY" target="2,4,5-TP" />
    <edge source="KIDNEY CANCER STUDY" target="GLYPHOSATE" />
    <edge source="KIDNEY CANCER STUDY" target="ENDOTHALL" />
    <edge source="KIDNEY CANCER STUDY" target="CARBARYL" />
    <edge source="KIDNEY CANCER STUDY" target="BROMIDE" />
    <edge source="NEWTONIAN PHYSICS" target="EINSTEIN" />
    <edge source="MAMMOGRAPHY COMPLETION" target="PROVIDER-INITIATED REFERRAL" />
    <edge source="PARTICLE PHYSICS" target="LABORATORY" />
    <edge source="PARTICLE PHYSICS" target="PHYSICISTS" />
    <edge source="LABORATORY" target="HEP EXPERIMENTS" />
    <edge source="LABORATORY" target="KNOWLEDGE SOCIETIES" />
    <edge source="JIMMA HEALTH CENTER" target="MATERNAL AND CHILD HEALTH SERVICE UNIT" />
    <edge source="JIMMA HEALTH CENTER" target="LOW-RESOURCE SETTING (LRS)" />
    <edge source="US DEPARTMENT OF DEFENSE" target="AUTOMATED CENTRAL TUMOR REGISTRY" />
    <edge source="AUTOMATED CENTRAL TUMOR REGISTRY" target="US MILITARY" />
    <edge source="US MILITARY" target="GENERAL US POPULATION" />
    <edge source="US MILITARY" target="CANCER OCCURRENCE STUDY" />
    <edge source="US MILITARY" target="TESTICULAR CANCER" />
    <edge source="GENERAL US POPULATION" target="CANCER OCCURRENCE STUDY" />
    <edge source="WOMEN'S HEALTH ACCELEROMETRY COLLABORATION" target="WOMEN'S HEALTH STUDY" />
    <edge source="WOMEN'S HEALTH ACCELEROMETRY COLLABORATION" target="WOMEN'S HEALTH INITIATIVE OBJECTIVE PHYSICAL ACTIVITY AND CARDIOVASCULAR HEALTH STUDY" />
    <edge source="WOMEN'S HEALTH ACCELEROMETRY COLLABORATION" target="ACTIGRAPH GT3X+" />
    <edge source="BIOBANKS" target="COMPREHENSIVE BIOBANK INFORMATION MANAGEMENT SYSTEM" />
    <edge source="BIOBANKS" target="BIG HEALTH" />
    <edge source="BIOBANKS" target="BIG DATA" />
    <edge source="COMPREHENSIVE BIOBANK INFORMATION MANAGEMENT SYSTEM" target="PREGNANCY&#8211;BIRTH COHORT" />
    <edge source="COMPREHENSIVE BIOBANK INFORMATION MANAGEMENT SYSTEM" target="QUALITY BY DESIGN" />
    <edge source="AI TOOL" target="PEER REVIEW WORKFLOW" />
    <edge source="AI TOOL" target="CONFERENCES" />
    <edge source="PEER REVIEW WORKFLOW" target="SCIENTIFIC LITERATURE" />
    <edge source="PEER REVIEW WORKFLOW" target="AUTOMATED SCREENING TOOLS" />
    <edge source="AUTOMATED SCREENING TOOLS" target="PEER REVIEW SYSTEM" />
    <edge source="AUTOMATED SCREENING TOOLS" target="AUTHORS" />
    <edge source="NORTH AMERICAN PARTICIPANTS" target="STUDY 1A" />
    <edge source="STUDY 1A" target="NATURALNESS BIAS" />
    <edge source="CHINESE PARTICIPANTS" target="STUDY 1B" />
    <edge source="CHINESE PARTICIPANTS" target="NATURALNESS BIAS" />
    <edge source="AMERICAN PARTICIPANTS" target="NATURALNESS BIAS" />
    <edge source="NATURALNESS BIAS" target="CANADIAN PARTICIPANTS" />
    <edge source="NATURALNESS BIAS" target="STUDY 1B" />
    <edge source="NATURALNESS BIAS" target="MEDICAL CONTEXT" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="PACIFIC-ASIAN ASSOCIATION FOR AGENT-BASED APPROACH IN SOCIAL SYSTEMS SCIENCES" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="EUROPEAN SOCIAL SIMULATION ASSOCIATION" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="COMPUTATIONAL SOCIAL SCIENCE SOCIETY OF THE AMERICAS" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="SOCIAL SIMULATION" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="AGENT-BASED SOCIAL SIMULATION" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="ARTIFICIAL FINANCIAL MARKETS" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="MACROECONOMIC FORECASTING" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="SUPPLY CHAIN MANAGEMENT" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="BANK NETWORKS" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="SOCIAL NETWORKS" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="URBAN PLANNING" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="SOCIAL NORMS AND GROUP FORMATION" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="CROSS-CULTURAL STUDIES" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="POLITICAL PARTY COMPETITION" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="VOTING BEHAVIOR" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="COMPUTATIONAL DEMOGRAPHY" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="COMPUTATIONAL ANTHROPOLOGY" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="EVOLUTION OF LANGUAGES" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="PUBLIC HEALTH AND EPIDEMICS" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="AIDS" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="SECURITY AND TERRORISM" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="METHODOLOGICAL AND EPISTEMOLOGICAL ISSUES" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="EMPIRICAL-BASED AGENT-BASED MODELING" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="MODELING OF EXPERIMENTAL SOCIAL SCIENCE" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="GAMING SIMULATION" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="COGNITIVE AGENTS" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="PARTICIPATORY SIMULATION" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="THEORETICAL FOUNDATIONS OF SOCIAL SIMULATION" />
    <edge source="4TH WORLD CONGRESS ON SOCIAL SIMULATION" target="CATEGORICAL SOCIAL SCIENCE" />
    <edge source="PALLIATIVE CARE" target="GOALS-OF-CARE DISCUSSIONS" />
    <edge source="NEUROTOXICITY" target="LATINO CHILDREN" />
    <edge source="NEUROTOXICITY" target="SERUM CREATININE ELEVATION" />
    <edge source="LATINO CHILDREN" target="SERUM CREATININE ELEVATION" />
    <edge source="ITALIAN PATIENTS" target="DASATINIB" />
    <edge source="ITALIAN PATIENTS" target="NILOTINIB" />
    <edge source="ITALIAN PATIENTS" target="CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML)" />
    <edge source="ITALIAN PATIENTS" target="SECOND-GENERATION TKIS" />
    <edge source="ITALIAN PATIENTS" target="EUROPEAN LONG-TERM SURVIVAL RISK" />
    <edge source="ITALIAN PATIENTS" target="FRONTLINE TREATMENT" />
    <edge source="FRONTLINE TREATMENT" target="SECOND-GENERATION TKIS" />
    <edge source="CLOTCATCHER" target="EMORY UNIVERSITY HOSPITAL" />
    <edge source="CLOTCATCHER" target="GRADY MEMORIAL HOSPITAL" />
    <edge source="CLOTCATCHER" target="GOOGLE PEGASUS" />
    <edge source="HOUSE" target="MC-SEIRSV MODEL" />
    <edge source="MC-SEIRSV MODEL" target="KEELING" />
    <edge source="MC-SEIRSV MODEL" target="EPIDEMIC FORECASTS" />
    <edge source="MC-SEIRSV MODEL" target="NPI" />
    <edge source="MC-SEIRSV MODEL" target="VACCINE" />
    <edge source="MC-SEIRSV MODEL" target="HOUSEHOLD TRANSMISSION" />
    <edge source="MC-SEIRSV MODEL" target="COMMUNITY TRANSMISSION" />
    <edge source="EPIDEMIC FORECASTS" target="NPI" />
    <edge source="EPIDEMIC FORECASTS" target="VACCINE" />
    <edge source="HOUSEHOLD TRANSMISSION" target="EPIDEMIC PEAK" />
    <edge source="HOUSEHOLD TRANSMISSION" target="COMMUNITY TRANSMISSION" />
    <edge source="COMMUNITY TRANSMISSION" target="EPIDEMIC PEAK" />
    <edge source="ULCERATIVE COLITIS" target="NORTH AMERICA" />
    <edge source="ULCERATIVE COLITIS" target="COLECTOMY" />
    <edge source="ULCERATIVE COLITIS" target="PRIMARY SCLEROSING CHOLANGITIS" />
    <edge source="ULCERATIVE COLITIS" target="MONTREAL CLASSIFICATION" />
    <edge source="ULCERATIVE COLITIS" target="MAYO SCORE" />
    <edge source="ULCERATIVE COLITIS" target="5-AMINOSALICYLIC ACID" />
    <edge source="ULCERATIVE COLITIS" target="VEDOLIZUMAB" />
    <edge source="ULCERATIVE COLITIS" target="USTEKINUMAB" />
    <edge source="ULCERATIVE COLITIS" target="TOFACITINIB" />
    <edge source="ULCERATIVE COLITIS" target="OZANIMOD" />
    <edge source="STYLEGANV2-ADA" target="GAZI BRAINS 2020" />
    <edge source="STYLEGANV2-ADA" target="BRATS 2021" />
    <edge source="STYLEGANV2-ADA" target="BR35H" />
    <edge source="GAZI BRAINS 2020" target="BRAIN TUMOR CLASSIFICATION" />
    <edge source="BRATS 2021" target="BRAIN TUMOR CLASSIFICATION" />
    <edge source="BR35H" target="BRAIN TUMOR CLASSIFICATION" />
    <edge source="GERMAN BREAST CANCER STUDY GROUP" target="EXCESS HAZARD METHODS" />
    <edge source="GERMAN BREAST CANCER STUDY GROUP" target="PARAMETRIC SURVIVAL MODELS" />
    <edge source="GERMAN BREAST CANCER STUDY GROUP" target="RESTRICTED MEAN SURVIVAL TIME" />
    <edge source="EXCESS HAZARD METHODS" target="PARAMETRIC SURVIVAL MODELS" />
    <edge source="EXCESS HAZARD METHODS" target="GENERAL POPULATION MORTALITY DATA" />
    <edge source="PARAMETRIC SURVIVAL MODELS" target="COST-EFFECTIVENESS ANALYSES" />
    <edge source="ADVANCED CARE PLANNING (ACP)" target="OUTPATIENT ACP" />
    <edge source="ADVANCED CARE PLANNING (ACP)" target="HEALTHCARE DELIVERY" />
    <edge source="OUTPATIENT ACP" target="INPATIENT ACP" />
    <edge source="PAUL HUMPHREYS" target="EXTENDING OURSELVES" />
    <edge source="EXTENDING OURSELVES" target="COMPUTATIONAL METHODS" />
    <edge source="COMPUTATIONAL METHODS" target="MONTE CARLO METHODS" />
    <edge source="PSYCHOSIS-SPECTRUM DISORDER" target="BIPOLAR AFFECTIVE DISORDER" />
    <edge source="DIGITAL EXCLUSION" target="DIGITAL HEALTH LITERACY" />
    <edge source="ENBS" target="CANCER TECHNOLOGY APPRAISAL" />
    <edge source="PEMBROLIZUMAB PLUS AXITINIB" target="ADVANCED RENAL CELL CARCINOMA" />
    <edge source="CUSHING SYNDROME" target="CUSHING DISEASE" />
    <edge source="CUSHING SYNDROME" target="PITUITARY TUMOR" />
    <edge source="CUSHING SYNDROME" target="ADRENAL STEROIDOGENESIS INHIBITORS" />
    <edge source="CUSHING SYNDROME" target="GLUCOCORTICOID RECEPTOR BLOCKERS" />
    <edge source="CUSHING SYNDROME" target="BILATERAL ADRENALECTOMY" />
    <edge source="CUSHING SYNDROME" target="PROTEIN CATABOLISM" />
    <edge source="CUSHING SYNDROME" target="IMMUNOSUPPRESSION" />
    <edge source="CUSHING SYNDROME" target="WEIGHT GAIN" />
    <edge source="CUSHING SYNDROME" target="NEUROCOGNITIVE CHANGES" />
    <edge source="CUSHING SYNDROME" target="MOOD DISORDERS" />
    <edge source="MEXICAN AMERICANS" target="MULTIETHNIC COHORT STUDY" />
    <edge source="DECISION-ANALYTIC MODELS" target="GUIDELINES" />
    <edge source="DECISION-ANALYTIC MODELS" target="ECONOMIC EVALUATION METHODOLOGY" />
    <edge source="VACCINATION INTENTION" target="HEALTH WORKERS" />
    <edge source="VACCINATION INTENTION" target="TRUSTWORTHY PHYSICIAN" />
    <edge source="VACCINATION INTENTION" target="UNTRUSTWORTHY PHYSICIAN" />
    <edge source="VACCINATION INTENTION" target="POSITIVE FRAMING" />
    <edge source="VACCINATION INTENTION" target="NEGATIVE FRAMING" />
    <edge source="TRUSTWORTHY PHYSICIAN" target="POSITIVE FRAMING" />
    <edge source="UNTRUSTWORTHY PHYSICIAN" target="NEGATIVE FRAMING" />
    <edge source="KIDNEY TUMORS" target="2.5D MFFAU-NET" />
    <edge source="2.5D MFFAU-NET" target="KITS19" />
    <edge source="2.5D MFFAU-NET" target="KITS21" />
    <edge source="JAPAN ADJUVANT STUDY GROUP OF PANCREATIC CANCER 01" target="S-1" />
    <edge source="S-1" target="BOARD-CERTIFIED INSTITUTIONS" />
    <edge source="S-1" target="STANDARD-DURATION GROUP" />
    <edge source="S-1" target="LONGER DURATION GROUP" />
    <edge source="STANDARD-DURATION GROUP" target="LONGER DURATION GROUP" />
    <edge source="CERVICAL CANCER INCIDENCE" target="CERVICAL CANCER MORTALITY" />
    <edge source="PEER REVIEW SYSTEM" target="AUTHORS" />
    <edge source="PEER REVIEW SYSTEM" target="PREPRINTS" />
    <edge source="PSYCHOSOCIAL FACTORS AND CANCER INCIDENCE (PSY-CA) CONSORTIUM" target="COHORTS" />
    <edge source="MHAMFD" target="AHIN" />
    <edge source="PRINCESS MARGARET CANCER CENTER" target="HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)" />
    <edge source="HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)" target="SMOKING CESSATION" />
    <edge source="HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)" target="LONG-TERM ABSTINENCE" />
    <edge source="SMOKING CESSATION" target="FORMER SMOKERS" />
    <edge source="SMOKING CESSATION" target="CURRENT SMOKERS" />
    <edge source="LONG-TERM ABSTINENCE" target="FORMER SMOKERS" />
    <edge source="CURRENT SMOKERS" target="FORMER SMOKERS" />
    <edge source="CARDIOGRAPH" target="GENOMICS HUB" />
    <edge source="COST-EFFECTIVENESS STUDIES" target="PROPR" />
    <edge source="COST-EFFECTIVENESS STUDIES" target="HUI-3" />
    <edge source="HUILE" target="PROMIS-GH" />
    <edge source="PROMIS-GH" target="EQ5DLE" />
    <edge source="PROMIS-GH" target="PROMIS" />
    <edge source="PROMIS" target="PROPR" />
    <edge source="QUEST" target="CONNECT FOR CANCER PREVENTION STUDY" />
    <edge source="REGRET THEORY" target="HYBRID THEORY" />
    <edge source="REGRET THEORY" target="DUAL PROCESSING THEORY" />
    <edge source="HYBRID THEORY" target="DUAL PROCESSING THEORY" />
    <edge source="MEDICAL DECISION-MAKING" target="DECISION THRESHOLDS" />
    <edge source="MEDICAL DECISION-MAKING" target="SYSTEMATIC SCOPING REVIEW" />
    <edge source="DECISION THRESHOLDS" target="SYSTEMATIC SCOPING REVIEW" />
    <edge source="FORMAL CONSENSUS METHOD" target="GUIDELINE COMMITTEE" />
    <edge source="FORMAL CONSENSUS METHOD" target="HEALTHCARE COMMITTEE MEMBERS" />
    <edge source="GUIDELINE COMMITTEE" target="HEALTHCARE COMMITTEE MEMBERS" />
    <edge source="CENTRE FOR NEW ART AND MEDIA (ZKM)" target="KARLSRUHE" />
    <edge source="CENTRE FOR NEW ART AND MEDIA (ZKM)" target="ICONOCLASH" />
    <edge source="ICONOCLASH" target="ART &amp; LANGUAGE" />
    <edge source="ICONOCLASH" target="WILL BAUMEISTER" />
    <edge source="ICONOCLASH" target="CHRISTIAN BOLTANSKI" />
    <edge source="ICONOCLASH" target="DANIEL BUREN" />
    <edge source="ICONOCLASH" target="LUCAS CRANACH" />
    <edge source="ICONOCLASH" target="MAX DEAN" />
    <edge source="ICONOCLASH" target="MARCEL DUCHAMP" />
    <edge source="ICONOCLASH" target="ALBRECHT DURER" />
    <edge source="ICONOCLASH" target="LUCIO FONTANA" />
    <edge source="ICONOCLASH" target="FRANCISCO GOYA" />
    <edge source="ICONOCLASH" target="HANS HAACKE" />
    <edge source="ICONOCLASH" target="RICHARD HAMILTON" />
    <edge source="ICONOCLASH" target="YOUNG HAY" />
    <edge source="ICONOCLASH" target="ARATA ISOZAKI" />
    <edge source="ICONOCLASH" target="ASGER JORN" />
    <edge source="ICONOCLASH" target="MARTIN KIPPENBERGER" />
    <edge source="ICONOCLASH" target="IMI KNOEBEL" />
    <edge source="ICONOCLASH" target="KOMAR &amp; MELAMID" />
    <edge source="ICONOCLASH" target="JOSEPH KOSUTH" />
    <edge source="ICONOCLASH" target="GORDON MATTA-CLARK" />
    <edge source="ICONOCLASH" target="TRACEY MOFFA" />
    <edge source="ICONOCLASH" target="NAM JUNE PAIK" />
    <edge source="ICONOCLASH" target="SIGMAR POLKE" />
    <edge source="ICONOCLASH" target="STEPHEN PRINA" />
    <edge source="ICONOCLASH" target="MAN RAY" />
    <edge source="ICONOCLASH" target="SOPHIE RISTELHUEBER" />
    <edge source="ICONOCLASH" target="HIROSHI SUGIMOTO" />
    <edge source="INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS AND OUTCOMES RESEARCH" target="SOCIETY FOR MEDICAL DECISION MAKING" />
    <edge source="INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS AND OUTCOMES RESEARCH" target="CHECKLIST" />
    <edge source="SOCIETY FOR MEDICAL DECISION MAKING" target="CHECKLIST" />
    <edge source="CHECKLIST" target="HEALTHCARE-RELATED DISCRETE EVENT SIMULATION" />
    <edge source="ISPOR-SMDM TASK FORCE" target="DISCRETE EVENT SIMULATION STUDIES" />
    <edge source="DISCRETE EVENT SIMULATION STUDIES" target="HEALTH ECONOMIC EVALUATION" />
    <edge source="TNM-8-N" target="OSCC" />
    <edge source="NECROSIS (NEC)" target="TERATOMA (TER)" />
    <edge source="TERATOMA (TER)" target="ANTERIOR GRADIENT PROTEIN 2 HOMOLOG (AGR2)" />
    <edge source="TERATOMA (TER)" target="KERATIN, TYPE I CYTOSKELETAL 19 (KRT19)" />
    <edge source="ANTERIOR GRADIENT PROTEIN 2 HOMOLOG (AGR2)" target="IMMUNOHISTOCHEMISTRY (IHC)" />
    <edge source="KERATIN, TYPE I CYTOSKELETAL 19 (KRT19)" target="IMMUNOHISTOCHEMISTRY (IHC)" />
    <edge source="MESSENGER RNA (MRNA)" target="NANOSTRING PANEL" />
    <edge source="MESSENGER RNA (MRNA)" target="PROTEINS" />
    <edge source="PROTEINS" target="PROTEOMICS" />
    <edge source="VANCOMYCIN DOSING STUDY" target="CRITICAL CARE PHARMACISTS" />
    <edge source="BMT SURVIVOR STUDY" target="BEERS CRITERIA" />
    <edge source="BMT SURVIVOR STUDY" target="US TRANSPLANT CENTERS" />
    <edge source="BMT SURVIVOR STUDY" target="CHRONIC GRAFT VERSUS HOST DISEASE" />
    <edge source="CHRONIC GRAFT VERSUS HOST DISEASE" target="BLOOD OR MARROW TRANSPLANTATION" />
    <edge source="HEMATOLOGIC MALIGNANCIES" target="BLOOD OR MARROW TRANSPLANTATION" />
    <edge source="DASH-TOP" target="APPLIED CLINICAL RESEARCH IN HEALTH SCIENCES" />
    <edge source="DASH-TOP" target="STUDENTS" />
    <edge source="SYSTEMATIC REVIEW TOOLBOX" target="NESTEDKNOWLEDGE" />
    <edge source="SYSTEMATIC REVIEW TOOLBOX" target="SWIFT-ACTIVESCREENER" />
    <edge source="NESTEDKNOWLEDGE" target="LIVING REVIEWS" />
    <edge source="SWIFT-ACTIVESCREENER" target="LIVING REVIEWS" />
    <edge source="LIVING REVIEWS" target="LIVING RAPID REVIEWS" />
    <edge source="LIVING REVIEWS" target="EVIDENCE MAPS" />
    <edge source="RACISM" target="ADVERSE HEALTH OUTCOMES" />
    <edge source="ADVERSE HEALTH OUTCOMES" target="NON-HISPANIC WHITE SURVIVORS" />
    <edge source="ADVERSE HEALTH OUTCOMES" target="HISTORICALLY MARGINALIZED RACIAL/ETHNIC GROUPS" />
    <edge source="DATA MANAGEMENT SYSTEM FOR DIABETES CLINICAL TRIALS" target="DIABETES CLINICAL TRIALS" />
    <edge source="ARTIFICIAL INTELLIGENCE MODEL" target="OBSTETRIC CESAREAN SECTION" />
    <edge source="CANADIAN EQ-5D-5L VALUATION STUDY" target="CANADIAN GENERAL PUBLIC" />
    <edge source="CANADIAN EQ-5D-5L VALUATION STUDY" target="WOMEN WITH BREAST CANCER" />
    <edge source="INACTIVE-UNHEALTHY-DIET PROFILE" target="ACTIVE-SEDENTARY-UNHEALTHY-DIET PROFILE" />
    <edge source="WILLINGNESS-TO-PAY ESTIMATES" target="PREFERENCE STABILITY" />
    <edge source="WILLINGNESS-TO-PAY ESTIMATES" target="PAYMENT-CARD CONTINGENT VALUATION METHOD" />
    <edge source="GENERATIVE ARTIFICIAL INTELLIGENCE" target="ACADEMIC RESEARCH" />
    <edge source="GENERATIVE ARTIFICIAL INTELLIGENCE" target="SYSTEMATIC LITERATURE REVIEW" />
    <edge source="ACADEMIC RESEARCH" target="SYSTEMATIC LITERATURE REVIEW" />
    <edge source="REDS" target="INFORMATION CONFLICT" />
    <edge source="ADVANCED LOW-GRADE OVARIAN CARCINOMA" target="ANTIHORMONAL THERAPY" />
    <edge source="ANTIHORMONAL THERAPY" target="SIGNAL TRANSDUCTION PATHWAY" />
    <edge source="AUSTRALIAN LIVING EVIDENCE CONSORTIUM" target="NATIONAL INSTITUTE OF HEALTH AND CARE EXCELLENCE" />
    <edge source="AUSTRALIAN LIVING EVIDENCE CONSORTIUM" target="INFECTIOUS DISEASES SOCIETY OF AMERICA" />
    <edge source="AUSTRALIAN LIVING EVIDENCE CONSORTIUM" target="US GRADING OF RECOMMENDATIONS, ASSESSMENT, DEVELOPMENT AND EVALUATIONS NETWORK" />
    <edge source="NATIONAL INSTITUTE OF HEALTH AND CARE EXCELLENCE" target="INFECTIOUS DISEASES SOCIETY OF AMERICA" />
    <edge source="NATIONAL INSTITUTE OF HEALTH AND CARE EXCELLENCE" target="US GRADING OF RECOMMENDATIONS, ASSESSMENT, DEVELOPMENT AND EVALUATIONS NETWORK" />
    <edge source="INFECTIOUS DISEASES SOCIETY OF AMERICA" target="US GRADING OF RECOMMENDATIONS, ASSESSMENT, DEVELOPMENT AND EVALUATIONS NETWORK" />
    <edge source="SMS TEXT MESSAGE-BASED HEALTH EDUCATION" target="PARENTS OF CHILDREN LESS THAN 2 YEARS OF AGE" />
    <edge source="SMS TEXT MESSAGE-BASED HEALTH EDUCATION" target="NUTRITION EXPERTS" />
    <edge source="SMS TEXT MESSAGE-BASED HEALTH EDUCATION" target="EXPECTANT COUPLES" />
    <edge source="BLAST PHASE" target="RUX-MF STUDY" />
    <edge source="PHILADELPHIA CHROMOSOME (PH)-LIKE B-ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)" target="MULTIPLEX REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION" />
    <edge source="PHILADELPHIA CHROMOSOME (PH)-LIKE B-ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)" target="NCOUNTER NANOSTRING" />
    <edge source="PHILADELPHIA CHROMOSOME (PH)-LIKE B-ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)" target="FLUORESCENCE IN SITU HYBRIDIZATION" />
    <edge source="PHILADELPHIA CHROMOSOME (PH)-LIKE B-ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)" target="FLOW CYTOMETRY-MINIMAL RESIDUAL DISEASE (MRD) ASSAY" />
    <edge source="PHILADELPHIA CHROMOSOME (PH)-LIKE B-ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)" target="CRLF2, IGJ, CEACAM6, MUC4, SPATS2L, NRXN3" />
    <edge source="ECONOMIC SCIENCE" target="BOOK" />
    <edge source="BOOK" target="ECONOMISTS" />
    <edge source="BOOK" target="SCIENCE STUDIES SCHOLARS" />
    <edge source="H2O AUTOML" target="RAHMANI K" />
    <edge source="H2O AUTOML" target="MORGER A" />
    <edge source="H2O AUTOML" target="DILMEGANI C" />
    <edge source="H2O AUTOML" target="DEFAULT RANDOM FOREST" />
    <edge source="H2O AUTOML" target="STACKED ENSEMBLES" />
    <edge source="UK TERTIARY CARE HOSPITALS" target="NURSE-LED REMOTE POSTOPERATIVE MONITORING" />
    <edge source="UK TERTIARY CARE HOSPITALS" target="NCT05069103" />
    <edge source="DIGITAL HEALTH" target="REMOTE POSTOPERATIVE MONITORING" />
    <edge source="YOUNG ADULT SURVIVORS OF CHILDHOOD CANCER" target="LONELINESS" />
    <edge source="LONELINESS" target="SUICIDAL IDEATION" />
    <edge source="LONELINESS" target="HEAVY/RISKY ALCOHOL CONSUMPTION" />
    <edge source="LONELINESS" target="NEW-ONSET GRADE 2-4 CHRONIC CONDITIONS" />
    <edge source="CRC-AIM" target="UKFSST" />
    <edge source="CRC-AIM" target="DNN" />
    <edge source="CANCER REGISTRY DATABASE" target="NATIONAL HEALTH INSURANCE RESEARCH DATABASE" />
    <edge source="CANCER REGISTRY DATABASE" target="NATIONAL DEATH REGISTRY" />
    <edge source="CURATIVE CRC RESECTION" target="STAGE I-III DISEASE" />
    <edge source="AI DIFFERENTIAL DIAGNOSIS APPLICATION" target="TEXTCNN" />
    <edge source="AI DIFFERENTIAL DIAGNOSIS APPLICATION" target="DEBIASED TEXTCNN" />
    <edge source="CROHN'S DISEASE" target="INTESTINAL TUBERCULOSIS" />
    <edge source="TEXTCNN" target="DEBIASED TEXTCNN" />
    <edge source="LONG-TERM CANCER SURVIVORS" target="CANCER-FREE CONTROLS" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEM FOR YOUTH DEPRESSION (CDSS-YD)" target="BEHAVIORAL HEALTH PROVIDERS" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEM FOR YOUTH DEPRESSION (CDSS-YD)" target="MACHINE LEARNING BASED CLINICAL DECISION SUPPORT SYSTEMS (CDSSS)" />
    <edge source="CLINICAL DECISION SUPPORT SYSTEM FOR YOUTH DEPRESSION (CDSS-YD)" target="YOUTH DEPRESSION" />
    <edge source="EMERGENCY MEDICAL SERVICES" target="NEUROLOGISTS" />
    <edge source="EMERGENCY MEDICAL SERVICES" target="NATIONAL INSTITUTES OF HEALTH STROKE SCALE" />
    <edge source="EMERGENCY MEDICAL SERVICES" target="STROKE PATIENTS" />
    <edge source="NEUROLOGISTS" target="REGIONAL STROKE CENTER" />
    <edge source="NEUROLOGISTS" target="STROKE PATIENTS" />
    <edge source="NATIONAL INSTITUTES OF HEALTH STROKE SCALE" target="VIDEO CONSULTATION" />
    <edge source="VIDEO CONSULTATION" target="AMBULANCE TEAMS" />
    <edge source="AMBULANCE TEAMS" target="SIMULATED PATIENTS" />
    <edge source="MICHOICE" target="DECISION SUPPORT TOOLS" />
    <edge source="DECISION SUPPORT TOOLS" target="ADVANCED PRACTICE PROVIDERS" />
    <edge source="DECISION SUPPORT TOOLS" target="CHEMOPREVENTION" />
    <edge source="AH" target="CHEMOPREVENTION" />
    <edge source="CHEMOPREVENTION" target="LCIS" />
    <edge source="CHEMOPREVENTION" target="ADVANCED PRACTICE PROVIDERS" />
    <edge source="CHEMOPREVENTION" target="WOMEN WITH HIGH-RISK BREAST LESIONS" />
    <edge source="NATIONAL CAMPAIGN" target="SURVEY OF ENDOSCOPIC CAPACITY" />
    <edge source="HOSPITAL FOR TROPICAL DISEASES" target="HO CHI MINH CITY" />
    <edge source="HOSPITAL FOR TROPICAL DISEASES" target="VIETNAM" />
    <edge source="HOSPITAL FOR TROPICAL DISEASES" target="DENGUE" />
    <edge source="HOSPITAL FOR TROPICAL DISEASES" target="DIGITAL CLINICAL DECISION-SUPPORT SYSTEMS (CDSS)" />
    <edge source="HO CHI MINH CITY" target="VIETNAM" />
    <edge source="DENGUE" target="SEASONALITY" />
    <edge source="LEARNING HEALTH SYSTEM" target="INTERNET OF FAIR DATA &amp; SERVICES" />
    <edge source="LEARNING HEALTH SYSTEM" target="PERSONOMICS" />
    <edge source="GUIDELINE DEVELOPMENT" target="DISSEMINATION" />
    <edge source="DISSEMINATION" target="IMPLEMENTATION STRATEGIES" />
    <edge source="SABR-BRIDGE" target="SABR" />
    <edge source="SABR-BRIDGE" target="THORACIC ONCOLOGY TEAMS" />
    <edge source="SABR-BRIDGE" target="LUNG MALIGNANCY" />
    <edge source="TELEMEDICINE TECHNOLOGY" target="OVID" />
    <edge source="TELEMEDICINE TECHNOLOGY" target="IEEE XPLORE" />
    <edge source="TELEMEDICINE TECHNOLOGY" target="TELECONSULTATION" />
    <edge source="TELEMEDICINE TECHNOLOGY" target="TELEVISIT" />
    <edge source="TELEMEDICINE TECHNOLOGY" target="TELEREHABILITATION" />
  </graph>
</graphml>